data_2kl4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kl4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 118.781 -0.628 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 mmt -56.02 -41.38 74.82 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.56 -28.51 55.35 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.857 1.263 . . . . 0.0 113.945 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.62 -53.3 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -81.58 -28.66 33.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.68 1.592 . . . . 0.0 112.556 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.95 0.93 14.14 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.807 1.643 . . . . 0.0 112.087 -171.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.478 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 41.3 mt-10 -86.99 -35.44 18.81 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.012 1.325 . . . . 0.0 109.332 167.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.32 -41.09 25.47 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -175.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -51.4 -37.84 50.4 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.233 1.413 . . . . 0.0 112.376 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 12.0 mtmt -61.85 -46.07 91.06 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.049 0.939 . . . . 0.0 110.901 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.55 -9.05 73.2 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.095 1.331 . . . . 0.0 113.729 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.82 103.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 165.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.11 3.43 10.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.097 1.359 . . . . 0.0 112.811 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -116.6 73.83 6.02 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 128.873 2.869 . . . . 0.0 109.705 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.01 -28.05 19.74 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.231 3.287 . . . . 0.0 111.433 -168.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 26.0 m-20 -64.98 -15.84 62.7 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.726 0.81 . . . . 0.0 110.348 -171.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.406 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -133.39 5.0 3.73 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.254 1.422 . . . . 0.0 110.22 178.1 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -66.06 -55.64 15.58 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 120.864 -1.148 . . . . 0.0 109.069 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.66 -14.8 15.34 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.7 1.371 . . . . 0.0 114.7 -165.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -43.18 97.39 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.55 1.068 . . . . 0.0 110.869 169.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -57.68 -37.43 73.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.252 1.421 . . . . 0.0 111.377 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -81.4 -20.71 39.88 Favored 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 120.89 -1.132 . . . . 0.0 113.996 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.17 -47.99 79.84 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.0 mt -61.41 -47.72 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.463 1.105 . . . . 0.0 110.227 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.6 mt -56.56 -49.33 75.14 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.676 0.671 . . . . 0.0 111.061 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 p -68.93 -40.0 79.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.241 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -60.19 -47.75 84.63 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.134 1.774 . . . . 0.0 111.401 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.7 t -56.32 -50.14 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 119.076 0.853 . . . . 0.0 108.716 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.78 3.51 1.9 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.57 -54.01 2.39 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.048 1.339 . . . . 0.0 111.003 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -72.73 -32.9 66.03 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.867 1.212 . . . . 0.0 111.047 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.74 57.54 5.9 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 119.311 0.96 . . . . 0.0 110.877 -173.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -65.26 -11.19 28.94 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.05 2.5 . . . . 0.0 113.636 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -12.16 61.12 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.57 -0.706 . . . . 0.0 112.702 175.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 85.7 mt -80.04 156.69 27.0 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.413 1.006 . . . . 0.0 109.889 169.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -129.23 152.58 79.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.506 1.522 . . . . 0.0 109.708 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.25 159.17 53.98 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.605 2.87 . . . . 0.0 113.186 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -161.95 120.19 2.27 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.507 1.523 . . . . 0.0 109.601 171.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.31 109.28 15.67 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.436 1.095 . . . . 0.0 108.381 166.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -135.56 149.32 49.39 Favored 'General case' 0 C--O 1.218 -0.603 0 O-C-N 120.921 -1.112 . . . . 0.0 108.125 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.1 m95 55.52 16.68 1.94 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 64.59 15.34 9.61 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 128.553 2.741 . . . . 0.0 113.848 -167.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.3 p -116.37 161.36 31.93 Favored Pre-proline 0 N--CA 1.44 -0.975 0 C-N-CA 124.72 1.208 . . . . 0.0 109.152 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.62 116.94 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 125.269 3.979 . . . . 0.0 112.13 171.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.3 ptm -128.43 170.3 13.29 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.683 0.754 . . . . 0.0 108.985 161.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.03 165.0 27.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 169.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.7 120.76 13.71 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -171.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -71.95 99.73 2.3 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 167.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 49.02 42.01 20.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.258 1.023 . . . . 0.0 110.674 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.41 -21.09 40.33 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 116.971 -2.016 . . . . 0.0 117.062 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -171.25 0.91 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 122.055 2.928 . . . . 0.0 112.756 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -117.19 26.51 9.72 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.037 -1.039 . . . . 0.0 113.097 -171.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.0 -1.18 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.05 0.94 . . . . 0.0 112.965 -168.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 tt -155.9 142.61 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 119.263 -2.148 . . . . 0.0 112.025 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.55 149.92 21.18 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.527 1.537 . . . . 0.0 109.324 166.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -145.18 178.48 8.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.954 1.377 . . . . 0.0 110.501 170.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.2 153.83 10.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 168.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.3 p -69.13 138.83 54.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.768 -0.583 . . . . 0.0 109.431 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.38 174.36 5.94 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 169.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -71.37 -5.12 30.22 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.866 -1.146 . . . . 0.0 113.645 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.28 7.49 0.11 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.1 -178.61 6.71 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.027 1.331 . . . . 0.0 108.692 -173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.09 120.06 18.61 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.494 1.118 . . . . 0.0 108.521 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.34 108.77 21.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.911 1.684 . . . . 0.0 109.913 -160.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 99.2 t -129.46 140.28 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.911 1.232 . . . . 0.0 109.504 -162.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 27.8 t -171.26 144.91 1.76 Allowed Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.033 1.733 . . . . 0.0 109.734 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.2 -56.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.616 1.544 . . . . 0.0 111.344 171.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -148.03 -83.77 0.11 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -131.5 -46.38 0.98 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.129 1.372 . . . . 0.0 110.945 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.26 -35.18 52.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 118.839 0.745 . . . . 0.0 112.753 -166.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.9 -24.74 28.03 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.745 1.641 . . . . 0.0 113.169 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 mm -112.93 -3.49 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.776 1.63 . . . . 0.0 109.819 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 m -91.14 -72.59 0.57 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -85.75 -49.23 8.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.425 0.557 . . . . 0.0 109.541 -171.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -69.45 -13.19 62.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.94 -21.61 66.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.83 -44.96 60.79 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.923 0.783 . . . . 0.0 110.645 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.42 -43.21 88.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.664 0.786 . . . . 0.0 110.643 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.39 -41.46 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.963 0.801 . . . . 0.0 110.331 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.25 -55.55 31.88 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.293 0.497 . . . . 0.0 110.319 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.64 -13.12 61.29 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.107 0.963 . . . . 0.0 112.345 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.15 -26.43 60.31 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.679 0.672 . . . . 0.0 110.579 169.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.39 4.97 6.22 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.972 -0.905 . . . . 0.0 113.735 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -112.88 160.88 17.59 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.848 1.324 . . . . 0.0 110.907 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.2 m -91.74 173.03 8.08 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.049 0.939 . . . . 0.0 108.922 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.97 -166.19 1.75 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 166.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.2 p -118.96 -168.73 1.61 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 153.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -68.74 -27.64 66.11 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 120.469 -1.395 . . . . 0.0 112.242 166.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.46 -14.14 10.93 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-O 118.795 -1.003 . . . . 0.0 114.432 -163.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.8 pp -156.39 166.59 32.98 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.42 1.61 . . . . 0.0 110.393 170.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -103.62 164.98 11.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.416 0.553 . . . . 0.0 109.94 172.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 126.61 22.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -174.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.96 142.69 25.18 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 164.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.54 145.79 14.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.995 2.464 . . . . 0.0 108.896 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -56.42 -30.49 62.88 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -170.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -65.83 -26.64 67.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -115.91 162.19 26.9 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.546 0.738 . . . . 0.0 110.125 -164.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -79.98 148.07 19.32 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 CA-C-N 121.125 1.437 . . . . 0.0 113.605 -169.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.6 t -73.69 124.18 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 170.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -74.99 77.23 2.19 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.526 1.13 . . . . 0.0 110.562 169.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -53.13 -40.92 64.56 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 125.145 1.378 . . . . 0.0 111.32 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -57.89 -60.91 2.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.468 1.507 . . . . 0.0 110.984 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.96 -38.72 65.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.759 0.79 . . . . 0.0 110.888 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.269 0.3 OUTLIER -79.93 -27.93 39.78 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 117.198 -1.382 . . . . 0.0 113.171 -176.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -62.01 -42.67 99.4 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.304 1.411 . . . . 0.0 108.402 170.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.64 -52.59 63.31 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.093 0.557 . . . . 0.0 109.613 -174.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.0 ptp -69.51 -36.61 76.62 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.564 -1.207 . . . . 0.0 113.544 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.7 -46.72 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 120.6 1.546 . . . . 0.0 108.876 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.56 -40.11 90.43 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.543 0.611 . . . . 0.0 109.845 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -60.96 -50.08 74.83 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.394 0.543 . . . . 0.0 110.783 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -38.31 80.7 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.105 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.9 mt -60.3 -52.28 63.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.092 0.957 . . . . 0.0 110.676 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -70.28 -22.54 62.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.041 0.837 . . . . 0.0 111.721 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -83.02 -20.56 34.81 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.311 0.644 . . . . 0.0 111.311 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -96.89 20.05 11.71 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.855 1.662 . . . . 0.0 111.236 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.767 166.61 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 30.8 mmm -56.82 -27.04 59.39 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.97 -34.82 70.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 118.337 0.517 . . . . 0.0 111.437 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.59 -44.46 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -78.13 -14.51 59.45 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.46 1.104 . . . . 0.0 112.795 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -34.32 77.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.426 1.491 . . . . 0.0 111.426 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.32 -16.28 61.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.88 1.672 . . . . 0.0 112.848 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -102.26 -37.6 8.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.908 0.883 . . . . 0.0 110.042 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.54 -39.83 65.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.252 0.933 . . . . 0.0 110.571 171.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -58.68 -29.84 66.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.414 0.686 . . . . 0.0 112.034 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.49 -4.52 62.28 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.842 -0.977 . . . . 0.0 114.57 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.3 mm -57.08 132.54 21.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 119.298 1.549 . . . . 0.0 109.334 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.73 -49.33 75.47 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.816 1.646 . . . . 0.0 108.724 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -141.15 143.95 32.85 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.42 -22.66 24.67 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.454 2.77 . . . . 0.0 111.264 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -6.16 13.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.61 173.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -125.29 -9.16 6.99 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -64.42 -60.81 2.72 Favored 'General case' 0 CA--C 1.519 -0.228 0 O-C-N 121.184 -0.947 . . . . 0.0 110.441 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -45.86 -44.55 14.47 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.122 2.169 . . . . 0.0 111.292 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -57.82 -48.1 80.72 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.042 -0.411 . . . . 0.0 110.397 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.0 m -65.67 -45.22 83.73 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.04 1.336 . . . . 0.0 109.885 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.96 -41.27 61.96 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.796 1.239 . . . . 0.0 112.282 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -60.29 -52.68 64.24 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.377 0.535 . . . . 0.0 109.695 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -61.72 -41.49 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.437 1.095 . . . . 0.0 110.056 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.88 -57.1 13.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.303 0.501 . . . . 0.0 110.583 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -60.29 -37.08 79.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 117.833 -1.08 . . . . 0.0 109.808 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 67.1 t90 -59.31 -59.4 5.52 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.797 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.3 t -52.64 -46.8 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 120.224 1.374 . . . . 0.0 110.697 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.2 -29.86 69.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.048 0.539 . . . . 0.0 112.012 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.45 -61.14 2.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.994 0.918 . . . . 0.0 110.537 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -65.86 -32.05 73.35 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.427 1.491 . . . . 0.0 111.849 -169.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -127.33 63.75 59.46 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 118.664 0.665 . . . . 0.0 109.253 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.68 -8.56 23.91 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.585 2.857 . . . . 0.0 113.923 -163.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.29 -26.51 62.0 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.262 -0.899 . . . . 0.0 111.799 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.1 mt -65.81 149.76 49.65 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -130.97 150.02 75.39 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 127.025 2.13 . . . . 0.0 110.719 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.12 152.76 40.59 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.329 2.686 . . . . 0.0 113.191 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.35 126.56 6.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.465 1.906 . . . . 0.0 108.967 167.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.34 102.77 15.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 170.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -149.93 141.23 23.21 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.968 -1.083 . . . . 0.0 111.139 -167.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 16.3 m95 54.84 21.96 3.94 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.881 1.272 . . . . 0.0 111.927 -161.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 53.42 14.69 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.828 1.651 . . . . 0.0 112.807 -162.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.7 p -97.87 148.84 35.05 Favored Pre-proline 0 C--O 1.238 0.493 0 CA-C-N 119.703 1.138 . . . . 0.0 109.352 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.24 100.43 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.924 3.083 . . . . 0.0 110.939 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.3 ptm -118.88 164.93 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.413 0.685 . . . . 0.0 109.672 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.39 169.67 15.72 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 173.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.9 m -141.77 138.86 32.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.858 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -76.28 94.09 3.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.128 1.331 . . . . 0.0 108.388 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 51.48 15.17 0.31 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.646 1.578 . . . . 0.0 114.73 -170.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.79 -20.61 4.3 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 117.896 -1.502 . . . . 0.0 113.941 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -78.16 141.83 38.42 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 121.12 2.46 . . . . 0.0 111.309 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -66.62 29.56 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.039 2.936 . . . . 0.0 116.966 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.25 0.37 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 125.32 1.448 . . . . 0.0 113.17 -167.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 tt -160.6 145.39 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 121.793 2.088 . . . . 0.0 113.516 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.29 136.08 3.92 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 121.466 -0.771 . . . . 0.0 112.337 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -136.01 167.55 21.01 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.093 1.357 . . . . 0.0 110.58 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.8 p -159.24 160.76 35.7 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 54.9 p -75.76 113.99 13.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.05 171.71 13.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 164.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -63.75 -32.69 74.26 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.291 -0.881 . . . . 0.0 111.717 -175.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -137.1 10.57 3.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.371 1.468 . . . . 0.0 113.149 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -156.8 -177.35 6.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.065 1.346 . . . . 0.0 108.839 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tp -124.17 121.43 35.09 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.558 1.543 . . . . 0.0 107.684 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 133.59 36.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 116.238 -1.839 . . . . 0.0 109.417 170.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.8 t -140.37 149.41 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 120.128 1.331 . . . . 0.0 110.566 172.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 t -160.42 158.87 26.01 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.58 1.152 . . . . 0.0 108.959 157.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -79.67 -57.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.098 0 CA-C-N 120.711 1.29 . . . . 0.0 110.519 165.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -138.16 -88.44 0.24 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 164.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -147.34 -36.15 0.23 Allowed 'General case' 0 N--CA 1.474 0.725 0 O-C-N 121.341 -0.85 . . . . 0.0 111.836 -163.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -25.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 123.549 0.74 . . . . 0.0 110.394 165.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.57 -35.93 38.25 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.823 0.725 . . . . 0.0 111.545 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.1 mm -110.43 13.46 8.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.32 1.448 . . . . 0.0 110.841 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.6 m -129.51 -33.57 1.86 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 170.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -63.6 1.33 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -79.86 0.41 31.21 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.61 -31.42 64.28 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -72.07 -48.52 43.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.75 0.786 . . . . 0.0 109.778 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.2 -42.83 91.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.822 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.53 -48.52 85.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.082 0.953 . . . . 0.0 109.749 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -51.45 70.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.468 0.707 . . . . 0.0 109.706 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -64.82 -37.83 88.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.85 1.26 . . . . 0.0 111.642 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.04 -22.76 67.08 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.951 0.796 . . . . 0.0 111.693 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.12 9.49 10.58 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-O 118.525 -1.153 . . . . 0.0 114.104 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -113.07 95.93 5.66 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.484 1.642 . . . . 0.0 113.251 -162.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.62 105.58 0.06 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 129.251 3.02 . . . . 0.0 113.355 174.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.34 175.87 6.94 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.733 2.013 . . . . 0.0 112.802 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.1 p -94.67 -164.85 1.22 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.108 1.363 . . . . 0.0 107.618 156.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -76.63 -19.31 57.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 117.079 -1.439 . . . . 0.0 112.588 166.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.94 -7.84 4.9 Favored Glycine 0 N--CA 1.47 0.958 0 CA-C-N 120.388 1.449 . . . . 0.0 115.054 -162.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 pp -151.54 161.61 42.39 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 164.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -99.45 165.79 11.48 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 166.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.5 153.2 44.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 121.774 -0.579 . . . . 0.0 109.637 169.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.11 143.74 34.63 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -71.64 149.52 55.22 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.496 2.797 . . . . 0.0 110.409 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -57.86 -41.33 82.22 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -54.15 -44.04 71.1 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.024 0.93 . . . . 0.0 112.17 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.83 146.86 32.59 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -159.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.04 139.1 23.78 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.268 1.312 . . . . 0.0 112.052 -163.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -69.69 150.17 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.325 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -109.92 73.66 0.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.328 1.051 . . . . 0.0 111.873 -161.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -58.01 -24.16 57.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.709 0.804 . . . . 0.0 112.962 -171.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -68.09 -60.2 2.67 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.091 -1.006 . . . . 0.0 110.3 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.44 -45.14 62.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.229 1.412 . . . . 0.0 109.076 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -53.97 50.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.835 1.254 . . . . 0.0 111.553 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -68.6 -40.13 80.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 117.484 -1.246 . . . . 0.0 111.786 -172.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -45.62 -57.06 4.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.541 0.736 . . . . 0.0 110.249 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.4 ptp -72.47 -42.63 64.73 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 118.046 -0.978 . . . . 0.0 112.888 -170.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -42.65 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 120.074 1.306 . . . . 0.0 109.689 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -64.17 -39.92 95.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.967 -0.54 . . . . 0.0 109.923 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -62.22 -46.89 86.85 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.349 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -21.22 63.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.09 1.314 . . . . 0.0 112.261 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.99 -61.6 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.456 1.102 . . . . 0.0 108.49 167.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -75.67 -2.9 31.65 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -171.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.3 -20.14 65.58 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.829 -1.169 . . . . 0.0 110.82 164.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -105.29 5.88 32.34 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.194 1.398 . . . . 0.0 111.344 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 124.697 1.199 . . . . 0.0 108.148 178.457 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 119.049 -0.5 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -6.33 15.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -64.15 -57.49 9.4 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.5 -42.53 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.877 1.671 . . . . 0.0 110.086 -167.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -93.99 -0.48 55.51 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.577 -169.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.58 -39.98 81.86 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.61 0.764 . . . . 0.0 109.609 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -66.33 -20.58 66.13 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -81.56 -55.21 4.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.2 -38.86 77.57 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.751 -0.642 . . . . 0.0 111.893 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -58.1 -33.05 68.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.396 0.678 . . . . 0.0 110.737 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.1 -3.24 82.78 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.529 1.061 . . . . 0.0 112.493 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.6 mt -77.69 90.79 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 171.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -76.11 8.19 3.48 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.182 2.193 . . . . 0.0 113.224 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -116.13 69.3 3.7 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 129.67 3.188 . . . . 0.0 108.767 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.97 -17.16 54.99 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 125.109 3.872 . . . . 0.0 113.856 -167.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.19 -16.39 59.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.135 0.88 . . . . 0.0 111.553 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -131.96 8.73 4.46 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.794 0.725 . . . . 0.0 112.326 -171.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -77.11 -62.33 1.69 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.308 1.443 . . . . 0.0 109.612 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.31 -32.55 38.27 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.134 2.174 . . . . 0.0 112.282 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -47.38 -53.46 13.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.805 0.842 . . . . 0.0 110.14 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.0 m -65.02 -29.24 70.13 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.74 -0.6 . . . . 0.0 111.277 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -72.45 -28.18 62.78 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 120.855 -1.153 . . . . 0.0 111.875 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.21 -54.66 43.12 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.676 1.125 . . . . 0.0 108.526 168.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -49.72 -53.22 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.169 0.987 . . . . 0.0 110.007 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.0 mt -64.63 -50.03 68.72 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.915 -170.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -69.47 -28.0 65.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.136 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -61.69 -60.39 3.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 37.8 t -48.5 -45.57 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.05 0.841 . . . . 0.0 111.526 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.15 -13.03 5.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.4 -50.58 2.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.509 1.924 . . . . 0.0 111.483 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.9 -35.03 79.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.928 0.785 . . . . 0.0 110.832 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -128.81 74.53 80.73 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.66 -13.1 34.42 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.872 1.715 . . . . 0.0 110.81 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -86.22 33.2 0.61 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.442 2.297 . . . . 0.0 111.158 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.1 mt -122.02 134.49 54.8 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 120.686 -1.258 . . . . 0.0 109.189 156.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -104.89 149.47 37.57 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 124.621 1.168 . . . . 0.0 109.41 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.71 154.83 49.38 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.599 2.866 . . . . 0.0 112.169 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -162.84 114.18 1.51 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.607 1.163 . . . . 0.0 108.534 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.0 mtp -82.22 121.49 26.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 166.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -138.65 138.44 37.81 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.9 m95 48.84 34.42 5.31 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.532 1.133 . . . . 0.0 112.165 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.26 18.09 10.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.471 1.908 . . . . 0.0 111.19 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.5 p -118.63 149.53 46.47 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.434 1.494 . . . . 0.0 109.304 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.49 106.68 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.251 3.301 . . . . 0.0 110.925 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.2 ptm -114.59 175.85 5.3 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.236 -0.915 . . . . 0.0 110.309 168.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.04 156.12 47.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 170.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.63 122.43 27.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -72.09 95.5 1.64 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 57.21 -3.32 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.93 -24.16 0.25 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 127.492 2.472 . . . . 0.0 113.67 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.61 -164.94 0.78 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.856 1.828 . . . . 0.0 114.718 -167.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -131.95 25.44 4.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.58 1.952 . . . . 0.0 111.445 -170.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.7 mt -65.4 -3.54 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.574 1.95 . . . . 0.0 111.725 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 tt -155.94 163.77 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 119.448 -2.033 . . . . 0.0 109.647 169.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.75 132.72 1.55 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -138.91 169.46 17.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.668 1.734 . . . . 0.0 110.085 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.59 161.83 38.15 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 159.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.4 p -65.09 149.19 50.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 165.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 t -137.47 168.25 20.03 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -58.7 -30.08 67.14 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -153.227 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -136.36 13.49 3.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.378 1.071 . . . . 0.0 112.638 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -158.32 168.74 26.18 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.143 -0.973 . . . . 0.0 110.38 -166.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.2 tp -107.63 123.22 48.16 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.82 122.19 31.96 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.824 1.193 . . . . 0.0 108.524 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.0 t -135.32 137.43 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.256 1.022 . . . . 0.0 108.516 -174.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.4 p -163.05 165.26 15.01 Favored Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 127.108 2.163 . . . . 0.0 109.851 154.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.43 -56.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.139 1.226 . . . . 0.0 113.005 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -148.48 -83.2 0.11 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.56 1.073 . . . . 0.0 108.11 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -146.97 -27.97 0.39 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.804 1.241 . . . . 0.0 112.216 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.1 tp -63.7 -31.94 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 120.791 -1.193 . . . . 0.0 111.37 176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -48.47 -26.06 4.89 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 126.815 2.15 . . . . 0.0 113.324 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 mm -125.62 7.32 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.167 1.387 . . . . 0.0 109.944 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 t -84.8 -71.56 0.51 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 170.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -88.09 -50.8 6.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -170.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -67.89 -15.33 63.57 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.32 -30.33 38.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.449 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -69.37 -59.47 2.97 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 118.556 0.617 . . . . 0.0 109.94 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.47 -35.48 74.17 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.476 0.58 . . . . 0.0 112.456 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.82 -48.82 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.929 0.891 . . . . 0.0 109.576 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.22 -47.45 86.06 Favored 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 121.488 -0.758 . . . . 0.0 110.902 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -61.4 -16.22 44.48 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 128.253 2.621 . . . . 0.0 111.631 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.68 4.28 50.07 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 112.454 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.33 14.63 47.25 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.261 0.934 . . . . 0.0 114.719 169.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -112.78 90.64 3.4 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.863 1.332 . . . . 0.0 111.701 -168.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 m -53.28 98.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.225 2.61 . . . . 0.0 113.619 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.78 -172.95 4.46 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.78 1.632 . . . . 0.0 112.238 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.7 p -111.15 -164.77 0.94 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.468 1.907 . . . . 0.0 106.694 163.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -80.29 -22.59 41.44 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.939 -1.101 . . . . 0.0 112.93 161.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.16 -28.33 6.53 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.29 -1.284 . . . . 0.0 114.805 -168.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 pp -154.31 172.53 17.51 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.208 2.004 . . . . 0.0 110.226 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -114.57 166.36 11.8 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 120.824 -1.172 . . . . 0.0 109.006 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.78 133.22 20.75 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.95 143.44 26.14 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 168.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.08 157.88 60.0 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.189 1.926 . . . . 0.0 109.925 172.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -61.07 -25.04 66.66 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.33 -0.856 . . . . 0.0 112.006 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -57.88 -62.46 1.79 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.044 1.737 . . . . 0.0 111.696 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -91.57 165.43 20.92 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 125.995 1.718 . . . . 0.0 111.814 -163.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.33 149.25 85.08 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.367 2.045 . . . . 0.0 110.672 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 p -96.94 127.07 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.17 83.34 7.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.462 1.125 . . . . 0.0 111.156 -169.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -57.03 -35.85 69.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.285 1.434 . . . . 0.0 110.222 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -39.33 77.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.486 -0.759 . . . . 0.0 112.339 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -49.06 46.79 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 122.03 0.919 . . . . 0.0 108.641 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.296 0.3 OUTLIER -75.82 -24.08 55.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.138 -169.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -37.71 88.44 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 120.535 1.516 . . . . 0.0 110.565 171.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -56.29 -52.0 66.13 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.102 0.865 . . . . 0.0 109.708 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.9 ptp -68.89 -36.75 78.42 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.312 -172.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -46.76 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 121.159 1.8 . . . . 0.0 109.262 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.75 -47.4 85.84 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.814 0.846 . . . . 0.0 110.352 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -61.87 -40.36 95.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.245 0.475 . . . . 0.0 110.643 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -24.62 66.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.042 0.837 . . . . 0.0 111.36 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 99.3 mt -79.24 -49.43 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.256 1.422 . . . . 0.0 108.905 169.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -61.38 -29.02 69.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.633 1.173 . . . . 0.0 110.826 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -82.97 -19.32 37.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.744 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -93.84 -1.21 55.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.983 1.713 . . . . 0.0 112.212 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 C--O 1.247 0.937 0 C-N-CA 128.546 2.738 . . . . 0.0 110.704 173.415 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.6 mmt -57.16 -14.07 3.69 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.005 1.322 . . . . 0.0 113.142 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -74.06 -30.25 62.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 120.506 -1.371 . . . . 0.0 112.407 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.9 t -70.64 -33.2 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 124.181 0.926 . . . . 0.0 108.745 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -102.61 -2.41 28.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.896 1.278 . . . . 0.0 112.343 -171.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.88 72.12 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 122.382 1.087 . . . . 0.0 110.359 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.46 -12.92 62.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.434 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -75.45 -57.0 4.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.121 0.873 . . . . 0.0 109.978 167.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.77 -44.38 73.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.917 1.287 . . . . 0.0 111.603 -174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -53.68 -32.25 50.94 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.6 -18.22 66.56 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.519 -168.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.7 mt -69.37 114.61 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.78 6.0 14.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.747 1.219 . . . . 0.0 111.71 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.79 74.58 75.68 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 128.013 2.525 . . . . 0.0 110.046 -170.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -59.43 -30.85 93.66 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.094 2.529 . . . . 0.0 112.757 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.41 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 57.4 m-20 -70.03 -1.92 11.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.286 1.034 . . . . 0.0 112.308 -177.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.41 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 13.9 m80 -132.6 -30.72 1.42 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.294 1.838 . . . . 0.0 109.751 -176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.26 -48.56 45.75 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.64 1.576 . . . . 0.0 110.548 169.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.69 -36.96 82.39 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.329 0.393 . . . . 0.0 111.767 -168.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -63.78 -30.55 71.63 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.853 -0.529 . . . . 0.0 111.725 175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.0 m -71.52 -41.65 68.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.859 0.864 . . . . 0.0 109.5 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -50.43 -43.64 55.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.169 0.895 . . . . 0.0 111.903 168.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.89 -27.5 69.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.342 0.974 . . . . 0.0 112.751 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.4 mt -73.53 -47.13 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.74 -63.41 1.21 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.86 0.864 . . . . 0.0 109.744 -169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -64.37 -25.52 68.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.583 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -68.36 -42.25 79.46 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.208 0.913 . . . . 0.0 110.457 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.74 -48.4 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.9 0.773 . . . . 0.0 109.034 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.76 -29.37 68.13 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.11 -56.56 4.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.896 -0.503 . . . . 0.0 110.818 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -78.9 -28.99 44.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.792 1.637 . . . . 0.0 111.655 -165.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -131.62 64.42 72.86 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.187 0.995 . . . . 0.0 108.749 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.71 -13.03 31.96 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.673 2.249 . . . . 0.0 113.09 -171.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -74.13 -18.16 60.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.827 0.74 . . . . 0.0 112.253 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.6 mt -69.27 152.98 44.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -124.84 142.73 41.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.19 137.36 28.58 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.213 1.942 . . . . 0.0 110.479 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -147.32 135.66 21.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.356 1.062 . . . . 0.0 108.268 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.63 114.01 27.92 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 175.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.34 146.94 31.81 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.432 1.093 . . . . 0.0 108.079 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.6 m95 55.54 21.11 4.19 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.868 1.213 . . . . 0.0 114.115 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.2 t30 57.67 17.9 4.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 112.598 -165.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.5 p -110.74 142.99 27.3 Favored Pre-proline 0 N--CA 1.449 -0.516 0 O-C-N 120.532 -1.355 . . . . 0.0 109.361 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.31 128.66 15.83 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.532 2.155 . . . . 0.0 110.083 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.6 ptm -142.37 168.82 18.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.98 0.912 . . . . 0.0 109.021 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -140.14 91.55 2.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -172.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 p -65.07 122.66 17.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -71.54 91.01 1.03 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.862 1.21 . . . . 0.0 108.338 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 48.8 18.14 0.18 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.653 1.181 . . . . 0.0 113.717 -170.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.39 -16.73 2.92 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.303 1.906 . . . . 0.0 115.621 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.12 -167.98 1.17 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 120.355 2.078 . . . . 0.0 112.811 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -128.99 43.82 3.08 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.155 1.382 . . . . 0.0 110.408 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.8 mt -75.73 -1.46 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.706 1.602 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 tt -164.92 157.59 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 119.746 -1.846 . . . . 0.0 112.542 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.35 136.2 2.19 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 165.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -131.09 163.76 26.94 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.231 1.015 . . . . 0.0 111.227 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 p -149.48 156.68 42.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.886 0.85 . . . . 0.0 110.388 163.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 53.1 p -59.4 145.26 44.23 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.183 0.993 . . . . 0.0 108.685 167.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 m -133.56 177.61 7.57 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.205 1.402 . . . . 0.0 107.834 168.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.38 -57.22 8.46 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.145 0.978 . . . . 0.0 112.102 -167.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.424 ' CE1' ' HD1' ' A' ' 64' ' ' HIS . 14.5 p80 -126.19 4.29 7.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.119 0.968 . . . . 0.0 112.748 -173.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.514 ' CD2' ' HE ' ' A' ' 94' ' ' ARG . 4.1 p-80 -145.81 168.42 20.82 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.096 1.758 . . . . 0.0 108.445 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.2 tp -88.19 169.32 11.99 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 160.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 p -120.09 127.67 52.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.781 1.173 . . . . 0.0 108.136 160.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HB ' ' CE1' ' A' ' 93' ' ' PHE . 92.8 t -135.19 148.0 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.2 t -165.94 165.37 10.79 Favored Pre-proline 0 C--O 1.241 0.631 0 C-N-CA 128.399 2.68 . . . . 0.0 105.947 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -83.16 -57.35 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.338 0 CA-C-N 120.153 1.09 . . . . 0.0 111.225 152.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -147.23 -86.34 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.9 -32.97 0.34 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.338 1.455 . . . . 0.0 111.7 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.77 -35.31 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 119.961 1.255 . . . . 0.0 111.064 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.97 -16.26 24.42 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.59 0.614 . . . . 0.0 113.817 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.1 mm -112.17 -14.44 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 126.735 2.014 . . . . 0.0 110.278 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.4 m -104.37 -55.6 2.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.0 0.52 . . . . 0.0 110.248 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -81.2 -63.49 1.39 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.417 ' CG ' ' HG3' ' A' ' 109' ' ' MET . 12.5 m-85 -72.94 -9.2 58.45 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.499 -0.48 . . . . 0.0 112.014 -170.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.28 -30.89 63.07 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.372 0.533 . . . . 0.0 112.23 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -63.92 -44.15 93.76 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 118.439 0.563 . . . . 0.0 110.295 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.46 52.35 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.114 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.1 mt -60.22 -48.68 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.684 1.194 . . . . 0.0 108.324 168.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.66 73.13 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.967 0.907 . . . . 0.0 110.712 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -58.06 -30.04 65.88 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.744 0.818 . . . . 0.0 111.983 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.39 95.9 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.502 1.046 . . . . 0.0 110.862 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 132.25 -11.1 5.31 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 127.283 2.373 . . . . 0.0 111.465 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -86.93 174.0 9.0 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 120.93 -1.335 . . . . 0.0 112.747 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.2 t -127.53 175.09 8.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.486 1.914 . . . . 0.0 109.297 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.61 -176.41 4.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.064 1.746 . . . . 0.0 110.618 -166.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.8 p -132.01 -168.75 2.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.796 1.638 . . . . 0.0 108.225 168.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.72 5.92 12.15 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.655 -1.278 . . . . 0.0 113.409 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.08 -14.19 0.03 OUTLIER Glycine 0 CA--C 1.524 0.644 0 CA-C-N 119.544 1.065 . . . . 0.0 115.186 -171.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.6 pp -159.81 -173.37 4.06 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.691 1.246 . . . . 0.0 109.644 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.403 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 12.2 p90 -135.0 165.63 24.91 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.875 -1.141 . . . . 0.0 111.66 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.514 ' HE ' ' CD2' ' A' ' 64' ' ' HIS . 1.8 mmt-85 -139.92 91.24 2.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.721 1.208 . . . . 0.0 111.658 -157.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -86.2 141.1 34.74 Favored Pre-proline 0 C--O 1.239 0.54 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.09 155.77 26.07 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.114 2.543 . . . . 0.0 110.516 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -63.35 -19.89 65.03 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -68.58 -44.96 73.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.759 1.163 . . . . 0.0 111.105 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -90.32 150.24 42.64 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 123.609 0.764 . . . . 0.0 109.85 -159.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.73 123.41 5.83 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.777 2.984 . . . . 0.0 112.169 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.1 m -68.6 9.69 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -166.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 43.76 81.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 128.043 2.537 . . . . 0.0 114.285 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -60.33 -27.71 67.57 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.957 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.72 -56.06 18.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.986 0.514 . . . . 0.0 110.813 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -46.76 88.47 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.595 0.712 . . . . 0.0 109.518 -173.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -27.43 62.14 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.811 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -58.46 -55.86 29.59 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 119.681 1.128 . . . . 0.0 108.933 165.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -59.68 -37.72 79.56 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.044 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.417 ' HG3' ' CG ' ' A' ' 77' ' ' PHE . 6.1 ttm -53.18 -61.19 2.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.532 1.933 . . . . 0.0 111.303 172.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -45.88 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.745 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.74 -46.59 74.32 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.828 0.851 . . . . 0.0 109.435 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.8 -47.97 81.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.389 0.276 . . . . 0.0 111.385 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -20.22 63.27 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.544 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 91.1 mt -78.24 -63.62 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.159 0.984 . . . . 0.0 109.177 165.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -71.37 -13.18 61.78 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -164.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.57 -35.99 82.78 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.979 0.512 . . . . 0.0 109.688 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -79.65 7.03 9.17 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.765 2.026 . . . . 0.0 112.428 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 128.263 2.625 . . . . 0.0 112.212 -162.648 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 117.311 -1.328 . . . . 0.0 113.813 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.32 -36.56 43.23 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 120.814 1.643 . . . . 0.0 112.151 174.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -45.88 -44.58 14.56 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.099 0.959 . . . . 0.0 113.228 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.61 -50.57 43.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -80.24 -9.68 59.73 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -165.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.44 90.5 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.393 1.477 . . . . 0.0 111.446 -167.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.39 -21.99 66.74 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.157 0.983 . . . . 0.0 112.897 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -81.28 -55.1 4.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -51.83 -40.99 61.43 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.682 1.193 . . . . 0.0 111.777 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -58.38 -46.87 85.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.402 0.681 . . . . 0.0 110.431 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.87 -4.77 88.48 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.97 1.272 . . . . 0.0 113.86 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.2 mt -65.22 95.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 164.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.11 3.08 3.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.937 1.295 . . . . 0.0 112.855 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -105.63 75.89 0.33 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 C-N-CA 129.316 3.046 . . . . 0.0 109.212 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.48 -19.86 65.52 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.77 2.313 . . . . 0.0 112.781 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.68 2.33 30.1 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.077 1.351 . . . . 0.0 112.612 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -145.09 15.91 1.53 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.154 1.382 . . . . 0.0 110.127 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -91.11 -50.64 5.73 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.882 1.673 . . . . 0.0 109.569 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -53.91 -26.75 26.65 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 126.593 1.957 . . . . 0.0 113.469 -167.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -52.66 -55.62 21.23 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -58.32 -34.96 71.17 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.525 -0.734 . . . . 0.0 112.499 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -41.16 96.61 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.017 0.927 . . . . 0.0 111.298 172.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.9 -54.63 42.69 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.099 0.863 . . . . 0.0 109.521 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -52.46 -51.12 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.757 0.823 . . . . 0.0 109.937 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.9 mt -63.07 -51.89 64.88 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.714 0.406 . . . . 0.0 110.04 -171.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -65.29 -33.18 75.37 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 123.2 0.313 . . . . 0.0 110.511 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -64.97 -48.36 74.3 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.16 0.984 . . . . 0.0 110.89 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.7 t -52.75 -47.73 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 118.793 0.724 . . . . 0.0 109.814 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.23 13.58 0.41 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.21 -34.83 0.52 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.748 1.219 . . . . 0.0 114.068 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.5 m -75.92 -39.46 56.18 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.009 -1.057 . . . . 0.0 108.876 168.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -122.87 70.46 39.13 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 122.203 1.001 . . . . 0.0 110.914 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.85 -4.72 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.041 2.494 . . . . 0.0 112.923 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -79.4 -17.8 53.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.33 1.852 . . . . 0.0 113.11 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 43.5 mt -80.93 144.92 31.54 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.566 -1.334 . . . . 0.0 109.785 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -119.8 143.99 36.26 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.024 1.73 . . . . 0.0 110.141 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.51 148.09 37.15 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.655 2.903 . . . . 0.0 113.762 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -153.7 119.4 5.28 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.982 1.313 . . . . 0.0 110.649 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.71 103.5 9.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.375 1.07 . . . . 0.0 108.823 170.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -135.32 149.33 49.73 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.265 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.7 m95 55.73 16.26 1.92 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 66.95 27.48 8.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.891 2.077 . . . . 0.0 112.239 -170.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.0 p -130.82 152.71 81.04 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.91 1.684 . . . . 0.0 108.162 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.29 112.68 3.6 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 124.573 3.515 . . . . 0.0 110.209 170.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.3 ptm -122.84 170.6 9.93 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.753 -0.592 . . . . 0.0 109.772 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.95 167.73 21.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.645 0.736 . . . . 0.0 109.258 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.2 p -140.85 112.31 7.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 123.173 0.589 . . . . 0.0 111.444 -165.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.81 102.09 3.3 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 47.39 40.44 10.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.128 0.971 . . . . 0.0 111.579 -171.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.87 -2.32 66.41 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.772 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -82.65 177.74 8.55 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.272 2.036 . . . . 0.0 109.723 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -102.88 9.1 39.05 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.334 -1.479 . . . . 0.0 114.378 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.75 8.58 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.261 0 C-N-CA 127.604 2.361 . . . . 0.0 114.178 -162.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 tt -154.21 150.5 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 O-C-N 117.806 -3.059 . . . . 0.0 111.464 165.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.95 153.32 24.44 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 162.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -147.97 161.4 41.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.147 1.473 . . . . 0.0 110.212 170.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.72 155.84 41.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.518 0.675 . . . . 0.0 110.092 172.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.3 p -66.84 154.33 41.16 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.041 1.336 . . . . 0.0 109.343 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB3' ' CD2' ' A' ' 64' ' ' HIS . 31.2 t -133.9 163.99 28.29 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 156.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -48.12 -40.5 23.8 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.321 1.048 . . . . 0.0 113.517 -168.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -124.95 8.59 8.08 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.404 ' CD2' ' HB3' ' A' ' 61' ' ' SER . 7.7 p-80 -158.55 157.46 32.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.118 0.872 . . . . 0.0 112.315 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.9 tp -85.57 156.9 20.55 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 166.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.23 112.34 16.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.151 1.38 . . . . 0.0 109.906 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.1 t -126.78 141.08 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.236 2.214 . . . . 0.0 110.721 -166.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.5 t -164.45 159.58 15.84 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 108.361 164.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.34 -58.48 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 120.524 1.223 . . . . 0.0 111.138 166.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -134.81 -86.25 0.39 Allowed 'General case' 0 C--O 1.233 0.211 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 168.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -136.96 -30.84 0.86 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.984 1.714 . . . . 0.0 111.69 -172.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -62.35 -32.27 54.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 119.321 0.964 . . . . 0.0 111.781 -165.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.51 -29.52 57.55 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.638 1.589 . . . . 0.0 113.52 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.7 mm -98.13 -5.74 9.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.868 1.667 . . . . 0.0 110.114 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.0 m -97.47 -80.22 0.45 Allowed 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 124.853 1.261 . . . . 0.0 108.879 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -83.68 -37.35 22.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.715 1.143 . . . . 0.0 110.159 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -80.82 -11.4 59.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.292 0.496 . . . . 0.0 111.82 -174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.78 67.96 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.734 0.814 . . . . 0.0 113.173 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.38 -52.04 44.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.37 80.63 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.789 0.836 . . . . 0.0 111.597 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.63 -52.34 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.997 0.817 . . . . 0.0 109.237 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.54 -48.64 80.11 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.419 0.688 . . . . 0.0 110.275 -175.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -52.8 -44.17 66.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.56 1.544 . . . . 0.0 111.326 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.17 -5.92 30.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.352 0.661 . . . . 0.0 112.401 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.01 9.52 53.86 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.146 1.355 . . . . 0.0 112.801 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -99.62 163.43 12.5 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.133 1.467 . . . . 0.0 111.208 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.8 m -124.51 93.08 3.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.965 -151.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . . . -80.04 165.36 22.62 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.367 -0.833 . . . . 0.0 112.01 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.0 p -103.23 -164.35 1.07 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.11 1.764 . . . . 0.0 106.249 152.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 -2.18 51.22 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.693 -1.254 . . . . 0.0 112.256 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.03 -2.42 2.14 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.467 1.032 . . . . 0.0 113.749 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.56 177.69 11.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.289 1.545 . . . . 0.0 109.101 162.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 13.1 p90 -124.16 164.23 19.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.59 -0.694 . . . . 0.0 110.779 166.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.65 152.44 48.09 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 121.885 -0.509 . . . . 0.0 111.815 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.3 mm -123.47 142.88 39.97 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.39 150.99 25.73 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.564 2.176 . . . . 0.0 111.53 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -61.89 -20.95 64.3 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.87 -34.95 72.15 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.588 -0.695 . . . . 0.0 111.843 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.99 159.99 44.73 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 122.845 0.458 . . . . 0.0 109.794 -151.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.13 139.35 13.36 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-O 123.503 1.376 . . . . 0.0 111.946 -157.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.47 111.04 20.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 85.61 0.67 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.679 1.192 . . . . 0.0 112.541 -175.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -63.21 -38.53 91.55 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.064 1.346 . . . . 0.0 111.311 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -58.09 9.93 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.454 0.702 . . . . 0.0 110.19 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.99 -41.61 98.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.096 -172.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.275 0.2 OUTLIER -75.66 -26.16 57.44 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.432 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.21 -35.51 78.08 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 121.088 1.767 . . . . 0.0 110.934 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -56.42 -59.19 5.33 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.774 0.716 . . . . 0.0 109.543 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.2 ptp -62.22 -43.26 99.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.64 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -46.24 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 118.855 0.752 . . . . 0.0 109.206 -174.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -65.92 -40.58 91.57 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.716 1.143 . . . . 0.0 110.743 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.94 -47.27 85.62 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.366 0.53 . . . . 0.0 110.693 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.02 -13.38 11.22 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.735 0.814 . . . . 0.0 110.905 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 62.9 mt -95.74 -49.77 12.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-N 120.063 1.301 . . . . 0.0 110.342 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -72.15 3.48 4.48 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.147 1.34 . . . . 0.0 112.579 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -87.91 -15.82 35.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.52 1.528 . . . . 0.0 112.511 164.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -113.18 32.55 5.66 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.525 1.53 . . . . 0.0 110.136 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.331 157.502 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.4 mmt -59.05 -33.37 70.7 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -172.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.71 -36.49 72.06 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.56 0.618 . . . . 0.0 112.431 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.95 -45.24 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.048 0.939 . . . . 0.0 109.486 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -90.9 -9.42 46.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -167.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.75 91.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.396 1.479 . . . . 0.0 111.789 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.25 -27.08 63.65 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.727 1.211 . . . . 0.0 112.327 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -77.36 -50.57 12.48 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.642 0.777 . . . . 0.0 109.651 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.18 -50.33 62.06 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.608 1.163 . . . . 0.0 109.852 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -58.34 -42.85 87.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.008 0.923 . . . . 0.0 110.688 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.14 -35.86 91.07 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.759 -1.578 . . . . 0.0 114.208 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -54.75 108.74 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -73.34 -3.49 27.45 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.961 1.304 . . . . 0.0 112.611 -171.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 76.05 33.18 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 127.363 2.265 . . . . 0.0 108.7 -170.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.8 -21.56 72.47 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.313 2.675 . . . . 0.0 113.391 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.448 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 6.3 m-20 -63.89 -19.84 65.38 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.611 0.641 . . . . 0.0 111.734 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 3.7 m80 -123.61 -24.03 4.63 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.428 1.491 . . . . 0.0 110.18 -170.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -48.79 -45.58 40.37 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.305 1.042 . . . . 0.0 110.228 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.02 -32.73 9.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.815 1.646 . . . . 0.0 113.424 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -67.31 -14.38 62.87 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.35 -1.469 . . . . 0.0 112.387 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.5 m -100.98 -35.72 9.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.716 1.206 . . . . 0.0 109.789 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -26.2 63.57 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.426 0.557 . . . . 0.0 111.38 172.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -55.82 -62.58 1.6 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.634 1.574 . . . . 0.0 110.156 168.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 mt -57.58 -42.81 82.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 124.45 1.1 . . . . 0.0 112.466 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.11 -49.76 75.83 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.259 0.936 . . . . 0.0 110.036 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -65.57 -36.79 84.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 118.161 -0.923 . . . . 0.0 112.155 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -57.65 -53.55 56.91 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.158 0.89 . . . . 0.0 111.028 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.01 -41.69 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 O-C-N 121.196 -0.94 . . . . 0.0 109.689 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.83 5.03 2.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.522 1.129 . . . . 0.0 113.722 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.69 -62.76 1.49 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.619 1.568 . . . . 0.0 110.456 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.1 m -63.65 -32.04 73.4 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.604 1.093 . . . . 0.0 111.871 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -121.72 66.13 19.49 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 119.703 1.138 . . . . 0.0 110.806 -172.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.07 -10.88 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.228 3.285 . . . . 0.0 112.539 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -58.97 -22.03 59.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.916 2.087 . . . . 0.0 113.755 163.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.6 mt -89.46 160.58 16.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -134.79 149.52 70.88 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 126.786 2.035 . . . . 0.0 108.866 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.61 146.25 66.64 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 122.826 2.351 . . . . 0.0 112.194 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -158.02 119.13 3.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.027 1.331 . . . . 0.0 108.219 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -84.01 119.04 24.46 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -141.49 136.29 31.09 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.671 -0.643 . . . . 0.0 109.939 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.6 m95 56.35 24.0 7.89 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.5 t30 69.89 9.55 7.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.001 2.12 . . . . 0.0 112.909 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -111.91 143.94 29.69 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 125.299 1.44 . . . . 0.0 109.208 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -70.28 125.91 12.4 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.154 1.902 . . . . 0.0 111.782 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.6 ptm -133.0 171.42 13.99 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.433 1.093 . . . . 0.0 108.904 169.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -138.22 105.62 5.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.15 125.71 29.51 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 120.514 -1.366 . . . . 0.0 109.45 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 52' ' ' GLY . 6.1 t30 -72.82 83.96 1.21 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 53.08 -19.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 118.829 2.9 . . . . 0.0 118.829 -162.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 50' ' ' ASN . . . 159.49 40.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -168.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.99 -176.58 3.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.011 0.906 . . . . 0.0 110.053 174.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -124.84 32.03 5.53 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.827 1.651 . . . . 0.0 111.132 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.1 mt -70.13 -0.92 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.187 1.395 . . . . 0.0 111.671 -168.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.1 tt -161.59 147.26 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 O-C-N 119.636 -1.915 . . . . 0.0 111.962 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.73 156.11 27.26 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 158.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.3 155.2 41.82 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.365 -1.079 . . . . 0.0 111.642 169.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 t -142.87 153.48 43.19 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.3 p -70.81 159.65 34.18 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.582 1.153 . . . . 0.0 109.81 171.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -146.18 179.78 7.27 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.402 1.481 . . . . 0.0 109.29 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -56.41 -60.24 3.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.075 0.95 . . . . 0.0 112.086 -169.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -121.6 8.7 10.11 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.994 0.918 . . . . 0.0 111.255 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -152.55 172.85 15.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.493 1.117 . . . . 0.0 109.058 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 tp -101.01 158.94 15.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.471 1.909 . . . . 0.0 107.785 166.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.2 p -124.93 113.11 17.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.974 1.261 . . . . 0.0 111.045 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.23 146.02 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 125.449 1.5 . . . . 0.0 109.408 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.0 t -165.79 157.55 12.41 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.781 1.633 . . . . 0.0 107.335 167.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.1 -56.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.209 0 N-CA-C 109.117 -1.147 . . . . 0.0 109.117 160.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -151.34 -85.32 0.08 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -140.54 -49.47 0.44 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.38 1.872 . . . . 0.0 110.779 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.3 tt -57.91 -34.26 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 121.509 -0.744 . . . . 0.0 111.829 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -44.57 -48.23 8.83 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 172.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mm -91.49 -2.53 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.529 1.132 . . . . 0.0 110.877 -168.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.3 m -105.96 -54.79 2.42 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 120.543 -1.348 . . . . 0.0 111.4 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -78.34 -56.81 4.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.959 1.704 . . . . 0.0 106.84 -170.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -80.63 -18.66 47.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.691 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.57 -21.92 54.37 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.78 -61.28 2.28 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.04 -36.89 68.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.111 0.964 . . . . 0.0 112.27 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.69 -45.33 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.782 1.233 . . . . 0.0 110.254 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.9 -52.62 64.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -21.9 64.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 178.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.29 -21.29 62.96 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.308 0.958 . . . . 0.0 110.716 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.07 10.24 5.28 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.36 -1.245 . . . . 0.0 113.709 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.69 122.33 47.53 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.2 2.0 . . . . 0.0 110.868 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.7 p -75.69 85.13 2.7 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.126 0.97 . . . . 0.0 110.89 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.65 171.23 0.66 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.83 0.852 . . . . 0.0 110.985 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.2 p -101.81 -172.35 2.13 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 167.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -82.85 -19.79 36.85 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 118.063 -0.97 . . . . 0.0 113.023 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -121.23 -14.86 4.83 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 119.079 0.854 . . . . 0.0 113.895 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.6 pp -150.61 164.85 35.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.934 1.694 . . . . 0.0 109.39 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -106.85 160.45 15.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.56 1.073 . . . . 0.0 110.55 170.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.81 141.85 23.04 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.865 -0.522 . . . . 0.0 110.139 -166.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.77 143.51 43.89 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -172.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.53 151.84 82.07 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.586 1.524 . . . . 0.0 109.896 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -64.32 -26.13 68.34 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.843 -0.599 . . . . 0.0 112.338 168.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -62.8 -70.0 0.23 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.696 0.798 . . . . 0.0 111.73 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.82 157.53 87.2 Favored Pre-proline 0 C--O 1.236 0.347 0 O-C-N 123.213 0.32 . . . . 0.0 110.228 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.17 161.29 46.47 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.188 1.925 . . . . 0.0 111.182 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.54 136.59 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.02 2.128 . . . . 0.0 108.764 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.86 102.38 5.5 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 163.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -73.56 -15.77 61.28 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.09 0.859 . . . . 0.0 111.207 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -66.62 -65.5 0.67 Allowed 'General case' 0 CA--C 1.527 0.096 0 O-C-N 121.196 -0.94 . . . . 0.0 111.154 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.26 -38.94 77.91 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -46.01 -45.58 15.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.571 2.748 . . . . 0.0 113.863 172.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -71.3 -48.02 53.22 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 125.567 1.547 . . . . 0.0 109.306 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.39 -49.27 78.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -172.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.1 ptp -70.49 3.77 2.81 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.069 1.747 . . . . 0.0 114.616 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.46 -48.56 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 120.555 1.525 . . . . 0.0 109.412 175.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -59.59 -45.51 91.68 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.564 1.074 . . . . 0.0 109.008 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -56.63 -49.49 74.83 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 119.669 -0.205 . . . . 0.0 110.536 172.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -18.65 65.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.798 -0.62 . . . . 0.0 112.387 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mt -82.58 -55.46 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -70.97 -12.58 61.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.058 0.845 . . . . 0.0 112.577 -172.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.39 -21.69 48.96 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.506 1.122 . . . . 0.0 111.345 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -93.12 34.75 1.1 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.896 2.078 . . . . 0.0 109.78 174.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.634 1.573 . . . . 0.0 110.963 167.64 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.8 mmt -53.7 -34.04 57.49 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.073 0.949 . . . . 0.0 112.036 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -57.09 -42.94 81.64 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.331 0.969 . . . . 0.0 111.93 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.4 -40.38 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.863 0.865 . . . . 0.0 110.432 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -97.18 -19.93 18.29 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -167.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.51 -33.7 76.5 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.629 1.104 . . . . 0.0 111.529 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.84 -43.17 48.69 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.861 1.264 . . . . 0.0 111.695 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -72.24 -43.72 63.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.451 0.7 . . . . 0.0 110.496 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.83 -47.16 80.96 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -55.54 -43.25 75.61 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.908 0.483 . . . . 0.0 110.697 173.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.82 -24.82 71.6 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.97 -0.906 . . . . 0.0 112.872 -174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.3 mt -64.32 110.24 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 119.302 1.551 . . . . 0.0 107.715 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -72.71 -8.04 53.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.468 1.907 . . . . 0.0 113.939 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.73 70.64 1.71 Allowed Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 126.191 1.796 . . . . 0.0 109.691 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.94 -29.21 87.59 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.965 3.11 . . . . 0.0 113.883 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.07 -8.29 11.45 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.733 0.697 . . . . 0.0 112.218 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -123.77 -13.36 7.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.813 1.645 . . . . 0.0 110.107 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.79 -56.34 9.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.965 1.306 . . . . 0.0 109.681 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -62.63 -30.54 71.43 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.64 0.776 . . . . 0.0 112.069 -161.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -50.45 21.58 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.189 1.395 . . . . 0.0 111.578 169.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 m -59.87 -44.73 94.01 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.549 1.54 . . . . 0.0 111.355 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -35.87 46.48 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.124 2.17 . . . . 0.0 112.883 175.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -68.55 -48.71 63.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.043 0.537 . . . . 0.0 111.539 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mt -55.83 -49.99 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 123.953 0.783 . . . . 0.0 109.341 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 mt -56.61 -49.17 75.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.21 0.459 . . . . 0.0 110.524 -171.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 t -65.49 -40.24 92.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.376 0.671 . . . . 0.0 111.213 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -63.18 -39.32 94.31 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.647 0.779 . . . . 0.0 111.01 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.77 -47.33 89.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-O 118.41 -0.805 . . . . 0.0 108.891 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.68 -8.76 15.8 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.328 0.967 . . . . 0.0 113.155 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.36 -60.24 1.56 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.221 1.008 . . . . 0.0 111.177 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 m -69.78 -38.82 76.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.569 1.077 . . . . 0.0 110.439 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.9 65.18 35.64 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -173.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.17 -10.3 28.67 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.318 2.012 . . . . 0.0 111.772 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.56 -28.67 66.19 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.838 1.255 . . . . 0.0 112.84 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.35 146.84 51.82 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -124.9 147.99 58.34 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.22 148.73 31.05 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.107 2.538 . . . . 0.0 112.323 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -163.82 82.46 0.44 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.412 1.485 . . . . 0.0 107.251 172.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -70.75 134.43 47.42 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.016 -1.678 . . . . 0.0 108.53 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -154.97 152.8 30.13 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.571 1.148 . . . . 0.0 110.337 -170.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.8 m95 47.89 28.98 1.51 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.257 1.423 . . . . 0.0 112.767 -171.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 67.47 24.68 8.7 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.449 1.9 . . . . 0.0 112.492 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -124.57 143.2 42.63 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 125.358 1.463 . . . . 0.0 109.267 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.8 124.88 10.03 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.844 2.362 . . . . 0.0 108.93 164.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.0 ptm -137.09 163.36 30.99 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 167.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.2 158.97 35.69 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 175.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 m -128.21 124.44 36.73 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -173.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -74.78 84.42 2.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.257 16.6 mt-30 64.34 -11.51 0.12 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.878 2.071 . . . . 0.0 114.884 -176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.73 -9.84 0.02 OUTLIER Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.202 1.382 . . . . 0.0 116.056 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.84 -166.98 1.56 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.242 1.521 . . . . 0.0 114.115 -163.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -126.48 26.37 6.35 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.978 1.711 . . . . 0.0 110.841 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.39 -2.02 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 O-C-N 120.114 -1.616 . . . . 0.0 112.657 -171.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.1 tt -161.08 142.69 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 121.716 2.053 . . . . 0.0 111.795 170.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.22 157.74 29.36 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 161.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -147.27 141.42 26.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.276 1.038 . . . . 0.0 109.224 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.45 114.25 12.69 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.037 -1.04 . . . . 0.0 108.446 -176.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.8 p -54.75 134.73 47.7 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.212 0.915 . . . . 0.0 110.613 -168.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -112.49 163.95 13.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -54.51 -27.04 35.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.679 1.592 . . . . 0.0 113.796 -165.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -137.71 0.24 2.21 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.132 0.973 . . . . 0.0 113.383 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -153.17 158.33 41.63 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.382 0.992 . . . . 0.0 110.137 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -104.48 113.12 26.47 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.07 131.25 43.35 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 167.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.7 t -135.32 138.44 48.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 t -167.86 153.16 6.79 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 125.175 1.39 . . . . 0.0 107.405 161.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.67 -57.61 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 CA-C-N 119.971 1.025 . . . . 0.0 110.699 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -146.24 -79.95 0.16 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -139.63 -38.37 0.48 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.367 1.467 . . . . 0.0 111.614 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -27.86 43.24 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 118.81 0.732 . . . . 0.0 112.422 -166.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -46.56 -43.26 15.11 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.029 0.824 . . . . 0.0 111.155 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 mm -91.31 -11.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 121.998 -0.707 . . . . 0.0 110.235 -168.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.9 m -107.98 -57.19 2.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.151 0.887 . . . . 0.0 110.471 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.76 -60.87 2.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.569 1.948 . . . . 0.0 107.415 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 109' ' ' MET . 59.8 m-85 -77.49 5.99 7.9 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.25 -48.69 12.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.944 1.697 . . . . 0.0 111.775 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -73.42 -41.09 63.71 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.109 0.964 . . . . 0.0 109.132 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.95 -43.21 91.21 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.054 0.942 . . . . 0.0 110.169 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.8 mt -66.8 -43.31 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 120.027 1.285 . . . . 0.0 109.493 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.86 -57.02 14.29 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.556 1.143 . . . . 0.0 110.795 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -25.05 68.16 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.404 1.082 . . . . 0.0 112.802 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.39 -17.26 63.66 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.696 0.68 . . . . 0.0 111.281 173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.14 9.21 5.7 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.347 1.927 . . . . 0.0 113.398 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -134.18 111.89 10.66 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 119.087 1.444 . . . . 0.0 110.705 -161.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.7 m -76.59 15.6 0.61 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.985 -1.697 . . . . 0.0 114.541 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 52.46 -155.24 0.18 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.398 1.879 . . . . 0.0 112.548 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.5 p -125.59 -164.35 1.29 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.074 2.15 . . . . 0.0 105.952 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -81.82 -10.29 59.37 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.558 -1.21 . . . . 0.0 112.943 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.79 13.8 0.19 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-N 120.333 1.424 . . . . 0.0 115.235 -167.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 pp -166.05 178.97 6.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 130.332 3.453 . . . . 0.0 106.29 162.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -119.84 166.22 13.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 120.235 1.38 . . . . 0.0 108.368 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 171.53 14.18 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.463 -0.773 . . . . 0.0 109.667 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -133.59 143.71 48.99 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 103.952 -2.611 . . . . 0.0 103.952 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.95 159.17 51.04 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 CA-C-N 120.785 1.316 . . . . 0.0 109.227 169.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -63.56 -15.91 59.36 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.301 -0.874 . . . . 0.0 112.562 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -66.7 -19.96 65.87 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.407 2.283 . . . . 0.0 114.217 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -135.28 162.8 55.31 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-N 119.476 1.035 . . . . 0.0 111.373 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.66 133.83 26.71 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.573 2.849 . . . . 0.0 110.519 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.04 145.81 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 167.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.86 90.33 8.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.554 1.541 . . . . 0.0 108.556 -172.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -58.57 -31.97 68.49 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.531 -0.731 . . . . 0.0 109.714 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -69.65 -36.21 75.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.173 -0.954 . . . . 0.0 112.813 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -32.67 24.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.329 0.3 OUTLIER -83.18 -23.46 32.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 117.354 -1.308 . . . . 0.0 111.289 -177.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -65.79 -48.53 71.47 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 120.729 1.604 . . . . 0.0 109.725 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -60.49 -31.63 70.66 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -159.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . 22.1 ptp -83.49 -29.01 28.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -44.57 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 119.348 0.977 . . . . 0.0 109.348 -177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.34 -40.06 73.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.682 0.674 . . . . 0.0 109.533 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -71.61 -54.03 11.75 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.859 1.264 . . . . 0.0 112.036 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -65.17 -21.7 66.81 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 119.644 1.111 . . . . 0.0 111.789 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.9 mt -68.93 -54.97 17.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 118.864 0.756 . . . . 0.0 109.729 168.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -70.76 -13.46 62.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.749 0.704 . . . . 0.0 112.371 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.94 -43.46 92.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.895 1.278 . . . . 0.0 111.124 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.42 12.08 3.23 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.285 2.234 . . . . 0.0 113.564 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.529 1.532 . . . . 0.0 110.33 175.835 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 117.176 -1.393 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -47.59 -41.64 22.16 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.226 1.375 . . . . 0.0 111.19 -172.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -54.27 -39.26 66.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.404 0.682 . . . . 0.0 112.56 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.7 t -56.23 -41.52 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.478 0.711 . . . . 0.0 109.744 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -102.19 -6.48 23.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.506 1.122 . . . . 0.0 113.495 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.78 -44.81 63.36 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 123.628 0.771 . . . . 0.0 110.202 -170.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -57.32 -34.91 69.24 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.947 0.899 . . . . 0.0 111.379 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -68.55 -42.9 77.72 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.088 0.955 . . . . 0.0 111.001 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.22 -38.37 86.38 Favored 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 123.937 0.895 . . . . 0.0 110.316 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -56.24 -37.14 69.33 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 122.133 -0.354 . . . . 0.0 110.847 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.18 0.9 88.89 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.079 1.323 . . . . 0.0 113.714 -173.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 mm -66.14 149.47 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.007 1.403 . . . . 0.0 107.312 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.64 -22.88 62.46 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.075 1.35 . . . . 0.0 113.568 -170.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.4 145.18 8.66 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 126.227 1.811 . . . . 0.0 108.724 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.07 -27.66 73.85 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.939 2.426 . . . . 0.0 112.386 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.45 -15.14 47.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.778 -0.576 . . . . 0.0 111.126 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.79 15.2 11.77 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.807 -0.558 . . . . 0.0 110.839 176.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -113.59 -45.09 3.14 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 125.412 1.485 . . . . 0.0 110.883 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -70.77 -5.73 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.603 1.161 . . . . 0.0 112.937 -161.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -102.94 -25.81 13.33 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.324 1.85 . . . . 0.0 112.87 168.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m -61.45 -44.9 96.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.743 0.817 . . . . 0.0 109.522 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.64 -39.0 86.67 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.575 1.15 . . . . 0.0 111.81 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -60.01 -46.95 87.82 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.851 -0.595 . . . . 0.0 110.704 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mt -61.71 -44.91 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.997 0.919 . . . . 0.0 110.455 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.02 -48.09 82.83 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -65.79 -42.87 90.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.25 1.42 . . . . 0.0 110.466 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -63.48 -44.56 94.06 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.25 1.82 . . . . 0.0 110.976 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 t -57.17 -49.21 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.465 1.029 . . . . 0.0 109.297 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.68 2.79 0.88 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.72 -50.23 1.97 Allowed 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.795 1.238 . . . . 0.0 111.435 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 m -70.02 -26.49 64.07 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.715 1.206 . . . . 0.0 109.856 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -131.29 78.53 72.09 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.623 0.769 . . . . 0.0 111.484 -170.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.07 -5.21 16.48 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.86 3.04 . . . . 0.0 114.618 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.6 -20.84 32.99 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.011 -1.056 . . . . 0.0 112.312 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.5 mt -78.36 145.98 34.92 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -123.57 144.77 45.18 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 124.765 1.226 . . . . 0.0 108.031 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.04 162.57 36.81 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.494 2.796 . . . . 0.0 112.745 -172.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -170.04 119.89 0.62 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.212 2.205 . . . . 0.0 105.448 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ptm -95.64 127.45 41.68 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 121.28 1.855 . . . . 0.0 108.005 165.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -136.02 150.63 49.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 124.854 1.262 . . . . 0.0 109.155 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 14.5 m95 61.04 24.73 14.82 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.3 t30 74.53 -0.42 3.35 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 128.295 2.638 . . . . 0.0 111.493 -171.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.7 p -105.31 144.48 28.89 Favored Pre-proline 0 N--CA 1.45 -0.445 0 O-C-N 120.419 -1.426 . . . . 0.0 109.537 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.62 143.27 56.03 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.755 1.637 . . . . 0.0 109.107 164.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 19.1 ptm -145.87 172.75 12.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 164.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.21 152.18 45.78 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 p -129.92 114.25 15.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.444 1.098 . . . . 0.0 108.422 -167.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -70.34 91.56 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.769 1.228 . . . . 0.0 108.071 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 48.11 34.56 4.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.298 0.639 . . . . 0.0 112.507 -170.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.25 -11.39 24.24 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 117.253 -1.859 . . . . 0.0 115.861 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.43 HG21 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -74.13 -168.43 0.63 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.793 2.297 . . . . 0.0 111.385 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.43 ' H ' HG21 ' A' ' 53' ' ' THR . 36.5 t80 -129.88 18.85 5.58 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.01 1.724 . . . . 0.0 112.476 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mt -70.27 7.61 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 126.099 1.759 . . . . 0.0 111.757 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 tt -159.67 143.14 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 O-C-N 119.335 -2.103 . . . . 0.0 111.507 167.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.63 159.97 32.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 162.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -149.63 170.73 17.98 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.045 1.422 . . . . 0.0 110.068 173.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.1 t -153.72 152.95 31.37 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 168.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.1 p -78.87 127.46 32.05 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t -101.51 171.13 7.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.06 -17.92 55.05 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -167.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.46 1.12 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -158.18 154.14 26.89 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.388 0.995 . . . . 0.0 110.461 -168.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 tp -92.74 127.94 38.42 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 167.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.19 119.66 39.08 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.16 139.25 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 127.801 2.44 . . . . 0.0 108.93 -164.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 t -165.33 157.89 13.41 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 125.845 1.658 . . . . 0.0 107.516 167.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.79 -57.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.817 1.678 . . . . 0.0 111.282 161.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -145.94 -86.11 0.11 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 172.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -142.89 -32.55 0.48 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.692 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.41 -34.77 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 120.881 1.673 . . . . 0.0 111.394 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.15 -18.89 29.48 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.654 1.121 . . . . 0.0 113.26 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 mm -111.47 1.6 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 127.185 2.194 . . . . 0.0 109.925 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 m -118.57 -61.34 1.67 Allowed 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.633 -0.667 . . . . 0.0 109.376 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -74.15 -51.99 13.88 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 127.894 2.477 . . . . 0.0 107.647 -173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -85.95 4.32 38.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.605 0.762 . . . . 0.0 112.54 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.3 73.75 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.406 1.082 . . . . 0.0 112.637 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -69.99 -43.33 71.66 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.95 -39.11 93.64 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.829 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.21 -49.6 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.755 0.707 . . . . 0.0 109.816 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.16 69.52 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.041 0.937 . . . . 0.0 110.478 -170.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.63 -22.43 63.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.335 1.454 . . . . 0.0 112.996 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.49 -10.29 59.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.783 0.72 . . . . 0.0 112.039 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.12 11.59 56.08 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.029 0.823 . . . . 0.0 113.977 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -97.77 107.65 20.19 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.563 1.182 . . . . 0.0 111.341 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.12 98.38 0.06 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.044 2.138 . . . . 0.0 111.369 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.96 -176.26 6.24 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.638 1.175 . . . . 0.0 111.535 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 p -118.96 -164.91 1.08 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.161 1.784 . . . . 0.0 107.853 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -9.12 57.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.06 -1.69 2.87 Favored Glycine 0 N--CA 1.462 0.395 0 CA-C-N 119.441 1.019 . . . . 0.0 112.527 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 pp -162.47 176.28 10.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.361 0.664 . . . . 0.0 110.743 170.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -119.09 164.42 15.55 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.398 -0.813 . . . . 0.0 109.495 167.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.7 158.97 44.02 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.915 -1.115 . . . . 0.0 109.58 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.58 142.82 44.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.41 153.65 50.31 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.64 1.56 . . . . 0.0 109.408 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -60.57 -21.63 62.81 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -57.66 -47.5 82.12 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.749 2.02 . . . . 0.0 112.084 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -110.58 162.48 20.43 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.356 1.062 . . . . 0.0 109.519 -161.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.39 148.54 23.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.313 1.342 . . . . 0.0 112.399 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -77.86 143.77 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.93 81.2 5.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.681 1.592 . . . . 0.0 108.468 171.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -56.79 -34.6 67.8 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.344 0.657 . . . . 0.0 110.071 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -60.13 -54.68 43.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.778 0.831 . . . . 0.0 111.288 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -47.15 84.23 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -176.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.339 0.4 OUTLIER -69.1 -29.66 67.79 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 116.877 -1.535 . . . . 0.0 112.352 -176.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -42.64 76.28 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 121.094 1.77 . . . . 0.0 110.901 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -58.8 -39.26 80.6 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.579 1.081 . . . . 0.0 111.953 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.3 ptp -78.73 -38.36 39.08 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 121.72 -0.612 . . . . 0.0 112.548 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -51.32 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -173.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -56.78 -44.36 81.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.584 0.753 . . . . 0.0 110.806 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -54.96 -50.9 67.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.667 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -70.51 -1.05 9.71 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.3 mt -96.12 -47.71 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 C-N-CA 125.464 1.506 . . . . 0.0 108.137 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -68.92 -8.24 42.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.536 1.062 . . . . 0.0 112.111 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -91.56 -0.38 57.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.513 1.525 . . . . 0.0 111.762 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -112.33 5.37 18.2 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.561 2.344 . . . . 0.0 111.164 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.121 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 163.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.7 mmt -61.7 -21.29 64.35 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 117.298 -1.334 . . . . 0.0 112.498 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -65.17 -38.3 90.09 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.254 1.388 . . . . 0.0 110.669 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.28 -40.86 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -96.51 36.83 1.32 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.807 1.643 . . . . 0.0 111.156 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.17 -56.18 2.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.688 1.595 . . . . 0.0 111.682 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.6 -15.65 60.83 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -162.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -73.64 -47.24 41.5 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 125.784 1.634 . . . . 0.0 110.566 164.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.37 -45.53 93.99 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.966 0.906 . . . . 0.0 110.597 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -59.04 -15.58 14.21 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.44 0.12 46.66 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.399 1.952 . . . . 0.0 114.162 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.8 135.56 27.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 119.94 1.87 . . . . 0.0 108.013 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -35.07 79.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.852 1.661 . . . . 0.0 112.293 -175.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.15 143.81 32.35 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.46 -20.12 42.14 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.828 2.352 . . . . 0.0 111.741 172.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.05 -21.48 63.68 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.211 0.46 . . . . 0.0 109.89 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -116.06 -16.6 11.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.249 0.931 . . . . 0.0 112.079 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -67.05 -57.32 7.06 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 123.641 0.776 . . . . 0.0 111.356 -170.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -44.21 -61.09 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.645 1.978 . . . . 0.0 112.088 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -38.55 82.75 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 121.403 -0.811 . . . . 0.0 112.426 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 m -52.8 -50.24 64.01 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.475 0.71 . . . . 0.0 111.347 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -55.81 -46.32 78.1 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.643 1.177 . . . . 0.0 111.121 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -62.69 -40.17 96.28 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 122.838 0.455 . . . . 0.0 111.632 -172.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 mt -57.03 -50.83 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 124.012 0.82 . . . . 0.0 109.451 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.06 -55.3 36.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.602 0.361 . . . . 0.0 110.159 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 m -71.95 -21.43 61.6 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.298 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -69.0 -44.57 72.55 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 120.265 1.393 . . . . 0.0 110.428 170.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.409 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 56.1 t -59.68 -45.6 94.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 119.478 1.035 . . . . 0.0 108.587 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.03 62.83 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.538 0.608 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.29 -61.45 2.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 122.154 -0.341 . . . . 0.0 110.311 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -74.73 -35.69 62.67 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.578 1.551 . . . . 0.0 111.746 -162.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.71 74.47 34.76 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.93 -4.27 14.71 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.567 2.178 . . . . 0.0 112.15 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -28.36 51.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.647 1.179 . . . . 0.0 111.384 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.59 143.62 42.24 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -96.87 150.83 37.34 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.66 151.93 52.82 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.553 2.168 . . . . 0.0 110.577 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -156.15 130.8 8.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.623 1.569 . . . . 0.0 107.169 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -107.91 96.07 6.12 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.48 147.5 30.39 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 125.977 1.711 . . . . 0.0 107.245 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 3.9 m95 57.41 17.89 4.09 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 172.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 t30 57.76 29.48 17.48 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.861 2.464 . . . . 0.0 112.778 -167.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -126.63 144.99 51.65 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.89 134.09 22.96 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.709 2.939 . . . . 0.0 111.757 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.9 ptm -148.25 172.36 14.48 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.097 0.559 . . . . 0.0 110.52 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.409 ' CE2' ' CG1' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -132.77 148.92 52.32 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.9 112.29 11.16 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.665 1.186 . . . . 0.0 108.879 -168.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.82 97.34 1.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 44.84 38.58 2.98 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.404 1.002 . . . . 0.0 111.449 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.01 -10.43 34.18 Favored Glycine 0 CA--C 1.533 1.219 0 CA-C-O 116.771 -2.127 . . . . 0.0 117.057 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.54 -170.13 0.97 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 121.643 2.721 . . . . 0.0 111.414 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -131.54 22.43 4.71 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 119.899 -1.751 . . . . 0.0 112.434 -170.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.32 -2.88 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 127.088 2.155 . . . . 0.0 112.413 -165.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 tt -155.91 132.03 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 119.239 -2.163 . . . . 0.0 109.814 165.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.83 150.0 21.71 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 165.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.88 174.59 10.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.682 1.241 . . . . 0.0 109.935 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -152.15 161.19 43.0 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 159.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.1 p -68.64 159.01 32.89 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 m -138.5 175.04 9.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.834 1.254 . . . . 0.0 108.212 168.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.82 -60.29 2.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.418 1.087 . . . . 0.0 112.89 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -123.56 6.72 8.9 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -172.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -146.78 157.96 43.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.042 1.737 . . . . 0.0 109.332 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.1 tp -88.61 155.77 19.43 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 154.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.0 p -115.75 114.81 25.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 116.778 -1.582 . . . . 0.0 109.013 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 79.0 t -126.19 144.08 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.832 1.196 . . . . 0.0 110.142 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.3 t -169.21 156.92 6.9 Favored Pre-proline 0 C--O 1.239 0.536 0 C-N-CA 127.069 2.148 . . . . 0.0 108.008 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -74.79 -56.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 120.713 0.942 . . . . 0.0 111.434 161.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -156.37 -80.89 0.07 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -147.33 -30.27 0.33 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -33.81 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 120.662 1.574 . . . . 0.0 110.578 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -44.91 -31.93 2.96 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.016 1.293 . . . . 0.0 112.532 169.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.7 mm -104.63 -0.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.936 1.294 . . . . 0.0 110.785 -168.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.8 m -121.35 -46.41 2.29 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -38.93 36.47 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.434 2.294 . . . . 0.0 109.404 -174.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -100.84 5.08 43.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.723 0.809 . . . . 0.0 111.498 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.33 -36.73 76.19 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.121 1.369 . . . . 0.0 111.758 -172.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -72.57 -46.77 52.72 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.625 1.17 . . . . 0.0 108.829 -175.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.76 -41.74 91.69 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.419 0.688 . . . . 0.0 111.388 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.7 mt -61.41 -46.18 97.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.038 0.835 . . . . 0.0 109.575 171.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.28 -49.19 76.65 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 123.702 0.801 . . . . 0.0 110.365 -170.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -62.18 -29.31 70.28 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.965 1.306 . . . . 0.0 112.248 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.5 -22.92 62.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.08 0.854 . . . . 0.0 111.315 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.34 16.49 7.11 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.44 1.495 . . . . 0.0 113.99 170.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -108.97 93.44 4.52 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.488 1.144 . . . . 0.0 112.487 -164.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.6 m -52.27 96.61 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.191 2.196 . . . . 0.0 112.837 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.73 177.84 8.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.927 1.691 . . . . 0.0 112.121 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -100.44 -169.51 1.73 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.405 1.882 . . . . 0.0 107.362 159.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -77.26 -24.23 51.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.818 0.847 . . . . 0.0 112.687 168.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.5 -25.62 5.15 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 123.729 0.681 . . . . 0.0 112.759 -168.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 pp -152.77 161.11 42.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.051 0.925 . . . . 0.0 110.057 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -98.07 163.47 12.74 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.703 -0.623 . . . . 0.0 109.523 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -117.95 163.52 16.45 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.51 147.94 67.97 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 162.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -59.83 157.44 33.23 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 121.467 1.56 . . . . 0.0 109.59 159.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -65.08 -46.47 81.01 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.48 -0.763 . . . . 0.0 111.714 166.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -71.06 -21.63 62.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -166.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.02 160.63 29.19 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.49 1.116 . . . . 0.0 108.841 -172.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.71 144.4 19.51 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.614 1.543 . . . . 0.0 112.789 -163.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -84.14 123.96 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.415 1.886 . . . . 0.0 109.339 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -78.29 78.77 4.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.384 1.874 . . . . 0.0 112.917 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -51.98 -47.27 64.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.405 1.082 . . . . 0.0 110.423 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -68.9 -24.89 64.37 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -170.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.27 -56.3 5.75 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.508 1.123 . . . . 0.0 108.69 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.87 -23.75 62.37 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.946 -171.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -50.21 -53.98 24.2 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 127.065 2.146 . . . . 0.0 110.346 162.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -60.51 -47.53 85.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.873 0.76 . . . . 0.0 110.036 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 17.9 ptp -78.36 16.98 0.7 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.274 0.1 OUTLIER -117.12 -47.77 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 O-C-N 120.375 -1.453 . . . . 0.0 107.382 162.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.43 -53.27 60.08 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 111.994 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.39 -46.17 90.92 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 121.72 -0.613 . . . . 0.0 109.443 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -29.39 68.85 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.71 0.804 . . . . 0.0 111.539 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.9 mt -75.06 -59.68 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 125.703 1.601 . . . . 0.0 109.728 171.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -66.86 -18.47 65.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.942 0.792 . . . . 0.0 111.71 -168.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.77 -14.04 62.77 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.907 1.283 . . . . 0.0 112.496 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -119.01 20.4 12.73 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 127.024 2.13 . . . . 0.0 111.153 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 123.585 0.754 . . . . 0.0 110.007 -177.62 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.9 mmt -54.14 -27.88 36.32 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.002 0.921 . . . . 0.0 112.232 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -55.26 -60.64 3.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.388 1.475 . . . . 0.0 111.732 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.21 -38.93 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.732 1.213 . . . . 0.0 111.029 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -88.09 -15.13 37.04 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.166 0.586 . . . . 0.0 112.367 -169.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.11 78.45 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.223 1.009 . . . . 0.0 111.535 -175.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.88 -9.05 13.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.12 1.368 . . . . 0.0 113.383 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -112.59 -35.87 5.39 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.981 0.912 . . . . 0.0 110.832 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.3 mt -52.97 -33.68 52.33 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.481 -0.762 . . . . 0.0 111.168 170.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -54.62 -35.5 63.47 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.272 1.029 . . . . 0.0 113.671 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.1 -0.1 56.07 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-O 118.923 -0.932 . . . . 0.0 112.78 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.51 91.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -2.35 0.96 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.58 2.352 . . . . 0.0 113.294 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.448 ' HB3' ' HD1' ' A' ' 19' ' ' HIS . 1.2 m-70 -114.47 67.02 1.73 Allowed Pre-proline 0 N--CA 1.444 -0.768 0 C-N-CA 129.055 2.942 . . . . 0.0 109.408 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.5 -21.91 65.71 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.862 3.041 . . . . 0.0 113.24 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -71.18 -4.67 26.77 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.727 1.611 . . . . 0.0 112.18 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.448 ' HD1' ' HB3' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -147.0 16.78 1.22 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.45 1.1 . . . . 0.0 110.06 -175.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -87.55 -47.84 8.39 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.092 1.357 . . . . 0.0 109.693 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -55.58 -30.04 60.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.516 2.326 . . . . 0.0 112.938 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -58.52 -38.22 77.25 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.887 -1.133 . . . . 0.0 111.145 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.6 m -66.85 -39.63 87.66 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.362 0.665 . . . . 0.0 109.668 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.1 -44.8 83.57 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.418 1.487 . . . . 0.0 110.622 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -61.17 -44.39 97.39 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.74 0.416 . . . . 0.0 109.974 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.7 mt -61.31 -49.99 82.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.985 1.314 . . . . 0.0 109.109 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.79 -41.37 91.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.477 0.711 . . . . 0.0 109.79 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -65.09 -43.96 90.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.913 0.885 . . . . 0.0 110.868 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.93 -38.66 86.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.884 1.274 . . . . 0.0 111.81 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.0 t -61.28 -43.67 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 O-C-N 121.415 -0.803 . . . . 0.0 109.553 175.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.67 -25.03 67.94 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.153 0.581 . . . . 0.0 111.519 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 -70.16 0.59 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.217 1.007 . . . . 0.0 109.543 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.2 m -67.87 -29.48 68.6 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.783 -0.627 . . . . 0.0 112.225 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -123.15 58.34 12.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.167 0.894 . . . . 0.0 110.267 -171.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.09 -18.88 45.74 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.907 3.071 . . . . 0.0 114.983 -160.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -79.0 -7.2 57.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.164 0.893 . . . . 0.0 111.862 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.47 141.07 38.51 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.579 1.081 . . . . 0.0 108.605 165.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -116.42 154.29 48.94 Favored Pre-proline 0 C--N 1.328 -0.362 0 C-N-CA 124.937 1.295 . . . . 0.0 110.39 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.33 138.74 30.73 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.628 2.885 . . . . 0.0 110.337 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -165.56 82.73 0.33 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.05 140.71 54.91 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.057 -1.027 . . . . 0.0 108.694 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -150.15 153.27 36.04 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 124.741 1.217 . . . . 0.0 108.426 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.3 m95 51.6 31.55 7.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.68 0.792 . . . . 0.0 112.256 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 t30 59.12 18.34 6.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.562 1.945 . . . . 0.0 113.784 -173.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -114.13 127.12 27.16 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.727 1.611 . . . . 0.0 107.106 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.13 114.77 3.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.686 2.257 . . . . 0.0 109.978 170.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.6 ptm -130.79 173.66 10.72 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.349 1.06 . . . . 0.0 109.259 173.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -135.18 132.21 37.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.1 p -92.05 125.12 36.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.084 0.954 . . . . 0.0 108.564 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 52' ' ' GLY . 17.1 t30 -74.54 85.94 2.07 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 161.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.268 20.8 mt-30 63.19 -15.23 0.06 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.145 1.778 . . . . 0.0 115.605 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 50' ' ' ASN . . . 179.74 -13.01 0.03 OUTLIER Glycine 0 CA--C 1.544 1.859 0 C-N-CA 126.938 2.208 . . . . 0.0 115.094 170.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.84 -165.79 1.15 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.765 1.226 . . . . 0.0 113.237 -163.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.48 29.32 4.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.14 2.176 . . . . 0.0 109.762 -173.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.2 mt -67.72 -19.73 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.527 1.131 . . . . 0.0 112.118 -168.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.4 tt -155.02 136.59 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 120.236 1.38 . . . . 0.0 110.263 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.92 157.08 27.35 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 166.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -138.72 168.84 18.92 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.222 -1.163 . . . . 0.0 109.104 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 81.4 p -150.2 144.13 25.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.8 p -91.28 155.3 18.64 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -173.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 t -135.16 177.99 7.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.113 1.365 . . . . 0.0 108.474 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -49.34 -65.67 0.53 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.059 1.343 . . . . 0.0 109.571 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -116.2 13.06 15.62 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -172.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -153.83 166.46 32.83 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.901 0.773 . . . . 0.0 111.571 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.1 tp -97.99 158.53 15.48 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 162.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.0 m -126.7 120.62 29.87 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.184 0.902 . . . . 0.0 109.859 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.88 140.9 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.189 1.796 . . . . 0.0 109.222 -161.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.2 t -167.43 157.02 9.42 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 127.68 2.392 . . . . 0.0 105.883 168.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.13 -57.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.059 0 CA-C-N 120.65 1.268 . . . . 0.0 108.957 166.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -145.34 -86.18 0.12 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -139.49 -29.57 0.74 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.016 1.327 . . . . 0.0 112.499 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.17 -29.16 45.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 119.192 0.905 . . . . 0.0 111.439 -172.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.16 -24.63 15.94 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.872 2.177 . . . . 0.0 113.205 171.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.3 mm -107.74 -6.98 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 127.082 2.153 . . . . 0.0 110.171 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -92.35 -85.46 0.26 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -83.83 -45.71 12.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -169.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -67.84 -22.43 65.14 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.112 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.53 -32.14 57.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.196 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -67.33 -45.2 77.14 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.433 0.693 . . . . 0.0 110.05 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.01 89.49 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.932 -1.105 . . . . 0.0 110.819 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.3 mt -66.62 -43.04 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 118.653 0.66 . . . . 0.0 109.722 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.35 89.42 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 124.643 1.177 . . . . 0.0 109.862 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -65.1 -24.65 67.49 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.679 1.191 . . . . 0.0 111.74 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.4 -29.23 41.9 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.353 0.979 . . . . 0.0 110.904 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 142.18 -31.37 2.07 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.999 1.762 . . . . 0.0 112.599 165.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -81.15 102.18 10.13 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.965 1.383 . . . . 0.0 109.76 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.4 m -69.8 9.7 0.49 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 58.47 -172.97 0.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.36 2.264 . . . . 0.0 112.065 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.5 p -110.89 179.31 4.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.85 1.66 . . . . 0.0 106.93 158.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -66.86 27.89 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.734 2.413 . . . . 0.0 113.323 164.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.1 -35.57 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 CA-C-O 118.287 -1.285 . . . . 0.0 114.88 -168.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 pp -161.47 173.6 14.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.214 1.007 . . . . 0.0 112.077 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -108.88 119.67 40.23 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 120.89 -1.131 . . . . 0.0 110.37 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.27 138.65 42.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.98 143.81 31.58 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 169.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.55 156.84 29.63 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.439 2.092 . . . . 0.0 110.715 170.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -59.64 -25.63 64.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.402 168.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.99 -67.91 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.713 0.688 . . . . 0.0 110.796 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.9 164.96 44.16 Favored Pre-proline 0 N--CA 1.465 0.295 0 C-N-CA 124.409 1.083 . . . . 0.0 111.707 -168.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.92 139.42 12.13 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.086 1.191 . . . . 0.0 112.814 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.2 t -72.84 115.83 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -68.42 89.4 0.35 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.054 1.342 . . . . 0.0 111.418 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -58.1 -39.54 78.88 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 124.831 1.253 . . . . 0.0 109.897 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -66.91 -38.64 86.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.719 1.207 . . . . 0.0 113.406 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -48.3 55.71 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.285 0.4 OUTLIER -71.11 -26.52 63.06 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.973 -173.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -66.73 -43.09 85.15 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.117 -1.42 . . . . 0.0 111.001 171.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -53.45 -52.21 60.19 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.338 1.426 . . . . 0.0 109.677 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.7 ptp -63.02 -47.38 83.32 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.858 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -43.01 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 120.306 1.412 . . . . 0.0 110.736 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -63.01 -44.81 94.97 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.411 0.551 . . . . 0.0 110.441 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -56.23 -45.99 79.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.847 0.459 . . . . 0.0 110.623 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.66 -22.19 65.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.054 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.6 mt -82.17 -47.53 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 119.613 1.097 . . . . 0.0 109.626 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -71.0 -19.27 62.54 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.23 0.923 . . . . 0.0 111.491 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.24 -28.83 57.3 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.101 1.761 . . . . 0.0 110.892 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -106.21 43.04 1.18 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 126.18 1.792 . . . . 0.0 108.054 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--O 1.246 0.889 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.811 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.285 22.3 p-80 . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mmt -50.26 -43.99 53.5 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.899 1.679 . . . . 0.0 109.691 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -54.46 -32.84 58.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.21 -33.0 19.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 123.002 0.521 . . . . 0.0 111.125 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -113.57 32.84 5.52 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.685 1.994 . . . . 0.0 113.73 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.57 -15.33 10.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 121.787 2.085 . . . . 0.0 113.747 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.7 -24.42 21.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -35.87 59.01 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -173.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -37.09 71.85 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.9 1.28 . . . . 0.0 112.074 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -54.35 -39.61 67.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.819 0.736 . . . . 0.0 110.74 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.88 -7.4 75.44 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.247 1.403 . . . . 0.0 113.997 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.8 mt -86.46 102.87 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.93 -8.4 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.569 1.147 . . . . 0.0 113.452 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.48 84.99 0.68 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.688 1.995 . . . . 0.0 111.18 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.77 -20.44 58.9 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.707 2.938 . . . . 0.0 114.241 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.27 -17.04 63.24 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.114 0.416 . . . . 0.0 110.545 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -128.16 -33.97 2.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.177 0.991 . . . . 0.0 111.268 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -48.52 -54.65 13.56 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.301 1.041 . . . . 0.0 109.849 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -13.15 34.55 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.11 1.364 . . . . 0.0 113.178 -175.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -88.32 -51.95 5.47 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.934 1.243 . . . . 0.0 108.36 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.1 m -46.56 -43.31 17.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.608 1.963 . . . . 0.0 112.685 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -71.94 -28.17 63.29 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.366 1.466 . . . . 0.0 112.592 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.13 -47.0 78.64 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.669 -0.644 . . . . 0.0 109.852 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -54.91 -45.71 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.22 -52.26 66.44 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.375 0.27 . . . . 0.0 110.969 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 p -62.09 -41.12 97.88 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.622 0.769 . . . . 0.0 112.961 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -56.49 -59.03 5.57 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.913 1.685 . . . . 0.0 109.96 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.6 t -50.53 -48.04 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 120.245 1.384 . . . . 0.0 111.182 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.79 -16.41 64.24 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.54 -54.83 3.98 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.868 0.867 . . . . 0.0 110.669 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -34.26 77.65 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.693 0.797 . . . . 0.0 111.669 -171.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.36 69.62 81.33 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.733 1.213 . . . . 0.0 108.388 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.82 -6.42 18.12 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.035 3.157 . . . . 0.0 115.044 -162.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -73.75 -14.45 61.13 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 120.036 1.289 . . . . 0.0 112.152 168.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.6 mt -75.66 135.15 40.44 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 120.944 -1.097 . . . . 0.0 110.948 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -110.99 149.79 40.95 Favored Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 126.537 1.935 . . . . 0.0 109.203 175.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.08 159.99 40.42 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.895 2.397 . . . . 0.0 111.523 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -158.16 111.83 2.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.209 1.003 . . . . 0.0 108.529 166.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.99 95.38 1.58 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 165.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -118.48 147.42 43.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.5 m95 53.16 23.32 3.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.8 t30 62.23 15.91 7.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.788 1.235 . . . . 0.0 112.327 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 p -121.31 150.23 53.7 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.25 113.11 3.62 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.93 2.42 . . . . 0.0 110.564 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.1 ptm -119.18 172.7 7.4 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 166.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.3 139.62 48.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -102.34 127.7 49.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.434 ' C ' ' H ' ' A' ' 52' ' ' GLY . 20.4 t30 -71.41 87.76 0.87 Allowed 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 166.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 58.75 -8.95 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.156 2.582 . . . . 0.0 114.655 -177.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 50' ' ' ASN . . . 167.47 -11.97 0.06 OUTLIER Glycine 0 CA--C 1.543 1.782 0 C-N-CA 126.745 2.117 . . . . 0.0 114.179 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.429 HG23 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -84.58 -169.86 2.83 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.374 1.587 . . . . 0.0 111.651 -174.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.429 ' H ' HG23 ' A' ' 53' ' ' THR . 78.4 t80 -125.43 19.19 8.13 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.696 1.998 . . . . 0.0 111.744 -177.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.35 4.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 126.852 2.061 . . . . 0.0 113.375 -171.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 tt -156.66 142.53 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 118.465 -2.647 . . . . 0.0 111.085 165.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.47 148.57 17.5 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 166.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -149.85 171.97 15.91 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.257 1.423 . . . . 0.0 108.523 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.18 162.05 41.05 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 166.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 p -61.03 152.92 26.7 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.408 0.623 . . . . 0.0 110.261 167.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -132.89 171.13 14.34 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.412 1.885 . . . . 0.0 106.504 163.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -49.41 -49.67 43.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.606 1.562 . . . . 0.0 112.158 -171.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -129.39 7.79 5.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.48 1.112 . . . . 0.0 112.82 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.469 ' CD2' ' HE ' ' A' ' 94' ' ' ARG . 33.5 p-80 -147.26 169.56 19.13 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.171 -0.956 . . . . 0.0 110.541 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.5 tp -102.77 147.03 27.37 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 162.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 m -121.81 125.41 46.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.234 0.925 . . . . 0.0 109.394 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.6 t -136.19 141.55 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 127.316 2.246 . . . . 0.0 109.156 -157.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 t -167.72 152.08 6.37 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.802 1.641 . . . . 0.0 108.7 168.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.64 -56.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.7 1.6 . . . . 0.0 111.679 164.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -139.75 -86.0 0.22 Allowed 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -143.14 -33.97 0.43 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.041 0.936 . . . . 0.0 112.746 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.1 tt -61.05 -33.64 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 120.039 1.29 . . . . 0.0 111.569 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -50.45 -22.37 5.3 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.249 1.404 . . . . 0.0 113.112 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.8 mm -110.69 -1.85 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 126.41 1.884 . . . . 0.0 110.157 -171.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.3 m -118.27 -51.31 2.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.163 0.985 . . . . 0.0 110.509 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -84.06 -58.28 2.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 127.431 2.293 . . . . 0.0 107.43 -173.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.55 0.26 17.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.072 1.349 . . . . 0.0 111.314 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.63 -40.3 78.89 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.855 1.262 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -72.8 -35.78 67.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.62 0.646 . . . . 0.0 109.535 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.25 82.3 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.498 0.719 . . . . 0.0 109.632 170.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.69 -44.89 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.108 0.963 . . . . 0.0 110.333 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.99 -55.84 29.49 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.167 0.987 . . . . 0.0 108.952 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -68.11 -15.86 63.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.692 0.797 . . . . 0.0 113.104 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.63 -16.18 52.26 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.399 1.0 . . . . 0.0 111.092 172.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.36 19.54 9.29 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 124.276 0.941 . . . . 0.0 113.998 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -119.81 99.45 6.64 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.028 1.414 . . . . 0.0 111.455 -166.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.9 m -56.55 117.01 3.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.904 1.281 . . . . 0.0 110.176 172.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.41 -168.18 1.55 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.34 1.856 . . . . 0.0 110.668 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 p -120.06 -164.78 1.11 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.75 1.62 . . . . 0.0 107.217 163.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -88.69 -20.48 24.8 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.06 0.846 . . . . 0.0 111.981 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.74 5.68 5.82 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.989 -0.895 . . . . 0.0 114.174 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 pp -156.34 169.66 24.07 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.873 1.337 . . . . 0.0 110.104 158.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -118.68 179.17 4.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.801 1.24 . . . . 0.0 109.52 170.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.469 ' HE ' ' CD2' ' A' ' 64' ' ' HIS . 2.4 ptp85 -140.49 170.77 15.17 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.071 -1.018 . . . . 0.0 113.341 -177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 mp -135.97 142.85 41.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 160.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.53 160.46 47.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.705 1.603 . . . . 0.0 109.414 166.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -73.47 -23.15 60.04 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -65.59 -67.93 0.4 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.663 0.785 . . . . 0.0 110.455 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.48 165.69 51.5 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.481 1.512 . . . . 0.0 111.593 -164.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.78 145.46 40.98 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.624 1.55 . . . . 0.0 112.765 -170.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.45 126.31 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.28 76.04 7.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 168.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -56.94 -32.96 66.51 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 123.367 0.667 . . . . 0.0 109.433 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.46 -48.54 81.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.46 0.704 . . . . 0.0 111.913 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.73 -42.57 73.8 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 122.522 1.153 . . . . 0.0 109.514 -169.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.276 0.5 OUTLIER -70.54 -30.9 67.76 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.747 176.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -58.45 -51.35 70.21 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.778 1.172 . . . . 0.0 110.641 166.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -51.76 -49.48 62.55 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.822 0.849 . . . . 0.0 109.889 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -69.39 -47.67 63.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.93 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -45.56 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 120.452 1.478 . . . . 0.0 109.919 -175.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.58 -47.63 81.58 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.193 0.997 . . . . 0.0 110.968 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -60.53 -46.22 90.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.028 -0.42 . . . . 0.0 110.792 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -64.16 -20.98 66.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.657 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.1 mt -71.46 -56.45 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 169.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.05 -15.2 63.49 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.933 0.788 . . . . 0.0 112.396 -173.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.76 -10.55 59.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.535 1.134 . . . . 0.0 112.708 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -114.7 21.37 14.5 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.749 2.02 . . . . 0.0 110.959 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.84 174.63 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.288 9.4 p-80 . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.7 mmt -44.65 -46.28 10.1 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 126.04 1.736 . . . . 0.0 110.747 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.93 -31.61 72.63 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -168.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.5 t -58.15 -45.87 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.436 1.094 . . . . 0.0 108.701 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -91.58 -9.3 44.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.237 1.415 . . . . 0.0 112.37 -170.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.4 -33.06 70.94 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.468 1.107 . . . . 0.0 111.431 -171.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -68.8 -15.72 63.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.789 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -79.23 -52.96 7.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 166.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -49.18 -45.12 43.68 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.498 1.119 . . . . 0.0 111.791 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -62.46 -25.2 67.86 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 118.051 0.387 . . . . 0.0 111.816 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.35 -2.29 60.46 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.279 1.418 . . . . 0.0 113.577 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 54.3 mt -77.84 111.65 14.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 CA-C-N 120.08 1.94 . . . . 0.0 107.369 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -1.07 24.14 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.601 0.76 . . . . 0.0 112.714 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -110.39 78.83 1.51 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 127.837 2.455 . . . . 0.0 110.021 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -61.11 -32.36 91.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.718 2.278 . . . . 0.0 112.436 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 36.9 m-20 -68.85 -1.55 7.48 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.398 0.999 . . . . 0.0 111.724 -173.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.425 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 14.3 m80 -135.88 -38.38 0.72 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.072 1.749 . . . . 0.0 110.498 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.4 ttp85 -46.14 -54.35 8.78 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 123.898 0.879 . . . . 0.0 109.42 166.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -53.14 -38.69 62.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.784 0.833 . . . . 0.0 112.194 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.67 -45.09 91.68 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.437 -0.789 . . . . 0.0 109.724 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 m -60.91 -35.21 76.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.13 1.772 . . . . 0.0 111.01 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -59.83 -38.45 82.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.693 1.133 . . . . 0.0 110.484 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -59.81 -46.47 89.13 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.566 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.9 mp -54.33 -52.07 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.48 -57.45 12.25 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 122.833 0.453 . . . . 0.0 110.017 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 m -60.66 -43.01 98.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 123.652 0.595 . . . . 0.0 110.454 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -62.87 -41.42 99.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.75 0.82 . . . . 0.0 110.772 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.5 t -58.33 -60.05 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.897 0.771 . . . . 0.0 109.874 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.09 -21.91 66.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.82 0.737 . . . . 0.0 112.597 -174.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.77 -62.38 1.47 Allowed 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.653 0.781 . . . . 0.0 111.562 171.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.3 m -72.27 -35.13 68.66 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.69 1.596 . . . . 0.0 110.753 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -120.65 66.68 13.41 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 124.714 1.206 . . . . 0.0 108.841 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -68.48 -11.63 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.029 1.819 . . . . 0.0 112.362 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -76.18 4.92 7.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.86 0.864 . . . . 0.0 112.477 171.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.42 141.08 36.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.298 1.039 . . . . 0.0 108.277 171.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -122.39 143.95 40.79 Favored Pre-proline 0 C--O 1.239 0.504 0 C-N-CA 124.691 1.196 . . . . 0.0 110.014 -173.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.99 148.04 21.59 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.518 2.812 . . . . 0.0 112.637 -165.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -155.25 119.45 4.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.431 0.693 . . . . 0.0 109.503 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -83.24 113.33 20.6 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 165.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt -150.88 154.99 38.24 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.511 1.125 . . . . 0.0 108.394 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.8 m95 49.77 24.65 1.3 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.659 1.584 . . . . 0.0 113.322 -168.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.48 21.7 8.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.078 1.351 . . . . 0.0 112.186 -171.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.2 p -118.77 158.15 48.29 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 125.783 1.633 . . . . 0.0 109.405 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.25 110.9 2.8 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.281 3.32 . . . . 0.0 110.499 169.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 19.2 ptm -117.73 170.04 9.1 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.054 0.93 . . . . 0.0 109.292 165.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.36 176.64 8.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 166.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.8 m -143.13 139.62 30.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -71.63 97.58 1.75 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 161.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.297 21.7 mt-30 59.78 -11.72 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.574 2.75 . . . . 0.0 116.711 174.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.69 -3.45 0.05 OUTLIER Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.526 2.488 . . . . 0.0 114.541 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.59 -166.14 0.25 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 120.406 2.103 . . . . 0.0 111.799 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -126.73 20.95 7.08 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 119.569 -1.957 . . . . 0.0 111.639 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.5 mt -71.19 15.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 O-C-N 120.29 -1.506 . . . . 0.0 111.802 -169.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 tt -160.5 146.22 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 118.62 -2.55 . . . . 0.0 110.799 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.2 144.26 8.89 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 162.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -137.0 174.24 10.84 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.094 1.447 . . . . 0.0 110.043 171.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.5 t -155.76 159.57 39.57 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 160.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.2 p -63.05 144.13 57.17 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 162.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t -120.19 172.81 7.51 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 162.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -58.45 -44.67 89.3 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 121.499 -0.751 . . . . 0.0 110.737 -163.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -137.44 37.12 2.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.881 0.872 . . . . 0.0 111.918 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -166.57 167.16 15.7 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.418 1.487 . . . . 0.0 109.801 171.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -98.74 157.25 16.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.656 1.182 . . . . 0.0 107.922 162.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.3 p -119.03 125.41 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.717 1.207 . . . . 0.0 108.604 169.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.7 t -135.46 141.7 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 119.619 1.1 . . . . 0.0 108.643 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -173.23 151.49 2.07 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.09 1.756 . . . . 0.0 107.368 175.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.65 -57.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 119.786 0.959 . . . . 0.0 112.318 165.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -149.49 -86.73 0.08 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -142.45 -32.57 0.49 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.836 1.254 . . . . 0.0 111.745 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.0 tt -63.32 -31.29 52.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 118.817 0.735 . . . . 0.0 110.934 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.69 -24.47 12.61 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 127.247 2.356 . . . . 0.0 113.263 173.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.9 mm -120.6 -3.5 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.98 1.312 . . . . 0.0 110.492 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.0 t -80.02 -71.76 0.44 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -88.65 -41.71 12.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.655 -0.653 . . . . 0.0 109.248 -166.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -71.95 -10.34 59.64 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.091 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.56 -27.39 57.62 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -72.93 -42.44 63.47 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.887 0.851 . . . . 0.0 110.406 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.61 -38.18 90.13 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.426 -0.796 . . . . 0.0 110.843 172.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.7 mt -59.91 -50.6 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.226 1.011 . . . . 0.0 108.926 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.18 -47.4 65.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.82 1.248 . . . . 0.0 111.386 -175.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.43 -30.15 68.28 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.586 1.155 . . . . 0.0 112.987 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.36 -15.8 61.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.378 0.99 . . . . 0.0 111.651 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.23 -14.57 43.74 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 125.339 1.447 . . . . 0.0 113.002 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -73.7 161.85 29.81 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 173.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.48 5.02 5.14 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.471 1.032 . . . . 0.0 113.689 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 55.94 -159.07 0.22 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.856 1.662 . . . . 0.0 111.728 -169.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.5 p -119.38 -164.38 1.05 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.19 2.996 . . . . 0.0 104.815 159.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -70.69 -31.19 67.98 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.068 1.303 . . . . 0.0 113.043 171.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.35 -20.46 1.59 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -162.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 pp -137.35 167.98 20.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 121.197 -1.178 . . . . 0.0 110.026 169.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -112.38 150.27 31.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -140.73 145.37 36.36 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.51 143.72 49.11 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 161.45 42.29 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 121.706 1.645 . . . . 0.0 110.604 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -65.99 -15.28 62.88 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -63.44 -38.9 92.91 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.464 1.106 . . . . 0.0 110.846 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.52 158.46 33.7 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 123.76 0.824 . . . . 0.0 110.127 -156.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.08 126.08 10.88 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.887 2.391 . . . . 0.0 108.197 166.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.1 m -78.98 18.16 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.297 0.3 OUTLIER 50.73 78.0 0.11 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.948 2.899 . . . . 0.0 113.492 177.074 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -69.42 -48.75 60.04 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.944 2.098 . . . . 0.0 111.674 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -58.94 -36.35 74.62 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.01 0.924 . . . . 0.0 111.383 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -50.53 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.579 0.704 . . . . 0.0 110.067 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.289 0.3 OUTLIER -71.29 -29.4 65.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.535 0.734 . . . . 0.0 112.765 -174.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.19 -39.36 93.83 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.404 -1.284 . . . . 0.0 110.312 172.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -57.91 -49.47 76.65 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.337 1.426 . . . . 0.0 110.444 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.5 ptp -69.51 -45.16 69.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.191 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.63 -46.62 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.697 1.135 . . . . 0.0 110.122 -175.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.13 -31.16 72.24 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.504 1.047 . . . . 0.0 111.998 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.07 -53.42 25.75 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 118.06 0.391 . . . . 0.0 110.358 169.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.72 -18.13 64.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.487 -170.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.05 -71.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 124.983 1.313 . . . . 0.0 108.812 158.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -66.18 -13.41 60.19 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -165.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -77.16 -12.07 59.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.78 2.032 . . . . 0.0 113.13 174.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -129.37 3.9 5.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.268 2.227 . . . . 0.0 110.476 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.251 24.0 tt0 . . . . . 0 C--O 1.255 1.383 0 C-N-CA 128.966 2.906 . . . . 0.0 115.022 166.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.293 8.3 p-80 . . . . . 0 N--CA 1.464 0.257 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mmt -44.74 -49.48 10.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 128.42 2.688 . . . . 0.0 110.349 -170.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.74 -31.15 58.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.433 1.093 . . . . 0.0 112.126 -169.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.09 -45.13 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 123.97 0.908 . . . . 0.0 110.535 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -96.85 -8.72 30.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.226 2.21 . . . . 0.0 112.649 -170.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.77 -12.32 60.31 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 126.231 1.812 . . . . 0.0 112.182 -160.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.465 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 27.4 mt-10 -111.4 -27.46 8.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.554 1.942 . . . . 0.0 109.184 -168.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.68 -34.63 69.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.02 -47.7 44.3 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.862 1.265 . . . . 0.0 112.611 173.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 1.4 mppt? -61.74 -27.09 68.47 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.829 1.195 . . . . 0.0 113.403 176.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.6 -12.47 84.37 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.874 -0.959 . . . . 0.0 113.028 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.1 mt -76.08 113.02 14.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 119.742 1.771 . . . . 0.0 106.682 168.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -79.19 -4.11 48.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 122.055 0.931 . . . . 0.0 113.478 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -100.15 85.91 0.57 Allowed Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 127.645 2.378 . . . . 0.0 111.702 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -62.56 -38.58 50.4 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.861 2.374 . . . . 0.0 111.349 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.21 10.75 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.815 1.246 . . . . 0.0 111.162 -172.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -135.5 -38.8 0.74 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.018 0.927 . . . . 0.0 111.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -43.77 83.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 116.492 -1.718 . . . . 0.0 114.688 -176.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -45.21 -42.89 9.76 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.028 1.285 . . . . 0.0 112.006 -172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -45.5 79.02 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.041 2.136 . . . . 0.0 111.971 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.0 m -59.71 -37.64 79.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.212 1.405 . . . . 0.0 109.744 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.09 -36.2 81.46 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 124.325 1.05 . . . . 0.0 110.788 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -59.84 -46.7 88.45 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.426 0.69 . . . . 0.0 109.722 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 mt -60.13 -44.76 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.021 0.929 . . . . 0.0 109.502 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.0 mt -58.05 -55.27 37.08 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.936 0.789 . . . . 0.0 110.054 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.4 m -62.4 -33.14 74.19 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.451 1.1 . . . . 0.0 113.202 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -73.2 -44.18 60.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.566 -0.709 . . . . 0.0 111.03 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.55 -53.89 38.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.16 -26.19 66.12 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.61 -50.96 8.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.545 0.738 . . . . 0.0 111.034 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.3 m -72.74 -40.39 66.11 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.534 0.734 . . . . 0.0 110.811 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.85 65.63 55.04 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.2 1.0 . . . . 0.0 109.99 -172.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.62 -6.74 19.6 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.09 2.527 . . . . 0.0 114.019 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.31 -16.27 61.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.479 1.036 . . . . 0.0 111.124 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.09 134.71 47.24 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 165.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.92 146.88 32.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.78 147.45 75.29 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.123 1.882 . . . . 0.0 109.787 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -156.57 109.53 2.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.471 -0.768 . . . . 0.0 109.353 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 75.6 mmm -76.54 131.12 38.78 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 161.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -139.17 139.92 37.7 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.0 m95 64.92 0.24 1.16 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 t30 74.58 14.7 3.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.576 2.75 . . . . 0.0 113.37 -162.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.3 p -107.84 147.17 34.93 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.89 138.06 27.94 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.507 2.138 . . . . 0.0 110.494 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.6 ptm -144.05 -179.59 6.59 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 162.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -140.16 161.1 38.44 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 p -125.19 114.36 18.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.154 0.582 . . . . 0.0 110.073 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -71.03 97.17 1.41 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 44.4 48.6 8.17 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.466 1.506 . . . . 0.0 111.758 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.52 35.67 25.3 Favored Glycine 0 CA--C 1.535 1.315 0 O-C-N 121.23 -0.919 . . . . 0.0 114.742 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 54' ' ' PHE . 1.7 m -112.85 -164.78 0.94 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 119.339 1.57 . . . . 0.0 109.617 170.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.437 ' H ' HG23 ' A' ' 53' ' ' THR . 46.3 t80 -129.64 13.19 5.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.275 1.83 . . . . 0.0 111.668 -174.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.9 0.94 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 128.797 2.839 . . . . 0.0 113.502 -167.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 tt -157.36 140.74 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 118.956 -2.34 . . . . 0.0 112.101 165.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.39 165.92 29.07 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.142 1.353 . . . . 0.0 110.324 166.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -157.71 176.15 12.97 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.685 0.755 . . . . 0.0 111.464 165.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.14 155.36 22.82 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 165.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.0 p -63.34 127.87 33.25 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.36 173.8 12.11 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 164.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -66.26 -26.78 67.51 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.858 -1.151 . . . . 0.0 112.971 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -140.59 5.45 2.01 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.852 1.261 . . . . 0.0 113.175 -173.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -157.55 -179.76 8.48 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.097 1.759 . . . . 0.0 106.727 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tt -119.74 133.97 55.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.44 125.62 50.8 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.549 -175.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.1 t -142.72 152.59 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 120.45 1.477 . . . . 0.0 109.82 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.8 t -161.23 165.16 17.4 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.805 2.042 . . . . 0.0 107.31 165.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -87.04 -56.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.401 2.067 . . . . 0.0 111.514 165.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -145.63 -80.86 0.16 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.69 -36.12 0.22 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.198 1.399 . . . . 0.0 111.772 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.0 tt -60.87 -32.34 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.803 0.729 . . . . 0.0 110.787 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.85 -17.81 44.3 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.386 1.946 . . . . 0.0 113.843 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.9 mm -113.65 -0.66 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.534 1.934 . . . . 0.0 108.792 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 t -90.85 -85.15 0.23 Allowed 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.951 1.3 . . . . 0.0 108.134 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -81.29 -43.18 19.53 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.844 0.857 . . . . 0.0 108.979 -170.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -71.81 -14.4 61.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.864 -0.523 . . . . 0.0 112.104 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.84 -32.71 70.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.511 0.724 . . . . 0.0 112.249 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.15 -45.85 83.29 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.91 82.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.82 1.248 . . . . 0.0 110.827 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.2 mt -58.11 -46.87 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.63 75.84 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.917 -0.489 . . . . 0.0 111.012 -171.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -65.41 -24.08 67.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.887 1.275 . . . . 0.0 113.191 -172.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.24 -47.21 83.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.66 55.59 0.04 OUTLIER Glycine 0 C--N 1.333 0.391 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -135.26 171.19 14.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.09 0.956 . . . . 0.0 109.427 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.8 m -130.4 106.99 8.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.58 1.552 . . . . 0.0 107.953 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.76 -178.09 3.04 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.36 0.6 . . . . 0.0 111.363 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 p -107.61 -164.66 0.99 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 162.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 11.27 39.89 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.663 1.585 . . . . 0.0 111.191 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.13 -35.31 0.59 Allowed Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.04 172.89 17.87 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.135 1.374 . . . . 0.0 109.149 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -104.46 162.79 12.94 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.35 0.977 . . . . 0.0 109.717 170.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 120.48 11.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.299 0.239 . . . . 0.0 110.545 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.75 143.73 26.68 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.18 155.12 68.8 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.591 1.528 . . . . 0.0 109.276 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -64.64 -16.3 62.56 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -71.46 -57.91 4.0 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.761 0.824 . . . . 0.0 112.152 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.79 165.81 46.78 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 123.889 0.875 . . . . 0.0 111.131 -165.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -63.21 173.27 4.24 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.603 1.536 . . . . 0.0 110.665 160.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 p -111.96 175.16 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 127.016 2.126 . . . . 0.0 107.408 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.71 78.06 1.29 Allowed 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 120.947 -1.095 . . . . 0.0 111.482 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -55.78 -30.36 61.17 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.066 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -67.64 -36.37 80.65 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.397 -0.814 . . . . 0.0 112.076 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.25 -36.89 58.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.587 1.085 . . . . 0.0 109.761 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.57 -55.65 23.9 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.93 0.492 . . . . 0.0 109.918 175.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -62.97 -49.58 74.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.761 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -54.16 -49.78 68.48 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.357 0.526 . . . . 0.0 110.448 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.4 ptp -72.46 -40.72 66.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.68 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.73 -46.81 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 120.615 1.552 . . . . 0.0 109.376 -172.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -55.03 -44.73 74.92 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.615 1.166 . . . . 0.0 110.736 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -65.05 -50.89 64.44 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.76 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -23.67 65.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.417 1.008 . . . . 0.0 111.592 -172.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.6 mt -75.16 -57.11 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.284 1.034 . . . . 0.0 109.337 169.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -63.95 -31.32 72.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 123.244 1.497 . . . . 0.0 112.1 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.33 -1.8 25.4 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 126.29 1.836 . . . . 0.0 112.914 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -127.36 -0.03 6.33 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 126.763 2.025 . . . . 0.0 111.931 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.25 1.096 0 C-N-CA 124.92 1.288 . . . . 0.0 109.664 -172.881 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.414 ' CE1' ' HG2' ' A' ' 4' ' ' MET 0.267 2.0 p-80 . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.414 ' HG2' ' CE1' ' A' ' 3' ' ' HIS . 6.6 mmt -51.67 -44.9 63.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.182 1.393 . . . . 0.0 110.627 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.43 -28.15 68.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.995 1.318 . . . . 0.0 112.033 -170.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.4 t -76.18 -39.14 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -89.81 -11.71 41.27 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.874 1.27 . . . . 0.0 112.968 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.96 -20.27 64.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.931 0.892 . . . . 0.0 111.795 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.62 -16.57 51.09 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.567 1.147 . . . . 0.0 112.741 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -81.41 -49.45 10.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.739 1.616 . . . . 0.0 107.008 167.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -47.98 -49.58 30.22 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.788 1.235 . . . . 0.0 112.553 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -51.09 -34.97 32.66 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.646 0.778 . . . . 0.0 111.79 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.96 -1.09 80.27 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.7 -1.055 . . . . 0.0 113.23 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.0 mt -74.71 117.81 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 119.537 1.669 . . . . 0.0 106.983 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.81 -1.74 58.01 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.996 0.918 . . . . 0.0 112.73 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.07 79.64 8.57 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.005 1.722 . . . . 0.0 111.149 -176.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.92 -20.44 64.29 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 124.128 3.219 . . . . 0.0 114.428 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -7.91 51.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.018 0.826 . . . . 0.0 111.914 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -134.73 -2.75 2.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.271 0.628 . . . . 0.0 112.192 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -60.31 -64.62 0.89 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 127.226 2.21 . . . . 0.0 111.073 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -53.71 -32.46 51.98 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 125.65 1.58 . . . . 0.0 111.228 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -56.39 -33.59 65.89 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.188 -0.945 . . . . 0.0 113.468 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 m -69.48 -41.67 75.85 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.552 0.741 . . . . 0.0 109.548 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -65.06 -33.66 76.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.062 1.345 . . . . 0.0 111.27 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -58.66 -48.54 80.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.6 mt -62.64 -47.94 90.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.094 0.957 . . . . 0.0 109.67 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.9 mt -51.57 -65.8 0.49 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.896 0.878 . . . . 0.0 109.816 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -66.46 -30.47 70.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.171 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -60.7 -35.71 76.97 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 118.985 0.811 . . . . 0.0 110.661 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.3 m -74.65 -45.69 44.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 C-N-CA 117.045 -1.862 . . . . 0.0 106.681 -175.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.71 -13.92 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.777 -0.63 . . . . 0.0 112.473 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.95 -68.08 0.74 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 123.389 0.676 . . . . 0.0 111.473 159.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.434 HG23 ' HE3' ' A' ' 107' ' ' LYS . 9.6 m -73.6 -41.64 62.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.907 0.883 . . . . 0.0 111.879 -163.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -115.08 72.39 3.04 Favored Pre-proline 0 N--CA 1.44 -0.927 0 C-N-CA 129.045 2.938 . . . . 0.0 108.748 175.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.57 -9.65 21.49 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.324 2.683 . . . . 0.0 111.942 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -38.88 90.99 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.874 1.669 . . . . 0.0 112.318 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -79.09 145.17 33.93 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -172.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -110.98 150.27 41.65 Favored Pre-proline 0 C--N 1.319 -0.743 0 C-N-CA 124.628 1.171 . . . . 0.0 108.26 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.65 139.77 37.89 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.614 2.209 . . . . 0.0 109.764 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -154.03 102.52 2.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 53.5 mmm -70.65 105.04 3.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 167.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -110.33 143.0 41.2 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.5 m95 54.51 18.85 2.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 62.44 31.38 17.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.211 1.404 . . . . 0.0 110.943 -170.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.8 p -128.97 147.07 63.24 Favored Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 120.951 -1.093 . . . . 0.0 109.246 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -73.37 129.76 14.26 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.828 3.019 . . . . 0.0 112.717 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.24 165.46 36.31 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.461 1.104 . . . . 0.0 109.138 172.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -126.56 163.88 22.42 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.444 0.64 . . . . 0.0 109.918 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.8 m -136.52 119.85 16.83 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.412 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . 43.8 t30 -77.14 89.72 3.64 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 50.48 51.17 17.38 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.944 0.878 . . . . 0.0 109.291 -171.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.56 -0.43 56.8 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 117.319 1.688 . . . . 0.0 117.319 171.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -165.92 1.1 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.667 2.734 . . . . 0.0 111.975 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -127.2 12.09 7.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.723 1.609 . . . . 0.0 112.748 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.6 mt -64.51 5.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.629 1.972 . . . . 0.0 113.816 -163.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.6 tt -160.93 132.48 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 118.709 -2.494 . . . . 0.0 110.608 174.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.53 157.42 29.36 Favored Glycine 0 C--N 1.339 0.718 0 O-C-N 122.094 -0.379 . . . . 0.0 112.662 171.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -155.84 168.56 26.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.871 0.868 . . . . 0.0 111.729 -176.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.79 158.01 22.22 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 120.611 -1.305 . . . . 0.0 110.393 170.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.6 p -77.29 113.04 14.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.007 0.923 . . . . 0.0 110.232 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.8 t -90.35 168.03 12.2 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.21 -29.79 6.14 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.304 1.442 . . . . 0.0 113.97 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -145.92 10.69 1.19 Allowed 'General case' 0 C--O 1.238 0.469 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -158.07 159.04 35.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.634 0.773 . . . . 0.0 109.268 -173.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.4 165.45 17.2 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 158.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.2 p -141.65 131.65 24.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.3 t -146.1 140.54 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.509 1.05 . . . . 0.0 109.274 -168.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 t -163.78 164.34 14.99 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.928 1.291 . . . . 0.0 108.394 165.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -78.98 -58.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 CA-C-N 119.433 0.833 . . . . 0.0 112.357 165.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -154.87 -85.8 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -138.23 -44.61 0.51 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.235 1.014 . . . . 0.0 111.568 -173.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.5 tt -55.15 -31.85 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.106 0.963 . . . . 0.0 113.102 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.66 -28.49 5.19 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.075 1.798 . . . . 0.0 113.162 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.2 mm -113.24 -5.52 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 117.918 0.859 . . . . 0.0 111.188 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.5 m -76.23 -78.13 0.12 Allowed 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.898 -1.126 . . . . 0.0 109.955 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -86.71 -47.23 9.31 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -68.07 -20.15 64.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.172 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.26 -30.65 51.31 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.756 1.162 . . . . 0.0 112.987 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.34 -48.63 80.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.255 1.422 . . . . 0.0 109.508 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.85 -29.9 62.37 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.58 0.752 . . . . 0.0 111.307 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.49 -45.49 97.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.254 1.021 . . . . 0.0 108.526 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.17 -46.47 88.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.04 0.936 . . . . 0.0 110.338 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -54.03 -42.35 69.05 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.792 1.237 . . . . 0.0 110.839 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.15 8.34 9.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.48 34.96 30.55 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 119.538 1.063 . . . . 0.0 113.653 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -123.71 169.18 11.76 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.145 0.978 . . . . 0.0 109.486 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 m -135.94 106.82 6.63 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.353 1.061 . . . . 0.0 111.059 -171.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.24 170.53 4.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.519 0.728 . . . . 0.0 112.285 168.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.4 p -128.93 -179.96 5.39 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.709 2.403 . . . . 0.0 107.186 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.82 62.98 6.69 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 120.393 -1.442 . . . . 0.0 110.15 -177.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.26 -59.03 0.1 OUTLIER Glycine 0 CA--C 1.498 -0.972 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -171.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -157.6 177.28 11.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.447 -1.377 . . . . 0.0 110.573 -165.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -110.89 158.41 18.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 167.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -144.11 136.76 26.98 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.747 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.6 mm -117.29 142.75 30.68 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -169.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.46 154.6 60.5 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.87 1.713 . . . . 0.0 110.597 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -62.48 -21.89 65.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 172.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.59 -70.6 0.22 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.037 1.735 . . . . 0.0 111.405 172.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.72 153.34 43.81 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.348 0.659 . . . . 0.0 111.353 -161.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.21 -178.73 4.63 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.767 2.978 . . . . 0.0 113.599 -164.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.96 146.35 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 125.716 1.606 . . . . 0.0 110.43 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.99 119.54 35.66 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.28 1.432 . . . . 0.0 109.924 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -87.1 -18.08 31.33 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 123.273 0.629 . . . . 0.0 111.742 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.26 -58.98 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.304 1.042 . . . . 0.0 110.821 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.65 -48.88 79.92 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.62 -56.74 4.84 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.614 1.966 . . . . 0.0 109.933 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.435 ' HE2' ' OE1' ' A' ' 111' ' ' GLU . 22.9 tttt -60.99 -45.01 96.54 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.124 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -58.5 -53.69 55.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.416 1.007 . . . . 0.0 110.155 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -75.56 6.87 4.2 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.9 -52.1 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 120.199 1.363 . . . . 0.0 107.831 173.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.435 ' OE1' ' HE2' ' A' ' 107' ' ' LYS . 42.6 mt-10 -60.91 -40.71 94.18 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 119.227 0.921 . . . . 0.0 111.464 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -61.78 -48.52 80.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -32.02 73.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.959 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.9 -63.85 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.096 1.359 . . . . 0.0 109.123 165.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -69.55 -5.93 27.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.618 1.099 . . . . 0.0 113.317 -170.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -78.58 -50.16 12.02 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.403 1.881 . . . . 0.0 111.462 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -85.8 22.92 1.54 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.899 1.679 . . . . 0.0 111.873 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.253 1.246 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 169.167 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 . . . . . 0 N--CA 1.467 0.396 0 CA-C-O 119.483 -0.294 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 mmt -58.13 -19.17 30.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.714 0.806 . . . . 0.0 113.008 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -69.07 -43.65 74.15 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 121.36 -0.837 . . . . 0.0 110.169 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.69 -50.42 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.908 0.883 . . . . 0.0 109.011 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.1 4.41 52.24 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.869 0.868 . . . . 0.0 112.14 -166.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.12 79.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.062 0.945 . . . . 0.0 109.989 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.91 -21.01 64.25 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.124 0.97 . . . . 0.0 112.602 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -79.45 -56.4 4.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.479 0.711 . . . . 0.0 109.22 173.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -55.76 -40.62 72.84 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.427 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -52.06 -38.95 58.83 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.689 0.677 . . . . 0.0 111.247 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.84 -7.37 78.21 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-O 118.487 -1.174 . . . . 0.0 112.534 -166.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -70.54 119.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.8 1.02 56.56 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.953 1.301 . . . . 0.0 111.688 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.33 65.81 1.52 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.732 2.413 . . . . 0.0 109.837 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.46 -30.63 93.07 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 124.087 3.191 . . . . 0.0 113.807 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -59.16 -11.32 3.65 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.844 1.258 . . . . 0.0 113.287 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -126.48 -13.85 5.93 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.302 1.841 . . . . 0.0 110.04 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -66.32 -45.98 78.43 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.627 1.171 . . . . 0.0 110.14 -176.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.66 -33.56 64.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.826 1.25 . . . . 0.0 112.776 -171.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -56.67 -39.98 74.72 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.672 -0.643 . . . . 0.0 111.257 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.1 m -69.42 -39.08 78.09 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.195 1.398 . . . . 0.0 109.294 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -63.09 -45.28 92.85 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.04 -1.038 . . . . 0.0 111.815 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -53.85 -51.71 62.72 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 126.076 1.75 . . . . 0.0 108.984 176.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.6 mt -52.4 -56.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.797 1.639 . . . . 0.0 110.453 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.5 mt -53.35 -53.71 47.07 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.59 0.632 . . . . 0.0 110.197 -174.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.1 m -69.07 -31.98 71.11 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.578 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -63.22 -50.16 71.35 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 124.638 1.175 . . . . 0.0 110.506 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 87.3 t -59.93 -52.03 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.17 -1.46 4.43 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.72 -56.3 2.2 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 120.781 -1.199 . . . . 0.0 109.336 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -67.04 -33.58 75.85 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.734 2.013 . . . . 0.0 111.987 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -129.86 72.59 81.9 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.16 -6.73 17.55 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.108 1.872 . . . . 0.0 112.727 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -63.56 -45.8 88.82 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.686 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.405 ' H ' ' CD2' ' A' ' 37' ' ' LEU . 2.8 mm? -60.35 147.32 41.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.055 0.942 . . . . 0.0 108.955 -171.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -104.64 144.97 29.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 124.234 1.014 . . . . 0.0 108.879 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.79 161.29 46.12 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.497 2.131 . . . . 0.0 111.24 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -158.64 130.27 6.55 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.211 1.404 . . . . 0.0 107.681 161.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.17 112.48 17.53 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.551 1.069 . . . . 0.0 108.334 162.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -123.21 128.33 49.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.645 1.178 . . . . 0.0 108.242 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.9 m95 53.29 25.97 4.86 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.809 0.844 . . . . 0.0 113.062 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.59 29.02 18.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.502 1.121 . . . . 0.0 110.18 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -121.12 147.38 46.56 Favored Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -71.96 133.35 21.45 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.711 2.274 . . . . 0.0 111.758 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.0 ptm -147.28 173.3 12.7 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.804 0.442 . . . . 0.0 110.925 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -134.05 152.71 51.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.1 p -122.76 138.74 54.54 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.306 1.442 . . . . 0.0 108.006 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.418 ' C ' ' H ' ' A' ' 52' ' ' GLY . 25.6 t30 -88.35 95.27 10.13 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 163.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 66.78 -13.39 0.19 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.945 1.698 . . . . 0.0 114.046 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 50' ' ' ASN . . . 177.61 -19.63 0.04 OUTLIER Glycine 0 CA--C 1.54 1.646 0 C-N-CA 127.044 2.259 . . . . 0.0 113.887 174.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.44 -171.05 1.68 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -165.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -125.31 24.99 7.25 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.442 2.297 . . . . 0.0 111.786 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.529 HG21 HD21 ' A' ' 113' ' ' ASN . 97.1 mt -68.65 -2.41 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 126.648 1.979 . . . . 0.0 113.515 -167.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 tt -160.68 145.86 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 119.357 -2.09 . . . . 0.0 109.692 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.13 148.81 11.53 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 165.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -144.1 166.09 25.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.849 0.825 . . . . 0.0 109.944 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 t -150.51 145.42 25.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 57.5 p -62.51 145.86 53.15 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.449 ' HB2' ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -127.75 174.59 8.99 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -59.59 -39.24 83.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.377 -162.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -138.6 14.27 2.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.199 1.0 . . . . 0.0 113.079 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.449 ' CD2' ' HB2' ' A' ' 61' ' ' SER . 3.9 p-80 -150.64 176.74 10.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.962 1.305 . . . . 0.0 108.794 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.27 161.88 14.39 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 166.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.35 114.96 24.31 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.127 1.371 . . . . 0.0 108.63 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.9 136.36 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.3 0.955 . . . . 0.0 109.434 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 t -165.68 161.82 13.37 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 125.261 1.424 . . . . 0.0 107.621 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.51 -57.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.131 0 CA-C-N 120.434 1.191 . . . . 0.0 110.998 157.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -149.55 -85.91 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -133.2 -38.85 0.94 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.444 1.498 . . . . 0.0 111.796 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.7 tp -53.76 -38.09 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.67 1.188 . . . . 0.0 112.981 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.42 -21.87 14.33 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.468 1.509 . . . . 0.0 112.835 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.7 mm -119.93 -5.3 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.437 1.495 . . . . 0.0 110.561 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.2 m -95.06 -64.04 1.11 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 168.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -76.62 -66.52 0.8 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -72.48 -6.24 42.38 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.5 -164.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.32 49.24 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 118.238 -0.887 . . . . 0.0 112.545 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -62.75 -47.54 83.11 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.101 0.864 . . . . 0.0 109.82 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.89 -22.8 45.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.755 0.822 . . . . 0.0 110.977 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.92 -46.98 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.004 0.921 . . . . 0.0 108.935 164.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.83 88.52 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.503 1.121 . . . . 0.0 111.088 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -63.07 -15.64 57.23 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 126.868 2.067 . . . . 0.0 112.894 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.6 -15.35 42.84 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 118.475 0.579 . . . . 0.0 111.623 172.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.96 -22.24 19.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.754 2.121 . . . . 0.0 112.879 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -74.17 114.7 12.82 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.236 1.014 . . . . 0.0 110.191 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.1 m -75.11 4.76 6.25 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 48.21 -155.71 0.07 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.798 2.439 . . . . 0.0 112.026 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.0 p -126.4 -164.7 1.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.549 2.34 . . . . 0.0 105.732 163.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -71.73 -33.0 68.34 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.109 1.322 . . . . 0.0 111.515 172.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.56 -10.56 2.92 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 114.479 0.552 . . . . 0.0 114.479 -160.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 pp -149.6 175.88 11.14 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.646 1.178 . . . . 0.0 109.675 168.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -113.26 157.4 21.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.651 0.66 . . . . 0.0 109.546 167.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.1 mtt85 -128.23 155.18 44.96 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.28 142.56 38.16 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.88 155.09 23.3 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.985 1.79 . . . . 0.0 109.343 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -63.81 -17.73 63.4 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -67.0 -45.15 78.46 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.17 0.988 . . . . 0.0 112.086 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.7 156.12 45.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 122.882 0.473 . . . . 0.0 110.982 -157.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.33 165.93 29.98 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.513 2.142 . . . . 0.0 112.911 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.32 124.86 51.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -75.81 78.58 2.74 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.284 1.04 . . . . 0.0 113.148 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -59.62 -37.22 78.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.842 0.857 . . . . 0.0 112.351 173.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.59 -46.8 71.56 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 120.148 1.34 . . . . 0.0 110.437 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 -47.5 67.2 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.435 -0.791 . . . . 0.0 109.289 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.279 0.3 OUTLIER -72.55 -27.07 61.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.339 -175.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -54.33 -52.63 60.94 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.382 0.992 . . . . 0.0 109.591 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -56.73 -52.34 65.37 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.056 -170.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.8 ptp -65.46 -34.63 78.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.025 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -53.01 21.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.988 1.267 . . . . 0.0 109.002 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.63 -50.7 59.77 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -55.66 -52.8 62.6 Favored 'General case' 0 N--CA 1.441 -0.905 0 O-C-N 124.016 0.823 . . . . 0.0 111.068 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.529 HD21 HG21 ' A' ' 55' ' ' ILE . 13.4 t30 -63.67 -22.28 66.82 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.351 0.978 . . . . 0.0 112.844 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.2 mt -71.65 -57.47 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.943 0.897 . . . . 0.0 108.636 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -74.95 -5.93 46.53 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -75.1 -19.86 59.74 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.529 0.731 . . . . 0.0 110.383 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -101.69 16.69 25.0 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.792 2.437 . . . . 0.0 111.071 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 117.351 -1.309 . . . . 0.0 108.198 172.27 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.444 ' CE1' ' HG2' ' A' ' 4' ' ' MET 0.256 2.8 p-80 . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.444 ' HG2' ' CE1' ' A' ' 3' ' ' HIS . 3.4 mmt -55.91 -31.04 62.53 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 119.892 1.224 . . . . 0.0 111.26 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -53.11 -48.14 68.06 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.519 0.728 . . . . 0.0 111.475 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.31 -43.74 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 121.643 -0.661 . . . . 0.0 109.652 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -103.63 50.14 0.81 Allowed 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.156 0.983 . . . . 0.0 111.236 -171.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -126.2 -27.05 3.28 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.682 0.793 . . . . 0.0 110.374 168.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.83 -12.91 60.26 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.112 -0.993 . . . . 0.0 112.436 -173.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -78.85 -48.77 14.07 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.397 1.479 . . . . 0.0 109.029 163.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -60.2 -22.98 63.63 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.713 2.405 . . . . 0.0 112.923 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -61.01 -44.13 97.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.741 1.155 . . . . 0.0 109.475 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.96 10.23 51.73 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.609 1.1 . . . . 0.0 114.907 -164.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 mm -58.42 123.94 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.072 1.349 . . . . 0.0 108.254 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -56.94 -36.02 69.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.753 1.221 . . . . 0.0 113.107 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.4 ' HB3' ' HD1' ' A' ' 19' ' ' HIS . 1.8 m-70 -116.78 85.95 18.24 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 126.521 1.929 . . . . 0.0 110.928 -168.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.07 -23.62 75.82 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.305 2.003 . . . . 0.0 111.828 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.408 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 23.6 m-20 -65.9 -16.9 64.27 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.306 -0.871 . . . . 0.0 111.888 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.408 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 0.8 OUTLIER -128.85 -0.53 5.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.338 1.455 . . . . 0.0 110.763 179.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.9 ttp85 -53.96 -57.45 10.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.142 0.977 . . . . 0.0 109.484 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -48.31 -35.07 11.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.549 1.54 . . . . 0.0 112.39 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -60.63 -39.09 86.97 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.318 -1.489 . . . . 0.0 111.824 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.8 m -63.42 -49.78 72.41 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.675 0.79 . . . . 0.0 109.397 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.53 -30.63 61.08 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.567 1.547 . . . . 0.0 113.33 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.03 -58.94 6.38 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 118.775 0.716 . . . . 0.0 110.297 173.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 mt -57.66 -38.86 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 123.875 0.87 . . . . 0.0 110.415 -173.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.2 mt -56.33 -62.66 1.56 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.157 0.983 . . . . 0.0 110.189 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -64.25 -31.66 72.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -62.24 -43.33 99.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 117.493 -1.241 . . . . 0.0 110.876 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.25 -40.56 80.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.763 0 C-N-CA 116.92 -1.912 . . . . 0.0 107.37 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.96 -25.36 8.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 117.748 -1.12 . . . . 0.0 112.529 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.17 -27.65 14.46 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.403 ' CG2' ' HE3' ' A' ' 107' ' ' LYS . 7.3 m -94.82 -40.18 9.87 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.645 1.111 . . . . 0.0 111.251 -174.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -120.28 58.44 5.91 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 129.575 3.15 . . . . 0.0 111.823 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.08 -13.92 38.38 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.834 2.356 . . . . 0.0 113.722 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.29 -23.67 66.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.165 1.386 . . . . 0.0 112.427 172.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.87 145.58 44.74 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -117.59 150.47 46.83 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 126.964 2.106 . . . . 0.0 108.444 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.27 140.28 13.7 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.872 2.381 . . . . 0.0 111.67 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -164.85 96.49 0.73 Allowed 'General case' 0 C--N 1.346 0.439 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 ptm -70.21 136.39 49.96 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.422 1.01 . . . . 0.0 108.886 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -150.52 155.32 39.25 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.9 m95 52.71 33.37 13.78 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.563 1.145 . . . . 0.0 113.06 -174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 61.78 18.84 10.06 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.207 1.803 . . . . 0.0 112.476 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.0 p -129.49 155.97 79.33 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.92 1.288 . . . . 0.0 110.007 -173.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.81 120.75 5.93 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.968 3.112 . . . . 0.0 110.235 170.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.5 ptm -135.01 162.52 32.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 163.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.93 168.28 14.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 p -134.19 121.63 21.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.144 0.578 . . . . 0.0 109.56 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -68.46 92.9 0.46 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 169.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 53.58 28.67 8.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.478 1.111 . . . . 0.0 111.882 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.3 -17.81 7.89 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 125.636 1.589 . . . . 0.0 115.642 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -79.32 -179.13 6.59 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 119.799 1.8 . . . . 0.0 111.242 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -111.09 18.25 19.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.462 1.905 . . . . 0.0 113.554 -168.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.67 12.51 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.849 1.66 . . . . 0.0 112.495 -163.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 tt -163.31 146.28 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 119.558 -1.964 . . . . 0.0 111.249 174.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.48 151.03 18.21 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 166.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.17 -179.89 8.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.417 0.687 . . . . 0.0 111.078 175.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t 178.79 147.1 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.4 p -62.86 146.91 51.66 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.302 0.641 . . . . 0.0 110.504 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -126.74 165.18 19.74 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -12.51 18.2 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.52 8.29 0.38 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.485 1.039 . . . . 0.0 112.245 176.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -162.49 -179.88 7.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.869 1.668 . . . . 0.0 108.645 -164.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -127.67 154.22 45.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.801 2.041 . . . . 0.0 107.012 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 p -132.07 122.82 26.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.761 1.624 . . . . 0.0 108.954 -173.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.462 HG12 ' CE1' ' A' ' 93' ' ' PHE . 1.6 p -144.78 145.45 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.882 1.219 . . . . 0.0 111.663 -171.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.473 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 13.7 t -160.0 165.03 18.59 Favored Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 125.59 1.556 . . . . 0.0 109.581 169.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -81.49 -57.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.444 2.096 . . . . 0.0 112.936 156.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -149.17 -86.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.122 1.769 . . . . 0.0 106.964 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -152.47 -27.32 0.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.651 1.18 . . . . 0.0 112.55 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.8 tt -62.71 -40.16 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 120.576 1.534 . . . . 0.0 109.891 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.96 -10.91 15.89 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.002 1.286 . . . . 0.0 113.104 173.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mm -117.03 -0.57 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.734 2.014 . . . . 0.0 110.025 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 m -125.62 -50.54 1.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.488 0.585 . . . . 0.0 111.844 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -79.67 -57.42 3.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.987 1.715 . . . . 0.0 107.443 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -73.46 -0.76 15.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.261 1.024 . . . . 0.0 112.5 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.25 -25.47 67.85 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.477 1.911 . . . . 0.0 112.701 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -79.07 -48.02 15.12 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.557 0.743 . . . . 0.0 109.028 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.28 87.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.552 0.741 . . . . 0.0 110.834 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.85 -50.33 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.053 0.941 . . . . 0.0 109.839 171.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.53 -50.58 73.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.97 0.908 . . . . 0.0 111.368 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -60.06 -25.74 65.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.655 1.582 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.41 -27.14 63.1 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.175 0.443 . . . . 0.0 110.854 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 122.61 6.21 8.06 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.466 1.508 . . . . 0.0 113.431 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.07 122.23 44.23 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.459 1.63 . . . . 0.0 110.005 -173.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.43 3.83 12.41 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -170.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 46.52 -168.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.962 2.105 . . . . 0.0 113.277 -172.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.3 p -141.67 -164.7 1.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.347 2.259 . . . . 0.0 108.092 168.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 5.26 13.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.16 2.184 . . . . 0.0 112.047 173.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.5 -7.94 0.03 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 116.667 1.427 . . . . 0.0 116.667 -172.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.473 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 2.9 pp -149.29 170.71 17.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.112 1.456 . . . . 0.0 108.607 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.462 ' CE1' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -116.22 125.83 52.78 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 164.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -72.37 134.75 45.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.494 170.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.6 mm -125.72 143.71 45.96 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 165.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.68 163.68 38.15 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.154 1.903 . . . . 0.0 110.159 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -70.49 -35.12 73.07 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 171.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -67.76 -59.95 2.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.218 0.533 . . . . 0.0 110.469 -174.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.22 162.83 65.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.48 1.912 . . . . 0.0 109.455 -172.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.15 165.61 25.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.587 1.525 . . . . 0.0 113.391 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.0 t -93.44 134.91 29.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 126.413 1.885 . . . . 0.0 106.719 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.41 76.35 3.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.328 1.451 . . . . 0.0 110.721 171.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -56.47 -44.25 80.38 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.028 0.931 . . . . 0.0 110.461 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -65.18 -26.2 68.05 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.778 0.831 . . . . 0.0 111.749 -174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.96 -53.92 6.56 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.277 0.3 OUTLIER -58.72 -24.87 62.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.77 1.228 . . . . 0.0 112.022 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.403 ' HE3' ' CG2' ' A' ' 33' ' ' THR . 16.1 tttt -65.52 -54.0 34.4 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.785 2.034 . . . . 0.0 113.252 169.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -57.81 -46.42 84.71 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.877 1.217 . . . . 0.0 111.192 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.0 ptp -66.35 -32.21 73.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.307 -0.854 . . . . 0.0 113.226 -175.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -44.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.195 0.907 . . . . 0.0 108.987 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.08 -43.75 98.15 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.639 0.775 . . . . 0.0 110.717 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.26 -48.06 81.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.458 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -59.1 -40.47 85.39 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 118.161 0.437 . . . . 0.0 110.383 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.85 -52.06 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 O-C-N 121.319 -0.863 . . . . 0.0 110.084 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -71.56 -4.92 29.6 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 120.27 1.396 . . . . 0.0 112.413 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -93.78 2.57 56.2 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.658 1.983 . . . . 0.0 112.281 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -129.38 19.35 5.8 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.317 1.447 . . . . 0.0 111.216 -174.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 124.282 1.033 . . . . 0.0 109.586 175.71 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.2 mmt -60.1 -30.4 69.22 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.652 -0.655 . . . . 0.0 112.534 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.73 -43.85 71.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.57 -44.98 99.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.61 1.164 . . . . 0.0 109.917 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.43 0.05 55.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.953 0.501 . . . . 0.0 112.118 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.54 67.93 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.786 1.235 . . . . 0.0 109.46 173.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.33 -13.36 62.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.273 1.429 . . . . 0.0 113.526 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -82.67 -59.6 2.46 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -44.32 78.36 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.821 1.248 . . . . 0.0 110.811 -175.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -56.36 -32.55 64.83 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.424 0.69 . . . . 0.0 112.471 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.0 -22.73 57.09 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 119.251 -0.749 . . . . 0.0 111.379 -171.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.5 mt -74.84 98.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -66.58 -2.83 5.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.227 1.411 . . . . 0.0 113.437 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -100.01 84.97 0.46 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 128.662 2.785 . . . . 0.0 110.978 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.79 -36.79 82.62 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.533 2.155 . . . . 0.0 112.295 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.88 5.79 2.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.013 0.824 . . . . 0.0 112.476 -170.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -137.13 -36.77 0.66 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.395 1.878 . . . . 0.0 110.425 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -52.78 -40.37 63.12 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.85 0.86 . . . . 0.0 110.889 171.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.93 -22.72 60.41 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.616 1.166 . . . . 0.0 112.362 -176.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -81.99 -31.54 31.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.1 0.864 . . . . 0.0 111.853 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.2 m -72.94 -39.69 66.02 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.157 0.983 . . . . 0.0 110.492 -175.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.19 -26.04 68.62 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.731 0.412 . . . . 0.0 111.906 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.46 -54.65 44.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.835 0.854 . . . . 0.0 110.142 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.9 mp -63.83 -40.59 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -174.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.1 mt -52.92 -53.89 42.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.236 0.614 . . . . 0.0 110.101 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -62.47 -44.45 96.37 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.528 1.131 . . . . 0.0 111.228 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.8 t90 -59.04 -44.31 91.77 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.502 1.121 . . . . 0.0 111.664 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.25 -46.16 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.306 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.25 -12.7 21.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.493 1.042 . . . . 0.0 113.452 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.49 -48.59 7.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.348 164.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 m -78.83 -34.47 45.18 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 117.431 -1.271 . . . . 0.0 111.314 -163.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -117.47 76.17 9.56 Favored Pre-proline 0 C--N 1.344 0.333 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.23 -14.04 39.43 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.665 2.243 . . . . 0.0 113.338 -172.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -20.83 59.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.528 0.731 . . . . 0.0 111.658 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mp -70.29 151.16 45.6 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.564 1.546 . . . . 0.0 109.085 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -122.93 143.02 39.48 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 113.032 -1.895 . . . . 0.0 108.738 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.54 154.21 35.22 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.19 2.593 . . . . 0.0 110.488 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -176.95 102.58 0.05 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.155 1.782 . . . . 0.0 106.26 171.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 62.2 mmm -60.63 129.95 44.11 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -134.58 138.96 45.01 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.0 m95 58.76 19.77 7.22 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m120 64.03 12.18 6.73 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 126.578 1.951 . . . . 0.0 113.101 -166.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.0 p -114.51 112.54 45.86 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 120.356 1.435 . . . . 0.0 108.169 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.05 132.83 33.34 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.927 2.418 . . . . 0.0 111.648 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 ptm -143.26 159.19 42.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.431 ' H ' ' CG2' ' A' ' 56' ' ' ILE . 1.2 m-85 -123.94 109.29 13.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.6 p -73.24 120.82 19.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -67.12 98.33 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 163.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 50.68 -4.64 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 130.207 3.403 . . . . 0.0 117.617 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.44 25.24 0.09 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.76 1.648 . . . . 0.0 113.028 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -117.0 177.32 4.75 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.184 1.394 . . . . 0.0 108.481 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -120.68 25.99 9.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.731 1.612 . . . . 0.0 110.777 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.78 19.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 125.234 1.413 . . . . 0.0 111.552 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.431 ' CG2' ' H ' ' A' ' 48' ' ' PHE . 1.1 tt -165.72 162.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 119.684 -1.885 . . . . 0.0 109.16 166.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.51 91.62 0.08 OUTLIER Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 159.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -90.98 162.47 14.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.532 0.666 . . . . 0.0 110.897 -175.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.0 t -152.92 155.39 36.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.992 0.901 . . . . 0.0 110.399 164.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.6 p -72.8 156.33 39.02 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.185 2.194 . . . . 0.0 109.787 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.28 -179.04 5.43 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.916 1.286 . . . . 0.0 109.739 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -49.66 -59.84 3.43 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 125.085 1.354 . . . . 0.0 111.824 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -132.32 15.31 4.57 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.255 1.022 . . . . 0.0 111.184 -174.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -152.08 173.64 14.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.824 1.249 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.7 tp -111.79 157.87 20.04 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.715 1.606 . . . . 0.0 108.131 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.51 111.62 9.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.277 1.431 . . . . 0.0 110.281 -171.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.5 p -142.15 151.36 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.702 1.601 . . . . 0.0 113.876 -167.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 t -174.83 165.16 2.29 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.136 2.575 . . . . 0.0 109.422 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.99 -55.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 124.327 3.351 . . . . 0.0 112.956 164.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -156.12 -74.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.776 2.03 . . . . 0.0 108.401 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -156.1 -46.75 0.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.861 1.665 . . . . 0.0 110.722 -168.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 tp -55.96 -42.42 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.516 1.053 . . . . 0.0 110.845 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.13 -16.04 24.62 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.075 0.845 . . . . 0.0 114.178 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.4 mm -115.9 -6.88 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.032 1.733 . . . . 0.0 110.131 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.8 m -100.95 -61.22 1.4 Allowed 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 121.569 -0.707 . . . . 0.0 109.881 172.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -82.61 -39.97 21.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.889 2.476 . . . . 0.0 109.597 -172.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -99.38 -8.21 25.13 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.56 -29.78 70.24 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.896 0.771 . . . . 0.0 112.496 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.64 -51.23 70.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.791 0.805 . . . . 0.0 109.483 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.57 -28.87 66.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.416 1.486 . . . . 0.0 111.359 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.9 mt -64.91 -48.82 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 123.76 0.824 . . . . 0.0 108.976 168.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.59 79.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.203 0.525 . . . . 0.0 110.403 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.2 -24.67 67.35 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.991 0.917 . . . . 0.0 112.197 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.57 -4.24 41.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.494 0.588 . . . . 0.0 112.344 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.01 29.21 10.66 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 121.243 -0.911 . . . . 0.0 112.817 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -126.01 -179.99 4.95 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.468 1.134 . . . . 0.0 111.377 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.23 158.84 34.62 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.249 1.819 . . . . 0.0 111.034 -172.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.35 169.83 17.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.495 1.518 . . . . 0.0 110.917 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.2 p -136.47 -163.79 1.46 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 127.857 2.463 . . . . 0.0 107.956 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -94.78 77.03 3.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 166.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.14 6.6 5.28 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.726 166.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.9 159.44 29.69 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.948 1.374 . . . . 0.0 110.706 169.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -117.84 156.76 27.81 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.927 0.891 . . . . 0.0 108.693 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.99 120.11 30.63 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.996 0.919 . . . . 0.0 108.642 -161.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.0 mm -119.61 142.86 33.6 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.51 155.49 31.92 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.785 1.657 . . . . 0.0 109.385 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -57.85 -15.16 7.56 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 170.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.22 -45.92 65.58 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.379 1.471 . . . . 0.0 113.343 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.97 161.92 21.34 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 123.642 0.777 . . . . 0.0 110.227 -163.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -66.23 154.2 75.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.734 2.29 . . . . 0.0 110.899 172.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.3 t -85.98 132.38 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -73.58 81.62 1.5 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.488 1.515 . . . . 0.0 110.365 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -50.55 -48.17 57.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.728 1.211 . . . . 0.0 110.051 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.44 -46.94 66.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 123.433 0.458 . . . . 0.0 111.286 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.6 -47.51 47.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 119.507 1.049 . . . . 0.0 109.886 -171.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -27.0 66.81 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.591 0.757 . . . . 0.0 110.618 174.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -65.99 -59.5 3.76 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.296 1.438 . . . . 0.0 110.187 172.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -61.32 -38.63 87.55 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.698 0.681 . . . . 0.0 109.677 -170.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.8 ptp -72.25 -17.83 61.86 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.63 -53.18 8.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 121.088 1.767 . . . . 0.0 109.176 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.83 -46.67 42.38 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 125.545 1.538 . . . . 0.0 109.128 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -49.56 -41.08 40.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.27 -0.871 . . . . 0.0 113.195 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -29.04 42.65 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 120.33 1.423 . . . . 0.0 109.325 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.2 mt -78.09 -25.94 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 120.711 -1.243 . . . . 0.0 110.202 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -84.32 -2.59 57.3 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.278 1.399 . . . . 0.0 112.165 166.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -92.57 -38.07 12.11 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.278 0.561 . . . . 0.0 110.975 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.59 24.34 3.11 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.059 1.344 . . . . 0.0 112.151 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.243 0.712 0 C-N-CA 124.845 1.258 . . . . 0.0 108.807 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 . . . . . 0 CA--C 1.525 0.01 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.9 mmt -60.7 -25.5 66.45 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.361 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.85 -53.06 62.5 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 118.578 0.626 . . . . 0.0 109.931 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.37 -44.63 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -175.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -76.46 -13.16 60.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 111.799 -171.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.6 91.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.787 0.835 . . . . 0.0 110.677 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -72.66 -9.31 58.46 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -83.22 -57.08 3.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.571 -0.706 . . . . 0.0 109.77 159.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -56.59 -37.19 70.28 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -170.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -51.46 -29.82 17.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.479 1.112 . . . . 0.0 112.279 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.35 4.15 62.04 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 117.025 -1.986 . . . . 0.0 113.615 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.08 102.87 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.395 0 CA-C-N 120.963 2.381 . . . . 0.0 107.978 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -0.59 2.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.331 2.253 . . . . 0.0 113.528 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -117.43 64.27 4.05 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 128.779 2.832 . . . . 0.0 109.993 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -62.73 -17.55 59.63 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.92 3.08 . . . . 0.0 112.822 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.64 -14.15 62.69 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.748 1.219 . . . . 0.0 112.592 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.95 -1.25 1.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.493 1.517 . . . . 0.0 110.295 -172.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -55.97 -58.58 7.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.665 1.586 . . . . 0.0 110.352 -173.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -54.01 -31.18 50.32 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.059 1.744 . . . . 0.0 112.471 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -52.88 -35.76 58.24 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.82 -0.55 . . . . 0.0 110.333 174.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -67.75 -47.62 68.73 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.25 1.42 . . . . 0.0 110.435 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.89 -31.95 73.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.821 1.648 . . . . 0.0 110.345 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HB3' ' HH ' ' A' ' 103' ' ' TYR . 51.5 mt-10 -58.15 -57.9 10.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.346 1.058 . . . . 0.0 108.513 173.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.3 mt -56.93 -46.71 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.4 mt -59.25 -49.65 77.01 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.901 0.773 . . . . 0.0 110.334 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -61.13 -43.05 99.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.791 1.236 . . . . 0.0 110.878 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -66.7 -42.75 85.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.627 1.971 . . . . 0.0 111.211 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 t -59.2 -54.59 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-N 119.26 0.936 . . . . 0.0 108.702 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.65 -1.31 1.78 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.612 0.765 . . . . 0.0 112.945 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.61 -68.1 0.87 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.782 1.233 . . . . 0.0 109.027 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -62.66 -32.91 74.05 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.334 1.853 . . . . 0.0 111.368 -170.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.23 68.42 18.73 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.94 -4.77 15.5 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.382 2.721 . . . . 0.0 113.105 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.01 -14.32 50.97 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.634 -1.291 . . . . 0.0 110.768 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.0 mt -80.92 149.59 29.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.236 0.925 . . . . 0.0 109.383 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -132.3 151.12 77.75 Favored Pre-proline 0 C--O 1.221 -0.42 0 C-N-CA 125.517 1.527 . . . . 0.0 111.78 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.42 132.8 18.15 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.521 2.814 . . . . 0.0 112.365 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -148.84 127.16 12.2 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.03 125.31 35.79 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 168.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -153.54 150.7 28.98 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 119.265 0.939 . . . . 0.0 111.701 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.3 m95 53.9 24.66 4.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.1 t30 65.11 10.25 6.19 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.923 2.089 . . . . 0.0 113.312 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.86 149.09 40.29 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.99 136.32 16.37 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.244 1.962 . . . . 0.0 109.88 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 17.4 ptm -142.89 -176.81 5.04 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.628 1.171 . . . . 0.0 108.11 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -140.35 157.12 46.04 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 117.751 -1.119 . . . . 0.0 108.682 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.1 p -117.07 132.58 56.65 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 120.589 1.541 . . . . 0.0 109.543 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -74.34 95.25 2.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 161.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 44.81 41.75 5.4 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.137 1.775 . . . . 0.0 112.941 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 115.06 -20.63 14.13 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.373 1.463 . . . . 0.0 114.502 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.433 HG21 ' H ' ' A' ' 54' ' ' PHE . 1.8 m -77.12 -175.92 3.81 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.63 1.972 . . . . 0.0 110.907 -171.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.433 ' H ' HG21 ' A' ' 53' ' ' THR . 21.0 t80 -124.11 22.25 8.73 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.256 -1.527 . . . . 0.0 112.88 -169.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 mt -68.23 8.54 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 127.341 2.256 . . . . 0.0 113.464 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 tt -162.52 148.47 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 121.853 2.115 . . . . 0.0 111.42 172.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.49 154.0 23.44 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.384 0.993 . . . . 0.0 111.433 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.41 170.46 20.06 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.637 1.219 . . . . 0.0 110.947 174.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.14 116.24 3.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.313 1.045 . . . . 0.0 108.827 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.2 p -62.22 130.68 46.5 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 119.907 1.231 . . . . 0.0 109.86 -170.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.4 t -90.53 171.25 9.54 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -55.72 -52.71 62.96 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 167.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -134.87 54.56 1.93 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.5 0.72 . . . . 0.0 109.726 -171.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.466 ' CD2' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER 175.84 170.66 0.37 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.638 2.375 . . . . 0.0 110.271 174.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tp -112.99 150.27 32.13 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.589 2.355 . . . . 0.0 106.768 153.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -132.76 121.32 22.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.473 2.709 . . . . 0.0 111.138 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.88 144.1 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 127.273 2.229 . . . . 0.0 111.314 -163.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.9 t -156.82 163.26 25.64 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 159.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.18 -57.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 120.736 0.957 . . . . 0.0 110.511 157.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -150.78 -86.5 0.08 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 171.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.26 -25.9 0.84 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.707 1.203 . . . . 0.0 112.584 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.0 tp -57.4 -41.47 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 121.065 1.757 . . . . 0.0 109.85 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.79 -23.4 10.58 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.445 1.021 . . . . 0.0 113.95 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.9 mm -111.73 -3.56 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.983 2.113 . . . . 0.0 110.237 -172.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.3 m -116.36 -54.31 2.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.349 1.06 . . . . 0.0 109.654 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -78.28 -51.85 9.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.112 2.165 . . . . 0.0 108.288 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -95.39 -3.22 47.5 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -167.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.57 -30.3 70.57 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -69.13 -42.07 76.53 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.984 0.811 . . . . 0.0 109.135 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.44 -45.85 92.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.277 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.0 mt -58.91 -43.41 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.464 0.705 . . . . 0.0 109.67 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.75 -53.47 57.86 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.278 0.631 . . . . 0.0 110.089 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.9 -21.71 62.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.609 0.763 . . . . 0.0 112.014 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.22 8.09 2.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.372 0.987 . . . . 0.0 111.566 170.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.74 37.24 57.54 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 121.142 -0.974 . . . . 0.0 112.043 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -136.8 161.18 36.68 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.055 0.942 . . . . 0.0 110.311 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -122.51 97.57 5.52 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.64 -0.662 . . . . 0.0 110.828 -160.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.87 165.04 7.18 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.518 0.675 . . . . 0.0 111.117 171.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.6 p -105.81 -165.55 1.12 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 157.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -77.62 -4.04 43.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.667 166.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.96 -11.42 0.42 Allowed Glycine 0 CA--C 1.529 0.918 0 CA-C-N 120.444 1.475 . . . . 0.0 115.535 -168.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.19 178.58 9.59 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.116 1.458 . . . . 0.0 110.472 164.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -122.68 144.36 49.19 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 165.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HD2' ' NE2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -139.12 154.95 48.19 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 120.625 -1.297 . . . . 0.0 110.047 -170.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.466 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 44.3 mm -143.05 142.36 21.68 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -163.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.08 153.05 72.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 CA-C-N 121.01 1.396 . . . . 0.0 109.886 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -69.88 92.1 0.68 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 157.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.38 -59.46 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 126.305 1.842 . . . . 0.0 108.749 166.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -90.52 157.23 44.71 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.803 -159.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.46 114.86 4.06 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.988 1.792 . . . . 0.0 110.886 -172.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.69 119.68 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.828 1.651 . . . . 0.0 107.99 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -76.03 85.83 2.93 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 126.034 1.734 . . . . 0.0 113.072 -173.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.453 ' HH ' ' HB3' ' A' ' 25' ' ' GLU . 7.7 m-30 -56.01 -43.82 78.11 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 124.348 1.059 . . . . 0.0 110.854 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -56.46 -51.67 67.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.729 1.212 . . . . 0.0 111.872 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -42.73 95.31 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.607 -0.683 . . . . 0.0 109.888 -177.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.302 0.2 OUTLIER -75.93 -24.66 55.55 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.76 -176.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.77 -44.65 85.17 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 120.19 1.359 . . . . 0.0 109.899 171.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -56.53 -50.44 71.84 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.75 0.704 . . . . 0.0 109.688 -175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 ptp -67.1 -35.35 79.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.224 -0.894 . . . . 0.0 113.192 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -49.65 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.651 1.114 . . . . 0.0 109.068 177.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -58.5 -42.72 88.29 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.694 1.198 . . . . 0.0 110.949 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.41 -51.11 67.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.431 -0.795 . . . . 0.0 109.514 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -69.81 -10.4 58.3 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.883 1.219 . . . . 0.0 113.573 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 76.4 mt -75.17 -59.88 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.396 1.078 . . . . 0.0 108.525 161.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -75.7 -15.62 60.27 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 121.601 -0.687 . . . . 0.0 112.737 -165.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.64 -11.14 59.96 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.676 1.99 . . . . 0.0 112.034 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -106.06 15.08 26.92 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.974 2.109 . . . . 0.0 110.498 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.249 1.071 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.091 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.261 5.6 p-80 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 116.264 1.949 . . . . 0.0 116.264 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 mmt -51.62 -34.09 36.07 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.872 1.669 . . . . 0.0 112.311 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.02 -24.5 54.14 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.66 -25.86 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 120.896 0.379 . . . . 0.0 110.333 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -114.43 -5.53 12.88 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.12 1.768 . . . . 0.0 113.122 -173.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.78 -22.79 45.82 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 120.508 -1.37 . . . . 0.0 112.082 -169.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.27 -8.73 54.75 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.762 -0.587 . . . . 0.0 111.848 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -68.0 -57.75 5.64 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 160.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -46.63 -50.18 18.0 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.641 1.577 . . . . 0.0 112.964 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -53.06 -29.91 32.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.8 9.68 29.88 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.058 -1.412 . . . . 0.0 114.635 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mt -69.12 111.53 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 120.705 2.252 . . . . 0.0 105.958 167.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.0 -9.43 59.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.815 0.846 . . . . 0.0 113.208 -173.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.83 73.42 34.14 Favored Pre-proline 0 N--CA 1.445 -0.695 0 C-N-CA 125.017 1.327 . . . . 0.0 110.776 -168.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.77 -18.75 53.36 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.749 2.966 . . . . 0.0 114.875 -167.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -64.15 -10.66 24.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.266 0.626 . . . . 0.0 110.533 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -119.28 -6.84 10.33 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.58 1.952 . . . . 0.0 112.039 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.95 -49.02 12.47 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.114 -0.991 . . . . 0.0 110.48 -171.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.68 -42.6 79.32 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.774 0.671 . . . . 0.0 110.064 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.52 -56.96 10.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 123.899 0.88 . . . . 0.0 110.426 171.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.3 m -58.43 -38.83 78.26 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.548 1.139 . . . . 0.0 110.629 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -30.87 66.43 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.769 1.628 . . . . 0.0 114.068 171.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -63.75 -51.1 66.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.972 -0.537 . . . . 0.0 109.806 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mp -57.9 -52.62 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.34 -61.34 2.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.536 1.134 . . . . 0.0 109.941 -170.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m -71.36 -31.53 67.44 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.802 -1.094 . . . . 0.0 111.054 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 74.3 t90 -61.31 -48.07 83.07 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.575 1.079 . . . . 0.0 111.316 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.0 t -58.15 -48.89 83.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.96 -15.29 63.54 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.77 -62.4 1.55 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.052 0.941 . . . . 0.0 109.529 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 m -68.97 -27.51 65.79 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.774 0.83 . . . . 0.0 110.886 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -124.21 73.62 58.32 Favored Pre-proline 0 N--CA 1.443 -0.822 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.8 -5.58 17.45 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.343 2.029 . . . . 0.0 111.763 175.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.63 -36.55 84.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.54 1.136 . . . . 0.0 112.013 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.447 ' CD2' ' H ' ' A' ' 37' ' ' LEU . 1.4 mm? -78.84 139.59 38.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -172.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -88.59 147.01 38.55 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 171.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.53 142.04 14.35 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.655 2.903 . . . . 0.0 111.348 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -146.8 139.04 24.77 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.738 0.699 . . . . 0.0 109.966 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 ttm -99.85 107.65 19.72 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -125.48 151.39 46.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.946 1.699 . . . . 0.0 107.078 170.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.0 m95 55.78 21.26 4.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.594 1.558 . . . . 0.0 114.749 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.07 26.23 11.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.341 1.056 . . . . 0.0 111.424 -168.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.4 p -119.1 146.91 41.57 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.459 1.504 . . . . 0.0 109.255 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.24 122.19 7.81 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.629 2.219 . . . . 0.0 109.74 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.5 ptm -137.26 167.38 21.7 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.363 0.601 . . . . 0.0 109.998 169.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.23 169.74 13.17 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.466 -2.049 . . . . 0.0 105.466 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 p -154.31 135.33 13.86 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 120.253 -1.529 . . . . 0.0 107.702 166.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -76.94 114.41 15.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 164.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 44.52 53.88 6.76 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.144 0.978 . . . . 0.0 112.656 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.7 9.07 86.46 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 170.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 55' ' ' ILE . 1.4 t -69.16 -164.65 0.06 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.007 1.403 . . . . 0.0 112.042 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -132.99 22.19 4.15 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 118.358 2.725 . . . . 0.0 118.358 162.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.538 ' H ' HG22 ' A' ' 53' ' ' THR . 10.1 mt -62.22 10.48 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 O-C-N 119.427 -2.046 . . . . 0.0 115.005 -170.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.3 tt -164.33 141.58 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 123.162 2.71 . . . . 0.0 112.048 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.4 140.33 3.83 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.001 1.286 . . . . 0.0 110.977 166.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -132.35 170.15 15.49 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.94 1.296 . . . . 0.0 111.505 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -152.87 161.13 42.94 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.678 156.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p -59.69 153.18 20.81 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 171.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 t -144.58 170.55 15.84 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.224 1.012 . . . . 0.0 108.394 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -62.67 -21.95 66.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -156.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.84 14.13 0.73 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.007 0.821 . . . . 0.0 111.844 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -156.52 169.85 23.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.084 1.754 . . . . 0.0 109.693 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.01 145.11 30.63 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 164.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -104.1 117.34 34.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.928 1.24 . . . . 0.0 109.727 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.42 ' HB ' ' CE1' ' A' ' 93' ' ' PHE . 39.0 t -128.42 147.96 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 120.282 1.401 . . . . 0.0 107.835 176.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.0 t -167.31 165.58 8.79 Favored Pre-proline 0 C--O 1.243 0.723 0 C-N-CA 125.709 1.604 . . . . 0.0 107.396 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -94.13 -57.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 119.394 0.819 . . . . 0.0 113.211 158.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -147.08 -85.78 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.162 1.385 . . . . 0.0 107.841 -173.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -143.98 -29.26 0.5 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.854 2.462 . . . . 0.0 110.825 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.0 tt -62.04 -41.53 91.45 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 119.451 1.023 . . . . 0.0 111.413 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.25 -19.89 13.69 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.369 1.938 . . . . 0.0 112.928 177.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.6 mm -121.47 -0.41 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.209 1.804 . . . . 0.0 109.767 -172.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.1 m -98.23 -78.77 0.48 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.37 -51.12 10.54 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.643 0.656 . . . . 0.0 109.294 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -65.75 -17.49 64.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.573 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.89 -32.65 63.91 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.31 -40.54 93.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.959 0.885 . . . . 0.0 110.134 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.77 76.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.401 -0.812 . . . . 0.0 111.462 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.26 -46.27 92.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.538 1.135 . . . . 0.0 108.714 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.39 -47.92 82.29 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.049 1.34 . . . . 0.0 111.861 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -63.91 -30.08 71.2 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.716 0.807 . . . . 0.0 112.044 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.25 83.18 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.842 0.746 . . . . 0.0 109.6 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.12 -2.2 3.54 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.161 1.362 . . . . 0.0 112.965 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -92.76 157.69 16.29 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.514 1.657 . . . . 0.0 111.265 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.0 m -118.93 156.55 29.35 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.137 0.975 . . . . 0.0 110.516 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.24 165.9 17.47 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.13 0.972 . . . . 0.0 110.646 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -83.58 -164.55 0.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 165.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -63.41 -27.44 69.3 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.164 -0.96 . . . . 0.0 112.672 165.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.98 -14.03 0.78 Allowed Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.568 0.987 . . . . 0.0 115.568 -156.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 pp -152.79 163.9 38.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.739 1.77 . . . . 0.0 111.05 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.42 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 20.7 p90 -107.17 146.8 30.9 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.559 -0.713 . . . . 0.0 110.061 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -131.78 91.21 2.95 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 123.225 0.61 . . . . 0.0 110.237 -165.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -79.83 141.97 55.98 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 -176.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.23 157.34 41.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.318 2.012 . . . . 0.0 109.95 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -69.1 -16.39 63.66 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -63.71 -38.33 90.7 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.669 0.668 . . . . 0.0 112.45 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -129.64 150.97 77.22 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.945 1.298 . . . . 0.0 108.638 -165.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.38 147.14 17.87 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.311 2.674 . . . . 0.0 113.972 -164.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 m -68.3 126.56 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 121.261 -0.899 . . . . 0.0 109.49 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -79.48 98.63 6.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.836 0.854 . . . . 0.0 110.753 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -61.09 -25.56 67.04 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.311 1.044 . . . . 0.0 112.505 -174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -65.69 -56.03 14.25 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.515 -0.74 . . . . 0.0 110.908 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.06 -39.76 91.09 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.543 -0.723 . . . . 0.0 110.841 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.7 mt -52.2 -53.59 41.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.872 1.669 . . . . 0.0 110.017 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.51 -42.06 75.21 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.579 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -58.82 -44.47 90.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.346 0.976 . . . . 0.0 111.816 -175.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 ptp -73.27 -41.38 63.69 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 118.254 0.479 . . . . 0.0 111.912 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -47.75 54.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -173.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.61 -41.08 85.07 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.48 1.036 . . . . 0.0 109.461 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -54.85 -49.57 70.78 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.529 0.332 . . . . 0.0 111.395 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.46 -29.59 70.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.023 0.929 . . . . 0.0 112.413 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.89 -31.3 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.631 1.105 . . . . 0.0 110.701 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -81.6 2.18 30.5 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.028 -1.045 . . . . 0.0 112.196 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -90.65 -40.51 11.85 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.442 -0.786 . . . . 0.0 113.032 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -97.12 23.56 7.22 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.184 1.394 . . . . 0.0 110.451 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 117.404 -1.284 . . . . 0.0 111.326 -177.594 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.23 -28.72 19.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.106 0.962 . . . . 0.0 111.294 172.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.83 -30.25 63.59 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.176 1.39 . . . . 0.0 113.333 177.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.3 t -81.0 -33.26 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.497 1.119 . . . . 0.0 111.485 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -89.04 -16.07 32.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.645 1.178 . . . . 0.0 113.378 -174.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.94 77.85 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.192 0.997 . . . . 0.0 112.025 -167.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.68 -5.61 53.54 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.521 1.528 . . . . 0.0 112.52 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -93.69 -45.39 7.71 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.018 1.281 . . . . 0.0 110.057 161.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -49.38 -42.68 42.94 Favored 'General case' 0 CA--C 1.523 -0.085 0 C-N-CA 123.95 0.9 . . . . 0.0 111.316 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -49.7 -36.65 25.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.351 1.06 . . . . 0.0 113.379 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.77 0.42 39.2 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 117.703 -1.609 . . . . 0.0 113.045 -168.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.9 mt -71.71 101.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.88 2.57 2.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.232 1.813 . . . . 0.0 113.512 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.51 ' CG ' ' HD1' ' A' ' 19' ' ' HIS . 0.3 OUTLIER -114.52 72.06 2.5 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 128.379 2.672 . . . . 0.0 111.159 -166.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.68 -11.37 31.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 124.125 3.217 . . . . 0.0 114.664 -172.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -81.99 -9.02 59.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.242 0.617 . . . . 0.0 112.365 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' HD1' ' CG ' ' A' ' 16' ' ' HIS . 17.6 m80 -129.07 -28.12 2.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.569 1.148 . . . . 0.0 112.38 -175.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -52.71 -45.2 66.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.775 1.23 . . . . 0.0 113.137 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -32.39 73.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.11 0.868 . . . . 0.0 110.816 -174.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -68.92 -41.23 78.43 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.637 1.108 . . . . 0.0 111.844 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.9 m -55.08 -39.78 69.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.594 0.758 . . . . 0.0 109.621 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.89 -35.83 80.92 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.483 1.513 . . . . 0.0 112.095 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -62.35 -48.28 80.48 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.396 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.5 mt -61.91 -44.53 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.666 0.666 . . . . 0.0 109.512 -177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.77 -68.01 0.21 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.961 1.305 . . . . 0.0 108.852 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.2 p -66.18 -28.0 68.43 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.591 1.157 . . . . 0.0 112.932 -170.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 43.9 t90 -56.52 -46.74 80.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.63 1.572 . . . . 0.0 110.889 173.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.48 -37.38 70.02 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 C-N-CA 116.791 -1.964 . . . . 0.0 108.499 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.64 -8.44 0.24 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.601 1.16 . . . . 0.0 113.609 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.28 -65.24 1.0 Allowed 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.89 -1.131 . . . . 0.0 110.716 158.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.97 -34.68 59.8 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.297 0.499 . . . . 0.0 111.995 -161.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.7 66.53 10.11 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 127.511 2.324 . . . . 0.0 109.263 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.17 -6.97 19.84 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.021 2.48 . . . . 0.0 112.42 -172.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -81.7 -11.75 58.92 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.119 0.968 . . . . 0.0 111.849 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.0 mt -74.92 143.45 43.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -119.52 152.51 53.15 Favored Pre-proline 0 C--N 1.322 -0.598 0 C-N-CA 127.718 2.407 . . . . 0.0 107.844 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -75.69 156.79 40.02 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.02 2.48 . . . . 0.0 111.073 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -171.96 106.59 0.21 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 126.327 1.851 . . . . 0.0 106.15 163.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 ppp? -78.03 134.09 37.84 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.321 0.964 . . . . 0.0 108.857 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.97 152.4 38.58 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.112 1.365 . . . . 0.0 109.224 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.6 m95 51.87 34.06 12.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.254 1.022 . . . . 0.0 113.171 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 57.74 20.88 6.83 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.444 1.498 . . . . 0.0 112.123 -173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.5 p -116.6 148.43 41.87 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.022 1.329 . . . . 0.0 108.588 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.05 144.45 42.55 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.451 2.101 . . . . 0.0 109.136 164.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.2 ptm -160.91 177.62 10.2 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 165.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.43 176.11 8.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.508 1.123 . . . . 0.0 108.134 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.4 p -146.98 134.54 20.95 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.984 -1.072 . . . . 0.0 108.752 172.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.466 ' H ' HG21 ' A' ' 53' ' ' THR . 30.7 t30 -75.83 111.32 11.06 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 165.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 49.18 43.79 22.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.661 0.784 . . . . 0.0 112.768 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.2 76.62 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.082 170.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.562 HG23 ' H ' ' A' ' 55' ' ' ILE . 1.7 t -61.67 -163.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 128.46 2.704 . . . . 0.0 117.349 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -129.11 29.55 5.15 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 157.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.562 ' H ' HG23 ' A' ' 53' ' ' THR . 38.0 mt -60.11 9.16 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 127.129 2.172 . . . . 0.0 114.024 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 tt -159.02 157.94 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 122.647 2.476 . . . . 0.0 112.93 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.61 164.36 23.14 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.841 0.734 . . . . 0.0 112.963 159.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -160.12 177.58 10.55 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.471 1.108 . . . . 0.0 112.142 -170.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.5 p -172.44 148.77 2.08 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.442 1.019 . . . . 0.0 109.172 170.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.1 p -63.96 129.1 38.69 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.428 -0.795 . . . . 0.0 108.975 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 t -97.43 -178.12 4.04 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 158.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -54.44 -65.49 0.57 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.686 -0.634 . . . . 0.0 110.281 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -101.82 2.17 37.98 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -164.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.433 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 6.8 p-80 -160.41 149.75 17.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.25 1.02 . . . . 0.0 109.556 -166.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -89.71 143.19 27.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 161.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.57 141.39 51.75 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.183 0.993 . . . . 0.0 110.275 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -159.46 155.79 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.003 0.921 . . . . 0.0 112.939 -167.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 29.5 t -163.08 165.53 14.57 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.295 1.838 . . . . 0.0 108.093 168.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.46 -56.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 121.853 1.702 . . . . 0.0 111.781 159.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -146.07 -86.17 0.11 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -138.28 -37.56 0.56 Allowed 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.77 1.628 . . . . 0.0 109.936 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.5 tt -57.27 -35.57 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.078 0.854 . . . . 0.0 111.42 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.58 -20.86 8.12 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 126.998 2.237 . . . . 0.0 113.444 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.5 mm -118.15 -14.7 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 127.185 2.194 . . . . 0.0 110.001 -172.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.8 m -81.92 -79.83 0.17 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.023 0.929 . . . . 0.0 109.542 166.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -87.9 -48.08 8.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -164.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -63.94 -19.21 64.96 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.08 -31.86 61.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.611 -1.185 . . . . 0.0 113.145 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -67.91 -52.47 35.98 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.857 0.753 . . . . 0.0 109.684 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.41 82.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.593 0.757 . . . . 0.0 110.982 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.31 -43.75 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.288 1.035 . . . . 0.0 109.699 175.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.15 80.99 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.06 0.944 . . . . 0.0 110.901 -173.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -27.76 57.71 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.015 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.94 8.56 22.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.044 0.838 . . . . 0.0 112.14 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.66 36.82 24.97 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 121.191 -0.943 . . . . 0.0 112.527 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -125.41 154.47 41.89 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.083 0.953 . . . . 0.0 109.721 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.9 t -114.49 124.38 51.76 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.393 0.615 . . . . 0.0 110.746 -163.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.77 159.75 22.43 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.358 0.663 . . . . 0.0 110.728 174.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -118.7 -162.59 0.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.593 1.957 . . . . 0.0 106.153 164.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -31.3 72.46 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 169.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -151.64 -6.07 0.15 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 114.218 0.447 . . . . 0.0 114.218 -156.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.42 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.9 pp -146.06 161.82 39.28 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.643 1.577 . . . . 0.0 108.006 169.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -122.15 157.27 31.9 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.433 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -132.03 142.4 49.55 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.504 -177.339 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 mp -105.58 142.2 24.25 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.02 151.45 44.76 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.029 2.486 . . . . 0.0 109.578 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -64.61 -19.05 65.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -31.51 72.74 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.88 1.218 . . . . 0.0 112.478 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.66 161.85 37.61 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 123.961 0.904 . . . . 0.0 110.181 -161.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.64 161.6 43.54 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.559 1.506 . . . . 0.0 110.862 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.4 t -89.24 130.71 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.07 89.21 4.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.176 1.39 . . . . 0.0 109.366 -176.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -67.24 -31.7 72.23 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.636 1.174 . . . . 0.0 112.532 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.51 -51.21 70.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.611 1.164 . . . . 0.0 109.753 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -68.28 -41.18 81.38 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 120.611 1.551 . . . . 0.0 110.865 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -50.18 51.87 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 123.473 0.709 . . . . 0.0 109.121 176.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -58.63 -55.48 34.55 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.988 1.315 . . . . 0.0 110.006 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -59.17 -35.74 74.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.492 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -87.8 -6.82 57.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 117.496 -1.24 . . . . 0.0 113.718 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.89 -54.23 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 120.977 1.717 . . . . 0.0 109.224 172.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -53.15 -48.6 67.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.023 1.329 . . . . 0.0 109.777 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -52.77 -45.81 67.28 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.24 -34.65 73.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.004 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.13 -52.03 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -72.23 -15.03 61.93 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.32 -37.9 27.61 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.49 1.516 . . . . 0.0 110.705 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.54 23.29 3.07 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.7 2.4 . . . . 0.0 111.821 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 124.523 1.129 . . . . 0.0 108.921 168.215 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.71 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.7 m -62.39 140.4 58.55 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.517 1.159 . . . . 0.0 109.257 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -150.57 -31.88 0.18 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.781 -0.628 . . . . 0.0 112.073 174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 mmt -56.02 -41.38 74.82 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.56 -28.51 55.35 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.857 1.263 . . . . 0.0 113.945 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.62 -53.3 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -81.58 -28.66 33.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.68 1.592 . . . . 0.0 112.556 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.95 0.93 14.14 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.807 1.643 . . . . 0.0 112.087 -171.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.478 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 41.3 mt-10 -86.99 -35.44 18.81 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.012 1.325 . . . . 0.0 109.332 167.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.32 -41.09 25.47 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -175.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -51.4 -37.84 50.4 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.233 1.413 . . . . 0.0 112.376 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 12.0 mtmt -61.85 -46.07 91.06 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.049 0.939 . . . . 0.0 110.901 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.55 -9.05 73.2 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.095 1.331 . . . . 0.0 113.729 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.82 103.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 165.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.11 3.43 10.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.097 1.359 . . . . 0.0 112.811 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -116.6 73.83 6.02 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 128.873 2.869 . . . . 0.0 109.705 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.01 -28.05 19.74 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.231 3.287 . . . . 0.0 111.433 -168.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 26.0 m-20 -64.98 -15.84 62.7 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.726 0.81 . . . . 0.0 110.348 -171.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.406 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -133.39 5.0 3.73 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.254 1.422 . . . . 0.0 110.22 178.1 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -66.06 -55.64 15.58 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 120.864 -1.148 . . . . 0.0 109.069 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.66 -14.8 15.34 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.7 1.371 . . . . 0.0 114.7 -165.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -43.18 97.39 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.55 1.068 . . . . 0.0 110.869 169.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -57.68 -37.43 73.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.252 1.421 . . . . 0.0 111.377 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -81.4 -20.71 39.88 Favored 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 120.89 -1.132 . . . . 0.0 113.996 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.17 -47.99 79.84 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.0 mt -61.41 -47.72 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.463 1.105 . . . . 0.0 110.227 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.6 mt -56.56 -49.33 75.14 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.676 0.671 . . . . 0.0 111.061 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 p -68.93 -40.0 79.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.241 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -60.19 -47.75 84.63 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.134 1.774 . . . . 0.0 111.401 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.7 t -56.32 -50.14 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 119.076 0.853 . . . . 0.0 108.716 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.78 3.51 1.9 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.57 -54.01 2.39 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.048 1.339 . . . . 0.0 111.003 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -72.73 -32.9 66.03 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.867 1.212 . . . . 0.0 111.047 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.74 57.54 5.9 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 119.311 0.96 . . . . 0.0 110.877 -173.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -65.26 -11.19 28.94 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.05 2.5 . . . . 0.0 113.636 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -12.16 61.12 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.57 -0.706 . . . . 0.0 112.702 175.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 85.7 mt -80.04 156.69 27.0 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.413 1.006 . . . . 0.0 109.889 169.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -129.23 152.58 79.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.506 1.522 . . . . 0.0 109.708 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.25 159.17 53.98 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.605 2.87 . . . . 0.0 113.186 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -161.95 120.19 2.27 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.507 1.523 . . . . 0.0 109.601 171.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.31 109.28 15.67 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.436 1.095 . . . . 0.0 108.381 166.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -135.56 149.32 49.39 Favored 'General case' 0 C--O 1.218 -0.603 0 O-C-N 120.921 -1.112 . . . . 0.0 108.125 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.1 m95 55.52 16.68 1.94 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 64.59 15.34 9.61 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 128.553 2.741 . . . . 0.0 113.848 -167.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.3 p -116.37 161.36 31.93 Favored Pre-proline 0 N--CA 1.44 -0.975 0 C-N-CA 124.72 1.208 . . . . 0.0 109.152 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.62 116.94 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 125.269 3.979 . . . . 0.0 112.13 171.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.3 ptm -128.43 170.3 13.29 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.683 0.754 . . . . 0.0 108.985 161.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.03 165.0 27.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 169.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.7 120.76 13.71 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -171.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -71.95 99.73 2.3 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 167.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 49.02 42.01 20.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.258 1.023 . . . . 0.0 110.674 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.41 -21.09 40.33 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 116.971 -2.016 . . . . 0.0 117.062 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -171.25 0.91 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 122.055 2.928 . . . . 0.0 112.756 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -117.19 26.51 9.72 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.037 -1.039 . . . . 0.0 113.097 -171.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.0 -1.18 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.05 0.94 . . . . 0.0 112.965 -168.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 tt -155.9 142.61 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 119.263 -2.148 . . . . 0.0 112.025 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.55 149.92 21.18 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.527 1.537 . . . . 0.0 109.324 166.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -145.18 178.48 8.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.954 1.377 . . . . 0.0 110.501 170.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.2 153.83 10.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 168.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.3 p -69.13 138.83 54.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.768 -0.583 . . . . 0.0 109.431 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.38 174.36 5.94 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 169.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -71.37 -5.12 30.22 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.866 -1.146 . . . . 0.0 113.645 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.28 7.49 0.11 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.1 -178.61 6.71 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.027 1.331 . . . . 0.0 108.692 -173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.09 120.06 18.61 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.494 1.118 . . . . 0.0 108.521 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.34 108.77 21.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.911 1.684 . . . . 0.0 109.913 -160.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 99.2 t -129.46 140.28 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.911 1.232 . . . . 0.0 109.504 -162.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 27.8 t -171.26 144.91 1.76 Allowed Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.033 1.733 . . . . 0.0 109.734 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.2 -56.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.616 1.544 . . . . 0.0 111.344 171.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -148.03 -83.77 0.11 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -131.5 -46.38 0.98 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.129 1.372 . . . . 0.0 110.945 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.26 -35.18 52.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 118.839 0.745 . . . . 0.0 112.753 -166.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.9 -24.74 28.03 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.745 1.641 . . . . 0.0 113.169 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 mm -112.93 -3.49 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.776 1.63 . . . . 0.0 109.819 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 m -91.14 -72.59 0.57 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -85.75 -49.23 8.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.425 0.557 . . . . 0.0 109.541 -171.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -69.45 -13.19 62.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.94 -21.61 66.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.83 -44.96 60.79 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.923 0.783 . . . . 0.0 110.645 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.42 -43.21 88.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.664 0.786 . . . . 0.0 110.643 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.39 -41.46 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.963 0.801 . . . . 0.0 110.331 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.25 -55.55 31.88 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.293 0.497 . . . . 0.0 110.319 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.64 -13.12 61.29 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.107 0.963 . . . . 0.0 112.345 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.15 -26.43 60.31 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.679 0.672 . . . . 0.0 110.579 169.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.39 4.97 6.22 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.972 -0.905 . . . . 0.0 113.735 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -112.88 160.88 17.59 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.848 1.324 . . . . 0.0 110.907 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.2 m -91.74 173.03 8.08 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.049 0.939 . . . . 0.0 108.922 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.97 -166.19 1.75 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 166.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.2 p -118.96 -168.73 1.61 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 153.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -68.74 -27.64 66.11 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 120.469 -1.395 . . . . 0.0 112.242 166.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.46 -14.14 10.93 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-O 118.795 -1.003 . . . . 0.0 114.432 -163.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.8 pp -156.39 166.59 32.98 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.42 1.61 . . . . 0.0 110.393 170.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -103.62 164.98 11.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.416 0.553 . . . . 0.0 109.94 172.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 126.61 22.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -174.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.96 142.69 25.18 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 164.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.54 145.79 14.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.995 2.464 . . . . 0.0 108.896 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -56.42 -30.49 62.88 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -170.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -65.83 -26.64 67.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -115.91 162.19 26.9 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.546 0.738 . . . . 0.0 110.125 -164.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -79.98 148.07 19.32 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 CA-C-N 121.125 1.437 . . . . 0.0 113.605 -169.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.6 t -73.69 124.18 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 170.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -74.99 77.23 2.19 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.526 1.13 . . . . 0.0 110.562 169.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -53.13 -40.92 64.56 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 125.145 1.378 . . . . 0.0 111.32 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -57.89 -60.91 2.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.468 1.507 . . . . 0.0 110.984 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.96 -38.72 65.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.759 0.79 . . . . 0.0 110.888 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.269 0.3 OUTLIER -79.93 -27.93 39.78 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 117.198 -1.382 . . . . 0.0 113.171 -176.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -62.01 -42.67 99.4 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.304 1.411 . . . . 0.0 108.402 170.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.64 -52.59 63.31 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.093 0.557 . . . . 0.0 109.613 -174.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.0 ptp -69.51 -36.61 76.62 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.564 -1.207 . . . . 0.0 113.544 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.7 -46.72 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 120.6 1.546 . . . . 0.0 108.876 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.56 -40.11 90.43 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.543 0.611 . . . . 0.0 109.845 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -60.96 -50.08 74.83 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.394 0.543 . . . . 0.0 110.783 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -38.31 80.7 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.105 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.9 mt -60.3 -52.28 63.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.092 0.957 . . . . 0.0 110.676 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -70.28 -22.54 62.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.041 0.837 . . . . 0.0 111.721 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -83.02 -20.56 34.81 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.311 0.644 . . . . 0.0 111.311 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -96.89 20.05 11.71 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.855 1.662 . . . . 0.0 111.236 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.767 166.61 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.86 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.8 m -65.32 164.05 14.28 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.456 -1.026 . . . . 0.0 112.054 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -156.94 -39.99 0.07 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.101 1.36 . . . . 0.0 110.284 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 30.8 mmm -56.82 -27.04 59.39 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.97 -34.82 70.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 118.337 0.517 . . . . 0.0 111.437 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.59 -44.46 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -78.13 -14.51 59.45 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.46 1.104 . . . . 0.0 112.795 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -34.32 77.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.426 1.491 . . . . 0.0 111.426 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.32 -16.28 61.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.88 1.672 . . . . 0.0 112.848 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -102.26 -37.6 8.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.908 0.883 . . . . 0.0 110.042 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.54 -39.83 65.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.252 0.933 . . . . 0.0 110.571 171.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -58.68 -29.84 66.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.414 0.686 . . . . 0.0 112.034 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.49 -4.52 62.28 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.842 -0.977 . . . . 0.0 114.57 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.3 mm -57.08 132.54 21.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 119.298 1.549 . . . . 0.0 109.334 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.73 -49.33 75.47 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.816 1.646 . . . . 0.0 108.724 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -141.15 143.95 32.85 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.42 -22.66 24.67 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.454 2.77 . . . . 0.0 111.264 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -6.16 13.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.61 173.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -125.29 -9.16 6.99 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -64.42 -60.81 2.72 Favored 'General case' 0 CA--C 1.519 -0.228 0 O-C-N 121.184 -0.947 . . . . 0.0 110.441 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -45.86 -44.55 14.47 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.122 2.169 . . . . 0.0 111.292 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -57.82 -48.1 80.72 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.042 -0.411 . . . . 0.0 110.397 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.0 m -65.67 -45.22 83.73 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.04 1.336 . . . . 0.0 109.885 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.96 -41.27 61.96 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.796 1.239 . . . . 0.0 112.282 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -60.29 -52.68 64.24 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.377 0.535 . . . . 0.0 109.695 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -61.72 -41.49 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.437 1.095 . . . . 0.0 110.056 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.88 -57.1 13.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.303 0.501 . . . . 0.0 110.583 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -60.29 -37.08 79.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 117.833 -1.08 . . . . 0.0 109.808 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 67.1 t90 -59.31 -59.4 5.52 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.797 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.3 t -52.64 -46.8 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 120.224 1.374 . . . . 0.0 110.697 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.2 -29.86 69.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.048 0.539 . . . . 0.0 112.012 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.45 -61.14 2.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.994 0.918 . . . . 0.0 110.537 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -65.86 -32.05 73.35 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.427 1.491 . . . . 0.0 111.849 -169.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -127.33 63.75 59.46 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 118.664 0.665 . . . . 0.0 109.253 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.68 -8.56 23.91 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.585 2.857 . . . . 0.0 113.923 -163.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.29 -26.51 62.0 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.262 -0.899 . . . . 0.0 111.799 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.1 mt -65.81 149.76 49.65 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -130.97 150.02 75.39 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 127.025 2.13 . . . . 0.0 110.719 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.12 152.76 40.59 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.329 2.686 . . . . 0.0 113.191 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.35 126.56 6.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.465 1.906 . . . . 0.0 108.967 167.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.34 102.77 15.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 170.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -149.93 141.23 23.21 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.968 -1.083 . . . . 0.0 111.139 -167.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 16.3 m95 54.84 21.96 3.94 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.881 1.272 . . . . 0.0 111.927 -161.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 53.42 14.69 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.828 1.651 . . . . 0.0 112.807 -162.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.7 p -97.87 148.84 35.05 Favored Pre-proline 0 C--O 1.238 0.493 0 CA-C-N 119.703 1.138 . . . . 0.0 109.352 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.24 100.43 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.924 3.083 . . . . 0.0 110.939 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.3 ptm -118.88 164.93 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.413 0.685 . . . . 0.0 109.672 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.39 169.67 15.72 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 173.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.9 m -141.77 138.86 32.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.858 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -76.28 94.09 3.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.128 1.331 . . . . 0.0 108.388 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 51.48 15.17 0.31 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.646 1.578 . . . . 0.0 114.73 -170.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.79 -20.61 4.3 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 117.896 -1.502 . . . . 0.0 113.941 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -78.16 141.83 38.42 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 121.12 2.46 . . . . 0.0 111.309 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -66.62 29.56 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.039 2.936 . . . . 0.0 116.966 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.25 0.37 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 125.32 1.448 . . . . 0.0 113.17 -167.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 tt -160.6 145.39 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 121.793 2.088 . . . . 0.0 113.516 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.29 136.08 3.92 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 121.466 -0.771 . . . . 0.0 112.337 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -136.01 167.55 21.01 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.093 1.357 . . . . 0.0 110.58 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.8 p -159.24 160.76 35.7 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 54.9 p -75.76 113.99 13.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.05 171.71 13.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 164.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -63.75 -32.69 74.26 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.291 -0.881 . . . . 0.0 111.717 -175.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -137.1 10.57 3.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.371 1.468 . . . . 0.0 113.149 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -156.8 -177.35 6.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.065 1.346 . . . . 0.0 108.839 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tp -124.17 121.43 35.09 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.558 1.543 . . . . 0.0 107.684 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 133.59 36.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 116.238 -1.839 . . . . 0.0 109.417 170.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.8 t -140.37 149.41 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 120.128 1.331 . . . . 0.0 110.566 172.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 t -160.42 158.87 26.01 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.58 1.152 . . . . 0.0 108.959 157.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -79.67 -57.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.098 0 CA-C-N 120.711 1.29 . . . . 0.0 110.519 165.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -138.16 -88.44 0.24 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 164.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -147.34 -36.15 0.23 Allowed 'General case' 0 N--CA 1.474 0.725 0 O-C-N 121.341 -0.85 . . . . 0.0 111.836 -163.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -25.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 123.549 0.74 . . . . 0.0 110.394 165.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.57 -35.93 38.25 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.823 0.725 . . . . 0.0 111.545 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.1 mm -110.43 13.46 8.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.32 1.448 . . . . 0.0 110.841 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.6 m -129.51 -33.57 1.86 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 170.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -63.6 1.33 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -79.86 0.41 31.21 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.61 -31.42 64.28 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -72.07 -48.52 43.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.75 0.786 . . . . 0.0 109.778 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.2 -42.83 91.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.822 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.53 -48.52 85.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.082 0.953 . . . . 0.0 109.749 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -51.45 70.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.468 0.707 . . . . 0.0 109.706 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -64.82 -37.83 88.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.85 1.26 . . . . 0.0 111.642 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.04 -22.76 67.08 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.951 0.796 . . . . 0.0 111.693 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.12 9.49 10.58 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-O 118.525 -1.153 . . . . 0.0 114.104 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -113.07 95.93 5.66 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.484 1.642 . . . . 0.0 113.251 -162.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.62 105.58 0.06 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 129.251 3.02 . . . . 0.0 113.355 174.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.34 175.87 6.94 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.733 2.013 . . . . 0.0 112.802 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.1 p -94.67 -164.85 1.22 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.108 1.363 . . . . 0.0 107.618 156.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -76.63 -19.31 57.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 117.079 -1.439 . . . . 0.0 112.588 166.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.94 -7.84 4.9 Favored Glycine 0 N--CA 1.47 0.958 0 CA-C-N 120.388 1.449 . . . . 0.0 115.054 -162.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 pp -151.54 161.61 42.39 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 164.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -99.45 165.79 11.48 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 166.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.5 153.2 44.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 121.774 -0.579 . . . . 0.0 109.637 169.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.11 143.74 34.63 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -71.64 149.52 55.22 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.496 2.797 . . . . 0.0 110.409 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -57.86 -41.33 82.22 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -54.15 -44.04 71.1 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.024 0.93 . . . . 0.0 112.17 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.83 146.86 32.59 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -159.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.04 139.1 23.78 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.268 1.312 . . . . 0.0 112.052 -163.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -69.69 150.17 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.325 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -109.92 73.66 0.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.328 1.051 . . . . 0.0 111.873 -161.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -58.01 -24.16 57.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.709 0.804 . . . . 0.0 112.962 -171.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -68.09 -60.2 2.67 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.091 -1.006 . . . . 0.0 110.3 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.44 -45.14 62.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.229 1.412 . . . . 0.0 109.076 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -53.97 50.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.835 1.254 . . . . 0.0 111.553 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -68.6 -40.13 80.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 117.484 -1.246 . . . . 0.0 111.786 -172.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -45.62 -57.06 4.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.541 0.736 . . . . 0.0 110.249 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.4 ptp -72.47 -42.63 64.73 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 118.046 -0.978 . . . . 0.0 112.888 -170.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -42.65 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 120.074 1.306 . . . . 0.0 109.689 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -64.17 -39.92 95.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.967 -0.54 . . . . 0.0 109.923 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -62.22 -46.89 86.85 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.349 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -21.22 63.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.09 1.314 . . . . 0.0 112.261 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.99 -61.6 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.456 1.102 . . . . 0.0 108.49 167.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -75.67 -2.9 31.65 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -171.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.3 -20.14 65.58 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.829 -1.169 . . . . 0.0 110.82 164.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -105.29 5.88 32.34 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.194 1.398 . . . . 0.0 111.344 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 124.697 1.199 . . . . 0.0 108.148 178.457 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.875 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -61.51 175.63 0.58 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.936 0.874 . . . . 0.0 110.629 162.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -147.27 -31.13 0.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.614 1.165 . . . . 0.0 109.87 163.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -6.33 15.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -64.15 -57.49 9.4 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.5 -42.53 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.877 1.671 . . . . 0.0 110.086 -167.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -93.99 -0.48 55.51 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.577 -169.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.58 -39.98 81.86 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.61 0.764 . . . . 0.0 109.609 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -66.33 -20.58 66.13 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -81.56 -55.21 4.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.2 -38.86 77.57 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.751 -0.642 . . . . 0.0 111.893 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -58.1 -33.05 68.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.396 0.678 . . . . 0.0 110.737 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.1 -3.24 82.78 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.529 1.061 . . . . 0.0 112.493 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.6 mt -77.69 90.79 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 171.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -76.11 8.19 3.48 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.182 2.193 . . . . 0.0 113.224 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -116.13 69.3 3.7 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 129.67 3.188 . . . . 0.0 108.767 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.97 -17.16 54.99 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 125.109 3.872 . . . . 0.0 113.856 -167.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.19 -16.39 59.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.135 0.88 . . . . 0.0 111.553 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -131.96 8.73 4.46 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.794 0.725 . . . . 0.0 112.326 -171.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -77.11 -62.33 1.69 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.308 1.443 . . . . 0.0 109.612 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.31 -32.55 38.27 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.134 2.174 . . . . 0.0 112.282 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -47.38 -53.46 13.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.805 0.842 . . . . 0.0 110.14 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.0 m -65.02 -29.24 70.13 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.74 -0.6 . . . . 0.0 111.277 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -72.45 -28.18 62.78 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 120.855 -1.153 . . . . 0.0 111.875 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.21 -54.66 43.12 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.676 1.125 . . . . 0.0 108.526 168.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -49.72 -53.22 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.169 0.987 . . . . 0.0 110.007 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.0 mt -64.63 -50.03 68.72 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.915 -170.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -69.47 -28.0 65.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.136 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -61.69 -60.39 3.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 37.8 t -48.5 -45.57 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.05 0.841 . . . . 0.0 111.526 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.15 -13.03 5.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.4 -50.58 2.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.509 1.924 . . . . 0.0 111.483 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.9 -35.03 79.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.928 0.785 . . . . 0.0 110.832 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -128.81 74.53 80.73 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.66 -13.1 34.42 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.872 1.715 . . . . 0.0 110.81 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -86.22 33.2 0.61 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.442 2.297 . . . . 0.0 111.158 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.1 mt -122.02 134.49 54.8 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 120.686 -1.258 . . . . 0.0 109.189 156.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -104.89 149.47 37.57 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 124.621 1.168 . . . . 0.0 109.41 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.71 154.83 49.38 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.599 2.866 . . . . 0.0 112.169 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -162.84 114.18 1.51 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.607 1.163 . . . . 0.0 108.534 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.0 mtp -82.22 121.49 26.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 166.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -138.65 138.44 37.81 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.9 m95 48.84 34.42 5.31 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.532 1.133 . . . . 0.0 112.165 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.26 18.09 10.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.471 1.908 . . . . 0.0 111.19 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.5 p -118.63 149.53 46.47 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.434 1.494 . . . . 0.0 109.304 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.49 106.68 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.251 3.301 . . . . 0.0 110.925 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.2 ptm -114.59 175.85 5.3 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.236 -0.915 . . . . 0.0 110.309 168.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.04 156.12 47.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 170.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.63 122.43 27.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -72.09 95.5 1.64 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 57.21 -3.32 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.93 -24.16 0.25 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 127.492 2.472 . . . . 0.0 113.67 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.61 -164.94 0.78 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.856 1.828 . . . . 0.0 114.718 -167.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -131.95 25.44 4.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.58 1.952 . . . . 0.0 111.445 -170.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.7 mt -65.4 -3.54 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.574 1.95 . . . . 0.0 111.725 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 tt -155.94 163.77 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 119.448 -2.033 . . . . 0.0 109.647 169.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.75 132.72 1.55 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -138.91 169.46 17.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.668 1.734 . . . . 0.0 110.085 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.59 161.83 38.15 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 159.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.4 p -65.09 149.19 50.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 165.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 t -137.47 168.25 20.03 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -58.7 -30.08 67.14 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -153.227 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -136.36 13.49 3.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.378 1.071 . . . . 0.0 112.638 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -158.32 168.74 26.18 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.143 -0.973 . . . . 0.0 110.38 -166.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.2 tp -107.63 123.22 48.16 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.82 122.19 31.96 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.824 1.193 . . . . 0.0 108.524 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.0 t -135.32 137.43 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.256 1.022 . . . . 0.0 108.516 -174.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.4 p -163.05 165.26 15.01 Favored Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 127.108 2.163 . . . . 0.0 109.851 154.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.43 -56.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.139 1.226 . . . . 0.0 113.005 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -148.48 -83.2 0.11 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.56 1.073 . . . . 0.0 108.11 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -146.97 -27.97 0.39 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.804 1.241 . . . . 0.0 112.216 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.1 tp -63.7 -31.94 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 120.791 -1.193 . . . . 0.0 111.37 176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -48.47 -26.06 4.89 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 126.815 2.15 . . . . 0.0 113.324 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 mm -125.62 7.32 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.167 1.387 . . . . 0.0 109.944 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 t -84.8 -71.56 0.51 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 170.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -88.09 -50.8 6.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -170.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -67.89 -15.33 63.57 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.32 -30.33 38.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.449 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -69.37 -59.47 2.97 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 118.556 0.617 . . . . 0.0 109.94 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.47 -35.48 74.17 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.476 0.58 . . . . 0.0 112.456 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.82 -48.82 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.929 0.891 . . . . 0.0 109.576 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.22 -47.45 86.06 Favored 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 121.488 -0.758 . . . . 0.0 110.902 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -61.4 -16.22 44.48 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 128.253 2.621 . . . . 0.0 111.631 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.68 4.28 50.07 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 112.454 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.33 14.63 47.25 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.261 0.934 . . . . 0.0 114.719 169.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -112.78 90.64 3.4 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.863 1.332 . . . . 0.0 111.701 -168.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 m -53.28 98.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.225 2.61 . . . . 0.0 113.619 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.78 -172.95 4.46 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.78 1.632 . . . . 0.0 112.238 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.7 p -111.15 -164.77 0.94 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.468 1.907 . . . . 0.0 106.694 163.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -80.29 -22.59 41.44 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.939 -1.101 . . . . 0.0 112.93 161.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.16 -28.33 6.53 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.29 -1.284 . . . . 0.0 114.805 -168.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 pp -154.31 172.53 17.51 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.208 2.004 . . . . 0.0 110.226 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -114.57 166.36 11.8 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 120.824 -1.172 . . . . 0.0 109.006 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.78 133.22 20.75 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.95 143.44 26.14 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 168.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.08 157.88 60.0 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.189 1.926 . . . . 0.0 109.925 172.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -61.07 -25.04 66.66 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.33 -0.856 . . . . 0.0 112.006 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -57.88 -62.46 1.79 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.044 1.737 . . . . 0.0 111.696 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -91.57 165.43 20.92 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 125.995 1.718 . . . . 0.0 111.814 -163.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.33 149.25 85.08 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.367 2.045 . . . . 0.0 110.672 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 p -96.94 127.07 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.17 83.34 7.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.462 1.125 . . . . 0.0 111.156 -169.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -57.03 -35.85 69.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.285 1.434 . . . . 0.0 110.222 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -39.33 77.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.486 -0.759 . . . . 0.0 112.339 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -49.06 46.79 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 122.03 0.919 . . . . 0.0 108.641 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.296 0.3 OUTLIER -75.82 -24.08 55.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.138 -169.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -37.71 88.44 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 120.535 1.516 . . . . 0.0 110.565 171.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -56.29 -52.0 66.13 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.102 0.865 . . . . 0.0 109.708 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.9 ptp -68.89 -36.75 78.42 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.312 -172.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -46.76 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 121.159 1.8 . . . . 0.0 109.262 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.75 -47.4 85.84 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.814 0.846 . . . . 0.0 110.352 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -61.87 -40.36 95.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.245 0.475 . . . . 0.0 110.643 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -24.62 66.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.042 0.837 . . . . 0.0 111.36 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 99.3 mt -79.24 -49.43 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.256 1.422 . . . . 0.0 108.905 169.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -61.38 -29.02 69.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.633 1.173 . . . . 0.0 110.826 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -82.97 -19.32 37.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.744 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -93.84 -1.21 55.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.983 1.713 . . . . 0.0 112.212 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 C--O 1.247 0.937 0 C-N-CA 128.546 2.738 . . . . 0.0 110.704 173.415 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.787 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -78.68 159.22 28.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.456 1.128 . . . . 0.0 108.607 163.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -138.95 -33.15 0.65 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.092 0.557 . . . . 0.0 111.412 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.6 mmt -57.16 -14.07 3.69 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.005 1.322 . . . . 0.0 113.142 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -74.06 -30.25 62.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 120.506 -1.371 . . . . 0.0 112.407 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.9 t -70.64 -33.2 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 124.181 0.926 . . . . 0.0 108.745 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -102.61 -2.41 28.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.896 1.278 . . . . 0.0 112.343 -171.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.88 72.12 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 122.382 1.087 . . . . 0.0 110.359 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.46 -12.92 62.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.434 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -75.45 -57.0 4.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.121 0.873 . . . . 0.0 109.978 167.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.77 -44.38 73.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.917 1.287 . . . . 0.0 111.603 -174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -53.68 -32.25 50.94 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.6 -18.22 66.56 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.519 -168.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.7 mt -69.37 114.61 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.78 6.0 14.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.747 1.219 . . . . 0.0 111.71 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.79 74.58 75.68 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 128.013 2.525 . . . . 0.0 110.046 -170.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -59.43 -30.85 93.66 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.094 2.529 . . . . 0.0 112.757 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.41 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 57.4 m-20 -70.03 -1.92 11.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.286 1.034 . . . . 0.0 112.308 -177.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.41 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 13.9 m80 -132.6 -30.72 1.42 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.294 1.838 . . . . 0.0 109.751 -176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.26 -48.56 45.75 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.64 1.576 . . . . 0.0 110.548 169.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.69 -36.96 82.39 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.329 0.393 . . . . 0.0 111.767 -168.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -63.78 -30.55 71.63 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.853 -0.529 . . . . 0.0 111.725 175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.0 m -71.52 -41.65 68.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.859 0.864 . . . . 0.0 109.5 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -50.43 -43.64 55.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.169 0.895 . . . . 0.0 111.903 168.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.89 -27.5 69.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.342 0.974 . . . . 0.0 112.751 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.4 mt -73.53 -47.13 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.74 -63.41 1.21 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.86 0.864 . . . . 0.0 109.744 -169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -64.37 -25.52 68.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.583 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -68.36 -42.25 79.46 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.208 0.913 . . . . 0.0 110.457 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.74 -48.4 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.9 0.773 . . . . 0.0 109.034 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.76 -29.37 68.13 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.11 -56.56 4.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.896 -0.503 . . . . 0.0 110.818 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -78.9 -28.99 44.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.792 1.637 . . . . 0.0 111.655 -165.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -131.62 64.42 72.86 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.187 0.995 . . . . 0.0 108.749 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.71 -13.03 31.96 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.673 2.249 . . . . 0.0 113.09 -171.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -74.13 -18.16 60.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.827 0.74 . . . . 0.0 112.253 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.6 mt -69.27 152.98 44.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -124.84 142.73 41.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.19 137.36 28.58 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.213 1.942 . . . . 0.0 110.479 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -147.32 135.66 21.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.356 1.062 . . . . 0.0 108.268 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.63 114.01 27.92 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 175.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.34 146.94 31.81 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.432 1.093 . . . . 0.0 108.079 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.6 m95 55.54 21.11 4.19 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.868 1.213 . . . . 0.0 114.115 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.2 t30 57.67 17.9 4.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 112.598 -165.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.5 p -110.74 142.99 27.3 Favored Pre-proline 0 N--CA 1.449 -0.516 0 O-C-N 120.532 -1.355 . . . . 0.0 109.361 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.31 128.66 15.83 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.532 2.155 . . . . 0.0 110.083 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.6 ptm -142.37 168.82 18.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.98 0.912 . . . . 0.0 109.021 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -140.14 91.55 2.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -172.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 p -65.07 122.66 17.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -71.54 91.01 1.03 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.862 1.21 . . . . 0.0 108.338 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 48.8 18.14 0.18 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.653 1.181 . . . . 0.0 113.717 -170.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.39 -16.73 2.92 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.303 1.906 . . . . 0.0 115.621 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.12 -167.98 1.17 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 120.355 2.078 . . . . 0.0 112.811 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -128.99 43.82 3.08 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.155 1.382 . . . . 0.0 110.408 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.8 mt -75.73 -1.46 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.706 1.602 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 tt -164.92 157.59 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 119.746 -1.846 . . . . 0.0 112.542 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.35 136.2 2.19 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 165.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -131.09 163.76 26.94 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.231 1.015 . . . . 0.0 111.227 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 p -149.48 156.68 42.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.886 0.85 . . . . 0.0 110.388 163.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 53.1 p -59.4 145.26 44.23 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.183 0.993 . . . . 0.0 108.685 167.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 m -133.56 177.61 7.57 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.205 1.402 . . . . 0.0 107.834 168.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.38 -57.22 8.46 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.145 0.978 . . . . 0.0 112.102 -167.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.424 ' CE1' ' HD1' ' A' ' 64' ' ' HIS . 14.5 p80 -126.19 4.29 7.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.119 0.968 . . . . 0.0 112.748 -173.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.514 ' CD2' ' HE ' ' A' ' 94' ' ' ARG . 4.1 p-80 -145.81 168.42 20.82 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.096 1.758 . . . . 0.0 108.445 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.2 tp -88.19 169.32 11.99 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 160.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 p -120.09 127.67 52.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.781 1.173 . . . . 0.0 108.136 160.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HB ' ' CE1' ' A' ' 93' ' ' PHE . 92.8 t -135.19 148.0 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.2 t -165.94 165.37 10.79 Favored Pre-proline 0 C--O 1.241 0.631 0 C-N-CA 128.399 2.68 . . . . 0.0 105.947 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -83.16 -57.35 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.338 0 CA-C-N 120.153 1.09 . . . . 0.0 111.225 152.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -147.23 -86.34 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.9 -32.97 0.34 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.338 1.455 . . . . 0.0 111.7 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.77 -35.31 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 119.961 1.255 . . . . 0.0 111.064 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.97 -16.26 24.42 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.59 0.614 . . . . 0.0 113.817 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.1 mm -112.17 -14.44 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 126.735 2.014 . . . . 0.0 110.278 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.4 m -104.37 -55.6 2.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.0 0.52 . . . . 0.0 110.248 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -81.2 -63.49 1.39 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.417 ' CG ' ' HG3' ' A' ' 109' ' ' MET . 12.5 m-85 -72.94 -9.2 58.45 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.499 -0.48 . . . . 0.0 112.014 -170.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.28 -30.89 63.07 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.372 0.533 . . . . 0.0 112.23 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -63.92 -44.15 93.76 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 118.439 0.563 . . . . 0.0 110.295 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.46 52.35 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.114 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.1 mt -60.22 -48.68 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.684 1.194 . . . . 0.0 108.324 168.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.66 73.13 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.967 0.907 . . . . 0.0 110.712 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -58.06 -30.04 65.88 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.744 0.818 . . . . 0.0 111.983 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.39 95.9 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.502 1.046 . . . . 0.0 110.862 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 132.25 -11.1 5.31 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 127.283 2.373 . . . . 0.0 111.465 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -86.93 174.0 9.0 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 120.93 -1.335 . . . . 0.0 112.747 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.2 t -127.53 175.09 8.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.486 1.914 . . . . 0.0 109.297 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.61 -176.41 4.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.064 1.746 . . . . 0.0 110.618 -166.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.8 p -132.01 -168.75 2.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.796 1.638 . . . . 0.0 108.225 168.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.72 5.92 12.15 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.655 -1.278 . . . . 0.0 113.409 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.08 -14.19 0.03 OUTLIER Glycine 0 CA--C 1.524 0.644 0 CA-C-N 119.544 1.065 . . . . 0.0 115.186 -171.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.6 pp -159.81 -173.37 4.06 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.691 1.246 . . . . 0.0 109.644 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.403 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 12.2 p90 -135.0 165.63 24.91 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.875 -1.141 . . . . 0.0 111.66 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.514 ' HE ' ' CD2' ' A' ' 64' ' ' HIS . 1.8 mmt-85 -139.92 91.24 2.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.721 1.208 . . . . 0.0 111.658 -157.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -86.2 141.1 34.74 Favored Pre-proline 0 C--O 1.239 0.54 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.09 155.77 26.07 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.114 2.543 . . . . 0.0 110.516 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -63.35 -19.89 65.03 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -68.58 -44.96 73.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.759 1.163 . . . . 0.0 111.105 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -90.32 150.24 42.64 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 123.609 0.764 . . . . 0.0 109.85 -159.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.73 123.41 5.83 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.777 2.984 . . . . 0.0 112.169 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.1 m -68.6 9.69 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -166.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 43.76 81.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 128.043 2.537 . . . . 0.0 114.285 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -60.33 -27.71 67.57 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.957 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.72 -56.06 18.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.986 0.514 . . . . 0.0 110.813 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -46.76 88.47 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.595 0.712 . . . . 0.0 109.518 -173.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -27.43 62.14 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.811 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -58.46 -55.86 29.59 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 119.681 1.128 . . . . 0.0 108.933 165.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -59.68 -37.72 79.56 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.044 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.417 ' HG3' ' CG ' ' A' ' 77' ' ' PHE . 6.1 ttm -53.18 -61.19 2.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.532 1.933 . . . . 0.0 111.303 172.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -45.88 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.745 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.74 -46.59 74.32 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.828 0.851 . . . . 0.0 109.435 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.8 -47.97 81.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.389 0.276 . . . . 0.0 111.385 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -20.22 63.27 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.544 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 91.1 mt -78.24 -63.62 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.159 0.984 . . . . 0.0 109.177 165.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -71.37 -13.18 61.78 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -164.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.57 -35.99 82.78 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.979 0.512 . . . . 0.0 109.688 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -79.65 7.03 9.17 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.765 2.026 . . . . 0.0 112.428 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 128.263 2.625 . . . . 0.0 112.212 -162.648 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.856 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 m -70.61 173.41 7.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.594 0.758 . . . . 0.0 109.918 169.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -159.14 -37.82 0.06 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.311 -1.328 . . . . 0.0 113.813 -176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.32 -36.56 43.23 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 120.814 1.643 . . . . 0.0 112.151 174.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -45.88 -44.58 14.56 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.099 0.959 . . . . 0.0 113.228 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.61 -50.57 43.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -80.24 -9.68 59.73 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -165.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.44 90.5 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.393 1.477 . . . . 0.0 111.446 -167.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.39 -21.99 66.74 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.157 0.983 . . . . 0.0 112.897 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -81.28 -55.1 4.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -51.83 -40.99 61.43 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.682 1.193 . . . . 0.0 111.777 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -58.38 -46.87 85.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.402 0.681 . . . . 0.0 110.431 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.87 -4.77 88.48 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.97 1.272 . . . . 0.0 113.86 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.2 mt -65.22 95.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 164.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.11 3.08 3.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.937 1.295 . . . . 0.0 112.855 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -105.63 75.89 0.33 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 C-N-CA 129.316 3.046 . . . . 0.0 109.212 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.48 -19.86 65.52 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.77 2.313 . . . . 0.0 112.781 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.68 2.33 30.1 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.077 1.351 . . . . 0.0 112.612 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -145.09 15.91 1.53 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.154 1.382 . . . . 0.0 110.127 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -91.11 -50.64 5.73 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.882 1.673 . . . . 0.0 109.569 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -53.91 -26.75 26.65 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 126.593 1.957 . . . . 0.0 113.469 -167.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -52.66 -55.62 21.23 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -58.32 -34.96 71.17 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.525 -0.734 . . . . 0.0 112.499 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -41.16 96.61 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.017 0.927 . . . . 0.0 111.298 172.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.9 -54.63 42.69 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.099 0.863 . . . . 0.0 109.521 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -52.46 -51.12 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.757 0.823 . . . . 0.0 109.937 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.9 mt -63.07 -51.89 64.88 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.714 0.406 . . . . 0.0 110.04 -171.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -65.29 -33.18 75.37 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 123.2 0.313 . . . . 0.0 110.511 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -64.97 -48.36 74.3 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.16 0.984 . . . . 0.0 110.89 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.7 t -52.75 -47.73 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 118.793 0.724 . . . . 0.0 109.814 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.23 13.58 0.41 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.21 -34.83 0.52 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.748 1.219 . . . . 0.0 114.068 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.5 m -75.92 -39.46 56.18 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.009 -1.057 . . . . 0.0 108.876 168.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -122.87 70.46 39.13 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 122.203 1.001 . . . . 0.0 110.914 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.85 -4.72 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.041 2.494 . . . . 0.0 112.923 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -79.4 -17.8 53.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.33 1.852 . . . . 0.0 113.11 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 43.5 mt -80.93 144.92 31.54 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.566 -1.334 . . . . 0.0 109.785 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -119.8 143.99 36.26 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.024 1.73 . . . . 0.0 110.141 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.51 148.09 37.15 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.655 2.903 . . . . 0.0 113.762 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -153.7 119.4 5.28 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.982 1.313 . . . . 0.0 110.649 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.71 103.5 9.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.375 1.07 . . . . 0.0 108.823 170.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -135.32 149.33 49.73 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.265 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.7 m95 55.73 16.26 1.92 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 66.95 27.48 8.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.891 2.077 . . . . 0.0 112.239 -170.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.0 p -130.82 152.71 81.04 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.91 1.684 . . . . 0.0 108.162 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.29 112.68 3.6 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 124.573 3.515 . . . . 0.0 110.209 170.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.3 ptm -122.84 170.6 9.93 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.753 -0.592 . . . . 0.0 109.772 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.95 167.73 21.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.645 0.736 . . . . 0.0 109.258 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.2 p -140.85 112.31 7.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 123.173 0.589 . . . . 0.0 111.444 -165.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.81 102.09 3.3 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 47.39 40.44 10.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.128 0.971 . . . . 0.0 111.579 -171.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.87 -2.32 66.41 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.772 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -82.65 177.74 8.55 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.272 2.036 . . . . 0.0 109.723 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -102.88 9.1 39.05 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.334 -1.479 . . . . 0.0 114.378 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.75 8.58 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.261 0 C-N-CA 127.604 2.361 . . . . 0.0 114.178 -162.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 tt -154.21 150.5 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 O-C-N 117.806 -3.059 . . . . 0.0 111.464 165.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.95 153.32 24.44 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 162.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -147.97 161.4 41.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.147 1.473 . . . . 0.0 110.212 170.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.72 155.84 41.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.518 0.675 . . . . 0.0 110.092 172.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.3 p -66.84 154.33 41.16 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.041 1.336 . . . . 0.0 109.343 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB3' ' CD2' ' A' ' 64' ' ' HIS . 31.2 t -133.9 163.99 28.29 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 156.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -48.12 -40.5 23.8 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.321 1.048 . . . . 0.0 113.517 -168.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -124.95 8.59 8.08 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.404 ' CD2' ' HB3' ' A' ' 61' ' ' SER . 7.7 p-80 -158.55 157.46 32.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.118 0.872 . . . . 0.0 112.315 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.9 tp -85.57 156.9 20.55 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 166.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.23 112.34 16.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.151 1.38 . . . . 0.0 109.906 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.1 t -126.78 141.08 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.236 2.214 . . . . 0.0 110.721 -166.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.5 t -164.45 159.58 15.84 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 108.361 164.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.34 -58.48 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 120.524 1.223 . . . . 0.0 111.138 166.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -134.81 -86.25 0.39 Allowed 'General case' 0 C--O 1.233 0.211 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 168.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -136.96 -30.84 0.86 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.984 1.714 . . . . 0.0 111.69 -172.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -62.35 -32.27 54.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 119.321 0.964 . . . . 0.0 111.781 -165.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.51 -29.52 57.55 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.638 1.589 . . . . 0.0 113.52 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.7 mm -98.13 -5.74 9.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.868 1.667 . . . . 0.0 110.114 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.0 m -97.47 -80.22 0.45 Allowed 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 124.853 1.261 . . . . 0.0 108.879 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -83.68 -37.35 22.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.715 1.143 . . . . 0.0 110.159 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -80.82 -11.4 59.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.292 0.496 . . . . 0.0 111.82 -174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.78 67.96 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.734 0.814 . . . . 0.0 113.173 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.38 -52.04 44.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.37 80.63 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.789 0.836 . . . . 0.0 111.597 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.63 -52.34 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.997 0.817 . . . . 0.0 109.237 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.54 -48.64 80.11 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.419 0.688 . . . . 0.0 110.275 -175.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -52.8 -44.17 66.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.56 1.544 . . . . 0.0 111.326 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.17 -5.92 30.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.352 0.661 . . . . 0.0 112.401 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.01 9.52 53.86 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.146 1.355 . . . . 0.0 112.801 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -99.62 163.43 12.5 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.133 1.467 . . . . 0.0 111.208 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.8 m -124.51 93.08 3.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.965 -151.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . . . -80.04 165.36 22.62 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.367 -0.833 . . . . 0.0 112.01 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.0 p -103.23 -164.35 1.07 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.11 1.764 . . . . 0.0 106.249 152.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 -2.18 51.22 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.693 -1.254 . . . . 0.0 112.256 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.03 -2.42 2.14 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.467 1.032 . . . . 0.0 113.749 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.56 177.69 11.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.289 1.545 . . . . 0.0 109.101 162.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 13.1 p90 -124.16 164.23 19.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.59 -0.694 . . . . 0.0 110.779 166.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.65 152.44 48.09 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 121.885 -0.509 . . . . 0.0 111.815 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.3 mm -123.47 142.88 39.97 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.39 150.99 25.73 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.564 2.176 . . . . 0.0 111.53 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -61.89 -20.95 64.3 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.87 -34.95 72.15 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.588 -0.695 . . . . 0.0 111.843 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.99 159.99 44.73 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 122.845 0.458 . . . . 0.0 109.794 -151.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.13 139.35 13.36 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-O 123.503 1.376 . . . . 0.0 111.946 -157.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.47 111.04 20.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 85.61 0.67 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.679 1.192 . . . . 0.0 112.541 -175.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -63.21 -38.53 91.55 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.064 1.346 . . . . 0.0 111.311 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -58.09 9.93 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.454 0.702 . . . . 0.0 110.19 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.99 -41.61 98.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.096 -172.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.275 0.2 OUTLIER -75.66 -26.16 57.44 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.432 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.21 -35.51 78.08 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 121.088 1.767 . . . . 0.0 110.934 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -56.42 -59.19 5.33 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.774 0.716 . . . . 0.0 109.543 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.2 ptp -62.22 -43.26 99.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.64 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -46.24 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 118.855 0.752 . . . . 0.0 109.206 -174.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -65.92 -40.58 91.57 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.716 1.143 . . . . 0.0 110.743 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.94 -47.27 85.62 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.366 0.53 . . . . 0.0 110.693 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.02 -13.38 11.22 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.735 0.814 . . . . 0.0 110.905 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 62.9 mt -95.74 -49.77 12.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-N 120.063 1.301 . . . . 0.0 110.342 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -72.15 3.48 4.48 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.147 1.34 . . . . 0.0 112.579 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -87.91 -15.82 35.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.52 1.528 . . . . 0.0 112.511 164.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -113.18 32.55 5.66 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.525 1.53 . . . . 0.0 110.136 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.331 157.502 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.757 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -64.64 173.71 2.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.903 -0.763 . . . . 0.0 110.413 171.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -136.99 -42.32 0.58 Allowed 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.809 -0.557 . . . . 0.0 112.363 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.4 mmt -59.05 -33.37 70.7 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -172.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.71 -36.49 72.06 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.56 0.618 . . . . 0.0 112.431 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.95 -45.24 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.048 0.939 . . . . 0.0 109.486 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -90.9 -9.42 46.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -167.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.75 91.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.396 1.479 . . . . 0.0 111.789 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.25 -27.08 63.65 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.727 1.211 . . . . 0.0 112.327 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -77.36 -50.57 12.48 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.642 0.777 . . . . 0.0 109.651 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.18 -50.33 62.06 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.608 1.163 . . . . 0.0 109.852 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -58.34 -42.85 87.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.008 0.923 . . . . 0.0 110.688 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.14 -35.86 91.07 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.759 -1.578 . . . . 0.0 114.208 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -54.75 108.74 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -73.34 -3.49 27.45 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.961 1.304 . . . . 0.0 112.611 -171.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 76.05 33.18 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 127.363 2.265 . . . . 0.0 108.7 -170.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.8 -21.56 72.47 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.313 2.675 . . . . 0.0 113.391 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.448 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 6.3 m-20 -63.89 -19.84 65.38 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.611 0.641 . . . . 0.0 111.734 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 3.7 m80 -123.61 -24.03 4.63 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.428 1.491 . . . . 0.0 110.18 -170.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -48.79 -45.58 40.37 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.305 1.042 . . . . 0.0 110.228 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.02 -32.73 9.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.815 1.646 . . . . 0.0 113.424 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -67.31 -14.38 62.87 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.35 -1.469 . . . . 0.0 112.387 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.5 m -100.98 -35.72 9.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.716 1.206 . . . . 0.0 109.789 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -26.2 63.57 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.426 0.557 . . . . 0.0 111.38 172.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -55.82 -62.58 1.6 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.634 1.574 . . . . 0.0 110.156 168.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 mt -57.58 -42.81 82.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 124.45 1.1 . . . . 0.0 112.466 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.11 -49.76 75.83 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.259 0.936 . . . . 0.0 110.036 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -65.57 -36.79 84.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 118.161 -0.923 . . . . 0.0 112.155 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -57.65 -53.55 56.91 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.158 0.89 . . . . 0.0 111.028 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.01 -41.69 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 O-C-N 121.196 -0.94 . . . . 0.0 109.689 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.83 5.03 2.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.522 1.129 . . . . 0.0 113.722 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.69 -62.76 1.49 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.619 1.568 . . . . 0.0 110.456 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.1 m -63.65 -32.04 73.4 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.604 1.093 . . . . 0.0 111.871 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -121.72 66.13 19.49 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 119.703 1.138 . . . . 0.0 110.806 -172.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.07 -10.88 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.228 3.285 . . . . 0.0 112.539 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -58.97 -22.03 59.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.916 2.087 . . . . 0.0 113.755 163.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.6 mt -89.46 160.58 16.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -134.79 149.52 70.88 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 126.786 2.035 . . . . 0.0 108.866 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.61 146.25 66.64 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 122.826 2.351 . . . . 0.0 112.194 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -158.02 119.13 3.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.027 1.331 . . . . 0.0 108.219 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -84.01 119.04 24.46 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -141.49 136.29 31.09 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.671 -0.643 . . . . 0.0 109.939 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.6 m95 56.35 24.0 7.89 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.5 t30 69.89 9.55 7.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.001 2.12 . . . . 0.0 112.909 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -111.91 143.94 29.69 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 125.299 1.44 . . . . 0.0 109.208 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -70.28 125.91 12.4 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.154 1.902 . . . . 0.0 111.782 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.6 ptm -133.0 171.42 13.99 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.433 1.093 . . . . 0.0 108.904 169.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -138.22 105.62 5.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.15 125.71 29.51 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 120.514 -1.366 . . . . 0.0 109.45 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 52' ' ' GLY . 6.1 t30 -72.82 83.96 1.21 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 53.08 -19.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 118.829 2.9 . . . . 0.0 118.829 -162.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 50' ' ' ASN . . . 159.49 40.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -168.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.99 -176.58 3.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.011 0.906 . . . . 0.0 110.053 174.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -124.84 32.03 5.53 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.827 1.651 . . . . 0.0 111.132 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.1 mt -70.13 -0.92 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.187 1.395 . . . . 0.0 111.671 -168.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.1 tt -161.59 147.26 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 O-C-N 119.636 -1.915 . . . . 0.0 111.962 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.73 156.11 27.26 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 158.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.3 155.2 41.82 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.365 -1.079 . . . . 0.0 111.642 169.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 t -142.87 153.48 43.19 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.3 p -70.81 159.65 34.18 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.582 1.153 . . . . 0.0 109.81 171.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -146.18 179.78 7.27 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.402 1.481 . . . . 0.0 109.29 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -56.41 -60.24 3.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.075 0.95 . . . . 0.0 112.086 -169.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -121.6 8.7 10.11 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.994 0.918 . . . . 0.0 111.255 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -152.55 172.85 15.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.493 1.117 . . . . 0.0 109.058 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 tp -101.01 158.94 15.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.471 1.909 . . . . 0.0 107.785 166.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.2 p -124.93 113.11 17.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.974 1.261 . . . . 0.0 111.045 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.23 146.02 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 125.449 1.5 . . . . 0.0 109.408 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.0 t -165.79 157.55 12.41 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.781 1.633 . . . . 0.0 107.335 167.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.1 -56.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.209 0 N-CA-C 109.117 -1.147 . . . . 0.0 109.117 160.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -151.34 -85.32 0.08 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -140.54 -49.47 0.44 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.38 1.872 . . . . 0.0 110.779 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.3 tt -57.91 -34.26 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 121.509 -0.744 . . . . 0.0 111.829 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -44.57 -48.23 8.83 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 172.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mm -91.49 -2.53 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.529 1.132 . . . . 0.0 110.877 -168.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.3 m -105.96 -54.79 2.42 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 120.543 -1.348 . . . . 0.0 111.4 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -78.34 -56.81 4.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.959 1.704 . . . . 0.0 106.84 -170.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -80.63 -18.66 47.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.691 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.57 -21.92 54.37 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.78 -61.28 2.28 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.04 -36.89 68.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.111 0.964 . . . . 0.0 112.27 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.69 -45.33 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.782 1.233 . . . . 0.0 110.254 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.9 -52.62 64.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -21.9 64.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 178.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.29 -21.29 62.96 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.308 0.958 . . . . 0.0 110.716 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.07 10.24 5.28 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.36 -1.245 . . . . 0.0 113.709 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.69 122.33 47.53 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.2 2.0 . . . . 0.0 110.868 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.7 p -75.69 85.13 2.7 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.126 0.97 . . . . 0.0 110.89 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.65 171.23 0.66 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.83 0.852 . . . . 0.0 110.985 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.2 p -101.81 -172.35 2.13 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 167.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -82.85 -19.79 36.85 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 118.063 -0.97 . . . . 0.0 113.023 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -121.23 -14.86 4.83 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 119.079 0.854 . . . . 0.0 113.895 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.6 pp -150.61 164.85 35.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.934 1.694 . . . . 0.0 109.39 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -106.85 160.45 15.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.56 1.073 . . . . 0.0 110.55 170.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.81 141.85 23.04 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.865 -0.522 . . . . 0.0 110.139 -166.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.77 143.51 43.89 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -172.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.53 151.84 82.07 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.586 1.524 . . . . 0.0 109.896 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -64.32 -26.13 68.34 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.843 -0.599 . . . . 0.0 112.338 168.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -62.8 -70.0 0.23 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.696 0.798 . . . . 0.0 111.73 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.82 157.53 87.2 Favored Pre-proline 0 C--O 1.236 0.347 0 O-C-N 123.213 0.32 . . . . 0.0 110.228 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.17 161.29 46.47 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.188 1.925 . . . . 0.0 111.182 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.54 136.59 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.02 2.128 . . . . 0.0 108.764 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.86 102.38 5.5 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 163.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -73.56 -15.77 61.28 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.09 0.859 . . . . 0.0 111.207 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -66.62 -65.5 0.67 Allowed 'General case' 0 CA--C 1.527 0.096 0 O-C-N 121.196 -0.94 . . . . 0.0 111.154 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.26 -38.94 77.91 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -46.01 -45.58 15.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.571 2.748 . . . . 0.0 113.863 172.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -71.3 -48.02 53.22 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 125.567 1.547 . . . . 0.0 109.306 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.39 -49.27 78.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -172.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.1 ptp -70.49 3.77 2.81 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.069 1.747 . . . . 0.0 114.616 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.46 -48.56 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 120.555 1.525 . . . . 0.0 109.412 175.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -59.59 -45.51 91.68 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.564 1.074 . . . . 0.0 109.008 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -56.63 -49.49 74.83 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 119.669 -0.205 . . . . 0.0 110.536 172.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -18.65 65.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.798 -0.62 . . . . 0.0 112.387 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mt -82.58 -55.46 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -70.97 -12.58 61.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.058 0.845 . . . . 0.0 112.577 -172.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.39 -21.69 48.96 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.506 1.122 . . . . 0.0 111.345 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -93.12 34.75 1.1 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.896 2.078 . . . . 0.0 109.78 174.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.634 1.573 . . . . 0.0 110.963 167.64 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.728 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -69.63 178.17 2.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.269 0.628 . . . . 0.0 110.327 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -114.54 -39.77 3.73 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.478 0.711 . . . . 0.0 109.55 164.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.8 mmt -53.7 -34.04 57.49 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.073 0.949 . . . . 0.0 112.036 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -57.09 -42.94 81.64 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.331 0.969 . . . . 0.0 111.93 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.4 -40.38 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.863 0.865 . . . . 0.0 110.432 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -97.18 -19.93 18.29 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -167.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.51 -33.7 76.5 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.629 1.104 . . . . 0.0 111.529 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.84 -43.17 48.69 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.861 1.264 . . . . 0.0 111.695 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -72.24 -43.72 63.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.451 0.7 . . . . 0.0 110.496 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.83 -47.16 80.96 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -55.54 -43.25 75.61 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.908 0.483 . . . . 0.0 110.697 173.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.82 -24.82 71.6 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.97 -0.906 . . . . 0.0 112.872 -174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.3 mt -64.32 110.24 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 119.302 1.551 . . . . 0.0 107.715 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -72.71 -8.04 53.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.468 1.907 . . . . 0.0 113.939 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.73 70.64 1.71 Allowed Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 126.191 1.796 . . . . 0.0 109.691 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.94 -29.21 87.59 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.965 3.11 . . . . 0.0 113.883 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.07 -8.29 11.45 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.733 0.697 . . . . 0.0 112.218 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -123.77 -13.36 7.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.813 1.645 . . . . 0.0 110.107 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.79 -56.34 9.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.965 1.306 . . . . 0.0 109.681 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -62.63 -30.54 71.43 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.64 0.776 . . . . 0.0 112.069 -161.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -50.45 21.58 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.189 1.395 . . . . 0.0 111.578 169.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 m -59.87 -44.73 94.01 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.549 1.54 . . . . 0.0 111.355 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -35.87 46.48 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.124 2.17 . . . . 0.0 112.883 175.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -68.55 -48.71 63.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.043 0.537 . . . . 0.0 111.539 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mt -55.83 -49.99 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 123.953 0.783 . . . . 0.0 109.341 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 mt -56.61 -49.17 75.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.21 0.459 . . . . 0.0 110.524 -171.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 t -65.49 -40.24 92.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.376 0.671 . . . . 0.0 111.213 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -63.18 -39.32 94.31 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.647 0.779 . . . . 0.0 111.01 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.77 -47.33 89.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-O 118.41 -0.805 . . . . 0.0 108.891 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.68 -8.76 15.8 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.328 0.967 . . . . 0.0 113.155 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.36 -60.24 1.56 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.221 1.008 . . . . 0.0 111.177 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 m -69.78 -38.82 76.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.569 1.077 . . . . 0.0 110.439 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -123.9 65.18 35.64 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -173.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.17 -10.3 28.67 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.318 2.012 . . . . 0.0 111.772 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.56 -28.67 66.19 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.838 1.255 . . . . 0.0 112.84 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.35 146.84 51.82 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -124.9 147.99 58.34 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.22 148.73 31.05 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.107 2.538 . . . . 0.0 112.323 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -163.82 82.46 0.44 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.412 1.485 . . . . 0.0 107.251 172.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -70.75 134.43 47.42 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.016 -1.678 . . . . 0.0 108.53 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -154.97 152.8 30.13 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.571 1.148 . . . . 0.0 110.337 -170.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.8 m95 47.89 28.98 1.51 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.257 1.423 . . . . 0.0 112.767 -171.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 67.47 24.68 8.7 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.449 1.9 . . . . 0.0 112.492 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.7 p -124.57 143.2 42.63 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 125.358 1.463 . . . . 0.0 109.267 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.8 124.88 10.03 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.844 2.362 . . . . 0.0 108.93 164.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.0 ptm -137.09 163.36 30.99 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 167.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.2 158.97 35.69 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 175.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 m -128.21 124.44 36.73 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -173.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -74.78 84.42 2.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.257 16.6 mt-30 64.34 -11.51 0.12 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.878 2.071 . . . . 0.0 114.884 -176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.73 -9.84 0.02 OUTLIER Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.202 1.382 . . . . 0.0 116.056 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.84 -166.98 1.56 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.242 1.521 . . . . 0.0 114.115 -163.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -126.48 26.37 6.35 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.978 1.711 . . . . 0.0 110.841 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.39 -2.02 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 O-C-N 120.114 -1.616 . . . . 0.0 112.657 -171.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.1 tt -161.08 142.69 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 121.716 2.053 . . . . 0.0 111.795 170.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.22 157.74 29.36 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 161.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -147.27 141.42 26.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.276 1.038 . . . . 0.0 109.224 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.45 114.25 12.69 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.037 -1.04 . . . . 0.0 108.446 -176.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.8 p -54.75 134.73 47.7 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.212 0.915 . . . . 0.0 110.613 -168.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -112.49 163.95 13.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -54.51 -27.04 35.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.679 1.592 . . . . 0.0 113.796 -165.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -137.71 0.24 2.21 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.132 0.973 . . . . 0.0 113.383 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -153.17 158.33 41.63 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.382 0.992 . . . . 0.0 110.137 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -104.48 113.12 26.47 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.07 131.25 43.35 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 167.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.7 t -135.32 138.44 48.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 t -167.86 153.16 6.79 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 125.175 1.39 . . . . 0.0 107.405 161.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.67 -57.61 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 CA-C-N 119.971 1.025 . . . . 0.0 110.699 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -146.24 -79.95 0.16 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -139.63 -38.37 0.48 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.367 1.467 . . . . 0.0 111.614 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -27.86 43.24 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 118.81 0.732 . . . . 0.0 112.422 -166.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -46.56 -43.26 15.11 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.029 0.824 . . . . 0.0 111.155 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 mm -91.31 -11.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 121.998 -0.707 . . . . 0.0 110.235 -168.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.9 m -107.98 -57.19 2.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.151 0.887 . . . . 0.0 110.471 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.76 -60.87 2.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.569 1.948 . . . . 0.0 107.415 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 109' ' ' MET . 59.8 m-85 -77.49 5.99 7.9 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.25 -48.69 12.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.944 1.697 . . . . 0.0 111.775 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -73.42 -41.09 63.71 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.109 0.964 . . . . 0.0 109.132 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.95 -43.21 91.21 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.054 0.942 . . . . 0.0 110.169 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.8 mt -66.8 -43.31 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 120.027 1.285 . . . . 0.0 109.493 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.86 -57.02 14.29 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.556 1.143 . . . . 0.0 110.795 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -25.05 68.16 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.404 1.082 . . . . 0.0 112.802 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.39 -17.26 63.66 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.696 0.68 . . . . 0.0 111.281 173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.14 9.21 5.7 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.347 1.927 . . . . 0.0 113.398 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -134.18 111.89 10.66 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 119.087 1.444 . . . . 0.0 110.705 -161.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.7 m -76.59 15.6 0.61 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.985 -1.697 . . . . 0.0 114.541 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 52.46 -155.24 0.18 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.398 1.879 . . . . 0.0 112.548 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.5 p -125.59 -164.35 1.29 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.074 2.15 . . . . 0.0 105.952 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -81.82 -10.29 59.37 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.558 -1.21 . . . . 0.0 112.943 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.79 13.8 0.19 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-N 120.333 1.424 . . . . 0.0 115.235 -167.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 pp -166.05 178.97 6.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 130.332 3.453 . . . . 0.0 106.29 162.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -119.84 166.22 13.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 120.235 1.38 . . . . 0.0 108.368 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 171.53 14.18 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.463 -0.773 . . . . 0.0 109.667 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -133.59 143.71 48.99 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 103.952 -2.611 . . . . 0.0 103.952 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.95 159.17 51.04 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 CA-C-N 120.785 1.316 . . . . 0.0 109.227 169.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -63.56 -15.91 59.36 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.301 -0.874 . . . . 0.0 112.562 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -66.7 -19.96 65.87 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.407 2.283 . . . . 0.0 114.217 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -135.28 162.8 55.31 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-N 119.476 1.035 . . . . 0.0 111.373 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.66 133.83 26.71 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.573 2.849 . . . . 0.0 110.519 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.04 145.81 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 167.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.86 90.33 8.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.554 1.541 . . . . 0.0 108.556 -172.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -58.57 -31.97 68.49 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.531 -0.731 . . . . 0.0 109.714 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -69.65 -36.21 75.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.173 -0.954 . . . . 0.0 112.813 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -32.67 24.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.329 0.3 OUTLIER -83.18 -23.46 32.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 117.354 -1.308 . . . . 0.0 111.289 -177.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -65.79 -48.53 71.47 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 120.729 1.604 . . . . 0.0 109.725 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -60.49 -31.63 70.66 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -159.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . 22.1 ptp -83.49 -29.01 28.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -44.57 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 119.348 0.977 . . . . 0.0 109.348 -177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.34 -40.06 73.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.682 0.674 . . . . 0.0 109.533 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -71.61 -54.03 11.75 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.859 1.264 . . . . 0.0 112.036 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -65.17 -21.7 66.81 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 119.644 1.111 . . . . 0.0 111.789 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.9 mt -68.93 -54.97 17.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 118.864 0.756 . . . . 0.0 109.729 168.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -70.76 -13.46 62.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.749 0.704 . . . . 0.0 112.371 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.94 -43.46 92.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.895 1.278 . . . . 0.0 111.124 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.42 12.08 3.23 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.285 2.234 . . . . 0.0 113.564 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.529 1.532 . . . . 0.0 110.33 175.835 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.677 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.7 m -56.91 158.0 5.2 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 121.877 -0.778 . . . . 0.0 110.525 165.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -117.68 -45.69 2.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 117.176 -1.393 . . . . 0.0 111.404 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -47.59 -41.64 22.16 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.226 1.375 . . . . 0.0 111.19 -172.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -54.27 -39.26 66.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.404 0.682 . . . . 0.0 112.56 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.7 t -56.23 -41.52 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.478 0.711 . . . . 0.0 109.744 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -102.19 -6.48 23.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.506 1.122 . . . . 0.0 113.495 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.78 -44.81 63.36 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 123.628 0.771 . . . . 0.0 110.202 -170.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -57.32 -34.91 69.24 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.947 0.899 . . . . 0.0 111.379 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -68.55 -42.9 77.72 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.088 0.955 . . . . 0.0 111.001 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.22 -38.37 86.38 Favored 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 123.937 0.895 . . . . 0.0 110.316 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -56.24 -37.14 69.33 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 122.133 -0.354 . . . . 0.0 110.847 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.18 0.9 88.89 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.079 1.323 . . . . 0.0 113.714 -173.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 mm -66.14 149.47 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.007 1.403 . . . . 0.0 107.312 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.64 -22.88 62.46 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.075 1.35 . . . . 0.0 113.568 -170.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.4 145.18 8.66 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 126.227 1.811 . . . . 0.0 108.724 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.07 -27.66 73.85 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.939 2.426 . . . . 0.0 112.386 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.45 -15.14 47.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.778 -0.576 . . . . 0.0 111.126 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.79 15.2 11.77 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.807 -0.558 . . . . 0.0 110.839 176.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -113.59 -45.09 3.14 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 125.412 1.485 . . . . 0.0 110.883 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -70.77 -5.73 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.603 1.161 . . . . 0.0 112.937 -161.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -102.94 -25.81 13.33 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.324 1.85 . . . . 0.0 112.87 168.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m -61.45 -44.9 96.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.743 0.817 . . . . 0.0 109.522 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.64 -39.0 86.67 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.575 1.15 . . . . 0.0 111.81 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -60.01 -46.95 87.82 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.851 -0.595 . . . . 0.0 110.704 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mt -61.71 -44.91 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.997 0.919 . . . . 0.0 110.455 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.02 -48.09 82.83 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -65.79 -42.87 90.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.25 1.42 . . . . 0.0 110.466 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -63.48 -44.56 94.06 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.25 1.82 . . . . 0.0 110.976 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 t -57.17 -49.21 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.465 1.029 . . . . 0.0 109.297 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.68 2.79 0.88 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.72 -50.23 1.97 Allowed 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.795 1.238 . . . . 0.0 111.435 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 m -70.02 -26.49 64.07 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.715 1.206 . . . . 0.0 109.856 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -131.29 78.53 72.09 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.623 0.769 . . . . 0.0 111.484 -170.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.07 -5.21 16.48 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.86 3.04 . . . . 0.0 114.618 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.6 -20.84 32.99 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.011 -1.056 . . . . 0.0 112.312 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.5 mt -78.36 145.98 34.92 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -123.57 144.77 45.18 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 124.765 1.226 . . . . 0.0 108.031 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.04 162.57 36.81 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.494 2.796 . . . . 0.0 112.745 -172.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -170.04 119.89 0.62 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.212 2.205 . . . . 0.0 105.448 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ptm -95.64 127.45 41.68 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 121.28 1.855 . . . . 0.0 108.005 165.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -136.02 150.63 49.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 124.854 1.262 . . . . 0.0 109.155 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 14.5 m95 61.04 24.73 14.82 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.3 t30 74.53 -0.42 3.35 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 128.295 2.638 . . . . 0.0 111.493 -171.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.7 p -105.31 144.48 28.89 Favored Pre-proline 0 N--CA 1.45 -0.445 0 O-C-N 120.419 -1.426 . . . . 0.0 109.537 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.62 143.27 56.03 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.755 1.637 . . . . 0.0 109.107 164.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 19.1 ptm -145.87 172.75 12.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 164.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.21 152.18 45.78 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 p -129.92 114.25 15.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.444 1.098 . . . . 0.0 108.422 -167.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -70.34 91.56 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.769 1.228 . . . . 0.0 108.071 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 48.11 34.56 4.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.298 0.639 . . . . 0.0 112.507 -170.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.25 -11.39 24.24 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 117.253 -1.859 . . . . 0.0 115.861 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.43 HG21 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -74.13 -168.43 0.63 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.793 2.297 . . . . 0.0 111.385 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.43 ' H ' HG21 ' A' ' 53' ' ' THR . 36.5 t80 -129.88 18.85 5.58 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.01 1.724 . . . . 0.0 112.476 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mt -70.27 7.61 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 126.099 1.759 . . . . 0.0 111.757 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 tt -159.67 143.14 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 O-C-N 119.335 -2.103 . . . . 0.0 111.507 167.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.63 159.97 32.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 162.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -149.63 170.73 17.98 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.045 1.422 . . . . 0.0 110.068 173.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.1 t -153.72 152.95 31.37 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 168.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.1 p -78.87 127.46 32.05 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t -101.51 171.13 7.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.06 -17.92 55.05 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -167.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.46 1.12 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -158.18 154.14 26.89 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.388 0.995 . . . . 0.0 110.461 -168.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 tp -92.74 127.94 38.42 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 167.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.19 119.66 39.08 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.16 139.25 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 127.801 2.44 . . . . 0.0 108.93 -164.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 t -165.33 157.89 13.41 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 125.845 1.658 . . . . 0.0 107.516 167.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.79 -57.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.817 1.678 . . . . 0.0 111.282 161.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -145.94 -86.11 0.11 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 172.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -142.89 -32.55 0.48 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.692 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.41 -34.77 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 120.881 1.673 . . . . 0.0 111.394 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.15 -18.89 29.48 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.654 1.121 . . . . 0.0 113.26 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 mm -111.47 1.6 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 127.185 2.194 . . . . 0.0 109.925 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 m -118.57 -61.34 1.67 Allowed 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.633 -0.667 . . . . 0.0 109.376 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -74.15 -51.99 13.88 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 127.894 2.477 . . . . 0.0 107.647 -173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -85.95 4.32 38.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.605 0.762 . . . . 0.0 112.54 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.3 73.75 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.406 1.082 . . . . 0.0 112.637 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -69.99 -43.33 71.66 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.95 -39.11 93.64 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.829 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.21 -49.6 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.755 0.707 . . . . 0.0 109.816 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.16 69.52 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.041 0.937 . . . . 0.0 110.478 -170.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.63 -22.43 63.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.335 1.454 . . . . 0.0 112.996 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.49 -10.29 59.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.783 0.72 . . . . 0.0 112.039 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.12 11.59 56.08 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.029 0.823 . . . . 0.0 113.977 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -97.77 107.65 20.19 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.563 1.182 . . . . 0.0 111.341 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.12 98.38 0.06 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.044 2.138 . . . . 0.0 111.369 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.96 -176.26 6.24 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.638 1.175 . . . . 0.0 111.535 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 p -118.96 -164.91 1.08 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.161 1.784 . . . . 0.0 107.853 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -9.12 57.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.06 -1.69 2.87 Favored Glycine 0 N--CA 1.462 0.395 0 CA-C-N 119.441 1.019 . . . . 0.0 112.527 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 pp -162.47 176.28 10.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.361 0.664 . . . . 0.0 110.743 170.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -119.09 164.42 15.55 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.398 -0.813 . . . . 0.0 109.495 167.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.7 158.97 44.02 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.915 -1.115 . . . . 0.0 109.58 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.58 142.82 44.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.41 153.65 50.31 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.64 1.56 . . . . 0.0 109.408 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -60.57 -21.63 62.81 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -57.66 -47.5 82.12 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.749 2.02 . . . . 0.0 112.084 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -110.58 162.48 20.43 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.356 1.062 . . . . 0.0 109.519 -161.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.39 148.54 23.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.313 1.342 . . . . 0.0 112.399 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -77.86 143.77 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.93 81.2 5.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.681 1.592 . . . . 0.0 108.468 171.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -56.79 -34.6 67.8 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.344 0.657 . . . . 0.0 110.071 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -60.13 -54.68 43.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.778 0.831 . . . . 0.0 111.288 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -47.15 84.23 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -176.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.339 0.4 OUTLIER -69.1 -29.66 67.79 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 116.877 -1.535 . . . . 0.0 112.352 -176.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -42.64 76.28 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 121.094 1.77 . . . . 0.0 110.901 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -58.8 -39.26 80.6 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.579 1.081 . . . . 0.0 111.953 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.3 ptp -78.73 -38.36 39.08 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 121.72 -0.612 . . . . 0.0 112.548 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -51.32 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -173.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -56.78 -44.36 81.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.584 0.753 . . . . 0.0 110.806 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -54.96 -50.9 67.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.667 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -70.51 -1.05 9.71 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.3 mt -96.12 -47.71 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 C-N-CA 125.464 1.506 . . . . 0.0 108.137 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -68.92 -8.24 42.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.536 1.062 . . . . 0.0 112.111 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -91.56 -0.38 57.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.513 1.525 . . . . 0.0 111.762 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -112.33 5.37 18.2 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.561 2.344 . . . . 0.0 111.164 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.121 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 163.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.98 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 m -71.84 150.42 44.31 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 121.79 -0.83 . . . . 0.0 109.187 166.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -142.77 -33.71 0.45 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.166 0.986 . . . . 0.0 112.1 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.7 mmt -61.7 -21.29 64.35 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 117.298 -1.334 . . . . 0.0 112.498 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -65.17 -38.3 90.09 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.254 1.388 . . . . 0.0 110.669 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.28 -40.86 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -96.51 36.83 1.32 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.807 1.643 . . . . 0.0 111.156 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.17 -56.18 2.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.688 1.595 . . . . 0.0 111.682 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.6 -15.65 60.83 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -162.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -73.64 -47.24 41.5 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 125.784 1.634 . . . . 0.0 110.566 164.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.37 -45.53 93.99 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.966 0.906 . . . . 0.0 110.597 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -59.04 -15.58 14.21 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.44 0.12 46.66 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.399 1.952 . . . . 0.0 114.162 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.8 135.56 27.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 119.94 1.87 . . . . 0.0 108.013 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -35.07 79.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.852 1.661 . . . . 0.0 112.293 -175.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.15 143.81 32.35 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.46 -20.12 42.14 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.828 2.352 . . . . 0.0 111.741 172.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.05 -21.48 63.68 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.211 0.46 . . . . 0.0 109.89 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -116.06 -16.6 11.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.249 0.931 . . . . 0.0 112.079 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -67.05 -57.32 7.06 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 123.641 0.776 . . . . 0.0 111.356 -170.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -44.21 -61.09 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.645 1.978 . . . . 0.0 112.088 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -38.55 82.75 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 121.403 -0.811 . . . . 0.0 112.426 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 m -52.8 -50.24 64.01 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.475 0.71 . . . . 0.0 111.347 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -55.81 -46.32 78.1 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.643 1.177 . . . . 0.0 111.121 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -62.69 -40.17 96.28 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 122.838 0.455 . . . . 0.0 111.632 -172.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 mt -57.03 -50.83 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 124.012 0.82 . . . . 0.0 109.451 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.06 -55.3 36.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.602 0.361 . . . . 0.0 110.159 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 m -71.95 -21.43 61.6 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.298 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -69.0 -44.57 72.55 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 120.265 1.393 . . . . 0.0 110.428 170.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.409 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 56.1 t -59.68 -45.6 94.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 119.478 1.035 . . . . 0.0 108.587 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.03 62.83 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.538 0.608 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.29 -61.45 2.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 122.154 -0.341 . . . . 0.0 110.311 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -74.73 -35.69 62.67 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.578 1.551 . . . . 0.0 111.746 -162.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.71 74.47 34.76 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.93 -4.27 14.71 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.567 2.178 . . . . 0.0 112.15 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -28.36 51.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.647 1.179 . . . . 0.0 111.384 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.59 143.62 42.24 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -96.87 150.83 37.34 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.66 151.93 52.82 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.553 2.168 . . . . 0.0 110.577 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -156.15 130.8 8.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.623 1.569 . . . . 0.0 107.169 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -107.91 96.07 6.12 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.48 147.5 30.39 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 125.977 1.711 . . . . 0.0 107.245 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 3.9 m95 57.41 17.89 4.09 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 172.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 t30 57.76 29.48 17.48 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.861 2.464 . . . . 0.0 112.778 -167.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -126.63 144.99 51.65 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.89 134.09 22.96 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.709 2.939 . . . . 0.0 111.757 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.9 ptm -148.25 172.36 14.48 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.097 0.559 . . . . 0.0 110.52 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.409 ' CE2' ' CG1' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -132.77 148.92 52.32 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.9 112.29 11.16 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.665 1.186 . . . . 0.0 108.879 -168.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.82 97.34 1.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 44.84 38.58 2.98 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.404 1.002 . . . . 0.0 111.449 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.01 -10.43 34.18 Favored Glycine 0 CA--C 1.533 1.219 0 CA-C-O 116.771 -2.127 . . . . 0.0 117.057 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.54 -170.13 0.97 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 121.643 2.721 . . . . 0.0 111.414 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -131.54 22.43 4.71 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 119.899 -1.751 . . . . 0.0 112.434 -170.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.32 -2.88 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 127.088 2.155 . . . . 0.0 112.413 -165.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 tt -155.91 132.03 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 119.239 -2.163 . . . . 0.0 109.814 165.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.83 150.0 21.71 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 165.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.88 174.59 10.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.682 1.241 . . . . 0.0 109.935 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -152.15 161.19 43.0 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 159.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.1 p -68.64 159.01 32.89 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 m -138.5 175.04 9.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.834 1.254 . . . . 0.0 108.212 168.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.82 -60.29 2.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.418 1.087 . . . . 0.0 112.89 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -123.56 6.72 8.9 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -172.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -146.78 157.96 43.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.042 1.737 . . . . 0.0 109.332 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.1 tp -88.61 155.77 19.43 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 154.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.0 p -115.75 114.81 25.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 116.778 -1.582 . . . . 0.0 109.013 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 79.0 t -126.19 144.08 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.832 1.196 . . . . 0.0 110.142 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.3 t -169.21 156.92 6.9 Favored Pre-proline 0 C--O 1.239 0.536 0 C-N-CA 127.069 2.148 . . . . 0.0 108.008 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -74.79 -56.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 120.713 0.942 . . . . 0.0 111.434 161.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -156.37 -80.89 0.07 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -147.33 -30.27 0.33 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -33.81 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 120.662 1.574 . . . . 0.0 110.578 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -44.91 -31.93 2.96 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.016 1.293 . . . . 0.0 112.532 169.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.7 mm -104.63 -0.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.936 1.294 . . . . 0.0 110.785 -168.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.8 m -121.35 -46.41 2.29 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -38.93 36.47 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.434 2.294 . . . . 0.0 109.404 -174.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -100.84 5.08 43.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.723 0.809 . . . . 0.0 111.498 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.33 -36.73 76.19 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.121 1.369 . . . . 0.0 111.758 -172.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -72.57 -46.77 52.72 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.625 1.17 . . . . 0.0 108.829 -175.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.76 -41.74 91.69 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.419 0.688 . . . . 0.0 111.388 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.7 mt -61.41 -46.18 97.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.038 0.835 . . . . 0.0 109.575 171.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.28 -49.19 76.65 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 123.702 0.801 . . . . 0.0 110.365 -170.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -62.18 -29.31 70.28 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.965 1.306 . . . . 0.0 112.248 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.5 -22.92 62.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.08 0.854 . . . . 0.0 111.315 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.34 16.49 7.11 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.44 1.495 . . . . 0.0 113.99 170.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -108.97 93.44 4.52 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.488 1.144 . . . . 0.0 112.487 -164.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.6 m -52.27 96.61 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.191 2.196 . . . . 0.0 112.837 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.73 177.84 8.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.927 1.691 . . . . 0.0 112.121 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -100.44 -169.51 1.73 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.405 1.882 . . . . 0.0 107.362 159.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -77.26 -24.23 51.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.818 0.847 . . . . 0.0 112.687 168.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.5 -25.62 5.15 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 123.729 0.681 . . . . 0.0 112.759 -168.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 pp -152.77 161.11 42.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.051 0.925 . . . . 0.0 110.057 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -98.07 163.47 12.74 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.703 -0.623 . . . . 0.0 109.523 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -117.95 163.52 16.45 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.51 147.94 67.97 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 162.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -59.83 157.44 33.23 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 121.467 1.56 . . . . 0.0 109.59 159.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -65.08 -46.47 81.01 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.48 -0.763 . . . . 0.0 111.714 166.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -71.06 -21.63 62.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -166.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.02 160.63 29.19 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.49 1.116 . . . . 0.0 108.841 -172.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.71 144.4 19.51 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.614 1.543 . . . . 0.0 112.789 -163.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -84.14 123.96 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.415 1.886 . . . . 0.0 109.339 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -78.29 78.77 4.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.384 1.874 . . . . 0.0 112.917 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -51.98 -47.27 64.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.405 1.082 . . . . 0.0 110.423 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -68.9 -24.89 64.37 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -170.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.27 -56.3 5.75 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.508 1.123 . . . . 0.0 108.69 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.87 -23.75 62.37 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.946 -171.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -50.21 -53.98 24.2 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 127.065 2.146 . . . . 0.0 110.346 162.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -60.51 -47.53 85.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.873 0.76 . . . . 0.0 110.036 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 17.9 ptp -78.36 16.98 0.7 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.274 0.1 OUTLIER -117.12 -47.77 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 O-C-N 120.375 -1.453 . . . . 0.0 107.382 162.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.43 -53.27 60.08 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 111.994 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.39 -46.17 90.92 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 121.72 -0.613 . . . . 0.0 109.443 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -29.39 68.85 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.71 0.804 . . . . 0.0 111.539 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.9 mt -75.06 -59.68 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 125.703 1.601 . . . . 0.0 109.728 171.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -66.86 -18.47 65.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.942 0.792 . . . . 0.0 111.71 -168.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.77 -14.04 62.77 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.907 1.283 . . . . 0.0 112.496 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -119.01 20.4 12.73 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 127.024 2.13 . . . . 0.0 111.153 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 123.585 0.754 . . . . 0.0 110.007 -177.62 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.575 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.8 m 49.9 -157.27 0.09 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.31 1.044 . . . . 0.0 112.378 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 174.8 -37.35 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 128.34 2.656 . . . . 0.0 110.379 161.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.9 mmt -54.14 -27.88 36.32 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.002 0.921 . . . . 0.0 112.232 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -55.26 -60.64 3.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.388 1.475 . . . . 0.0 111.732 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.21 -38.93 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.732 1.213 . . . . 0.0 111.029 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -88.09 -15.13 37.04 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.166 0.586 . . . . 0.0 112.367 -169.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.11 78.45 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.223 1.009 . . . . 0.0 111.535 -175.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.88 -9.05 13.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.12 1.368 . . . . 0.0 113.383 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -112.59 -35.87 5.39 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.981 0.912 . . . . 0.0 110.832 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.3 mt -52.97 -33.68 52.33 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.481 -0.762 . . . . 0.0 111.168 170.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -54.62 -35.5 63.47 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.272 1.029 . . . . 0.0 113.671 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.1 -0.1 56.07 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-O 118.923 -0.932 . . . . 0.0 112.78 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.51 91.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -2.35 0.96 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.58 2.352 . . . . 0.0 113.294 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.448 ' HB3' ' HD1' ' A' ' 19' ' ' HIS . 1.2 m-70 -114.47 67.02 1.73 Allowed Pre-proline 0 N--CA 1.444 -0.768 0 C-N-CA 129.055 2.942 . . . . 0.0 109.408 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.5 -21.91 65.71 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.862 3.041 . . . . 0.0 113.24 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -71.18 -4.67 26.77 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.727 1.611 . . . . 0.0 112.18 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.448 ' HD1' ' HB3' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -147.0 16.78 1.22 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.45 1.1 . . . . 0.0 110.06 -175.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -87.55 -47.84 8.39 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.092 1.357 . . . . 0.0 109.693 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -55.58 -30.04 60.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.516 2.326 . . . . 0.0 112.938 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -58.52 -38.22 77.25 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.887 -1.133 . . . . 0.0 111.145 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.6 m -66.85 -39.63 87.66 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.362 0.665 . . . . 0.0 109.668 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.1 -44.8 83.57 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.418 1.487 . . . . 0.0 110.622 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -61.17 -44.39 97.39 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.74 0.416 . . . . 0.0 109.974 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.7 mt -61.31 -49.99 82.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.985 1.314 . . . . 0.0 109.109 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.79 -41.37 91.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.477 0.711 . . . . 0.0 109.79 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -65.09 -43.96 90.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.913 0.885 . . . . 0.0 110.868 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -66.93 -38.66 86.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.884 1.274 . . . . 0.0 111.81 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.0 t -61.28 -43.67 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 O-C-N 121.415 -0.803 . . . . 0.0 109.553 175.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.67 -25.03 67.94 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.153 0.581 . . . . 0.0 111.519 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 -70.16 0.59 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.217 1.007 . . . . 0.0 109.543 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.2 m -67.87 -29.48 68.6 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.783 -0.627 . . . . 0.0 112.225 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -123.15 58.34 12.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.167 0.894 . . . . 0.0 110.267 -171.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.09 -18.88 45.74 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.907 3.071 . . . . 0.0 114.983 -160.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -79.0 -7.2 57.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.164 0.893 . . . . 0.0 111.862 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.47 141.07 38.51 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.579 1.081 . . . . 0.0 108.605 165.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -116.42 154.29 48.94 Favored Pre-proline 0 C--N 1.328 -0.362 0 C-N-CA 124.937 1.295 . . . . 0.0 110.39 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.33 138.74 30.73 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.628 2.885 . . . . 0.0 110.337 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -165.56 82.73 0.33 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.05 140.71 54.91 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.057 -1.027 . . . . 0.0 108.694 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -150.15 153.27 36.04 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 124.741 1.217 . . . . 0.0 108.426 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.3 m95 51.6 31.55 7.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.68 0.792 . . . . 0.0 112.256 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 t30 59.12 18.34 6.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.562 1.945 . . . . 0.0 113.784 -173.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -114.13 127.12 27.16 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.727 1.611 . . . . 0.0 107.106 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.13 114.77 3.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.686 2.257 . . . . 0.0 109.978 170.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.6 ptm -130.79 173.66 10.72 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.349 1.06 . . . . 0.0 109.259 173.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -135.18 132.21 37.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.1 p -92.05 125.12 36.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.084 0.954 . . . . 0.0 108.564 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 52' ' ' GLY . 17.1 t30 -74.54 85.94 2.07 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 161.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.268 20.8 mt-30 63.19 -15.23 0.06 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.145 1.778 . . . . 0.0 115.605 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 50' ' ' ASN . . . 179.74 -13.01 0.03 OUTLIER Glycine 0 CA--C 1.544 1.859 0 C-N-CA 126.938 2.208 . . . . 0.0 115.094 170.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.84 -165.79 1.15 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.765 1.226 . . . . 0.0 113.237 -163.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.48 29.32 4.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.14 2.176 . . . . 0.0 109.762 -173.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.2 mt -67.72 -19.73 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.527 1.131 . . . . 0.0 112.118 -168.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.4 tt -155.02 136.59 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 120.236 1.38 . . . . 0.0 110.263 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.92 157.08 27.35 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 166.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -138.72 168.84 18.92 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.222 -1.163 . . . . 0.0 109.104 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 81.4 p -150.2 144.13 25.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.8 p -91.28 155.3 18.64 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -173.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 t -135.16 177.99 7.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.113 1.365 . . . . 0.0 108.474 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -49.34 -65.67 0.53 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.059 1.343 . . . . 0.0 109.571 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -116.2 13.06 15.62 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -172.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -153.83 166.46 32.83 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.901 0.773 . . . . 0.0 111.571 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.1 tp -97.99 158.53 15.48 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 162.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.0 m -126.7 120.62 29.87 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.184 0.902 . . . . 0.0 109.859 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.88 140.9 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.189 1.796 . . . . 0.0 109.222 -161.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.2 t -167.43 157.02 9.42 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 127.68 2.392 . . . . 0.0 105.883 168.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.13 -57.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.059 0 CA-C-N 120.65 1.268 . . . . 0.0 108.957 166.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -145.34 -86.18 0.12 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -139.49 -29.57 0.74 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.016 1.327 . . . . 0.0 112.499 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.17 -29.16 45.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 119.192 0.905 . . . . 0.0 111.439 -172.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.16 -24.63 15.94 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.872 2.177 . . . . 0.0 113.205 171.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.3 mm -107.74 -6.98 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 127.082 2.153 . . . . 0.0 110.171 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -92.35 -85.46 0.26 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -83.83 -45.71 12.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -169.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -67.84 -22.43 65.14 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.112 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.53 -32.14 57.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.196 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -67.33 -45.2 77.14 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.433 0.693 . . . . 0.0 110.05 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.01 89.49 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.932 -1.105 . . . . 0.0 110.819 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.3 mt -66.62 -43.04 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 118.653 0.66 . . . . 0.0 109.722 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.35 89.42 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 124.643 1.177 . . . . 0.0 109.862 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -65.1 -24.65 67.49 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.679 1.191 . . . . 0.0 111.74 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.4 -29.23 41.9 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.353 0.979 . . . . 0.0 110.904 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 142.18 -31.37 2.07 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.999 1.762 . . . . 0.0 112.599 165.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -81.15 102.18 10.13 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.965 1.383 . . . . 0.0 109.76 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.4 m -69.8 9.7 0.49 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 58.47 -172.97 0.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.36 2.264 . . . . 0.0 112.065 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.5 p -110.89 179.31 4.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.85 1.66 . . . . 0.0 106.93 158.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -66.86 27.89 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.734 2.413 . . . . 0.0 113.323 164.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.1 -35.57 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 CA-C-O 118.287 -1.285 . . . . 0.0 114.88 -168.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 pp -161.47 173.6 14.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.214 1.007 . . . . 0.0 112.077 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -108.88 119.67 40.23 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 120.89 -1.131 . . . . 0.0 110.37 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.27 138.65 42.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.98 143.81 31.58 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 169.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.55 156.84 29.63 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.439 2.092 . . . . 0.0 110.715 170.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -59.64 -25.63 64.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.402 168.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.99 -67.91 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.713 0.688 . . . . 0.0 110.796 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.9 164.96 44.16 Favored Pre-proline 0 N--CA 1.465 0.295 0 C-N-CA 124.409 1.083 . . . . 0.0 111.707 -168.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.92 139.42 12.13 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.086 1.191 . . . . 0.0 112.814 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.2 t -72.84 115.83 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -68.42 89.4 0.35 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.054 1.342 . . . . 0.0 111.418 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -58.1 -39.54 78.88 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 124.831 1.253 . . . . 0.0 109.897 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -66.91 -38.64 86.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.719 1.207 . . . . 0.0 113.406 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -48.3 55.71 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.285 0.4 OUTLIER -71.11 -26.52 63.06 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.973 -173.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -66.73 -43.09 85.15 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.117 -1.42 . . . . 0.0 111.001 171.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -53.45 -52.21 60.19 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.338 1.426 . . . . 0.0 109.677 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.7 ptp -63.02 -47.38 83.32 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.858 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -43.01 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 120.306 1.412 . . . . 0.0 110.736 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -63.01 -44.81 94.97 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.411 0.551 . . . . 0.0 110.441 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -56.23 -45.99 79.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.847 0.459 . . . . 0.0 110.623 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.66 -22.19 65.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.054 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.6 mt -82.17 -47.53 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 119.613 1.097 . . . . 0.0 109.626 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -71.0 -19.27 62.54 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.23 0.923 . . . . 0.0 111.491 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.24 -28.83 57.3 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.101 1.761 . . . . 0.0 110.892 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -106.21 43.04 1.18 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 126.18 1.792 . . . . 0.0 108.054 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--O 1.246 0.889 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.811 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.892 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.4 m -73.41 -10.96 60.28 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.13 -1.414 . . . . 0.0 113.806 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.285 22.3 p-80 51.51 -47.54 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 131.138 3.775 . . . . 0.0 115.174 -167.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mmt -50.26 -43.99 53.5 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.899 1.679 . . . . 0.0 109.691 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -54.46 -32.84 58.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.21 -33.0 19.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 123.002 0.521 . . . . 0.0 111.125 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -113.57 32.84 5.52 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.685 1.994 . . . . 0.0 113.73 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.57 -15.33 10.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 121.787 2.085 . . . . 0.0 113.747 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.7 -24.42 21.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -35.87 59.01 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -173.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -37.09 71.85 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.9 1.28 . . . . 0.0 112.074 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -54.35 -39.61 67.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.819 0.736 . . . . 0.0 110.74 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.88 -7.4 75.44 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.247 1.403 . . . . 0.0 113.997 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.8 mt -86.46 102.87 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.93 -8.4 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.569 1.147 . . . . 0.0 113.452 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.48 84.99 0.68 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.688 1.995 . . . . 0.0 111.18 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.77 -20.44 58.9 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.707 2.938 . . . . 0.0 114.241 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.27 -17.04 63.24 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.114 0.416 . . . . 0.0 110.545 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -128.16 -33.97 2.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.177 0.991 . . . . 0.0 111.268 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -48.52 -54.65 13.56 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.301 1.041 . . . . 0.0 109.849 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -13.15 34.55 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.11 1.364 . . . . 0.0 113.178 -175.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -88.32 -51.95 5.47 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.934 1.243 . . . . 0.0 108.36 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.1 m -46.56 -43.31 17.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.608 1.963 . . . . 0.0 112.685 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -71.94 -28.17 63.29 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.366 1.466 . . . . 0.0 112.592 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.13 -47.0 78.64 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.669 -0.644 . . . . 0.0 109.852 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -54.91 -45.71 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.22 -52.26 66.44 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.375 0.27 . . . . 0.0 110.969 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 p -62.09 -41.12 97.88 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.622 0.769 . . . . 0.0 112.961 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -56.49 -59.03 5.57 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.913 1.685 . . . . 0.0 109.96 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.6 t -50.53 -48.04 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 120.245 1.384 . . . . 0.0 111.182 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.79 -16.41 64.24 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.54 -54.83 3.98 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.868 0.867 . . . . 0.0 110.669 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -34.26 77.65 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.693 0.797 . . . . 0.0 111.669 -171.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.36 69.62 81.33 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.733 1.213 . . . . 0.0 108.388 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.82 -6.42 18.12 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.035 3.157 . . . . 0.0 115.044 -162.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -73.75 -14.45 61.13 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 120.036 1.289 . . . . 0.0 112.152 168.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.6 mt -75.66 135.15 40.44 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 120.944 -1.097 . . . . 0.0 110.948 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -110.99 149.79 40.95 Favored Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 126.537 1.935 . . . . 0.0 109.203 175.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.08 159.99 40.42 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.895 2.397 . . . . 0.0 111.523 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -158.16 111.83 2.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.209 1.003 . . . . 0.0 108.529 166.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.99 95.38 1.58 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 165.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -118.48 147.42 43.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.5 m95 53.16 23.32 3.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.8 t30 62.23 15.91 7.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.788 1.235 . . . . 0.0 112.327 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 p -121.31 150.23 53.7 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.25 113.11 3.62 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.93 2.42 . . . . 0.0 110.564 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.1 ptm -119.18 172.7 7.4 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 166.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.3 139.62 48.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -102.34 127.7 49.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.434 ' C ' ' H ' ' A' ' 52' ' ' GLY . 20.4 t30 -71.41 87.76 0.87 Allowed 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 166.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 58.75 -8.95 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.156 2.582 . . . . 0.0 114.655 -177.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 50' ' ' ASN . . . 167.47 -11.97 0.06 OUTLIER Glycine 0 CA--C 1.543 1.782 0 C-N-CA 126.745 2.117 . . . . 0.0 114.179 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.429 HG23 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -84.58 -169.86 2.83 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.374 1.587 . . . . 0.0 111.651 -174.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.429 ' H ' HG23 ' A' ' 53' ' ' THR . 78.4 t80 -125.43 19.19 8.13 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.696 1.998 . . . . 0.0 111.744 -177.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.35 4.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 126.852 2.061 . . . . 0.0 113.375 -171.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 tt -156.66 142.53 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 118.465 -2.647 . . . . 0.0 111.085 165.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.47 148.57 17.5 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 166.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -149.85 171.97 15.91 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.257 1.423 . . . . 0.0 108.523 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.18 162.05 41.05 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 166.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 p -61.03 152.92 26.7 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.408 0.623 . . . . 0.0 110.261 167.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -132.89 171.13 14.34 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.412 1.885 . . . . 0.0 106.504 163.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -49.41 -49.67 43.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.606 1.562 . . . . 0.0 112.158 -171.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -129.39 7.79 5.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.48 1.112 . . . . 0.0 112.82 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.469 ' CD2' ' HE ' ' A' ' 94' ' ' ARG . 33.5 p-80 -147.26 169.56 19.13 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.171 -0.956 . . . . 0.0 110.541 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.5 tp -102.77 147.03 27.37 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 162.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 m -121.81 125.41 46.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.234 0.925 . . . . 0.0 109.394 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.6 t -136.19 141.55 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 127.316 2.246 . . . . 0.0 109.156 -157.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 t -167.72 152.08 6.37 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.802 1.641 . . . . 0.0 108.7 168.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.64 -56.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.7 1.6 . . . . 0.0 111.679 164.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -139.75 -86.0 0.22 Allowed 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -143.14 -33.97 0.43 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.041 0.936 . . . . 0.0 112.746 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.1 tt -61.05 -33.64 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 120.039 1.29 . . . . 0.0 111.569 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -50.45 -22.37 5.3 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.249 1.404 . . . . 0.0 113.112 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.8 mm -110.69 -1.85 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 126.41 1.884 . . . . 0.0 110.157 -171.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.3 m -118.27 -51.31 2.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.163 0.985 . . . . 0.0 110.509 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -84.06 -58.28 2.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 127.431 2.293 . . . . 0.0 107.43 -173.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.55 0.26 17.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.072 1.349 . . . . 0.0 111.314 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.63 -40.3 78.89 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.855 1.262 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -72.8 -35.78 67.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.62 0.646 . . . . 0.0 109.535 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.25 82.3 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.498 0.719 . . . . 0.0 109.632 170.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.69 -44.89 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.108 0.963 . . . . 0.0 110.333 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.99 -55.84 29.49 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.167 0.987 . . . . 0.0 108.952 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -68.11 -15.86 63.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.692 0.797 . . . . 0.0 113.104 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.63 -16.18 52.26 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.399 1.0 . . . . 0.0 111.092 172.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.36 19.54 9.29 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 124.276 0.941 . . . . 0.0 113.998 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -119.81 99.45 6.64 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.028 1.414 . . . . 0.0 111.455 -166.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.9 m -56.55 117.01 3.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.904 1.281 . . . . 0.0 110.176 172.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.41 -168.18 1.55 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.34 1.856 . . . . 0.0 110.668 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 p -120.06 -164.78 1.11 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.75 1.62 . . . . 0.0 107.217 163.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -88.69 -20.48 24.8 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.06 0.846 . . . . 0.0 111.981 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.74 5.68 5.82 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.989 -0.895 . . . . 0.0 114.174 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 pp -156.34 169.66 24.07 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.873 1.337 . . . . 0.0 110.104 158.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -118.68 179.17 4.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.801 1.24 . . . . 0.0 109.52 170.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.469 ' HE ' ' CD2' ' A' ' 64' ' ' HIS . 2.4 ptp85 -140.49 170.77 15.17 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.071 -1.018 . . . . 0.0 113.341 -177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 mp -135.97 142.85 41.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 160.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.53 160.46 47.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.705 1.603 . . . . 0.0 109.414 166.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -73.47 -23.15 60.04 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -65.59 -67.93 0.4 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.663 0.785 . . . . 0.0 110.455 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.48 165.69 51.5 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.481 1.512 . . . . 0.0 111.593 -164.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.78 145.46 40.98 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.624 1.55 . . . . 0.0 112.765 -170.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.45 126.31 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.28 76.04 7.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 168.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -56.94 -32.96 66.51 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 123.367 0.667 . . . . 0.0 109.433 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.46 -48.54 81.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.46 0.704 . . . . 0.0 111.913 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.73 -42.57 73.8 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 122.522 1.153 . . . . 0.0 109.514 -169.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.276 0.5 OUTLIER -70.54 -30.9 67.76 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.747 176.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -58.45 -51.35 70.21 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.778 1.172 . . . . 0.0 110.641 166.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -51.76 -49.48 62.55 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.822 0.849 . . . . 0.0 109.889 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -69.39 -47.67 63.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.93 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -45.56 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 120.452 1.478 . . . . 0.0 109.919 -175.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.58 -47.63 81.58 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.193 0.997 . . . . 0.0 110.968 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -60.53 -46.22 90.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.028 -0.42 . . . . 0.0 110.792 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -64.16 -20.98 66.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.657 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.1 mt -71.46 -56.45 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 169.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.05 -15.2 63.49 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.933 0.788 . . . . 0.0 112.396 -173.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.76 -10.55 59.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.535 1.134 . . . . 0.0 112.708 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -114.7 21.37 14.5 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.749 2.02 . . . . 0.0 110.959 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.84 174.63 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.928 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -74.28 -10.07 59.23 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 117.728 -1.129 . . . . 0.0 113.824 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.288 9.4 p-80 56.79 -55.78 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 129.786 3.234 . . . . 0.0 114.172 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.7 mmt -44.65 -46.28 10.1 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 126.04 1.736 . . . . 0.0 110.747 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.93 -31.61 72.63 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -168.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.5 t -58.15 -45.87 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.436 1.094 . . . . 0.0 108.701 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -91.58 -9.3 44.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.237 1.415 . . . . 0.0 112.37 -170.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.4 -33.06 70.94 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.468 1.107 . . . . 0.0 111.431 -171.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -68.8 -15.72 63.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.789 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -79.23 -52.96 7.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 166.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -49.18 -45.12 43.68 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.498 1.119 . . . . 0.0 111.791 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -62.46 -25.2 67.86 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 118.051 0.387 . . . . 0.0 111.816 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.35 -2.29 60.46 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.279 1.418 . . . . 0.0 113.577 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 54.3 mt -77.84 111.65 14.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 CA-C-N 120.08 1.94 . . . . 0.0 107.369 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -1.07 24.14 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.601 0.76 . . . . 0.0 112.714 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -110.39 78.83 1.51 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 127.837 2.455 . . . . 0.0 110.021 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -61.11 -32.36 91.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.718 2.278 . . . . 0.0 112.436 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 36.9 m-20 -68.85 -1.55 7.48 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.398 0.999 . . . . 0.0 111.724 -173.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.425 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 14.3 m80 -135.88 -38.38 0.72 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.072 1.749 . . . . 0.0 110.498 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.4 ttp85 -46.14 -54.35 8.78 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 123.898 0.879 . . . . 0.0 109.42 166.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -53.14 -38.69 62.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.784 0.833 . . . . 0.0 112.194 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.67 -45.09 91.68 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.437 -0.789 . . . . 0.0 109.724 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 m -60.91 -35.21 76.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.13 1.772 . . . . 0.0 111.01 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -59.83 -38.45 82.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.693 1.133 . . . . 0.0 110.484 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -59.81 -46.47 89.13 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.566 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.9 mp -54.33 -52.07 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.48 -57.45 12.25 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 122.833 0.453 . . . . 0.0 110.017 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 m -60.66 -43.01 98.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 123.652 0.595 . . . . 0.0 110.454 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -62.87 -41.42 99.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.75 0.82 . . . . 0.0 110.772 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.5 t -58.33 -60.05 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.897 0.771 . . . . 0.0 109.874 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.09 -21.91 66.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.82 0.737 . . . . 0.0 112.597 -174.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.77 -62.38 1.47 Allowed 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.653 0.781 . . . . 0.0 111.562 171.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.3 m -72.27 -35.13 68.66 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.69 1.596 . . . . 0.0 110.753 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -120.65 66.68 13.41 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 124.714 1.206 . . . . 0.0 108.841 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -68.48 -11.63 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.029 1.819 . . . . 0.0 112.362 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -76.18 4.92 7.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.86 0.864 . . . . 0.0 112.477 171.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.42 141.08 36.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.298 1.039 . . . . 0.0 108.277 171.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -122.39 143.95 40.79 Favored Pre-proline 0 C--O 1.239 0.504 0 C-N-CA 124.691 1.196 . . . . 0.0 110.014 -173.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.99 148.04 21.59 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.518 2.812 . . . . 0.0 112.637 -165.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -155.25 119.45 4.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.431 0.693 . . . . 0.0 109.503 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -83.24 113.33 20.6 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 165.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt -150.88 154.99 38.24 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.511 1.125 . . . . 0.0 108.394 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.8 m95 49.77 24.65 1.3 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.659 1.584 . . . . 0.0 113.322 -168.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.48 21.7 8.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.078 1.351 . . . . 0.0 112.186 -171.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.2 p -118.77 158.15 48.29 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 125.783 1.633 . . . . 0.0 109.405 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.25 110.9 2.8 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.281 3.32 . . . . 0.0 110.499 169.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 19.2 ptm -117.73 170.04 9.1 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.054 0.93 . . . . 0.0 109.292 165.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.36 176.64 8.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 166.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.8 m -143.13 139.62 30.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -71.63 97.58 1.75 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 161.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.297 21.7 mt-30 59.78 -11.72 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.574 2.75 . . . . 0.0 116.711 174.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.69 -3.45 0.05 OUTLIER Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.526 2.488 . . . . 0.0 114.541 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.59 -166.14 0.25 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 120.406 2.103 . . . . 0.0 111.799 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -126.73 20.95 7.08 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 119.569 -1.957 . . . . 0.0 111.639 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.5 mt -71.19 15.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 O-C-N 120.29 -1.506 . . . . 0.0 111.802 -169.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 tt -160.5 146.22 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 118.62 -2.55 . . . . 0.0 110.799 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.2 144.26 8.89 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 162.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -137.0 174.24 10.84 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.094 1.447 . . . . 0.0 110.043 171.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.5 t -155.76 159.57 39.57 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 160.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.2 p -63.05 144.13 57.17 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 162.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t -120.19 172.81 7.51 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 162.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -58.45 -44.67 89.3 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 121.499 -0.751 . . . . 0.0 110.737 -163.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -137.44 37.12 2.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.881 0.872 . . . . 0.0 111.918 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -166.57 167.16 15.7 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.418 1.487 . . . . 0.0 109.801 171.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -98.74 157.25 16.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.656 1.182 . . . . 0.0 107.922 162.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.3 p -119.03 125.41 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.717 1.207 . . . . 0.0 108.604 169.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.7 t -135.46 141.7 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 119.619 1.1 . . . . 0.0 108.643 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -173.23 151.49 2.07 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.09 1.756 . . . . 0.0 107.368 175.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.65 -57.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 119.786 0.959 . . . . 0.0 112.318 165.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -149.49 -86.73 0.08 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -142.45 -32.57 0.49 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.836 1.254 . . . . 0.0 111.745 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.0 tt -63.32 -31.29 52.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 118.817 0.735 . . . . 0.0 110.934 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.69 -24.47 12.61 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 127.247 2.356 . . . . 0.0 113.263 173.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.9 mm -120.6 -3.5 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.98 1.312 . . . . 0.0 110.492 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.0 t -80.02 -71.76 0.44 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -88.65 -41.71 12.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.655 -0.653 . . . . 0.0 109.248 -166.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -71.95 -10.34 59.64 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.091 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.56 -27.39 57.62 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -72.93 -42.44 63.47 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.887 0.851 . . . . 0.0 110.406 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.61 -38.18 90.13 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.426 -0.796 . . . . 0.0 110.843 172.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.7 mt -59.91 -50.6 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.226 1.011 . . . . 0.0 108.926 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.18 -47.4 65.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.82 1.248 . . . . 0.0 111.386 -175.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.43 -30.15 68.28 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.586 1.155 . . . . 0.0 112.987 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.36 -15.8 61.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.378 0.99 . . . . 0.0 111.651 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.23 -14.57 43.74 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 125.339 1.447 . . . . 0.0 113.002 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -73.7 161.85 29.81 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 173.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.48 5.02 5.14 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.471 1.032 . . . . 0.0 113.689 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 55.94 -159.07 0.22 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.856 1.662 . . . . 0.0 111.728 -169.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.5 p -119.38 -164.38 1.05 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.19 2.996 . . . . 0.0 104.815 159.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -70.69 -31.19 67.98 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.068 1.303 . . . . 0.0 113.043 171.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.35 -20.46 1.59 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -162.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 pp -137.35 167.98 20.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 121.197 -1.178 . . . . 0.0 110.026 169.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -112.38 150.27 31.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -140.73 145.37 36.36 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.51 143.72 49.11 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 161.45 42.29 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 121.706 1.645 . . . . 0.0 110.604 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -65.99 -15.28 62.88 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -63.44 -38.9 92.91 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.464 1.106 . . . . 0.0 110.846 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.52 158.46 33.7 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 123.76 0.824 . . . . 0.0 110.127 -156.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.08 126.08 10.88 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.887 2.391 . . . . 0.0 108.197 166.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.1 m -78.98 18.16 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.297 0.3 OUTLIER 50.73 78.0 0.11 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.948 2.899 . . . . 0.0 113.492 177.074 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -69.42 -48.75 60.04 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.944 2.098 . . . . 0.0 111.674 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -58.94 -36.35 74.62 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.01 0.924 . . . . 0.0 111.383 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -50.53 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.579 0.704 . . . . 0.0 110.067 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.289 0.3 OUTLIER -71.29 -29.4 65.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.535 0.734 . . . . 0.0 112.765 -174.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.19 -39.36 93.83 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.404 -1.284 . . . . 0.0 110.312 172.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -57.91 -49.47 76.65 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.337 1.426 . . . . 0.0 110.444 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.5 ptp -69.51 -45.16 69.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.191 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.63 -46.62 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.697 1.135 . . . . 0.0 110.122 -175.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.13 -31.16 72.24 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.504 1.047 . . . . 0.0 111.998 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.07 -53.42 25.75 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 118.06 0.391 . . . . 0.0 110.358 169.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.72 -18.13 64.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.487 -170.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.05 -71.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 124.983 1.313 . . . . 0.0 108.812 158.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -66.18 -13.41 60.19 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -165.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -77.16 -12.07 59.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.78 2.032 . . . . 0.0 113.13 174.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -129.37 3.9 5.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.268 2.227 . . . . 0.0 110.476 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.251 24.0 tt0 . . . . . 0 C--O 1.255 1.383 0 C-N-CA 128.966 2.906 . . . . 0.0 115.022 166.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.382 0 CA-C-O 119.398 -0.668 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.7 m -70.49 -27.28 64.08 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.75 1.275 . . . . 0.0 111.986 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.293 8.3 p-80 45.0 -54.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.257 1 C-N-CA 132.023 4.129 . . . . 0.0 115.039 -165.328 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mmt -44.74 -49.48 10.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 128.42 2.688 . . . . 0.0 110.349 -170.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.74 -31.15 58.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.433 1.093 . . . . 0.0 112.126 -169.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.09 -45.13 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 123.97 0.908 . . . . 0.0 110.535 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -96.85 -8.72 30.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.226 2.21 . . . . 0.0 112.649 -170.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.77 -12.32 60.31 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 126.231 1.812 . . . . 0.0 112.182 -160.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.465 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 27.4 mt-10 -111.4 -27.46 8.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.554 1.942 . . . . 0.0 109.184 -168.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.68 -34.63 69.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.02 -47.7 44.3 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.862 1.265 . . . . 0.0 112.611 173.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 1.4 mppt? -61.74 -27.09 68.47 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.829 1.195 . . . . 0.0 113.403 176.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.6 -12.47 84.37 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.874 -0.959 . . . . 0.0 113.028 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.1 mt -76.08 113.02 14.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 119.742 1.771 . . . . 0.0 106.682 168.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -79.19 -4.11 48.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 122.055 0.931 . . . . 0.0 113.478 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -100.15 85.91 0.57 Allowed Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 127.645 2.378 . . . . 0.0 111.702 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -62.56 -38.58 50.4 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.861 2.374 . . . . 0.0 111.349 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.21 10.75 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.815 1.246 . . . . 0.0 111.162 -172.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -135.5 -38.8 0.74 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.018 0.927 . . . . 0.0 111.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -43.77 83.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 116.492 -1.718 . . . . 0.0 114.688 -176.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -45.21 -42.89 9.76 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.028 1.285 . . . . 0.0 112.006 -172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -45.5 79.02 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.041 2.136 . . . . 0.0 111.971 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.0 m -59.71 -37.64 79.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.212 1.405 . . . . 0.0 109.744 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.09 -36.2 81.46 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 124.325 1.05 . . . . 0.0 110.788 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -59.84 -46.7 88.45 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.426 0.69 . . . . 0.0 109.722 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 mt -60.13 -44.76 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.021 0.929 . . . . 0.0 109.502 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.0 mt -58.05 -55.27 37.08 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.936 0.789 . . . . 0.0 110.054 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.4 m -62.4 -33.14 74.19 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.451 1.1 . . . . 0.0 113.202 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -73.2 -44.18 60.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.566 -0.709 . . . . 0.0 111.03 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.55 -53.89 38.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.16 -26.19 66.12 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.61 -50.96 8.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.545 0.738 . . . . 0.0 111.034 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.3 m -72.74 -40.39 66.11 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.534 0.734 . . . . 0.0 110.811 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.85 65.63 55.04 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.2 1.0 . . . . 0.0 109.99 -172.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.62 -6.74 19.6 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.09 2.527 . . . . 0.0 114.019 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.31 -16.27 61.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.479 1.036 . . . . 0.0 111.124 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.09 134.71 47.24 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 165.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.92 146.88 32.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.78 147.45 75.29 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.123 1.882 . . . . 0.0 109.787 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -156.57 109.53 2.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.471 -0.768 . . . . 0.0 109.353 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 75.6 mmm -76.54 131.12 38.78 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 161.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -139.17 139.92 37.7 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.0 m95 64.92 0.24 1.16 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 t30 74.58 14.7 3.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.576 2.75 . . . . 0.0 113.37 -162.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.3 p -107.84 147.17 34.93 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.89 138.06 27.94 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.507 2.138 . . . . 0.0 110.494 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.6 ptm -144.05 -179.59 6.59 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 162.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -140.16 161.1 38.44 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 p -125.19 114.36 18.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.154 0.582 . . . . 0.0 110.073 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -71.03 97.17 1.41 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 44.4 48.6 8.17 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.466 1.506 . . . . 0.0 111.758 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.52 35.67 25.3 Favored Glycine 0 CA--C 1.535 1.315 0 O-C-N 121.23 -0.919 . . . . 0.0 114.742 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 54' ' ' PHE . 1.7 m -112.85 -164.78 0.94 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 119.339 1.57 . . . . 0.0 109.617 170.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.437 ' H ' HG23 ' A' ' 53' ' ' THR . 46.3 t80 -129.64 13.19 5.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.275 1.83 . . . . 0.0 111.668 -174.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.9 0.94 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 128.797 2.839 . . . . 0.0 113.502 -167.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 tt -157.36 140.74 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 118.956 -2.34 . . . . 0.0 112.101 165.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.39 165.92 29.07 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.142 1.353 . . . . 0.0 110.324 166.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -157.71 176.15 12.97 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.685 0.755 . . . . 0.0 111.464 165.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.14 155.36 22.82 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 165.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.0 p -63.34 127.87 33.25 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.36 173.8 12.11 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 164.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -66.26 -26.78 67.51 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.858 -1.151 . . . . 0.0 112.971 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -140.59 5.45 2.01 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.852 1.261 . . . . 0.0 113.175 -173.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -157.55 -179.76 8.48 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.097 1.759 . . . . 0.0 106.727 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tt -119.74 133.97 55.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.44 125.62 50.8 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.549 -175.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.1 t -142.72 152.59 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 120.45 1.477 . . . . 0.0 109.82 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.8 t -161.23 165.16 17.4 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.805 2.042 . . . . 0.0 107.31 165.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -87.04 -56.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.401 2.067 . . . . 0.0 111.514 165.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -145.63 -80.86 0.16 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.69 -36.12 0.22 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.198 1.399 . . . . 0.0 111.772 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.0 tt -60.87 -32.34 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.803 0.729 . . . . 0.0 110.787 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.85 -17.81 44.3 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.386 1.946 . . . . 0.0 113.843 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.9 mm -113.65 -0.66 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.534 1.934 . . . . 0.0 108.792 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 t -90.85 -85.15 0.23 Allowed 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.951 1.3 . . . . 0.0 108.134 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -81.29 -43.18 19.53 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.844 0.857 . . . . 0.0 108.979 -170.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -71.81 -14.4 61.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.864 -0.523 . . . . 0.0 112.104 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.84 -32.71 70.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.511 0.724 . . . . 0.0 112.249 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.15 -45.85 83.29 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.91 82.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.82 1.248 . . . . 0.0 110.827 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.2 mt -58.11 -46.87 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.63 75.84 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.917 -0.489 . . . . 0.0 111.012 -171.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -65.41 -24.08 67.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.887 1.275 . . . . 0.0 113.191 -172.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.24 -47.21 83.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.66 55.59 0.04 OUTLIER Glycine 0 C--N 1.333 0.391 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -135.26 171.19 14.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.09 0.956 . . . . 0.0 109.427 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.8 m -130.4 106.99 8.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.58 1.552 . . . . 0.0 107.953 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.76 -178.09 3.04 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.36 0.6 . . . . 0.0 111.363 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 p -107.61 -164.66 0.99 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 162.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 11.27 39.89 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.663 1.585 . . . . 0.0 111.191 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.13 -35.31 0.59 Allowed Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.04 172.89 17.87 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.135 1.374 . . . . 0.0 109.149 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -104.46 162.79 12.94 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.35 0.977 . . . . 0.0 109.717 170.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 120.48 11.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.299 0.239 . . . . 0.0 110.545 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.75 143.73 26.68 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.18 155.12 68.8 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.591 1.528 . . . . 0.0 109.276 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -64.64 -16.3 62.56 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -71.46 -57.91 4.0 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.761 0.824 . . . . 0.0 112.152 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.79 165.81 46.78 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 123.889 0.875 . . . . 0.0 111.131 -165.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -63.21 173.27 4.24 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.603 1.536 . . . . 0.0 110.665 160.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 p -111.96 175.16 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 127.016 2.126 . . . . 0.0 107.408 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.71 78.06 1.29 Allowed 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 120.947 -1.095 . . . . 0.0 111.482 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -55.78 -30.36 61.17 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.066 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -67.64 -36.37 80.65 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.397 -0.814 . . . . 0.0 112.076 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.25 -36.89 58.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.587 1.085 . . . . 0.0 109.761 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.57 -55.65 23.9 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.93 0.492 . . . . 0.0 109.918 175.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -62.97 -49.58 74.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.761 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -54.16 -49.78 68.48 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.357 0.526 . . . . 0.0 110.448 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.4 ptp -72.46 -40.72 66.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.68 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.73 -46.81 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 120.615 1.552 . . . . 0.0 109.376 -172.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -55.03 -44.73 74.92 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.615 1.166 . . . . 0.0 110.736 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -65.05 -50.89 64.44 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.76 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -23.67 65.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.417 1.008 . . . . 0.0 111.592 -172.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.6 mt -75.16 -57.11 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.284 1.034 . . . . 0.0 109.337 169.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -63.95 -31.32 72.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 123.244 1.497 . . . . 0.0 112.1 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.33 -1.8 25.4 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 126.29 1.836 . . . . 0.0 112.914 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -127.36 -0.03 6.33 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 126.763 2.025 . . . . 0.0 111.931 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.25 1.096 0 C-N-CA 124.92 1.288 . . . . 0.0 109.664 -172.881 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.663 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 m 45.54 -55.74 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 131.409 3.884 . . . . 0.0 119.636 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.414 ' CE1' ' HG2' ' A' ' 4' ' ' MET 0.267 2.0 p-80 55.31 -45.32 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.525 1 C-N-CA 132.796 4.438 . . . . 0.0 116.127 -167.751 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.414 ' HG2' ' CE1' ' A' ' 3' ' ' HIS . 6.6 mmt -51.67 -44.9 63.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.182 1.393 . . . . 0.0 110.627 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.43 -28.15 68.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.995 1.318 . . . . 0.0 112.033 -170.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.4 t -76.18 -39.14 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -89.81 -11.71 41.27 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.874 1.27 . . . . 0.0 112.968 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.96 -20.27 64.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.931 0.892 . . . . 0.0 111.795 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.62 -16.57 51.09 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.567 1.147 . . . . 0.0 112.741 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -81.41 -49.45 10.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.739 1.616 . . . . 0.0 107.008 167.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -47.98 -49.58 30.22 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.788 1.235 . . . . 0.0 112.553 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -51.09 -34.97 32.66 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.646 0.778 . . . . 0.0 111.79 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.96 -1.09 80.27 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.7 -1.055 . . . . 0.0 113.23 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.0 mt -74.71 117.81 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 119.537 1.669 . . . . 0.0 106.983 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.81 -1.74 58.01 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.996 0.918 . . . . 0.0 112.73 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.07 79.64 8.57 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.005 1.722 . . . . 0.0 111.149 -176.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.92 -20.44 64.29 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 124.128 3.219 . . . . 0.0 114.428 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -7.91 51.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.018 0.826 . . . . 0.0 111.914 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -134.73 -2.75 2.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.271 0.628 . . . . 0.0 112.192 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -60.31 -64.62 0.89 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 127.226 2.21 . . . . 0.0 111.073 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -53.71 -32.46 51.98 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 125.65 1.58 . . . . 0.0 111.228 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -56.39 -33.59 65.89 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.188 -0.945 . . . . 0.0 113.468 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 m -69.48 -41.67 75.85 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.552 0.741 . . . . 0.0 109.548 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -65.06 -33.66 76.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.062 1.345 . . . . 0.0 111.27 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -58.66 -48.54 80.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.6 mt -62.64 -47.94 90.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.094 0.957 . . . . 0.0 109.67 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.9 mt -51.57 -65.8 0.49 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.896 0.878 . . . . 0.0 109.816 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -66.46 -30.47 70.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.171 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -60.7 -35.71 76.97 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 118.985 0.811 . . . . 0.0 110.661 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.3 m -74.65 -45.69 44.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 C-N-CA 117.045 -1.862 . . . . 0.0 106.681 -175.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.71 -13.92 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.777 -0.63 . . . . 0.0 112.473 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.95 -68.08 0.74 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 123.389 0.676 . . . . 0.0 111.473 159.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.434 HG23 ' HE3' ' A' ' 107' ' ' LYS . 9.6 m -73.6 -41.64 62.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.907 0.883 . . . . 0.0 111.879 -163.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -115.08 72.39 3.04 Favored Pre-proline 0 N--CA 1.44 -0.927 0 C-N-CA 129.045 2.938 . . . . 0.0 108.748 175.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.57 -9.65 21.49 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.324 2.683 . . . . 0.0 111.942 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -38.88 90.99 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.874 1.669 . . . . 0.0 112.318 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -79.09 145.17 33.93 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -172.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -110.98 150.27 41.65 Favored Pre-proline 0 C--N 1.319 -0.743 0 C-N-CA 124.628 1.171 . . . . 0.0 108.26 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.65 139.77 37.89 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.614 2.209 . . . . 0.0 109.764 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -154.03 102.52 2.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 53.5 mmm -70.65 105.04 3.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 167.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -110.33 143.0 41.2 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.5 m95 54.51 18.85 2.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 62.44 31.38 17.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.211 1.404 . . . . 0.0 110.943 -170.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.8 p -128.97 147.07 63.24 Favored Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 120.951 -1.093 . . . . 0.0 109.246 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -73.37 129.76 14.26 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.828 3.019 . . . . 0.0 112.717 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.24 165.46 36.31 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.461 1.104 . . . . 0.0 109.138 172.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -126.56 163.88 22.42 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.444 0.64 . . . . 0.0 109.918 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.8 m -136.52 119.85 16.83 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.412 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . 43.8 t30 -77.14 89.72 3.64 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 50.48 51.17 17.38 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.944 0.878 . . . . 0.0 109.291 -171.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.56 -0.43 56.8 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 117.319 1.688 . . . . 0.0 117.319 171.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -165.92 1.1 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.667 2.734 . . . . 0.0 111.975 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -127.2 12.09 7.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.723 1.609 . . . . 0.0 112.748 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.6 mt -64.51 5.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.629 1.972 . . . . 0.0 113.816 -163.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.6 tt -160.93 132.48 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 118.709 -2.494 . . . . 0.0 110.608 174.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.53 157.42 29.36 Favored Glycine 0 C--N 1.339 0.718 0 O-C-N 122.094 -0.379 . . . . 0.0 112.662 171.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -155.84 168.56 26.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.871 0.868 . . . . 0.0 111.729 -176.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.79 158.01 22.22 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 120.611 -1.305 . . . . 0.0 110.393 170.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.6 p -77.29 113.04 14.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.007 0.923 . . . . 0.0 110.232 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.8 t -90.35 168.03 12.2 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.21 -29.79 6.14 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.304 1.442 . . . . 0.0 113.97 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -145.92 10.69 1.19 Allowed 'General case' 0 C--O 1.238 0.469 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -158.07 159.04 35.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.634 0.773 . . . . 0.0 109.268 -173.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.4 165.45 17.2 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 158.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.2 p -141.65 131.65 24.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.3 t -146.1 140.54 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.509 1.05 . . . . 0.0 109.274 -168.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 t -163.78 164.34 14.99 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.928 1.291 . . . . 0.0 108.394 165.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -78.98 -58.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 CA-C-N 119.433 0.833 . . . . 0.0 112.357 165.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -154.87 -85.8 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -138.23 -44.61 0.51 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.235 1.014 . . . . 0.0 111.568 -173.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.5 tt -55.15 -31.85 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.106 0.963 . . . . 0.0 113.102 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.66 -28.49 5.19 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.075 1.798 . . . . 0.0 113.162 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.2 mm -113.24 -5.52 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 117.918 0.859 . . . . 0.0 111.188 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.5 m -76.23 -78.13 0.12 Allowed 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.898 -1.126 . . . . 0.0 109.955 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -86.71 -47.23 9.31 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -68.07 -20.15 64.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.172 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.26 -30.65 51.31 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.756 1.162 . . . . 0.0 112.987 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.34 -48.63 80.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.255 1.422 . . . . 0.0 109.508 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.85 -29.9 62.37 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.58 0.752 . . . . 0.0 111.307 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.49 -45.49 97.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.254 1.021 . . . . 0.0 108.526 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.17 -46.47 88.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.04 0.936 . . . . 0.0 110.338 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -54.03 -42.35 69.05 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.792 1.237 . . . . 0.0 110.839 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.15 8.34 9.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.48 34.96 30.55 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 119.538 1.063 . . . . 0.0 113.653 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -123.71 169.18 11.76 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.145 0.978 . . . . 0.0 109.486 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 m -135.94 106.82 6.63 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.353 1.061 . . . . 0.0 111.059 -171.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.24 170.53 4.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.519 0.728 . . . . 0.0 112.285 168.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.4 p -128.93 -179.96 5.39 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.709 2.403 . . . . 0.0 107.186 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.82 62.98 6.69 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 120.393 -1.442 . . . . 0.0 110.15 -177.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.26 -59.03 0.1 OUTLIER Glycine 0 CA--C 1.498 -0.972 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -171.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -157.6 177.28 11.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.447 -1.377 . . . . 0.0 110.573 -165.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -110.89 158.41 18.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 167.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -144.11 136.76 26.98 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.747 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.6 mm -117.29 142.75 30.68 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -169.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.46 154.6 60.5 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.87 1.713 . . . . 0.0 110.597 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -62.48 -21.89 65.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 172.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.59 -70.6 0.22 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.037 1.735 . . . . 0.0 111.405 172.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.72 153.34 43.81 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.348 0.659 . . . . 0.0 111.353 -161.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.21 -178.73 4.63 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.767 2.978 . . . . 0.0 113.599 -164.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.96 146.35 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 125.716 1.606 . . . . 0.0 110.43 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.99 119.54 35.66 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.28 1.432 . . . . 0.0 109.924 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -87.1 -18.08 31.33 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 123.273 0.629 . . . . 0.0 111.742 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.26 -58.98 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.304 1.042 . . . . 0.0 110.821 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.65 -48.88 79.92 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.62 -56.74 4.84 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.614 1.966 . . . . 0.0 109.933 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.435 ' HE2' ' OE1' ' A' ' 111' ' ' GLU . 22.9 tttt -60.99 -45.01 96.54 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.124 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -58.5 -53.69 55.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.416 1.007 . . . . 0.0 110.155 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -75.56 6.87 4.2 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.9 -52.1 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 120.199 1.363 . . . . 0.0 107.831 173.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.435 ' OE1' ' HE2' ' A' ' 107' ' ' LYS . 42.6 mt-10 -60.91 -40.71 94.18 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 119.227 0.921 . . . . 0.0 111.464 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -61.78 -48.52 80.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -32.02 73.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.959 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.9 -63.85 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.096 1.359 . . . . 0.0 109.123 165.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -69.55 -5.93 27.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.618 1.099 . . . . 0.0 113.317 -170.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -78.58 -50.16 12.02 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.403 1.881 . . . . 0.0 111.462 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -85.8 22.92 1.54 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.899 1.679 . . . . 0.0 111.873 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.253 1.246 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 169.167 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.787 0 CA-C-O 119.466 -0.63 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m 57.0 -171.13 0.09 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.231 2.612 . . . . 0.0 113.542 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -146.92 -39.38 0.2 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.824 0.849 . . . . 0.0 111.001 168.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 mmt -58.13 -19.17 30.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.714 0.806 . . . . 0.0 113.008 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -69.07 -43.65 74.15 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 121.36 -0.837 . . . . 0.0 110.169 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.69 -50.42 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.908 0.883 . . . . 0.0 109.011 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.1 4.41 52.24 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.869 0.868 . . . . 0.0 112.14 -166.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.12 79.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.062 0.945 . . . . 0.0 109.989 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.91 -21.01 64.25 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.124 0.97 . . . . 0.0 112.602 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -79.45 -56.4 4.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.479 0.711 . . . . 0.0 109.22 173.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -55.76 -40.62 72.84 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.427 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -52.06 -38.95 58.83 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.689 0.677 . . . . 0.0 111.247 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.84 -7.37 78.21 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-O 118.487 -1.174 . . . . 0.0 112.534 -166.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -70.54 119.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.8 1.02 56.56 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.953 1.301 . . . . 0.0 111.688 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.33 65.81 1.52 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.732 2.413 . . . . 0.0 109.837 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.46 -30.63 93.07 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 124.087 3.191 . . . . 0.0 113.807 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -59.16 -11.32 3.65 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.844 1.258 . . . . 0.0 113.287 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -126.48 -13.85 5.93 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.302 1.841 . . . . 0.0 110.04 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -66.32 -45.98 78.43 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.627 1.171 . . . . 0.0 110.14 -176.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.66 -33.56 64.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.826 1.25 . . . . 0.0 112.776 -171.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -56.67 -39.98 74.72 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.672 -0.643 . . . . 0.0 111.257 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.1 m -69.42 -39.08 78.09 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.195 1.398 . . . . 0.0 109.294 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -63.09 -45.28 92.85 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.04 -1.038 . . . . 0.0 111.815 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -53.85 -51.71 62.72 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 126.076 1.75 . . . . 0.0 108.984 176.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.6 mt -52.4 -56.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.797 1.639 . . . . 0.0 110.453 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.5 mt -53.35 -53.71 47.07 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.59 0.632 . . . . 0.0 110.197 -174.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.1 m -69.07 -31.98 71.11 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.578 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -63.22 -50.16 71.35 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 124.638 1.175 . . . . 0.0 110.506 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 87.3 t -59.93 -52.03 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.17 -1.46 4.43 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.72 -56.3 2.2 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 120.781 -1.199 . . . . 0.0 109.336 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -67.04 -33.58 75.85 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.734 2.013 . . . . 0.0 111.987 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -129.86 72.59 81.9 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.16 -6.73 17.55 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.108 1.872 . . . . 0.0 112.727 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -63.56 -45.8 88.82 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.686 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.405 ' H ' ' CD2' ' A' ' 37' ' ' LEU . 2.8 mm? -60.35 147.32 41.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.055 0.942 . . . . 0.0 108.955 -171.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -104.64 144.97 29.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 124.234 1.014 . . . . 0.0 108.879 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.79 161.29 46.12 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.497 2.131 . . . . 0.0 111.24 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -158.64 130.27 6.55 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.211 1.404 . . . . 0.0 107.681 161.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.17 112.48 17.53 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.551 1.069 . . . . 0.0 108.334 162.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -123.21 128.33 49.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.645 1.178 . . . . 0.0 108.242 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.9 m95 53.29 25.97 4.86 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.809 0.844 . . . . 0.0 113.062 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.59 29.02 18.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.502 1.121 . . . . 0.0 110.18 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -121.12 147.38 46.56 Favored Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -71.96 133.35 21.45 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.711 2.274 . . . . 0.0 111.758 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.0 ptm -147.28 173.3 12.7 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.804 0.442 . . . . 0.0 110.925 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -134.05 152.71 51.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.1 p -122.76 138.74 54.54 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.306 1.442 . . . . 0.0 108.006 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.418 ' C ' ' H ' ' A' ' 52' ' ' GLY . 25.6 t30 -88.35 95.27 10.13 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 163.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 66.78 -13.39 0.19 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.945 1.698 . . . . 0.0 114.046 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 50' ' ' ASN . . . 177.61 -19.63 0.04 OUTLIER Glycine 0 CA--C 1.54 1.646 0 C-N-CA 127.044 2.259 . . . . 0.0 113.887 174.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.44 -171.05 1.68 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -165.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -125.31 24.99 7.25 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.442 2.297 . . . . 0.0 111.786 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.529 HG21 HD21 ' A' ' 113' ' ' ASN . 97.1 mt -68.65 -2.41 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 126.648 1.979 . . . . 0.0 113.515 -167.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 tt -160.68 145.86 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 119.357 -2.09 . . . . 0.0 109.692 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.13 148.81 11.53 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 165.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -144.1 166.09 25.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.849 0.825 . . . . 0.0 109.944 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 t -150.51 145.42 25.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 57.5 p -62.51 145.86 53.15 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.449 ' HB2' ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -127.75 174.59 8.99 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -59.59 -39.24 83.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.377 -162.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -138.6 14.27 2.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.199 1.0 . . . . 0.0 113.079 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.449 ' CD2' ' HB2' ' A' ' 61' ' ' SER . 3.9 p-80 -150.64 176.74 10.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.962 1.305 . . . . 0.0 108.794 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.27 161.88 14.39 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 166.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.35 114.96 24.31 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.127 1.371 . . . . 0.0 108.63 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.9 136.36 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.3 0.955 . . . . 0.0 109.434 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 t -165.68 161.82 13.37 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 125.261 1.424 . . . . 0.0 107.621 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.51 -57.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.131 0 CA-C-N 120.434 1.191 . . . . 0.0 110.998 157.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -149.55 -85.91 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -133.2 -38.85 0.94 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.444 1.498 . . . . 0.0 111.796 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.7 tp -53.76 -38.09 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.67 1.188 . . . . 0.0 112.981 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.42 -21.87 14.33 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.468 1.509 . . . . 0.0 112.835 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.7 mm -119.93 -5.3 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.437 1.495 . . . . 0.0 110.561 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.2 m -95.06 -64.04 1.11 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 168.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -76.62 -66.52 0.8 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -72.48 -6.24 42.38 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.5 -164.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.32 49.24 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 118.238 -0.887 . . . . 0.0 112.545 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -62.75 -47.54 83.11 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.101 0.864 . . . . 0.0 109.82 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.89 -22.8 45.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.755 0.822 . . . . 0.0 110.977 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.92 -46.98 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.004 0.921 . . . . 0.0 108.935 164.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.83 88.52 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.503 1.121 . . . . 0.0 111.088 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -63.07 -15.64 57.23 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 126.868 2.067 . . . . 0.0 112.894 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.6 -15.35 42.84 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 118.475 0.579 . . . . 0.0 111.623 172.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.96 -22.24 19.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.754 2.121 . . . . 0.0 112.879 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -74.17 114.7 12.82 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.236 1.014 . . . . 0.0 110.191 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.1 m -75.11 4.76 6.25 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 48.21 -155.71 0.07 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.798 2.439 . . . . 0.0 112.026 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.0 p -126.4 -164.7 1.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.549 2.34 . . . . 0.0 105.732 163.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -71.73 -33.0 68.34 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.109 1.322 . . . . 0.0 111.515 172.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.56 -10.56 2.92 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 114.479 0.552 . . . . 0.0 114.479 -160.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 pp -149.6 175.88 11.14 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.646 1.178 . . . . 0.0 109.675 168.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -113.26 157.4 21.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.651 0.66 . . . . 0.0 109.546 167.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.1 mtt85 -128.23 155.18 44.96 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.28 142.56 38.16 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.88 155.09 23.3 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.985 1.79 . . . . 0.0 109.343 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -63.81 -17.73 63.4 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -67.0 -45.15 78.46 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.17 0.988 . . . . 0.0 112.086 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.7 156.12 45.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 122.882 0.473 . . . . 0.0 110.982 -157.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.33 165.93 29.98 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.513 2.142 . . . . 0.0 112.911 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.32 124.86 51.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -75.81 78.58 2.74 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.284 1.04 . . . . 0.0 113.148 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -59.62 -37.22 78.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.842 0.857 . . . . 0.0 112.351 173.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.59 -46.8 71.56 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 120.148 1.34 . . . . 0.0 110.437 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 -47.5 67.2 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.435 -0.791 . . . . 0.0 109.289 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.279 0.3 OUTLIER -72.55 -27.07 61.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.339 -175.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -54.33 -52.63 60.94 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.382 0.992 . . . . 0.0 109.591 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -56.73 -52.34 65.37 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.056 -170.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.8 ptp -65.46 -34.63 78.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.025 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -53.01 21.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.988 1.267 . . . . 0.0 109.002 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.63 -50.7 59.77 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -55.66 -52.8 62.6 Favored 'General case' 0 N--CA 1.441 -0.905 0 O-C-N 124.016 0.823 . . . . 0.0 111.068 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.529 HD21 HG21 ' A' ' 55' ' ' ILE . 13.4 t30 -63.67 -22.28 66.82 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.351 0.978 . . . . 0.0 112.844 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.2 mt -71.65 -57.47 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.943 0.897 . . . . 0.0 108.636 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -74.95 -5.93 46.53 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -75.1 -19.86 59.74 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.529 0.731 . . . . 0.0 110.383 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -101.69 16.69 25.0 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.792 2.437 . . . . 0.0 111.071 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 117.351 -1.309 . . . . 0.0 108.198 172.27 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.807 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.43 -43.61 64.95 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.748 1.619 . . . . 0.0 113.233 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.444 ' CE1' ' HG2' ' A' ' 4' ' ' MET 0.256 2.8 p-80 50.87 -48.47 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.594 1 C-N-CA 132.019 4.127 . . . . 0.0 116.435 -171.769 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.444 ' HG2' ' CE1' ' A' ' 3' ' ' HIS . 3.4 mmt -55.91 -31.04 62.53 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 119.892 1.224 . . . . 0.0 111.26 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -53.11 -48.14 68.06 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.519 0.728 . . . . 0.0 111.475 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.31 -43.74 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 121.643 -0.661 . . . . 0.0 109.652 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -103.63 50.14 0.81 Allowed 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.156 0.983 . . . . 0.0 111.236 -171.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -126.2 -27.05 3.28 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.682 0.793 . . . . 0.0 110.374 168.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.83 -12.91 60.26 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.112 -0.993 . . . . 0.0 112.436 -173.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -78.85 -48.77 14.07 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.397 1.479 . . . . 0.0 109.029 163.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -60.2 -22.98 63.63 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.713 2.405 . . . . 0.0 112.923 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -61.01 -44.13 97.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.741 1.155 . . . . 0.0 109.475 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.96 10.23 51.73 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.609 1.1 . . . . 0.0 114.907 -164.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 mm -58.42 123.94 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.072 1.349 . . . . 0.0 108.254 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -56.94 -36.02 69.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.753 1.221 . . . . 0.0 113.107 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.4 ' HB3' ' HD1' ' A' ' 19' ' ' HIS . 1.8 m-70 -116.78 85.95 18.24 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 126.521 1.929 . . . . 0.0 110.928 -168.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.07 -23.62 75.82 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.305 2.003 . . . . 0.0 111.828 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 23.6 m-20 -65.9 -16.9 64.27 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.306 -0.871 . . . . 0.0 111.888 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.408 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 0.8 OUTLIER -128.85 -0.53 5.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.338 1.455 . . . . 0.0 110.763 179.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.9 ttp85 -53.96 -57.45 10.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.142 0.977 . . . . 0.0 109.484 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -48.31 -35.07 11.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.549 1.54 . . . . 0.0 112.39 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -60.63 -39.09 86.97 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.318 -1.489 . . . . 0.0 111.824 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.8 m -63.42 -49.78 72.41 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.675 0.79 . . . . 0.0 109.397 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.53 -30.63 61.08 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.567 1.547 . . . . 0.0 113.33 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.03 -58.94 6.38 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 118.775 0.716 . . . . 0.0 110.297 173.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 mt -57.66 -38.86 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 123.875 0.87 . . . . 0.0 110.415 -173.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.2 mt -56.33 -62.66 1.56 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.157 0.983 . . . . 0.0 110.189 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -64.25 -31.66 72.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -62.24 -43.33 99.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 117.493 -1.241 . . . . 0.0 110.876 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.25 -40.56 80.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.763 0 C-N-CA 116.92 -1.912 . . . . 0.0 107.37 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.96 -25.36 8.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 117.748 -1.12 . . . . 0.0 112.529 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.17 -27.65 14.46 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.403 ' CG2' ' HE3' ' A' ' 107' ' ' LYS . 7.3 m -94.82 -40.18 9.87 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.645 1.111 . . . . 0.0 111.251 -174.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -120.28 58.44 5.91 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 129.575 3.15 . . . . 0.0 111.823 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.08 -13.92 38.38 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.834 2.356 . . . . 0.0 113.722 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.29 -23.67 66.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.165 1.386 . . . . 0.0 112.427 172.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.87 145.58 44.74 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -117.59 150.47 46.83 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 126.964 2.106 . . . . 0.0 108.444 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.27 140.28 13.7 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.872 2.381 . . . . 0.0 111.67 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -164.85 96.49 0.73 Allowed 'General case' 0 C--N 1.346 0.439 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 ptm -70.21 136.39 49.96 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.422 1.01 . . . . 0.0 108.886 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -150.52 155.32 39.25 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.9 m95 52.71 33.37 13.78 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.563 1.145 . . . . 0.0 113.06 -174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 61.78 18.84 10.06 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.207 1.803 . . . . 0.0 112.476 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.0 p -129.49 155.97 79.33 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.92 1.288 . . . . 0.0 110.007 -173.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.81 120.75 5.93 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.968 3.112 . . . . 0.0 110.235 170.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.5 ptm -135.01 162.52 32.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 163.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.93 168.28 14.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 p -134.19 121.63 21.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.144 0.578 . . . . 0.0 109.56 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -68.46 92.9 0.46 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 169.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 53.58 28.67 8.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.478 1.111 . . . . 0.0 111.882 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.3 -17.81 7.89 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 125.636 1.589 . . . . 0.0 115.642 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -79.32 -179.13 6.59 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 119.799 1.8 . . . . 0.0 111.242 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -111.09 18.25 19.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.462 1.905 . . . . 0.0 113.554 -168.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.67 12.51 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.849 1.66 . . . . 0.0 112.495 -163.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 tt -163.31 146.28 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 119.558 -1.964 . . . . 0.0 111.249 174.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.48 151.03 18.21 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 166.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.17 -179.89 8.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.417 0.687 . . . . 0.0 111.078 175.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t 178.79 147.1 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.4 p -62.86 146.91 51.66 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.302 0.641 . . . . 0.0 110.504 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -126.74 165.18 19.74 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -12.51 18.2 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.52 8.29 0.38 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.485 1.039 . . . . 0.0 112.245 176.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -162.49 -179.88 7.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.869 1.668 . . . . 0.0 108.645 -164.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -127.67 154.22 45.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.801 2.041 . . . . 0.0 107.012 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 p -132.07 122.82 26.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.761 1.624 . . . . 0.0 108.954 -173.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.462 HG12 ' CE1' ' A' ' 93' ' ' PHE . 1.6 p -144.78 145.45 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.882 1.219 . . . . 0.0 111.663 -171.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.473 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 13.7 t -160.0 165.03 18.59 Favored Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 125.59 1.556 . . . . 0.0 109.581 169.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -81.49 -57.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.444 2.096 . . . . 0.0 112.936 156.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -149.17 -86.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.122 1.769 . . . . 0.0 106.964 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -152.47 -27.32 0.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.651 1.18 . . . . 0.0 112.55 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.8 tt -62.71 -40.16 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 120.576 1.534 . . . . 0.0 109.891 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.96 -10.91 15.89 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.002 1.286 . . . . 0.0 113.104 173.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mm -117.03 -0.57 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.734 2.014 . . . . 0.0 110.025 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 m -125.62 -50.54 1.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.488 0.585 . . . . 0.0 111.844 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -79.67 -57.42 3.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.987 1.715 . . . . 0.0 107.443 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -73.46 -0.76 15.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.261 1.024 . . . . 0.0 112.5 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.25 -25.47 67.85 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.477 1.911 . . . . 0.0 112.701 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -79.07 -48.02 15.12 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.557 0.743 . . . . 0.0 109.028 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.28 87.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.552 0.741 . . . . 0.0 110.834 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.85 -50.33 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.053 0.941 . . . . 0.0 109.839 171.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.53 -50.58 73.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.97 0.908 . . . . 0.0 111.368 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -60.06 -25.74 65.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.655 1.582 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.41 -27.14 63.1 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.175 0.443 . . . . 0.0 110.854 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 122.61 6.21 8.06 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.466 1.508 . . . . 0.0 113.431 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.07 122.23 44.23 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.459 1.63 . . . . 0.0 110.005 -173.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.43 3.83 12.41 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -170.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 46.52 -168.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.962 2.105 . . . . 0.0 113.277 -172.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.3 p -141.67 -164.7 1.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.347 2.259 . . . . 0.0 108.092 168.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 5.26 13.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.16 2.184 . . . . 0.0 112.047 173.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.5 -7.94 0.03 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 116.667 1.427 . . . . 0.0 116.667 -172.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.473 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 2.9 pp -149.29 170.71 17.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.112 1.456 . . . . 0.0 108.607 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.462 ' CE1' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -116.22 125.83 52.78 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 164.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -72.37 134.75 45.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.494 170.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.6 mm -125.72 143.71 45.96 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 165.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.68 163.68 38.15 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.154 1.903 . . . . 0.0 110.159 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -70.49 -35.12 73.07 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 171.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -67.76 -59.95 2.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.218 0.533 . . . . 0.0 110.469 -174.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.22 162.83 65.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.48 1.912 . . . . 0.0 109.455 -172.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.15 165.61 25.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.587 1.525 . . . . 0.0 113.391 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.0 t -93.44 134.91 29.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 126.413 1.885 . . . . 0.0 106.719 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.41 76.35 3.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.328 1.451 . . . . 0.0 110.721 171.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -56.47 -44.25 80.38 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.028 0.931 . . . . 0.0 110.461 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -65.18 -26.2 68.05 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.778 0.831 . . . . 0.0 111.749 -174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.96 -53.92 6.56 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.277 0.3 OUTLIER -58.72 -24.87 62.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.77 1.228 . . . . 0.0 112.022 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.403 ' HE3' ' CG2' ' A' ' 33' ' ' THR . 16.1 tttt -65.52 -54.0 34.4 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.785 2.034 . . . . 0.0 113.252 169.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -57.81 -46.42 84.71 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.877 1.217 . . . . 0.0 111.192 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.0 ptp -66.35 -32.21 73.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.307 -0.854 . . . . 0.0 113.226 -175.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -44.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.195 0.907 . . . . 0.0 108.987 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.08 -43.75 98.15 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.639 0.775 . . . . 0.0 110.717 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.26 -48.06 81.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.458 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -59.1 -40.47 85.39 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 118.161 0.437 . . . . 0.0 110.383 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.85 -52.06 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 O-C-N 121.319 -0.863 . . . . 0.0 110.084 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -71.56 -4.92 29.6 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 120.27 1.396 . . . . 0.0 112.413 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -93.78 2.57 56.2 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.658 1.983 . . . . 0.0 112.281 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -129.38 19.35 5.8 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.317 1.447 . . . . 0.0 111.216 -174.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 124.282 1.033 . . . . 0.0 109.586 175.71 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -133.69 92.05 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.905 1.352 . . . . 0.0 110.977 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -56.04 -37.5 69.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.992 0.917 . . . . 0.0 113.302 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.2 mmt -60.1 -30.4 69.22 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.652 -0.655 . . . . 0.0 112.534 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.73 -43.85 71.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.57 -44.98 99.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.61 1.164 . . . . 0.0 109.917 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.43 0.05 55.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.953 0.501 . . . . 0.0 112.118 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.54 67.93 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.786 1.235 . . . . 0.0 109.46 173.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.33 -13.36 62.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.273 1.429 . . . . 0.0 113.526 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -82.67 -59.6 2.46 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -44.32 78.36 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.821 1.248 . . . . 0.0 110.811 -175.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -56.36 -32.55 64.83 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.424 0.69 . . . . 0.0 112.471 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.0 -22.73 57.09 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 119.251 -0.749 . . . . 0.0 111.379 -171.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.5 mt -74.84 98.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -66.58 -2.83 5.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.227 1.411 . . . . 0.0 113.437 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -100.01 84.97 0.46 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 128.662 2.785 . . . . 0.0 110.978 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.79 -36.79 82.62 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.533 2.155 . . . . 0.0 112.295 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.88 5.79 2.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.013 0.824 . . . . 0.0 112.476 -170.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -137.13 -36.77 0.66 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.395 1.878 . . . . 0.0 110.425 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -52.78 -40.37 63.12 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.85 0.86 . . . . 0.0 110.889 171.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.93 -22.72 60.41 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.616 1.166 . . . . 0.0 112.362 -176.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -81.99 -31.54 31.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.1 0.864 . . . . 0.0 111.853 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.2 m -72.94 -39.69 66.02 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.157 0.983 . . . . 0.0 110.492 -175.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.19 -26.04 68.62 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.731 0.412 . . . . 0.0 111.906 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.46 -54.65 44.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.835 0.854 . . . . 0.0 110.142 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.9 mp -63.83 -40.59 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -174.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.1 mt -52.92 -53.89 42.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.236 0.614 . . . . 0.0 110.101 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -62.47 -44.45 96.37 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.528 1.131 . . . . 0.0 111.228 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.8 t90 -59.04 -44.31 91.77 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.502 1.121 . . . . 0.0 111.664 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.25 -46.16 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.306 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.25 -12.7 21.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.493 1.042 . . . . 0.0 113.452 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.49 -48.59 7.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.348 164.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 m -78.83 -34.47 45.18 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 117.431 -1.271 . . . . 0.0 111.314 -163.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -117.47 76.17 9.56 Favored Pre-proline 0 C--N 1.344 0.333 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.23 -14.04 39.43 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.665 2.243 . . . . 0.0 113.338 -172.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -20.83 59.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.528 0.731 . . . . 0.0 111.658 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mp -70.29 151.16 45.6 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.564 1.546 . . . . 0.0 109.085 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -122.93 143.02 39.48 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 113.032 -1.895 . . . . 0.0 108.738 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.54 154.21 35.22 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.19 2.593 . . . . 0.0 110.488 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -176.95 102.58 0.05 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.155 1.782 . . . . 0.0 106.26 171.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 62.2 mmm -60.63 129.95 44.11 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -134.58 138.96 45.01 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.0 m95 58.76 19.77 7.22 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m120 64.03 12.18 6.73 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 126.578 1.951 . . . . 0.0 113.101 -166.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.0 p -114.51 112.54 45.86 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 120.356 1.435 . . . . 0.0 108.169 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.05 132.83 33.34 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.927 2.418 . . . . 0.0 111.648 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 ptm -143.26 159.19 42.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.431 ' H ' ' CG2' ' A' ' 56' ' ' ILE . 1.2 m-85 -123.94 109.29 13.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.6 p -73.24 120.82 19.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -67.12 98.33 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 163.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 50.68 -4.64 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 130.207 3.403 . . . . 0.0 117.617 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.44 25.24 0.09 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.76 1.648 . . . . 0.0 113.028 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -117.0 177.32 4.75 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.184 1.394 . . . . 0.0 108.481 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -120.68 25.99 9.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.731 1.612 . . . . 0.0 110.777 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.78 19.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 125.234 1.413 . . . . 0.0 111.552 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.431 ' CG2' ' H ' ' A' ' 48' ' ' PHE . 1.1 tt -165.72 162.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 119.684 -1.885 . . . . 0.0 109.16 166.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.51 91.62 0.08 OUTLIER Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 159.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -90.98 162.47 14.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.532 0.666 . . . . 0.0 110.897 -175.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.0 t -152.92 155.39 36.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.992 0.901 . . . . 0.0 110.399 164.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.6 p -72.8 156.33 39.02 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.185 2.194 . . . . 0.0 109.787 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.28 -179.04 5.43 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.916 1.286 . . . . 0.0 109.739 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -49.66 -59.84 3.43 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 125.085 1.354 . . . . 0.0 111.824 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -132.32 15.31 4.57 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.255 1.022 . . . . 0.0 111.184 -174.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -152.08 173.64 14.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.824 1.249 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.7 tp -111.79 157.87 20.04 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.715 1.606 . . . . 0.0 108.131 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.51 111.62 9.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.277 1.431 . . . . 0.0 110.281 -171.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.5 p -142.15 151.36 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.702 1.601 . . . . 0.0 113.876 -167.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 t -174.83 165.16 2.29 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.136 2.575 . . . . 0.0 109.422 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.99 -55.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 124.327 3.351 . . . . 0.0 112.956 164.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -156.12 -74.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.776 2.03 . . . . 0.0 108.401 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -156.1 -46.75 0.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.861 1.665 . . . . 0.0 110.722 -168.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 tp -55.96 -42.42 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.516 1.053 . . . . 0.0 110.845 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.13 -16.04 24.62 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.075 0.845 . . . . 0.0 114.178 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.4 mm -115.9 -6.88 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.032 1.733 . . . . 0.0 110.131 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.8 m -100.95 -61.22 1.4 Allowed 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 121.569 -0.707 . . . . 0.0 109.881 172.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -82.61 -39.97 21.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.889 2.476 . . . . 0.0 109.597 -172.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -99.38 -8.21 25.13 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.56 -29.78 70.24 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.896 0.771 . . . . 0.0 112.496 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.64 -51.23 70.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.791 0.805 . . . . 0.0 109.483 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.57 -28.87 66.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.416 1.486 . . . . 0.0 111.359 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.9 mt -64.91 -48.82 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 123.76 0.824 . . . . 0.0 108.976 168.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.59 79.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.203 0.525 . . . . 0.0 110.403 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.2 -24.67 67.35 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.991 0.917 . . . . 0.0 112.197 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.57 -4.24 41.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.494 0.588 . . . . 0.0 112.344 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.01 29.21 10.66 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 121.243 -0.911 . . . . 0.0 112.817 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -126.01 -179.99 4.95 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.468 1.134 . . . . 0.0 111.377 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.23 158.84 34.62 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.249 1.819 . . . . 0.0 111.034 -172.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.35 169.83 17.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.495 1.518 . . . . 0.0 110.917 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.2 p -136.47 -163.79 1.46 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 127.857 2.463 . . . . 0.0 107.956 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -94.78 77.03 3.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 166.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.14 6.6 5.28 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.726 166.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.9 159.44 29.69 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.948 1.374 . . . . 0.0 110.706 169.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -117.84 156.76 27.81 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.927 0.891 . . . . 0.0 108.693 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.99 120.11 30.63 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.996 0.919 . . . . 0.0 108.642 -161.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.0 mm -119.61 142.86 33.6 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.51 155.49 31.92 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.785 1.657 . . . . 0.0 109.385 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -57.85 -15.16 7.56 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 170.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.22 -45.92 65.58 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.379 1.471 . . . . 0.0 113.343 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.97 161.92 21.34 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 123.642 0.777 . . . . 0.0 110.227 -163.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -66.23 154.2 75.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.734 2.29 . . . . 0.0 110.899 172.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.3 t -85.98 132.38 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -73.58 81.62 1.5 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.488 1.515 . . . . 0.0 110.365 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -50.55 -48.17 57.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.728 1.211 . . . . 0.0 110.051 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.44 -46.94 66.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 123.433 0.458 . . . . 0.0 111.286 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.6 -47.51 47.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 119.507 1.049 . . . . 0.0 109.886 -171.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -27.0 66.81 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.591 0.757 . . . . 0.0 110.618 174.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -65.99 -59.5 3.76 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.296 1.438 . . . . 0.0 110.187 172.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -61.32 -38.63 87.55 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.698 0.681 . . . . 0.0 109.677 -170.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.8 ptp -72.25 -17.83 61.86 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.63 -53.18 8.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 121.088 1.767 . . . . 0.0 109.176 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.83 -46.67 42.38 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 125.545 1.538 . . . . 0.0 109.128 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -49.56 -41.08 40.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.27 -0.871 . . . . 0.0 113.195 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -29.04 42.65 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 120.33 1.423 . . . . 0.0 109.325 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.2 mt -78.09 -25.94 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 120.711 -1.243 . . . . 0.0 110.202 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -84.32 -2.59 57.3 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.278 1.399 . . . . 0.0 112.165 166.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -92.57 -38.07 12.11 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.278 0.561 . . . . 0.0 110.975 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.59 24.34 3.11 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.059 1.344 . . . . 0.0 112.151 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.243 0.712 0 C-N-CA 124.845 1.258 . . . . 0.0 108.807 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.611 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.51 151.32 20.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.654 0.782 . . . . 0.0 110.406 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -166.93 -35.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.712 1.205 . . . . 0.0 110.593 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.9 mmt -60.7 -25.5 66.45 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.361 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.85 -53.06 62.5 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 118.578 0.626 . . . . 0.0 109.931 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.37 -44.63 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -175.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -76.46 -13.16 60.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 111.799 -171.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.6 91.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.787 0.835 . . . . 0.0 110.677 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -72.66 -9.31 58.46 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -83.22 -57.08 3.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.571 -0.706 . . . . 0.0 109.77 159.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -56.59 -37.19 70.28 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -170.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -51.46 -29.82 17.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.479 1.112 . . . . 0.0 112.279 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.35 4.15 62.04 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 117.025 -1.986 . . . . 0.0 113.615 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.08 102.87 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.395 0 CA-C-N 120.963 2.381 . . . . 0.0 107.978 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -0.59 2.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.331 2.253 . . . . 0.0 113.528 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -117.43 64.27 4.05 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 128.779 2.832 . . . . 0.0 109.993 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -62.73 -17.55 59.63 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.92 3.08 . . . . 0.0 112.822 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.64 -14.15 62.69 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.748 1.219 . . . . 0.0 112.592 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.95 -1.25 1.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.493 1.517 . . . . 0.0 110.295 -172.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -55.97 -58.58 7.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.665 1.586 . . . . 0.0 110.352 -173.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -54.01 -31.18 50.32 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.059 1.744 . . . . 0.0 112.471 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -52.88 -35.76 58.24 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.82 -0.55 . . . . 0.0 110.333 174.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -67.75 -47.62 68.73 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.25 1.42 . . . . 0.0 110.435 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.89 -31.95 73.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.821 1.648 . . . . 0.0 110.345 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HB3' ' HH ' ' A' ' 103' ' ' TYR . 51.5 mt-10 -58.15 -57.9 10.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.346 1.058 . . . . 0.0 108.513 173.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.3 mt -56.93 -46.71 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.4 mt -59.25 -49.65 77.01 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.901 0.773 . . . . 0.0 110.334 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -61.13 -43.05 99.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.791 1.236 . . . . 0.0 110.878 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -66.7 -42.75 85.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.627 1.971 . . . . 0.0 111.211 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 t -59.2 -54.59 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-N 119.26 0.936 . . . . 0.0 108.702 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.65 -1.31 1.78 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.612 0.765 . . . . 0.0 112.945 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.61 -68.1 0.87 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.782 1.233 . . . . 0.0 109.027 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -62.66 -32.91 74.05 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.334 1.853 . . . . 0.0 111.368 -170.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.23 68.42 18.73 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.94 -4.77 15.5 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.382 2.721 . . . . 0.0 113.105 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.01 -14.32 50.97 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.634 -1.291 . . . . 0.0 110.768 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.0 mt -80.92 149.59 29.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.236 0.925 . . . . 0.0 109.383 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -132.3 151.12 77.75 Favored Pre-proline 0 C--O 1.221 -0.42 0 C-N-CA 125.517 1.527 . . . . 0.0 111.78 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.42 132.8 18.15 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.521 2.814 . . . . 0.0 112.365 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -148.84 127.16 12.2 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.03 125.31 35.79 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 168.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -153.54 150.7 28.98 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 119.265 0.939 . . . . 0.0 111.701 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.3 m95 53.9 24.66 4.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.1 t30 65.11 10.25 6.19 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.923 2.089 . . . . 0.0 113.312 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.86 149.09 40.29 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.99 136.32 16.37 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.244 1.962 . . . . 0.0 109.88 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 17.4 ptm -142.89 -176.81 5.04 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.628 1.171 . . . . 0.0 108.11 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -140.35 157.12 46.04 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 117.751 -1.119 . . . . 0.0 108.682 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.1 p -117.07 132.58 56.65 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 120.589 1.541 . . . . 0.0 109.543 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -74.34 95.25 2.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 161.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 44.81 41.75 5.4 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.137 1.775 . . . . 0.0 112.941 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 115.06 -20.63 14.13 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.373 1.463 . . . . 0.0 114.502 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.433 HG21 ' H ' ' A' ' 54' ' ' PHE . 1.8 m -77.12 -175.92 3.81 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.63 1.972 . . . . 0.0 110.907 -171.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.433 ' H ' HG21 ' A' ' 53' ' ' THR . 21.0 t80 -124.11 22.25 8.73 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.256 -1.527 . . . . 0.0 112.88 -169.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 mt -68.23 8.54 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 127.341 2.256 . . . . 0.0 113.464 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 tt -162.52 148.47 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 121.853 2.115 . . . . 0.0 111.42 172.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.49 154.0 23.44 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.384 0.993 . . . . 0.0 111.433 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.41 170.46 20.06 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.637 1.219 . . . . 0.0 110.947 174.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.14 116.24 3.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.313 1.045 . . . . 0.0 108.827 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.2 p -62.22 130.68 46.5 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 119.907 1.231 . . . . 0.0 109.86 -170.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.4 t -90.53 171.25 9.54 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -55.72 -52.71 62.96 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 167.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -134.87 54.56 1.93 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.5 0.72 . . . . 0.0 109.726 -171.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.466 ' CD2' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER 175.84 170.66 0.37 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.638 2.375 . . . . 0.0 110.271 174.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tp -112.99 150.27 32.13 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.589 2.355 . . . . 0.0 106.768 153.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -132.76 121.32 22.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.473 2.709 . . . . 0.0 111.138 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.88 144.1 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 127.273 2.229 . . . . 0.0 111.314 -163.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.9 t -156.82 163.26 25.64 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 159.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.18 -57.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 120.736 0.957 . . . . 0.0 110.511 157.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -150.78 -86.5 0.08 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 171.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.26 -25.9 0.84 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.707 1.203 . . . . 0.0 112.584 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.0 tp -57.4 -41.47 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 121.065 1.757 . . . . 0.0 109.85 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.79 -23.4 10.58 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.445 1.021 . . . . 0.0 113.95 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.9 mm -111.73 -3.56 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.983 2.113 . . . . 0.0 110.237 -172.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.3 m -116.36 -54.31 2.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.349 1.06 . . . . 0.0 109.654 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -78.28 -51.85 9.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.112 2.165 . . . . 0.0 108.288 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -95.39 -3.22 47.5 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -167.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.57 -30.3 70.57 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -69.13 -42.07 76.53 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.984 0.811 . . . . 0.0 109.135 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.44 -45.85 92.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.277 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.0 mt -58.91 -43.41 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.464 0.705 . . . . 0.0 109.67 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.75 -53.47 57.86 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.278 0.631 . . . . 0.0 110.089 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.9 -21.71 62.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.609 0.763 . . . . 0.0 112.014 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.22 8.09 2.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.372 0.987 . . . . 0.0 111.566 170.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.74 37.24 57.54 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 121.142 -0.974 . . . . 0.0 112.043 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -136.8 161.18 36.68 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.055 0.942 . . . . 0.0 110.311 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -122.51 97.57 5.52 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.64 -0.662 . . . . 0.0 110.828 -160.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.87 165.04 7.18 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.518 0.675 . . . . 0.0 111.117 171.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.6 p -105.81 -165.55 1.12 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 157.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -77.62 -4.04 43.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.667 166.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.96 -11.42 0.42 Allowed Glycine 0 CA--C 1.529 0.918 0 CA-C-N 120.444 1.475 . . . . 0.0 115.535 -168.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.19 178.58 9.59 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.116 1.458 . . . . 0.0 110.472 164.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -122.68 144.36 49.19 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 165.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HD2' ' NE2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -139.12 154.95 48.19 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 120.625 -1.297 . . . . 0.0 110.047 -170.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.466 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 44.3 mm -143.05 142.36 21.68 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -163.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.08 153.05 72.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 CA-C-N 121.01 1.396 . . . . 0.0 109.886 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -69.88 92.1 0.68 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 157.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.38 -59.46 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 126.305 1.842 . . . . 0.0 108.749 166.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -90.52 157.23 44.71 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.803 -159.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.46 114.86 4.06 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.988 1.792 . . . . 0.0 110.886 -172.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.69 119.68 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.828 1.651 . . . . 0.0 107.99 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -76.03 85.83 2.93 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 126.034 1.734 . . . . 0.0 113.072 -173.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.453 ' HH ' ' HB3' ' A' ' 25' ' ' GLU . 7.7 m-30 -56.01 -43.82 78.11 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 124.348 1.059 . . . . 0.0 110.854 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -56.46 -51.67 67.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.729 1.212 . . . . 0.0 111.872 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -42.73 95.31 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.607 -0.683 . . . . 0.0 109.888 -177.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.302 0.2 OUTLIER -75.93 -24.66 55.55 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.76 -176.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.77 -44.65 85.17 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 120.19 1.359 . . . . 0.0 109.899 171.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -56.53 -50.44 71.84 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.75 0.704 . . . . 0.0 109.688 -175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 ptp -67.1 -35.35 79.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.224 -0.894 . . . . 0.0 113.192 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -49.65 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.651 1.114 . . . . 0.0 109.068 177.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -58.5 -42.72 88.29 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.694 1.198 . . . . 0.0 110.949 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.41 -51.11 67.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.431 -0.795 . . . . 0.0 109.514 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -69.81 -10.4 58.3 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.883 1.219 . . . . 0.0 113.573 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 76.4 mt -75.17 -59.88 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.396 1.078 . . . . 0.0 108.525 161.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -75.7 -15.62 60.27 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 121.601 -0.687 . . . . 0.0 112.737 -165.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.64 -11.14 59.96 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.676 1.99 . . . . 0.0 112.034 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -106.06 15.08 26.92 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.974 2.109 . . . . 0.0 110.498 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.249 1.071 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.091 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -23.11 65.12 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 117.999 -1.001 . . . . 0.0 111.549 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.261 5.6 p-80 55.87 -45.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 130.109 3.364 . . . . 0.0 116.264 -173.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 mmt -51.62 -34.09 36.07 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.872 1.669 . . . . 0.0 112.311 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.02 -24.5 54.14 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.66 -25.86 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 120.896 0.379 . . . . 0.0 110.333 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -114.43 -5.53 12.88 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.12 1.768 . . . . 0.0 113.122 -173.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.78 -22.79 45.82 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 120.508 -1.37 . . . . 0.0 112.082 -169.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.27 -8.73 54.75 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.762 -0.587 . . . . 0.0 111.848 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -68.0 -57.75 5.64 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 160.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -46.63 -50.18 18.0 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.641 1.577 . . . . 0.0 112.964 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -53.06 -29.91 32.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.8 9.68 29.88 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.058 -1.412 . . . . 0.0 114.635 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mt -69.12 111.53 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 120.705 2.252 . . . . 0.0 105.958 167.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.0 -9.43 59.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.815 0.846 . . . . 0.0 113.208 -173.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.83 73.42 34.14 Favored Pre-proline 0 N--CA 1.445 -0.695 0 C-N-CA 125.017 1.327 . . . . 0.0 110.776 -168.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.77 -18.75 53.36 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.749 2.966 . . . . 0.0 114.875 -167.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -64.15 -10.66 24.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.266 0.626 . . . . 0.0 110.533 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -119.28 -6.84 10.33 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.58 1.952 . . . . 0.0 112.039 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.95 -49.02 12.47 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.114 -0.991 . . . . 0.0 110.48 -171.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.68 -42.6 79.32 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.774 0.671 . . . . 0.0 110.064 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.52 -56.96 10.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 123.899 0.88 . . . . 0.0 110.426 171.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.3 m -58.43 -38.83 78.26 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.548 1.139 . . . . 0.0 110.629 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -30.87 66.43 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.769 1.628 . . . . 0.0 114.068 171.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -63.75 -51.1 66.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.972 -0.537 . . . . 0.0 109.806 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mp -57.9 -52.62 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.34 -61.34 2.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.536 1.134 . . . . 0.0 109.941 -170.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m -71.36 -31.53 67.44 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.802 -1.094 . . . . 0.0 111.054 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 74.3 t90 -61.31 -48.07 83.07 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.575 1.079 . . . . 0.0 111.316 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.0 t -58.15 -48.89 83.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.96 -15.29 63.54 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.77 -62.4 1.55 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.052 0.941 . . . . 0.0 109.529 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 m -68.97 -27.51 65.79 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.774 0.83 . . . . 0.0 110.886 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -124.21 73.62 58.32 Favored Pre-proline 0 N--CA 1.443 -0.822 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.8 -5.58 17.45 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.343 2.029 . . . . 0.0 111.763 175.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.63 -36.55 84.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.54 1.136 . . . . 0.0 112.013 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.447 ' CD2' ' H ' ' A' ' 37' ' ' LEU . 1.4 mm? -78.84 139.59 38.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -172.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -88.59 147.01 38.55 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 171.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.53 142.04 14.35 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.655 2.903 . . . . 0.0 111.348 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -146.8 139.04 24.77 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.738 0.699 . . . . 0.0 109.966 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 ttm -99.85 107.65 19.72 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -125.48 151.39 46.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.946 1.699 . . . . 0.0 107.078 170.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.0 m95 55.78 21.26 4.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.594 1.558 . . . . 0.0 114.749 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.07 26.23 11.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.341 1.056 . . . . 0.0 111.424 -168.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.4 p -119.1 146.91 41.57 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.459 1.504 . . . . 0.0 109.255 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.24 122.19 7.81 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.629 2.219 . . . . 0.0 109.74 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.5 ptm -137.26 167.38 21.7 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.363 0.601 . . . . 0.0 109.998 169.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.23 169.74 13.17 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.466 -2.049 . . . . 0.0 105.466 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 p -154.31 135.33 13.86 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 120.253 -1.529 . . . . 0.0 107.702 166.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -76.94 114.41 15.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 164.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 44.52 53.88 6.76 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.144 0.978 . . . . 0.0 112.656 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.7 9.07 86.46 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 170.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 55' ' ' ILE . 1.4 t -69.16 -164.65 0.06 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.007 1.403 . . . . 0.0 112.042 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -132.99 22.19 4.15 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 118.358 2.725 . . . . 0.0 118.358 162.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.538 ' H ' HG22 ' A' ' 53' ' ' THR . 10.1 mt -62.22 10.48 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 O-C-N 119.427 -2.046 . . . . 0.0 115.005 -170.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.3 tt -164.33 141.58 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 123.162 2.71 . . . . 0.0 112.048 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.4 140.33 3.83 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.001 1.286 . . . . 0.0 110.977 166.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -132.35 170.15 15.49 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.94 1.296 . . . . 0.0 111.505 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -152.87 161.13 42.94 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.678 156.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p -59.69 153.18 20.81 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 171.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 t -144.58 170.55 15.84 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.224 1.012 . . . . 0.0 108.394 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -62.67 -21.95 66.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -156.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.84 14.13 0.73 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.007 0.821 . . . . 0.0 111.844 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -156.52 169.85 23.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.084 1.754 . . . . 0.0 109.693 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.01 145.11 30.63 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 164.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -104.1 117.34 34.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.928 1.24 . . . . 0.0 109.727 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.42 ' HB ' ' CE1' ' A' ' 93' ' ' PHE . 39.0 t -128.42 147.96 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 120.282 1.401 . . . . 0.0 107.835 176.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.0 t -167.31 165.58 8.79 Favored Pre-proline 0 C--O 1.243 0.723 0 C-N-CA 125.709 1.604 . . . . 0.0 107.396 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -94.13 -57.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 119.394 0.819 . . . . 0.0 113.211 158.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -147.08 -85.78 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.162 1.385 . . . . 0.0 107.841 -173.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -143.98 -29.26 0.5 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.854 2.462 . . . . 0.0 110.825 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.0 tt -62.04 -41.53 91.45 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 119.451 1.023 . . . . 0.0 111.413 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.25 -19.89 13.69 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.369 1.938 . . . . 0.0 112.928 177.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.6 mm -121.47 -0.41 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.209 1.804 . . . . 0.0 109.767 -172.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.1 m -98.23 -78.77 0.48 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.37 -51.12 10.54 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.643 0.656 . . . . 0.0 109.294 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -65.75 -17.49 64.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.573 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.89 -32.65 63.91 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.31 -40.54 93.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.959 0.885 . . . . 0.0 110.134 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.77 76.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.401 -0.812 . . . . 0.0 111.462 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.26 -46.27 92.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.538 1.135 . . . . 0.0 108.714 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.39 -47.92 82.29 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.049 1.34 . . . . 0.0 111.861 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -63.91 -30.08 71.2 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.716 0.807 . . . . 0.0 112.044 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.25 83.18 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.842 0.746 . . . . 0.0 109.6 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.12 -2.2 3.54 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.161 1.362 . . . . 0.0 112.965 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -92.76 157.69 16.29 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.514 1.657 . . . . 0.0 111.265 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.0 m -118.93 156.55 29.35 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.137 0.975 . . . . 0.0 110.516 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.24 165.9 17.47 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.13 0.972 . . . . 0.0 110.646 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -83.58 -164.55 0.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 165.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -63.41 -27.44 69.3 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.164 -0.96 . . . . 0.0 112.672 165.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.98 -14.03 0.78 Allowed Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.568 0.987 . . . . 0.0 115.568 -156.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 pp -152.79 163.9 38.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.739 1.77 . . . . 0.0 111.05 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.42 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 20.7 p90 -107.17 146.8 30.9 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.559 -0.713 . . . . 0.0 110.061 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -131.78 91.21 2.95 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 123.225 0.61 . . . . 0.0 110.237 -165.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -79.83 141.97 55.98 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 -176.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.23 157.34 41.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.318 2.012 . . . . 0.0 109.95 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -69.1 -16.39 63.66 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -63.71 -38.33 90.7 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.669 0.668 . . . . 0.0 112.45 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -129.64 150.97 77.22 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.945 1.298 . . . . 0.0 108.638 -165.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.38 147.14 17.87 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.311 2.674 . . . . 0.0 113.972 -164.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 m -68.3 126.56 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 121.261 -0.899 . . . . 0.0 109.49 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -79.48 98.63 6.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.836 0.854 . . . . 0.0 110.753 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -61.09 -25.56 67.04 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.311 1.044 . . . . 0.0 112.505 -174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -65.69 -56.03 14.25 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.515 -0.74 . . . . 0.0 110.908 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.06 -39.76 91.09 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.543 -0.723 . . . . 0.0 110.841 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.7 mt -52.2 -53.59 41.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.872 1.669 . . . . 0.0 110.017 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.51 -42.06 75.21 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.579 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -58.82 -44.47 90.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.346 0.976 . . . . 0.0 111.816 -175.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 ptp -73.27 -41.38 63.69 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 118.254 0.479 . . . . 0.0 111.912 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -47.75 54.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -173.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.61 -41.08 85.07 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.48 1.036 . . . . 0.0 109.461 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -54.85 -49.57 70.78 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.529 0.332 . . . . 0.0 111.395 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.46 -29.59 70.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.023 0.929 . . . . 0.0 112.413 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.89 -31.3 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.631 1.105 . . . . 0.0 110.701 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -81.6 2.18 30.5 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.028 -1.045 . . . . 0.0 112.196 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -90.65 -40.51 11.85 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.442 -0.786 . . . . 0.0 113.032 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -97.12 23.56 7.22 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.184 1.394 . . . . 0.0 110.451 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 117.404 -1.284 . . . . 0.0 111.326 -177.594 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.83 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.7 m -84.29 176.28 8.83 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.625 0.713 . . . . 0.0 110.522 168.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -135.68 -27.88 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.798 1.639 . . . . 0.0 110.046 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.23 -28.72 19.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.106 0.962 . . . . 0.0 111.294 172.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.83 -30.25 63.59 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.176 1.39 . . . . 0.0 113.333 177.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.3 t -81.0 -33.26 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.497 1.119 . . . . 0.0 111.485 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -89.04 -16.07 32.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.645 1.178 . . . . 0.0 113.378 -174.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.94 77.85 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.192 0.997 . . . . 0.0 112.025 -167.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.68 -5.61 53.54 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.521 1.528 . . . . 0.0 112.52 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -93.69 -45.39 7.71 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.018 1.281 . . . . 0.0 110.057 161.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -49.38 -42.68 42.94 Favored 'General case' 0 CA--C 1.523 -0.085 0 C-N-CA 123.95 0.9 . . . . 0.0 111.316 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -49.7 -36.65 25.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.351 1.06 . . . . 0.0 113.379 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.77 0.42 39.2 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 117.703 -1.609 . . . . 0.0 113.045 -168.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.9 mt -71.71 101.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.88 2.57 2.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.232 1.813 . . . . 0.0 113.512 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.51 ' CG ' ' HD1' ' A' ' 19' ' ' HIS . 0.3 OUTLIER -114.52 72.06 2.5 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 128.379 2.672 . . . . 0.0 111.159 -166.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.68 -11.37 31.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 124.125 3.217 . . . . 0.0 114.664 -172.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -81.99 -9.02 59.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.242 0.617 . . . . 0.0 112.365 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' HD1' ' CG ' ' A' ' 16' ' ' HIS . 17.6 m80 -129.07 -28.12 2.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.569 1.148 . . . . 0.0 112.38 -175.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -52.71 -45.2 66.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.775 1.23 . . . . 0.0 113.137 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -32.39 73.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.11 0.868 . . . . 0.0 110.816 -174.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -68.92 -41.23 78.43 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.637 1.108 . . . . 0.0 111.844 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.9 m -55.08 -39.78 69.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.594 0.758 . . . . 0.0 109.621 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.89 -35.83 80.92 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.483 1.513 . . . . 0.0 112.095 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -62.35 -48.28 80.48 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.396 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.5 mt -61.91 -44.53 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.666 0.666 . . . . 0.0 109.512 -177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.77 -68.01 0.21 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.961 1.305 . . . . 0.0 108.852 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.2 p -66.18 -28.0 68.43 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.591 1.157 . . . . 0.0 112.932 -170.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 43.9 t90 -56.52 -46.74 80.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.63 1.572 . . . . 0.0 110.889 173.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.48 -37.38 70.02 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 C-N-CA 116.791 -1.964 . . . . 0.0 108.499 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.64 -8.44 0.24 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.601 1.16 . . . . 0.0 113.609 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.28 -65.24 1.0 Allowed 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.89 -1.131 . . . . 0.0 110.716 158.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.97 -34.68 59.8 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.297 0.499 . . . . 0.0 111.995 -161.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.7 66.53 10.11 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 127.511 2.324 . . . . 0.0 109.263 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.17 -6.97 19.84 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.021 2.48 . . . . 0.0 112.42 -172.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -81.7 -11.75 58.92 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.119 0.968 . . . . 0.0 111.849 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.0 mt -74.92 143.45 43.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -119.52 152.51 53.15 Favored Pre-proline 0 C--N 1.322 -0.598 0 C-N-CA 127.718 2.407 . . . . 0.0 107.844 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -75.69 156.79 40.02 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.02 2.48 . . . . 0.0 111.073 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -171.96 106.59 0.21 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 126.327 1.851 . . . . 0.0 106.15 163.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 ppp? -78.03 134.09 37.84 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.321 0.964 . . . . 0.0 108.857 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.97 152.4 38.58 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.112 1.365 . . . . 0.0 109.224 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.6 m95 51.87 34.06 12.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.254 1.022 . . . . 0.0 113.171 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 57.74 20.88 6.83 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.444 1.498 . . . . 0.0 112.123 -173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.5 p -116.6 148.43 41.87 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.022 1.329 . . . . 0.0 108.588 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.05 144.45 42.55 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.451 2.101 . . . . 0.0 109.136 164.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.2 ptm -160.91 177.62 10.2 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 165.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.43 176.11 8.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.508 1.123 . . . . 0.0 108.134 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.4 p -146.98 134.54 20.95 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.984 -1.072 . . . . 0.0 108.752 172.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.466 ' H ' HG21 ' A' ' 53' ' ' THR . 30.7 t30 -75.83 111.32 11.06 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 165.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 49.18 43.79 22.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.661 0.784 . . . . 0.0 112.768 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.2 76.62 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.082 170.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.562 HG23 ' H ' ' A' ' 55' ' ' ILE . 1.7 t -61.67 -163.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 128.46 2.704 . . . . 0.0 117.349 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -129.11 29.55 5.15 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 157.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.562 ' H ' HG23 ' A' ' 53' ' ' THR . 38.0 mt -60.11 9.16 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 127.129 2.172 . . . . 0.0 114.024 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 tt -159.02 157.94 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 122.647 2.476 . . . . 0.0 112.93 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.61 164.36 23.14 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.841 0.734 . . . . 0.0 112.963 159.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -160.12 177.58 10.55 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.471 1.108 . . . . 0.0 112.142 -170.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.5 p -172.44 148.77 2.08 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.442 1.019 . . . . 0.0 109.172 170.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.1 p -63.96 129.1 38.69 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.428 -0.795 . . . . 0.0 108.975 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 t -97.43 -178.12 4.04 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 158.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -54.44 -65.49 0.57 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.686 -0.634 . . . . 0.0 110.281 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -101.82 2.17 37.98 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -164.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.433 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 6.8 p-80 -160.41 149.75 17.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.25 1.02 . . . . 0.0 109.556 -166.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -89.71 143.19 27.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 161.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.57 141.39 51.75 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.183 0.993 . . . . 0.0 110.275 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -159.46 155.79 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.003 0.921 . . . . 0.0 112.939 -167.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 29.5 t -163.08 165.53 14.57 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.295 1.838 . . . . 0.0 108.093 168.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.46 -56.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 121.853 1.702 . . . . 0.0 111.781 159.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -146.07 -86.17 0.11 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -138.28 -37.56 0.56 Allowed 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.77 1.628 . . . . 0.0 109.936 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.5 tt -57.27 -35.57 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.078 0.854 . . . . 0.0 111.42 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.58 -20.86 8.12 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 126.998 2.237 . . . . 0.0 113.444 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.5 mm -118.15 -14.7 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 127.185 2.194 . . . . 0.0 110.001 -172.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.8 m -81.92 -79.83 0.17 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.023 0.929 . . . . 0.0 109.542 166.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -87.9 -48.08 8.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -164.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -63.94 -19.21 64.96 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.08 -31.86 61.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.611 -1.185 . . . . 0.0 113.145 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -67.91 -52.47 35.98 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.857 0.753 . . . . 0.0 109.684 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.41 82.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.593 0.757 . . . . 0.0 110.982 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.31 -43.75 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.288 1.035 . . . . 0.0 109.699 175.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.15 80.99 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.06 0.944 . . . . 0.0 110.901 -173.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -27.76 57.71 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.015 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.94 8.56 22.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.044 0.838 . . . . 0.0 112.14 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.66 36.82 24.97 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 121.191 -0.943 . . . . 0.0 112.527 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -125.41 154.47 41.89 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.083 0.953 . . . . 0.0 109.721 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.9 t -114.49 124.38 51.76 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.393 0.615 . . . . 0.0 110.746 -163.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.77 159.75 22.43 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.358 0.663 . . . . 0.0 110.728 174.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -118.7 -162.59 0.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.593 1.957 . . . . 0.0 106.153 164.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -31.3 72.46 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 169.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -151.64 -6.07 0.15 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 114.218 0.447 . . . . 0.0 114.218 -156.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.42 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.9 pp -146.06 161.82 39.28 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.643 1.577 . . . . 0.0 108.006 169.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -122.15 157.27 31.9 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.433 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -132.03 142.4 49.55 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.504 -177.339 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 mp -105.58 142.2 24.25 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.02 151.45 44.76 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.029 2.486 . . . . 0.0 109.578 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -64.61 -19.05 65.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -31.51 72.74 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.88 1.218 . . . . 0.0 112.478 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.66 161.85 37.61 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 123.961 0.904 . . . . 0.0 110.181 -161.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.64 161.6 43.54 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.559 1.506 . . . . 0.0 110.862 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.4 t -89.24 130.71 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.07 89.21 4.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.176 1.39 . . . . 0.0 109.366 -176.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -67.24 -31.7 72.23 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.636 1.174 . . . . 0.0 112.532 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.51 -51.21 70.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.611 1.164 . . . . 0.0 109.753 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -68.28 -41.18 81.38 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 120.611 1.551 . . . . 0.0 110.865 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -50.18 51.87 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 123.473 0.709 . . . . 0.0 109.121 176.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -58.63 -55.48 34.55 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.988 1.315 . . . . 0.0 110.006 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -59.17 -35.74 74.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.492 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -87.8 -6.82 57.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 117.496 -1.24 . . . . 0.0 113.718 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.89 -54.23 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 120.977 1.717 . . . . 0.0 109.224 172.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -53.15 -48.6 67.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.023 1.329 . . . . 0.0 109.777 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -52.77 -45.81 67.28 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.24 -34.65 73.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.004 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.13 -52.03 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -72.23 -15.03 61.93 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.32 -37.9 27.61 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.49 1.516 . . . . 0.0 110.705 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.54 23.29 3.07 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.7 2.4 . . . . 0.0 111.821 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 124.523 1.129 . . . . 0.0 108.921 168.215 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 118.781 -0.628 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 mmt -56.02 -41.38 74.82 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.56 -28.51 55.35 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.857 1.263 . . . . 0.0 113.945 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.62 -53.3 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -81.58 -28.66 33.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.68 1.592 . . . . 0.0 112.556 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.95 0.93 14.14 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.807 1.643 . . . . 0.0 112.087 -171.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 41.3 mt-10 -86.99 -35.44 18.81 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.012 1.325 . . . . 0.0 109.332 167.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.32 -41.09 25.47 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -175.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -51.4 -37.84 50.4 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.233 1.413 . . . . 0.0 112.376 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 12.0 mtmt -61.85 -46.07 91.06 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.049 0.939 . . . . 0.0 110.901 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.55 -9.05 73.2 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.095 1.331 . . . . 0.0 113.729 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.82 103.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 165.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.11 3.43 10.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.097 1.359 . . . . 0.0 112.811 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -116.6 73.83 6.02 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 128.873 2.869 . . . . 0.0 109.705 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.01 -28.05 19.74 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.231 3.287 . . . . 0.0 111.433 -168.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.437 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 26.0 m-20 -64.98 -15.84 62.7 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.726 0.81 . . . . 0.0 110.348 -171.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -133.39 5.0 3.73 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.254 1.422 . . . . 0.0 110.22 178.1 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -66.06 -55.64 15.58 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 120.864 -1.148 . . . . 0.0 109.069 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.66 -14.8 15.34 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.7 1.371 . . . . 0.0 114.7 -165.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -43.18 97.39 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.55 1.068 . . . . 0.0 110.869 169.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -57.68 -37.43 73.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.252 1.421 . . . . 0.0 111.377 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -81.4 -20.71 39.88 Favored 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 120.89 -1.132 . . . . 0.0 113.996 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.17 -47.99 79.84 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.0 mt -61.41 -47.72 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.463 1.105 . . . . 0.0 110.227 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.6 mt -56.56 -49.33 75.14 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.676 0.671 . . . . 0.0 111.061 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 p -68.93 -40.0 79.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.241 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -60.19 -47.75 84.63 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.134 1.774 . . . . 0.0 111.401 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.7 t -56.32 -50.14 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 119.076 0.853 . . . . 0.0 108.716 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.78 3.51 1.9 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.57 -54.01 2.39 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.048 1.339 . . . . 0.0 111.003 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -72.73 -32.9 66.03 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.867 1.212 . . . . 0.0 111.047 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.74 57.54 5.9 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 119.311 0.96 . . . . 0.0 110.877 -173.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -65.26 -11.19 28.94 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.05 2.5 . . . . 0.0 113.636 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -12.16 61.12 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.57 -0.706 . . . . 0.0 112.702 175.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 85.7 mt -80.04 156.69 27.0 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.413 1.006 . . . . 0.0 109.889 169.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -129.23 152.58 79.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.506 1.522 . . . . 0.0 109.708 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.25 159.17 53.98 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.605 2.87 . . . . 0.0 113.186 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -161.95 120.19 2.27 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.507 1.523 . . . . 0.0 109.601 171.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.31 109.28 15.67 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.436 1.095 . . . . 0.0 108.381 166.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -135.56 149.32 49.39 Favored 'General case' 0 C--O 1.218 -0.603 0 O-C-N 120.921 -1.112 . . . . 0.0 108.125 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.1 m95 55.52 16.68 1.94 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 64.59 15.34 9.61 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 128.553 2.741 . . . . 0.0 113.848 -167.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.3 p -116.37 161.36 31.93 Favored Pre-proline 0 N--CA 1.44 -0.975 0 C-N-CA 124.72 1.208 . . . . 0.0 109.152 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.62 116.94 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 125.269 3.979 . . . . 0.0 112.13 171.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.3 ptm -128.43 170.3 13.29 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.683 0.754 . . . . 0.0 108.985 161.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.03 165.0 27.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 169.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.7 120.76 13.71 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -171.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -71.95 99.73 2.3 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 167.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 49.02 42.01 20.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.258 1.023 . . . . 0.0 110.674 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.41 -21.09 40.33 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 116.971 -2.016 . . . . 0.0 117.062 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -171.25 0.91 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 122.055 2.928 . . . . 0.0 112.756 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -117.19 26.51 9.72 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.037 -1.039 . . . . 0.0 113.097 -171.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.0 -1.18 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.05 0.94 . . . . 0.0 112.965 -168.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 tt -155.9 142.61 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 119.263 -2.148 . . . . 0.0 112.025 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.55 149.92 21.18 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.527 1.537 . . . . 0.0 109.324 166.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -145.18 178.48 8.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.954 1.377 . . . . 0.0 110.501 170.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.2 153.83 10.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 168.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.3 p -69.13 138.83 54.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.768 -0.583 . . . . 0.0 109.431 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.38 174.36 5.94 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 169.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.471 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -71.37 -5.12 30.22 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.866 -1.146 . . . . 0.0 113.645 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.28 7.49 0.11 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.1 -178.61 6.71 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.027 1.331 . . . . 0.0 108.692 -173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.09 120.06 18.61 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.494 1.118 . . . . 0.0 108.521 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.34 108.77 21.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.911 1.684 . . . . 0.0 109.913 -160.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 99.2 t -129.46 140.28 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.911 1.232 . . . . 0.0 109.504 -162.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 27.8 t -171.26 144.91 1.76 Allowed Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.033 1.733 . . . . 0.0 109.734 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.2 -56.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.616 1.544 . . . . 0.0 111.344 171.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -148.03 -83.77 0.11 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -131.5 -46.38 0.98 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.129 1.372 . . . . 0.0 110.945 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.26 -35.18 52.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 118.839 0.745 . . . . 0.0 112.753 -166.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.9 -24.74 28.03 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.745 1.641 . . . . 0.0 113.169 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 mm -112.93 -3.49 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.776 1.63 . . . . 0.0 109.819 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 m -91.14 -72.59 0.57 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -85.75 -49.23 8.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.425 0.557 . . . . 0.0 109.541 -171.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -69.45 -13.19 62.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.94 -21.61 66.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.83 -44.96 60.79 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.923 0.783 . . . . 0.0 110.645 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.42 -43.21 88.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.664 0.786 . . . . 0.0 110.643 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.39 -41.46 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.963 0.801 . . . . 0.0 110.331 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.25 -55.55 31.88 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.293 0.497 . . . . 0.0 110.319 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.64 -13.12 61.29 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.107 0.963 . . . . 0.0 112.345 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.15 -26.43 60.31 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.679 0.672 . . . . 0.0 110.579 169.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.39 4.97 6.22 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.972 -0.905 . . . . 0.0 113.735 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -112.88 160.88 17.59 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.848 1.324 . . . . 0.0 110.907 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.2 m -91.74 173.03 8.08 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.049 0.939 . . . . 0.0 108.922 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . . . -133.97 -166.19 1.75 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 166.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.2 p -118.96 -168.73 1.61 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 153.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -68.74 -27.64 66.11 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 120.469 -1.395 . . . . 0.0 112.242 166.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.46 -14.14 10.93 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-O 118.795 -1.003 . . . . 0.0 114.432 -163.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.8 pp -156.39 166.59 32.98 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.42 1.61 . . . . 0.0 110.393 170.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 18.0 p90 -103.62 164.98 11.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.416 0.553 . . . . 0.0 109.94 172.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 126.61 22.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.96 142.69 25.18 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 164.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.54 145.79 14.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.995 2.464 . . . . 0.0 108.896 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -56.42 -30.49 62.88 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -170.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -65.83 -26.64 67.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -115.91 162.19 26.9 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.546 0.738 . . . . 0.0 110.125 -164.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -79.98 148.07 19.32 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 CA-C-N 121.125 1.437 . . . . 0.0 113.605 -169.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.6 t -73.69 124.18 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 170.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -74.99 77.23 2.19 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.526 1.13 . . . . 0.0 110.562 169.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -53.13 -40.92 64.56 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 125.145 1.378 . . . . 0.0 111.32 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -57.89 -60.91 2.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.468 1.507 . . . . 0.0 110.984 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.96 -38.72 65.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.759 0.79 . . . . 0.0 110.888 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.269 0.3 OUTLIER -79.93 -27.93 39.78 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 117.198 -1.382 . . . . 0.0 113.171 -176.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -62.01 -42.67 99.4 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.304 1.411 . . . . 0.0 108.402 170.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.64 -52.59 63.31 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.093 0.557 . . . . 0.0 109.613 -174.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.0 ptp -69.51 -36.61 76.62 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.564 -1.207 . . . . 0.0 113.544 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.7 -46.72 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 120.6 1.546 . . . . 0.0 108.876 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.56 -40.11 90.43 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.543 0.611 . . . . 0.0 109.845 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.4 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 29.1 t80 -60.96 -50.08 74.83 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.394 0.543 . . . . 0.0 110.783 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -38.31 80.7 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.105 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.9 mt -60.3 -52.28 63.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.092 0.957 . . . . 0.0 110.676 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.4 ' HG2' ' HA ' ' A' ' 112' ' ' PHE . 5.4 pt20 -70.28 -22.54 62.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.041 0.837 . . . . 0.0 111.721 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -83.02 -20.56 34.81 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.311 0.644 . . . . 0.0 111.311 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -96.89 20.05 11.71 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.855 1.662 . . . . 0.0 111.236 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.767 166.61 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 30.8 mmm -56.82 -27.04 59.39 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.97 -34.82 70.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 118.337 0.517 . . . . 0.0 111.437 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.59 -44.46 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -78.13 -14.51 59.45 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.46 1.104 . . . . 0.0 112.795 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -34.32 77.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.426 1.491 . . . . 0.0 111.426 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.32 -16.28 61.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.88 1.672 . . . . 0.0 112.848 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -102.26 -37.6 8.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.908 0.883 . . . . 0.0 110.042 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.54 -39.83 65.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.252 0.933 . . . . 0.0 110.571 171.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -58.68 -29.84 66.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.414 0.686 . . . . 0.0 112.034 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.49 -4.52 62.28 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.842 -0.977 . . . . 0.0 114.57 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.3 mm -57.08 132.54 21.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 119.298 1.549 . . . . 0.0 109.334 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.73 -49.33 75.47 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.816 1.646 . . . . 0.0 108.724 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -141.15 143.95 32.85 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.42 -22.66 24.67 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.454 2.77 . . . . 0.0 111.264 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -6.16 13.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.61 173.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -125.29 -9.16 6.99 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -64.42 -60.81 2.72 Favored 'General case' 0 CA--C 1.519 -0.228 0 O-C-N 121.184 -0.947 . . . . 0.0 110.441 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -45.86 -44.55 14.47 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.122 2.169 . . . . 0.0 111.292 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -57.82 -48.1 80.72 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.042 -0.411 . . . . 0.0 110.397 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.0 m -65.67 -45.22 83.73 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.04 1.336 . . . . 0.0 109.885 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.96 -41.27 61.96 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.796 1.239 . . . . 0.0 112.282 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -60.29 -52.68 64.24 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.377 0.535 . . . . 0.0 109.695 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -61.72 -41.49 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.437 1.095 . . . . 0.0 110.056 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.88 -57.1 13.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.303 0.501 . . . . 0.0 110.583 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -60.29 -37.08 79.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 117.833 -1.08 . . . . 0.0 109.808 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 67.1 t90 -59.31 -59.4 5.52 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.797 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.412 HG11 ' CE1' ' A' ' 48' ' ' PHE . 28.3 t -52.64 -46.8 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 120.224 1.374 . . . . 0.0 110.697 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.2 -29.86 69.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.048 0.539 . . . . 0.0 112.012 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.45 -61.14 2.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.994 0.918 . . . . 0.0 110.537 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -65.86 -32.05 73.35 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.427 1.491 . . . . 0.0 111.849 -169.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -127.33 63.75 59.46 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 118.664 0.665 . . . . 0.0 109.253 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.68 -8.56 23.91 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.585 2.857 . . . . 0.0 113.923 -163.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.29 -26.51 62.0 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.262 -0.899 . . . . 0.0 111.799 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.1 mt -65.81 149.76 49.65 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -130.97 150.02 75.39 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 127.025 2.13 . . . . 0.0 110.719 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.12 152.76 40.59 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.329 2.686 . . . . 0.0 113.191 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.35 126.56 6.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.465 1.906 . . . . 0.0 108.967 167.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.34 102.77 15.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 170.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -149.93 141.23 23.21 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.968 -1.083 . . . . 0.0 111.139 -167.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 16.3 m95 54.84 21.96 3.94 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.881 1.272 . . . . 0.0 111.927 -161.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 53.42 14.69 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.828 1.651 . . . . 0.0 112.807 -162.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.7 p -97.87 148.84 35.05 Favored Pre-proline 0 C--O 1.238 0.493 0 CA-C-N 119.703 1.138 . . . . 0.0 109.352 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.24 100.43 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.924 3.083 . . . . 0.0 110.939 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.3 ptm -118.88 164.93 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.413 0.685 . . . . 0.0 109.672 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.412 ' CE1' HG11 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -131.39 169.67 15.72 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 173.399 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.9 m -141.77 138.86 32.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.858 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -76.28 94.09 3.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.128 1.331 . . . . 0.0 108.388 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 51.48 15.17 0.31 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.646 1.578 . . . . 0.0 114.73 -170.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.79 -20.61 4.3 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 117.896 -1.502 . . . . 0.0 113.941 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -78.16 141.83 38.42 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 121.12 2.46 . . . . 0.0 111.309 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -66.62 29.56 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.039 2.936 . . . . 0.0 116.966 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.25 0.37 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 125.32 1.448 . . . . 0.0 113.17 -167.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 tt -160.6 145.39 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 121.793 2.088 . . . . 0.0 113.516 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.29 136.08 3.92 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 121.466 -0.771 . . . . 0.0 112.337 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -136.01 167.55 21.01 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.093 1.357 . . . . 0.0 110.58 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.8 p -159.24 160.76 35.7 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 54.9 p -75.76 113.99 13.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.05 171.71 13.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 164.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -63.75 -32.69 74.26 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.291 -0.881 . . . . 0.0 111.717 -175.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -137.1 10.57 3.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.371 1.468 . . . . 0.0 113.149 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -156.8 -177.35 6.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.065 1.346 . . . . 0.0 108.839 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tp -124.17 121.43 35.09 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.558 1.543 . . . . 0.0 107.684 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.461 ' HB2' HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -79.03 133.59 36.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 116.238 -1.839 . . . . 0.0 109.417 170.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.8 t -140.37 149.41 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 120.128 1.331 . . . . 0.0 110.566 172.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 t -160.42 158.87 26.01 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.58 1.152 . . . . 0.0 108.959 157.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -79.67 -57.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.098 0 CA-C-N 120.711 1.29 . . . . 0.0 110.519 165.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -138.16 -88.44 0.24 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 164.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -147.34 -36.15 0.23 Allowed 'General case' 0 N--CA 1.474 0.725 0 O-C-N 121.341 -0.85 . . . . 0.0 111.836 -163.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -25.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 123.549 0.74 . . . . 0.0 110.394 165.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.57 -35.93 38.25 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.823 0.725 . . . . 0.0 111.545 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.1 mm -110.43 13.46 8.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.32 1.448 . . . . 0.0 110.841 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.6 m -129.51 -33.57 1.86 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 170.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -63.6 1.33 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.407 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 11.2 m-85 -79.86 0.41 31.21 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.61 -31.42 64.28 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -72.07 -48.52 43.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.75 0.786 . . . . 0.0 109.778 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.2 -42.83 91.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.822 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.53 -48.52 85.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.082 0.953 . . . . 0.0 109.749 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -51.45 70.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.468 0.707 . . . . 0.0 109.706 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -64.82 -37.83 88.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.85 1.26 . . . . 0.0 111.642 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.04 -22.76 67.08 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.951 0.796 . . . . 0.0 111.693 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.12 9.49 10.58 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-O 118.525 -1.153 . . . . 0.0 114.104 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -113.07 95.93 5.66 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.484 1.642 . . . . 0.0 113.251 -162.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.62 105.58 0.06 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 129.251 3.02 . . . . 0.0 113.355 174.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.34 175.87 6.94 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.733 2.013 . . . . 0.0 112.802 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.1 p -94.67 -164.85 1.22 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.108 1.363 . . . . 0.0 107.618 156.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -76.63 -19.31 57.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 117.079 -1.439 . . . . 0.0 112.588 166.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.94 -7.84 4.9 Favored Glycine 0 N--CA 1.47 0.958 0 CA-C-N 120.388 1.449 . . . . 0.0 115.054 -162.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 66' ' ' SER . 2.9 pp -151.54 161.61 42.39 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 164.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -99.45 165.79 11.48 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 166.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.5 153.2 44.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 121.774 -0.579 . . . . 0.0 109.637 169.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.11 143.74 34.63 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -71.64 149.52 55.22 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.496 2.797 . . . . 0.0 110.409 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -57.86 -41.33 82.22 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -54.15 -44.04 71.1 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.024 0.93 . . . . 0.0 112.17 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.83 146.86 32.59 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -159.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.04 139.1 23.78 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.268 1.312 . . . . 0.0 112.052 -163.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -69.69 150.17 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.325 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -109.92 73.66 0.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.328 1.051 . . . . 0.0 111.873 -161.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -58.01 -24.16 57.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.709 0.804 . . . . 0.0 112.962 -171.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -68.09 -60.2 2.67 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.091 -1.006 . . . . 0.0 110.3 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.44 -45.14 62.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.229 1.412 . . . . 0.0 109.076 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -53.97 50.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.835 1.254 . . . . 0.0 111.553 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -68.6 -40.13 80.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 117.484 -1.246 . . . . 0.0 111.786 -172.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -45.62 -57.06 4.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.541 0.736 . . . . 0.0 110.249 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.407 ' HE1' ' HB2' ' A' ' 77' ' ' PHE . 23.4 ptp -72.47 -42.63 64.73 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 118.046 -0.978 . . . . 0.0 112.888 -170.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -42.65 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 120.074 1.306 . . . . 0.0 109.689 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -64.17 -39.92 95.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.967 -0.54 . . . . 0.0 109.923 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -62.22 -46.89 86.85 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.349 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -21.22 63.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.09 1.314 . . . . 0.0 112.261 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.99 -61.6 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.456 1.102 . . . . 0.0 108.49 167.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -75.67 -2.9 31.65 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -171.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.3 -20.14 65.58 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.829 -1.169 . . . . 0.0 110.82 164.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -105.29 5.88 32.34 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.194 1.398 . . . . 0.0 111.344 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 124.697 1.199 . . . . 0.0 108.148 178.457 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 119.049 -0.5 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -6.33 15.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -64.15 -57.49 9.4 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.5 -42.53 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.877 1.671 . . . . 0.0 110.086 -167.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -93.99 -0.48 55.51 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.577 -169.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.58 -39.98 81.86 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.61 0.764 . . . . 0.0 109.609 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -66.33 -20.58 66.13 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -81.56 -55.21 4.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.2 -38.86 77.57 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.751 -0.642 . . . . 0.0 111.893 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -58.1 -33.05 68.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.396 0.678 . . . . 0.0 110.737 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.1 -3.24 82.78 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.529 1.061 . . . . 0.0 112.493 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.6 mt -77.69 90.79 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 171.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -76.11 8.19 3.48 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.182 2.193 . . . . 0.0 113.224 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -116.13 69.3 3.7 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 129.67 3.188 . . . . 0.0 108.767 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.97 -17.16 54.99 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 125.109 3.872 . . . . 0.0 113.856 -167.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.19 -16.39 59.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.135 0.88 . . . . 0.0 111.553 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -131.96 8.73 4.46 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.794 0.725 . . . . 0.0 112.326 -171.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -77.11 -62.33 1.69 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.308 1.443 . . . . 0.0 109.612 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.31 -32.55 38.27 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.134 2.174 . . . . 0.0 112.282 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -47.38 -53.46 13.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.805 0.842 . . . . 0.0 110.14 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.0 m -65.02 -29.24 70.13 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.74 -0.6 . . . . 0.0 111.277 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -72.45 -28.18 62.78 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 120.855 -1.153 . . . . 0.0 111.875 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.21 -54.66 43.12 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.676 1.125 . . . . 0.0 108.526 168.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -49.72 -53.22 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.169 0.987 . . . . 0.0 110.007 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.0 mt -64.63 -50.03 68.72 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.915 -170.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -69.47 -28.0 65.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.136 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -61.69 -60.39 3.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.413 HG11 ' CZ ' ' A' ' 48' ' ' PHE . 37.8 t -48.5 -45.57 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.05 0.841 . . . . 0.0 111.526 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.15 -13.03 5.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.4 -50.58 2.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.509 1.924 . . . . 0.0 111.483 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.9 -35.03 79.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.928 0.785 . . . . 0.0 110.832 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -128.81 74.53 80.73 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.66 -13.1 34.42 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.872 1.715 . . . . 0.0 110.81 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -86.22 33.2 0.61 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.442 2.297 . . . . 0.0 111.158 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 56' ' ' ILE . 51.1 mt -122.02 134.49 54.8 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 120.686 -1.258 . . . . 0.0 109.189 156.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -104.89 149.47 37.57 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 124.621 1.168 . . . . 0.0 109.41 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.71 154.83 49.38 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.599 2.866 . . . . 0.0 112.169 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -162.84 114.18 1.51 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.607 1.163 . . . . 0.0 108.534 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.0 mtp -82.22 121.49 26.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 166.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -138.65 138.44 37.81 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.9 m95 48.84 34.42 5.31 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.532 1.133 . . . . 0.0 112.165 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.26 18.09 10.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.471 1.908 . . . . 0.0 111.19 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.5 p -118.63 149.53 46.47 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.434 1.494 . . . . 0.0 109.304 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.49 106.68 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.251 3.301 . . . . 0.0 110.925 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.2 ptm -114.59 175.85 5.3 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.236 -0.915 . . . . 0.0 110.309 168.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' HG11 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -139.04 156.12 47.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 170.131 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.63 122.43 27.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -72.09 95.5 1.64 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 57.21 -3.32 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.93 -24.16 0.25 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 127.492 2.472 . . . . 0.0 113.67 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.61 -164.94 0.78 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.856 1.828 . . . . 0.0 114.718 -167.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -131.95 25.44 4.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.58 1.952 . . . . 0.0 111.445 -170.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.7 mt -65.4 -3.54 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.574 1.95 . . . . 0.0 111.725 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.439 HG21 HD13 ' A' ' 37' ' ' LEU . 6.1 tt -155.94 163.77 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 119.448 -2.033 . . . . 0.0 109.647 169.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.75 132.72 1.55 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -138.91 169.46 17.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.668 1.734 . . . . 0.0 110.085 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.59 161.83 38.15 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 159.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.4 p -65.09 149.19 50.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 165.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 t -137.47 168.25 20.03 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -58.7 -30.08 67.14 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -153.227 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -136.36 13.49 3.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.378 1.071 . . . . 0.0 112.638 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -158.32 168.74 26.18 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.143 -0.973 . . . . 0.0 110.38 -166.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.2 tp -107.63 123.22 48.16 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.82 122.19 31.96 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.824 1.193 . . . . 0.0 108.524 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.0 t -135.32 137.43 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.256 1.022 . . . . 0.0 108.516 -174.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.4 p -163.05 165.26 15.01 Favored Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 127.108 2.163 . . . . 0.0 109.851 154.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.43 -56.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.139 1.226 . . . . 0.0 113.005 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -148.48 -83.2 0.11 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.56 1.073 . . . . 0.0 108.11 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -146.97 -27.97 0.39 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.804 1.241 . . . . 0.0 112.216 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.1 tp -63.7 -31.94 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 120.791 -1.193 . . . . 0.0 111.37 176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -48.47 -26.06 4.89 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 126.815 2.15 . . . . 0.0 113.324 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 mm -125.62 7.32 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.167 1.387 . . . . 0.0 109.944 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 t -84.8 -71.56 0.51 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 170.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -88.09 -50.8 6.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -170.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -67.89 -15.33 63.57 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.32 -30.33 38.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.449 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -69.37 -59.47 2.97 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 118.556 0.617 . . . . 0.0 109.94 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.47 -35.48 74.17 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.476 0.58 . . . . 0.0 112.456 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.82 -48.82 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.929 0.891 . . . . 0.0 109.576 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.22 -47.45 86.06 Favored 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 121.488 -0.758 . . . . 0.0 110.902 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -61.4 -16.22 44.48 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 128.253 2.621 . . . . 0.0 111.631 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.68 4.28 50.07 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 112.454 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.33 14.63 47.25 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.261 0.934 . . . . 0.0 114.719 169.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -112.78 90.64 3.4 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.863 1.332 . . . . 0.0 111.701 -168.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 m -53.28 98.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.225 2.61 . . . . 0.0 113.619 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.78 -172.95 4.46 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.78 1.632 . . . . 0.0 112.238 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.7 p -111.15 -164.77 0.94 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.468 1.907 . . . . 0.0 106.694 163.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -80.29 -22.59 41.44 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.939 -1.101 . . . . 0.0 112.93 161.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.16 -28.33 6.53 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.29 -1.284 . . . . 0.0 114.805 -168.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 pp -154.31 172.53 17.51 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.208 2.004 . . . . 0.0 110.226 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -114.57 166.36 11.8 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 120.824 -1.172 . . . . 0.0 109.006 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.78 133.22 20.75 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.95 143.44 26.14 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 168.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.08 157.88 60.0 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.189 1.926 . . . . 0.0 109.925 172.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -61.07 -25.04 66.66 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.33 -0.856 . . . . 0.0 112.006 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -57.88 -62.46 1.79 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.044 1.737 . . . . 0.0 111.696 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -91.57 165.43 20.92 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 125.995 1.718 . . . . 0.0 111.814 -163.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.33 149.25 85.08 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.367 2.045 . . . . 0.0 110.672 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 p -96.94 127.07 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.17 83.34 7.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.462 1.125 . . . . 0.0 111.156 -169.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -57.03 -35.85 69.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.285 1.434 . . . . 0.0 110.222 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -39.33 77.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.486 -0.759 . . . . 0.0 112.339 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -49.06 46.79 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 122.03 0.919 . . . . 0.0 108.641 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.296 0.3 OUTLIER -75.82 -24.08 55.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.138 -169.584 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -37.71 88.44 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 120.535 1.516 . . . . 0.0 110.565 171.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -56.29 -52.0 66.13 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.102 0.865 . . . . 0.0 109.708 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.9 ptp -68.89 -36.75 78.42 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.312 -172.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -46.76 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 121.159 1.8 . . . . 0.0 109.262 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.75 -47.4 85.84 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.814 0.846 . . . . 0.0 110.352 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -61.87 -40.36 95.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.245 0.475 . . . . 0.0 110.643 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -24.62 66.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.042 0.837 . . . . 0.0 111.36 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 99.3 mt -79.24 -49.43 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.256 1.422 . . . . 0.0 108.905 169.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -61.38 -29.02 69.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.633 1.173 . . . . 0.0 110.826 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -82.97 -19.32 37.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.744 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -93.84 -1.21 55.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.983 1.713 . . . . 0.0 112.212 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 C--O 1.247 0.937 0 C-N-CA 128.546 2.738 . . . . 0.0 110.704 173.415 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.6 mmt -57.16 -14.07 3.69 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.005 1.322 . . . . 0.0 113.142 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -74.06 -30.25 62.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 120.506 -1.371 . . . . 0.0 112.407 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.9 t -70.64 -33.2 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 124.181 0.926 . . . . 0.0 108.745 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -102.61 -2.41 28.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.896 1.278 . . . . 0.0 112.343 -171.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.88 72.12 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 122.382 1.087 . . . . 0.0 110.359 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.46 -12.92 62.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.434 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -75.45 -57.0 4.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.121 0.873 . . . . 0.0 109.978 167.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.77 -44.38 73.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.917 1.287 . . . . 0.0 111.603 -174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -53.68 -32.25 50.94 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.6 -18.22 66.56 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.519 -168.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.7 mt -69.37 114.61 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.78 6.0 14.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.747 1.219 . . . . 0.0 111.71 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.79 74.58 75.68 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 128.013 2.525 . . . . 0.0 110.046 -170.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -59.43 -30.85 93.66 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.094 2.529 . . . . 0.0 112.757 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.428 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 57.4 m-20 -70.03 -1.92 11.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.286 1.034 . . . . 0.0 112.308 -177.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 13.9 m80 -132.6 -30.72 1.42 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.294 1.838 . . . . 0.0 109.751 -176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.26 -48.56 45.75 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.64 1.576 . . . . 0.0 110.548 169.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.69 -36.96 82.39 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.329 0.393 . . . . 0.0 111.767 -168.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -63.78 -30.55 71.63 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.853 -0.529 . . . . 0.0 111.725 175.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.0 m -71.52 -41.65 68.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.859 0.864 . . . . 0.0 109.5 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -50.43 -43.64 55.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.169 0.895 . . . . 0.0 111.903 168.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.89 -27.5 69.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.342 0.974 . . . . 0.0 112.751 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.4 mt -73.53 -47.13 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.74 -63.41 1.21 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.86 0.864 . . . . 0.0 109.744 -169.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -64.37 -25.52 68.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.583 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -68.36 -42.25 79.46 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.208 0.913 . . . . 0.0 110.457 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.57 HG11 ' CD2' ' A' ' 48' ' ' PHE . 41.2 t -59.74 -48.4 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.9 0.773 . . . . 0.0 109.034 174.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.76 -29.37 68.13 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.11 -56.56 4.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.896 -0.503 . . . . 0.0 110.818 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -78.9 -28.99 44.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.792 1.637 . . . . 0.0 111.655 -165.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -131.62 64.42 72.86 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.187 0.995 . . . . 0.0 108.749 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.71 -13.03 31.96 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.673 2.249 . . . . 0.0 113.09 -171.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -74.13 -18.16 60.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.827 0.74 . . . . 0.0 112.253 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.6 mt -69.27 152.98 44.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -124.84 142.73 41.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.19 137.36 28.58 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.213 1.942 . . . . 0.0 110.479 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -147.32 135.66 21.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.356 1.062 . . . . 0.0 108.268 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.63 114.01 27.92 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 175.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.34 146.94 31.81 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.432 1.093 . . . . 0.0 108.079 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.6 m95 55.54 21.11 4.19 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.868 1.213 . . . . 0.0 114.115 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.2 t30 57.67 17.9 4.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 112.598 -165.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 59' ' ' SER . 68.5 p -110.74 142.99 27.3 Favored Pre-proline 0 N--CA 1.449 -0.516 0 O-C-N 120.532 -1.355 . . . . 0.0 109.361 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.31 128.66 15.83 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.532 2.155 . . . . 0.0 110.083 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.6 ptm -142.37 168.82 18.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.98 0.912 . . . . 0.0 109.021 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.57 ' CD2' HG11 ' A' ' 30' ' ' VAL . 1.8 m-85 -140.14 91.55 2.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -172.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 p -65.07 122.66 17.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -71.54 91.01 1.03 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.862 1.21 . . . . 0.0 108.338 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 48.8 18.14 0.18 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.653 1.181 . . . . 0.0 113.717 -170.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.39 -16.73 2.92 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.303 1.906 . . . . 0.0 115.621 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.12 -167.98 1.17 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 120.355 2.078 . . . . 0.0 112.811 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -128.99 43.82 3.08 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.155 1.382 . . . . 0.0 110.408 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.8 mt -75.73 -1.46 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.706 1.602 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 tt -164.92 157.59 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 119.746 -1.846 . . . . 0.0 112.542 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.35 136.2 2.19 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 165.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -131.09 163.76 26.94 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.231 1.015 . . . . 0.0 111.227 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.426 ' HB3' HG22 ' A' ' 45' ' ' THR . 2.4 p -149.48 156.68 42.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.886 0.85 . . . . 0.0 110.388 163.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 53.1 p -59.4 145.26 44.23 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.183 0.993 . . . . 0.0 108.685 167.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 m -133.56 177.61 7.57 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.205 1.402 . . . . 0.0 107.834 168.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.38 -57.22 8.46 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.145 0.978 . . . . 0.0 112.102 -167.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -126.19 4.29 7.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.119 0.968 . . . . 0.0 112.748 -173.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.501 ' CD2' ' HE ' ' A' ' 94' ' ' ARG . 4.1 p-80 -145.81 168.42 20.82 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.096 1.758 . . . . 0.0 108.445 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.2 tp -88.19 169.32 11.99 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 160.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 p -120.09 127.67 52.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.781 1.173 . . . . 0.0 108.136 160.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.417 ' HB ' ' CE1' ' A' ' 93' ' ' PHE . 92.8 t -135.19 148.0 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.2 t -165.94 165.37 10.79 Favored Pre-proline 0 C--O 1.241 0.631 0 C-N-CA 128.399 2.68 . . . . 0.0 105.947 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -83.16 -57.35 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.338 0 CA-C-N 120.153 1.09 . . . . 0.0 111.225 152.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -147.23 -86.34 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.9 -32.97 0.34 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.338 1.455 . . . . 0.0 111.7 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.77 -35.31 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 119.961 1.255 . . . . 0.0 111.064 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.97 -16.26 24.42 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.59 0.614 . . . . 0.0 113.817 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.1 mm -112.17 -14.44 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 126.735 2.014 . . . . 0.0 110.278 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.4 m -104.37 -55.6 2.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.0 0.52 . . . . 0.0 110.248 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -81.2 -63.49 1.39 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.427 ' CG ' ' HG3' ' A' ' 109' ' ' MET . 12.5 m-85 -72.94 -9.2 58.45 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.499 -0.48 . . . . 0.0 112.014 -170.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.28 -30.89 63.07 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.372 0.533 . . . . 0.0 112.23 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -63.92 -44.15 93.76 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 118.439 0.563 . . . . 0.0 110.295 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.508 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -77.53 -29.46 52.35 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.114 -175.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.1 mt -60.22 -48.68 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.684 1.194 . . . . 0.0 108.324 168.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.66 73.13 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.967 0.907 . . . . 0.0 110.712 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -58.06 -30.04 65.88 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.744 0.818 . . . . 0.0 111.983 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.39 95.9 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.502 1.046 . . . . 0.0 110.862 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 132.25 -11.1 5.31 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 127.283 2.373 . . . . 0.0 111.465 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -86.93 174.0 9.0 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 120.93 -1.335 . . . . 0.0 112.747 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.2 t -127.53 175.09 8.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.486 1.914 . . . . 0.0 109.297 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.61 -176.41 4.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.064 1.746 . . . . 0.0 110.618 -166.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.8 p -132.01 -168.75 2.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.796 1.638 . . . . 0.0 108.225 168.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.72 5.92 12.15 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.655 -1.278 . . . . 0.0 113.409 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.08 -14.19 0.03 OUTLIER Glycine 0 CA--C 1.524 0.644 0 CA-C-N 119.544 1.065 . . . . 0.0 115.186 -171.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.6 pp -159.81 -173.37 4.06 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.691 1.246 . . . . 0.0 109.644 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.417 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 12.2 p90 -135.0 165.63 24.91 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.875 -1.141 . . . . 0.0 111.66 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.501 ' HE ' ' CD2' ' A' ' 64' ' ' HIS . 1.8 mmt-85 -139.92 91.24 2.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.721 1.208 . . . . 0.0 111.658 -157.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -86.2 141.1 34.74 Favored Pre-proline 0 C--O 1.239 0.54 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.09 155.77 26.07 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.114 2.543 . . . . 0.0 110.516 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -63.35 -19.89 65.03 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -68.58 -44.96 73.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.759 1.163 . . . . 0.0 111.105 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -90.32 150.24 42.64 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 123.609 0.764 . . . . 0.0 109.85 -159.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.73 123.41 5.83 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.777 2.984 . . . . 0.0 112.169 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.1 m -68.6 9.69 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -166.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 43.76 81.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 128.043 2.537 . . . . 0.0 114.285 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -60.33 -27.71 67.57 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.957 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.72 -56.06 18.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.986 0.514 . . . . 0.0 110.813 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.508 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -61.6 -46.76 88.47 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.595 0.712 . . . . 0.0 109.518 -173.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -27.43 62.14 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.811 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -58.46 -55.86 29.59 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 119.681 1.128 . . . . 0.0 108.933 165.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -59.68 -37.72 79.56 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.044 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.427 ' HG3' ' CG ' ' A' ' 77' ' ' PHE . 6.1 ttm -53.18 -61.19 2.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.532 1.933 . . . . 0.0 111.303 172.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -45.88 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.745 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.74 -46.59 74.32 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.828 0.851 . . . . 0.0 109.435 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.8 -47.97 81.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.389 0.276 . . . . 0.0 111.385 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -20.22 63.27 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.544 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 91.1 mt -78.24 -63.62 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.159 0.984 . . . . 0.0 109.177 165.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -71.37 -13.18 61.78 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -164.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.57 -35.99 82.78 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.979 0.512 . . . . 0.0 109.688 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -79.65 7.03 9.17 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.765 2.026 . . . . 0.0 112.428 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 128.263 2.625 . . . . 0.0 112.212 -162.648 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 117.311 -1.328 . . . . 0.0 113.813 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.32 -36.56 43.23 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 120.814 1.643 . . . . 0.0 112.151 174.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -45.88 -44.58 14.56 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.099 0.959 . . . . 0.0 113.228 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.61 -50.57 43.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -80.24 -9.68 59.73 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -165.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.44 90.5 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.393 1.477 . . . . 0.0 111.446 -167.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.39 -21.99 66.74 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.157 0.983 . . . . 0.0 112.897 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -81.28 -55.1 4.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -51.83 -40.99 61.43 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.682 1.193 . . . . 0.0 111.777 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -58.38 -46.87 85.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.402 0.681 . . . . 0.0 110.431 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.87 -4.77 88.48 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.97 1.272 . . . . 0.0 113.86 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.2 mt -65.22 95.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 164.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.11 3.08 3.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.937 1.295 . . . . 0.0 112.855 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -105.63 75.89 0.33 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 C-N-CA 129.316 3.046 . . . . 0.0 109.212 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.48 -19.86 65.52 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.77 2.313 . . . . 0.0 112.781 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.68 2.33 30.1 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.077 1.351 . . . . 0.0 112.612 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -145.09 15.91 1.53 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.154 1.382 . . . . 0.0 110.127 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -91.11 -50.64 5.73 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.882 1.673 . . . . 0.0 109.569 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -53.91 -26.75 26.65 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 126.593 1.957 . . . . 0.0 113.469 -167.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -52.66 -55.62 21.23 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -58.32 -34.96 71.17 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.525 -0.734 . . . . 0.0 112.499 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -41.16 96.61 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.017 0.927 . . . . 0.0 111.298 172.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.9 -54.63 42.69 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.099 0.863 . . . . 0.0 109.521 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -52.46 -51.12 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.757 0.823 . . . . 0.0 109.937 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.9 mt -63.07 -51.89 64.88 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.714 0.406 . . . . 0.0 110.04 -171.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -65.29 -33.18 75.37 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 123.2 0.313 . . . . 0.0 110.511 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -64.97 -48.36 74.3 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.16 0.984 . . . . 0.0 110.89 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 48' ' ' PHE . 24.7 t -52.75 -47.73 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 118.793 0.724 . . . . 0.0 109.814 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.23 13.58 0.41 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.21 -34.83 0.52 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.748 1.219 . . . . 0.0 114.068 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.5 m -75.92 -39.46 56.18 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.009 -1.057 . . . . 0.0 108.876 168.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -122.87 70.46 39.13 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 122.203 1.001 . . . . 0.0 110.914 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.85 -4.72 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.041 2.494 . . . . 0.0 112.923 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -79.4 -17.8 53.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.33 1.852 . . . . 0.0 113.11 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.444 HD12 HG13 ' A' ' 30' ' ' VAL . 43.5 mt -80.93 144.92 31.54 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.566 -1.334 . . . . 0.0 109.785 175.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -119.8 143.99 36.26 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.024 1.73 . . . . 0.0 110.141 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.51 148.09 37.15 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.655 2.903 . . . . 0.0 113.762 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -153.7 119.4 5.28 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.982 1.313 . . . . 0.0 110.649 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.71 103.5 9.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.375 1.07 . . . . 0.0 108.823 170.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -135.32 149.33 49.73 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.265 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.7 m95 55.73 16.26 1.92 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 66.95 27.48 8.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.891 2.077 . . . . 0.0 112.239 -170.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.0 p -130.82 152.71 81.04 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.91 1.684 . . . . 0.0 108.162 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.29 112.68 3.6 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 124.573 3.515 . . . . 0.0 110.209 170.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.3 ptm -122.84 170.6 9.93 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.753 -0.592 . . . . 0.0 109.772 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CZ ' HG11 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -138.95 167.73 21.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.645 0.736 . . . . 0.0 109.258 176.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.2 p -140.85 112.31 7.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 123.173 0.589 . . . . 0.0 111.444 -165.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.81 102.09 3.3 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 47.39 40.44 10.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.128 0.971 . . . . 0.0 111.579 -171.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.87 -2.32 66.41 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.772 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.5 m -82.65 177.74 8.55 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.272 2.036 . . . . 0.0 109.723 -177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.427 ' H ' HG22 ' A' ' 53' ' ' THR . 62.0 t80 -102.88 9.1 39.05 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.334 -1.479 . . . . 0.0 114.378 -170.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.75 8.58 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.261 0 C-N-CA 127.604 2.361 . . . . 0.0 114.178 -162.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 tt -154.21 150.5 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 O-C-N 117.806 -3.059 . . . . 0.0 111.464 165.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.95 153.32 24.44 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 162.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -147.97 161.4 41.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.147 1.473 . . . . 0.0 110.212 170.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.72 155.84 41.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.518 0.675 . . . . 0.0 110.092 172.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.3 p -66.84 154.33 41.16 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.041 1.336 . . . . 0.0 109.343 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB3' ' CD2' ' A' ' 64' ' ' HIS . 31.2 t -133.9 163.99 28.29 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 156.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -48.12 -40.5 23.8 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.321 1.048 . . . . 0.0 113.517 -168.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -124.95 8.59 8.08 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.413 ' CD2' ' HB3' ' A' ' 61' ' ' SER . 7.7 p-80 -158.55 157.46 32.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.118 0.872 . . . . 0.0 112.315 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.9 tp -85.57 156.9 20.55 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 166.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.23 112.34 16.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.151 1.38 . . . . 0.0 109.906 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.1 t -126.78 141.08 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.236 2.214 . . . . 0.0 110.721 -166.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.5 t -164.45 159.58 15.84 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 108.361 164.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.34 -58.48 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 120.524 1.223 . . . . 0.0 111.138 166.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -134.81 -86.25 0.39 Allowed 'General case' 0 C--O 1.233 0.211 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 168.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -136.96 -30.84 0.86 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.984 1.714 . . . . 0.0 111.69 -172.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -62.35 -32.27 54.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 119.321 0.964 . . . . 0.0 111.781 -165.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.51 -29.52 57.55 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.638 1.589 . . . . 0.0 113.52 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.7 mm -98.13 -5.74 9.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.868 1.667 . . . . 0.0 110.114 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.0 m -97.47 -80.22 0.45 Allowed 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 124.853 1.261 . . . . 0.0 108.879 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -83.68 -37.35 22.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.715 1.143 . . . . 0.0 110.159 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 109' ' ' MET . 59.8 m-85 -80.82 -11.4 59.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.292 0.496 . . . . 0.0 111.82 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.78 67.96 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.734 0.814 . . . . 0.0 113.173 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.38 -52.04 44.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.37 80.63 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.789 0.836 . . . . 0.0 111.597 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.63 -52.34 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.997 0.817 . . . . 0.0 109.237 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.54 -48.64 80.11 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.419 0.688 . . . . 0.0 110.275 -175.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -52.8 -44.17 66.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.56 1.544 . . . . 0.0 111.326 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.17 -5.92 30.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.352 0.661 . . . . 0.0 112.401 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.01 9.52 53.86 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.146 1.355 . . . . 0.0 112.801 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -99.62 163.43 12.5 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.133 1.467 . . . . 0.0 111.208 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.8 m -124.51 93.08 3.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.965 -151.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . . . -80.04 165.36 22.62 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.367 -0.833 . . . . 0.0 112.01 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.0 p -103.23 -164.35 1.07 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.11 1.764 . . . . 0.0 106.249 152.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 -2.18 51.22 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.693 -1.254 . . . . 0.0 112.256 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.03 -2.42 2.14 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.467 1.032 . . . . 0.0 113.749 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.56 177.69 11.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.289 1.545 . . . . 0.0 109.101 162.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 13.1 p90 -124.16 164.23 19.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.59 -0.694 . . . . 0.0 110.779 166.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.65 152.44 48.09 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 121.885 -0.509 . . . . 0.0 111.815 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.3 mm -123.47 142.88 39.97 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.39 150.99 25.73 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.564 2.176 . . . . 0.0 111.53 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -61.89 -20.95 64.3 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.87 -34.95 72.15 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.588 -0.695 . . . . 0.0 111.843 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.99 159.99 44.73 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 122.845 0.458 . . . . 0.0 109.794 -151.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.13 139.35 13.36 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-O 123.503 1.376 . . . . 0.0 111.946 -157.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.47 111.04 20.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 85.61 0.67 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.679 1.192 . . . . 0.0 112.541 -175.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -63.21 -38.53 91.55 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.064 1.346 . . . . 0.0 111.311 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -58.09 9.93 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.454 0.702 . . . . 0.0 110.19 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.99 -41.61 98.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.096 -172.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.275 0.2 OUTLIER -75.66 -26.16 57.44 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.432 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.438 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -68.21 -35.51 78.08 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 121.088 1.767 . . . . 0.0 110.934 174.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -56.42 -59.19 5.33 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.774 0.716 . . . . 0.0 109.543 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . 22.2 ptp -62.22 -43.26 99.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.64 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -68.9 -46.24 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 118.855 0.752 . . . . 0.0 109.206 -174.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -65.92 -40.58 91.57 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.716 1.143 . . . . 0.0 110.743 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.94 -47.27 85.62 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.366 0.53 . . . . 0.0 110.693 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.02 -13.38 11.22 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.735 0.814 . . . . 0.0 110.905 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 62.9 mt -95.74 -49.77 12.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-N 120.063 1.301 . . . . 0.0 110.342 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -72.15 3.48 4.48 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.147 1.34 . . . . 0.0 112.579 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -87.91 -15.82 35.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.52 1.528 . . . . 0.0 112.511 164.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -113.18 32.55 5.66 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.525 1.53 . . . . 0.0 110.136 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.331 157.502 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.4 mmt -59.05 -33.37 70.7 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -172.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.71 -36.49 72.06 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.56 0.618 . . . . 0.0 112.431 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.95 -45.24 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.048 0.939 . . . . 0.0 109.486 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -90.9 -9.42 46.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -167.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.75 91.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.396 1.479 . . . . 0.0 111.789 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.25 -27.08 63.65 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.727 1.211 . . . . 0.0 112.327 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -77.36 -50.57 12.48 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.642 0.777 . . . . 0.0 109.651 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.18 -50.33 62.06 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.608 1.163 . . . . 0.0 109.852 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -58.34 -42.85 87.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.008 0.923 . . . . 0.0 110.688 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.14 -35.86 91.07 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.759 -1.578 . . . . 0.0 114.208 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -54.75 108.74 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -73.34 -3.49 27.45 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.961 1.304 . . . . 0.0 112.611 -171.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 76.05 33.18 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 127.363 2.265 . . . . 0.0 108.7 -170.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.8 -21.56 72.47 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.313 2.675 . . . . 0.0 113.391 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.469 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 6.3 m-20 -63.89 -19.84 65.38 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.611 0.641 . . . . 0.0 111.734 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 3.7 m80 -123.61 -24.03 4.63 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.428 1.491 . . . . 0.0 110.18 -170.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -48.79 -45.58 40.37 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.305 1.042 . . . . 0.0 110.228 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.02 -32.73 9.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.815 1.646 . . . . 0.0 113.424 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -67.31 -14.38 62.87 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.35 -1.469 . . . . 0.0 112.387 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.5 m -100.98 -35.72 9.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.716 1.206 . . . . 0.0 109.789 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -26.2 63.57 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.426 0.557 . . . . 0.0 111.38 172.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -55.82 -62.58 1.6 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.634 1.574 . . . . 0.0 110.156 168.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 mt -57.58 -42.81 82.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 124.45 1.1 . . . . 0.0 112.466 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.11 -49.76 75.83 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.259 0.936 . . . . 0.0 110.036 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -65.57 -36.79 84.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 118.161 -0.923 . . . . 0.0 112.155 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -57.65 -53.55 56.91 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.158 0.89 . . . . 0.0 111.028 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.685 HG11 ' CE2' ' A' ' 48' ' ' PHE . 72.2 t -63.01 -41.69 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 O-C-N 121.196 -0.94 . . . . 0.0 109.689 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.83 5.03 2.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.522 1.129 . . . . 0.0 113.722 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.69 -62.76 1.49 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.619 1.568 . . . . 0.0 110.456 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.1 m -63.65 -32.04 73.4 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.604 1.093 . . . . 0.0 111.871 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -121.72 66.13 19.49 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 119.703 1.138 . . . . 0.0 110.806 -172.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.07 -10.88 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.228 3.285 . . . . 0.0 112.539 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -58.97 -22.03 59.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.916 2.087 . . . . 0.0 113.755 163.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 110' ' ' ILE . 35.6 mt -89.46 160.58 16.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -134.79 149.52 70.88 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 126.786 2.035 . . . . 0.0 108.866 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.61 146.25 66.64 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 122.826 2.351 . . . . 0.0 112.194 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -158.02 119.13 3.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.027 1.331 . . . . 0.0 108.219 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -84.01 119.04 24.46 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -141.49 136.29 31.09 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.671 -0.643 . . . . 0.0 109.939 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.6 m95 56.35 24.0 7.89 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.5 t30 69.89 9.55 7.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.001 2.12 . . . . 0.0 112.909 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -111.91 143.94 29.69 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 125.299 1.44 . . . . 0.0 109.208 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -70.28 125.91 12.4 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.154 1.902 . . . . 0.0 111.782 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.6 ptm -133.0 171.42 13.99 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.433 1.093 . . . . 0.0 108.904 169.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.685 ' CE2' HG11 ' A' ' 30' ' ' VAL . 3.2 m-85 -138.22 105.62 5.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.15 125.71 29.51 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 120.514 -1.366 . . . . 0.0 109.45 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -72.82 83.96 1.21 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 53.08 -19.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 118.829 2.9 . . . . 0.0 118.829 -162.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.49 40.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -168.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.99 -176.58 3.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.011 0.906 . . . . 0.0 110.053 174.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -124.84 32.03 5.53 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.827 1.651 . . . . 0.0 111.132 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.1 mt -70.13 -0.92 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.187 1.395 . . . . 0.0 111.671 -168.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.1 tt -161.59 147.26 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 O-C-N 119.636 -1.915 . . . . 0.0 111.962 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.73 156.11 27.26 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 158.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.3 155.2 41.82 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.365 -1.079 . . . . 0.0 111.642 169.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 t -142.87 153.48 43.19 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.3 p -70.81 159.65 34.18 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.582 1.153 . . . . 0.0 109.81 171.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -146.18 179.78 7.27 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.402 1.481 . . . . 0.0 109.29 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -56.41 -60.24 3.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.075 0.95 . . . . 0.0 112.086 -169.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -121.6 8.7 10.11 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.994 0.918 . . . . 0.0 111.255 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -152.55 172.85 15.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.493 1.117 . . . . 0.0 109.058 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 tp -101.01 158.94 15.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.471 1.909 . . . . 0.0 107.785 166.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 92' ' ' LEU . 46.2 p -124.93 113.11 17.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.974 1.261 . . . . 0.0 111.045 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.23 146.02 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 125.449 1.5 . . . . 0.0 109.408 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.0 t -165.79 157.55 12.41 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.781 1.633 . . . . 0.0 107.335 167.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.1 -56.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.209 0 N-CA-C 109.117 -1.147 . . . . 0.0 109.117 160.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -151.34 -85.32 0.08 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -140.54 -49.47 0.44 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.38 1.872 . . . . 0.0 110.779 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.3 tt -57.91 -34.26 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 121.509 -0.744 . . . . 0.0 111.829 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -44.57 -48.23 8.83 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 172.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mm -91.49 -2.53 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.529 1.132 . . . . 0.0 110.877 -168.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.3 m -105.96 -54.79 2.42 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 120.543 -1.348 . . . . 0.0 111.4 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -78.34 -56.81 4.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.959 1.704 . . . . 0.0 106.84 -170.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -80.63 -18.66 47.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.691 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.57 -21.92 54.37 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.78 -61.28 2.28 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.04 -36.89 68.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.111 0.964 . . . . 0.0 112.27 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.69 -45.33 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.782 1.233 . . . . 0.0 110.254 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.9 -52.62 64.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -21.9 64.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 178.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.29 -21.29 62.96 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.308 0.958 . . . . 0.0 110.716 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.07 10.24 5.28 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.36 -1.245 . . . . 0.0 113.709 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.69 122.33 47.53 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.2 2.0 . . . . 0.0 110.868 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.7 p -75.69 85.13 2.7 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.126 0.97 . . . . 0.0 110.89 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.65 171.23 0.66 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.83 0.852 . . . . 0.0 110.985 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.2 p -101.81 -172.35 2.13 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 167.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -82.85 -19.79 36.85 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 118.063 -0.97 . . . . 0.0 113.023 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -121.23 -14.86 4.83 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 119.079 0.854 . . . . 0.0 113.895 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 66' ' ' SER . 4.6 pp -150.61 164.85 35.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.934 1.694 . . . . 0.0 109.39 167.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -106.85 160.45 15.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.56 1.073 . . . . 0.0 110.55 170.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.81 141.85 23.04 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.865 -0.522 . . . . 0.0 110.139 -166.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.77 143.51 43.89 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -172.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.53 151.84 82.07 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.586 1.524 . . . . 0.0 109.896 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -64.32 -26.13 68.34 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.843 -0.599 . . . . 0.0 112.338 168.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -62.8 -70.0 0.23 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.696 0.798 . . . . 0.0 111.73 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.82 157.53 87.2 Favored Pre-proline 0 C--O 1.236 0.347 0 O-C-N 123.213 0.32 . . . . 0.0 110.228 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.17 161.29 46.47 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.188 1.925 . . . . 0.0 111.182 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.54 136.59 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.02 2.128 . . . . 0.0 108.764 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.86 102.38 5.5 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 163.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -73.56 -15.77 61.28 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.09 0.859 . . . . 0.0 111.207 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -66.62 -65.5 0.67 Allowed 'General case' 0 CA--C 1.527 0.096 0 O-C-N 121.196 -0.94 . . . . 0.0 111.154 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.26 -38.94 77.91 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -46.01 -45.58 15.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.571 2.748 . . . . 0.0 113.863 172.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -71.3 -48.02 53.22 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 125.567 1.547 . . . . 0.0 109.306 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.39 -49.27 78.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -172.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.1 ptp -70.49 3.77 2.81 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.069 1.747 . . . . 0.0 114.616 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -120.46 -48.56 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 120.555 1.525 . . . . 0.0 109.412 175.209 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -59.59 -45.51 91.68 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.564 1.074 . . . . 0.0 109.008 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -56.63 -49.49 74.83 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 119.669 -0.205 . . . . 0.0 110.536 172.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -18.65 65.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.798 -0.62 . . . . 0.0 112.387 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mt -82.58 -55.46 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -70.97 -12.58 61.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.058 0.845 . . . . 0.0 112.577 -172.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.39 -21.69 48.96 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.506 1.122 . . . . 0.0 111.345 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -93.12 34.75 1.1 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.896 2.078 . . . . 0.0 109.78 174.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.634 1.573 . . . . 0.0 110.963 167.64 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.8 mmt -53.7 -34.04 57.49 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.073 0.949 . . . . 0.0 112.036 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -57.09 -42.94 81.64 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.331 0.969 . . . . 0.0 111.93 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.4 -40.38 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.863 0.865 . . . . 0.0 110.432 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -97.18 -19.93 18.29 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -167.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.51 -33.7 76.5 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.629 1.104 . . . . 0.0 111.529 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.84 -43.17 48.69 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.861 1.264 . . . . 0.0 111.695 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -72.24 -43.72 63.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.451 0.7 . . . . 0.0 110.496 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.83 -47.16 80.96 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -55.54 -43.25 75.61 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.908 0.483 . . . . 0.0 110.697 173.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.82 -24.82 71.6 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.97 -0.906 . . . . 0.0 112.872 -174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.3 mt -64.32 110.24 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 119.302 1.551 . . . . 0.0 107.715 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -72.71 -8.04 53.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.468 1.907 . . . . 0.0 113.939 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.73 70.64 1.71 Allowed Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 126.191 1.796 . . . . 0.0 109.691 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.94 -29.21 87.59 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.965 3.11 . . . . 0.0 113.883 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.07 -8.29 11.45 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.733 0.697 . . . . 0.0 112.218 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -123.77 -13.36 7.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.813 1.645 . . . . 0.0 110.107 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.79 -56.34 9.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.965 1.306 . . . . 0.0 109.681 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -62.63 -30.54 71.43 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.64 0.776 . . . . 0.0 112.069 -161.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -50.45 21.58 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.189 1.395 . . . . 0.0 111.578 169.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 m -59.87 -44.73 94.01 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.549 1.54 . . . . 0.0 111.355 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -35.87 46.48 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.124 2.17 . . . . 0.0 112.883 175.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -68.55 -48.71 63.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.043 0.537 . . . . 0.0 111.539 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mt -55.83 -49.99 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 123.953 0.783 . . . . 0.0 109.341 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 mt -56.61 -49.17 75.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.21 0.459 . . . . 0.0 110.524 -171.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 t -65.49 -40.24 92.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.376 0.671 . . . . 0.0 111.213 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -63.18 -39.32 94.31 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.647 0.779 . . . . 0.0 111.01 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.755 HG11 ' CE2' ' A' ' 48' ' ' PHE . 54.9 t -58.77 -47.33 89.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-O 118.41 -0.805 . . . . 0.0 108.891 174.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.68 -8.76 15.8 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.328 0.967 . . . . 0.0 113.155 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.36 -60.24 1.56 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.221 1.008 . . . . 0.0 111.177 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 m -69.78 -38.82 76.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.569 1.077 . . . . 0.0 110.439 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.436 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -123.9 65.18 35.64 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -173.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.17 -10.3 28.67 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.318 2.012 . . . . 0.0 111.772 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.56 -28.67 66.19 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.838 1.255 . . . . 0.0 112.84 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.642 HD21 ' CD1' ' A' ' 114' ' ' ILE . 3.5 mm? -69.35 146.84 51.82 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 171.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -124.9 147.99 58.34 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.22 148.73 31.05 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.107 2.538 . . . . 0.0 112.323 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -163.82 82.46 0.44 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.412 1.485 . . . . 0.0 107.251 172.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -70.75 134.43 47.42 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.016 -1.678 . . . . 0.0 108.53 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -154.97 152.8 30.13 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.571 1.148 . . . . 0.0 110.337 -170.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.8 m95 47.89 28.98 1.51 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.257 1.423 . . . . 0.0 112.767 -171.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 67.47 24.68 8.7 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.449 1.9 . . . . 0.0 112.492 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.402 HG22 ' HB3' ' A' ' 59' ' ' SER . 26.7 p -124.57 143.2 42.63 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 125.358 1.463 . . . . 0.0 109.267 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.8 124.88 10.03 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.844 2.362 . . . . 0.0 108.93 164.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.0 ptm -137.09 163.36 30.99 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 167.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.755 ' CE2' HG11 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -127.2 158.97 35.69 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 175.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 m -128.21 124.44 36.73 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -173.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -74.78 84.42 2.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.257 16.6 mt-30 64.34 -11.51 0.12 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.878 2.071 . . . . 0.0 114.884 -176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.73 -9.84 0.02 OUTLIER Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.202 1.382 . . . . 0.0 116.056 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.84 -166.98 1.56 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.242 1.521 . . . . 0.0 114.115 -163.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -126.48 26.37 6.35 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.978 1.711 . . . . 0.0 110.841 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.39 -2.02 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 O-C-N 120.114 -1.616 . . . . 0.0 112.657 -171.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.425 HD12 HG13 ' A' ' 110' ' ' ILE . 10.1 tt -161.08 142.69 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 121.716 2.053 . . . . 0.0 111.795 170.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.22 157.74 29.36 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 161.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -147.27 141.42 26.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.276 1.038 . . . . 0.0 109.224 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -134.45 114.25 12.69 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.037 -1.04 . . . . 0.0 108.446 -176.218 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.8 p -54.75 134.73 47.7 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.212 0.915 . . . . 0.0 110.613 -168.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -112.49 163.95 13.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -54.51 -27.04 35.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.679 1.592 . . . . 0.0 113.796 -165.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -137.71 0.24 2.21 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.132 0.973 . . . . 0.0 113.383 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -153.17 158.33 41.63 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.382 0.992 . . . . 0.0 110.137 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -104.48 113.12 26.47 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.427 ' HB2' HD22 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -71.07 131.25 43.35 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 167.026 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.7 t -135.32 138.44 48.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 t -167.86 153.16 6.79 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 125.175 1.39 . . . . 0.0 107.405 161.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.67 -57.61 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 CA-C-N 119.971 1.025 . . . . 0.0 110.699 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -146.24 -79.95 0.16 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -139.63 -38.37 0.48 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.367 1.467 . . . . 0.0 111.614 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -27.86 43.24 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 118.81 0.732 . . . . 0.0 112.422 -166.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -46.56 -43.26 15.11 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.029 0.824 . . . . 0.0 111.155 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 mm -91.31 -11.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 121.998 -0.707 . . . . 0.0 110.235 -168.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.9 m -107.98 -57.19 2.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.151 0.887 . . . . 0.0 110.471 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.76 -60.87 2.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.569 1.948 . . . . 0.0 107.415 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 109' ' ' MET . 59.8 m-85 -77.49 5.99 7.9 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.25 -48.69 12.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.944 1.697 . . . . 0.0 111.775 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -73.42 -41.09 63.71 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.109 0.964 . . . . 0.0 109.132 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -58.95 -43.21 91.21 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.054 0.942 . . . . 0.0 110.169 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.8 mt -66.8 -43.31 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 120.027 1.285 . . . . 0.0 109.493 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.86 -57.02 14.29 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.556 1.143 . . . . 0.0 110.795 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.94 -25.05 68.16 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.404 1.082 . . . . 0.0 112.802 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.39 -17.26 63.66 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.696 0.68 . . . . 0.0 111.281 173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.14 9.21 5.7 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.347 1.927 . . . . 0.0 113.398 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -134.18 111.89 10.66 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 119.087 1.444 . . . . 0.0 110.705 -161.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.7 m -76.59 15.6 0.61 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.985 -1.697 . . . . 0.0 114.541 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 52.46 -155.24 0.18 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.398 1.879 . . . . 0.0 112.548 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.5 p -125.59 -164.35 1.29 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.074 2.15 . . . . 0.0 105.952 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -81.82 -10.29 59.37 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.558 -1.21 . . . . 0.0 112.943 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.79 13.8 0.19 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-N 120.333 1.424 . . . . 0.0 115.235 -167.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 66' ' ' SER . 3.9 pp -166.05 178.97 6.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 130.332 3.453 . . . . 0.0 106.29 162.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -119.84 166.22 13.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 120.235 1.38 . . . . 0.0 108.368 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 171.53 14.18 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.463 -0.773 . . . . 0.0 109.667 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -133.59 143.71 48.99 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 103.952 -2.611 . . . . 0.0 103.952 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.95 159.17 51.04 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 CA-C-N 120.785 1.316 . . . . 0.0 109.227 169.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -63.56 -15.91 59.36 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.301 -0.874 . . . . 0.0 112.562 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -66.7 -19.96 65.87 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.407 2.283 . . . . 0.0 114.217 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -135.28 162.8 55.31 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-N 119.476 1.035 . . . . 0.0 111.373 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.66 133.83 26.71 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.573 2.849 . . . . 0.0 110.519 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.04 145.81 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 167.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.86 90.33 8.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.554 1.541 . . . . 0.0 108.556 -172.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -58.57 -31.97 68.49 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.531 -0.731 . . . . 0.0 109.714 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -69.65 -36.21 75.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.173 -0.954 . . . . 0.0 112.813 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.468 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -84.07 -32.67 24.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.317 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.329 0.3 OUTLIER -83.18 -23.46 32.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 117.354 -1.308 . . . . 0.0 111.289 -177.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -65.79 -48.53 71.47 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 120.729 1.604 . . . . 0.0 109.725 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -60.49 -31.63 70.66 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -159.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . 22.1 ptp -83.49 -29.01 28.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.425 HG13 HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -79.83 -44.57 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 119.348 0.977 . . . . 0.0 109.348 -177.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.34 -40.06 73.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.682 0.674 . . . . 0.0 109.533 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -71.61 -54.03 11.75 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.859 1.264 . . . . 0.0 112.036 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -65.17 -21.7 66.81 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 119.644 1.111 . . . . 0.0 111.789 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.642 ' CD1' HD21 ' A' ' 37' ' ' LEU . 47.9 mt -68.93 -54.97 17.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 118.864 0.756 . . . . 0.0 109.729 168.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -70.76 -13.46 62.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.749 0.704 . . . . 0.0 112.371 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.94 -43.46 92.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.895 1.278 . . . . 0.0 111.124 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.42 12.08 3.23 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.285 2.234 . . . . 0.0 113.564 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.529 1.532 . . . . 0.0 110.33 175.835 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 117.176 -1.393 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -47.59 -41.64 22.16 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.226 1.375 . . . . 0.0 111.19 -172.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -54.27 -39.26 66.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.404 0.682 . . . . 0.0 112.56 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.7 t -56.23 -41.52 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.478 0.711 . . . . 0.0 109.744 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -102.19 -6.48 23.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.506 1.122 . . . . 0.0 113.495 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.78 -44.81 63.36 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 123.628 0.771 . . . . 0.0 110.202 -170.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -57.32 -34.91 69.24 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.947 0.899 . . . . 0.0 111.379 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -68.55 -42.9 77.72 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.088 0.955 . . . . 0.0 111.001 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.22 -38.37 86.38 Favored 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 123.937 0.895 . . . . 0.0 110.316 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -56.24 -37.14 69.33 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 122.133 -0.354 . . . . 0.0 110.847 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.18 0.9 88.89 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.079 1.323 . . . . 0.0 113.714 -173.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 mm -66.14 149.47 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.007 1.403 . . . . 0.0 107.312 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.64 -22.88 62.46 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.075 1.35 . . . . 0.0 113.568 -170.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.4 145.18 8.66 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 126.227 1.811 . . . . 0.0 108.724 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.07 -27.66 73.85 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.939 2.426 . . . . 0.0 112.386 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.45 -15.14 47.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.778 -0.576 . . . . 0.0 111.126 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.79 15.2 11.77 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.807 -0.558 . . . . 0.0 110.839 176.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -113.59 -45.09 3.14 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 125.412 1.485 . . . . 0.0 110.883 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -70.77 -5.73 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.603 1.161 . . . . 0.0 112.937 -161.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -102.94 -25.81 13.33 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.324 1.85 . . . . 0.0 112.87 168.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m -61.45 -44.9 96.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.743 0.817 . . . . 0.0 109.522 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.64 -39.0 86.67 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.575 1.15 . . . . 0.0 111.81 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -60.01 -46.95 87.82 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.851 -0.595 . . . . 0.0 110.704 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mt -61.71 -44.91 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.997 0.919 . . . . 0.0 110.455 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.02 -48.09 82.83 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -65.79 -42.87 90.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.25 1.42 . . . . 0.0 110.466 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -63.48 -44.56 94.06 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.25 1.82 . . . . 0.0 110.976 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 t -57.17 -49.21 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.465 1.029 . . . . 0.0 109.297 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.68 2.79 0.88 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.72 -50.23 1.97 Allowed 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.795 1.238 . . . . 0.0 111.435 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 m -70.02 -26.49 64.07 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.715 1.206 . . . . 0.0 109.856 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -131.29 78.53 72.09 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.623 0.769 . . . . 0.0 111.484 -170.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.07 -5.21 16.48 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.86 3.04 . . . . 0.0 114.618 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.6 -20.84 32.99 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.011 -1.056 . . . . 0.0 112.312 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.5 mt -78.36 145.98 34.92 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -123.57 144.77 45.18 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 124.765 1.226 . . . . 0.0 108.031 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.04 162.57 36.81 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.494 2.796 . . . . 0.0 112.745 -172.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -170.04 119.89 0.62 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.212 2.205 . . . . 0.0 105.448 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ptm -95.64 127.45 41.68 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 121.28 1.855 . . . . 0.0 108.005 165.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -136.02 150.63 49.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 124.854 1.262 . . . . 0.0 109.155 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 14.5 m95 61.04 24.73 14.82 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.3 t30 74.53 -0.42 3.35 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 128.295 2.638 . . . . 0.0 111.493 -171.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.7 p -105.31 144.48 28.89 Favored Pre-proline 0 N--CA 1.45 -0.445 0 O-C-N 120.419 -1.426 . . . . 0.0 109.537 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.62 143.27 56.03 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.755 1.637 . . . . 0.0 109.107 164.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 19.1 ptm -145.87 172.75 12.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 164.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.21 152.18 45.78 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 p -129.92 114.25 15.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.444 1.098 . . . . 0.0 108.422 -167.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -70.34 91.56 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.769 1.228 . . . . 0.0 108.071 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 48.11 34.56 4.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.298 0.639 . . . . 0.0 112.507 -170.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.25 -11.39 24.24 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 117.253 -1.859 . . . . 0.0 115.861 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -74.13 -168.43 0.63 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.793 2.297 . . . . 0.0 111.385 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.437 ' H ' HG22 ' A' ' 53' ' ' THR . 36.5 t80 -129.88 18.85 5.58 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.01 1.724 . . . . 0.0 112.476 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mt -70.27 7.61 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 126.099 1.759 . . . . 0.0 111.757 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.433 HD12 HG13 ' A' ' 110' ' ' ILE . 5.3 tt -159.67 143.14 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 O-C-N 119.335 -2.103 . . . . 0.0 111.507 167.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.63 159.97 32.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 162.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -149.63 170.73 17.98 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.045 1.422 . . . . 0.0 110.068 173.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.1 t -153.72 152.95 31.37 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 168.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.1 p -78.87 127.46 32.05 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t -101.51 171.13 7.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.06 -17.92 55.05 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -167.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.46 1.12 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -158.18 154.14 26.89 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.388 0.995 . . . . 0.0 110.461 -168.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 tp -92.74 127.94 38.42 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 167.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.19 119.66 39.08 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.16 139.25 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 127.801 2.44 . . . . 0.0 108.93 -164.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 t -165.33 157.89 13.41 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 125.845 1.658 . . . . 0.0 107.516 167.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.79 -57.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.817 1.678 . . . . 0.0 111.282 161.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -145.94 -86.11 0.11 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 172.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -142.89 -32.55 0.48 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.692 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.41 -34.77 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 120.881 1.673 . . . . 0.0 111.394 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.15 -18.89 29.48 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.654 1.121 . . . . 0.0 113.26 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 mm -111.47 1.6 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 127.185 2.194 . . . . 0.0 109.925 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 m -118.57 -61.34 1.67 Allowed 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.633 -0.667 . . . . 0.0 109.376 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -74.15 -51.99 13.88 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 127.894 2.477 . . . . 0.0 107.647 -173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -85.95 4.32 38.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.605 0.762 . . . . 0.0 112.54 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.3 73.75 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.406 1.082 . . . . 0.0 112.637 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -69.99 -43.33 71.66 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.554 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -62.95 -39.11 93.64 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.829 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.21 -49.6 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.755 0.707 . . . . 0.0 109.816 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.16 69.52 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.041 0.937 . . . . 0.0 110.478 -170.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.63 -22.43 63.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.335 1.454 . . . . 0.0 112.996 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.49 -10.29 59.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.783 0.72 . . . . 0.0 112.039 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.12 11.59 56.08 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.029 0.823 . . . . 0.0 113.977 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -97.77 107.65 20.19 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.563 1.182 . . . . 0.0 111.341 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.12 98.38 0.06 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.044 2.138 . . . . 0.0 111.369 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.96 -176.26 6.24 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.638 1.175 . . . . 0.0 111.535 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 p -118.96 -164.91 1.08 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.161 1.784 . . . . 0.0 107.853 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.406 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -85.53 -9.12 57.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.06 -1.69 2.87 Favored Glycine 0 N--CA 1.462 0.395 0 CA-C-N 119.441 1.019 . . . . 0.0 112.527 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 pp -162.47 176.28 10.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.361 0.664 . . . . 0.0 110.743 170.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -119.09 164.42 15.55 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.398 -0.813 . . . . 0.0 109.495 167.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.7 158.97 44.02 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.915 -1.115 . . . . 0.0 109.58 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.58 142.82 44.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.41 153.65 50.31 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.64 1.56 . . . . 0.0 109.408 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -60.57 -21.63 62.81 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -57.66 -47.5 82.12 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.749 2.02 . . . . 0.0 112.084 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -110.58 162.48 20.43 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.356 1.062 . . . . 0.0 109.519 -161.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.39 148.54 23.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.313 1.342 . . . . 0.0 112.399 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -77.86 143.77 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.93 81.2 5.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.681 1.592 . . . . 0.0 108.468 171.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -56.79 -34.6 67.8 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.344 0.657 . . . . 0.0 110.071 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -60.13 -54.68 43.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.778 0.831 . . . . 0.0 111.288 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.554 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -58.15 -47.15 84.23 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -176.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.339 0.4 OUTLIER -69.1 -29.66 67.79 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 116.877 -1.535 . . . . 0.0 112.352 -176.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -68.98 -42.64 76.28 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 121.094 1.77 . . . . 0.0 110.901 175.213 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -58.8 -39.26 80.6 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.579 1.081 . . . . 0.0 111.953 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.3 ptp -78.73 -38.36 39.08 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 121.72 -0.612 . . . . 0.0 112.548 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -71.34 -51.32 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -173.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -56.78 -44.36 81.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.584 0.753 . . . . 0.0 110.806 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -54.96 -50.9 67.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.667 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -70.51 -1.05 9.71 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.3 mt -96.12 -47.71 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 C-N-CA 125.464 1.506 . . . . 0.0 108.137 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -68.92 -8.24 42.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.536 1.062 . . . . 0.0 112.111 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -91.56 -0.38 57.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.513 1.525 . . . . 0.0 111.762 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -112.33 5.37 18.2 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.561 2.344 . . . . 0.0 111.164 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.121 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 163.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.7 mmt -61.7 -21.29 64.35 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 117.298 -1.334 . . . . 0.0 112.498 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -65.17 -38.3 90.09 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.254 1.388 . . . . 0.0 110.669 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.28 -40.86 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -96.51 36.83 1.32 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.807 1.643 . . . . 0.0 111.156 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.17 -56.18 2.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.688 1.595 . . . . 0.0 111.682 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.6 -15.65 60.83 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -162.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -73.64 -47.24 41.5 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 125.784 1.634 . . . . 0.0 110.566 164.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.37 -45.53 93.99 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.966 0.906 . . . . 0.0 110.597 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -59.04 -15.58 14.21 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.44 0.12 46.66 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.399 1.952 . . . . 0.0 114.162 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.8 135.56 27.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 119.94 1.87 . . . . 0.0 108.013 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -35.07 79.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.852 1.661 . . . . 0.0 112.293 -175.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.15 143.81 32.35 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.46 -20.12 42.14 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.828 2.352 . . . . 0.0 111.741 172.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.05 -21.48 63.68 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.211 0.46 . . . . 0.0 109.89 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 22' ' ' ARG . 7.7 m80 -116.06 -16.6 11.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.249 0.931 . . . . 0.0 112.079 -175.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -67.05 -57.32 7.06 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 123.641 0.776 . . . . 0.0 111.356 -170.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -44.21 -61.09 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.645 1.978 . . . . 0.0 112.088 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -59.94 -38.55 82.75 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 121.403 -0.811 . . . . 0.0 112.426 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 m -52.8 -50.24 64.01 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.475 0.71 . . . . 0.0 111.347 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -55.81 -46.32 78.1 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.643 1.177 . . . . 0.0 111.121 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -62.69 -40.17 96.28 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 122.838 0.455 . . . . 0.0 111.632 -172.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 mt -57.03 -50.83 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 124.012 0.82 . . . . 0.0 109.451 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.06 -55.3 36.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.602 0.361 . . . . 0.0 110.159 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 m -71.95 -21.43 61.6 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.298 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -69.0 -44.57 72.55 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 120.265 1.393 . . . . 0.0 110.428 170.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.409 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 56.1 t -59.68 -45.6 94.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 119.478 1.035 . . . . 0.0 108.587 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.03 62.83 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.538 0.608 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.29 -61.45 2.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 122.154 -0.341 . . . . 0.0 110.311 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -74.73 -35.69 62.67 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.578 1.551 . . . . 0.0 111.746 -162.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.71 74.47 34.76 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.93 -4.27 14.71 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.567 2.178 . . . . 0.0 112.15 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -28.36 51.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.647 1.179 . . . . 0.0 111.384 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.601 HD22 ' H ' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -75.59 143.62 42.24 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.405 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -96.87 150.83 37.34 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.66 151.93 52.82 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.553 2.168 . . . . 0.0 110.577 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -156.15 130.8 8.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.623 1.569 . . . . 0.0 107.169 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -107.91 96.07 6.12 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.48 147.5 30.39 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 125.977 1.711 . . . . 0.0 107.245 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 3.9 m95 57.41 17.89 4.09 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 172.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 t30 57.76 29.48 17.48 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.861 2.464 . . . . 0.0 112.778 -167.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -126.63 144.99 51.65 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.89 134.09 22.96 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.709 2.939 . . . . 0.0 111.757 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.9 ptm -148.25 172.36 14.48 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.097 0.559 . . . . 0.0 110.52 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -132.77 148.92 52.32 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.9 112.29 11.16 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.665 1.186 . . . . 0.0 108.879 -168.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.82 97.34 1.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 44.84 38.58 2.98 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.404 1.002 . . . . 0.0 111.449 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.01 -10.43 34.18 Favored Glycine 0 CA--C 1.533 1.219 0 CA-C-O 116.771 -2.127 . . . . 0.0 117.057 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.54 -170.13 0.97 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 121.643 2.721 . . . . 0.0 111.414 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -131.54 22.43 4.71 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 119.899 -1.751 . . . . 0.0 112.434 -170.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.32 -2.88 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 127.088 2.155 . . . . 0.0 112.413 -165.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 tt -155.91 132.03 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 119.239 -2.163 . . . . 0.0 109.814 165.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.83 150.0 21.71 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 165.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.88 174.59 10.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.682 1.241 . . . . 0.0 109.935 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -152.15 161.19 43.0 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 159.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.1 p -68.64 159.01 32.89 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 m -138.5 175.04 9.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.834 1.254 . . . . 0.0 108.212 168.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.82 -60.29 2.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.418 1.087 . . . . 0.0 112.89 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -123.56 6.72 8.9 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -172.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -146.78 157.96 43.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.042 1.737 . . . . 0.0 109.332 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.1 tp -88.61 155.77 19.43 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 154.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.46 ' HB2' HD22 ' A' ' 92' ' ' LEU . 11.0 p -115.75 114.81 25.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 116.778 -1.582 . . . . 0.0 109.013 172.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 79.0 t -126.19 144.08 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.832 1.196 . . . . 0.0 110.142 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.3 t -169.21 156.92 6.9 Favored Pre-proline 0 C--O 1.239 0.536 0 C-N-CA 127.069 2.148 . . . . 0.0 108.008 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -74.79 -56.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 120.713 0.942 . . . . 0.0 111.434 161.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -156.37 -80.89 0.07 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -147.33 -30.27 0.33 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -33.81 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 120.662 1.574 . . . . 0.0 110.578 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' A' ' 77' ' ' PHE . . . -44.91 -31.93 2.96 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.016 1.293 . . . . 0.0 112.532 169.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.7 mm -104.63 -0.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.936 1.294 . . . . 0.0 110.785 -168.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.8 m -121.35 -46.41 2.29 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -38.93 36.47 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.434 2.294 . . . . 0.0 109.404 -174.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.408 ' CD1' ' HA2' ' A' ' 73' ' ' GLY . 11.2 m-85 -100.84 5.08 43.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.723 0.809 . . . . 0.0 111.498 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.33 -36.73 76.19 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.121 1.369 . . . . 0.0 111.758 -172.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -72.57 -46.77 52.72 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.625 1.17 . . . . 0.0 108.829 -175.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.76 -41.74 91.69 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.419 0.688 . . . . 0.0 111.388 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.7 mt -61.41 -46.18 97.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.038 0.835 . . . . 0.0 109.575 171.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.28 -49.19 76.65 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 123.702 0.801 . . . . 0.0 110.365 -170.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -62.18 -29.31 70.28 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.965 1.306 . . . . 0.0 112.248 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.5 -22.92 62.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.08 0.854 . . . . 0.0 111.315 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.34 16.49 7.11 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.44 1.495 . . . . 0.0 113.99 170.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -108.97 93.44 4.52 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.488 1.144 . . . . 0.0 112.487 -164.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.6 m -52.27 96.61 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.191 2.196 . . . . 0.0 112.837 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.73 177.84 8.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.927 1.691 . . . . 0.0 112.121 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -100.44 -169.51 1.73 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.405 1.882 . . . . 0.0 107.362 159.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -77.26 -24.23 51.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.818 0.847 . . . . 0.0 112.687 168.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.5 -25.62 5.15 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 123.729 0.681 . . . . 0.0 112.759 -168.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 66' ' ' SER . 4.3 pp -152.77 161.11 42.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.051 0.925 . . . . 0.0 110.057 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -98.07 163.47 12.74 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.703 -0.623 . . . . 0.0 109.523 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -117.95 163.52 16.45 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.51 147.94 67.97 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 162.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -59.83 157.44 33.23 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 121.467 1.56 . . . . 0.0 109.59 159.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -65.08 -46.47 81.01 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.48 -0.763 . . . . 0.0 111.714 166.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -71.06 -21.63 62.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -166.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.02 160.63 29.19 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.49 1.116 . . . . 0.0 108.841 -172.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.71 144.4 19.51 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.614 1.543 . . . . 0.0 112.789 -163.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -84.14 123.96 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.415 1.886 . . . . 0.0 109.339 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -78.29 78.77 4.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.384 1.874 . . . . 0.0 112.917 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -51.98 -47.27 64.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.405 1.082 . . . . 0.0 110.423 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -68.9 -24.89 64.37 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -170.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.27 -56.3 5.75 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.508 1.123 . . . . 0.0 108.69 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.87 -23.75 62.37 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.946 -171.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -50.21 -53.98 24.2 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 127.065 2.146 . . . . 0.0 110.346 162.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -60.51 -47.53 85.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.873 0.76 . . . . 0.0 110.036 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 17.9 ptp -78.36 16.98 0.7 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.274 0.1 OUTLIER -117.12 -47.77 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 O-C-N 120.375 -1.453 . . . . 0.0 107.382 162.389 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.43 -53.27 60.08 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 111.994 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.39 -46.17 90.92 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 121.72 -0.613 . . . . 0.0 109.443 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -29.39 68.85 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.71 0.804 . . . . 0.0 111.539 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.558 HD11 HD11 ' A' ' 37' ' ' LEU . 38.9 mt -75.06 -59.68 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 125.703 1.601 . . . . 0.0 109.728 171.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -66.86 -18.47 65.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.942 0.792 . . . . 0.0 111.71 -168.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.77 -14.04 62.77 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.907 1.283 . . . . 0.0 112.496 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -119.01 20.4 12.73 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 127.024 2.13 . . . . 0.0 111.153 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 123.585 0.754 . . . . 0.0 110.007 -177.62 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.9 mmt -54.14 -27.88 36.32 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.002 0.921 . . . . 0.0 112.232 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -55.26 -60.64 3.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.388 1.475 . . . . 0.0 111.732 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.21 -38.93 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.732 1.213 . . . . 0.0 111.029 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -88.09 -15.13 37.04 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.166 0.586 . . . . 0.0 112.367 -169.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.11 78.45 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.223 1.009 . . . . 0.0 111.535 -175.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.88 -9.05 13.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.12 1.368 . . . . 0.0 113.383 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -112.59 -35.87 5.39 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.981 0.912 . . . . 0.0 110.832 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.3 mt -52.97 -33.68 52.33 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.481 -0.762 . . . . 0.0 111.168 170.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -54.62 -35.5 63.47 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.272 1.029 . . . . 0.0 113.671 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.1 -0.1 56.07 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-O 118.923 -0.932 . . . . 0.0 112.78 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.51 91.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -2.35 0.96 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.58 2.352 . . . . 0.0 113.294 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -114.47 67.02 1.73 Allowed Pre-proline 0 N--CA 1.444 -0.768 0 C-N-CA 129.055 2.942 . . . . 0.0 109.408 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.5 -21.91 65.71 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.862 3.041 . . . . 0.0 113.24 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -71.18 -4.67 26.77 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.727 1.611 . . . . 0.0 112.18 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.0 16.78 1.22 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.45 1.1 . . . . 0.0 110.06 -175.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -87.55 -47.84 8.39 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.092 1.357 . . . . 0.0 109.693 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -55.58 -30.04 60.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.516 2.326 . . . . 0.0 112.938 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -58.52 -38.22 77.25 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.887 -1.133 . . . . 0.0 111.145 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.6 m -66.85 -39.63 87.66 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.362 0.665 . . . . 0.0 109.668 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.1 -44.8 83.57 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.418 1.487 . . . . 0.0 110.622 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -61.17 -44.39 97.39 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.74 0.416 . . . . 0.0 109.974 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.7 mt -61.31 -49.99 82.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.985 1.314 . . . . 0.0 109.109 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.79 -41.37 91.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.477 0.711 . . . . 0.0 109.79 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -65.09 -43.96 90.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.913 0.885 . . . . 0.0 110.868 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.537 ' HZ3' HD11 ' A' ' 106' ' ' LEU . 68.0 t90 -66.93 -38.66 86.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.884 1.274 . . . . 0.0 111.81 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.0 t -61.28 -43.67 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 O-C-N 121.415 -0.803 . . . . 0.0 109.553 175.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.67 -25.03 67.94 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.153 0.581 . . . . 0.0 111.519 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 -70.16 0.59 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.217 1.007 . . . . 0.0 109.543 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.2 m -67.87 -29.48 68.6 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.783 -0.627 . . . . 0.0 112.225 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -123.15 58.34 12.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.167 0.894 . . . . 0.0 110.267 -171.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.09 -18.88 45.74 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.907 3.071 . . . . 0.0 114.983 -160.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -79.0 -7.2 57.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.164 0.893 . . . . 0.0 111.862 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.47 141.07 38.51 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.579 1.081 . . . . 0.0 108.605 165.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -116.42 154.29 48.94 Favored Pre-proline 0 C--N 1.328 -0.362 0 C-N-CA 124.937 1.295 . . . . 0.0 110.39 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.33 138.74 30.73 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.628 2.885 . . . . 0.0 110.337 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -165.56 82.73 0.33 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.05 140.71 54.91 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.057 -1.027 . . . . 0.0 108.694 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -150.15 153.27 36.04 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 124.741 1.217 . . . . 0.0 108.426 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.3 m95 51.6 31.55 7.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.68 0.792 . . . . 0.0 112.256 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 t30 59.12 18.34 6.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.562 1.945 . . . . 0.0 113.784 -173.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -114.13 127.12 27.16 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.727 1.611 . . . . 0.0 107.106 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.13 114.77 3.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.686 2.257 . . . . 0.0 109.978 170.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.6 ptm -130.79 173.66 10.72 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.349 1.06 . . . . 0.0 109.259 173.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -135.18 132.21 37.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.1 p -92.05 125.12 36.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.084 0.954 . . . . 0.0 108.564 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -74.54 85.94 2.07 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 161.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.268 20.8 mt-30 63.19 -15.23 0.06 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.145 1.778 . . . . 0.0 115.605 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.74 -13.01 0.03 OUTLIER Glycine 0 CA--C 1.544 1.859 0 C-N-CA 126.938 2.208 . . . . 0.0 115.094 170.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.84 -165.79 1.15 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.765 1.226 . . . . 0.0 113.237 -163.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.48 29.32 4.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.14 2.176 . . . . 0.0 109.762 -173.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.2 mt -67.72 -19.73 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.527 1.131 . . . . 0.0 112.118 -168.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.4 tt -155.02 136.59 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 120.236 1.38 . . . . 0.0 110.263 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.92 157.08 27.35 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 166.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -138.72 168.84 18.92 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.222 -1.163 . . . . 0.0 109.104 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 81.4 p -150.2 144.13 25.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.8 p -91.28 155.3 18.64 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -173.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 t -135.16 177.99 7.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.113 1.365 . . . . 0.0 108.474 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -49.34 -65.67 0.53 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.059 1.343 . . . . 0.0 109.571 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.408 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 90.2 m-70 -116.2 13.06 15.62 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -172.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -153.83 166.46 32.83 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.901 0.773 . . . . 0.0 111.571 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.1 tp -97.99 158.53 15.48 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 162.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . 4.0 m -126.7 120.62 29.87 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.184 0.902 . . . . 0.0 109.859 174.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.88 140.9 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.189 1.796 . . . . 0.0 109.222 -161.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.2 t -167.43 157.02 9.42 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 127.68 2.392 . . . . 0.0 105.883 168.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.13 -57.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.059 0 CA-C-N 120.65 1.268 . . . . 0.0 108.957 166.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -145.34 -86.18 0.12 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -139.49 -29.57 0.74 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.016 1.327 . . . . 0.0 112.499 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.17 -29.16 45.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 119.192 0.905 . . . . 0.0 111.439 -172.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.16 -24.63 15.94 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.872 2.177 . . . . 0.0 113.205 171.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 92' ' ' LEU . 18.3 mm -107.74 -6.98 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 127.082 2.153 . . . . 0.0 110.171 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -92.35 -85.46 0.26 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -83.83 -45.71 12.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -169.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -67.84 -22.43 65.14 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.112 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.53 -32.14 57.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.196 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -67.33 -45.2 77.14 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.433 0.693 . . . . 0.0 110.05 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.01 89.49 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.932 -1.105 . . . . 0.0 110.819 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.3 mt -66.62 -43.04 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 118.653 0.66 . . . . 0.0 109.722 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.35 89.42 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 124.643 1.177 . . . . 0.0 109.862 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -65.1 -24.65 67.49 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.679 1.191 . . . . 0.0 111.74 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.4 -29.23 41.9 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.353 0.979 . . . . 0.0 110.904 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 142.18 -31.37 2.07 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.999 1.762 . . . . 0.0 112.599 165.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -81.15 102.18 10.13 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.965 1.383 . . . . 0.0 109.76 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.4 m -69.8 9.7 0.49 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 58.47 -172.97 0.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.36 2.264 . . . . 0.0 112.065 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.5 p -110.89 179.31 4.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.85 1.66 . . . . 0.0 106.93 158.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -66.86 27.89 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.734 2.413 . . . . 0.0 113.323 164.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.1 -35.57 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 CA-C-O 118.287 -1.285 . . . . 0.0 114.88 -168.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HA ' HD11 ' A' ' 74' ' ' ILE . 1.1 pp -161.47 173.6 14.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.214 1.007 . . . . 0.0 112.077 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -108.88 119.67 40.23 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 120.89 -1.131 . . . . 0.0 110.37 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.27 138.65 42.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.98 143.81 31.58 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 169.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.55 156.84 29.63 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.439 2.092 . . . . 0.0 110.715 170.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.408 ' CD1' ' HA ' ' A' ' 63' ' ' HIS . 9.0 m95 -59.64 -25.63 64.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.402 168.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.99 -67.91 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.713 0.688 . . . . 0.0 110.796 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.9 164.96 44.16 Favored Pre-proline 0 N--CA 1.465 0.295 0 C-N-CA 124.409 1.083 . . . . 0.0 111.707 -168.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.92 139.42 12.13 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.086 1.191 . . . . 0.0 112.814 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.2 t -72.84 115.83 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -68.42 89.4 0.35 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.054 1.342 . . . . 0.0 111.418 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -58.1 -39.54 78.88 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 124.831 1.253 . . . . 0.0 109.897 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -66.91 -38.64 86.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.719 1.207 . . . . 0.0 113.406 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -48.3 55.71 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.537 HD11 ' HZ3' ' A' ' 29' ' ' TRP 0.285 0.4 OUTLIER -71.11 -26.52 63.06 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.973 -173.439 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -66.73 -43.09 85.15 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.117 -1.42 . . . . 0.0 111.001 171.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -53.45 -52.21 60.19 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.338 1.426 . . . . 0.0 109.677 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.7 ptp -63.02 -47.38 83.32 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.858 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -43.01 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 120.306 1.412 . . . . 0.0 110.736 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -63.01 -44.81 94.97 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.411 0.551 . . . . 0.0 110.441 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -56.23 -45.99 79.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.847 0.459 . . . . 0.0 110.623 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.66 -22.19 65.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.054 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.6 mt -82.17 -47.53 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 119.613 1.097 . . . . 0.0 109.626 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -71.0 -19.27 62.54 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.23 0.923 . . . . 0.0 111.491 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.24 -28.83 57.3 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.101 1.761 . . . . 0.0 110.892 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -106.21 43.04 1.18 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 126.18 1.792 . . . . 0.0 108.054 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--O 1.246 0.889 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.811 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.285 22.3 p-80 . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mmt -50.26 -43.99 53.5 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.899 1.679 . . . . 0.0 109.691 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -54.46 -32.84 58.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.21 -33.0 19.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 123.002 0.521 . . . . 0.0 111.125 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -113.57 32.84 5.52 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.685 1.994 . . . . 0.0 113.73 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.57 -15.33 10.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 121.787 2.085 . . . . 0.0 113.747 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.7 -24.42 21.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -35.87 59.01 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -173.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.484 HD12 HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -57.27 -37.09 71.85 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.9 1.28 . . . . 0.0 112.074 176.592 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -54.35 -39.61 67.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.819 0.736 . . . . 0.0 110.74 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.88 -7.4 75.44 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.247 1.403 . . . . 0.0 113.997 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.484 HD12 HD12 ' A' ' 11' ' ' LEU . 18.8 mt -86.46 102.87 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.93 -8.4 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.569 1.147 . . . . 0.0 113.452 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.48 84.99 0.68 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.688 1.995 . . . . 0.0 111.18 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.77 -20.44 58.9 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.707 2.938 . . . . 0.0 114.241 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.27 -17.04 63.24 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.114 0.416 . . . . 0.0 110.545 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -128.16 -33.97 2.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.177 0.991 . . . . 0.0 111.268 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -48.52 -54.65 13.56 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.301 1.041 . . . . 0.0 109.849 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -13.15 34.55 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.11 1.364 . . . . 0.0 113.178 -175.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -88.32 -51.95 5.47 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.934 1.243 . . . . 0.0 108.36 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.1 m -46.56 -43.31 17.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.608 1.963 . . . . 0.0 112.685 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -71.94 -28.17 63.29 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.366 1.466 . . . . 0.0 112.592 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.13 -47.0 78.64 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.669 -0.644 . . . . 0.0 109.852 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -54.91 -45.71 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 46' ' ' PRO . 21.6 mt -59.22 -52.26 66.44 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.375 0.27 . . . . 0.0 110.969 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 p -62.09 -41.12 97.88 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.622 0.769 . . . . 0.0 112.961 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -56.49 -59.03 5.57 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.913 1.685 . . . . 0.0 109.96 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.6 t -50.53 -48.04 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 120.245 1.384 . . . . 0.0 111.182 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.79 -16.41 64.24 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.54 -54.83 3.98 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.868 0.867 . . . . 0.0 110.669 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -34.26 77.65 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.693 0.797 . . . . 0.0 111.669 -171.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.36 69.62 81.33 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.733 1.213 . . . . 0.0 108.388 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.82 -6.42 18.12 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.035 3.157 . . . . 0.0 115.044 -162.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -73.75 -14.45 61.13 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 120.036 1.289 . . . . 0.0 112.152 168.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.6 mt -75.66 135.15 40.44 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 120.944 -1.097 . . . . 0.0 110.948 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -110.99 149.79 40.95 Favored Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 126.537 1.935 . . . . 0.0 109.203 175.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.08 159.99 40.42 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.895 2.397 . . . . 0.0 111.523 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -158.16 111.83 2.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.209 1.003 . . . . 0.0 108.529 166.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.99 95.38 1.58 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 165.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -118.48 147.42 43.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.5 m95 53.16 23.32 3.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.8 t30 62.23 15.91 7.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.788 1.235 . . . . 0.0 112.327 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 p -121.31 150.23 53.7 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HB2' HD21 ' A' ' 27' ' ' LEU . 72.8 Cg_endo -76.25 113.11 3.62 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.93 2.42 . . . . 0.0 110.564 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.1 ptm -119.18 172.7 7.4 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 166.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.3 139.62 48.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -102.34 127.7 49.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -71.41 87.76 0.87 Allowed 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 166.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 58.75 -8.95 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.156 2.582 . . . . 0.0 114.655 -177.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.47 -11.97 0.06 OUTLIER Glycine 0 CA--C 1.543 1.782 0 C-N-CA 126.745 2.117 . . . . 0.0 114.179 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -84.58 -169.86 2.83 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.374 1.587 . . . . 0.0 111.651 -174.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.507 ' H ' HG22 ' A' ' 53' ' ' THR . 78.4 t80 -125.43 19.19 8.13 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.696 1.998 . . . . 0.0 111.744 -177.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 113' ' ' ASN . 17.4 mt -65.35 4.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 126.852 2.061 . . . . 0.0 113.375 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 tt -156.66 142.53 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 118.465 -2.647 . . . . 0.0 111.085 165.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.47 148.57 17.5 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 166.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -149.85 171.97 15.91 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.257 1.423 . . . . 0.0 108.523 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.18 162.05 41.05 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 166.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 p -61.03 152.92 26.7 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.408 0.623 . . . . 0.0 110.261 167.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -132.89 171.13 14.34 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.412 1.885 . . . . 0.0 106.504 163.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -49.41 -49.67 43.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.606 1.562 . . . . 0.0 112.158 -171.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -129.39 7.79 5.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.48 1.112 . . . . 0.0 112.82 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -147.26 169.56 19.13 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.171 -0.956 . . . . 0.0 110.541 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.5 tp -102.77 147.03 27.37 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 162.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB3' HD13 ' A' ' 92' ' ' LEU . 1.5 m -121.81 125.41 46.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.234 0.925 . . . . 0.0 109.394 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.6 t -136.19 141.55 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 127.316 2.246 . . . . 0.0 109.156 -157.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 t -167.72 152.08 6.37 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.802 1.641 . . . . 0.0 108.7 168.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.64 -56.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.7 1.6 . . . . 0.0 111.679 164.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -139.75 -86.0 0.22 Allowed 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -143.14 -33.97 0.43 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.041 0.936 . . . . 0.0 112.746 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.1 tt -61.05 -33.64 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 120.039 1.29 . . . . 0.0 111.569 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -50.45 -22.37 5.3 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.249 1.404 . . . . 0.0 113.112 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.8 mm -110.69 -1.85 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 126.41 1.884 . . . . 0.0 110.157 -171.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.3 m -118.27 -51.31 2.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.163 0.985 . . . . 0.0 110.509 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -84.06 -58.28 2.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 127.431 2.293 . . . . 0.0 107.43 -173.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.55 0.26 17.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.072 1.349 . . . . 0.0 111.314 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.63 -40.3 78.89 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.855 1.262 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -72.8 -35.78 67.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.62 0.646 . . . . 0.0 109.535 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.25 82.3 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.498 0.719 . . . . 0.0 109.632 170.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.69 -44.89 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.108 0.963 . . . . 0.0 110.333 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.99 -55.84 29.49 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.167 0.987 . . . . 0.0 108.952 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -68.11 -15.86 63.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.692 0.797 . . . . 0.0 113.104 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.63 -16.18 52.26 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.399 1.0 . . . . 0.0 111.092 172.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.36 19.54 9.29 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 124.276 0.941 . . . . 0.0 113.998 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -119.81 99.45 6.64 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.028 1.414 . . . . 0.0 111.455 -166.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.9 m -56.55 117.01 3.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.904 1.281 . . . . 0.0 110.176 172.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.41 -168.18 1.55 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.34 1.856 . . . . 0.0 110.668 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 p -120.06 -164.78 1.11 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.75 1.62 . . . . 0.0 107.217 163.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -88.69 -20.48 24.8 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.06 0.846 . . . . 0.0 111.981 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.74 5.68 5.82 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.989 -0.895 . . . . 0.0 114.174 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.441 HD13 ' HB3' ' A' ' 66' ' ' SER . 1.5 pp -156.34 169.66 24.07 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.873 1.337 . . . . 0.0 110.104 158.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -118.68 179.17 4.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.801 1.24 . . . . 0.0 109.52 170.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -140.49 170.77 15.17 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.071 -1.018 . . . . 0.0 113.341 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 mp -135.97 142.85 41.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 160.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.53 160.46 47.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.705 1.603 . . . . 0.0 109.414 166.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -73.47 -23.15 60.04 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -65.59 -67.93 0.4 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.663 0.785 . . . . 0.0 110.455 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.48 165.69 51.5 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.481 1.512 . . . . 0.0 111.593 -164.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.78 145.46 40.98 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.624 1.55 . . . . 0.0 112.765 -170.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.45 126.31 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.28 76.04 7.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 168.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -56.94 -32.96 66.51 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 123.367 0.667 . . . . 0.0 109.433 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.46 -48.54 81.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.46 0.704 . . . . 0.0 111.913 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.73 -42.57 73.8 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 122.522 1.153 . . . . 0.0 109.514 -169.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.276 0.5 OUTLIER -70.54 -30.9 67.76 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.747 176.365 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -58.45 -51.35 70.21 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.778 1.172 . . . . 0.0 110.641 166.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -51.76 -49.48 62.55 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.822 0.849 . . . . 0.0 109.889 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -69.39 -47.67 63.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.93 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -45.56 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 120.452 1.478 . . . . 0.0 109.919 -175.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.58 -47.63 81.58 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.193 0.997 . . . . 0.0 110.968 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -60.53 -46.22 90.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.028 -0.42 . . . . 0.0 110.792 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.452 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 3.0 m120 -64.16 -20.98 66.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.657 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.1 mt -71.46 -56.45 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 169.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.05 -15.2 63.49 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.933 0.788 . . . . 0.0 112.396 -173.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.76 -10.55 59.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.535 1.134 . . . . 0.0 112.708 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -114.7 21.37 14.5 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.749 2.02 . . . . 0.0 110.959 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.84 174.63 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.288 9.4 p-80 . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.7 mmt -44.65 -46.28 10.1 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 126.04 1.736 . . . . 0.0 110.747 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.93 -31.61 72.63 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -168.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.5 t -58.15 -45.87 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.436 1.094 . . . . 0.0 108.701 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -91.58 -9.3 44.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.237 1.415 . . . . 0.0 112.37 -170.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.4 -33.06 70.94 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.468 1.107 . . . . 0.0 111.431 -171.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -68.8 -15.72 63.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.789 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -79.23 -52.96 7.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 166.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -49.18 -45.12 43.68 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.498 1.119 . . . . 0.0 111.791 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -62.46 -25.2 67.86 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 118.051 0.387 . . . . 0.0 111.816 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.35 -2.29 60.46 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.279 1.418 . . . . 0.0 113.577 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 16' ' ' HIS . 54.3 mt -77.84 111.65 14.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 CA-C-N 120.08 1.94 . . . . 0.0 107.369 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -1.07 24.14 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.601 0.76 . . . . 0.0 112.714 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.478 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.2 m170 -110.39 78.83 1.51 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 127.837 2.455 . . . . 0.0 110.021 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -61.11 -32.36 91.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.718 2.278 . . . . 0.0 112.436 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.446 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 36.9 m-20 -68.85 -1.55 7.48 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.398 0.999 . . . . 0.0 111.724 -173.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 14.3 m80 -135.88 -38.38 0.72 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.072 1.749 . . . . 0.0 110.498 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.4 ttp85 -46.14 -54.35 8.78 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 123.898 0.879 . . . . 0.0 109.42 166.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -53.14 -38.69 62.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.784 0.833 . . . . 0.0 112.194 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.67 -45.09 91.68 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.437 -0.789 . . . . 0.0 109.724 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.415 ' HA ' HD13 ' A' ' 26' ' ' ILE . 3.0 m -60.91 -35.21 76.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.13 1.772 . . . . 0.0 111.01 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -59.83 -38.45 82.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.693 1.133 . . . . 0.0 110.484 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -59.81 -46.47 89.13 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.566 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 23' ' ' THR . 2.9 mp -54.33 -52.07 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.48 -57.45 12.25 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 122.833 0.453 . . . . 0.0 110.017 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 m -60.66 -43.01 98.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 123.652 0.595 . . . . 0.0 110.454 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -62.87 -41.42 99.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.75 0.82 . . . . 0.0 110.772 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.534 HG11 ' CE2' ' A' ' 48' ' ' PHE . 26.5 t -58.33 -60.05 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.897 0.771 . . . . 0.0 109.874 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.09 -21.91 66.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.82 0.737 . . . . 0.0 112.597 -174.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.77 -62.38 1.47 Allowed 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.653 0.781 . . . . 0.0 111.562 171.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.3 m -72.27 -35.13 68.66 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.69 1.596 . . . . 0.0 110.753 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -120.65 66.68 13.41 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 124.714 1.206 . . . . 0.0 108.841 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -68.48 -11.63 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.029 1.819 . . . . 0.0 112.362 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -76.18 4.92 7.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.86 0.864 . . . . 0.0 112.477 171.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.42 141.08 36.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.298 1.039 . . . . 0.0 108.277 171.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -122.39 143.95 40.79 Favored Pre-proline 0 C--O 1.239 0.504 0 C-N-CA 124.691 1.196 . . . . 0.0 110.014 -173.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.99 148.04 21.59 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.518 2.812 . . . . 0.0 112.637 -165.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -155.25 119.45 4.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.431 0.693 . . . . 0.0 109.503 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -83.24 113.33 20.6 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 165.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt -150.88 154.99 38.24 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.511 1.125 . . . . 0.0 108.394 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.8 m95 49.77 24.65 1.3 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.659 1.584 . . . . 0.0 113.322 -168.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.48 21.7 8.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.078 1.351 . . . . 0.0 112.186 -171.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.2 p -118.77 158.15 48.29 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 125.783 1.633 . . . . 0.0 109.405 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.25 110.9 2.8 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.281 3.32 . . . . 0.0 110.499 169.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 19.2 ptm -117.73 170.04 9.1 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.054 0.93 . . . . 0.0 109.292 165.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CE2' HG11 ' A' ' 30' ' ' VAL . 0.6 OUTLIER -132.36 176.64 8.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 166.242 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.8 m -143.13 139.62 30.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -71.63 97.58 1.75 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 161.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.297 21.7 mt-30 59.78 -11.72 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.574 2.75 . . . . 0.0 116.711 174.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.69 -3.45 0.05 OUTLIER Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.526 2.488 . . . . 0.0 114.541 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.59 -166.14 0.25 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 120.406 2.103 . . . . 0.0 111.799 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -126.73 20.95 7.08 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 119.569 -1.957 . . . . 0.0 111.639 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.5 mt -71.19 15.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 O-C-N 120.29 -1.506 . . . . 0.0 111.802 -169.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 tt -160.5 146.22 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 118.62 -2.55 . . . . 0.0 110.799 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.2 144.26 8.89 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 162.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -137.0 174.24 10.84 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.094 1.447 . . . . 0.0 110.043 171.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.5 t -155.76 159.57 39.57 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 160.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.2 p -63.05 144.13 57.17 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 162.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t -120.19 172.81 7.51 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 162.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -58.45 -44.67 89.3 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 121.499 -0.751 . . . . 0.0 110.737 -163.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -137.44 37.12 2.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.881 0.872 . . . . 0.0 111.918 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -166.57 167.16 15.7 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.418 1.487 . . . . 0.0 109.801 171.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -98.74 157.25 16.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.656 1.182 . . . . 0.0 107.922 162.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.422 ' HB2' HD22 ' A' ' 92' ' ' LEU . 34.3 p -119.03 125.41 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.717 1.207 . . . . 0.0 108.604 169.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.7 t -135.46 141.7 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 119.619 1.1 . . . . 0.0 108.643 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -173.23 151.49 2.07 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.09 1.756 . . . . 0.0 107.368 175.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.65 -57.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 119.786 0.959 . . . . 0.0 112.318 165.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -149.49 -86.73 0.08 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -142.45 -32.57 0.49 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.836 1.254 . . . . 0.0 111.745 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.0 tt -63.32 -31.29 52.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 118.817 0.735 . . . . 0.0 110.934 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.69 -24.47 12.61 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 127.247 2.356 . . . . 0.0 113.263 173.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.9 mm -120.6 -3.5 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.98 1.312 . . . . 0.0 110.492 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.0 t -80.02 -71.76 0.44 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -88.65 -41.71 12.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.655 -0.653 . . . . 0.0 109.248 -166.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -71.95 -10.34 59.64 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.091 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.56 -27.39 57.62 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -72.93 -42.44 63.47 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.887 0.851 . . . . 0.0 110.406 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.61 -38.18 90.13 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.426 -0.796 . . . . 0.0 110.843 172.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.7 mt -59.91 -50.6 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.226 1.011 . . . . 0.0 108.926 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.18 -47.4 65.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.82 1.248 . . . . 0.0 111.386 -175.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.43 -30.15 68.28 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.586 1.155 . . . . 0.0 112.987 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.36 -15.8 61.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.378 0.99 . . . . 0.0 111.651 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.23 -14.57 43.74 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 125.339 1.447 . . . . 0.0 113.002 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -73.7 161.85 29.81 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 173.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.48 5.02 5.14 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.471 1.032 . . . . 0.0 113.689 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 55.94 -159.07 0.22 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.856 1.662 . . . . 0.0 111.728 -169.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.5 p -119.38 -164.38 1.05 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.19 2.996 . . . . 0.0 104.815 159.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -70.69 -31.19 67.98 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.068 1.303 . . . . 0.0 113.043 171.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.35 -20.46 1.59 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -162.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 66' ' ' SER . 4.2 pp -137.35 167.98 20.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 121.197 -1.178 . . . . 0.0 110.026 169.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -112.38 150.27 31.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -140.73 145.37 36.36 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 101' ' ' VAL . 0.8 OUTLIER -133.51 143.72 49.11 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -176.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 161.45 42.29 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 121.706 1.645 . . . . 0.0 110.604 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -65.99 -15.28 62.88 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -63.44 -38.9 92.91 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.464 1.106 . . . . 0.0 110.846 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.52 158.46 33.7 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 123.76 0.824 . . . . 0.0 110.127 -156.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.08 126.08 10.88 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.887 2.391 . . . . 0.0 108.197 166.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.439 ' HA ' HD12 ' A' ' 95' ' ' ILE . 5.1 m -78.98 18.16 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.297 0.3 OUTLIER 50.73 78.0 0.11 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.948 2.899 . . . . 0.0 113.492 177.074 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -69.42 -48.75 60.04 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.944 2.098 . . . . 0.0 111.674 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -58.94 -36.35 74.62 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.01 0.924 . . . . 0.0 111.383 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -50.53 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.579 0.704 . . . . 0.0 110.067 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.289 0.3 OUTLIER -71.29 -29.4 65.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.535 0.734 . . . . 0.0 112.765 -174.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -64.19 -39.36 93.83 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.404 -1.284 . . . . 0.0 110.312 172.238 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -57.91 -49.47 76.65 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.337 1.426 . . . . 0.0 110.444 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.5 ptp -69.51 -45.16 69.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.191 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -70.63 -46.62 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.697 1.135 . . . . 0.0 110.122 -175.355 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.13 -31.16 72.24 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.504 1.047 . . . . 0.0 111.998 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.07 -53.42 25.75 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 118.06 0.391 . . . . 0.0 110.358 169.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.72 -18.13 64.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.487 -170.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.05 -71.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 124.983 1.313 . . . . 0.0 108.812 158.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -66.18 -13.41 60.19 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -165.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -77.16 -12.07 59.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.78 2.032 . . . . 0.0 113.13 174.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -129.37 3.9 5.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.268 2.227 . . . . 0.0 110.476 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.251 24.0 tt0 . . . . . 0 C--O 1.255 1.383 0 C-N-CA 128.966 2.906 . . . . 0.0 115.022 166.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.293 8.3 p-80 . . . . . 0 N--CA 1.464 0.257 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mmt -44.74 -49.48 10.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 128.42 2.688 . . . . 0.0 110.349 -170.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.74 -31.15 58.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.433 1.093 . . . . 0.0 112.126 -169.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.09 -45.13 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 123.97 0.908 . . . . 0.0 110.535 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -96.85 -8.72 30.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.226 2.21 . . . . 0.0 112.649 -170.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.77 -12.32 60.31 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 126.231 1.812 . . . . 0.0 112.182 -160.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.482 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 27.4 mt-10 -111.4 -27.46 8.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.554 1.942 . . . . 0.0 109.184 -168.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.68 -34.63 69.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.02 -47.7 44.3 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.862 1.265 . . . . 0.0 112.611 173.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 1.4 mppt? -61.74 -27.09 68.47 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.829 1.195 . . . . 0.0 113.403 176.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.6 -12.47 84.37 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.874 -0.959 . . . . 0.0 113.028 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 16' ' ' HIS . 53.1 mt -76.08 113.02 14.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 119.742 1.771 . . . . 0.0 106.682 168.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -79.19 -4.11 48.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 122.055 0.931 . . . . 0.0 113.478 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.426 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.3 m-70 -100.15 85.91 0.57 Allowed Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 127.645 2.378 . . . . 0.0 111.702 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -62.56 -38.58 50.4 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.861 2.374 . . . . 0.0 111.349 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.21 10.75 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.815 1.246 . . . . 0.0 111.162 -172.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -135.5 -38.8 0.74 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.018 0.927 . . . . 0.0 111.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -43.77 83.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 116.492 -1.718 . . . . 0.0 114.688 -176.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -45.21 -42.89 9.76 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.028 1.285 . . . . 0.0 112.006 -172.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -45.5 79.02 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.041 2.136 . . . . 0.0 111.971 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.0 m -59.71 -37.64 79.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.212 1.405 . . . . 0.0 109.744 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.09 -36.2 81.46 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 124.325 1.05 . . . . 0.0 110.788 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -59.84 -46.7 88.45 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.426 0.69 . . . . 0.0 109.722 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 mt -60.13 -44.76 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.021 0.929 . . . . 0.0 109.502 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.0 mt -58.05 -55.27 37.08 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.936 0.789 . . . . 0.0 110.054 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.4 m -62.4 -33.14 74.19 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.451 1.1 . . . . 0.0 113.202 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -73.2 -44.18 60.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.566 -0.709 . . . . 0.0 111.03 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.55 -53.89 38.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.16 -26.19 66.12 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.61 -50.96 8.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.545 0.738 . . . . 0.0 111.034 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.3 m -72.74 -40.39 66.11 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.534 0.734 . . . . 0.0 110.811 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.85 65.63 55.04 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.2 1.0 . . . . 0.0 109.99 -172.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.62 -6.74 19.6 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.09 2.527 . . . . 0.0 114.019 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.31 -16.27 61.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.479 1.036 . . . . 0.0 111.124 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.09 134.71 47.24 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 165.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.92 146.88 32.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.78 147.45 75.29 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.123 1.882 . . . . 0.0 109.787 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -156.57 109.53 2.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.471 -0.768 . . . . 0.0 109.353 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 75.6 mmm -76.54 131.12 38.78 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 161.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -139.17 139.92 37.7 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.0 m95 64.92 0.24 1.16 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 t30 74.58 14.7 3.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.576 2.75 . . . . 0.0 113.37 -162.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.3 p -107.84 147.17 34.93 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.89 138.06 27.94 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.507 2.138 . . . . 0.0 110.494 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.6 ptm -144.05 -179.59 6.59 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 162.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -140.16 161.1 38.44 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 p -125.19 114.36 18.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.154 0.582 . . . . 0.0 110.073 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -71.03 97.17 1.41 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 44.4 48.6 8.17 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.466 1.506 . . . . 0.0 111.758 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.52 35.67 25.3 Favored Glycine 0 CA--C 1.535 1.315 0 O-C-N 121.23 -0.919 . . . . 0.0 114.742 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.7 m -112.85 -164.78 0.94 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 119.339 1.57 . . . . 0.0 109.617 170.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.46 ' H ' HG22 ' A' ' 53' ' ' THR . 46.3 t80 -129.64 13.19 5.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.275 1.83 . . . . 0.0 111.668 -174.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.9 0.94 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 128.797 2.839 . . . . 0.0 113.502 -167.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 tt -157.36 140.74 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 118.956 -2.34 . . . . 0.0 112.101 165.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.39 165.92 29.07 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.142 1.353 . . . . 0.0 110.324 166.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -157.71 176.15 12.97 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.685 0.755 . . . . 0.0 111.464 165.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.14 155.36 22.82 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 165.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.0 p -63.34 127.87 33.25 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.36 173.8 12.11 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 164.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -66.26 -26.78 67.51 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.858 -1.151 . . . . 0.0 112.971 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -140.59 5.45 2.01 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.852 1.261 . . . . 0.0 113.175 -173.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -157.55 -179.76 8.48 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.097 1.759 . . . . 0.0 106.727 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tt -119.74 133.97 55.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.44 125.62 50.8 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.549 -175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.1 t -142.72 152.59 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 120.45 1.477 . . . . 0.0 109.82 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.8 t -161.23 165.16 17.4 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.805 2.042 . . . . 0.0 107.31 165.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -87.04 -56.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.401 2.067 . . . . 0.0 111.514 165.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -145.63 -80.86 0.16 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.69 -36.12 0.22 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.198 1.399 . . . . 0.0 111.772 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.0 tt -60.87 -32.34 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.803 0.729 . . . . 0.0 110.787 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.85 -17.81 44.3 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.386 1.946 . . . . 0.0 113.843 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.9 mm -113.65 -0.66 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.534 1.934 . . . . 0.0 108.792 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 t -90.85 -85.15 0.23 Allowed 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.951 1.3 . . . . 0.0 108.134 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -81.29 -43.18 19.53 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.844 0.857 . . . . 0.0 108.979 -170.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -71.81 -14.4 61.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.864 -0.523 . . . . 0.0 112.104 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.84 -32.71 70.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.511 0.724 . . . . 0.0 112.249 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.15 -45.85 83.29 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.91 82.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.82 1.248 . . . . 0.0 110.827 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.2 mt -58.11 -46.87 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.63 75.84 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.917 -0.489 . . . . 0.0 111.012 -171.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -65.41 -24.08 67.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.887 1.275 . . . . 0.0 113.191 -172.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.24 -47.21 83.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.66 55.59 0.04 OUTLIER Glycine 0 C--N 1.333 0.391 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -135.26 171.19 14.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.09 0.956 . . . . 0.0 109.427 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.8 m -130.4 106.99 8.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.58 1.552 . . . . 0.0 107.953 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.76 -178.09 3.04 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.36 0.6 . . . . 0.0 111.363 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 p -107.61 -164.66 0.99 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 162.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 11.27 39.89 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.663 1.585 . . . . 0.0 111.191 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.13 -35.31 0.59 Allowed Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.04 172.89 17.87 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.135 1.374 . . . . 0.0 109.149 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -104.46 162.79 12.94 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.35 0.977 . . . . 0.0 109.717 170.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 120.48 11.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.299 0.239 . . . . 0.0 110.545 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.75 143.73 26.68 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.18 155.12 68.8 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.591 1.528 . . . . 0.0 109.276 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -64.64 -16.3 62.56 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -71.46 -57.91 4.0 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.761 0.824 . . . . 0.0 112.152 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.79 165.81 46.78 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 123.889 0.875 . . . . 0.0 111.131 -165.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -63.21 173.27 4.24 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.603 1.536 . . . . 0.0 110.665 160.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 p -111.96 175.16 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 127.016 2.126 . . . . 0.0 107.408 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.71 78.06 1.29 Allowed 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 120.947 -1.095 . . . . 0.0 111.482 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -55.78 -30.36 61.17 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.066 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -67.64 -36.37 80.65 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.397 -0.814 . . . . 0.0 112.076 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.25 -36.89 58.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.587 1.085 . . . . 0.0 109.761 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.57 -55.65 23.9 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.93 0.492 . . . . 0.0 109.918 175.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -62.97 -49.58 74.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.761 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -54.16 -49.78 68.48 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.357 0.526 . . . . 0.0 110.448 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.4 ptp -72.46 -40.72 66.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.68 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.73 -46.81 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 120.615 1.552 . . . . 0.0 109.376 -172.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -55.03 -44.73 74.92 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.615 1.166 . . . . 0.0 110.736 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -65.05 -50.89 64.44 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.76 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -23.67 65.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.417 1.008 . . . . 0.0 111.592 -172.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.6 mt -75.16 -57.11 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.284 1.034 . . . . 0.0 109.337 169.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -63.95 -31.32 72.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 123.244 1.497 . . . . 0.0 112.1 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.33 -1.8 25.4 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 126.29 1.836 . . . . 0.0 112.914 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -127.36 -0.03 6.33 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 126.763 2.025 . . . . 0.0 111.931 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.25 1.096 0 C-N-CA 124.92 1.288 . . . . 0.0 109.664 -172.881 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.42 ' CE1' ' HG2' ' A' ' 4' ' ' MET 0.267 2.0 p-80 . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.42 ' HG2' ' CE1' ' A' ' 3' ' ' HIS . 6.6 mmt -51.67 -44.9 63.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.182 1.393 . . . . 0.0 110.627 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.43 -28.15 68.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.995 1.318 . . . . 0.0 112.033 -170.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.4 t -76.18 -39.14 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -89.81 -11.71 41.27 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.874 1.27 . . . . 0.0 112.968 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.96 -20.27 64.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.931 0.892 . . . . 0.0 111.795 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.62 -16.57 51.09 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.567 1.147 . . . . 0.0 112.741 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -81.41 -49.45 10.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.739 1.616 . . . . 0.0 107.008 167.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.485 HD12 ' HE ' ' A' ' 20' ' ' ARG . 1.6 mm? -47.98 -49.58 30.22 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.788 1.235 . . . . 0.0 112.553 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -51.09 -34.97 32.66 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.646 0.778 . . . . 0.0 111.79 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.96 -1.09 80.27 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.7 -1.055 . . . . 0.0 113.23 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.0 mt -74.71 117.81 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 119.537 1.669 . . . . 0.0 106.983 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.81 -1.74 58.01 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.996 0.918 . . . . 0.0 112.73 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.07 79.64 8.57 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.005 1.722 . . . . 0.0 111.149 -176.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.92 -20.44 64.29 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 124.128 3.219 . . . . 0.0 114.428 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -7.91 51.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.018 0.826 . . . . 0.0 111.914 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -134.73 -2.75 2.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.271 0.628 . . . . 0.0 112.192 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.485 ' HE ' HD12 ' A' ' 11' ' ' LEU . 62.4 ttt180 -60.31 -64.62 0.89 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 127.226 2.21 . . . . 0.0 111.073 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -53.71 -32.46 51.98 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 125.65 1.58 . . . . 0.0 111.228 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -56.39 -33.59 65.89 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.188 -0.945 . . . . 0.0 113.468 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 m -69.48 -41.67 75.85 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.552 0.741 . . . . 0.0 109.548 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -65.06 -33.66 76.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.062 1.345 . . . . 0.0 111.27 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -58.66 -48.54 80.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.6 mt -62.64 -47.94 90.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.094 0.957 . . . . 0.0 109.67 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.9 mt -51.57 -65.8 0.49 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.896 0.878 . . . . 0.0 109.816 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -66.46 -30.47 70.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.171 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -60.7 -35.71 76.97 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 118.985 0.811 . . . . 0.0 110.661 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.452 HG21 ' CE2' ' A' ' 48' ' ' PHE . 34.3 m -74.65 -45.69 44.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 C-N-CA 117.045 -1.862 . . . . 0.0 106.681 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.71 -13.92 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.777 -0.63 . . . . 0.0 112.473 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.95 -68.08 0.74 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 123.389 0.676 . . . . 0.0 111.473 159.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.458 ' CG2' ' HE3' ' A' ' 107' ' ' LYS . 9.6 m -73.6 -41.64 62.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.907 0.883 . . . . 0.0 111.879 -163.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.454 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -115.08 72.39 3.04 Favored Pre-proline 0 N--CA 1.44 -0.927 0 C-N-CA 129.045 2.938 . . . . 0.0 108.748 175.657 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.57 -9.65 21.49 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.324 2.683 . . . . 0.0 111.942 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -38.88 90.99 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.874 1.669 . . . . 0.0 112.318 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.651 HD22 ' H ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -79.09 145.17 33.93 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -172.298 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -110.98 150.27 41.65 Favored Pre-proline 0 C--N 1.319 -0.743 0 C-N-CA 124.628 1.171 . . . . 0.0 108.26 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.65 139.77 37.89 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.614 2.209 . . . . 0.0 109.764 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -154.03 102.52 2.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.477 ' HE3' ' HA ' ' A' ' 44' ' ' ASN . 53.5 mmm -70.65 105.04 3.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 167.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -110.33 143.0 41.2 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.5 m95 54.51 18.85 2.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.477 ' HA ' ' HE3' ' A' ' 41' ' ' MET . 3.0 t-20 62.44 31.38 17.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.211 1.404 . . . . 0.0 110.943 -170.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.8 p -128.97 147.07 63.24 Favored Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 120.951 -1.093 . . . . 0.0 109.246 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -73.37 129.76 14.26 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.828 3.019 . . . . 0.0 112.717 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.24 165.46 36.31 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.461 1.104 . . . . 0.0 109.138 172.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 30' ' ' VAL . 1.3 m-85 -126.56 163.88 22.42 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.444 0.64 . . . . 0.0 109.918 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.8 m -136.52 119.85 16.83 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -77.14 89.72 3.64 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 50.48 51.17 17.38 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.944 0.878 . . . . 0.0 109.291 -171.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.56 -0.43 56.8 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 117.319 1.688 . . . . 0.0 117.319 171.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -165.92 1.1 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.667 2.734 . . . . 0.0 111.975 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -127.2 12.09 7.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.723 1.609 . . . . 0.0 112.748 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 55' ' ' ILE . 33.6 mt -64.51 5.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.629 1.972 . . . . 0.0 113.816 -163.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.6 tt -160.93 132.48 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 118.709 -2.494 . . . . 0.0 110.608 174.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.53 157.42 29.36 Favored Glycine 0 C--N 1.339 0.718 0 O-C-N 122.094 -0.379 . . . . 0.0 112.662 171.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -155.84 168.56 26.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.871 0.868 . . . . 0.0 111.729 -176.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.79 158.01 22.22 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 120.611 -1.305 . . . . 0.0 110.393 170.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.6 p -77.29 113.04 14.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.007 0.923 . . . . 0.0 110.232 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.8 t -90.35 168.03 12.2 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.21 -29.79 6.14 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.304 1.442 . . . . 0.0 113.97 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -145.92 10.69 1.19 Allowed 'General case' 0 C--O 1.238 0.469 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -158.07 159.04 35.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.634 0.773 . . . . 0.0 109.268 -173.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.533 HD23 ' H ' ' A' ' 66' ' ' SER . 0.6 OUTLIER -85.4 165.45 17.2 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 158.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.533 ' H ' HD23 ' A' ' 65' ' ' LEU . 92.2 p -141.65 131.65 24.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.3 t -146.1 140.54 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.509 1.05 . . . . 0.0 109.274 -168.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 t -163.78 164.34 14.99 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.928 1.291 . . . . 0.0 108.394 165.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -78.98 -58.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 CA-C-N 119.433 0.833 . . . . 0.0 112.357 165.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -154.87 -85.8 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -138.23 -44.61 0.51 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.235 1.014 . . . . 0.0 111.568 -173.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.5 tt -55.15 -31.85 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.106 0.963 . . . . 0.0 113.102 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.66 -28.49 5.19 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.075 1.798 . . . . 0.0 113.162 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.2 mm -113.24 -5.52 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 117.918 0.859 . . . . 0.0 111.188 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.5 m -76.23 -78.13 0.12 Allowed 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.898 -1.126 . . . . 0.0 109.955 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -86.71 -47.23 9.31 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -68.07 -20.15 64.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.172 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.26 -30.65 51.31 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.756 1.162 . . . . 0.0 112.987 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.34 -48.63 80.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.255 1.422 . . . . 0.0 109.508 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.85 -29.9 62.37 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.58 0.752 . . . . 0.0 111.307 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.49 -45.49 97.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.254 1.021 . . . . 0.0 108.526 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.17 -46.47 88.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.04 0.936 . . . . 0.0 110.338 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -54.03 -42.35 69.05 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.792 1.237 . . . . 0.0 110.839 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.15 8.34 9.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.48 34.96 30.55 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 119.538 1.063 . . . . 0.0 113.653 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -123.71 169.18 11.76 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.145 0.978 . . . . 0.0 109.486 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 m -135.94 106.82 6.63 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.353 1.061 . . . . 0.0 111.059 -171.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.24 170.53 4.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.519 0.728 . . . . 0.0 112.285 168.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.4 p -128.93 -179.96 5.39 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.709 2.403 . . . . 0.0 107.186 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.82 62.98 6.69 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 120.393 -1.442 . . . . 0.0 110.15 -177.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.26 -59.03 0.1 OUTLIER Glycine 0 CA--C 1.498 -0.972 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -171.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 66' ' ' SER . 1.5 pt? -157.6 177.28 11.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.447 -1.377 . . . . 0.0 110.573 -165.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -110.89 158.41 18.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 167.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -144.11 136.76 26.98 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.747 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.6 mm -117.29 142.75 30.68 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -169.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.46 154.6 60.5 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.87 1.713 . . . . 0.0 110.597 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -62.48 -21.89 65.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 172.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -64.59 -70.6 0.22 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.037 1.735 . . . . 0.0 111.405 172.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.72 153.34 43.81 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.348 0.659 . . . . 0.0 111.353 -161.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.21 -178.73 4.63 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.767 2.978 . . . . 0.0 113.599 -164.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.96 146.35 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 125.716 1.606 . . . . 0.0 110.43 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.99 119.54 35.66 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.28 1.432 . . . . 0.0 109.924 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -87.1 -18.08 31.33 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 123.273 0.629 . . . . 0.0 111.742 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.26 -58.98 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.304 1.042 . . . . 0.0 110.821 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.65 -48.88 79.92 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.62 -56.74 4.84 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.614 1.966 . . . . 0.0 109.933 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.458 ' HE3' ' CG2' ' A' ' 33' ' ' THR . 22.9 tttt -60.99 -45.01 96.54 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.124 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -58.5 -53.69 55.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.416 1.007 . . . . 0.0 110.155 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -75.56 6.87 4.2 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.9 -52.1 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 120.199 1.363 . . . . 0.0 107.831 173.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.425 ' OE1' ' HE2' ' A' ' 107' ' ' LYS . 42.6 mt-10 -60.91 -40.71 94.18 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 119.227 0.921 . . . . 0.0 111.464 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -61.78 -48.52 80.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -32.02 73.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.959 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.486 HD11 HD21 ' A' ' 37' ' ' LEU . 71.9 mt -58.9 -63.85 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.096 1.359 . . . . 0.0 109.123 165.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -69.55 -5.93 27.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.618 1.099 . . . . 0.0 113.317 -170.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -78.58 -50.16 12.02 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.403 1.881 . . . . 0.0 111.462 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -85.8 22.92 1.54 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.899 1.679 . . . . 0.0 111.873 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.253 1.246 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 169.167 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 . . . . . 0 N--CA 1.467 0.396 0 CA-C-O 119.483 -0.294 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 mmt -58.13 -19.17 30.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.714 0.806 . . . . 0.0 113.008 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -69.07 -43.65 74.15 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 121.36 -0.837 . . . . 0.0 110.169 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.69 -50.42 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.908 0.883 . . . . 0.0 109.011 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.1 4.41 52.24 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.869 0.868 . . . . 0.0 112.14 -166.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.12 79.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.062 0.945 . . . . 0.0 109.989 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.91 -21.01 64.25 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.124 0.97 . . . . 0.0 112.602 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -79.45 -56.4 4.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.479 0.711 . . . . 0.0 109.22 173.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -55.76 -40.62 72.84 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.427 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -52.06 -38.95 58.83 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.689 0.677 . . . . 0.0 111.247 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.84 -7.37 78.21 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-O 118.487 -1.174 . . . . 0.0 112.534 -166.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -70.54 119.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.8 1.02 56.56 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.953 1.301 . . . . 0.0 111.688 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.33 65.81 1.52 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.732 2.413 . . . . 0.0 109.837 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.46 -30.63 93.07 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 124.087 3.191 . . . . 0.0 113.807 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -59.16 -11.32 3.65 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.844 1.258 . . . . 0.0 113.287 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -126.48 -13.85 5.93 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.302 1.841 . . . . 0.0 110.04 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -66.32 -45.98 78.43 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.627 1.171 . . . . 0.0 110.14 -176.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.66 -33.56 64.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.826 1.25 . . . . 0.0 112.776 -171.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -56.67 -39.98 74.72 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.672 -0.643 . . . . 0.0 111.257 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.1 m -69.42 -39.08 78.09 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.195 1.398 . . . . 0.0 109.294 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -63.09 -45.28 92.85 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.04 -1.038 . . . . 0.0 111.815 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -53.85 -51.71 62.72 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 126.076 1.75 . . . . 0.0 108.984 176.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.6 mt -52.4 -56.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.797 1.639 . . . . 0.0 110.453 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.5 mt -53.35 -53.71 47.07 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.59 0.632 . . . . 0.0 110.197 -174.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.1 m -69.07 -31.98 71.11 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.578 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -63.22 -50.16 71.35 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 124.638 1.175 . . . . 0.0 110.506 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 87.3 t -59.93 -52.03 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.17 -1.46 4.43 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.72 -56.3 2.2 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 120.781 -1.199 . . . . 0.0 109.336 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -67.04 -33.58 75.85 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.734 2.013 . . . . 0.0 111.987 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.518 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -129.86 72.59 81.9 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -178.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.16 -6.73 17.55 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.108 1.872 . . . . 0.0 112.727 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -63.56 -45.8 88.82 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.686 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.602 HD22 ' H ' ' A' ' 37' ' ' LEU . 2.8 mm? -60.35 147.32 41.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.055 0.942 . . . . 0.0 108.955 -171.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -104.64 144.97 29.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 124.234 1.014 . . . . 0.0 108.879 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.79 161.29 46.12 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.497 2.131 . . . . 0.0 111.24 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -158.64 130.27 6.55 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.211 1.404 . . . . 0.0 107.681 161.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.17 112.48 17.53 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.551 1.069 . . . . 0.0 108.334 162.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -123.21 128.33 49.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.645 1.178 . . . . 0.0 108.242 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.9 m95 53.29 25.97 4.86 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.809 0.844 . . . . 0.0 113.062 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.59 29.02 18.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.502 1.121 . . . . 0.0 110.18 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -121.12 147.38 46.56 Favored Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -71.96 133.35 21.45 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.711 2.274 . . . . 0.0 111.758 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.0 ptm -147.28 173.3 12.7 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.804 0.442 . . . . 0.0 110.925 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.48 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -134.05 152.71 51.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.1 p -122.76 138.74 54.54 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.306 1.442 . . . . 0.0 108.006 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -88.35 95.27 10.13 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 163.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 66.78 -13.39 0.19 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.945 1.698 . . . . 0.0 114.046 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.61 -19.63 0.04 OUTLIER Glycine 0 CA--C 1.54 1.646 0 C-N-CA 127.044 2.259 . . . . 0.0 113.887 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.44 -171.05 1.68 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -165.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -125.31 24.99 7.25 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.442 2.297 . . . . 0.0 111.786 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.65 -2.41 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 126.648 1.979 . . . . 0.0 113.515 -167.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 tt -160.68 145.86 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 119.357 -2.09 . . . . 0.0 109.692 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.13 148.81 11.53 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 165.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -144.1 166.09 25.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.849 0.825 . . . . 0.0 109.944 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 t -150.51 145.42 25.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 57.5 p -62.51 145.86 53.15 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.75 174.59 8.99 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -59.59 -39.24 83.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.377 -162.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -138.6 14.27 2.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.199 1.0 . . . . 0.0 113.079 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -150.64 176.74 10.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.962 1.305 . . . . 0.0 108.794 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.27 161.88 14.39 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 166.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.35 114.96 24.31 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.127 1.371 . . . . 0.0 108.63 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.9 136.36 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.3 0.955 . . . . 0.0 109.434 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 t -165.68 161.82 13.37 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 125.261 1.424 . . . . 0.0 107.621 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.51 -57.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.131 0 CA-C-N 120.434 1.191 . . . . 0.0 110.998 157.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -149.55 -85.91 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -133.2 -38.85 0.94 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.444 1.498 . . . . 0.0 111.796 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.7 tp -53.76 -38.09 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.67 1.188 . . . . 0.0 112.981 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.42 -21.87 14.33 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.468 1.509 . . . . 0.0 112.835 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.7 mm -119.93 -5.3 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.437 1.495 . . . . 0.0 110.561 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.2 m -95.06 -64.04 1.11 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 168.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -76.62 -66.52 0.8 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -72.48 -6.24 42.38 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.5 -164.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.32 49.24 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 118.238 -0.887 . . . . 0.0 112.545 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -62.75 -47.54 83.11 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.101 0.864 . . . . 0.0 109.82 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.626 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -78.89 -22.8 45.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.755 0.822 . . . . 0.0 110.977 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.92 -46.98 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.004 0.921 . . . . 0.0 108.935 164.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.83 88.52 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.503 1.121 . . . . 0.0 111.088 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -63.07 -15.64 57.23 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 126.868 2.067 . . . . 0.0 112.894 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.6 -15.35 42.84 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 118.475 0.579 . . . . 0.0 111.623 172.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.96 -22.24 19.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.754 2.121 . . . . 0.0 112.879 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -74.17 114.7 12.82 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.236 1.014 . . . . 0.0 110.191 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.1 m -75.11 4.76 6.25 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 48.21 -155.71 0.07 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.798 2.439 . . . . 0.0 112.026 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.0 p -126.4 -164.7 1.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.549 2.34 . . . . 0.0 105.732 163.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -71.73 -33.0 68.34 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.109 1.322 . . . . 0.0 111.515 172.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.56 -10.56 2.92 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 114.479 0.552 . . . . 0.0 114.479 -160.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 pp -149.6 175.88 11.14 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.646 1.178 . . . . 0.0 109.675 168.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -113.26 157.4 21.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.651 0.66 . . . . 0.0 109.546 167.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.1 mtt85 -128.23 155.18 44.96 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -137.28 142.56 38.16 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 178.521 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.88 155.09 23.3 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.985 1.79 . . . . 0.0 109.343 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -63.81 -17.73 63.4 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -67.0 -45.15 78.46 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.17 0.988 . . . . 0.0 112.086 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.7 156.12 45.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 122.882 0.473 . . . . 0.0 110.982 -157.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.33 165.93 29.98 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.513 2.142 . . . . 0.0 112.911 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.32 124.86 51.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -75.81 78.58 2.74 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.284 1.04 . . . . 0.0 113.148 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -59.62 -37.22 78.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.842 0.857 . . . . 0.0 112.351 173.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.59 -46.8 71.56 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 120.148 1.34 . . . . 0.0 110.437 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.626 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -68.38 -47.5 67.2 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.435 -0.791 . . . . 0.0 109.289 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.279 0.3 OUTLIER -72.55 -27.07 61.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.339 -175.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -54.33 -52.63 60.94 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.382 0.992 . . . . 0.0 109.591 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -56.73 -52.34 65.37 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.056 -170.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.8 ptp -65.46 -34.63 78.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.025 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -53.01 21.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.988 1.267 . . . . 0.0 109.002 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.63 -50.7 59.77 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -55.66 -52.8 62.6 Favored 'General case' 0 N--CA 1.441 -0.905 0 O-C-N 124.016 0.823 . . . . 0.0 111.068 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -63.67 -22.28 66.82 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.351 0.978 . . . . 0.0 112.844 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.2 mt -71.65 -57.47 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.943 0.897 . . . . 0.0 108.636 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -74.95 -5.93 46.53 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -75.1 -19.86 59.74 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.529 0.731 . . . . 0.0 110.383 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -101.69 16.69 25.0 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.792 2.437 . . . . 0.0 111.071 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 117.351 -1.309 . . . . 0.0 108.198 172.27 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.433 ' CE1' ' HG2' ' A' ' 4' ' ' MET 0.256 2.8 p-80 . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.433 ' HG2' ' CE1' ' A' ' 3' ' ' HIS . 3.4 mmt -55.91 -31.04 62.53 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 119.892 1.224 . . . . 0.0 111.26 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.451 ' H ' ' HG3' ' A' ' 5' ' ' GLU . 1.1 pp20? -53.11 -48.14 68.06 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.519 0.728 . . . . 0.0 111.475 175.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.31 -43.74 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 121.643 -0.661 . . . . 0.0 109.652 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -103.63 50.14 0.81 Allowed 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.156 0.983 . . . . 0.0 111.236 -171.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -126.2 -27.05 3.28 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.682 0.793 . . . . 0.0 110.374 168.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.401 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 50.1 mt-10 -75.83 -12.91 60.26 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.112 -0.993 . . . . 0.0 112.436 -173.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -78.85 -48.77 14.07 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.397 1.479 . . . . 0.0 109.029 163.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -60.2 -22.98 63.63 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.713 2.405 . . . . 0.0 112.923 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 9' ' ' GLU . 51.7 pttt -61.01 -44.13 97.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.741 1.155 . . . . 0.0 109.475 173.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.96 10.23 51.73 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.609 1.1 . . . . 0.0 114.907 -164.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.467 HD12 HG21 ' A' ' 60' ' ' THR . 4.6 mm -58.42 123.94 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.072 1.349 . . . . 0.0 108.254 174.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -56.94 -36.02 69.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.753 1.221 . . . . 0.0 113.107 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -116.78 85.95 18.24 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 126.521 1.929 . . . . 0.0 110.928 -168.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.07 -23.62 75.82 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.305 2.003 . . . . 0.0 111.828 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 23.6 m-20 -65.9 -16.9 64.27 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.306 -0.871 . . . . 0.0 111.888 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 0.8 OUTLIER -128.85 -0.53 5.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.338 1.455 . . . . 0.0 110.763 179.497 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.9 ttp85 -53.96 -57.45 10.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.142 0.977 . . . . 0.0 109.484 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -48.31 -35.07 11.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.549 1.54 . . . . 0.0 112.39 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -60.63 -39.09 86.97 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.318 -1.489 . . . . 0.0 111.824 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.8 m -63.42 -49.78 72.41 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.675 0.79 . . . . 0.0 109.397 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.53 -30.63 61.08 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.567 1.547 . . . . 0.0 113.33 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.03 -58.94 6.38 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 118.775 0.716 . . . . 0.0 110.297 173.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 mt -57.66 -38.86 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 123.875 0.87 . . . . 0.0 110.415 -173.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.2 mt -56.33 -62.66 1.56 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.157 0.983 . . . . 0.0 110.189 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -64.25 -31.66 72.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -62.24 -43.33 99.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 117.493 -1.241 . . . . 0.0 110.876 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.25 -40.56 80.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.763 0 C-N-CA 116.92 -1.912 . . . . 0.0 107.37 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.96 -25.36 8.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 117.748 -1.12 . . . . 0.0 112.529 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.17 -27.65 14.46 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.471 HG21 ' HE3' ' A' ' 107' ' ' LYS . 7.3 m -94.82 -40.18 9.87 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.645 1.111 . . . . 0.0 111.251 -174.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.451 ' CE1' HG22 ' A' ' 33' ' ' THR . 2.6 m-85 -120.28 58.44 5.91 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 129.575 3.15 . . . . 0.0 111.823 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.08 -13.92 38.38 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.834 2.356 . . . . 0.0 113.722 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.29 -23.67 66.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.165 1.386 . . . . 0.0 112.427 172.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.87 145.58 44.74 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -117.59 150.47 46.83 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 126.964 2.106 . . . . 0.0 108.444 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.27 140.28 13.7 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.872 2.381 . . . . 0.0 111.67 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -164.85 96.49 0.73 Allowed 'General case' 0 C--N 1.346 0.439 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 ptm -70.21 136.39 49.96 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.422 1.01 . . . . 0.0 108.886 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -150.52 155.32 39.25 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.9 m95 52.71 33.37 13.78 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.563 1.145 . . . . 0.0 113.06 -174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 61.78 18.84 10.06 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.207 1.803 . . . . 0.0 112.476 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.0 p -129.49 155.97 79.33 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.92 1.288 . . . . 0.0 110.007 -173.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.81 120.75 5.93 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.968 3.112 . . . . 0.0 110.235 170.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.5 ptm -135.01 162.52 32.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 163.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.93 168.28 14.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 p -134.19 121.63 21.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.144 0.578 . . . . 0.0 109.56 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -68.46 92.9 0.46 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 169.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 53.58 28.67 8.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.478 1.111 . . . . 0.0 111.882 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.3 -17.81 7.89 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 125.636 1.589 . . . . 0.0 115.642 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.6 m -79.32 -179.13 6.59 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 119.799 1.8 . . . . 0.0 111.242 -173.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.548 ' H ' HG22 ' A' ' 53' ' ' THR . 61.6 t80 -111.09 18.25 19.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.462 1.905 . . . . 0.0 113.554 -168.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.67 12.51 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.849 1.66 . . . . 0.0 112.495 -163.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 tt -163.31 146.28 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 119.558 -1.964 . . . . 0.0 111.249 174.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.48 151.03 18.21 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 166.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.421 ' CD2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -153.17 -179.89 8.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.417 0.687 . . . . 0.0 111.078 175.502 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t 178.79 147.1 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 14' ' ' ILE . 81.4 p -62.86 146.91 51.66 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.302 0.641 . . . . 0.0 110.504 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -126.74 165.18 19.74 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -12.51 18.2 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.52 8.29 0.38 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.485 1.039 . . . . 0.0 112.245 176.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -162.49 -179.88 7.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.869 1.668 . . . . 0.0 108.645 -164.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.522 HD22 ' H ' ' A' ' 66' ' ' SER . 1.8 tm? -127.67 154.22 45.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.801 2.041 . . . . 0.0 107.012 174.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.625 ' HB2' HD22 ' A' ' 92' ' ' LEU . 3.8 p -132.07 122.82 26.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.761 1.624 . . . . 0.0 108.954 -173.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG13 ' CE1' ' A' ' 93' ' ' PHE . 1.6 p -144.78 145.45 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.882 1.219 . . . . 0.0 111.663 -171.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.545 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 13.7 t -160.0 165.03 18.59 Favored Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 125.59 1.556 . . . . 0.0 109.581 169.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -81.49 -57.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.444 2.096 . . . . 0.0 112.936 156.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -149.17 -86.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.122 1.769 . . . . 0.0 106.964 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -152.47 -27.32 0.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.651 1.18 . . . . 0.0 112.55 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.8 tt -62.71 -40.16 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 120.576 1.534 . . . . 0.0 109.891 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.96 -10.91 15.89 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.002 1.286 . . . . 0.0 113.104 173.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 68' ' ' SER . 5.3 mm -117.03 -0.57 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.734 2.014 . . . . 0.0 110.025 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 m -125.62 -50.54 1.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.488 0.585 . . . . 0.0 111.844 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -79.67 -57.42 3.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.987 1.715 . . . . 0.0 107.443 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -73.46 -0.76 15.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.261 1.024 . . . . 0.0 112.5 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.25 -25.47 67.85 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.477 1.911 . . . . 0.0 112.701 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -79.07 -48.02 15.12 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.557 0.743 . . . . 0.0 109.028 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.28 87.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.552 0.741 . . . . 0.0 110.834 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.85 -50.33 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.053 0.941 . . . . 0.0 109.839 171.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.53 -50.58 73.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.97 0.908 . . . . 0.0 111.368 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -60.06 -25.74 65.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.655 1.582 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.41 -27.14 63.1 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.175 0.443 . . . . 0.0 110.854 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 122.61 6.21 8.06 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.466 1.508 . . . . 0.0 113.431 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.07 122.23 44.23 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.459 1.63 . . . . 0.0 110.005 -173.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.43 3.83 12.41 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -170.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 46.52 -168.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.962 2.105 . . . . 0.0 113.277 -172.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.3 p -141.67 -164.7 1.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.347 2.259 . . . . 0.0 108.092 168.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 5.26 13.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.16 2.184 . . . . 0.0 112.047 173.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.5 -7.94 0.03 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 116.667 1.427 . . . . 0.0 116.667 -172.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 66' ' ' SER . 2.9 pp -149.29 170.71 17.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.112 1.456 . . . . 0.0 108.607 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.425 ' CE1' HG13 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -116.22 125.83 52.78 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 164.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -72.37 134.75 45.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.494 170.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.6 mm -125.72 143.71 45.96 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 165.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.68 163.68 38.15 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.154 1.903 . . . . 0.0 110.159 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -70.49 -35.12 73.07 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 171.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -67.76 -59.95 2.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.218 0.533 . . . . 0.0 110.469 -174.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.22 162.83 65.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.48 1.912 . . . . 0.0 109.455 -172.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.15 165.61 25.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.587 1.525 . . . . 0.0 113.391 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.0 t -93.44 134.91 29.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 126.413 1.885 . . . . 0.0 106.719 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.41 76.35 3.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.328 1.451 . . . . 0.0 110.721 171.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -56.47 -44.25 80.38 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.028 0.931 . . . . 0.0 110.461 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -65.18 -26.2 68.05 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.778 0.831 . . . . 0.0 111.749 -174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.96 -53.92 6.56 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.277 0.3 OUTLIER -58.72 -24.87 62.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.77 1.228 . . . . 0.0 112.022 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.471 ' HE3' HG21 ' A' ' 33' ' ' THR . 16.1 tttt -65.52 -54.0 34.4 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.785 2.034 . . . . 0.0 113.252 169.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -57.81 -46.42 84.71 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.877 1.217 . . . . 0.0 111.192 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.0 ptp -66.35 -32.21 73.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.307 -0.854 . . . . 0.0 113.226 -175.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -44.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.195 0.907 . . . . 0.0 108.987 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.08 -43.75 98.15 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.639 0.775 . . . . 0.0 110.717 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.425 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 5.1 t80 -58.26 -48.06 81.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.458 175.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -59.1 -40.47 85.39 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 118.161 0.437 . . . . 0.0 110.383 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.85 -52.06 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 O-C-N 121.319 -0.863 . . . . 0.0 110.084 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 112' ' ' PHE . 17.6 pt20 -71.56 -4.92 29.6 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 120.27 1.396 . . . . 0.0 112.413 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -93.78 2.57 56.2 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.658 1.983 . . . . 0.0 112.281 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -129.38 19.35 5.8 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.317 1.447 . . . . 0.0 111.216 -174.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 124.282 1.033 . . . . 0.0 109.586 175.71 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.2 mmt -60.1 -30.4 69.22 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.652 -0.655 . . . . 0.0 112.534 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.73 -43.85 71.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.57 -44.98 99.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.61 1.164 . . . . 0.0 109.917 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.43 0.05 55.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.953 0.501 . . . . 0.0 112.118 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.54 67.93 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.786 1.235 . . . . 0.0 109.46 173.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.33 -13.36 62.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.273 1.429 . . . . 0.0 113.526 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -82.67 -59.6 2.46 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -55.96 -44.32 78.36 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.821 1.248 . . . . 0.0 110.811 -175.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -56.36 -32.55 64.83 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.424 0.69 . . . . 0.0 112.471 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.0 -22.73 57.09 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 119.251 -0.749 . . . . 0.0 111.379 -171.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.5 mt -74.84 98.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -66.58 -2.83 5.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.227 1.411 . . . . 0.0 113.437 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -100.01 84.97 0.46 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 128.662 2.785 . . . . 0.0 110.978 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.79 -36.79 82.62 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.533 2.155 . . . . 0.0 112.295 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.88 5.79 2.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.013 0.824 . . . . 0.0 112.476 -170.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -137.13 -36.77 0.66 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.395 1.878 . . . . 0.0 110.425 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -52.78 -40.37 63.12 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.85 0.86 . . . . 0.0 110.889 171.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.93 -22.72 60.41 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.616 1.166 . . . . 0.0 112.362 -176.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -81.99 -31.54 31.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.1 0.864 . . . . 0.0 111.853 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.2 m -72.94 -39.69 66.02 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.157 0.983 . . . . 0.0 110.492 -175.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HB3' HD21 ' A' ' 11' ' ' LEU . 3.0 pt-20 -63.19 -26.04 68.62 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.731 0.412 . . . . 0.0 111.906 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.46 -54.65 44.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.835 0.854 . . . . 0.0 110.142 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.9 mp -63.83 -40.59 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -174.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.1 mt -52.92 -53.89 42.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.236 0.614 . . . . 0.0 110.101 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -62.47 -44.45 96.37 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.528 1.131 . . . . 0.0 111.228 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.8 t90 -59.04 -44.31 91.77 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.502 1.121 . . . . 0.0 111.664 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.832 HG11 ' CE2' ' A' ' 48' ' ' PHE . 40.9 t -63.25 -46.16 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.306 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.25 -12.7 21.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.493 1.042 . . . . 0.0 113.452 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.49 -48.59 7.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.348 164.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 m -78.83 -34.47 45.18 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 117.431 -1.271 . . . . 0.0 111.314 -163.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.602 ' HD2' HG13 ' A' ' 30' ' ' VAL . 1.5 m-85 -117.47 76.17 9.56 Favored Pre-proline 0 C--N 1.344 0.333 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.23 -14.04 39.43 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.665 2.243 . . . . 0.0 113.338 -172.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -20.83 59.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.528 0.731 . . . . 0.0 111.658 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.481 HD11 ' CD1' ' A' ' 114' ' ' ILE . 2.7 mp -70.29 151.16 45.6 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.564 1.546 . . . . 0.0 109.085 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -122.93 143.02 39.48 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 113.032 -1.895 . . . . 0.0 108.738 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.54 154.21 35.22 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.19 2.593 . . . . 0.0 110.488 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -176.95 102.58 0.05 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.155 1.782 . . . . 0.0 106.26 171.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 62.2 mmm -60.63 129.95 44.11 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -134.58 138.96 45.01 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.0 m95 58.76 19.77 7.22 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m120 64.03 12.18 6.73 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 126.578 1.951 . . . . 0.0 113.101 -166.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.0 p -114.51 112.54 45.86 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 120.356 1.435 . . . . 0.0 108.169 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.05 132.83 33.34 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.927 2.418 . . . . 0.0 111.648 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 ptm -143.26 159.19 42.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.832 ' CE2' HG11 ' A' ' 30' ' ' VAL . 1.2 m-85 -123.94 109.29 13.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.6 p -73.24 120.82 19.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -67.12 98.33 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 163.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 50.68 -4.64 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 130.207 3.403 . . . . 0.0 117.617 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.44 25.24 0.09 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.76 1.648 . . . . 0.0 113.028 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -117.0 177.32 4.75 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.184 1.394 . . . . 0.0 108.481 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -120.68 25.99 9.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.731 1.612 . . . . 0.0 110.777 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.78 19.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 125.234 1.413 . . . . 0.0 111.552 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.471 ' CG2' ' H ' ' A' ' 48' ' ' PHE . 1.1 tt -165.72 162.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 119.684 -1.885 . . . . 0.0 109.16 166.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.51 91.62 0.08 OUTLIER Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 159.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.509 ' CD2' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -90.98 162.47 14.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.532 0.666 . . . . 0.0 110.897 -175.428 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.0 t -152.92 155.39 36.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.992 0.901 . . . . 0.0 110.399 164.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.6 p -72.8 156.33 39.02 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.185 2.194 . . . . 0.0 109.787 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.28 -179.04 5.43 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.916 1.286 . . . . 0.0 109.739 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -49.66 -59.84 3.43 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 125.085 1.354 . . . . 0.0 111.824 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -132.32 15.31 4.57 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.255 1.022 . . . . 0.0 111.184 -174.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -152.08 173.64 14.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.824 1.249 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.528 HD12 ' H ' ' A' ' 66' ' ' SER . 33.7 tp -111.79 157.87 20.04 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.715 1.606 . . . . 0.0 108.131 170.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.528 ' H ' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -135.51 111.62 9.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.277 1.431 . . . . 0.0 110.281 -171.01 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG13 ' CZ ' ' A' ' 93' ' ' PHE . 1.5 p -142.15 151.36 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.702 1.601 . . . . 0.0 113.876 -167.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 1.4 t -174.83 165.16 2.29 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.136 2.575 . . . . 0.0 109.422 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.99 -55.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 124.327 3.351 . . . . 0.0 112.956 164.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -156.12 -74.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.776 2.03 . . . . 0.0 108.401 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -156.1 -46.75 0.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.861 1.665 . . . . 0.0 110.722 -168.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 tp -55.96 -42.42 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.516 1.053 . . . . 0.0 110.845 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.13 -16.04 24.62 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.075 0.845 . . . . 0.0 114.178 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.476 HG21 ' H ' ' A' ' 91' ' ' GLY . 34.4 mm -115.9 -6.88 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.032 1.733 . . . . 0.0 110.131 -176.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.8 m -100.95 -61.22 1.4 Allowed 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 121.569 -0.707 . . . . 0.0 109.881 172.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -82.61 -39.97 21.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.889 2.476 . . . . 0.0 109.597 -172.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -99.38 -8.21 25.13 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' A' ' 81' ' ' ILE . . . -61.56 -29.78 70.24 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.896 0.771 . . . . 0.0 112.496 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.64 -51.23 70.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.791 0.805 . . . . 0.0 109.483 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.57 -28.87 66.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.416 1.486 . . . . 0.0 111.359 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 78' ' ' ALA . 77.9 mt -64.91 -48.82 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 123.76 0.824 . . . . 0.0 108.976 168.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.59 79.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.203 0.525 . . . . 0.0 110.403 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.2 -24.67 67.35 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.991 0.917 . . . . 0.0 112.197 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.57 -4.24 41.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.494 0.588 . . . . 0.0 112.344 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.01 29.21 10.66 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 121.243 -0.911 . . . . 0.0 112.817 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -126.01 -179.99 4.95 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.468 1.134 . . . . 0.0 111.377 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.23 158.84 34.62 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.249 1.819 . . . . 0.0 111.034 -172.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.35 169.83 17.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.495 1.518 . . . . 0.0 110.917 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.2 p -136.47 -163.79 1.46 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 127.857 2.463 . . . . 0.0 107.956 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -94.78 77.03 3.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 166.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.476 ' H ' HG21 ' A' ' 74' ' ' ILE . . . 127.14 6.6 5.28 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.726 166.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 0.3 OUTLIER -160.9 159.44 29.69 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.948 1.374 . . . . 0.0 110.706 169.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CZ ' HG13 ' A' ' 67' ' ' VAL . 27.1 p90 -117.84 156.76 27.81 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.927 0.891 . . . . 0.0 108.693 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.99 120.11 30.63 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.996 0.919 . . . . 0.0 108.642 -161.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.0 mm -119.61 142.86 33.6 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.51 155.49 31.92 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.785 1.657 . . . . 0.0 109.385 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -57.85 -15.16 7.56 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 170.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.22 -45.92 65.58 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.379 1.471 . . . . 0.0 113.343 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.97 161.92 21.34 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 123.642 0.777 . . . . 0.0 110.227 -163.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -66.23 154.2 75.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.734 2.29 . . . . 0.0 110.899 172.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.3 t -85.98 132.38 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -73.58 81.62 1.5 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.488 1.515 . . . . 0.0 110.365 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -50.55 -48.17 57.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.728 1.211 . . . . 0.0 110.051 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.44 -46.94 66.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 123.433 0.458 . . . . 0.0 111.286 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.6 -47.51 47.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 119.507 1.049 . . . . 0.0 109.886 -171.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -27.0 66.81 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.591 0.757 . . . . 0.0 110.618 174.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -65.99 -59.5 3.76 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.296 1.438 . . . . 0.0 110.187 172.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -61.32 -38.63 87.55 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.698 0.681 . . . . 0.0 109.677 -170.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.8 ptp -72.25 -17.83 61.86 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.63 -53.18 8.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 121.088 1.767 . . . . 0.0 109.176 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.83 -46.67 42.38 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 125.545 1.538 . . . . 0.0 109.128 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 16.9 t80 -49.56 -41.08 40.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.27 -0.871 . . . . 0.0 113.195 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -29.04 42.65 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 120.33 1.423 . . . . 0.0 109.325 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' HD11 ' A' ' 37' ' ' LEU . 7.2 mt -78.09 -25.94 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 120.711 -1.243 . . . . 0.0 110.202 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 112' ' ' PHE . 16.6 pt20 -84.32 -2.59 57.3 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.278 1.399 . . . . 0.0 112.165 166.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -92.57 -38.07 12.11 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.278 0.561 . . . . 0.0 110.975 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.59 24.34 3.11 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.059 1.344 . . . . 0.0 112.151 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.243 0.712 0 C-N-CA 124.845 1.258 . . . . 0.0 108.807 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 . . . . . 0 CA--C 1.525 0.01 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.9 mmt -60.7 -25.5 66.45 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.361 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.85 -53.06 62.5 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 118.578 0.626 . . . . 0.0 109.931 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.37 -44.63 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -175.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -76.46 -13.16 60.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 111.799 -171.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.6 91.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.787 0.835 . . . . 0.0 110.677 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -72.66 -9.31 58.46 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -83.22 -57.08 3.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.571 -0.706 . . . . 0.0 109.77 159.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.1 mm? -56.59 -37.19 70.28 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -170.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -51.46 -29.82 17.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.479 1.112 . . . . 0.0 112.279 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.35 4.15 62.04 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 117.025 -1.986 . . . . 0.0 113.615 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.08 102.87 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.395 0 CA-C-N 120.963 2.381 . . . . 0.0 107.978 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -0.59 2.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.331 2.253 . . . . 0.0 113.528 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -117.43 64.27 4.05 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 128.779 2.832 . . . . 0.0 109.993 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -62.73 -17.55 59.63 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.92 3.08 . . . . 0.0 112.822 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.64 -14.15 62.69 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.748 1.219 . . . . 0.0 112.592 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.95 -1.25 1.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.493 1.517 . . . . 0.0 110.295 -172.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -55.97 -58.58 7.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.665 1.586 . . . . 0.0 110.352 -173.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -54.01 -31.18 50.32 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.059 1.744 . . . . 0.0 112.471 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -52.88 -35.76 58.24 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.82 -0.55 . . . . 0.0 110.333 174.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -67.75 -47.62 68.73 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.25 1.42 . . . . 0.0 110.435 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.89 -31.95 73.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.821 1.648 . . . . 0.0 110.345 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -58.15 -57.9 10.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.346 1.058 . . . . 0.0 108.513 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.3 mt -56.93 -46.71 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.4 mt -59.25 -49.65 77.01 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.901 0.773 . . . . 0.0 110.334 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -61.13 -43.05 99.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.791 1.236 . . . . 0.0 110.878 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -66.7 -42.75 85.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.627 1.971 . . . . 0.0 111.211 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 t -59.2 -54.59 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-N 119.26 0.936 . . . . 0.0 108.702 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.65 -1.31 1.78 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.612 0.765 . . . . 0.0 112.945 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.61 -68.1 0.87 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.782 1.233 . . . . 0.0 109.027 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -62.66 -32.91 74.05 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.334 1.853 . . . . 0.0 111.368 -170.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.23 68.42 18.73 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.94 -4.77 15.5 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.382 2.721 . . . . 0.0 113.105 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.01 -14.32 50.97 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.634 -1.291 . . . . 0.0 110.768 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 56' ' ' ILE . 46.0 mt -80.92 149.59 29.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.236 0.925 . . . . 0.0 109.383 171.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -132.3 151.12 77.75 Favored Pre-proline 0 C--O 1.221 -0.42 0 C-N-CA 125.517 1.527 . . . . 0.0 111.78 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.42 132.8 18.15 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.521 2.814 . . . . 0.0 112.365 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -148.84 127.16 12.2 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.03 125.31 35.79 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 168.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -153.54 150.7 28.98 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 119.265 0.939 . . . . 0.0 111.701 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.3 m95 53.9 24.66 4.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.1 t30 65.11 10.25 6.19 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.923 2.089 . . . . 0.0 113.312 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.86 149.09 40.29 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.99 136.32 16.37 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.244 1.962 . . . . 0.0 109.88 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 17.4 ptm -142.89 -176.81 5.04 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.628 1.171 . . . . 0.0 108.11 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -140.35 157.12 46.04 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 117.751 -1.119 . . . . 0.0 108.682 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.1 p -117.07 132.58 56.65 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 120.589 1.541 . . . . 0.0 109.543 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -74.34 95.25 2.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 161.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 44.81 41.75 5.4 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.137 1.775 . . . . 0.0 112.941 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 115.06 -20.63 14.13 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.373 1.463 . . . . 0.0 114.502 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.8 m -77.12 -175.92 3.81 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.63 1.972 . . . . 0.0 110.907 -171.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' H ' HG22 ' A' ' 53' ' ' THR . 21.0 t80 -124.11 22.25 8.73 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.256 -1.527 . . . . 0.0 112.88 -169.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 mt -68.23 8.54 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 127.341 2.256 . . . . 0.0 113.464 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 37' ' ' LEU . 4.5 tt -162.52 148.47 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 121.853 2.115 . . . . 0.0 111.42 172.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.49 154.0 23.44 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.384 0.993 . . . . 0.0 111.433 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.41 170.46 20.06 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.637 1.219 . . . . 0.0 110.947 174.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.14 116.24 3.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.313 1.045 . . . . 0.0 108.827 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.2 p -62.22 130.68 46.5 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 119.907 1.231 . . . . 0.0 109.86 -170.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.4 t -90.53 171.25 9.54 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -55.72 -52.71 62.96 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 167.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -134.87 54.56 1.93 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.5 0.72 . . . . 0.0 109.726 -171.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.466 ' CD2' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER 175.84 170.66 0.37 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.638 2.375 . . . . 0.0 110.271 174.917 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tp -112.99 150.27 32.13 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.589 2.355 . . . . 0.0 106.768 153.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -132.76 121.32 22.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.473 2.709 . . . . 0.0 111.138 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.88 144.1 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 127.273 2.229 . . . . 0.0 111.314 -163.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.9 t -156.82 163.26 25.64 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 159.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.18 -57.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 120.736 0.957 . . . . 0.0 110.511 157.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -150.78 -86.5 0.08 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 171.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.26 -25.9 0.84 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.707 1.203 . . . . 0.0 112.584 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.0 tp -57.4 -41.47 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 121.065 1.757 . . . . 0.0 109.85 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.79 -23.4 10.58 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.445 1.021 . . . . 0.0 113.95 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.9 mm -111.73 -3.56 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.983 2.113 . . . . 0.0 110.237 -172.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.3 m -116.36 -54.31 2.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.349 1.06 . . . . 0.0 109.654 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -78.28 -51.85 9.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.112 2.165 . . . . 0.0 108.288 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -95.39 -3.22 47.5 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -167.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.57 -30.3 70.57 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -69.13 -42.07 76.53 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.984 0.811 . . . . 0.0 109.135 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.44 -45.85 92.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.277 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.0 mt -58.91 -43.41 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.464 0.705 . . . . 0.0 109.67 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.75 -53.47 57.86 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.278 0.631 . . . . 0.0 110.089 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.9 -21.71 62.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.609 0.763 . . . . 0.0 112.014 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.22 8.09 2.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.372 0.987 . . . . 0.0 111.566 170.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.74 37.24 57.54 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 121.142 -0.974 . . . . 0.0 112.043 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -136.8 161.18 36.68 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.055 0.942 . . . . 0.0 110.311 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -122.51 97.57 5.52 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.64 -0.662 . . . . 0.0 110.828 -160.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.87 165.04 7.18 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.518 0.675 . . . . 0.0 111.117 171.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.6 p -105.81 -165.55 1.12 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 157.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -77.62 -4.04 43.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.667 166.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.96 -11.42 0.42 Allowed Glycine 0 CA--C 1.529 0.918 0 CA-C-N 120.444 1.475 . . . . 0.0 115.535 -168.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.19 178.58 9.59 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.116 1.458 . . . . 0.0 110.472 164.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -122.68 144.36 49.19 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 165.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.459 ' HD2' ' NE2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -139.12 154.95 48.19 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 120.625 -1.297 . . . . 0.0 110.047 -170.896 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.466 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 44.3 mm -143.05 142.36 21.68 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -163.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.08 153.05 72.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 CA-C-N 121.01 1.396 . . . . 0.0 109.886 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -69.88 92.1 0.68 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 157.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.38 -59.46 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 126.305 1.842 . . . . 0.0 108.749 166.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -90.52 157.23 44.71 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.803 -159.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.46 114.86 4.06 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.988 1.792 . . . . 0.0 110.886 -172.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.69 119.68 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.828 1.651 . . . . 0.0 107.99 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -76.03 85.83 2.93 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 126.034 1.734 . . . . 0.0 113.072 -173.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -56.01 -43.82 78.11 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 124.348 1.059 . . . . 0.0 110.854 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -56.46 -51.67 67.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.729 1.212 . . . . 0.0 111.872 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -42.73 95.31 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.607 -0.683 . . . . 0.0 109.888 -177.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.302 0.2 OUTLIER -75.93 -24.66 55.55 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.76 -176.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.77 -44.65 85.17 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 120.19 1.359 . . . . 0.0 109.899 171.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -56.53 -50.44 71.84 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.75 0.704 . . . . 0.0 109.688 -175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 ptp -67.1 -35.35 79.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.224 -0.894 . . . . 0.0 113.192 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -49.65 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.651 1.114 . . . . 0.0 109.068 177.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -58.5 -42.72 88.29 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.694 1.198 . . . . 0.0 110.949 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.41 -51.11 67.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.431 -0.795 . . . . 0.0 109.514 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -69.81 -10.4 58.3 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.883 1.219 . . . . 0.0 113.573 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 76.4 mt -75.17 -59.88 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.396 1.078 . . . . 0.0 108.525 161.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -75.7 -15.62 60.27 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 121.601 -0.687 . . . . 0.0 112.737 -165.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.64 -11.14 59.96 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.676 1.99 . . . . 0.0 112.034 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -106.06 15.08 26.92 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.974 2.109 . . . . 0.0 110.498 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.249 1.071 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.091 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.261 5.6 p-80 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 116.264 1.949 . . . . 0.0 116.264 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 mmt -51.62 -34.09 36.07 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.872 1.669 . . . . 0.0 112.311 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.02 -24.5 54.14 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.66 -25.86 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 120.896 0.379 . . . . 0.0 110.333 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -114.43 -5.53 12.88 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.12 1.768 . . . . 0.0 113.122 -173.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.78 -22.79 45.82 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 120.508 -1.37 . . . . 0.0 112.082 -169.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.27 -8.73 54.75 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.762 -0.587 . . . . 0.0 111.848 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -68.0 -57.75 5.64 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 160.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.434 HD12 ' CG ' ' A' ' 20' ' ' ARG . 1.2 mm? -46.63 -50.18 18.0 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.641 1.577 . . . . 0.0 112.964 -175.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -53.06 -29.91 32.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.8 9.68 29.88 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.058 -1.412 . . . . 0.0 114.635 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.409 HD12 HD13 ' A' ' 11' ' ' LEU . 24.4 mt -69.12 111.53 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 120.705 2.252 . . . . 0.0 105.958 167.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.0 -9.43 59.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.815 0.846 . . . . 0.0 113.208 -173.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.83 73.42 34.14 Favored Pre-proline 0 N--CA 1.445 -0.695 0 C-N-CA 125.017 1.327 . . . . 0.0 110.776 -168.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.77 -18.75 53.36 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.749 2.966 . . . . 0.0 114.875 -167.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -64.15 -10.66 24.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.266 0.626 . . . . 0.0 110.533 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -119.28 -6.84 10.33 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.58 1.952 . . . . 0.0 112.039 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.434 ' CG ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -79.95 -49.02 12.47 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.114 -0.991 . . . . 0.0 110.48 -171.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.68 -42.6 79.32 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.774 0.671 . . . . 0.0 110.064 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.52 -56.96 10.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 123.899 0.88 . . . . 0.0 110.426 171.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.3 m -58.43 -38.83 78.26 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.548 1.139 . . . . 0.0 110.629 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -30.87 66.43 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.769 1.628 . . . . 0.0 114.068 171.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -63.75 -51.1 66.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.972 -0.537 . . . . 0.0 109.806 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mp -57.9 -52.62 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.34 -61.34 2.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.536 1.134 . . . . 0.0 109.941 -170.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m -71.36 -31.53 67.44 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.802 -1.094 . . . . 0.0 111.054 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 74.3 t90 -61.31 -48.07 83.07 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.575 1.079 . . . . 0.0 111.316 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.425 HG13 ' HD2' ' A' ' 34' ' ' PHE . 88.0 t -58.15 -48.89 83.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.96 -15.29 63.54 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.77 -62.4 1.55 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.052 0.941 . . . . 0.0 109.529 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 m -68.97 -27.51 65.79 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.774 0.83 . . . . 0.0 110.886 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.507 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -124.21 73.62 58.32 Favored Pre-proline 0 N--CA 1.443 -0.822 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.111 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.8 -5.58 17.45 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.343 2.029 . . . . 0.0 111.763 175.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.63 -36.55 84.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.54 1.136 . . . . 0.0 112.013 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.578 HD22 ' H ' ' A' ' 37' ' ' LEU . 1.4 mm? -78.84 139.59 38.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -172.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -88.59 147.01 38.55 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 171.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.53 142.04 14.35 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.655 2.903 . . . . 0.0 111.348 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -146.8 139.04 24.77 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.738 0.699 . . . . 0.0 109.966 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 ttm -99.85 107.65 19.72 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -125.48 151.39 46.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.946 1.699 . . . . 0.0 107.078 170.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.0 m95 55.78 21.26 4.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.594 1.558 . . . . 0.0 114.749 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.07 26.23 11.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.341 1.056 . . . . 0.0 111.424 -168.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 59' ' ' SER . 44.4 p -119.1 146.91 41.57 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.459 1.504 . . . . 0.0 109.255 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.24 122.19 7.81 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.629 2.219 . . . . 0.0 109.74 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.5 ptm -137.26 167.38 21.7 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.363 0.601 . . . . 0.0 109.998 169.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -127.23 169.74 13.17 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.466 -2.049 . . . . 0.0 105.466 178.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 p -154.31 135.33 13.86 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 120.253 -1.529 . . . . 0.0 107.702 166.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -76.94 114.41 15.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 164.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 44.52 53.88 6.76 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.144 0.978 . . . . 0.0 112.656 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.7 9.07 86.46 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 170.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 55' ' ' ILE . 1.4 t -69.16 -164.65 0.06 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.007 1.403 . . . . 0.0 112.042 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -132.99 22.19 4.15 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 118.358 2.725 . . . . 0.0 118.358 162.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' A' ' 113' ' ' ASN . 10.1 mt -62.22 10.48 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 O-C-N 119.427 -2.046 . . . . 0.0 115.005 -170.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.3 tt -164.33 141.58 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 123.162 2.71 . . . . 0.0 112.048 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.4 140.33 3.83 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.001 1.286 . . . . 0.0 110.977 166.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -132.35 170.15 15.49 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.94 1.296 . . . . 0.0 111.505 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.441 ' HB3' HG22 ' A' ' 45' ' ' THR . 2.8 p -152.87 161.13 42.94 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.678 156.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p -59.69 153.18 20.81 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 171.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 t -144.58 170.55 15.84 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.224 1.012 . . . . 0.0 108.394 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -62.67 -21.95 66.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -156.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.84 14.13 0.73 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.007 0.821 . . . . 0.0 111.844 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -156.52 169.85 23.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.084 1.754 . . . . 0.0 109.693 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.01 145.11 30.63 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 164.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -104.1 117.34 34.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.928 1.24 . . . . 0.0 109.727 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.454 HG11 HD21 ' A' ' 106' ' ' LEU . 39.0 t -128.42 147.96 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 120.282 1.401 . . . . 0.0 107.835 176.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.0 t -167.31 165.58 8.79 Favored Pre-proline 0 C--O 1.243 0.723 0 C-N-CA 125.709 1.604 . . . . 0.0 107.396 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -94.13 -57.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 119.394 0.819 . . . . 0.0 113.211 158.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -147.08 -85.78 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.162 1.385 . . . . 0.0 107.841 -173.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -143.98 -29.26 0.5 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.854 2.462 . . . . 0.0 110.825 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.0 tt -62.04 -41.53 91.45 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 119.451 1.023 . . . . 0.0 111.413 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.25 -19.89 13.69 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.369 1.938 . . . . 0.0 112.928 177.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.6 mm -121.47 -0.41 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.209 1.804 . . . . 0.0 109.767 -172.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.1 m -98.23 -78.77 0.48 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.37 -51.12 10.54 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.643 0.656 . . . . 0.0 109.294 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -65.75 -17.49 64.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.573 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.89 -32.65 63.91 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.31 -40.54 93.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.959 0.885 . . . . 0.0 110.134 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.464 ' HB3' HD11 ' A' ' 105' ' ' LEU . . . -69.74 -38.77 76.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.401 -0.812 . . . . 0.0 111.462 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.26 -46.27 92.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.538 1.135 . . . . 0.0 108.714 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.39 -47.92 82.29 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.049 1.34 . . . . 0.0 111.861 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -63.91 -30.08 71.2 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.716 0.807 . . . . 0.0 112.044 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.25 83.18 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.842 0.746 . . . . 0.0 109.6 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.12 -2.2 3.54 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.161 1.362 . . . . 0.0 112.965 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -92.76 157.69 16.29 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.514 1.657 . . . . 0.0 111.265 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.0 m -118.93 156.55 29.35 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.137 0.975 . . . . 0.0 110.516 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.24 165.9 17.47 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.13 0.972 . . . . 0.0 110.646 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -83.58 -164.55 0.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 165.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -63.41 -27.44 69.3 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.164 -0.96 . . . . 0.0 112.672 165.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.98 -14.03 0.78 Allowed Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.568 0.987 . . . . 0.0 115.568 -156.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 pp -152.79 163.9 38.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.739 1.77 . . . . 0.0 111.05 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.412 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 20.7 p90 -107.17 146.8 30.9 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.559 -0.713 . . . . 0.0 110.061 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -131.78 91.21 2.95 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 123.225 0.61 . . . . 0.0 110.237 -165.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.697 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -79.83 141.97 55.98 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 -176.763 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.23 157.34 41.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.318 2.012 . . . . 0.0 109.95 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -69.1 -16.39 63.66 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -63.71 -38.33 90.7 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.669 0.668 . . . . 0.0 112.45 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -129.64 150.97 77.22 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.945 1.298 . . . . 0.0 108.638 -165.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.38 147.14 17.87 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.311 2.674 . . . . 0.0 113.972 -164.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 m -68.3 126.56 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 121.261 -0.899 . . . . 0.0 109.49 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -79.48 98.63 6.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.836 0.854 . . . . 0.0 110.753 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -61.09 -25.56 67.04 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.311 1.044 . . . . 0.0 112.505 -174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -65.69 -56.03 14.25 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.515 -0.74 . . . . 0.0 110.908 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -61.06 -39.76 91.09 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.543 -0.723 . . . . 0.0 110.841 178.43 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.454 HD21 HG11 ' A' ' 67' ' ' VAL . 2.7 mt -52.2 -53.59 41.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.872 1.669 . . . . 0.0 110.017 176.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -69.51 -42.06 75.21 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.579 -175.138 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -58.82 -44.47 90.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.346 0.976 . . . . 0.0 111.816 -175.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 ptp -73.27 -41.38 63.69 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 118.254 0.479 . . . . 0.0 111.912 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.42 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -71.8 -47.75 54.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -173.705 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.61 -41.08 85.07 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.48 1.036 . . . . 0.0 109.461 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -54.85 -49.57 70.78 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.529 0.332 . . . . 0.0 111.395 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.658 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.3 m120 -62.46 -29.59 70.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.023 0.929 . . . . 0.0 112.413 -175.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.89 -31.3 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.631 1.105 . . . . 0.0 110.701 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -81.6 2.18 30.5 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.028 -1.045 . . . . 0.0 112.196 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -90.65 -40.51 11.85 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.442 -0.786 . . . . 0.0 113.032 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -97.12 23.56 7.22 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.184 1.394 . . . . 0.0 110.451 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 117.404 -1.284 . . . . 0.0 111.326 -177.594 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.23 -28.72 19.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.106 0.962 . . . . 0.0 111.294 172.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.83 -30.25 63.59 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.176 1.39 . . . . 0.0 113.333 177.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.3 t -81.0 -33.26 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.497 1.119 . . . . 0.0 111.485 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -89.04 -16.07 32.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.645 1.178 . . . . 0.0 113.378 -174.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.94 77.85 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.192 0.997 . . . . 0.0 112.025 -167.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.68 -5.61 53.54 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.521 1.528 . . . . 0.0 112.52 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -93.69 -45.39 7.71 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.018 1.281 . . . . 0.0 110.057 161.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.574 HD12 ' HD3' ' A' ' 20' ' ' ARG . 1.3 mm? -49.38 -42.68 42.94 Favored 'General case' 0 CA--C 1.523 -0.085 0 C-N-CA 123.95 0.9 . . . . 0.0 111.316 -176.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -49.7 -36.65 25.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.351 1.06 . . . . 0.0 113.379 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.77 0.42 39.2 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 117.703 -1.609 . . . . 0.0 113.045 -168.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.9 mt -71.71 101.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.88 2.57 2.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.232 1.813 . . . . 0.0 113.512 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.52 72.06 2.5 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 128.379 2.672 . . . . 0.0 111.159 -166.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.68 -11.37 31.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 124.125 3.217 . . . . 0.0 114.664 -172.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -81.99 -9.02 59.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.242 0.617 . . . . 0.0 112.365 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -129.07 -28.12 2.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.569 1.148 . . . . 0.0 112.38 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.574 ' HD3' HD12 ' A' ' 11' ' ' LEU . 3.0 tmm_? -52.71 -45.2 66.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.775 1.23 . . . . 0.0 113.137 -175.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -32.39 73.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.11 0.868 . . . . 0.0 110.816 -174.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -68.92 -41.23 78.43 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.637 1.108 . . . . 0.0 111.844 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.9 m -55.08 -39.78 69.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.594 0.758 . . . . 0.0 109.621 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.89 -35.83 80.92 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.483 1.513 . . . . 0.0 112.095 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -62.35 -48.28 80.48 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.396 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.5 mt -61.91 -44.53 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.666 0.666 . . . . 0.0 109.512 -177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.77 -68.01 0.21 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.961 1.305 . . . . 0.0 108.852 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.2 p -66.18 -28.0 68.43 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.591 1.157 . . . . 0.0 112.932 -170.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 43.9 t90 -56.52 -46.74 80.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.63 1.572 . . . . 0.0 110.889 173.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.48 -37.38 70.02 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 C-N-CA 116.791 -1.964 . . . . 0.0 108.499 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.64 -8.44 0.24 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.601 1.16 . . . . 0.0 113.609 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.28 -65.24 1.0 Allowed 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.89 -1.131 . . . . 0.0 110.716 158.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.97 -34.68 59.8 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.297 0.499 . . . . 0.0 111.995 -161.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.7 66.53 10.11 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 127.511 2.324 . . . . 0.0 109.263 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.17 -6.97 19.84 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.021 2.48 . . . . 0.0 112.42 -172.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -81.7 -11.75 58.92 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.119 0.968 . . . . 0.0 111.849 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.0 mt -74.92 143.45 43.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -119.52 152.51 53.15 Favored Pre-proline 0 C--N 1.322 -0.598 0 C-N-CA 127.718 2.407 . . . . 0.0 107.844 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -75.69 156.79 40.02 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.02 2.48 . . . . 0.0 111.073 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -171.96 106.59 0.21 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 126.327 1.851 . . . . 0.0 106.15 163.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 ppp? -78.03 134.09 37.84 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.321 0.964 . . . . 0.0 108.857 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.97 152.4 38.58 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.112 1.365 . . . . 0.0 109.224 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.6 m95 51.87 34.06 12.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.254 1.022 . . . . 0.0 113.171 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 57.74 20.88 6.83 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.444 1.498 . . . . 0.0 112.123 -173.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.5 p -116.6 148.43 41.87 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.022 1.329 . . . . 0.0 108.588 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.05 144.45 42.55 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.451 2.101 . . . . 0.0 109.136 164.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.2 ptm -160.91 177.62 10.2 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 165.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.43 176.11 8.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.508 1.123 . . . . 0.0 108.134 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.4 p -146.98 134.54 20.95 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.984 -1.072 . . . . 0.0 108.752 172.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.442 ' N ' HG22 ' A' ' 53' ' ' THR . 30.7 t30 -75.83 111.32 11.06 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 165.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 49.18 43.79 22.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.661 0.784 . . . . 0.0 112.768 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.2 76.62 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.082 170.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 55' ' ' ILE . 1.7 t -61.67 -163.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 128.46 2.704 . . . . 0.0 117.349 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -129.11 29.55 5.15 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 157.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.529 ' H ' HG23 ' A' ' 53' ' ' THR . 38.0 mt -60.11 9.16 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 127.129 2.172 . . . . 0.0 114.024 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 tt -159.02 157.94 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 122.647 2.476 . . . . 0.0 112.93 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.61 164.36 23.14 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.841 0.734 . . . . 0.0 112.963 159.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -160.12 177.58 10.55 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.471 1.108 . . . . 0.0 112.142 -170.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.5 p -172.44 148.77 2.08 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.442 1.019 . . . . 0.0 109.172 170.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.1 p -63.96 129.1 38.69 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.428 -0.795 . . . . 0.0 108.975 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 t -97.43 -178.12 4.04 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 158.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -54.44 -65.49 0.57 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.686 -0.634 . . . . 0.0 110.281 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -101.82 2.17 37.98 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -164.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.464 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 6.8 p-80 -160.41 149.75 17.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.25 1.02 . . . . 0.0 109.556 -166.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -89.71 143.19 27.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 161.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.57 141.39 51.75 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.183 0.993 . . . . 0.0 110.275 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -159.46 155.79 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.003 0.921 . . . . 0.0 112.939 -167.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 29.5 t -163.08 165.53 14.57 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.295 1.838 . . . . 0.0 108.093 168.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.46 -56.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 121.853 1.702 . . . . 0.0 111.781 159.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -146.07 -86.17 0.11 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -138.28 -37.56 0.56 Allowed 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.77 1.628 . . . . 0.0 109.936 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.5 tt -57.27 -35.57 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.078 0.854 . . . . 0.0 111.42 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.58 -20.86 8.12 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 126.998 2.237 . . . . 0.0 113.444 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.5 mm -118.15 -14.7 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 127.185 2.194 . . . . 0.0 110.001 -172.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.8 m -81.92 -79.83 0.17 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.023 0.929 . . . . 0.0 109.542 166.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -87.9 -48.08 8.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -164.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -63.94 -19.21 64.96 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.08 -31.86 61.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.611 -1.185 . . . . 0.0 113.145 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -67.91 -52.47 35.98 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.857 0.753 . . . . 0.0 109.684 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.41 82.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.593 0.757 . . . . 0.0 110.982 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.31 -43.75 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.288 1.035 . . . . 0.0 109.699 175.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.15 80.99 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.06 0.944 . . . . 0.0 110.901 -173.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -27.76 57.71 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.015 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.94 8.56 22.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.044 0.838 . . . . 0.0 112.14 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.66 36.82 24.97 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 121.191 -0.943 . . . . 0.0 112.527 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -125.41 154.47 41.89 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.083 0.953 . . . . 0.0 109.721 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.9 t -114.49 124.38 51.76 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.393 0.615 . . . . 0.0 110.746 -163.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.77 159.75 22.43 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.358 0.663 . . . . 0.0 110.728 174.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -118.7 -162.59 0.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.593 1.957 . . . . 0.0 106.153 164.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.466 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -64.59 -31.3 72.46 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 169.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -151.64 -6.07 0.15 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 114.218 0.447 . . . . 0.0 114.218 -156.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.9 pp -146.06 161.82 39.28 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.643 1.577 . . . . 0.0 108.006 169.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -122.15 157.27 31.9 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.464 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -132.03 142.4 49.55 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.504 -177.339 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.6 mp -105.58 142.2 24.25 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.02 151.45 44.76 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.029 2.486 . . . . 0.0 109.578 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -64.61 -19.05 65.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -31.51 72.74 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.88 1.218 . . . . 0.0 112.478 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.66 161.85 37.61 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 123.961 0.904 . . . . 0.0 110.181 -161.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.64 161.6 43.54 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.559 1.506 . . . . 0.0 110.862 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.4 t -89.24 130.71 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.07 89.21 4.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.176 1.39 . . . . 0.0 109.366 -176.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -67.24 -31.7 72.23 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.636 1.174 . . . . 0.0 112.532 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.51 -51.21 70.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.611 1.164 . . . . 0.0 109.753 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -68.28 -41.18 81.38 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 120.611 1.551 . . . . 0.0 110.865 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -50.18 51.87 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 123.473 0.709 . . . . 0.0 109.121 176.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -58.63 -55.48 34.55 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.988 1.315 . . . . 0.0 110.006 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -59.17 -35.74 74.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.492 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -87.8 -6.82 57.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 117.496 -1.24 . . . . 0.0 113.718 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.89 -54.23 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 120.977 1.717 . . . . 0.0 109.224 172.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -53.15 -48.6 67.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.023 1.329 . . . . 0.0 109.777 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -52.77 -45.81 67.28 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.24 -34.65 73.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.004 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.13 -52.03 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -72.23 -15.03 61.93 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.32 -37.9 27.61 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.49 1.516 . . . . 0.0 110.705 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.54 23.29 3.07 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.7 2.4 . . . . 0.0 111.821 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 124.523 1.129 . . . . 0.0 108.921 168.215 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.71 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.7 m -62.39 140.4 58.55 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.517 1.159 . . . . 0.0 109.257 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -150.57 -31.88 0.18 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.781 -0.628 . . . . 0.0 112.073 174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 mmt -56.02 -41.38 74.82 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.56 -28.51 55.35 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.857 1.263 . . . . 0.0 113.945 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.62 -53.3 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -81.58 -28.66 33.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.68 1.592 . . . . 0.0 112.556 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.95 0.93 14.14 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.807 1.643 . . . . 0.0 112.087 -171.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 41.3 mt-10 -86.99 -35.44 18.81 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.012 1.325 . . . . 0.0 109.332 167.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.32 -41.09 25.47 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -175.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -51.4 -37.84 50.4 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.233 1.413 . . . . 0.0 112.376 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 12.0 mtmt -61.85 -46.07 91.06 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.049 0.939 . . . . 0.0 110.901 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.55 -9.05 73.2 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.095 1.331 . . . . 0.0 113.729 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.82 103.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 165.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.11 3.43 10.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.097 1.359 . . . . 0.0 112.811 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -116.6 73.83 6.02 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 128.873 2.869 . . . . 0.0 109.705 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.01 -28.05 19.74 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.231 3.287 . . . . 0.0 111.433 -168.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.437 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 26.0 m-20 -64.98 -15.84 62.7 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.726 0.81 . . . . 0.0 110.348 -171.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -133.39 5.0 3.73 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.254 1.422 . . . . 0.0 110.22 178.1 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -66.06 -55.64 15.58 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 120.864 -1.148 . . . . 0.0 109.069 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.66 -14.8 15.34 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.7 1.371 . . . . 0.0 114.7 -165.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -43.18 97.39 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.55 1.068 . . . . 0.0 110.869 169.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -57.68 -37.43 73.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.252 1.421 . . . . 0.0 111.377 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -81.4 -20.71 39.88 Favored 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 120.89 -1.132 . . . . 0.0 113.996 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.17 -47.99 79.84 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.0 mt -61.41 -47.72 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.463 1.105 . . . . 0.0 110.227 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.6 mt -56.56 -49.33 75.14 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.676 0.671 . . . . 0.0 111.061 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 p -68.93 -40.0 79.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.241 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -60.19 -47.75 84.63 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.134 1.774 . . . . 0.0 111.401 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.7 t -56.32 -50.14 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 119.076 0.853 . . . . 0.0 108.716 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.78 3.51 1.9 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.57 -54.01 2.39 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.048 1.339 . . . . 0.0 111.003 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -72.73 -32.9 66.03 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.867 1.212 . . . . 0.0 111.047 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.74 57.54 5.9 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 119.311 0.96 . . . . 0.0 110.877 -173.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -65.26 -11.19 28.94 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.05 2.5 . . . . 0.0 113.636 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -12.16 61.12 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.57 -0.706 . . . . 0.0 112.702 175.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 85.7 mt -80.04 156.69 27.0 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.413 1.006 . . . . 0.0 109.889 169.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -129.23 152.58 79.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.506 1.522 . . . . 0.0 109.708 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.25 159.17 53.98 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.605 2.87 . . . . 0.0 113.186 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -161.95 120.19 2.27 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.507 1.523 . . . . 0.0 109.601 171.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.31 109.28 15.67 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.436 1.095 . . . . 0.0 108.381 166.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -135.56 149.32 49.39 Favored 'General case' 0 C--O 1.218 -0.603 0 O-C-N 120.921 -1.112 . . . . 0.0 108.125 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.1 m95 55.52 16.68 1.94 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 64.59 15.34 9.61 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 128.553 2.741 . . . . 0.0 113.848 -167.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.3 p -116.37 161.36 31.93 Favored Pre-proline 0 N--CA 1.44 -0.975 0 C-N-CA 124.72 1.208 . . . . 0.0 109.152 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.62 116.94 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 125.269 3.979 . . . . 0.0 112.13 171.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.3 ptm -128.43 170.3 13.29 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.683 0.754 . . . . 0.0 108.985 161.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.03 165.0 27.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 169.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.7 120.76 13.71 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -171.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -71.95 99.73 2.3 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 167.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 49.02 42.01 20.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.258 1.023 . . . . 0.0 110.674 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.41 -21.09 40.33 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 116.971 -2.016 . . . . 0.0 117.062 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -171.25 0.91 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 122.055 2.928 . . . . 0.0 112.756 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -117.19 26.51 9.72 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.037 -1.039 . . . . 0.0 113.097 -171.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.0 -1.18 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.05 0.94 . . . . 0.0 112.965 -168.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 tt -155.9 142.61 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 119.263 -2.148 . . . . 0.0 112.025 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.55 149.92 21.18 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.527 1.537 . . . . 0.0 109.324 166.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -145.18 178.48 8.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.954 1.377 . . . . 0.0 110.501 170.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.2 153.83 10.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 168.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.3 p -69.13 138.83 54.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.768 -0.583 . . . . 0.0 109.431 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.38 174.36 5.94 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 169.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.471 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -71.37 -5.12 30.22 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.866 -1.146 . . . . 0.0 113.645 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.28 7.49 0.11 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.1 -178.61 6.71 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.027 1.331 . . . . 0.0 108.692 -173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.09 120.06 18.61 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.494 1.118 . . . . 0.0 108.521 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.34 108.77 21.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.911 1.684 . . . . 0.0 109.913 -160.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 99.2 t -129.46 140.28 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.911 1.232 . . . . 0.0 109.504 -162.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 27.8 t -171.26 144.91 1.76 Allowed Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.033 1.733 . . . . 0.0 109.734 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.2 -56.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.616 1.544 . . . . 0.0 111.344 171.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -148.03 -83.77 0.11 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -131.5 -46.38 0.98 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.129 1.372 . . . . 0.0 110.945 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.26 -35.18 52.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 118.839 0.745 . . . . 0.0 112.753 -166.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.9 -24.74 28.03 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.745 1.641 . . . . 0.0 113.169 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 mm -112.93 -3.49 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.776 1.63 . . . . 0.0 109.819 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 m -91.14 -72.59 0.57 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -85.75 -49.23 8.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.425 0.557 . . . . 0.0 109.541 -171.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -69.45 -13.19 62.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.94 -21.61 66.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.83 -44.96 60.79 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.923 0.783 . . . . 0.0 110.645 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.42 -43.21 88.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.664 0.786 . . . . 0.0 110.643 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.39 -41.46 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.963 0.801 . . . . 0.0 110.331 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.25 -55.55 31.88 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.293 0.497 . . . . 0.0 110.319 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.64 -13.12 61.29 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.107 0.963 . . . . 0.0 112.345 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.15 -26.43 60.31 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.679 0.672 . . . . 0.0 110.579 169.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.39 4.97 6.22 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.972 -0.905 . . . . 0.0 113.735 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -112.88 160.88 17.59 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.848 1.324 . . . . 0.0 110.907 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.2 m -91.74 173.03 8.08 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.049 0.939 . . . . 0.0 108.922 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . . . -133.97 -166.19 1.75 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 166.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.2 p -118.96 -168.73 1.61 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 153.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -68.74 -27.64 66.11 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 120.469 -1.395 . . . . 0.0 112.242 166.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.46 -14.14 10.93 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-O 118.795 -1.003 . . . . 0.0 114.432 -163.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.8 pp -156.39 166.59 32.98 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.42 1.61 . . . . 0.0 110.393 170.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 18.0 p90 -103.62 164.98 11.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.416 0.553 . . . . 0.0 109.94 172.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 126.61 22.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.96 142.69 25.18 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 164.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.54 145.79 14.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.995 2.464 . . . . 0.0 108.896 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -56.42 -30.49 62.88 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -170.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -65.83 -26.64 67.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -115.91 162.19 26.9 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.546 0.738 . . . . 0.0 110.125 -164.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -79.98 148.07 19.32 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 CA-C-N 121.125 1.437 . . . . 0.0 113.605 -169.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.6 t -73.69 124.18 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 170.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -74.99 77.23 2.19 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.526 1.13 . . . . 0.0 110.562 169.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -53.13 -40.92 64.56 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 125.145 1.378 . . . . 0.0 111.32 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -57.89 -60.91 2.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.468 1.507 . . . . 0.0 110.984 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.96 -38.72 65.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.759 0.79 . . . . 0.0 110.888 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.269 0.3 OUTLIER -79.93 -27.93 39.78 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 117.198 -1.382 . . . . 0.0 113.171 -176.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -62.01 -42.67 99.4 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.304 1.411 . . . . 0.0 108.402 170.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.64 -52.59 63.31 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.093 0.557 . . . . 0.0 109.613 -174.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.0 ptp -69.51 -36.61 76.62 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.564 -1.207 . . . . 0.0 113.544 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.7 -46.72 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 120.6 1.546 . . . . 0.0 108.876 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.56 -40.11 90.43 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.543 0.611 . . . . 0.0 109.845 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 29.1 t80 -60.96 -50.08 74.83 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.394 0.543 . . . . 0.0 110.783 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -38.31 80.7 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.105 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.9 mt -60.3 -52.28 63.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.092 0.957 . . . . 0.0 110.676 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.4 ' HG2' ' HA ' ' A' ' 112' ' ' PHE . 5.4 pt20 -70.28 -22.54 62.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.041 0.837 . . . . 0.0 111.721 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -83.02 -20.56 34.81 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.311 0.644 . . . . 0.0 111.311 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -96.89 20.05 11.71 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.855 1.662 . . . . 0.0 111.236 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.767 166.61 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.86 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.8 m -65.32 164.05 14.28 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.456 -1.026 . . . . 0.0 112.054 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -156.94 -39.99 0.07 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.101 1.36 . . . . 0.0 110.284 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 30.8 mmm -56.82 -27.04 59.39 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.97 -34.82 70.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 118.337 0.517 . . . . 0.0 111.437 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.59 -44.46 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -78.13 -14.51 59.45 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.46 1.104 . . . . 0.0 112.795 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -34.32 77.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.426 1.491 . . . . 0.0 111.426 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.32 -16.28 61.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.88 1.672 . . . . 0.0 112.848 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -102.26 -37.6 8.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.908 0.883 . . . . 0.0 110.042 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.54 -39.83 65.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.252 0.933 . . . . 0.0 110.571 171.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -58.68 -29.84 66.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.414 0.686 . . . . 0.0 112.034 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.49 -4.52 62.28 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.842 -0.977 . . . . 0.0 114.57 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.3 mm -57.08 132.54 21.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 119.298 1.549 . . . . 0.0 109.334 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.73 -49.33 75.47 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.816 1.646 . . . . 0.0 108.724 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -141.15 143.95 32.85 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.42 -22.66 24.67 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.454 2.77 . . . . 0.0 111.264 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -6.16 13.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.61 173.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -125.29 -9.16 6.99 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -64.42 -60.81 2.72 Favored 'General case' 0 CA--C 1.519 -0.228 0 O-C-N 121.184 -0.947 . . . . 0.0 110.441 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -45.86 -44.55 14.47 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.122 2.169 . . . . 0.0 111.292 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -57.82 -48.1 80.72 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.042 -0.411 . . . . 0.0 110.397 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.0 m -65.67 -45.22 83.73 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.04 1.336 . . . . 0.0 109.885 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.96 -41.27 61.96 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.796 1.239 . . . . 0.0 112.282 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -60.29 -52.68 64.24 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.377 0.535 . . . . 0.0 109.695 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -61.72 -41.49 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.437 1.095 . . . . 0.0 110.056 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.88 -57.1 13.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.303 0.501 . . . . 0.0 110.583 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -60.29 -37.08 79.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 117.833 -1.08 . . . . 0.0 109.808 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 67.1 t90 -59.31 -59.4 5.52 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.797 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.412 HG11 ' CE1' ' A' ' 48' ' ' PHE . 28.3 t -52.64 -46.8 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 120.224 1.374 . . . . 0.0 110.697 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.2 -29.86 69.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.048 0.539 . . . . 0.0 112.012 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.45 -61.14 2.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.994 0.918 . . . . 0.0 110.537 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -65.86 -32.05 73.35 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.427 1.491 . . . . 0.0 111.849 -169.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -127.33 63.75 59.46 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 118.664 0.665 . . . . 0.0 109.253 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.68 -8.56 23.91 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.585 2.857 . . . . 0.0 113.923 -163.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.29 -26.51 62.0 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.262 -0.899 . . . . 0.0 111.799 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.1 mt -65.81 149.76 49.65 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -130.97 150.02 75.39 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 127.025 2.13 . . . . 0.0 110.719 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.12 152.76 40.59 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.329 2.686 . . . . 0.0 113.191 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.35 126.56 6.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.465 1.906 . . . . 0.0 108.967 167.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.34 102.77 15.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 170.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -149.93 141.23 23.21 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.968 -1.083 . . . . 0.0 111.139 -167.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 16.3 m95 54.84 21.96 3.94 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.881 1.272 . . . . 0.0 111.927 -161.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 53.42 14.69 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.828 1.651 . . . . 0.0 112.807 -162.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.7 p -97.87 148.84 35.05 Favored Pre-proline 0 C--O 1.238 0.493 0 CA-C-N 119.703 1.138 . . . . 0.0 109.352 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.24 100.43 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.924 3.083 . . . . 0.0 110.939 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.3 ptm -118.88 164.93 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.413 0.685 . . . . 0.0 109.672 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.412 ' CE1' HG11 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -131.39 169.67 15.72 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 173.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.9 m -141.77 138.86 32.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.858 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -76.28 94.09 3.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.128 1.331 . . . . 0.0 108.388 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 51.48 15.17 0.31 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.646 1.578 . . . . 0.0 114.73 -170.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.79 -20.61 4.3 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 117.896 -1.502 . . . . 0.0 113.941 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -78.16 141.83 38.42 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 121.12 2.46 . . . . 0.0 111.309 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -66.62 29.56 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.039 2.936 . . . . 0.0 116.966 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.25 0.37 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 125.32 1.448 . . . . 0.0 113.17 -167.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 tt -160.6 145.39 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 121.793 2.088 . . . . 0.0 113.516 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.29 136.08 3.92 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 121.466 -0.771 . . . . 0.0 112.337 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -136.01 167.55 21.01 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.093 1.357 . . . . 0.0 110.58 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.8 p -159.24 160.76 35.7 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 54.9 p -75.76 113.99 13.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.05 171.71 13.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 164.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -63.75 -32.69 74.26 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.291 -0.881 . . . . 0.0 111.717 -175.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -137.1 10.57 3.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.371 1.468 . . . . 0.0 113.149 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -156.8 -177.35 6.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.065 1.346 . . . . 0.0 108.839 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tp -124.17 121.43 35.09 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.558 1.543 . . . . 0.0 107.684 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.461 ' HB2' HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -79.03 133.59 36.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 116.238 -1.839 . . . . 0.0 109.417 170.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.8 t -140.37 149.41 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 120.128 1.331 . . . . 0.0 110.566 172.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 t -160.42 158.87 26.01 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.58 1.152 . . . . 0.0 108.959 157.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -79.67 -57.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.098 0 CA-C-N 120.711 1.29 . . . . 0.0 110.519 165.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -138.16 -88.44 0.24 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 164.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -147.34 -36.15 0.23 Allowed 'General case' 0 N--CA 1.474 0.725 0 O-C-N 121.341 -0.85 . . . . 0.0 111.836 -163.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -25.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 123.549 0.74 . . . . 0.0 110.394 165.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.57 -35.93 38.25 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.823 0.725 . . . . 0.0 111.545 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.1 mm -110.43 13.46 8.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.32 1.448 . . . . 0.0 110.841 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.6 m -129.51 -33.57 1.86 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 170.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -63.6 1.33 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.407 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 11.2 m-85 -79.86 0.41 31.21 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.61 -31.42 64.28 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -72.07 -48.52 43.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.75 0.786 . . . . 0.0 109.778 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.2 -42.83 91.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.822 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.53 -48.52 85.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.082 0.953 . . . . 0.0 109.749 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -51.45 70.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.468 0.707 . . . . 0.0 109.706 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -64.82 -37.83 88.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.85 1.26 . . . . 0.0 111.642 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.04 -22.76 67.08 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.951 0.796 . . . . 0.0 111.693 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.12 9.49 10.58 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-O 118.525 -1.153 . . . . 0.0 114.104 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -113.07 95.93 5.66 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.484 1.642 . . . . 0.0 113.251 -162.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.62 105.58 0.06 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 129.251 3.02 . . . . 0.0 113.355 174.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.34 175.87 6.94 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.733 2.013 . . . . 0.0 112.802 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.1 p -94.67 -164.85 1.22 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.108 1.363 . . . . 0.0 107.618 156.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -76.63 -19.31 57.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 117.079 -1.439 . . . . 0.0 112.588 166.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.94 -7.84 4.9 Favored Glycine 0 N--CA 1.47 0.958 0 CA-C-N 120.388 1.449 . . . . 0.0 115.054 -162.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 66' ' ' SER . 2.9 pp -151.54 161.61 42.39 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 164.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -99.45 165.79 11.48 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 166.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.5 153.2 44.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 121.774 -0.579 . . . . 0.0 109.637 169.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.11 143.74 34.63 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -71.64 149.52 55.22 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.496 2.797 . . . . 0.0 110.409 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -57.86 -41.33 82.22 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -54.15 -44.04 71.1 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.024 0.93 . . . . 0.0 112.17 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.83 146.86 32.59 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -159.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.04 139.1 23.78 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.268 1.312 . . . . 0.0 112.052 -163.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -69.69 150.17 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.325 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -109.92 73.66 0.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.328 1.051 . . . . 0.0 111.873 -161.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -58.01 -24.16 57.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.709 0.804 . . . . 0.0 112.962 -171.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -68.09 -60.2 2.67 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.091 -1.006 . . . . 0.0 110.3 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.44 -45.14 62.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.229 1.412 . . . . 0.0 109.076 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -53.97 50.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.835 1.254 . . . . 0.0 111.553 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -68.6 -40.13 80.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 117.484 -1.246 . . . . 0.0 111.786 -172.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -45.62 -57.06 4.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.541 0.736 . . . . 0.0 110.249 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.407 ' HE1' ' HB2' ' A' ' 77' ' ' PHE . 23.4 ptp -72.47 -42.63 64.73 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 118.046 -0.978 . . . . 0.0 112.888 -170.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -42.65 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 120.074 1.306 . . . . 0.0 109.689 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -64.17 -39.92 95.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.967 -0.54 . . . . 0.0 109.923 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -62.22 -46.89 86.85 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.349 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -21.22 63.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.09 1.314 . . . . 0.0 112.261 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.99 -61.6 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.456 1.102 . . . . 0.0 108.49 167.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -75.67 -2.9 31.65 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -171.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.3 -20.14 65.58 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.829 -1.169 . . . . 0.0 110.82 164.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -105.29 5.88 32.34 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.194 1.398 . . . . 0.0 111.344 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 124.697 1.199 . . . . 0.0 108.148 178.457 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.875 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -61.51 175.63 0.58 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.936 0.874 . . . . 0.0 110.629 162.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -147.27 -31.13 0.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.614 1.165 . . . . 0.0 109.87 163.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -6.33 15.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -64.15 -57.49 9.4 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.5 -42.53 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.877 1.671 . . . . 0.0 110.086 -167.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -93.99 -0.48 55.51 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.577 -169.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.58 -39.98 81.86 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.61 0.764 . . . . 0.0 109.609 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -66.33 -20.58 66.13 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -81.56 -55.21 4.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.2 -38.86 77.57 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.751 -0.642 . . . . 0.0 111.893 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -58.1 -33.05 68.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.396 0.678 . . . . 0.0 110.737 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.1 -3.24 82.78 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.529 1.061 . . . . 0.0 112.493 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.6 mt -77.69 90.79 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 171.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -76.11 8.19 3.48 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.182 2.193 . . . . 0.0 113.224 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -116.13 69.3 3.7 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 129.67 3.188 . . . . 0.0 108.767 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.97 -17.16 54.99 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 125.109 3.872 . . . . 0.0 113.856 -167.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.19 -16.39 59.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.135 0.88 . . . . 0.0 111.553 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -131.96 8.73 4.46 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.794 0.725 . . . . 0.0 112.326 -171.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -77.11 -62.33 1.69 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.308 1.443 . . . . 0.0 109.612 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.31 -32.55 38.27 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.134 2.174 . . . . 0.0 112.282 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -47.38 -53.46 13.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.805 0.842 . . . . 0.0 110.14 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.0 m -65.02 -29.24 70.13 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.74 -0.6 . . . . 0.0 111.277 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -72.45 -28.18 62.78 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 120.855 -1.153 . . . . 0.0 111.875 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.21 -54.66 43.12 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.676 1.125 . . . . 0.0 108.526 168.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -49.72 -53.22 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.169 0.987 . . . . 0.0 110.007 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.0 mt -64.63 -50.03 68.72 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.915 -170.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -69.47 -28.0 65.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.136 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -61.69 -60.39 3.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.413 HG11 ' CZ ' ' A' ' 48' ' ' PHE . 37.8 t -48.5 -45.57 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.05 0.841 . . . . 0.0 111.526 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.15 -13.03 5.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.4 -50.58 2.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.509 1.924 . . . . 0.0 111.483 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.9 -35.03 79.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.928 0.785 . . . . 0.0 110.832 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -128.81 74.53 80.73 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.66 -13.1 34.42 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.872 1.715 . . . . 0.0 110.81 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -86.22 33.2 0.61 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.442 2.297 . . . . 0.0 111.158 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 56' ' ' ILE . 51.1 mt -122.02 134.49 54.8 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 120.686 -1.258 . . . . 0.0 109.189 156.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -104.89 149.47 37.57 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 124.621 1.168 . . . . 0.0 109.41 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.71 154.83 49.38 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.599 2.866 . . . . 0.0 112.169 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -162.84 114.18 1.51 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.607 1.163 . . . . 0.0 108.534 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.0 mtp -82.22 121.49 26.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 166.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -138.65 138.44 37.81 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.9 m95 48.84 34.42 5.31 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.532 1.133 . . . . 0.0 112.165 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.26 18.09 10.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.471 1.908 . . . . 0.0 111.19 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.5 p -118.63 149.53 46.47 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.434 1.494 . . . . 0.0 109.304 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.49 106.68 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.251 3.301 . . . . 0.0 110.925 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.2 ptm -114.59 175.85 5.3 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.236 -0.915 . . . . 0.0 110.309 168.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' HG11 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -139.04 156.12 47.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 170.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.63 122.43 27.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -72.09 95.5 1.64 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 57.21 -3.32 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.93 -24.16 0.25 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 127.492 2.472 . . . . 0.0 113.67 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.61 -164.94 0.78 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.856 1.828 . . . . 0.0 114.718 -167.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -131.95 25.44 4.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.58 1.952 . . . . 0.0 111.445 -170.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.7 mt -65.4 -3.54 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.574 1.95 . . . . 0.0 111.725 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.439 HG21 HD13 ' A' ' 37' ' ' LEU . 6.1 tt -155.94 163.77 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 119.448 -2.033 . . . . 0.0 109.647 169.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.75 132.72 1.55 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -138.91 169.46 17.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.668 1.734 . . . . 0.0 110.085 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.59 161.83 38.15 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 159.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.4 p -65.09 149.19 50.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 165.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 t -137.47 168.25 20.03 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -58.7 -30.08 67.14 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -153.227 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -136.36 13.49 3.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.378 1.071 . . . . 0.0 112.638 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -158.32 168.74 26.18 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.143 -0.973 . . . . 0.0 110.38 -166.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.2 tp -107.63 123.22 48.16 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.82 122.19 31.96 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.824 1.193 . . . . 0.0 108.524 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.0 t -135.32 137.43 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.256 1.022 . . . . 0.0 108.516 -174.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.4 p -163.05 165.26 15.01 Favored Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 127.108 2.163 . . . . 0.0 109.851 154.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.43 -56.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.139 1.226 . . . . 0.0 113.005 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -148.48 -83.2 0.11 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.56 1.073 . . . . 0.0 108.11 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -146.97 -27.97 0.39 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.804 1.241 . . . . 0.0 112.216 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.1 tp -63.7 -31.94 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 120.791 -1.193 . . . . 0.0 111.37 176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -48.47 -26.06 4.89 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 126.815 2.15 . . . . 0.0 113.324 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 mm -125.62 7.32 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.167 1.387 . . . . 0.0 109.944 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 t -84.8 -71.56 0.51 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 170.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -88.09 -50.8 6.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -170.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -67.89 -15.33 63.57 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.32 -30.33 38.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.449 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -69.37 -59.47 2.97 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 118.556 0.617 . . . . 0.0 109.94 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.47 -35.48 74.17 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.476 0.58 . . . . 0.0 112.456 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.82 -48.82 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.929 0.891 . . . . 0.0 109.576 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.22 -47.45 86.06 Favored 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 121.488 -0.758 . . . . 0.0 110.902 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -61.4 -16.22 44.48 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 128.253 2.621 . . . . 0.0 111.631 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.68 4.28 50.07 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 112.454 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.33 14.63 47.25 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.261 0.934 . . . . 0.0 114.719 169.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -112.78 90.64 3.4 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.863 1.332 . . . . 0.0 111.701 -168.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 m -53.28 98.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.225 2.61 . . . . 0.0 113.619 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.78 -172.95 4.46 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.78 1.632 . . . . 0.0 112.238 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.7 p -111.15 -164.77 0.94 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.468 1.907 . . . . 0.0 106.694 163.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -80.29 -22.59 41.44 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.939 -1.101 . . . . 0.0 112.93 161.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.16 -28.33 6.53 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.29 -1.284 . . . . 0.0 114.805 -168.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 pp -154.31 172.53 17.51 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.208 2.004 . . . . 0.0 110.226 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -114.57 166.36 11.8 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 120.824 -1.172 . . . . 0.0 109.006 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.78 133.22 20.75 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.95 143.44 26.14 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 168.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.08 157.88 60.0 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.189 1.926 . . . . 0.0 109.925 172.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -61.07 -25.04 66.66 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.33 -0.856 . . . . 0.0 112.006 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -57.88 -62.46 1.79 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.044 1.737 . . . . 0.0 111.696 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -91.57 165.43 20.92 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 125.995 1.718 . . . . 0.0 111.814 -163.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.33 149.25 85.08 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.367 2.045 . . . . 0.0 110.672 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 p -96.94 127.07 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.17 83.34 7.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.462 1.125 . . . . 0.0 111.156 -169.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -57.03 -35.85 69.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.285 1.434 . . . . 0.0 110.222 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -39.33 77.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.486 -0.759 . . . . 0.0 112.339 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -49.06 46.79 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 122.03 0.919 . . . . 0.0 108.641 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.296 0.3 OUTLIER -75.82 -24.08 55.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.138 -169.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -37.71 88.44 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 120.535 1.516 . . . . 0.0 110.565 171.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -56.29 -52.0 66.13 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.102 0.865 . . . . 0.0 109.708 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.9 ptp -68.89 -36.75 78.42 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.312 -172.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -46.76 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 121.159 1.8 . . . . 0.0 109.262 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.75 -47.4 85.84 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.814 0.846 . . . . 0.0 110.352 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -61.87 -40.36 95.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.245 0.475 . . . . 0.0 110.643 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -24.62 66.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.042 0.837 . . . . 0.0 111.36 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 99.3 mt -79.24 -49.43 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.256 1.422 . . . . 0.0 108.905 169.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -61.38 -29.02 69.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.633 1.173 . . . . 0.0 110.826 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -82.97 -19.32 37.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.744 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -93.84 -1.21 55.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.983 1.713 . . . . 0.0 112.212 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 C--O 1.247 0.937 0 C-N-CA 128.546 2.738 . . . . 0.0 110.704 173.415 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.787 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -78.68 159.22 28.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.456 1.128 . . . . 0.0 108.607 163.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -138.95 -33.15 0.65 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.092 0.557 . . . . 0.0 111.412 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.6 mmt -57.16 -14.07 3.69 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.005 1.322 . . . . 0.0 113.142 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -74.06 -30.25 62.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 120.506 -1.371 . . . . 0.0 112.407 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.9 t -70.64 -33.2 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 124.181 0.926 . . . . 0.0 108.745 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -102.61 -2.41 28.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.896 1.278 . . . . 0.0 112.343 -171.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.88 72.12 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 122.382 1.087 . . . . 0.0 110.359 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.46 -12.92 62.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.434 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -75.45 -57.0 4.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.121 0.873 . . . . 0.0 109.978 167.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.77 -44.38 73.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.917 1.287 . . . . 0.0 111.603 -174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -53.68 -32.25 50.94 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.6 -18.22 66.56 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.519 -168.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.7 mt -69.37 114.61 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.78 6.0 14.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.747 1.219 . . . . 0.0 111.71 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.79 74.58 75.68 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 128.013 2.525 . . . . 0.0 110.046 -170.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -59.43 -30.85 93.66 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.094 2.529 . . . . 0.0 112.757 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.428 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 57.4 m-20 -70.03 -1.92 11.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.286 1.034 . . . . 0.0 112.308 -177.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 13.9 m80 -132.6 -30.72 1.42 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.294 1.838 . . . . 0.0 109.751 -176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.26 -48.56 45.75 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.64 1.576 . . . . 0.0 110.548 169.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.69 -36.96 82.39 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.329 0.393 . . . . 0.0 111.767 -168.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -63.78 -30.55 71.63 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.853 -0.529 . . . . 0.0 111.725 175.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.0 m -71.52 -41.65 68.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.859 0.864 . . . . 0.0 109.5 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -50.43 -43.64 55.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.169 0.895 . . . . 0.0 111.903 168.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.89 -27.5 69.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.342 0.974 . . . . 0.0 112.751 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.4 mt -73.53 -47.13 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.74 -63.41 1.21 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.86 0.864 . . . . 0.0 109.744 -169.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -64.37 -25.52 68.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.583 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -68.36 -42.25 79.46 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.208 0.913 . . . . 0.0 110.457 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.57 HG11 ' CD2' ' A' ' 48' ' ' PHE . 41.2 t -59.74 -48.4 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.9 0.773 . . . . 0.0 109.034 174.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.76 -29.37 68.13 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.11 -56.56 4.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.896 -0.503 . . . . 0.0 110.818 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -78.9 -28.99 44.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.792 1.637 . . . . 0.0 111.655 -165.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -131.62 64.42 72.86 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.187 0.995 . . . . 0.0 108.749 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.71 -13.03 31.96 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.673 2.249 . . . . 0.0 113.09 -171.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -74.13 -18.16 60.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.827 0.74 . . . . 0.0 112.253 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.6 mt -69.27 152.98 44.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -124.84 142.73 41.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.19 137.36 28.58 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.213 1.942 . . . . 0.0 110.479 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -147.32 135.66 21.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.356 1.062 . . . . 0.0 108.268 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.63 114.01 27.92 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 175.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.34 146.94 31.81 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.432 1.093 . . . . 0.0 108.079 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.6 m95 55.54 21.11 4.19 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.868 1.213 . . . . 0.0 114.115 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.2 t30 57.67 17.9 4.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 112.598 -165.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 59' ' ' SER . 68.5 p -110.74 142.99 27.3 Favored Pre-proline 0 N--CA 1.449 -0.516 0 O-C-N 120.532 -1.355 . . . . 0.0 109.361 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.31 128.66 15.83 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.532 2.155 . . . . 0.0 110.083 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.6 ptm -142.37 168.82 18.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.98 0.912 . . . . 0.0 109.021 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.57 ' CD2' HG11 ' A' ' 30' ' ' VAL . 1.8 m-85 -140.14 91.55 2.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -172.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 p -65.07 122.66 17.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -71.54 91.01 1.03 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.862 1.21 . . . . 0.0 108.338 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 48.8 18.14 0.18 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.653 1.181 . . . . 0.0 113.717 -170.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.39 -16.73 2.92 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.303 1.906 . . . . 0.0 115.621 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.12 -167.98 1.17 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 120.355 2.078 . . . . 0.0 112.811 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -128.99 43.82 3.08 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.155 1.382 . . . . 0.0 110.408 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.8 mt -75.73 -1.46 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.706 1.602 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 tt -164.92 157.59 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 119.746 -1.846 . . . . 0.0 112.542 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.35 136.2 2.19 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 165.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -131.09 163.76 26.94 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.231 1.015 . . . . 0.0 111.227 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.426 ' HB3' HG22 ' A' ' 45' ' ' THR . 2.4 p -149.48 156.68 42.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.886 0.85 . . . . 0.0 110.388 163.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 53.1 p -59.4 145.26 44.23 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.183 0.993 . . . . 0.0 108.685 167.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 m -133.56 177.61 7.57 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.205 1.402 . . . . 0.0 107.834 168.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.38 -57.22 8.46 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.145 0.978 . . . . 0.0 112.102 -167.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -126.19 4.29 7.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.119 0.968 . . . . 0.0 112.748 -173.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.501 ' CD2' ' HE ' ' A' ' 94' ' ' ARG . 4.1 p-80 -145.81 168.42 20.82 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.096 1.758 . . . . 0.0 108.445 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.2 tp -88.19 169.32 11.99 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 160.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 p -120.09 127.67 52.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.781 1.173 . . . . 0.0 108.136 160.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.417 ' HB ' ' CE1' ' A' ' 93' ' ' PHE . 92.8 t -135.19 148.0 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.2 t -165.94 165.37 10.79 Favored Pre-proline 0 C--O 1.241 0.631 0 C-N-CA 128.399 2.68 . . . . 0.0 105.947 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -83.16 -57.35 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.338 0 CA-C-N 120.153 1.09 . . . . 0.0 111.225 152.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -147.23 -86.34 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.9 -32.97 0.34 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.338 1.455 . . . . 0.0 111.7 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.77 -35.31 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 119.961 1.255 . . . . 0.0 111.064 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.97 -16.26 24.42 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.59 0.614 . . . . 0.0 113.817 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.1 mm -112.17 -14.44 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 126.735 2.014 . . . . 0.0 110.278 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.4 m -104.37 -55.6 2.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.0 0.52 . . . . 0.0 110.248 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -81.2 -63.49 1.39 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.427 ' CG ' ' HG3' ' A' ' 109' ' ' MET . 12.5 m-85 -72.94 -9.2 58.45 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.499 -0.48 . . . . 0.0 112.014 -170.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.28 -30.89 63.07 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.372 0.533 . . . . 0.0 112.23 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -63.92 -44.15 93.76 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 118.439 0.563 . . . . 0.0 110.295 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.508 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -77.53 -29.46 52.35 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.114 -175.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.1 mt -60.22 -48.68 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.684 1.194 . . . . 0.0 108.324 168.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.66 73.13 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.967 0.907 . . . . 0.0 110.712 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -58.06 -30.04 65.88 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.744 0.818 . . . . 0.0 111.983 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.39 95.9 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.502 1.046 . . . . 0.0 110.862 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 132.25 -11.1 5.31 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 127.283 2.373 . . . . 0.0 111.465 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -86.93 174.0 9.0 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 120.93 -1.335 . . . . 0.0 112.747 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.2 t -127.53 175.09 8.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.486 1.914 . . . . 0.0 109.297 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.61 -176.41 4.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.064 1.746 . . . . 0.0 110.618 -166.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.8 p -132.01 -168.75 2.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.796 1.638 . . . . 0.0 108.225 168.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.72 5.92 12.15 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.655 -1.278 . . . . 0.0 113.409 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.08 -14.19 0.03 OUTLIER Glycine 0 CA--C 1.524 0.644 0 CA-C-N 119.544 1.065 . . . . 0.0 115.186 -171.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.6 pp -159.81 -173.37 4.06 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.691 1.246 . . . . 0.0 109.644 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.417 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 12.2 p90 -135.0 165.63 24.91 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.875 -1.141 . . . . 0.0 111.66 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.501 ' HE ' ' CD2' ' A' ' 64' ' ' HIS . 1.8 mmt-85 -139.92 91.24 2.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.721 1.208 . . . . 0.0 111.658 -157.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -86.2 141.1 34.74 Favored Pre-proline 0 C--O 1.239 0.54 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.09 155.77 26.07 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.114 2.543 . . . . 0.0 110.516 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -63.35 -19.89 65.03 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -68.58 -44.96 73.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.759 1.163 . . . . 0.0 111.105 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -90.32 150.24 42.64 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 123.609 0.764 . . . . 0.0 109.85 -159.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.73 123.41 5.83 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.777 2.984 . . . . 0.0 112.169 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.1 m -68.6 9.69 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -166.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 43.76 81.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 128.043 2.537 . . . . 0.0 114.285 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -60.33 -27.71 67.57 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.957 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.72 -56.06 18.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.986 0.514 . . . . 0.0 110.813 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.508 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -61.6 -46.76 88.47 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.595 0.712 . . . . 0.0 109.518 -173.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -27.43 62.14 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.811 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -58.46 -55.86 29.59 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 119.681 1.128 . . . . 0.0 108.933 165.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -59.68 -37.72 79.56 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.044 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.427 ' HG3' ' CG ' ' A' ' 77' ' ' PHE . 6.1 ttm -53.18 -61.19 2.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.532 1.933 . . . . 0.0 111.303 172.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -45.88 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.745 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.74 -46.59 74.32 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.828 0.851 . . . . 0.0 109.435 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.8 -47.97 81.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.389 0.276 . . . . 0.0 111.385 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -20.22 63.27 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.544 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 91.1 mt -78.24 -63.62 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.159 0.984 . . . . 0.0 109.177 165.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -71.37 -13.18 61.78 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -164.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.57 -35.99 82.78 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.979 0.512 . . . . 0.0 109.688 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -79.65 7.03 9.17 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.765 2.026 . . . . 0.0 112.428 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 128.263 2.625 . . . . 0.0 112.212 -162.648 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.856 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 m -70.61 173.41 7.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.594 0.758 . . . . 0.0 109.918 169.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -159.14 -37.82 0.06 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.311 -1.328 . . . . 0.0 113.813 -176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.32 -36.56 43.23 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 120.814 1.643 . . . . 0.0 112.151 174.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -45.88 -44.58 14.56 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.099 0.959 . . . . 0.0 113.228 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.61 -50.57 43.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -80.24 -9.68 59.73 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -165.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.44 90.5 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.393 1.477 . . . . 0.0 111.446 -167.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.39 -21.99 66.74 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.157 0.983 . . . . 0.0 112.897 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -81.28 -55.1 4.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -51.83 -40.99 61.43 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.682 1.193 . . . . 0.0 111.777 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -58.38 -46.87 85.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.402 0.681 . . . . 0.0 110.431 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.87 -4.77 88.48 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.97 1.272 . . . . 0.0 113.86 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.2 mt -65.22 95.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 164.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.11 3.08 3.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.937 1.295 . . . . 0.0 112.855 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -105.63 75.89 0.33 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 C-N-CA 129.316 3.046 . . . . 0.0 109.212 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.48 -19.86 65.52 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.77 2.313 . . . . 0.0 112.781 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.68 2.33 30.1 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.077 1.351 . . . . 0.0 112.612 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -145.09 15.91 1.53 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.154 1.382 . . . . 0.0 110.127 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -91.11 -50.64 5.73 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.882 1.673 . . . . 0.0 109.569 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -53.91 -26.75 26.65 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 126.593 1.957 . . . . 0.0 113.469 -167.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -52.66 -55.62 21.23 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -58.32 -34.96 71.17 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.525 -0.734 . . . . 0.0 112.499 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -41.16 96.61 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.017 0.927 . . . . 0.0 111.298 172.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.9 -54.63 42.69 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.099 0.863 . . . . 0.0 109.521 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -52.46 -51.12 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.757 0.823 . . . . 0.0 109.937 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.9 mt -63.07 -51.89 64.88 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.714 0.406 . . . . 0.0 110.04 -171.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -65.29 -33.18 75.37 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 123.2 0.313 . . . . 0.0 110.511 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -64.97 -48.36 74.3 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.16 0.984 . . . . 0.0 110.89 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 48' ' ' PHE . 24.7 t -52.75 -47.73 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 118.793 0.724 . . . . 0.0 109.814 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.23 13.58 0.41 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.21 -34.83 0.52 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.748 1.219 . . . . 0.0 114.068 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.5 m -75.92 -39.46 56.18 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.009 -1.057 . . . . 0.0 108.876 168.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -122.87 70.46 39.13 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 122.203 1.001 . . . . 0.0 110.914 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.85 -4.72 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.041 2.494 . . . . 0.0 112.923 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -79.4 -17.8 53.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.33 1.852 . . . . 0.0 113.11 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.444 HD12 HG13 ' A' ' 30' ' ' VAL . 43.5 mt -80.93 144.92 31.54 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.566 -1.334 . . . . 0.0 109.785 175.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -119.8 143.99 36.26 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.024 1.73 . . . . 0.0 110.141 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.51 148.09 37.15 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.655 2.903 . . . . 0.0 113.762 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -153.7 119.4 5.28 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.982 1.313 . . . . 0.0 110.649 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.71 103.5 9.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.375 1.07 . . . . 0.0 108.823 170.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -135.32 149.33 49.73 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.265 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.7 m95 55.73 16.26 1.92 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 66.95 27.48 8.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.891 2.077 . . . . 0.0 112.239 -170.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.0 p -130.82 152.71 81.04 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.91 1.684 . . . . 0.0 108.162 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.29 112.68 3.6 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 124.573 3.515 . . . . 0.0 110.209 170.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.3 ptm -122.84 170.6 9.93 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.753 -0.592 . . . . 0.0 109.772 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CZ ' HG11 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -138.95 167.73 21.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.645 0.736 . . . . 0.0 109.258 176.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.2 p -140.85 112.31 7.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 123.173 0.589 . . . . 0.0 111.444 -165.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.81 102.09 3.3 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 47.39 40.44 10.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.128 0.971 . . . . 0.0 111.579 -171.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.87 -2.32 66.41 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.772 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.5 m -82.65 177.74 8.55 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.272 2.036 . . . . 0.0 109.723 -177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.427 ' H ' HG22 ' A' ' 53' ' ' THR . 62.0 t80 -102.88 9.1 39.05 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.334 -1.479 . . . . 0.0 114.378 -170.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.75 8.58 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.261 0 C-N-CA 127.604 2.361 . . . . 0.0 114.178 -162.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 tt -154.21 150.5 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 O-C-N 117.806 -3.059 . . . . 0.0 111.464 165.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.95 153.32 24.44 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 162.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -147.97 161.4 41.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.147 1.473 . . . . 0.0 110.212 170.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.72 155.84 41.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.518 0.675 . . . . 0.0 110.092 172.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.3 p -66.84 154.33 41.16 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.041 1.336 . . . . 0.0 109.343 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB3' ' CD2' ' A' ' 64' ' ' HIS . 31.2 t -133.9 163.99 28.29 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 156.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -48.12 -40.5 23.8 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.321 1.048 . . . . 0.0 113.517 -168.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -124.95 8.59 8.08 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.413 ' CD2' ' HB3' ' A' ' 61' ' ' SER . 7.7 p-80 -158.55 157.46 32.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.118 0.872 . . . . 0.0 112.315 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.9 tp -85.57 156.9 20.55 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 166.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.23 112.34 16.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.151 1.38 . . . . 0.0 109.906 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.1 t -126.78 141.08 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.236 2.214 . . . . 0.0 110.721 -166.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.5 t -164.45 159.58 15.84 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 108.361 164.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.34 -58.48 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 120.524 1.223 . . . . 0.0 111.138 166.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -134.81 -86.25 0.39 Allowed 'General case' 0 C--O 1.233 0.211 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 168.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -136.96 -30.84 0.86 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.984 1.714 . . . . 0.0 111.69 -172.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -62.35 -32.27 54.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 119.321 0.964 . . . . 0.0 111.781 -165.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.51 -29.52 57.55 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.638 1.589 . . . . 0.0 113.52 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.7 mm -98.13 -5.74 9.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.868 1.667 . . . . 0.0 110.114 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.0 m -97.47 -80.22 0.45 Allowed 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 124.853 1.261 . . . . 0.0 108.879 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -83.68 -37.35 22.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.715 1.143 . . . . 0.0 110.159 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 109' ' ' MET . 59.8 m-85 -80.82 -11.4 59.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.292 0.496 . . . . 0.0 111.82 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.78 67.96 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.734 0.814 . . . . 0.0 113.173 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.38 -52.04 44.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.37 80.63 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.789 0.836 . . . . 0.0 111.597 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.63 -52.34 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.997 0.817 . . . . 0.0 109.237 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.54 -48.64 80.11 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.419 0.688 . . . . 0.0 110.275 -175.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -52.8 -44.17 66.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.56 1.544 . . . . 0.0 111.326 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.17 -5.92 30.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.352 0.661 . . . . 0.0 112.401 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.01 9.52 53.86 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.146 1.355 . . . . 0.0 112.801 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -99.62 163.43 12.5 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.133 1.467 . . . . 0.0 111.208 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.8 m -124.51 93.08 3.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.965 -151.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . . . -80.04 165.36 22.62 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.367 -0.833 . . . . 0.0 112.01 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.0 p -103.23 -164.35 1.07 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.11 1.764 . . . . 0.0 106.249 152.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 -2.18 51.22 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.693 -1.254 . . . . 0.0 112.256 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.03 -2.42 2.14 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.467 1.032 . . . . 0.0 113.749 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.56 177.69 11.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.289 1.545 . . . . 0.0 109.101 162.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 13.1 p90 -124.16 164.23 19.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.59 -0.694 . . . . 0.0 110.779 166.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.65 152.44 48.09 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 121.885 -0.509 . . . . 0.0 111.815 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.3 mm -123.47 142.88 39.97 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.39 150.99 25.73 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.564 2.176 . . . . 0.0 111.53 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -61.89 -20.95 64.3 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.87 -34.95 72.15 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.588 -0.695 . . . . 0.0 111.843 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.99 159.99 44.73 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 122.845 0.458 . . . . 0.0 109.794 -151.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.13 139.35 13.36 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-O 123.503 1.376 . . . . 0.0 111.946 -157.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.47 111.04 20.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 85.61 0.67 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.679 1.192 . . . . 0.0 112.541 -175.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -63.21 -38.53 91.55 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.064 1.346 . . . . 0.0 111.311 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -58.09 9.93 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.454 0.702 . . . . 0.0 110.19 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.99 -41.61 98.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.096 -172.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.275 0.2 OUTLIER -75.66 -26.16 57.44 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.432 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.438 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -68.21 -35.51 78.08 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 121.088 1.767 . . . . 0.0 110.934 174.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -56.42 -59.19 5.33 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.774 0.716 . . . . 0.0 109.543 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . 22.2 ptp -62.22 -43.26 99.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.64 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -68.9 -46.24 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 118.855 0.752 . . . . 0.0 109.206 -174.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -65.92 -40.58 91.57 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.716 1.143 . . . . 0.0 110.743 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.94 -47.27 85.62 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.366 0.53 . . . . 0.0 110.693 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.02 -13.38 11.22 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.735 0.814 . . . . 0.0 110.905 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 62.9 mt -95.74 -49.77 12.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-N 120.063 1.301 . . . . 0.0 110.342 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -72.15 3.48 4.48 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.147 1.34 . . . . 0.0 112.579 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -87.91 -15.82 35.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.52 1.528 . . . . 0.0 112.511 164.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -113.18 32.55 5.66 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.525 1.53 . . . . 0.0 110.136 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.331 157.502 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.757 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -64.64 173.71 2.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.903 -0.763 . . . . 0.0 110.413 171.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -136.99 -42.32 0.58 Allowed 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.809 -0.557 . . . . 0.0 112.363 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.4 mmt -59.05 -33.37 70.7 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -172.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.71 -36.49 72.06 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.56 0.618 . . . . 0.0 112.431 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.95 -45.24 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.048 0.939 . . . . 0.0 109.486 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -90.9 -9.42 46.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -167.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.75 91.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.396 1.479 . . . . 0.0 111.789 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.25 -27.08 63.65 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.727 1.211 . . . . 0.0 112.327 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -77.36 -50.57 12.48 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.642 0.777 . . . . 0.0 109.651 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.18 -50.33 62.06 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.608 1.163 . . . . 0.0 109.852 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -58.34 -42.85 87.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.008 0.923 . . . . 0.0 110.688 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.14 -35.86 91.07 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.759 -1.578 . . . . 0.0 114.208 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -54.75 108.74 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -73.34 -3.49 27.45 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.961 1.304 . . . . 0.0 112.611 -171.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 76.05 33.18 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 127.363 2.265 . . . . 0.0 108.7 -170.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.8 -21.56 72.47 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.313 2.675 . . . . 0.0 113.391 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.469 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 6.3 m-20 -63.89 -19.84 65.38 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.611 0.641 . . . . 0.0 111.734 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 3.7 m80 -123.61 -24.03 4.63 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.428 1.491 . . . . 0.0 110.18 -170.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -48.79 -45.58 40.37 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.305 1.042 . . . . 0.0 110.228 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.02 -32.73 9.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.815 1.646 . . . . 0.0 113.424 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -67.31 -14.38 62.87 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.35 -1.469 . . . . 0.0 112.387 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.5 m -100.98 -35.72 9.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.716 1.206 . . . . 0.0 109.789 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -26.2 63.57 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.426 0.557 . . . . 0.0 111.38 172.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -55.82 -62.58 1.6 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.634 1.574 . . . . 0.0 110.156 168.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 mt -57.58 -42.81 82.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 124.45 1.1 . . . . 0.0 112.466 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.11 -49.76 75.83 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.259 0.936 . . . . 0.0 110.036 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -65.57 -36.79 84.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 118.161 -0.923 . . . . 0.0 112.155 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -57.65 -53.55 56.91 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.158 0.89 . . . . 0.0 111.028 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.685 HG11 ' CE2' ' A' ' 48' ' ' PHE . 72.2 t -63.01 -41.69 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 O-C-N 121.196 -0.94 . . . . 0.0 109.689 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.83 5.03 2.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.522 1.129 . . . . 0.0 113.722 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.69 -62.76 1.49 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.619 1.568 . . . . 0.0 110.456 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.1 m -63.65 -32.04 73.4 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.604 1.093 . . . . 0.0 111.871 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -121.72 66.13 19.49 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 119.703 1.138 . . . . 0.0 110.806 -172.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.07 -10.88 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.228 3.285 . . . . 0.0 112.539 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -58.97 -22.03 59.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.916 2.087 . . . . 0.0 113.755 163.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 110' ' ' ILE . 35.6 mt -89.46 160.58 16.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -134.79 149.52 70.88 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 126.786 2.035 . . . . 0.0 108.866 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.61 146.25 66.64 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 122.826 2.351 . . . . 0.0 112.194 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -158.02 119.13 3.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.027 1.331 . . . . 0.0 108.219 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -84.01 119.04 24.46 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -141.49 136.29 31.09 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.671 -0.643 . . . . 0.0 109.939 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.6 m95 56.35 24.0 7.89 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.5 t30 69.89 9.55 7.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.001 2.12 . . . . 0.0 112.909 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -111.91 143.94 29.69 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 125.299 1.44 . . . . 0.0 109.208 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -70.28 125.91 12.4 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.154 1.902 . . . . 0.0 111.782 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.6 ptm -133.0 171.42 13.99 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.433 1.093 . . . . 0.0 108.904 169.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.685 ' CE2' HG11 ' A' ' 30' ' ' VAL . 3.2 m-85 -138.22 105.62 5.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.15 125.71 29.51 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 120.514 -1.366 . . . . 0.0 109.45 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -72.82 83.96 1.21 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 53.08 -19.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 118.829 2.9 . . . . 0.0 118.829 -162.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.49 40.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -168.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.99 -176.58 3.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.011 0.906 . . . . 0.0 110.053 174.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -124.84 32.03 5.53 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.827 1.651 . . . . 0.0 111.132 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.1 mt -70.13 -0.92 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.187 1.395 . . . . 0.0 111.671 -168.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.1 tt -161.59 147.26 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 O-C-N 119.636 -1.915 . . . . 0.0 111.962 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.73 156.11 27.26 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 158.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.3 155.2 41.82 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.365 -1.079 . . . . 0.0 111.642 169.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 t -142.87 153.48 43.19 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.3 p -70.81 159.65 34.18 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.582 1.153 . . . . 0.0 109.81 171.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -146.18 179.78 7.27 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.402 1.481 . . . . 0.0 109.29 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -56.41 -60.24 3.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.075 0.95 . . . . 0.0 112.086 -169.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -121.6 8.7 10.11 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.994 0.918 . . . . 0.0 111.255 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -152.55 172.85 15.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.493 1.117 . . . . 0.0 109.058 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 tp -101.01 158.94 15.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.471 1.909 . . . . 0.0 107.785 166.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 92' ' ' LEU . 46.2 p -124.93 113.11 17.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.974 1.261 . . . . 0.0 111.045 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.23 146.02 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 125.449 1.5 . . . . 0.0 109.408 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.0 t -165.79 157.55 12.41 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.781 1.633 . . . . 0.0 107.335 167.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.1 -56.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.209 0 N-CA-C 109.117 -1.147 . . . . 0.0 109.117 160.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -151.34 -85.32 0.08 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -140.54 -49.47 0.44 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.38 1.872 . . . . 0.0 110.779 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.3 tt -57.91 -34.26 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 121.509 -0.744 . . . . 0.0 111.829 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -44.57 -48.23 8.83 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 172.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mm -91.49 -2.53 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.529 1.132 . . . . 0.0 110.877 -168.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.3 m -105.96 -54.79 2.42 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 120.543 -1.348 . . . . 0.0 111.4 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -78.34 -56.81 4.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.959 1.704 . . . . 0.0 106.84 -170.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -80.63 -18.66 47.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.691 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.57 -21.92 54.37 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.78 -61.28 2.28 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.04 -36.89 68.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.111 0.964 . . . . 0.0 112.27 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.69 -45.33 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.782 1.233 . . . . 0.0 110.254 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.9 -52.62 64.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -21.9 64.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 178.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.29 -21.29 62.96 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.308 0.958 . . . . 0.0 110.716 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.07 10.24 5.28 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.36 -1.245 . . . . 0.0 113.709 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.69 122.33 47.53 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.2 2.0 . . . . 0.0 110.868 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.7 p -75.69 85.13 2.7 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.126 0.97 . . . . 0.0 110.89 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.65 171.23 0.66 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.83 0.852 . . . . 0.0 110.985 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.2 p -101.81 -172.35 2.13 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 167.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -82.85 -19.79 36.85 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 118.063 -0.97 . . . . 0.0 113.023 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -121.23 -14.86 4.83 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 119.079 0.854 . . . . 0.0 113.895 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 66' ' ' SER . 4.6 pp -150.61 164.85 35.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.934 1.694 . . . . 0.0 109.39 167.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -106.85 160.45 15.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.56 1.073 . . . . 0.0 110.55 170.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.81 141.85 23.04 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.865 -0.522 . . . . 0.0 110.139 -166.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.77 143.51 43.89 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -172.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.53 151.84 82.07 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.586 1.524 . . . . 0.0 109.896 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -64.32 -26.13 68.34 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.843 -0.599 . . . . 0.0 112.338 168.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -62.8 -70.0 0.23 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.696 0.798 . . . . 0.0 111.73 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.82 157.53 87.2 Favored Pre-proline 0 C--O 1.236 0.347 0 O-C-N 123.213 0.32 . . . . 0.0 110.228 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.17 161.29 46.47 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.188 1.925 . . . . 0.0 111.182 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.54 136.59 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.02 2.128 . . . . 0.0 108.764 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.86 102.38 5.5 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 163.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -73.56 -15.77 61.28 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.09 0.859 . . . . 0.0 111.207 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -66.62 -65.5 0.67 Allowed 'General case' 0 CA--C 1.527 0.096 0 O-C-N 121.196 -0.94 . . . . 0.0 111.154 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.26 -38.94 77.91 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -46.01 -45.58 15.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.571 2.748 . . . . 0.0 113.863 172.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -71.3 -48.02 53.22 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 125.567 1.547 . . . . 0.0 109.306 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.39 -49.27 78.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -172.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.1 ptp -70.49 3.77 2.81 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.069 1.747 . . . . 0.0 114.616 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -120.46 -48.56 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 120.555 1.525 . . . . 0.0 109.412 175.209 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -59.59 -45.51 91.68 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.564 1.074 . . . . 0.0 109.008 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -56.63 -49.49 74.83 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 119.669 -0.205 . . . . 0.0 110.536 172.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -18.65 65.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.798 -0.62 . . . . 0.0 112.387 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mt -82.58 -55.46 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -70.97 -12.58 61.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.058 0.845 . . . . 0.0 112.577 -172.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.39 -21.69 48.96 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.506 1.122 . . . . 0.0 111.345 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -93.12 34.75 1.1 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.896 2.078 . . . . 0.0 109.78 174.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.634 1.573 . . . . 0.0 110.963 167.64 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.728 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -69.63 178.17 2.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.269 0.628 . . . . 0.0 110.327 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -114.54 -39.77 3.73 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.478 0.711 . . . . 0.0 109.55 164.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.8 mmt -53.7 -34.04 57.49 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.073 0.949 . . . . 0.0 112.036 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -57.09 -42.94 81.64 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.331 0.969 . . . . 0.0 111.93 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.4 -40.38 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.863 0.865 . . . . 0.0 110.432 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -97.18 -19.93 18.29 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -167.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.51 -33.7 76.5 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.629 1.104 . . . . 0.0 111.529 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.84 -43.17 48.69 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.861 1.264 . . . . 0.0 111.695 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -72.24 -43.72 63.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.451 0.7 . . . . 0.0 110.496 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.83 -47.16 80.96 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -55.54 -43.25 75.61 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.908 0.483 . . . . 0.0 110.697 173.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.82 -24.82 71.6 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.97 -0.906 . . . . 0.0 112.872 -174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.3 mt -64.32 110.24 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 119.302 1.551 . . . . 0.0 107.715 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -72.71 -8.04 53.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.468 1.907 . . . . 0.0 113.939 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.73 70.64 1.71 Allowed Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 126.191 1.796 . . . . 0.0 109.691 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.94 -29.21 87.59 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.965 3.11 . . . . 0.0 113.883 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.07 -8.29 11.45 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.733 0.697 . . . . 0.0 112.218 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -123.77 -13.36 7.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.813 1.645 . . . . 0.0 110.107 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.79 -56.34 9.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.965 1.306 . . . . 0.0 109.681 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -62.63 -30.54 71.43 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.64 0.776 . . . . 0.0 112.069 -161.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -50.45 21.58 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.189 1.395 . . . . 0.0 111.578 169.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 m -59.87 -44.73 94.01 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.549 1.54 . . . . 0.0 111.355 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -35.87 46.48 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.124 2.17 . . . . 0.0 112.883 175.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -68.55 -48.71 63.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.043 0.537 . . . . 0.0 111.539 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mt -55.83 -49.99 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 123.953 0.783 . . . . 0.0 109.341 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 mt -56.61 -49.17 75.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.21 0.459 . . . . 0.0 110.524 -171.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 t -65.49 -40.24 92.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.376 0.671 . . . . 0.0 111.213 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -63.18 -39.32 94.31 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.647 0.779 . . . . 0.0 111.01 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.755 HG11 ' CE2' ' A' ' 48' ' ' PHE . 54.9 t -58.77 -47.33 89.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-O 118.41 -0.805 . . . . 0.0 108.891 174.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.68 -8.76 15.8 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.328 0.967 . . . . 0.0 113.155 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.36 -60.24 1.56 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.221 1.008 . . . . 0.0 111.177 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 m -69.78 -38.82 76.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.569 1.077 . . . . 0.0 110.439 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.436 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -123.9 65.18 35.64 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -173.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.17 -10.3 28.67 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.318 2.012 . . . . 0.0 111.772 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.56 -28.67 66.19 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.838 1.255 . . . . 0.0 112.84 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.642 HD21 ' CD1' ' A' ' 114' ' ' ILE . 3.5 mm? -69.35 146.84 51.82 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 171.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -124.9 147.99 58.34 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.22 148.73 31.05 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.107 2.538 . . . . 0.0 112.323 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -163.82 82.46 0.44 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.412 1.485 . . . . 0.0 107.251 172.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -70.75 134.43 47.42 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.016 -1.678 . . . . 0.0 108.53 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -154.97 152.8 30.13 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.571 1.148 . . . . 0.0 110.337 -170.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.8 m95 47.89 28.98 1.51 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.257 1.423 . . . . 0.0 112.767 -171.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 67.47 24.68 8.7 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.449 1.9 . . . . 0.0 112.492 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.402 HG22 ' HB3' ' A' ' 59' ' ' SER . 26.7 p -124.57 143.2 42.63 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 125.358 1.463 . . . . 0.0 109.267 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.8 124.88 10.03 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.844 2.362 . . . . 0.0 108.93 164.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.0 ptm -137.09 163.36 30.99 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 167.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.755 ' CE2' HG11 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -127.2 158.97 35.69 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 175.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 m -128.21 124.44 36.73 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -173.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -74.78 84.42 2.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.257 16.6 mt-30 64.34 -11.51 0.12 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.878 2.071 . . . . 0.0 114.884 -176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.73 -9.84 0.02 OUTLIER Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.202 1.382 . . . . 0.0 116.056 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.84 -166.98 1.56 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.242 1.521 . . . . 0.0 114.115 -163.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -126.48 26.37 6.35 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.978 1.711 . . . . 0.0 110.841 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.39 -2.02 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 O-C-N 120.114 -1.616 . . . . 0.0 112.657 -171.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.425 HD12 HG13 ' A' ' 110' ' ' ILE . 10.1 tt -161.08 142.69 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 121.716 2.053 . . . . 0.0 111.795 170.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.22 157.74 29.36 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 161.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -147.27 141.42 26.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.276 1.038 . . . . 0.0 109.224 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -134.45 114.25 12.69 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.037 -1.04 . . . . 0.0 108.446 -176.218 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.8 p -54.75 134.73 47.7 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.212 0.915 . . . . 0.0 110.613 -168.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -112.49 163.95 13.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -54.51 -27.04 35.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.679 1.592 . . . . 0.0 113.796 -165.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -137.71 0.24 2.21 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.132 0.973 . . . . 0.0 113.383 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -153.17 158.33 41.63 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.382 0.992 . . . . 0.0 110.137 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -104.48 113.12 26.47 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.427 ' HB2' HD22 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -71.07 131.25 43.35 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 167.026 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.7 t -135.32 138.44 48.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 t -167.86 153.16 6.79 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 125.175 1.39 . . . . 0.0 107.405 161.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.67 -57.61 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 CA-C-N 119.971 1.025 . . . . 0.0 110.699 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -146.24 -79.95 0.16 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -139.63 -38.37 0.48 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.367 1.467 . . . . 0.0 111.614 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -27.86 43.24 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 118.81 0.732 . . . . 0.0 112.422 -166.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -46.56 -43.26 15.11 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.029 0.824 . . . . 0.0 111.155 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 mm -91.31 -11.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 121.998 -0.707 . . . . 0.0 110.235 -168.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.9 m -107.98 -57.19 2.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.151 0.887 . . . . 0.0 110.471 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.76 -60.87 2.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.569 1.948 . . . . 0.0 107.415 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 109' ' ' MET . 59.8 m-85 -77.49 5.99 7.9 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.25 -48.69 12.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.944 1.697 . . . . 0.0 111.775 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -73.42 -41.09 63.71 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.109 0.964 . . . . 0.0 109.132 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -58.95 -43.21 91.21 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.054 0.942 . . . . 0.0 110.169 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.8 mt -66.8 -43.31 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 120.027 1.285 . . . . 0.0 109.493 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.86 -57.02 14.29 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.556 1.143 . . . . 0.0 110.795 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.94 -25.05 68.16 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.404 1.082 . . . . 0.0 112.802 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.39 -17.26 63.66 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.696 0.68 . . . . 0.0 111.281 173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.14 9.21 5.7 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.347 1.927 . . . . 0.0 113.398 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -134.18 111.89 10.66 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 119.087 1.444 . . . . 0.0 110.705 -161.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.7 m -76.59 15.6 0.61 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.985 -1.697 . . . . 0.0 114.541 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 52.46 -155.24 0.18 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.398 1.879 . . . . 0.0 112.548 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.5 p -125.59 -164.35 1.29 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.074 2.15 . . . . 0.0 105.952 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -81.82 -10.29 59.37 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.558 -1.21 . . . . 0.0 112.943 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.79 13.8 0.19 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-N 120.333 1.424 . . . . 0.0 115.235 -167.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 66' ' ' SER . 3.9 pp -166.05 178.97 6.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 130.332 3.453 . . . . 0.0 106.29 162.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -119.84 166.22 13.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 120.235 1.38 . . . . 0.0 108.368 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 171.53 14.18 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.463 -0.773 . . . . 0.0 109.667 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -133.59 143.71 48.99 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 103.952 -2.611 . . . . 0.0 103.952 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.95 159.17 51.04 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 CA-C-N 120.785 1.316 . . . . 0.0 109.227 169.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -63.56 -15.91 59.36 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.301 -0.874 . . . . 0.0 112.562 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -66.7 -19.96 65.87 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.407 2.283 . . . . 0.0 114.217 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -135.28 162.8 55.31 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-N 119.476 1.035 . . . . 0.0 111.373 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.66 133.83 26.71 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.573 2.849 . . . . 0.0 110.519 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.04 145.81 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 167.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.86 90.33 8.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.554 1.541 . . . . 0.0 108.556 -172.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -58.57 -31.97 68.49 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.531 -0.731 . . . . 0.0 109.714 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -69.65 -36.21 75.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.173 -0.954 . . . . 0.0 112.813 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.468 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -84.07 -32.67 24.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.317 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.329 0.3 OUTLIER -83.18 -23.46 32.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 117.354 -1.308 . . . . 0.0 111.289 -177.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -65.79 -48.53 71.47 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 120.729 1.604 . . . . 0.0 109.725 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -60.49 -31.63 70.66 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -159.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . 22.1 ptp -83.49 -29.01 28.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.425 HG13 HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -79.83 -44.57 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 119.348 0.977 . . . . 0.0 109.348 -177.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.34 -40.06 73.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.682 0.674 . . . . 0.0 109.533 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -71.61 -54.03 11.75 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.859 1.264 . . . . 0.0 112.036 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -65.17 -21.7 66.81 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 119.644 1.111 . . . . 0.0 111.789 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.642 ' CD1' HD21 ' A' ' 37' ' ' LEU . 47.9 mt -68.93 -54.97 17.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 118.864 0.756 . . . . 0.0 109.729 168.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -70.76 -13.46 62.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.749 0.704 . . . . 0.0 112.371 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.94 -43.46 92.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.895 1.278 . . . . 0.0 111.124 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.42 12.08 3.23 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.285 2.234 . . . . 0.0 113.564 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.529 1.532 . . . . 0.0 110.33 175.835 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.677 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.7 m -56.91 158.0 5.2 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 121.877 -0.778 . . . . 0.0 110.525 165.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -117.68 -45.69 2.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 117.176 -1.393 . . . . 0.0 111.404 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -47.59 -41.64 22.16 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.226 1.375 . . . . 0.0 111.19 -172.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -54.27 -39.26 66.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.404 0.682 . . . . 0.0 112.56 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.7 t -56.23 -41.52 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.478 0.711 . . . . 0.0 109.744 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -102.19 -6.48 23.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.506 1.122 . . . . 0.0 113.495 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.78 -44.81 63.36 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 123.628 0.771 . . . . 0.0 110.202 -170.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -57.32 -34.91 69.24 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.947 0.899 . . . . 0.0 111.379 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -68.55 -42.9 77.72 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.088 0.955 . . . . 0.0 111.001 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.22 -38.37 86.38 Favored 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 123.937 0.895 . . . . 0.0 110.316 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -56.24 -37.14 69.33 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 122.133 -0.354 . . . . 0.0 110.847 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.18 0.9 88.89 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.079 1.323 . . . . 0.0 113.714 -173.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 mm -66.14 149.47 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.007 1.403 . . . . 0.0 107.312 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.64 -22.88 62.46 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.075 1.35 . . . . 0.0 113.568 -170.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.4 145.18 8.66 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 126.227 1.811 . . . . 0.0 108.724 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.07 -27.66 73.85 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.939 2.426 . . . . 0.0 112.386 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.45 -15.14 47.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.778 -0.576 . . . . 0.0 111.126 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.79 15.2 11.77 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.807 -0.558 . . . . 0.0 110.839 176.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -113.59 -45.09 3.14 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 125.412 1.485 . . . . 0.0 110.883 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -70.77 -5.73 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.603 1.161 . . . . 0.0 112.937 -161.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -102.94 -25.81 13.33 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.324 1.85 . . . . 0.0 112.87 168.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m -61.45 -44.9 96.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.743 0.817 . . . . 0.0 109.522 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.64 -39.0 86.67 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.575 1.15 . . . . 0.0 111.81 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -60.01 -46.95 87.82 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.851 -0.595 . . . . 0.0 110.704 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mt -61.71 -44.91 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.997 0.919 . . . . 0.0 110.455 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.02 -48.09 82.83 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -65.79 -42.87 90.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.25 1.42 . . . . 0.0 110.466 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -63.48 -44.56 94.06 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.25 1.82 . . . . 0.0 110.976 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 t -57.17 -49.21 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.465 1.029 . . . . 0.0 109.297 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.68 2.79 0.88 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.72 -50.23 1.97 Allowed 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.795 1.238 . . . . 0.0 111.435 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 m -70.02 -26.49 64.07 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.715 1.206 . . . . 0.0 109.856 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -131.29 78.53 72.09 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.623 0.769 . . . . 0.0 111.484 -170.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.07 -5.21 16.48 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.86 3.04 . . . . 0.0 114.618 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.6 -20.84 32.99 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.011 -1.056 . . . . 0.0 112.312 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.5 mt -78.36 145.98 34.92 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -123.57 144.77 45.18 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 124.765 1.226 . . . . 0.0 108.031 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.04 162.57 36.81 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.494 2.796 . . . . 0.0 112.745 -172.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -170.04 119.89 0.62 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.212 2.205 . . . . 0.0 105.448 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ptm -95.64 127.45 41.68 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 121.28 1.855 . . . . 0.0 108.005 165.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -136.02 150.63 49.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 124.854 1.262 . . . . 0.0 109.155 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 14.5 m95 61.04 24.73 14.82 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.3 t30 74.53 -0.42 3.35 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 128.295 2.638 . . . . 0.0 111.493 -171.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.7 p -105.31 144.48 28.89 Favored Pre-proline 0 N--CA 1.45 -0.445 0 O-C-N 120.419 -1.426 . . . . 0.0 109.537 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.62 143.27 56.03 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.755 1.637 . . . . 0.0 109.107 164.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 19.1 ptm -145.87 172.75 12.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 164.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.21 152.18 45.78 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 p -129.92 114.25 15.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.444 1.098 . . . . 0.0 108.422 -167.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -70.34 91.56 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.769 1.228 . . . . 0.0 108.071 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 48.11 34.56 4.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.298 0.639 . . . . 0.0 112.507 -170.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.25 -11.39 24.24 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 117.253 -1.859 . . . . 0.0 115.861 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -74.13 -168.43 0.63 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.793 2.297 . . . . 0.0 111.385 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.437 ' H ' HG22 ' A' ' 53' ' ' THR . 36.5 t80 -129.88 18.85 5.58 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.01 1.724 . . . . 0.0 112.476 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mt -70.27 7.61 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 126.099 1.759 . . . . 0.0 111.757 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.433 HD12 HG13 ' A' ' 110' ' ' ILE . 5.3 tt -159.67 143.14 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 O-C-N 119.335 -2.103 . . . . 0.0 111.507 167.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.63 159.97 32.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 162.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -149.63 170.73 17.98 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.045 1.422 . . . . 0.0 110.068 173.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.1 t -153.72 152.95 31.37 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 168.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.1 p -78.87 127.46 32.05 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t -101.51 171.13 7.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.06 -17.92 55.05 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -167.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.46 1.12 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -158.18 154.14 26.89 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.388 0.995 . . . . 0.0 110.461 -168.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 tp -92.74 127.94 38.42 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 167.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.19 119.66 39.08 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.16 139.25 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 127.801 2.44 . . . . 0.0 108.93 -164.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 t -165.33 157.89 13.41 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 125.845 1.658 . . . . 0.0 107.516 167.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.79 -57.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.817 1.678 . . . . 0.0 111.282 161.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -145.94 -86.11 0.11 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 172.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -142.89 -32.55 0.48 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.692 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.41 -34.77 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 120.881 1.673 . . . . 0.0 111.394 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.15 -18.89 29.48 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.654 1.121 . . . . 0.0 113.26 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 mm -111.47 1.6 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 127.185 2.194 . . . . 0.0 109.925 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 m -118.57 -61.34 1.67 Allowed 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.633 -0.667 . . . . 0.0 109.376 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -74.15 -51.99 13.88 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 127.894 2.477 . . . . 0.0 107.647 -173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -85.95 4.32 38.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.605 0.762 . . . . 0.0 112.54 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.3 73.75 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.406 1.082 . . . . 0.0 112.637 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -69.99 -43.33 71.66 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.554 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -62.95 -39.11 93.64 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.829 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.21 -49.6 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.755 0.707 . . . . 0.0 109.816 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.16 69.52 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.041 0.937 . . . . 0.0 110.478 -170.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.63 -22.43 63.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.335 1.454 . . . . 0.0 112.996 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.49 -10.29 59.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.783 0.72 . . . . 0.0 112.039 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.12 11.59 56.08 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.029 0.823 . . . . 0.0 113.977 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -97.77 107.65 20.19 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.563 1.182 . . . . 0.0 111.341 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.12 98.38 0.06 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.044 2.138 . . . . 0.0 111.369 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.96 -176.26 6.24 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.638 1.175 . . . . 0.0 111.535 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 p -118.96 -164.91 1.08 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.161 1.784 . . . . 0.0 107.853 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.406 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -85.53 -9.12 57.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.06 -1.69 2.87 Favored Glycine 0 N--CA 1.462 0.395 0 CA-C-N 119.441 1.019 . . . . 0.0 112.527 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 pp -162.47 176.28 10.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.361 0.664 . . . . 0.0 110.743 170.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -119.09 164.42 15.55 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.398 -0.813 . . . . 0.0 109.495 167.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.7 158.97 44.02 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.915 -1.115 . . . . 0.0 109.58 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.58 142.82 44.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.41 153.65 50.31 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.64 1.56 . . . . 0.0 109.408 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -60.57 -21.63 62.81 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -57.66 -47.5 82.12 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.749 2.02 . . . . 0.0 112.084 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -110.58 162.48 20.43 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.356 1.062 . . . . 0.0 109.519 -161.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.39 148.54 23.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.313 1.342 . . . . 0.0 112.399 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -77.86 143.77 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.93 81.2 5.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.681 1.592 . . . . 0.0 108.468 171.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -56.79 -34.6 67.8 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.344 0.657 . . . . 0.0 110.071 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -60.13 -54.68 43.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.778 0.831 . . . . 0.0 111.288 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.554 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -58.15 -47.15 84.23 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -176.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.339 0.4 OUTLIER -69.1 -29.66 67.79 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 116.877 -1.535 . . . . 0.0 112.352 -176.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -68.98 -42.64 76.28 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 121.094 1.77 . . . . 0.0 110.901 175.213 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -58.8 -39.26 80.6 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.579 1.081 . . . . 0.0 111.953 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.3 ptp -78.73 -38.36 39.08 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 121.72 -0.612 . . . . 0.0 112.548 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -71.34 -51.32 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -173.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -56.78 -44.36 81.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.584 0.753 . . . . 0.0 110.806 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -54.96 -50.9 67.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.667 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -70.51 -1.05 9.71 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.3 mt -96.12 -47.71 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 C-N-CA 125.464 1.506 . . . . 0.0 108.137 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -68.92 -8.24 42.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.536 1.062 . . . . 0.0 112.111 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -91.56 -0.38 57.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.513 1.525 . . . . 0.0 111.762 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -112.33 5.37 18.2 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.561 2.344 . . . . 0.0 111.164 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.121 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 163.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.98 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 m -71.84 150.42 44.31 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 121.79 -0.83 . . . . 0.0 109.187 166.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -142.77 -33.71 0.45 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.166 0.986 . . . . 0.0 112.1 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.7 mmt -61.7 -21.29 64.35 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 117.298 -1.334 . . . . 0.0 112.498 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -65.17 -38.3 90.09 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.254 1.388 . . . . 0.0 110.669 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.28 -40.86 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -96.51 36.83 1.32 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.807 1.643 . . . . 0.0 111.156 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.17 -56.18 2.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.688 1.595 . . . . 0.0 111.682 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.6 -15.65 60.83 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -162.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -73.64 -47.24 41.5 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 125.784 1.634 . . . . 0.0 110.566 164.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.37 -45.53 93.99 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.966 0.906 . . . . 0.0 110.597 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -59.04 -15.58 14.21 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.44 0.12 46.66 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.399 1.952 . . . . 0.0 114.162 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.8 135.56 27.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 119.94 1.87 . . . . 0.0 108.013 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -35.07 79.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.852 1.661 . . . . 0.0 112.293 -175.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.15 143.81 32.35 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.46 -20.12 42.14 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.828 2.352 . . . . 0.0 111.741 172.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.05 -21.48 63.68 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.211 0.46 . . . . 0.0 109.89 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 22' ' ' ARG . 7.7 m80 -116.06 -16.6 11.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.249 0.931 . . . . 0.0 112.079 -175.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -67.05 -57.32 7.06 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 123.641 0.776 . . . . 0.0 111.356 -170.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -44.21 -61.09 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.645 1.978 . . . . 0.0 112.088 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -59.94 -38.55 82.75 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 121.403 -0.811 . . . . 0.0 112.426 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 m -52.8 -50.24 64.01 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.475 0.71 . . . . 0.0 111.347 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -55.81 -46.32 78.1 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.643 1.177 . . . . 0.0 111.121 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -62.69 -40.17 96.28 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 122.838 0.455 . . . . 0.0 111.632 -172.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 mt -57.03 -50.83 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 124.012 0.82 . . . . 0.0 109.451 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.06 -55.3 36.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.602 0.361 . . . . 0.0 110.159 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 m -71.95 -21.43 61.6 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.298 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -69.0 -44.57 72.55 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 120.265 1.393 . . . . 0.0 110.428 170.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.409 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 56.1 t -59.68 -45.6 94.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 119.478 1.035 . . . . 0.0 108.587 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.03 62.83 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.538 0.608 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.29 -61.45 2.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 122.154 -0.341 . . . . 0.0 110.311 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -74.73 -35.69 62.67 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.578 1.551 . . . . 0.0 111.746 -162.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.71 74.47 34.76 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.93 -4.27 14.71 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.567 2.178 . . . . 0.0 112.15 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -28.36 51.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.647 1.179 . . . . 0.0 111.384 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.601 HD22 ' H ' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -75.59 143.62 42.24 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.405 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -96.87 150.83 37.34 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.66 151.93 52.82 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.553 2.168 . . . . 0.0 110.577 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -156.15 130.8 8.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.623 1.569 . . . . 0.0 107.169 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -107.91 96.07 6.12 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.48 147.5 30.39 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 125.977 1.711 . . . . 0.0 107.245 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 3.9 m95 57.41 17.89 4.09 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 172.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 t30 57.76 29.48 17.48 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.861 2.464 . . . . 0.0 112.778 -167.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -126.63 144.99 51.65 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.89 134.09 22.96 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.709 2.939 . . . . 0.0 111.757 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.9 ptm -148.25 172.36 14.48 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.097 0.559 . . . . 0.0 110.52 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -132.77 148.92 52.32 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.9 112.29 11.16 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.665 1.186 . . . . 0.0 108.879 -168.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.82 97.34 1.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 44.84 38.58 2.98 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.404 1.002 . . . . 0.0 111.449 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.01 -10.43 34.18 Favored Glycine 0 CA--C 1.533 1.219 0 CA-C-O 116.771 -2.127 . . . . 0.0 117.057 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.54 -170.13 0.97 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 121.643 2.721 . . . . 0.0 111.414 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -131.54 22.43 4.71 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 119.899 -1.751 . . . . 0.0 112.434 -170.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.32 -2.88 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 127.088 2.155 . . . . 0.0 112.413 -165.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 tt -155.91 132.03 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 119.239 -2.163 . . . . 0.0 109.814 165.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.83 150.0 21.71 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 165.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.88 174.59 10.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.682 1.241 . . . . 0.0 109.935 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -152.15 161.19 43.0 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 159.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.1 p -68.64 159.01 32.89 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 m -138.5 175.04 9.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.834 1.254 . . . . 0.0 108.212 168.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.82 -60.29 2.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.418 1.087 . . . . 0.0 112.89 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -123.56 6.72 8.9 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -172.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -146.78 157.96 43.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.042 1.737 . . . . 0.0 109.332 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.1 tp -88.61 155.77 19.43 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 154.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.46 ' HB2' HD22 ' A' ' 92' ' ' LEU . 11.0 p -115.75 114.81 25.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 116.778 -1.582 . . . . 0.0 109.013 172.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 79.0 t -126.19 144.08 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.832 1.196 . . . . 0.0 110.142 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.3 t -169.21 156.92 6.9 Favored Pre-proline 0 C--O 1.239 0.536 0 C-N-CA 127.069 2.148 . . . . 0.0 108.008 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -74.79 -56.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 120.713 0.942 . . . . 0.0 111.434 161.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -156.37 -80.89 0.07 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -147.33 -30.27 0.33 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -33.81 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 120.662 1.574 . . . . 0.0 110.578 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' A' ' 77' ' ' PHE . . . -44.91 -31.93 2.96 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.016 1.293 . . . . 0.0 112.532 169.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.7 mm -104.63 -0.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.936 1.294 . . . . 0.0 110.785 -168.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.8 m -121.35 -46.41 2.29 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -38.93 36.47 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.434 2.294 . . . . 0.0 109.404 -174.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.408 ' CD1' ' HA2' ' A' ' 73' ' ' GLY . 11.2 m-85 -100.84 5.08 43.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.723 0.809 . . . . 0.0 111.498 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.33 -36.73 76.19 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.121 1.369 . . . . 0.0 111.758 -172.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -72.57 -46.77 52.72 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.625 1.17 . . . . 0.0 108.829 -175.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.76 -41.74 91.69 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.419 0.688 . . . . 0.0 111.388 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.7 mt -61.41 -46.18 97.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.038 0.835 . . . . 0.0 109.575 171.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.28 -49.19 76.65 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 123.702 0.801 . . . . 0.0 110.365 -170.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -62.18 -29.31 70.28 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.965 1.306 . . . . 0.0 112.248 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.5 -22.92 62.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.08 0.854 . . . . 0.0 111.315 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.34 16.49 7.11 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.44 1.495 . . . . 0.0 113.99 170.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -108.97 93.44 4.52 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.488 1.144 . . . . 0.0 112.487 -164.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.6 m -52.27 96.61 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.191 2.196 . . . . 0.0 112.837 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.73 177.84 8.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.927 1.691 . . . . 0.0 112.121 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -100.44 -169.51 1.73 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.405 1.882 . . . . 0.0 107.362 159.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -77.26 -24.23 51.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.818 0.847 . . . . 0.0 112.687 168.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.5 -25.62 5.15 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 123.729 0.681 . . . . 0.0 112.759 -168.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 66' ' ' SER . 4.3 pp -152.77 161.11 42.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.051 0.925 . . . . 0.0 110.057 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -98.07 163.47 12.74 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.703 -0.623 . . . . 0.0 109.523 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -117.95 163.52 16.45 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.51 147.94 67.97 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 162.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -59.83 157.44 33.23 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 121.467 1.56 . . . . 0.0 109.59 159.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -65.08 -46.47 81.01 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.48 -0.763 . . . . 0.0 111.714 166.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -71.06 -21.63 62.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -166.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.02 160.63 29.19 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.49 1.116 . . . . 0.0 108.841 -172.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.71 144.4 19.51 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.614 1.543 . . . . 0.0 112.789 -163.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -84.14 123.96 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.415 1.886 . . . . 0.0 109.339 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -78.29 78.77 4.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.384 1.874 . . . . 0.0 112.917 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -51.98 -47.27 64.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.405 1.082 . . . . 0.0 110.423 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -68.9 -24.89 64.37 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -170.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.27 -56.3 5.75 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.508 1.123 . . . . 0.0 108.69 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.87 -23.75 62.37 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.946 -171.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -50.21 -53.98 24.2 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 127.065 2.146 . . . . 0.0 110.346 162.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -60.51 -47.53 85.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.873 0.76 . . . . 0.0 110.036 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 17.9 ptp -78.36 16.98 0.7 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.274 0.1 OUTLIER -117.12 -47.77 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 O-C-N 120.375 -1.453 . . . . 0.0 107.382 162.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.43 -53.27 60.08 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 111.994 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.39 -46.17 90.92 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 121.72 -0.613 . . . . 0.0 109.443 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -29.39 68.85 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.71 0.804 . . . . 0.0 111.539 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.558 HD11 HD11 ' A' ' 37' ' ' LEU . 38.9 mt -75.06 -59.68 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 125.703 1.601 . . . . 0.0 109.728 171.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -66.86 -18.47 65.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.942 0.792 . . . . 0.0 111.71 -168.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.77 -14.04 62.77 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.907 1.283 . . . . 0.0 112.496 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -119.01 20.4 12.73 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 127.024 2.13 . . . . 0.0 111.153 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 123.585 0.754 . . . . 0.0 110.007 -177.62 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.575 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.8 m 49.9 -157.27 0.09 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.31 1.044 . . . . 0.0 112.378 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 174.8 -37.35 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 128.34 2.656 . . . . 0.0 110.379 161.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.9 mmt -54.14 -27.88 36.32 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.002 0.921 . . . . 0.0 112.232 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -55.26 -60.64 3.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.388 1.475 . . . . 0.0 111.732 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.21 -38.93 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.732 1.213 . . . . 0.0 111.029 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -88.09 -15.13 37.04 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.166 0.586 . . . . 0.0 112.367 -169.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.11 78.45 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.223 1.009 . . . . 0.0 111.535 -175.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.88 -9.05 13.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.12 1.368 . . . . 0.0 113.383 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -112.59 -35.87 5.39 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.981 0.912 . . . . 0.0 110.832 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.3 mt -52.97 -33.68 52.33 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.481 -0.762 . . . . 0.0 111.168 170.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -54.62 -35.5 63.47 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.272 1.029 . . . . 0.0 113.671 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.1 -0.1 56.07 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-O 118.923 -0.932 . . . . 0.0 112.78 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.51 91.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -2.35 0.96 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.58 2.352 . . . . 0.0 113.294 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -114.47 67.02 1.73 Allowed Pre-proline 0 N--CA 1.444 -0.768 0 C-N-CA 129.055 2.942 . . . . 0.0 109.408 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.5 -21.91 65.71 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.862 3.041 . . . . 0.0 113.24 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -71.18 -4.67 26.77 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.727 1.611 . . . . 0.0 112.18 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.0 16.78 1.22 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.45 1.1 . . . . 0.0 110.06 -175.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -87.55 -47.84 8.39 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.092 1.357 . . . . 0.0 109.693 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -55.58 -30.04 60.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.516 2.326 . . . . 0.0 112.938 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -58.52 -38.22 77.25 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.887 -1.133 . . . . 0.0 111.145 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.6 m -66.85 -39.63 87.66 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.362 0.665 . . . . 0.0 109.668 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.1 -44.8 83.57 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.418 1.487 . . . . 0.0 110.622 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -61.17 -44.39 97.39 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.74 0.416 . . . . 0.0 109.974 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.7 mt -61.31 -49.99 82.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.985 1.314 . . . . 0.0 109.109 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.79 -41.37 91.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.477 0.711 . . . . 0.0 109.79 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -65.09 -43.96 90.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.913 0.885 . . . . 0.0 110.868 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.537 ' HZ3' HD11 ' A' ' 106' ' ' LEU . 68.0 t90 -66.93 -38.66 86.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.884 1.274 . . . . 0.0 111.81 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.0 t -61.28 -43.67 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 O-C-N 121.415 -0.803 . . . . 0.0 109.553 175.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.67 -25.03 67.94 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.153 0.581 . . . . 0.0 111.519 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 -70.16 0.59 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.217 1.007 . . . . 0.0 109.543 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.2 m -67.87 -29.48 68.6 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.783 -0.627 . . . . 0.0 112.225 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -123.15 58.34 12.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.167 0.894 . . . . 0.0 110.267 -171.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.09 -18.88 45.74 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.907 3.071 . . . . 0.0 114.983 -160.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -79.0 -7.2 57.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.164 0.893 . . . . 0.0 111.862 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.47 141.07 38.51 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.579 1.081 . . . . 0.0 108.605 165.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -116.42 154.29 48.94 Favored Pre-proline 0 C--N 1.328 -0.362 0 C-N-CA 124.937 1.295 . . . . 0.0 110.39 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.33 138.74 30.73 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.628 2.885 . . . . 0.0 110.337 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -165.56 82.73 0.33 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.05 140.71 54.91 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.057 -1.027 . . . . 0.0 108.694 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -150.15 153.27 36.04 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 124.741 1.217 . . . . 0.0 108.426 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.3 m95 51.6 31.55 7.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.68 0.792 . . . . 0.0 112.256 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 t30 59.12 18.34 6.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.562 1.945 . . . . 0.0 113.784 -173.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -114.13 127.12 27.16 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.727 1.611 . . . . 0.0 107.106 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.13 114.77 3.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.686 2.257 . . . . 0.0 109.978 170.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.6 ptm -130.79 173.66 10.72 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.349 1.06 . . . . 0.0 109.259 173.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -135.18 132.21 37.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.1 p -92.05 125.12 36.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.084 0.954 . . . . 0.0 108.564 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -74.54 85.94 2.07 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 161.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.268 20.8 mt-30 63.19 -15.23 0.06 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.145 1.778 . . . . 0.0 115.605 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.74 -13.01 0.03 OUTLIER Glycine 0 CA--C 1.544 1.859 0 C-N-CA 126.938 2.208 . . . . 0.0 115.094 170.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.84 -165.79 1.15 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.765 1.226 . . . . 0.0 113.237 -163.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.48 29.32 4.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.14 2.176 . . . . 0.0 109.762 -173.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.2 mt -67.72 -19.73 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.527 1.131 . . . . 0.0 112.118 -168.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.4 tt -155.02 136.59 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 120.236 1.38 . . . . 0.0 110.263 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.92 157.08 27.35 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 166.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -138.72 168.84 18.92 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.222 -1.163 . . . . 0.0 109.104 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 81.4 p -150.2 144.13 25.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.8 p -91.28 155.3 18.64 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -173.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 t -135.16 177.99 7.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.113 1.365 . . . . 0.0 108.474 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -49.34 -65.67 0.53 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.059 1.343 . . . . 0.0 109.571 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.408 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 90.2 m-70 -116.2 13.06 15.62 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -172.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -153.83 166.46 32.83 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.901 0.773 . . . . 0.0 111.571 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.1 tp -97.99 158.53 15.48 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 162.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . 4.0 m -126.7 120.62 29.87 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.184 0.902 . . . . 0.0 109.859 174.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.88 140.9 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.189 1.796 . . . . 0.0 109.222 -161.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.2 t -167.43 157.02 9.42 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 127.68 2.392 . . . . 0.0 105.883 168.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.13 -57.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.059 0 CA-C-N 120.65 1.268 . . . . 0.0 108.957 166.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -145.34 -86.18 0.12 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -139.49 -29.57 0.74 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.016 1.327 . . . . 0.0 112.499 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.17 -29.16 45.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 119.192 0.905 . . . . 0.0 111.439 -172.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.16 -24.63 15.94 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.872 2.177 . . . . 0.0 113.205 171.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 92' ' ' LEU . 18.3 mm -107.74 -6.98 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 127.082 2.153 . . . . 0.0 110.171 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -92.35 -85.46 0.26 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -83.83 -45.71 12.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -169.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -67.84 -22.43 65.14 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.112 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.53 -32.14 57.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.196 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -67.33 -45.2 77.14 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.433 0.693 . . . . 0.0 110.05 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.01 89.49 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.932 -1.105 . . . . 0.0 110.819 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.3 mt -66.62 -43.04 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 118.653 0.66 . . . . 0.0 109.722 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.35 89.42 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 124.643 1.177 . . . . 0.0 109.862 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -65.1 -24.65 67.49 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.679 1.191 . . . . 0.0 111.74 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.4 -29.23 41.9 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.353 0.979 . . . . 0.0 110.904 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 142.18 -31.37 2.07 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.999 1.762 . . . . 0.0 112.599 165.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -81.15 102.18 10.13 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.965 1.383 . . . . 0.0 109.76 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.4 m -69.8 9.7 0.49 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 58.47 -172.97 0.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.36 2.264 . . . . 0.0 112.065 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.5 p -110.89 179.31 4.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.85 1.66 . . . . 0.0 106.93 158.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -66.86 27.89 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.734 2.413 . . . . 0.0 113.323 164.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.1 -35.57 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 CA-C-O 118.287 -1.285 . . . . 0.0 114.88 -168.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HA ' HD11 ' A' ' 74' ' ' ILE . 1.1 pp -161.47 173.6 14.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.214 1.007 . . . . 0.0 112.077 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -108.88 119.67 40.23 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 120.89 -1.131 . . . . 0.0 110.37 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.27 138.65 42.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.98 143.81 31.58 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 169.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.55 156.84 29.63 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.439 2.092 . . . . 0.0 110.715 170.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.408 ' CD1' ' HA ' ' A' ' 63' ' ' HIS . 9.0 m95 -59.64 -25.63 64.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.402 168.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.99 -67.91 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.713 0.688 . . . . 0.0 110.796 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.9 164.96 44.16 Favored Pre-proline 0 N--CA 1.465 0.295 0 C-N-CA 124.409 1.083 . . . . 0.0 111.707 -168.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.92 139.42 12.13 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.086 1.191 . . . . 0.0 112.814 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.2 t -72.84 115.83 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -68.42 89.4 0.35 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.054 1.342 . . . . 0.0 111.418 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -58.1 -39.54 78.88 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 124.831 1.253 . . . . 0.0 109.897 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -66.91 -38.64 86.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.719 1.207 . . . . 0.0 113.406 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -48.3 55.71 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.537 HD11 ' HZ3' ' A' ' 29' ' ' TRP 0.285 0.4 OUTLIER -71.11 -26.52 63.06 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.973 -173.439 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -66.73 -43.09 85.15 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.117 -1.42 . . . . 0.0 111.001 171.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -53.45 -52.21 60.19 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.338 1.426 . . . . 0.0 109.677 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.7 ptp -63.02 -47.38 83.32 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.858 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -43.01 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 120.306 1.412 . . . . 0.0 110.736 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -63.01 -44.81 94.97 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.411 0.551 . . . . 0.0 110.441 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -56.23 -45.99 79.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.847 0.459 . . . . 0.0 110.623 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.66 -22.19 65.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.054 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.6 mt -82.17 -47.53 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 119.613 1.097 . . . . 0.0 109.626 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -71.0 -19.27 62.54 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.23 0.923 . . . . 0.0 111.491 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.24 -28.83 57.3 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.101 1.761 . . . . 0.0 110.892 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -106.21 43.04 1.18 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 126.18 1.792 . . . . 0.0 108.054 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--O 1.246 0.889 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.811 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.892 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.4 m -73.41 -10.96 60.28 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.13 -1.414 . . . . 0.0 113.806 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.285 22.3 p-80 51.51 -47.54 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 131.138 3.775 . . . . 0.0 115.174 -167.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mmt -50.26 -43.99 53.5 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.899 1.679 . . . . 0.0 109.691 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -54.46 -32.84 58.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.21 -33.0 19.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 123.002 0.521 . . . . 0.0 111.125 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -113.57 32.84 5.52 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.685 1.994 . . . . 0.0 113.73 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.57 -15.33 10.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 121.787 2.085 . . . . 0.0 113.747 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.7 -24.42 21.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -35.87 59.01 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -173.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.484 HD12 HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -57.27 -37.09 71.85 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.9 1.28 . . . . 0.0 112.074 176.592 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -54.35 -39.61 67.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.819 0.736 . . . . 0.0 110.74 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.88 -7.4 75.44 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.247 1.403 . . . . 0.0 113.997 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.484 HD12 HD12 ' A' ' 11' ' ' LEU . 18.8 mt -86.46 102.87 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.93 -8.4 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.569 1.147 . . . . 0.0 113.452 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.48 84.99 0.68 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.688 1.995 . . . . 0.0 111.18 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.77 -20.44 58.9 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.707 2.938 . . . . 0.0 114.241 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.27 -17.04 63.24 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.114 0.416 . . . . 0.0 110.545 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -128.16 -33.97 2.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.177 0.991 . . . . 0.0 111.268 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -48.52 -54.65 13.56 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.301 1.041 . . . . 0.0 109.849 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -13.15 34.55 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.11 1.364 . . . . 0.0 113.178 -175.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -88.32 -51.95 5.47 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.934 1.243 . . . . 0.0 108.36 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.1 m -46.56 -43.31 17.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.608 1.963 . . . . 0.0 112.685 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -71.94 -28.17 63.29 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.366 1.466 . . . . 0.0 112.592 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.13 -47.0 78.64 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.669 -0.644 . . . . 0.0 109.852 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -54.91 -45.71 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 46' ' ' PRO . 21.6 mt -59.22 -52.26 66.44 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.375 0.27 . . . . 0.0 110.969 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 p -62.09 -41.12 97.88 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.622 0.769 . . . . 0.0 112.961 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -56.49 -59.03 5.57 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.913 1.685 . . . . 0.0 109.96 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.6 t -50.53 -48.04 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 120.245 1.384 . . . . 0.0 111.182 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.79 -16.41 64.24 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.54 -54.83 3.98 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.868 0.867 . . . . 0.0 110.669 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -34.26 77.65 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.693 0.797 . . . . 0.0 111.669 -171.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.36 69.62 81.33 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.733 1.213 . . . . 0.0 108.388 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.82 -6.42 18.12 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.035 3.157 . . . . 0.0 115.044 -162.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -73.75 -14.45 61.13 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 120.036 1.289 . . . . 0.0 112.152 168.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.6 mt -75.66 135.15 40.44 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 120.944 -1.097 . . . . 0.0 110.948 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -110.99 149.79 40.95 Favored Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 126.537 1.935 . . . . 0.0 109.203 175.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.08 159.99 40.42 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.895 2.397 . . . . 0.0 111.523 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -158.16 111.83 2.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.209 1.003 . . . . 0.0 108.529 166.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.99 95.38 1.58 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 165.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -118.48 147.42 43.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.5 m95 53.16 23.32 3.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.8 t30 62.23 15.91 7.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.788 1.235 . . . . 0.0 112.327 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 p -121.31 150.23 53.7 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HB2' HD21 ' A' ' 27' ' ' LEU . 72.8 Cg_endo -76.25 113.11 3.62 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.93 2.42 . . . . 0.0 110.564 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.1 ptm -119.18 172.7 7.4 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 166.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.3 139.62 48.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -102.34 127.7 49.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -71.41 87.76 0.87 Allowed 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 166.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 58.75 -8.95 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.156 2.582 . . . . 0.0 114.655 -177.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.47 -11.97 0.06 OUTLIER Glycine 0 CA--C 1.543 1.782 0 C-N-CA 126.745 2.117 . . . . 0.0 114.179 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -84.58 -169.86 2.83 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.374 1.587 . . . . 0.0 111.651 -174.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.507 ' H ' HG22 ' A' ' 53' ' ' THR . 78.4 t80 -125.43 19.19 8.13 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.696 1.998 . . . . 0.0 111.744 -177.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 113' ' ' ASN . 17.4 mt -65.35 4.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 126.852 2.061 . . . . 0.0 113.375 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 tt -156.66 142.53 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 118.465 -2.647 . . . . 0.0 111.085 165.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.47 148.57 17.5 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 166.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -149.85 171.97 15.91 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.257 1.423 . . . . 0.0 108.523 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.18 162.05 41.05 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 166.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 p -61.03 152.92 26.7 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.408 0.623 . . . . 0.0 110.261 167.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -132.89 171.13 14.34 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.412 1.885 . . . . 0.0 106.504 163.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -49.41 -49.67 43.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.606 1.562 . . . . 0.0 112.158 -171.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -129.39 7.79 5.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.48 1.112 . . . . 0.0 112.82 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -147.26 169.56 19.13 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.171 -0.956 . . . . 0.0 110.541 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.5 tp -102.77 147.03 27.37 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 162.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB3' HD13 ' A' ' 92' ' ' LEU . 1.5 m -121.81 125.41 46.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.234 0.925 . . . . 0.0 109.394 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.6 t -136.19 141.55 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 127.316 2.246 . . . . 0.0 109.156 -157.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 t -167.72 152.08 6.37 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.802 1.641 . . . . 0.0 108.7 168.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.64 -56.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.7 1.6 . . . . 0.0 111.679 164.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -139.75 -86.0 0.22 Allowed 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -143.14 -33.97 0.43 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.041 0.936 . . . . 0.0 112.746 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.1 tt -61.05 -33.64 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 120.039 1.29 . . . . 0.0 111.569 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -50.45 -22.37 5.3 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.249 1.404 . . . . 0.0 113.112 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.8 mm -110.69 -1.85 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 126.41 1.884 . . . . 0.0 110.157 -171.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.3 m -118.27 -51.31 2.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.163 0.985 . . . . 0.0 110.509 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -84.06 -58.28 2.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 127.431 2.293 . . . . 0.0 107.43 -173.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.55 0.26 17.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.072 1.349 . . . . 0.0 111.314 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.63 -40.3 78.89 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.855 1.262 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -72.8 -35.78 67.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.62 0.646 . . . . 0.0 109.535 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.25 82.3 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.498 0.719 . . . . 0.0 109.632 170.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.69 -44.89 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.108 0.963 . . . . 0.0 110.333 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.99 -55.84 29.49 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.167 0.987 . . . . 0.0 108.952 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -68.11 -15.86 63.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.692 0.797 . . . . 0.0 113.104 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.63 -16.18 52.26 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.399 1.0 . . . . 0.0 111.092 172.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.36 19.54 9.29 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 124.276 0.941 . . . . 0.0 113.998 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -119.81 99.45 6.64 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.028 1.414 . . . . 0.0 111.455 -166.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.9 m -56.55 117.01 3.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.904 1.281 . . . . 0.0 110.176 172.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.41 -168.18 1.55 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.34 1.856 . . . . 0.0 110.668 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 p -120.06 -164.78 1.11 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.75 1.62 . . . . 0.0 107.217 163.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -88.69 -20.48 24.8 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.06 0.846 . . . . 0.0 111.981 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.74 5.68 5.82 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.989 -0.895 . . . . 0.0 114.174 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.441 HD13 ' HB3' ' A' ' 66' ' ' SER . 1.5 pp -156.34 169.66 24.07 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.873 1.337 . . . . 0.0 110.104 158.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -118.68 179.17 4.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.801 1.24 . . . . 0.0 109.52 170.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -140.49 170.77 15.17 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.071 -1.018 . . . . 0.0 113.341 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 mp -135.97 142.85 41.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 160.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.53 160.46 47.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.705 1.603 . . . . 0.0 109.414 166.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -73.47 -23.15 60.04 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -65.59 -67.93 0.4 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.663 0.785 . . . . 0.0 110.455 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.48 165.69 51.5 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.481 1.512 . . . . 0.0 111.593 -164.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.78 145.46 40.98 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.624 1.55 . . . . 0.0 112.765 -170.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.45 126.31 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.28 76.04 7.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 168.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -56.94 -32.96 66.51 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 123.367 0.667 . . . . 0.0 109.433 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.46 -48.54 81.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.46 0.704 . . . . 0.0 111.913 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.73 -42.57 73.8 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 122.522 1.153 . . . . 0.0 109.514 -169.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.276 0.5 OUTLIER -70.54 -30.9 67.76 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.747 176.365 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -58.45 -51.35 70.21 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.778 1.172 . . . . 0.0 110.641 166.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -51.76 -49.48 62.55 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.822 0.849 . . . . 0.0 109.889 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -69.39 -47.67 63.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.93 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -45.56 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 120.452 1.478 . . . . 0.0 109.919 -175.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.58 -47.63 81.58 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.193 0.997 . . . . 0.0 110.968 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -60.53 -46.22 90.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.028 -0.42 . . . . 0.0 110.792 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.452 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 3.0 m120 -64.16 -20.98 66.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.657 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.1 mt -71.46 -56.45 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 169.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.05 -15.2 63.49 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.933 0.788 . . . . 0.0 112.396 -173.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.76 -10.55 59.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.535 1.134 . . . . 0.0 112.708 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -114.7 21.37 14.5 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.749 2.02 . . . . 0.0 110.959 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.84 174.63 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.928 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -74.28 -10.07 59.23 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 117.728 -1.129 . . . . 0.0 113.824 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.288 9.4 p-80 56.79 -55.78 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 129.786 3.234 . . . . 0.0 114.172 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.7 mmt -44.65 -46.28 10.1 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 126.04 1.736 . . . . 0.0 110.747 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.93 -31.61 72.63 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -168.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.5 t -58.15 -45.87 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.436 1.094 . . . . 0.0 108.701 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -91.58 -9.3 44.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.237 1.415 . . . . 0.0 112.37 -170.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.4 -33.06 70.94 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.468 1.107 . . . . 0.0 111.431 -171.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -68.8 -15.72 63.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.789 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -79.23 -52.96 7.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 166.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -49.18 -45.12 43.68 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.498 1.119 . . . . 0.0 111.791 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -62.46 -25.2 67.86 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 118.051 0.387 . . . . 0.0 111.816 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.35 -2.29 60.46 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.279 1.418 . . . . 0.0 113.577 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 16' ' ' HIS . 54.3 mt -77.84 111.65 14.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 CA-C-N 120.08 1.94 . . . . 0.0 107.369 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -1.07 24.14 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.601 0.76 . . . . 0.0 112.714 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.478 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.2 m170 -110.39 78.83 1.51 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 127.837 2.455 . . . . 0.0 110.021 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -61.11 -32.36 91.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.718 2.278 . . . . 0.0 112.436 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.446 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 36.9 m-20 -68.85 -1.55 7.48 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.398 0.999 . . . . 0.0 111.724 -173.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 14.3 m80 -135.88 -38.38 0.72 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.072 1.749 . . . . 0.0 110.498 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.4 ttp85 -46.14 -54.35 8.78 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 123.898 0.879 . . . . 0.0 109.42 166.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -53.14 -38.69 62.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.784 0.833 . . . . 0.0 112.194 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.67 -45.09 91.68 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.437 -0.789 . . . . 0.0 109.724 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.415 ' HA ' HD13 ' A' ' 26' ' ' ILE . 3.0 m -60.91 -35.21 76.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.13 1.772 . . . . 0.0 111.01 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -59.83 -38.45 82.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.693 1.133 . . . . 0.0 110.484 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -59.81 -46.47 89.13 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.566 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 23' ' ' THR . 2.9 mp -54.33 -52.07 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.48 -57.45 12.25 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 122.833 0.453 . . . . 0.0 110.017 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 m -60.66 -43.01 98.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 123.652 0.595 . . . . 0.0 110.454 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -62.87 -41.42 99.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.75 0.82 . . . . 0.0 110.772 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.534 HG11 ' CE2' ' A' ' 48' ' ' PHE . 26.5 t -58.33 -60.05 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.897 0.771 . . . . 0.0 109.874 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.09 -21.91 66.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.82 0.737 . . . . 0.0 112.597 -174.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.77 -62.38 1.47 Allowed 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.653 0.781 . . . . 0.0 111.562 171.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.3 m -72.27 -35.13 68.66 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.69 1.596 . . . . 0.0 110.753 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -120.65 66.68 13.41 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 124.714 1.206 . . . . 0.0 108.841 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -68.48 -11.63 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.029 1.819 . . . . 0.0 112.362 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -76.18 4.92 7.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.86 0.864 . . . . 0.0 112.477 171.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.42 141.08 36.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.298 1.039 . . . . 0.0 108.277 171.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -122.39 143.95 40.79 Favored Pre-proline 0 C--O 1.239 0.504 0 C-N-CA 124.691 1.196 . . . . 0.0 110.014 -173.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.99 148.04 21.59 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.518 2.812 . . . . 0.0 112.637 -165.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -155.25 119.45 4.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.431 0.693 . . . . 0.0 109.503 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -83.24 113.33 20.6 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 165.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt -150.88 154.99 38.24 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.511 1.125 . . . . 0.0 108.394 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.8 m95 49.77 24.65 1.3 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.659 1.584 . . . . 0.0 113.322 -168.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.48 21.7 8.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.078 1.351 . . . . 0.0 112.186 -171.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.2 p -118.77 158.15 48.29 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 125.783 1.633 . . . . 0.0 109.405 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.25 110.9 2.8 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.281 3.32 . . . . 0.0 110.499 169.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 19.2 ptm -117.73 170.04 9.1 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.054 0.93 . . . . 0.0 109.292 165.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CE2' HG11 ' A' ' 30' ' ' VAL . 0.6 OUTLIER -132.36 176.64 8.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 166.242 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.8 m -143.13 139.62 30.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -71.63 97.58 1.75 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 161.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.297 21.7 mt-30 59.78 -11.72 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.574 2.75 . . . . 0.0 116.711 174.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.69 -3.45 0.05 OUTLIER Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.526 2.488 . . . . 0.0 114.541 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.59 -166.14 0.25 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 120.406 2.103 . . . . 0.0 111.799 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -126.73 20.95 7.08 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 119.569 -1.957 . . . . 0.0 111.639 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.5 mt -71.19 15.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 O-C-N 120.29 -1.506 . . . . 0.0 111.802 -169.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 tt -160.5 146.22 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 118.62 -2.55 . . . . 0.0 110.799 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.2 144.26 8.89 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 162.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -137.0 174.24 10.84 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.094 1.447 . . . . 0.0 110.043 171.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.5 t -155.76 159.57 39.57 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 160.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.2 p -63.05 144.13 57.17 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 162.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t -120.19 172.81 7.51 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 162.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -58.45 -44.67 89.3 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 121.499 -0.751 . . . . 0.0 110.737 -163.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -137.44 37.12 2.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.881 0.872 . . . . 0.0 111.918 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -166.57 167.16 15.7 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.418 1.487 . . . . 0.0 109.801 171.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -98.74 157.25 16.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.656 1.182 . . . . 0.0 107.922 162.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.422 ' HB2' HD22 ' A' ' 92' ' ' LEU . 34.3 p -119.03 125.41 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.717 1.207 . . . . 0.0 108.604 169.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.7 t -135.46 141.7 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 119.619 1.1 . . . . 0.0 108.643 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -173.23 151.49 2.07 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.09 1.756 . . . . 0.0 107.368 175.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.65 -57.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 119.786 0.959 . . . . 0.0 112.318 165.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -149.49 -86.73 0.08 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -142.45 -32.57 0.49 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.836 1.254 . . . . 0.0 111.745 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.0 tt -63.32 -31.29 52.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 118.817 0.735 . . . . 0.0 110.934 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.69 -24.47 12.61 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 127.247 2.356 . . . . 0.0 113.263 173.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.9 mm -120.6 -3.5 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.98 1.312 . . . . 0.0 110.492 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.0 t -80.02 -71.76 0.44 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -88.65 -41.71 12.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.655 -0.653 . . . . 0.0 109.248 -166.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -71.95 -10.34 59.64 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.091 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.56 -27.39 57.62 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -72.93 -42.44 63.47 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.887 0.851 . . . . 0.0 110.406 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.61 -38.18 90.13 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.426 -0.796 . . . . 0.0 110.843 172.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.7 mt -59.91 -50.6 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.226 1.011 . . . . 0.0 108.926 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.18 -47.4 65.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.82 1.248 . . . . 0.0 111.386 -175.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.43 -30.15 68.28 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.586 1.155 . . . . 0.0 112.987 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.36 -15.8 61.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.378 0.99 . . . . 0.0 111.651 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.23 -14.57 43.74 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 125.339 1.447 . . . . 0.0 113.002 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -73.7 161.85 29.81 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 173.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.48 5.02 5.14 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.471 1.032 . . . . 0.0 113.689 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 55.94 -159.07 0.22 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.856 1.662 . . . . 0.0 111.728 -169.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.5 p -119.38 -164.38 1.05 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.19 2.996 . . . . 0.0 104.815 159.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -70.69 -31.19 67.98 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.068 1.303 . . . . 0.0 113.043 171.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.35 -20.46 1.59 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -162.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 66' ' ' SER . 4.2 pp -137.35 167.98 20.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 121.197 -1.178 . . . . 0.0 110.026 169.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -112.38 150.27 31.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -140.73 145.37 36.36 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 101' ' ' VAL . 0.8 OUTLIER -133.51 143.72 49.11 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -176.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 161.45 42.29 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 121.706 1.645 . . . . 0.0 110.604 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -65.99 -15.28 62.88 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -63.44 -38.9 92.91 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.464 1.106 . . . . 0.0 110.846 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.52 158.46 33.7 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 123.76 0.824 . . . . 0.0 110.127 -156.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.08 126.08 10.88 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.887 2.391 . . . . 0.0 108.197 166.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.439 ' HA ' HD12 ' A' ' 95' ' ' ILE . 5.1 m -78.98 18.16 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.297 0.3 OUTLIER 50.73 78.0 0.11 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.948 2.899 . . . . 0.0 113.492 177.074 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -69.42 -48.75 60.04 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.944 2.098 . . . . 0.0 111.674 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -58.94 -36.35 74.62 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.01 0.924 . . . . 0.0 111.383 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -50.53 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.579 0.704 . . . . 0.0 110.067 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.289 0.3 OUTLIER -71.29 -29.4 65.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.535 0.734 . . . . 0.0 112.765 -174.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -64.19 -39.36 93.83 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.404 -1.284 . . . . 0.0 110.312 172.238 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -57.91 -49.47 76.65 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.337 1.426 . . . . 0.0 110.444 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.5 ptp -69.51 -45.16 69.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.191 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -70.63 -46.62 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.697 1.135 . . . . 0.0 110.122 -175.355 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.13 -31.16 72.24 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.504 1.047 . . . . 0.0 111.998 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.07 -53.42 25.75 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 118.06 0.391 . . . . 0.0 110.358 169.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.72 -18.13 64.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.487 -170.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.05 -71.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 124.983 1.313 . . . . 0.0 108.812 158.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -66.18 -13.41 60.19 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -165.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -77.16 -12.07 59.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.78 2.032 . . . . 0.0 113.13 174.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -129.37 3.9 5.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.268 2.227 . . . . 0.0 110.476 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.251 24.0 tt0 . . . . . 0 C--O 1.255 1.383 0 C-N-CA 128.966 2.906 . . . . 0.0 115.022 166.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.382 0 CA-C-O 119.398 -0.668 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.7 m -70.49 -27.28 64.08 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.75 1.275 . . . . 0.0 111.986 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.293 8.3 p-80 45.0 -54.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.257 1 C-N-CA 132.023 4.129 . . . . 0.0 115.039 -165.328 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mmt -44.74 -49.48 10.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 128.42 2.688 . . . . 0.0 110.349 -170.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.74 -31.15 58.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.433 1.093 . . . . 0.0 112.126 -169.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.09 -45.13 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 123.97 0.908 . . . . 0.0 110.535 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -96.85 -8.72 30.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.226 2.21 . . . . 0.0 112.649 -170.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.77 -12.32 60.31 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 126.231 1.812 . . . . 0.0 112.182 -160.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.482 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 27.4 mt-10 -111.4 -27.46 8.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.554 1.942 . . . . 0.0 109.184 -168.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.68 -34.63 69.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.02 -47.7 44.3 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.862 1.265 . . . . 0.0 112.611 173.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 1.4 mppt? -61.74 -27.09 68.47 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.829 1.195 . . . . 0.0 113.403 176.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.6 -12.47 84.37 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.874 -0.959 . . . . 0.0 113.028 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 16' ' ' HIS . 53.1 mt -76.08 113.02 14.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 119.742 1.771 . . . . 0.0 106.682 168.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -79.19 -4.11 48.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 122.055 0.931 . . . . 0.0 113.478 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.426 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.3 m-70 -100.15 85.91 0.57 Allowed Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 127.645 2.378 . . . . 0.0 111.702 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -62.56 -38.58 50.4 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.861 2.374 . . . . 0.0 111.349 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.21 10.75 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.815 1.246 . . . . 0.0 111.162 -172.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -135.5 -38.8 0.74 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.018 0.927 . . . . 0.0 111.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -43.77 83.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 116.492 -1.718 . . . . 0.0 114.688 -176.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -45.21 -42.89 9.76 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.028 1.285 . . . . 0.0 112.006 -172.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -45.5 79.02 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.041 2.136 . . . . 0.0 111.971 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.0 m -59.71 -37.64 79.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.212 1.405 . . . . 0.0 109.744 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.09 -36.2 81.46 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 124.325 1.05 . . . . 0.0 110.788 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -59.84 -46.7 88.45 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.426 0.69 . . . . 0.0 109.722 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 mt -60.13 -44.76 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.021 0.929 . . . . 0.0 109.502 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.0 mt -58.05 -55.27 37.08 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.936 0.789 . . . . 0.0 110.054 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.4 m -62.4 -33.14 74.19 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.451 1.1 . . . . 0.0 113.202 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -73.2 -44.18 60.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.566 -0.709 . . . . 0.0 111.03 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.55 -53.89 38.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.16 -26.19 66.12 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.61 -50.96 8.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.545 0.738 . . . . 0.0 111.034 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.3 m -72.74 -40.39 66.11 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.534 0.734 . . . . 0.0 110.811 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.85 65.63 55.04 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.2 1.0 . . . . 0.0 109.99 -172.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.62 -6.74 19.6 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.09 2.527 . . . . 0.0 114.019 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.31 -16.27 61.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.479 1.036 . . . . 0.0 111.124 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.09 134.71 47.24 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 165.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.92 146.88 32.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.78 147.45 75.29 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.123 1.882 . . . . 0.0 109.787 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -156.57 109.53 2.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.471 -0.768 . . . . 0.0 109.353 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 75.6 mmm -76.54 131.12 38.78 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 161.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -139.17 139.92 37.7 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.0 m95 64.92 0.24 1.16 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 t30 74.58 14.7 3.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.576 2.75 . . . . 0.0 113.37 -162.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.3 p -107.84 147.17 34.93 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.89 138.06 27.94 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.507 2.138 . . . . 0.0 110.494 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.6 ptm -144.05 -179.59 6.59 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 162.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -140.16 161.1 38.44 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 p -125.19 114.36 18.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.154 0.582 . . . . 0.0 110.073 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -71.03 97.17 1.41 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 44.4 48.6 8.17 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.466 1.506 . . . . 0.0 111.758 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.52 35.67 25.3 Favored Glycine 0 CA--C 1.535 1.315 0 O-C-N 121.23 -0.919 . . . . 0.0 114.742 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.7 m -112.85 -164.78 0.94 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 119.339 1.57 . . . . 0.0 109.617 170.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.46 ' H ' HG22 ' A' ' 53' ' ' THR . 46.3 t80 -129.64 13.19 5.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.275 1.83 . . . . 0.0 111.668 -174.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.9 0.94 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 128.797 2.839 . . . . 0.0 113.502 -167.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 tt -157.36 140.74 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 118.956 -2.34 . . . . 0.0 112.101 165.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.39 165.92 29.07 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.142 1.353 . . . . 0.0 110.324 166.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -157.71 176.15 12.97 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.685 0.755 . . . . 0.0 111.464 165.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.14 155.36 22.82 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 165.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.0 p -63.34 127.87 33.25 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.36 173.8 12.11 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 164.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -66.26 -26.78 67.51 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.858 -1.151 . . . . 0.0 112.971 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -140.59 5.45 2.01 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.852 1.261 . . . . 0.0 113.175 -173.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -157.55 -179.76 8.48 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.097 1.759 . . . . 0.0 106.727 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tt -119.74 133.97 55.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.44 125.62 50.8 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.549 -175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.1 t -142.72 152.59 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 120.45 1.477 . . . . 0.0 109.82 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.8 t -161.23 165.16 17.4 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.805 2.042 . . . . 0.0 107.31 165.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -87.04 -56.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.401 2.067 . . . . 0.0 111.514 165.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -145.63 -80.86 0.16 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.69 -36.12 0.22 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.198 1.399 . . . . 0.0 111.772 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.0 tt -60.87 -32.34 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.803 0.729 . . . . 0.0 110.787 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.85 -17.81 44.3 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.386 1.946 . . . . 0.0 113.843 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.9 mm -113.65 -0.66 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.534 1.934 . . . . 0.0 108.792 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 t -90.85 -85.15 0.23 Allowed 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.951 1.3 . . . . 0.0 108.134 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -81.29 -43.18 19.53 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.844 0.857 . . . . 0.0 108.979 -170.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -71.81 -14.4 61.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.864 -0.523 . . . . 0.0 112.104 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.84 -32.71 70.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.511 0.724 . . . . 0.0 112.249 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.15 -45.85 83.29 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.91 82.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.82 1.248 . . . . 0.0 110.827 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.2 mt -58.11 -46.87 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.63 75.84 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.917 -0.489 . . . . 0.0 111.012 -171.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -65.41 -24.08 67.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.887 1.275 . . . . 0.0 113.191 -172.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.24 -47.21 83.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.66 55.59 0.04 OUTLIER Glycine 0 C--N 1.333 0.391 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -135.26 171.19 14.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.09 0.956 . . . . 0.0 109.427 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.8 m -130.4 106.99 8.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.58 1.552 . . . . 0.0 107.953 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.76 -178.09 3.04 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.36 0.6 . . . . 0.0 111.363 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 p -107.61 -164.66 0.99 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 162.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 11.27 39.89 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.663 1.585 . . . . 0.0 111.191 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.13 -35.31 0.59 Allowed Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.04 172.89 17.87 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.135 1.374 . . . . 0.0 109.149 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -104.46 162.79 12.94 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.35 0.977 . . . . 0.0 109.717 170.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 120.48 11.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.299 0.239 . . . . 0.0 110.545 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.75 143.73 26.68 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.18 155.12 68.8 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.591 1.528 . . . . 0.0 109.276 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -64.64 -16.3 62.56 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -71.46 -57.91 4.0 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.761 0.824 . . . . 0.0 112.152 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.79 165.81 46.78 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 123.889 0.875 . . . . 0.0 111.131 -165.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -63.21 173.27 4.24 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.603 1.536 . . . . 0.0 110.665 160.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 p -111.96 175.16 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 127.016 2.126 . . . . 0.0 107.408 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.71 78.06 1.29 Allowed 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 120.947 -1.095 . . . . 0.0 111.482 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -55.78 -30.36 61.17 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.066 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -67.64 -36.37 80.65 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.397 -0.814 . . . . 0.0 112.076 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.25 -36.89 58.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.587 1.085 . . . . 0.0 109.761 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.57 -55.65 23.9 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.93 0.492 . . . . 0.0 109.918 175.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -62.97 -49.58 74.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.761 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -54.16 -49.78 68.48 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.357 0.526 . . . . 0.0 110.448 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.4 ptp -72.46 -40.72 66.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.68 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.73 -46.81 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 120.615 1.552 . . . . 0.0 109.376 -172.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -55.03 -44.73 74.92 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.615 1.166 . . . . 0.0 110.736 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -65.05 -50.89 64.44 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.76 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -23.67 65.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.417 1.008 . . . . 0.0 111.592 -172.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.6 mt -75.16 -57.11 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.284 1.034 . . . . 0.0 109.337 169.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -63.95 -31.32 72.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 123.244 1.497 . . . . 0.0 112.1 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.33 -1.8 25.4 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 126.29 1.836 . . . . 0.0 112.914 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -127.36 -0.03 6.33 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 126.763 2.025 . . . . 0.0 111.931 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.25 1.096 0 C-N-CA 124.92 1.288 . . . . 0.0 109.664 -172.881 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.663 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 m 45.54 -55.74 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 131.409 3.884 . . . . 0.0 119.636 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.42 ' CE1' ' HG2' ' A' ' 4' ' ' MET 0.267 2.0 p-80 55.31 -45.32 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.525 1 C-N-CA 132.796 4.438 . . . . 0.0 116.127 -167.751 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.42 ' HG2' ' CE1' ' A' ' 3' ' ' HIS . 6.6 mmt -51.67 -44.9 63.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.182 1.393 . . . . 0.0 110.627 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.43 -28.15 68.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.995 1.318 . . . . 0.0 112.033 -170.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.4 t -76.18 -39.14 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -89.81 -11.71 41.27 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.874 1.27 . . . . 0.0 112.968 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.96 -20.27 64.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.931 0.892 . . . . 0.0 111.795 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.62 -16.57 51.09 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.567 1.147 . . . . 0.0 112.741 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -81.41 -49.45 10.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.739 1.616 . . . . 0.0 107.008 167.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.485 HD12 ' HE ' ' A' ' 20' ' ' ARG . 1.6 mm? -47.98 -49.58 30.22 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.788 1.235 . . . . 0.0 112.553 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -51.09 -34.97 32.66 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.646 0.778 . . . . 0.0 111.79 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.96 -1.09 80.27 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.7 -1.055 . . . . 0.0 113.23 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.0 mt -74.71 117.81 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 119.537 1.669 . . . . 0.0 106.983 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.81 -1.74 58.01 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.996 0.918 . . . . 0.0 112.73 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.07 79.64 8.57 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.005 1.722 . . . . 0.0 111.149 -176.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.92 -20.44 64.29 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 124.128 3.219 . . . . 0.0 114.428 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -7.91 51.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.018 0.826 . . . . 0.0 111.914 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -134.73 -2.75 2.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.271 0.628 . . . . 0.0 112.192 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.485 ' HE ' HD12 ' A' ' 11' ' ' LEU . 62.4 ttt180 -60.31 -64.62 0.89 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 127.226 2.21 . . . . 0.0 111.073 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -53.71 -32.46 51.98 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 125.65 1.58 . . . . 0.0 111.228 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -56.39 -33.59 65.89 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.188 -0.945 . . . . 0.0 113.468 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 m -69.48 -41.67 75.85 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.552 0.741 . . . . 0.0 109.548 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -65.06 -33.66 76.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.062 1.345 . . . . 0.0 111.27 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -58.66 -48.54 80.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.6 mt -62.64 -47.94 90.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.094 0.957 . . . . 0.0 109.67 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.9 mt -51.57 -65.8 0.49 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.896 0.878 . . . . 0.0 109.816 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -66.46 -30.47 70.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.171 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -60.7 -35.71 76.97 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 118.985 0.811 . . . . 0.0 110.661 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.452 HG21 ' CE2' ' A' ' 48' ' ' PHE . 34.3 m -74.65 -45.69 44.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 C-N-CA 117.045 -1.862 . . . . 0.0 106.681 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.71 -13.92 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.777 -0.63 . . . . 0.0 112.473 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.95 -68.08 0.74 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 123.389 0.676 . . . . 0.0 111.473 159.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.458 ' CG2' ' HE3' ' A' ' 107' ' ' LYS . 9.6 m -73.6 -41.64 62.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.907 0.883 . . . . 0.0 111.879 -163.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.454 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -115.08 72.39 3.04 Favored Pre-proline 0 N--CA 1.44 -0.927 0 C-N-CA 129.045 2.938 . . . . 0.0 108.748 175.657 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.57 -9.65 21.49 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.324 2.683 . . . . 0.0 111.942 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -38.88 90.99 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.874 1.669 . . . . 0.0 112.318 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.651 HD22 ' H ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -79.09 145.17 33.93 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -172.298 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -110.98 150.27 41.65 Favored Pre-proline 0 C--N 1.319 -0.743 0 C-N-CA 124.628 1.171 . . . . 0.0 108.26 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.65 139.77 37.89 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.614 2.209 . . . . 0.0 109.764 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -154.03 102.52 2.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.477 ' HE3' ' HA ' ' A' ' 44' ' ' ASN . 53.5 mmm -70.65 105.04 3.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 167.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -110.33 143.0 41.2 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.5 m95 54.51 18.85 2.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.477 ' HA ' ' HE3' ' A' ' 41' ' ' MET . 3.0 t-20 62.44 31.38 17.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.211 1.404 . . . . 0.0 110.943 -170.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.8 p -128.97 147.07 63.24 Favored Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 120.951 -1.093 . . . . 0.0 109.246 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -73.37 129.76 14.26 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.828 3.019 . . . . 0.0 112.717 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.24 165.46 36.31 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.461 1.104 . . . . 0.0 109.138 172.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 30' ' ' VAL . 1.3 m-85 -126.56 163.88 22.42 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.444 0.64 . . . . 0.0 109.918 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.8 m -136.52 119.85 16.83 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -77.14 89.72 3.64 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 50.48 51.17 17.38 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.944 0.878 . . . . 0.0 109.291 -171.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.56 -0.43 56.8 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 117.319 1.688 . . . . 0.0 117.319 171.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -165.92 1.1 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.667 2.734 . . . . 0.0 111.975 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -127.2 12.09 7.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.723 1.609 . . . . 0.0 112.748 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 55' ' ' ILE . 33.6 mt -64.51 5.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.629 1.972 . . . . 0.0 113.816 -163.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.6 tt -160.93 132.48 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 118.709 -2.494 . . . . 0.0 110.608 174.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.53 157.42 29.36 Favored Glycine 0 C--N 1.339 0.718 0 O-C-N 122.094 -0.379 . . . . 0.0 112.662 171.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -155.84 168.56 26.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.871 0.868 . . . . 0.0 111.729 -176.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.79 158.01 22.22 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 120.611 -1.305 . . . . 0.0 110.393 170.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.6 p -77.29 113.04 14.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.007 0.923 . . . . 0.0 110.232 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.8 t -90.35 168.03 12.2 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.21 -29.79 6.14 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.304 1.442 . . . . 0.0 113.97 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -145.92 10.69 1.19 Allowed 'General case' 0 C--O 1.238 0.469 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -158.07 159.04 35.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.634 0.773 . . . . 0.0 109.268 -173.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.533 HD23 ' H ' ' A' ' 66' ' ' SER . 0.6 OUTLIER -85.4 165.45 17.2 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 158.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.533 ' H ' HD23 ' A' ' 65' ' ' LEU . 92.2 p -141.65 131.65 24.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.3 t -146.1 140.54 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.509 1.05 . . . . 0.0 109.274 -168.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 t -163.78 164.34 14.99 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.928 1.291 . . . . 0.0 108.394 165.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -78.98 -58.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 CA-C-N 119.433 0.833 . . . . 0.0 112.357 165.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -154.87 -85.8 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -138.23 -44.61 0.51 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.235 1.014 . . . . 0.0 111.568 -173.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.5 tt -55.15 -31.85 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.106 0.963 . . . . 0.0 113.102 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.66 -28.49 5.19 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.075 1.798 . . . . 0.0 113.162 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.2 mm -113.24 -5.52 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 117.918 0.859 . . . . 0.0 111.188 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.5 m -76.23 -78.13 0.12 Allowed 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.898 -1.126 . . . . 0.0 109.955 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -86.71 -47.23 9.31 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -68.07 -20.15 64.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.172 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.26 -30.65 51.31 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.756 1.162 . . . . 0.0 112.987 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.34 -48.63 80.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.255 1.422 . . . . 0.0 109.508 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.85 -29.9 62.37 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.58 0.752 . . . . 0.0 111.307 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.49 -45.49 97.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.254 1.021 . . . . 0.0 108.526 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.17 -46.47 88.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.04 0.936 . . . . 0.0 110.338 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -54.03 -42.35 69.05 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.792 1.237 . . . . 0.0 110.839 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.15 8.34 9.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.48 34.96 30.55 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 119.538 1.063 . . . . 0.0 113.653 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -123.71 169.18 11.76 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.145 0.978 . . . . 0.0 109.486 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 m -135.94 106.82 6.63 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.353 1.061 . . . . 0.0 111.059 -171.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.24 170.53 4.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.519 0.728 . . . . 0.0 112.285 168.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.4 p -128.93 -179.96 5.39 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.709 2.403 . . . . 0.0 107.186 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.82 62.98 6.69 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 120.393 -1.442 . . . . 0.0 110.15 -177.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.26 -59.03 0.1 OUTLIER Glycine 0 CA--C 1.498 -0.972 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -171.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 66' ' ' SER . 1.5 pt? -157.6 177.28 11.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.447 -1.377 . . . . 0.0 110.573 -165.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -110.89 158.41 18.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 167.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -144.11 136.76 26.98 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.747 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.6 mm -117.29 142.75 30.68 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -169.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.46 154.6 60.5 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.87 1.713 . . . . 0.0 110.597 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -62.48 -21.89 65.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 172.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -64.59 -70.6 0.22 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.037 1.735 . . . . 0.0 111.405 172.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.72 153.34 43.81 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.348 0.659 . . . . 0.0 111.353 -161.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.21 -178.73 4.63 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.767 2.978 . . . . 0.0 113.599 -164.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.96 146.35 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 125.716 1.606 . . . . 0.0 110.43 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.99 119.54 35.66 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.28 1.432 . . . . 0.0 109.924 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -87.1 -18.08 31.33 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 123.273 0.629 . . . . 0.0 111.742 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.26 -58.98 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.304 1.042 . . . . 0.0 110.821 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.65 -48.88 79.92 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.62 -56.74 4.84 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.614 1.966 . . . . 0.0 109.933 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.458 ' HE3' ' CG2' ' A' ' 33' ' ' THR . 22.9 tttt -60.99 -45.01 96.54 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.124 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -58.5 -53.69 55.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.416 1.007 . . . . 0.0 110.155 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -75.56 6.87 4.2 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.9 -52.1 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 120.199 1.363 . . . . 0.0 107.831 173.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.425 ' OE1' ' HE2' ' A' ' 107' ' ' LYS . 42.6 mt-10 -60.91 -40.71 94.18 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 119.227 0.921 . . . . 0.0 111.464 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -61.78 -48.52 80.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -32.02 73.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.959 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.486 HD11 HD21 ' A' ' 37' ' ' LEU . 71.9 mt -58.9 -63.85 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.096 1.359 . . . . 0.0 109.123 165.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -69.55 -5.93 27.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.618 1.099 . . . . 0.0 113.317 -170.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -78.58 -50.16 12.02 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.403 1.881 . . . . 0.0 111.462 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -85.8 22.92 1.54 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.899 1.679 . . . . 0.0 111.873 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.253 1.246 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 169.167 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.787 0 CA-C-O 119.466 -0.63 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m 57.0 -171.13 0.09 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.231 2.612 . . . . 0.0 113.542 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -146.92 -39.38 0.2 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.824 0.849 . . . . 0.0 111.001 168.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 mmt -58.13 -19.17 30.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.714 0.806 . . . . 0.0 113.008 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -69.07 -43.65 74.15 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 121.36 -0.837 . . . . 0.0 110.169 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.69 -50.42 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.908 0.883 . . . . 0.0 109.011 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.1 4.41 52.24 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.869 0.868 . . . . 0.0 112.14 -166.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.12 79.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.062 0.945 . . . . 0.0 109.989 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.91 -21.01 64.25 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.124 0.97 . . . . 0.0 112.602 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -79.45 -56.4 4.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.479 0.711 . . . . 0.0 109.22 173.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -55.76 -40.62 72.84 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.427 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -52.06 -38.95 58.83 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.689 0.677 . . . . 0.0 111.247 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.84 -7.37 78.21 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-O 118.487 -1.174 . . . . 0.0 112.534 -166.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -70.54 119.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.8 1.02 56.56 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.953 1.301 . . . . 0.0 111.688 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.33 65.81 1.52 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.732 2.413 . . . . 0.0 109.837 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.46 -30.63 93.07 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 124.087 3.191 . . . . 0.0 113.807 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -59.16 -11.32 3.65 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.844 1.258 . . . . 0.0 113.287 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -126.48 -13.85 5.93 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.302 1.841 . . . . 0.0 110.04 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -66.32 -45.98 78.43 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.627 1.171 . . . . 0.0 110.14 -176.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.66 -33.56 64.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.826 1.25 . . . . 0.0 112.776 -171.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -56.67 -39.98 74.72 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.672 -0.643 . . . . 0.0 111.257 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.1 m -69.42 -39.08 78.09 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.195 1.398 . . . . 0.0 109.294 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -63.09 -45.28 92.85 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.04 -1.038 . . . . 0.0 111.815 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -53.85 -51.71 62.72 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 126.076 1.75 . . . . 0.0 108.984 176.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.6 mt -52.4 -56.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.797 1.639 . . . . 0.0 110.453 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.5 mt -53.35 -53.71 47.07 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.59 0.632 . . . . 0.0 110.197 -174.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.1 m -69.07 -31.98 71.11 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.578 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -63.22 -50.16 71.35 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 124.638 1.175 . . . . 0.0 110.506 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 87.3 t -59.93 -52.03 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.17 -1.46 4.43 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.72 -56.3 2.2 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 120.781 -1.199 . . . . 0.0 109.336 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -67.04 -33.58 75.85 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.734 2.013 . . . . 0.0 111.987 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.518 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -129.86 72.59 81.9 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -178.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.16 -6.73 17.55 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.108 1.872 . . . . 0.0 112.727 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -63.56 -45.8 88.82 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.686 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.602 HD22 ' H ' ' A' ' 37' ' ' LEU . 2.8 mm? -60.35 147.32 41.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.055 0.942 . . . . 0.0 108.955 -171.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -104.64 144.97 29.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 124.234 1.014 . . . . 0.0 108.879 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.79 161.29 46.12 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.497 2.131 . . . . 0.0 111.24 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -158.64 130.27 6.55 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.211 1.404 . . . . 0.0 107.681 161.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.17 112.48 17.53 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.551 1.069 . . . . 0.0 108.334 162.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -123.21 128.33 49.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.645 1.178 . . . . 0.0 108.242 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.9 m95 53.29 25.97 4.86 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.809 0.844 . . . . 0.0 113.062 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.59 29.02 18.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.502 1.121 . . . . 0.0 110.18 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -121.12 147.38 46.56 Favored Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -71.96 133.35 21.45 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.711 2.274 . . . . 0.0 111.758 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.0 ptm -147.28 173.3 12.7 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.804 0.442 . . . . 0.0 110.925 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.48 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -134.05 152.71 51.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.1 p -122.76 138.74 54.54 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.306 1.442 . . . . 0.0 108.006 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -88.35 95.27 10.13 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 163.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 66.78 -13.39 0.19 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.945 1.698 . . . . 0.0 114.046 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.61 -19.63 0.04 OUTLIER Glycine 0 CA--C 1.54 1.646 0 C-N-CA 127.044 2.259 . . . . 0.0 113.887 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.44 -171.05 1.68 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -165.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -125.31 24.99 7.25 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.442 2.297 . . . . 0.0 111.786 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.65 -2.41 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 126.648 1.979 . . . . 0.0 113.515 -167.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 tt -160.68 145.86 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 119.357 -2.09 . . . . 0.0 109.692 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.13 148.81 11.53 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 165.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -144.1 166.09 25.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.849 0.825 . . . . 0.0 109.944 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 t -150.51 145.42 25.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 57.5 p -62.51 145.86 53.15 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.75 174.59 8.99 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -59.59 -39.24 83.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.377 -162.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -138.6 14.27 2.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.199 1.0 . . . . 0.0 113.079 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -150.64 176.74 10.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.962 1.305 . . . . 0.0 108.794 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.27 161.88 14.39 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 166.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.35 114.96 24.31 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.127 1.371 . . . . 0.0 108.63 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.9 136.36 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.3 0.955 . . . . 0.0 109.434 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 t -165.68 161.82 13.37 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 125.261 1.424 . . . . 0.0 107.621 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.51 -57.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.131 0 CA-C-N 120.434 1.191 . . . . 0.0 110.998 157.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -149.55 -85.91 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -133.2 -38.85 0.94 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.444 1.498 . . . . 0.0 111.796 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.7 tp -53.76 -38.09 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.67 1.188 . . . . 0.0 112.981 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.42 -21.87 14.33 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.468 1.509 . . . . 0.0 112.835 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.7 mm -119.93 -5.3 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.437 1.495 . . . . 0.0 110.561 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.2 m -95.06 -64.04 1.11 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 168.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -76.62 -66.52 0.8 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -72.48 -6.24 42.38 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.5 -164.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.32 49.24 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 118.238 -0.887 . . . . 0.0 112.545 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -62.75 -47.54 83.11 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.101 0.864 . . . . 0.0 109.82 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.626 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -78.89 -22.8 45.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.755 0.822 . . . . 0.0 110.977 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.92 -46.98 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.004 0.921 . . . . 0.0 108.935 164.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.83 88.52 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.503 1.121 . . . . 0.0 111.088 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -63.07 -15.64 57.23 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 126.868 2.067 . . . . 0.0 112.894 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.6 -15.35 42.84 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 118.475 0.579 . . . . 0.0 111.623 172.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.96 -22.24 19.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.754 2.121 . . . . 0.0 112.879 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -74.17 114.7 12.82 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.236 1.014 . . . . 0.0 110.191 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.1 m -75.11 4.76 6.25 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 48.21 -155.71 0.07 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.798 2.439 . . . . 0.0 112.026 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.0 p -126.4 -164.7 1.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.549 2.34 . . . . 0.0 105.732 163.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -71.73 -33.0 68.34 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.109 1.322 . . . . 0.0 111.515 172.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.56 -10.56 2.92 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 114.479 0.552 . . . . 0.0 114.479 -160.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 pp -149.6 175.88 11.14 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.646 1.178 . . . . 0.0 109.675 168.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -113.26 157.4 21.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.651 0.66 . . . . 0.0 109.546 167.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.1 mtt85 -128.23 155.18 44.96 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -137.28 142.56 38.16 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 178.521 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.88 155.09 23.3 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.985 1.79 . . . . 0.0 109.343 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -63.81 -17.73 63.4 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -67.0 -45.15 78.46 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.17 0.988 . . . . 0.0 112.086 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.7 156.12 45.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 122.882 0.473 . . . . 0.0 110.982 -157.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.33 165.93 29.98 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.513 2.142 . . . . 0.0 112.911 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.32 124.86 51.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -75.81 78.58 2.74 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.284 1.04 . . . . 0.0 113.148 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -59.62 -37.22 78.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.842 0.857 . . . . 0.0 112.351 173.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.59 -46.8 71.56 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 120.148 1.34 . . . . 0.0 110.437 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.626 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -68.38 -47.5 67.2 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.435 -0.791 . . . . 0.0 109.289 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.279 0.3 OUTLIER -72.55 -27.07 61.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.339 -175.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -54.33 -52.63 60.94 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.382 0.992 . . . . 0.0 109.591 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -56.73 -52.34 65.37 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.056 -170.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.8 ptp -65.46 -34.63 78.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.025 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -53.01 21.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.988 1.267 . . . . 0.0 109.002 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.63 -50.7 59.77 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -55.66 -52.8 62.6 Favored 'General case' 0 N--CA 1.441 -0.905 0 O-C-N 124.016 0.823 . . . . 0.0 111.068 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -63.67 -22.28 66.82 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.351 0.978 . . . . 0.0 112.844 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.2 mt -71.65 -57.47 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.943 0.897 . . . . 0.0 108.636 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -74.95 -5.93 46.53 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -75.1 -19.86 59.74 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.529 0.731 . . . . 0.0 110.383 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -101.69 16.69 25.0 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.792 2.437 . . . . 0.0 111.071 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 117.351 -1.309 . . . . 0.0 108.198 172.27 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.807 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.433 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -52.43 -43.61 64.95 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.748 1.619 . . . . 0.0 113.233 -175.405 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.433 ' CE1' ' HG2' ' A' ' 4' ' ' MET 0.256 2.8 p-80 50.87 -48.47 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.594 1 C-N-CA 132.019 4.127 . . . . 0.0 116.435 -171.769 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.433 ' HG2' ' CE1' ' A' ' 3' ' ' HIS . 3.4 mmt -55.91 -31.04 62.53 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 119.892 1.224 . . . . 0.0 111.26 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.451 ' H ' ' HG3' ' A' ' 5' ' ' GLU . 1.1 pp20? -53.11 -48.14 68.06 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.519 0.728 . . . . 0.0 111.475 175.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.31 -43.74 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 121.643 -0.661 . . . . 0.0 109.652 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -103.63 50.14 0.81 Allowed 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.156 0.983 . . . . 0.0 111.236 -171.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -126.2 -27.05 3.28 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.682 0.793 . . . . 0.0 110.374 168.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.401 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 50.1 mt-10 -75.83 -12.91 60.26 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.112 -0.993 . . . . 0.0 112.436 -173.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -78.85 -48.77 14.07 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.397 1.479 . . . . 0.0 109.029 163.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -60.2 -22.98 63.63 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.713 2.405 . . . . 0.0 112.923 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 9' ' ' GLU . 51.7 pttt -61.01 -44.13 97.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.741 1.155 . . . . 0.0 109.475 173.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.96 10.23 51.73 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.609 1.1 . . . . 0.0 114.907 -164.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.467 HD12 HG21 ' A' ' 60' ' ' THR . 4.6 mm -58.42 123.94 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.072 1.349 . . . . 0.0 108.254 174.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -56.94 -36.02 69.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.753 1.221 . . . . 0.0 113.107 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -116.78 85.95 18.24 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 126.521 1.929 . . . . 0.0 110.928 -168.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.07 -23.62 75.82 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.305 2.003 . . . . 0.0 111.828 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 23.6 m-20 -65.9 -16.9 64.27 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.306 -0.871 . . . . 0.0 111.888 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 0.8 OUTLIER -128.85 -0.53 5.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.338 1.455 . . . . 0.0 110.763 179.497 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.9 ttp85 -53.96 -57.45 10.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.142 0.977 . . . . 0.0 109.484 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -48.31 -35.07 11.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.549 1.54 . . . . 0.0 112.39 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -60.63 -39.09 86.97 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.318 -1.489 . . . . 0.0 111.824 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.8 m -63.42 -49.78 72.41 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.675 0.79 . . . . 0.0 109.397 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.53 -30.63 61.08 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.567 1.547 . . . . 0.0 113.33 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.03 -58.94 6.38 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 118.775 0.716 . . . . 0.0 110.297 173.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 mt -57.66 -38.86 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 123.875 0.87 . . . . 0.0 110.415 -173.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.2 mt -56.33 -62.66 1.56 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.157 0.983 . . . . 0.0 110.189 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -64.25 -31.66 72.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -62.24 -43.33 99.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 117.493 -1.241 . . . . 0.0 110.876 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.25 -40.56 80.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.763 0 C-N-CA 116.92 -1.912 . . . . 0.0 107.37 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.96 -25.36 8.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 117.748 -1.12 . . . . 0.0 112.529 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.17 -27.65 14.46 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.471 HG21 ' HE3' ' A' ' 107' ' ' LYS . 7.3 m -94.82 -40.18 9.87 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.645 1.111 . . . . 0.0 111.251 -174.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.451 ' CE1' HG22 ' A' ' 33' ' ' THR . 2.6 m-85 -120.28 58.44 5.91 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 129.575 3.15 . . . . 0.0 111.823 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.08 -13.92 38.38 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.834 2.356 . . . . 0.0 113.722 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.29 -23.67 66.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.165 1.386 . . . . 0.0 112.427 172.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.87 145.58 44.74 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -117.59 150.47 46.83 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 126.964 2.106 . . . . 0.0 108.444 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.27 140.28 13.7 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.872 2.381 . . . . 0.0 111.67 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -164.85 96.49 0.73 Allowed 'General case' 0 C--N 1.346 0.439 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 ptm -70.21 136.39 49.96 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.422 1.01 . . . . 0.0 108.886 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -150.52 155.32 39.25 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.9 m95 52.71 33.37 13.78 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.563 1.145 . . . . 0.0 113.06 -174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 61.78 18.84 10.06 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.207 1.803 . . . . 0.0 112.476 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.0 p -129.49 155.97 79.33 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.92 1.288 . . . . 0.0 110.007 -173.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.81 120.75 5.93 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.968 3.112 . . . . 0.0 110.235 170.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.5 ptm -135.01 162.52 32.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 163.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.93 168.28 14.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 p -134.19 121.63 21.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.144 0.578 . . . . 0.0 109.56 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -68.46 92.9 0.46 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 169.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 53.58 28.67 8.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.478 1.111 . . . . 0.0 111.882 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.3 -17.81 7.89 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 125.636 1.589 . . . . 0.0 115.642 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.6 m -79.32 -179.13 6.59 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 119.799 1.8 . . . . 0.0 111.242 -173.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.548 ' H ' HG22 ' A' ' 53' ' ' THR . 61.6 t80 -111.09 18.25 19.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.462 1.905 . . . . 0.0 113.554 -168.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.67 12.51 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.849 1.66 . . . . 0.0 112.495 -163.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 tt -163.31 146.28 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 119.558 -1.964 . . . . 0.0 111.249 174.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.48 151.03 18.21 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 166.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.421 ' CD2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -153.17 -179.89 8.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.417 0.687 . . . . 0.0 111.078 175.502 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t 178.79 147.1 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 14' ' ' ILE . 81.4 p -62.86 146.91 51.66 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.302 0.641 . . . . 0.0 110.504 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -126.74 165.18 19.74 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -12.51 18.2 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.52 8.29 0.38 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.485 1.039 . . . . 0.0 112.245 176.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -162.49 -179.88 7.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.869 1.668 . . . . 0.0 108.645 -164.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.522 HD22 ' H ' ' A' ' 66' ' ' SER . 1.8 tm? -127.67 154.22 45.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.801 2.041 . . . . 0.0 107.012 174.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.625 ' HB2' HD22 ' A' ' 92' ' ' LEU . 3.8 p -132.07 122.82 26.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.761 1.624 . . . . 0.0 108.954 -173.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG13 ' CE1' ' A' ' 93' ' ' PHE . 1.6 p -144.78 145.45 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.882 1.219 . . . . 0.0 111.663 -171.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.545 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 13.7 t -160.0 165.03 18.59 Favored Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 125.59 1.556 . . . . 0.0 109.581 169.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -81.49 -57.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.444 2.096 . . . . 0.0 112.936 156.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -149.17 -86.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.122 1.769 . . . . 0.0 106.964 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -152.47 -27.32 0.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.651 1.18 . . . . 0.0 112.55 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.8 tt -62.71 -40.16 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 120.576 1.534 . . . . 0.0 109.891 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.96 -10.91 15.89 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.002 1.286 . . . . 0.0 113.104 173.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 68' ' ' SER . 5.3 mm -117.03 -0.57 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.734 2.014 . . . . 0.0 110.025 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 m -125.62 -50.54 1.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.488 0.585 . . . . 0.0 111.844 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -79.67 -57.42 3.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.987 1.715 . . . . 0.0 107.443 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -73.46 -0.76 15.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.261 1.024 . . . . 0.0 112.5 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.25 -25.47 67.85 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.477 1.911 . . . . 0.0 112.701 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -79.07 -48.02 15.12 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.557 0.743 . . . . 0.0 109.028 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.28 87.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.552 0.741 . . . . 0.0 110.834 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.85 -50.33 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.053 0.941 . . . . 0.0 109.839 171.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.53 -50.58 73.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.97 0.908 . . . . 0.0 111.368 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -60.06 -25.74 65.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.655 1.582 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.41 -27.14 63.1 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.175 0.443 . . . . 0.0 110.854 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 122.61 6.21 8.06 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.466 1.508 . . . . 0.0 113.431 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.07 122.23 44.23 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.459 1.63 . . . . 0.0 110.005 -173.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.43 3.83 12.41 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -170.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 46.52 -168.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.962 2.105 . . . . 0.0 113.277 -172.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.3 p -141.67 -164.7 1.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.347 2.259 . . . . 0.0 108.092 168.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 5.26 13.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.16 2.184 . . . . 0.0 112.047 173.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.5 -7.94 0.03 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 116.667 1.427 . . . . 0.0 116.667 -172.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 66' ' ' SER . 2.9 pp -149.29 170.71 17.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.112 1.456 . . . . 0.0 108.607 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.425 ' CE1' HG13 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -116.22 125.83 52.78 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 164.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -72.37 134.75 45.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.494 170.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.6 mm -125.72 143.71 45.96 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 165.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.68 163.68 38.15 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.154 1.903 . . . . 0.0 110.159 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -70.49 -35.12 73.07 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 171.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -67.76 -59.95 2.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.218 0.533 . . . . 0.0 110.469 -174.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.22 162.83 65.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.48 1.912 . . . . 0.0 109.455 -172.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.15 165.61 25.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.587 1.525 . . . . 0.0 113.391 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.0 t -93.44 134.91 29.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 126.413 1.885 . . . . 0.0 106.719 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.41 76.35 3.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.328 1.451 . . . . 0.0 110.721 171.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -56.47 -44.25 80.38 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.028 0.931 . . . . 0.0 110.461 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -65.18 -26.2 68.05 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.778 0.831 . . . . 0.0 111.749 -174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.96 -53.92 6.56 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.277 0.3 OUTLIER -58.72 -24.87 62.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.77 1.228 . . . . 0.0 112.022 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.471 ' HE3' HG21 ' A' ' 33' ' ' THR . 16.1 tttt -65.52 -54.0 34.4 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.785 2.034 . . . . 0.0 113.252 169.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -57.81 -46.42 84.71 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.877 1.217 . . . . 0.0 111.192 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.0 ptp -66.35 -32.21 73.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.307 -0.854 . . . . 0.0 113.226 -175.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -44.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.195 0.907 . . . . 0.0 108.987 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.08 -43.75 98.15 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.639 0.775 . . . . 0.0 110.717 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.425 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 5.1 t80 -58.26 -48.06 81.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.458 175.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -59.1 -40.47 85.39 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 118.161 0.437 . . . . 0.0 110.383 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.85 -52.06 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 O-C-N 121.319 -0.863 . . . . 0.0 110.084 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 112' ' ' PHE . 17.6 pt20 -71.56 -4.92 29.6 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 120.27 1.396 . . . . 0.0 112.413 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -93.78 2.57 56.2 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.658 1.983 . . . . 0.0 112.281 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -129.38 19.35 5.8 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.317 1.447 . . . . 0.0 111.216 -174.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 124.282 1.033 . . . . 0.0 109.586 175.71 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -133.69 92.05 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.905 1.352 . . . . 0.0 110.977 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -56.04 -37.5 69.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.992 0.917 . . . . 0.0 113.302 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.2 mmt -60.1 -30.4 69.22 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.652 -0.655 . . . . 0.0 112.534 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.73 -43.85 71.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.57 -44.98 99.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.61 1.164 . . . . 0.0 109.917 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.43 0.05 55.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.953 0.501 . . . . 0.0 112.118 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.54 67.93 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.786 1.235 . . . . 0.0 109.46 173.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.33 -13.36 62.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.273 1.429 . . . . 0.0 113.526 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -82.67 -59.6 2.46 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -55.96 -44.32 78.36 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.821 1.248 . . . . 0.0 110.811 -175.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -56.36 -32.55 64.83 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.424 0.69 . . . . 0.0 112.471 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.0 -22.73 57.09 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 119.251 -0.749 . . . . 0.0 111.379 -171.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.5 mt -74.84 98.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -66.58 -2.83 5.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.227 1.411 . . . . 0.0 113.437 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -100.01 84.97 0.46 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 128.662 2.785 . . . . 0.0 110.978 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.79 -36.79 82.62 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.533 2.155 . . . . 0.0 112.295 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.88 5.79 2.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.013 0.824 . . . . 0.0 112.476 -170.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -137.13 -36.77 0.66 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.395 1.878 . . . . 0.0 110.425 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -52.78 -40.37 63.12 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.85 0.86 . . . . 0.0 110.889 171.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.93 -22.72 60.41 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.616 1.166 . . . . 0.0 112.362 -176.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -81.99 -31.54 31.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.1 0.864 . . . . 0.0 111.853 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.2 m -72.94 -39.69 66.02 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.157 0.983 . . . . 0.0 110.492 -175.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HB3' HD21 ' A' ' 11' ' ' LEU . 3.0 pt-20 -63.19 -26.04 68.62 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.731 0.412 . . . . 0.0 111.906 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.46 -54.65 44.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.835 0.854 . . . . 0.0 110.142 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.9 mp -63.83 -40.59 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -174.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.1 mt -52.92 -53.89 42.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.236 0.614 . . . . 0.0 110.101 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -62.47 -44.45 96.37 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.528 1.131 . . . . 0.0 111.228 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.8 t90 -59.04 -44.31 91.77 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.502 1.121 . . . . 0.0 111.664 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.832 HG11 ' CE2' ' A' ' 48' ' ' PHE . 40.9 t -63.25 -46.16 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.306 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.25 -12.7 21.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.493 1.042 . . . . 0.0 113.452 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.49 -48.59 7.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.348 164.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 m -78.83 -34.47 45.18 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 117.431 -1.271 . . . . 0.0 111.314 -163.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.602 ' HD2' HG13 ' A' ' 30' ' ' VAL . 1.5 m-85 -117.47 76.17 9.56 Favored Pre-proline 0 C--N 1.344 0.333 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.23 -14.04 39.43 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.665 2.243 . . . . 0.0 113.338 -172.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -20.83 59.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.528 0.731 . . . . 0.0 111.658 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.481 HD11 ' CD1' ' A' ' 114' ' ' ILE . 2.7 mp -70.29 151.16 45.6 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.564 1.546 . . . . 0.0 109.085 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -122.93 143.02 39.48 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 113.032 -1.895 . . . . 0.0 108.738 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.54 154.21 35.22 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.19 2.593 . . . . 0.0 110.488 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -176.95 102.58 0.05 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.155 1.782 . . . . 0.0 106.26 171.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 62.2 mmm -60.63 129.95 44.11 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -134.58 138.96 45.01 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.0 m95 58.76 19.77 7.22 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m120 64.03 12.18 6.73 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 126.578 1.951 . . . . 0.0 113.101 -166.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.0 p -114.51 112.54 45.86 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 120.356 1.435 . . . . 0.0 108.169 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.05 132.83 33.34 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.927 2.418 . . . . 0.0 111.648 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 ptm -143.26 159.19 42.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.832 ' CE2' HG11 ' A' ' 30' ' ' VAL . 1.2 m-85 -123.94 109.29 13.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.6 p -73.24 120.82 19.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -67.12 98.33 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 163.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 50.68 -4.64 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 130.207 3.403 . . . . 0.0 117.617 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.44 25.24 0.09 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.76 1.648 . . . . 0.0 113.028 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -117.0 177.32 4.75 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.184 1.394 . . . . 0.0 108.481 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -120.68 25.99 9.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.731 1.612 . . . . 0.0 110.777 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.78 19.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 125.234 1.413 . . . . 0.0 111.552 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.471 ' CG2' ' H ' ' A' ' 48' ' ' PHE . 1.1 tt -165.72 162.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 119.684 -1.885 . . . . 0.0 109.16 166.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.51 91.62 0.08 OUTLIER Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 159.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.509 ' CD2' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -90.98 162.47 14.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.532 0.666 . . . . 0.0 110.897 -175.428 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.0 t -152.92 155.39 36.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.992 0.901 . . . . 0.0 110.399 164.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.6 p -72.8 156.33 39.02 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.185 2.194 . . . . 0.0 109.787 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.28 -179.04 5.43 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.916 1.286 . . . . 0.0 109.739 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -49.66 -59.84 3.43 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 125.085 1.354 . . . . 0.0 111.824 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -132.32 15.31 4.57 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.255 1.022 . . . . 0.0 111.184 -174.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -152.08 173.64 14.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.824 1.249 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.528 HD12 ' H ' ' A' ' 66' ' ' SER . 33.7 tp -111.79 157.87 20.04 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.715 1.606 . . . . 0.0 108.131 170.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.528 ' H ' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -135.51 111.62 9.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.277 1.431 . . . . 0.0 110.281 -171.01 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG13 ' CZ ' ' A' ' 93' ' ' PHE . 1.5 p -142.15 151.36 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.702 1.601 . . . . 0.0 113.876 -167.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 1.4 t -174.83 165.16 2.29 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.136 2.575 . . . . 0.0 109.422 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.99 -55.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 124.327 3.351 . . . . 0.0 112.956 164.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -156.12 -74.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.776 2.03 . . . . 0.0 108.401 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -156.1 -46.75 0.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.861 1.665 . . . . 0.0 110.722 -168.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 tp -55.96 -42.42 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.516 1.053 . . . . 0.0 110.845 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.13 -16.04 24.62 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.075 0.845 . . . . 0.0 114.178 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.476 HG21 ' H ' ' A' ' 91' ' ' GLY . 34.4 mm -115.9 -6.88 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.032 1.733 . . . . 0.0 110.131 -176.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.8 m -100.95 -61.22 1.4 Allowed 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 121.569 -0.707 . . . . 0.0 109.881 172.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -82.61 -39.97 21.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.889 2.476 . . . . 0.0 109.597 -172.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -99.38 -8.21 25.13 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' A' ' 81' ' ' ILE . . . -61.56 -29.78 70.24 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.896 0.771 . . . . 0.0 112.496 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.64 -51.23 70.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.791 0.805 . . . . 0.0 109.483 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.57 -28.87 66.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.416 1.486 . . . . 0.0 111.359 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 78' ' ' ALA . 77.9 mt -64.91 -48.82 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 123.76 0.824 . . . . 0.0 108.976 168.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.59 79.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.203 0.525 . . . . 0.0 110.403 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.2 -24.67 67.35 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.991 0.917 . . . . 0.0 112.197 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.57 -4.24 41.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.494 0.588 . . . . 0.0 112.344 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.01 29.21 10.66 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 121.243 -0.911 . . . . 0.0 112.817 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -126.01 -179.99 4.95 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.468 1.134 . . . . 0.0 111.377 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.23 158.84 34.62 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.249 1.819 . . . . 0.0 111.034 -172.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.35 169.83 17.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.495 1.518 . . . . 0.0 110.917 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.2 p -136.47 -163.79 1.46 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 127.857 2.463 . . . . 0.0 107.956 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -94.78 77.03 3.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 166.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.476 ' H ' HG21 ' A' ' 74' ' ' ILE . . . 127.14 6.6 5.28 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.726 166.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 0.3 OUTLIER -160.9 159.44 29.69 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.948 1.374 . . . . 0.0 110.706 169.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CZ ' HG13 ' A' ' 67' ' ' VAL . 27.1 p90 -117.84 156.76 27.81 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.927 0.891 . . . . 0.0 108.693 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.99 120.11 30.63 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.996 0.919 . . . . 0.0 108.642 -161.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.0 mm -119.61 142.86 33.6 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.51 155.49 31.92 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.785 1.657 . . . . 0.0 109.385 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -57.85 -15.16 7.56 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 170.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.22 -45.92 65.58 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.379 1.471 . . . . 0.0 113.343 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.97 161.92 21.34 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 123.642 0.777 . . . . 0.0 110.227 -163.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -66.23 154.2 75.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.734 2.29 . . . . 0.0 110.899 172.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.3 t -85.98 132.38 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -73.58 81.62 1.5 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.488 1.515 . . . . 0.0 110.365 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -50.55 -48.17 57.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.728 1.211 . . . . 0.0 110.051 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.44 -46.94 66.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 123.433 0.458 . . . . 0.0 111.286 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.6 -47.51 47.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 119.507 1.049 . . . . 0.0 109.886 -171.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -27.0 66.81 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.591 0.757 . . . . 0.0 110.618 174.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -65.99 -59.5 3.76 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.296 1.438 . . . . 0.0 110.187 172.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -61.32 -38.63 87.55 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.698 0.681 . . . . 0.0 109.677 -170.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.8 ptp -72.25 -17.83 61.86 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.63 -53.18 8.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 121.088 1.767 . . . . 0.0 109.176 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.83 -46.67 42.38 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 125.545 1.538 . . . . 0.0 109.128 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 16.9 t80 -49.56 -41.08 40.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.27 -0.871 . . . . 0.0 113.195 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -29.04 42.65 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 120.33 1.423 . . . . 0.0 109.325 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' HD11 ' A' ' 37' ' ' LEU . 7.2 mt -78.09 -25.94 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 120.711 -1.243 . . . . 0.0 110.202 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 112' ' ' PHE . 16.6 pt20 -84.32 -2.59 57.3 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.278 1.399 . . . . 0.0 112.165 166.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -92.57 -38.07 12.11 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.278 0.561 . . . . 0.0 110.975 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.59 24.34 3.11 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.059 1.344 . . . . 0.0 112.151 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.243 0.712 0 C-N-CA 124.845 1.258 . . . . 0.0 108.807 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.611 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.51 151.32 20.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.654 0.782 . . . . 0.0 110.406 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -166.93 -35.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.712 1.205 . . . . 0.0 110.593 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.9 mmt -60.7 -25.5 66.45 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.361 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.85 -53.06 62.5 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 118.578 0.626 . . . . 0.0 109.931 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.37 -44.63 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -175.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -76.46 -13.16 60.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 111.799 -171.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.6 91.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.787 0.835 . . . . 0.0 110.677 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -72.66 -9.31 58.46 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -83.22 -57.08 3.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.571 -0.706 . . . . 0.0 109.77 159.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.1 mm? -56.59 -37.19 70.28 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -170.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -51.46 -29.82 17.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.479 1.112 . . . . 0.0 112.279 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.35 4.15 62.04 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 117.025 -1.986 . . . . 0.0 113.615 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.08 102.87 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.395 0 CA-C-N 120.963 2.381 . . . . 0.0 107.978 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -0.59 2.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.331 2.253 . . . . 0.0 113.528 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -117.43 64.27 4.05 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 128.779 2.832 . . . . 0.0 109.993 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -62.73 -17.55 59.63 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.92 3.08 . . . . 0.0 112.822 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.64 -14.15 62.69 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.748 1.219 . . . . 0.0 112.592 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.95 -1.25 1.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.493 1.517 . . . . 0.0 110.295 -172.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -55.97 -58.58 7.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.665 1.586 . . . . 0.0 110.352 -173.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -54.01 -31.18 50.32 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.059 1.744 . . . . 0.0 112.471 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -52.88 -35.76 58.24 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.82 -0.55 . . . . 0.0 110.333 174.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -67.75 -47.62 68.73 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.25 1.42 . . . . 0.0 110.435 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.89 -31.95 73.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.821 1.648 . . . . 0.0 110.345 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -58.15 -57.9 10.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.346 1.058 . . . . 0.0 108.513 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.3 mt -56.93 -46.71 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.4 mt -59.25 -49.65 77.01 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.901 0.773 . . . . 0.0 110.334 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -61.13 -43.05 99.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.791 1.236 . . . . 0.0 110.878 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -66.7 -42.75 85.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.627 1.971 . . . . 0.0 111.211 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 t -59.2 -54.59 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-N 119.26 0.936 . . . . 0.0 108.702 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.65 -1.31 1.78 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.612 0.765 . . . . 0.0 112.945 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.61 -68.1 0.87 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.782 1.233 . . . . 0.0 109.027 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -62.66 -32.91 74.05 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.334 1.853 . . . . 0.0 111.368 -170.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.23 68.42 18.73 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.94 -4.77 15.5 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.382 2.721 . . . . 0.0 113.105 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.01 -14.32 50.97 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.634 -1.291 . . . . 0.0 110.768 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 56' ' ' ILE . 46.0 mt -80.92 149.59 29.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.236 0.925 . . . . 0.0 109.383 171.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -132.3 151.12 77.75 Favored Pre-proline 0 C--O 1.221 -0.42 0 C-N-CA 125.517 1.527 . . . . 0.0 111.78 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.42 132.8 18.15 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.521 2.814 . . . . 0.0 112.365 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -148.84 127.16 12.2 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.03 125.31 35.79 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 168.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -153.54 150.7 28.98 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 119.265 0.939 . . . . 0.0 111.701 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.3 m95 53.9 24.66 4.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.1 t30 65.11 10.25 6.19 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.923 2.089 . . . . 0.0 113.312 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.86 149.09 40.29 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.99 136.32 16.37 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.244 1.962 . . . . 0.0 109.88 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 17.4 ptm -142.89 -176.81 5.04 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.628 1.171 . . . . 0.0 108.11 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -140.35 157.12 46.04 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 117.751 -1.119 . . . . 0.0 108.682 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.1 p -117.07 132.58 56.65 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 120.589 1.541 . . . . 0.0 109.543 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -74.34 95.25 2.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 161.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 44.81 41.75 5.4 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.137 1.775 . . . . 0.0 112.941 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 115.06 -20.63 14.13 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.373 1.463 . . . . 0.0 114.502 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.8 m -77.12 -175.92 3.81 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.63 1.972 . . . . 0.0 110.907 -171.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' H ' HG22 ' A' ' 53' ' ' THR . 21.0 t80 -124.11 22.25 8.73 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.256 -1.527 . . . . 0.0 112.88 -169.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 mt -68.23 8.54 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 127.341 2.256 . . . . 0.0 113.464 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 37' ' ' LEU . 4.5 tt -162.52 148.47 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 121.853 2.115 . . . . 0.0 111.42 172.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.49 154.0 23.44 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.384 0.993 . . . . 0.0 111.433 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.41 170.46 20.06 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.637 1.219 . . . . 0.0 110.947 174.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.14 116.24 3.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.313 1.045 . . . . 0.0 108.827 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.2 p -62.22 130.68 46.5 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 119.907 1.231 . . . . 0.0 109.86 -170.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.4 t -90.53 171.25 9.54 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -55.72 -52.71 62.96 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 167.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -134.87 54.56 1.93 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.5 0.72 . . . . 0.0 109.726 -171.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.466 ' CD2' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER 175.84 170.66 0.37 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.638 2.375 . . . . 0.0 110.271 174.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tp -112.99 150.27 32.13 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.589 2.355 . . . . 0.0 106.768 153.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -132.76 121.32 22.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.473 2.709 . . . . 0.0 111.138 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.88 144.1 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 127.273 2.229 . . . . 0.0 111.314 -163.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.9 t -156.82 163.26 25.64 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 159.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.18 -57.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 120.736 0.957 . . . . 0.0 110.511 157.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -150.78 -86.5 0.08 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 171.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.26 -25.9 0.84 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.707 1.203 . . . . 0.0 112.584 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.0 tp -57.4 -41.47 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 121.065 1.757 . . . . 0.0 109.85 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.79 -23.4 10.58 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.445 1.021 . . . . 0.0 113.95 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.9 mm -111.73 -3.56 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.983 2.113 . . . . 0.0 110.237 -172.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.3 m -116.36 -54.31 2.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.349 1.06 . . . . 0.0 109.654 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -78.28 -51.85 9.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.112 2.165 . . . . 0.0 108.288 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -95.39 -3.22 47.5 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -167.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.57 -30.3 70.57 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -69.13 -42.07 76.53 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.984 0.811 . . . . 0.0 109.135 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.44 -45.85 92.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.277 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.0 mt -58.91 -43.41 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.464 0.705 . . . . 0.0 109.67 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.75 -53.47 57.86 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.278 0.631 . . . . 0.0 110.089 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.9 -21.71 62.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.609 0.763 . . . . 0.0 112.014 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.22 8.09 2.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.372 0.987 . . . . 0.0 111.566 170.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.74 37.24 57.54 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 121.142 -0.974 . . . . 0.0 112.043 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -136.8 161.18 36.68 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.055 0.942 . . . . 0.0 110.311 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -122.51 97.57 5.52 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.64 -0.662 . . . . 0.0 110.828 -160.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.87 165.04 7.18 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.518 0.675 . . . . 0.0 111.117 171.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.6 p -105.81 -165.55 1.12 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 157.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -77.62 -4.04 43.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.667 166.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.96 -11.42 0.42 Allowed Glycine 0 CA--C 1.529 0.918 0 CA-C-N 120.444 1.475 . . . . 0.0 115.535 -168.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.19 178.58 9.59 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.116 1.458 . . . . 0.0 110.472 164.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -122.68 144.36 49.19 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 165.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.459 ' HD2' ' NE2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -139.12 154.95 48.19 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 120.625 -1.297 . . . . 0.0 110.047 -170.896 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.466 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 44.3 mm -143.05 142.36 21.68 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -163.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.08 153.05 72.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 CA-C-N 121.01 1.396 . . . . 0.0 109.886 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -69.88 92.1 0.68 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 157.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.38 -59.46 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 126.305 1.842 . . . . 0.0 108.749 166.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -90.52 157.23 44.71 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.803 -159.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.46 114.86 4.06 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.988 1.792 . . . . 0.0 110.886 -172.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.69 119.68 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.828 1.651 . . . . 0.0 107.99 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -76.03 85.83 2.93 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 126.034 1.734 . . . . 0.0 113.072 -173.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -56.01 -43.82 78.11 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 124.348 1.059 . . . . 0.0 110.854 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -56.46 -51.67 67.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.729 1.212 . . . . 0.0 111.872 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -42.73 95.31 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.607 -0.683 . . . . 0.0 109.888 -177.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.302 0.2 OUTLIER -75.93 -24.66 55.55 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.76 -176.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.77 -44.65 85.17 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 120.19 1.359 . . . . 0.0 109.899 171.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -56.53 -50.44 71.84 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.75 0.704 . . . . 0.0 109.688 -175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 ptp -67.1 -35.35 79.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.224 -0.894 . . . . 0.0 113.192 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -49.65 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.651 1.114 . . . . 0.0 109.068 177.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -58.5 -42.72 88.29 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.694 1.198 . . . . 0.0 110.949 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.41 -51.11 67.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.431 -0.795 . . . . 0.0 109.514 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -69.81 -10.4 58.3 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.883 1.219 . . . . 0.0 113.573 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 76.4 mt -75.17 -59.88 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.396 1.078 . . . . 0.0 108.525 161.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -75.7 -15.62 60.27 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 121.601 -0.687 . . . . 0.0 112.737 -165.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.64 -11.14 59.96 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.676 1.99 . . . . 0.0 112.034 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -106.06 15.08 26.92 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.974 2.109 . . . . 0.0 110.498 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.249 1.071 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.091 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -23.11 65.12 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 117.999 -1.001 . . . . 0.0 111.549 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.261 5.6 p-80 55.87 -45.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 130.109 3.364 . . . . 0.0 116.264 -173.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 mmt -51.62 -34.09 36.07 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.872 1.669 . . . . 0.0 112.311 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.02 -24.5 54.14 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.66 -25.86 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 120.896 0.379 . . . . 0.0 110.333 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -114.43 -5.53 12.88 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.12 1.768 . . . . 0.0 113.122 -173.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.78 -22.79 45.82 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 120.508 -1.37 . . . . 0.0 112.082 -169.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.27 -8.73 54.75 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.762 -0.587 . . . . 0.0 111.848 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -68.0 -57.75 5.64 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 160.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.434 HD12 ' CG ' ' A' ' 20' ' ' ARG . 1.2 mm? -46.63 -50.18 18.0 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.641 1.577 . . . . 0.0 112.964 -175.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -53.06 -29.91 32.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.8 9.68 29.88 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.058 -1.412 . . . . 0.0 114.635 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.409 HD12 HD13 ' A' ' 11' ' ' LEU . 24.4 mt -69.12 111.53 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 120.705 2.252 . . . . 0.0 105.958 167.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.0 -9.43 59.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.815 0.846 . . . . 0.0 113.208 -173.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.83 73.42 34.14 Favored Pre-proline 0 N--CA 1.445 -0.695 0 C-N-CA 125.017 1.327 . . . . 0.0 110.776 -168.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.77 -18.75 53.36 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.749 2.966 . . . . 0.0 114.875 -167.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -64.15 -10.66 24.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.266 0.626 . . . . 0.0 110.533 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -119.28 -6.84 10.33 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.58 1.952 . . . . 0.0 112.039 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.434 ' CG ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -79.95 -49.02 12.47 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.114 -0.991 . . . . 0.0 110.48 -171.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.68 -42.6 79.32 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.774 0.671 . . . . 0.0 110.064 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.52 -56.96 10.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 123.899 0.88 . . . . 0.0 110.426 171.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.3 m -58.43 -38.83 78.26 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.548 1.139 . . . . 0.0 110.629 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -30.87 66.43 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.769 1.628 . . . . 0.0 114.068 171.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -63.75 -51.1 66.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.972 -0.537 . . . . 0.0 109.806 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mp -57.9 -52.62 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.34 -61.34 2.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.536 1.134 . . . . 0.0 109.941 -170.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m -71.36 -31.53 67.44 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.802 -1.094 . . . . 0.0 111.054 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 74.3 t90 -61.31 -48.07 83.07 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.575 1.079 . . . . 0.0 111.316 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.425 HG13 ' HD2' ' A' ' 34' ' ' PHE . 88.0 t -58.15 -48.89 83.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.96 -15.29 63.54 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.77 -62.4 1.55 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.052 0.941 . . . . 0.0 109.529 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 m -68.97 -27.51 65.79 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.774 0.83 . . . . 0.0 110.886 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.507 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -124.21 73.62 58.32 Favored Pre-proline 0 N--CA 1.443 -0.822 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.111 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.8 -5.58 17.45 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.343 2.029 . . . . 0.0 111.763 175.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.63 -36.55 84.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.54 1.136 . . . . 0.0 112.013 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.578 HD22 ' H ' ' A' ' 37' ' ' LEU . 1.4 mm? -78.84 139.59 38.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -172.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -88.59 147.01 38.55 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 171.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.53 142.04 14.35 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.655 2.903 . . . . 0.0 111.348 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -146.8 139.04 24.77 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.738 0.699 . . . . 0.0 109.966 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 ttm -99.85 107.65 19.72 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -125.48 151.39 46.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.946 1.699 . . . . 0.0 107.078 170.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.0 m95 55.78 21.26 4.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.594 1.558 . . . . 0.0 114.749 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.07 26.23 11.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.341 1.056 . . . . 0.0 111.424 -168.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 59' ' ' SER . 44.4 p -119.1 146.91 41.57 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.459 1.504 . . . . 0.0 109.255 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.24 122.19 7.81 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.629 2.219 . . . . 0.0 109.74 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.5 ptm -137.26 167.38 21.7 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.363 0.601 . . . . 0.0 109.998 169.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -127.23 169.74 13.17 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.466 -2.049 . . . . 0.0 105.466 178.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 p -154.31 135.33 13.86 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 120.253 -1.529 . . . . 0.0 107.702 166.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -76.94 114.41 15.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 164.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 44.52 53.88 6.76 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.144 0.978 . . . . 0.0 112.656 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.7 9.07 86.46 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 170.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 55' ' ' ILE . 1.4 t -69.16 -164.65 0.06 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.007 1.403 . . . . 0.0 112.042 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -132.99 22.19 4.15 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 118.358 2.725 . . . . 0.0 118.358 162.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' A' ' 113' ' ' ASN . 10.1 mt -62.22 10.48 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 O-C-N 119.427 -2.046 . . . . 0.0 115.005 -170.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.3 tt -164.33 141.58 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 123.162 2.71 . . . . 0.0 112.048 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.4 140.33 3.83 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.001 1.286 . . . . 0.0 110.977 166.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -132.35 170.15 15.49 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.94 1.296 . . . . 0.0 111.505 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.441 ' HB3' HG22 ' A' ' 45' ' ' THR . 2.8 p -152.87 161.13 42.94 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.678 156.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p -59.69 153.18 20.81 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 171.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 t -144.58 170.55 15.84 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.224 1.012 . . . . 0.0 108.394 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -62.67 -21.95 66.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -156.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.84 14.13 0.73 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.007 0.821 . . . . 0.0 111.844 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -156.52 169.85 23.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.084 1.754 . . . . 0.0 109.693 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.01 145.11 30.63 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 164.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -104.1 117.34 34.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.928 1.24 . . . . 0.0 109.727 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.454 HG11 HD21 ' A' ' 106' ' ' LEU . 39.0 t -128.42 147.96 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 120.282 1.401 . . . . 0.0 107.835 176.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.0 t -167.31 165.58 8.79 Favored Pre-proline 0 C--O 1.243 0.723 0 C-N-CA 125.709 1.604 . . . . 0.0 107.396 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -94.13 -57.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 119.394 0.819 . . . . 0.0 113.211 158.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -147.08 -85.78 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.162 1.385 . . . . 0.0 107.841 -173.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -143.98 -29.26 0.5 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.854 2.462 . . . . 0.0 110.825 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.0 tt -62.04 -41.53 91.45 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 119.451 1.023 . . . . 0.0 111.413 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.25 -19.89 13.69 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.369 1.938 . . . . 0.0 112.928 177.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.6 mm -121.47 -0.41 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.209 1.804 . . . . 0.0 109.767 -172.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.1 m -98.23 -78.77 0.48 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.37 -51.12 10.54 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.643 0.656 . . . . 0.0 109.294 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -65.75 -17.49 64.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.573 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.89 -32.65 63.91 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.31 -40.54 93.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.959 0.885 . . . . 0.0 110.134 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.464 ' HB3' HD11 ' A' ' 105' ' ' LEU . . . -69.74 -38.77 76.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.401 -0.812 . . . . 0.0 111.462 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.26 -46.27 92.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.538 1.135 . . . . 0.0 108.714 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.39 -47.92 82.29 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.049 1.34 . . . . 0.0 111.861 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -63.91 -30.08 71.2 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.716 0.807 . . . . 0.0 112.044 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.25 83.18 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.842 0.746 . . . . 0.0 109.6 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.12 -2.2 3.54 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.161 1.362 . . . . 0.0 112.965 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -92.76 157.69 16.29 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.514 1.657 . . . . 0.0 111.265 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.0 m -118.93 156.55 29.35 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.137 0.975 . . . . 0.0 110.516 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.24 165.9 17.47 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.13 0.972 . . . . 0.0 110.646 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -83.58 -164.55 0.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 165.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -63.41 -27.44 69.3 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.164 -0.96 . . . . 0.0 112.672 165.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.98 -14.03 0.78 Allowed Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.568 0.987 . . . . 0.0 115.568 -156.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 pp -152.79 163.9 38.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.739 1.77 . . . . 0.0 111.05 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.412 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 20.7 p90 -107.17 146.8 30.9 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.559 -0.713 . . . . 0.0 110.061 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -131.78 91.21 2.95 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 123.225 0.61 . . . . 0.0 110.237 -165.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.697 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -79.83 141.97 55.98 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 -176.763 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.23 157.34 41.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.318 2.012 . . . . 0.0 109.95 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -69.1 -16.39 63.66 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -63.71 -38.33 90.7 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.669 0.668 . . . . 0.0 112.45 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -129.64 150.97 77.22 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.945 1.298 . . . . 0.0 108.638 -165.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.38 147.14 17.87 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.311 2.674 . . . . 0.0 113.972 -164.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 m -68.3 126.56 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 121.261 -0.899 . . . . 0.0 109.49 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -79.48 98.63 6.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.836 0.854 . . . . 0.0 110.753 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -61.09 -25.56 67.04 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.311 1.044 . . . . 0.0 112.505 -174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -65.69 -56.03 14.25 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.515 -0.74 . . . . 0.0 110.908 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -61.06 -39.76 91.09 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.543 -0.723 . . . . 0.0 110.841 178.43 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.454 HD21 HG11 ' A' ' 67' ' ' VAL . 2.7 mt -52.2 -53.59 41.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.872 1.669 . . . . 0.0 110.017 176.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -69.51 -42.06 75.21 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.579 -175.138 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -58.82 -44.47 90.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.346 0.976 . . . . 0.0 111.816 -175.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 ptp -73.27 -41.38 63.69 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 118.254 0.479 . . . . 0.0 111.912 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.42 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -71.8 -47.75 54.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -173.705 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.61 -41.08 85.07 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.48 1.036 . . . . 0.0 109.461 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -54.85 -49.57 70.78 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.529 0.332 . . . . 0.0 111.395 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.658 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.3 m120 -62.46 -29.59 70.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.023 0.929 . . . . 0.0 112.413 -175.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.89 -31.3 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.631 1.105 . . . . 0.0 110.701 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -81.6 2.18 30.5 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.028 -1.045 . . . . 0.0 112.196 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -90.65 -40.51 11.85 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.442 -0.786 . . . . 0.0 113.032 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -97.12 23.56 7.22 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.184 1.394 . . . . 0.0 110.451 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 117.404 -1.284 . . . . 0.0 111.326 -177.594 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.83 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.7 m -84.29 176.28 8.83 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.625 0.713 . . . . 0.0 110.522 168.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -135.68 -27.88 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.798 1.639 . . . . 0.0 110.046 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.23 -28.72 19.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.106 0.962 . . . . 0.0 111.294 172.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.83 -30.25 63.59 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.176 1.39 . . . . 0.0 113.333 177.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.3 t -81.0 -33.26 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.497 1.119 . . . . 0.0 111.485 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -89.04 -16.07 32.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.645 1.178 . . . . 0.0 113.378 -174.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.94 77.85 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.192 0.997 . . . . 0.0 112.025 -167.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.68 -5.61 53.54 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.521 1.528 . . . . 0.0 112.52 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -93.69 -45.39 7.71 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.018 1.281 . . . . 0.0 110.057 161.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.574 HD12 ' HD3' ' A' ' 20' ' ' ARG . 1.3 mm? -49.38 -42.68 42.94 Favored 'General case' 0 CA--C 1.523 -0.085 0 C-N-CA 123.95 0.9 . . . . 0.0 111.316 -176.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -49.7 -36.65 25.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.351 1.06 . . . . 0.0 113.379 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.77 0.42 39.2 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 117.703 -1.609 . . . . 0.0 113.045 -168.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.9 mt -71.71 101.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.88 2.57 2.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.232 1.813 . . . . 0.0 113.512 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.52 72.06 2.5 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 128.379 2.672 . . . . 0.0 111.159 -166.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.68 -11.37 31.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 124.125 3.217 . . . . 0.0 114.664 -172.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -81.99 -9.02 59.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.242 0.617 . . . . 0.0 112.365 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -129.07 -28.12 2.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.569 1.148 . . . . 0.0 112.38 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.574 ' HD3' HD12 ' A' ' 11' ' ' LEU . 3.0 tmm_? -52.71 -45.2 66.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.775 1.23 . . . . 0.0 113.137 -175.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -32.39 73.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.11 0.868 . . . . 0.0 110.816 -174.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -68.92 -41.23 78.43 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.637 1.108 . . . . 0.0 111.844 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.9 m -55.08 -39.78 69.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.594 0.758 . . . . 0.0 109.621 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.89 -35.83 80.92 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.483 1.513 . . . . 0.0 112.095 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -62.35 -48.28 80.48 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.396 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.5 mt -61.91 -44.53 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.666 0.666 . . . . 0.0 109.512 -177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.77 -68.01 0.21 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.961 1.305 . . . . 0.0 108.852 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.2 p -66.18 -28.0 68.43 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.591 1.157 . . . . 0.0 112.932 -170.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 43.9 t90 -56.52 -46.74 80.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.63 1.572 . . . . 0.0 110.889 173.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.48 -37.38 70.02 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 C-N-CA 116.791 -1.964 . . . . 0.0 108.499 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.64 -8.44 0.24 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.601 1.16 . . . . 0.0 113.609 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.28 -65.24 1.0 Allowed 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.89 -1.131 . . . . 0.0 110.716 158.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.97 -34.68 59.8 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.297 0.499 . . . . 0.0 111.995 -161.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.7 66.53 10.11 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 127.511 2.324 . . . . 0.0 109.263 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.17 -6.97 19.84 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.021 2.48 . . . . 0.0 112.42 -172.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -81.7 -11.75 58.92 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.119 0.968 . . . . 0.0 111.849 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.0 mt -74.92 143.45 43.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -119.52 152.51 53.15 Favored Pre-proline 0 C--N 1.322 -0.598 0 C-N-CA 127.718 2.407 . . . . 0.0 107.844 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -75.69 156.79 40.02 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.02 2.48 . . . . 0.0 111.073 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -171.96 106.59 0.21 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 126.327 1.851 . . . . 0.0 106.15 163.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 ppp? -78.03 134.09 37.84 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.321 0.964 . . . . 0.0 108.857 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.97 152.4 38.58 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.112 1.365 . . . . 0.0 109.224 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.6 m95 51.87 34.06 12.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.254 1.022 . . . . 0.0 113.171 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 57.74 20.88 6.83 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.444 1.498 . . . . 0.0 112.123 -173.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.5 p -116.6 148.43 41.87 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.022 1.329 . . . . 0.0 108.588 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.05 144.45 42.55 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.451 2.101 . . . . 0.0 109.136 164.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.2 ptm -160.91 177.62 10.2 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 165.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.43 176.11 8.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.508 1.123 . . . . 0.0 108.134 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.4 p -146.98 134.54 20.95 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.984 -1.072 . . . . 0.0 108.752 172.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.442 ' N ' HG22 ' A' ' 53' ' ' THR . 30.7 t30 -75.83 111.32 11.06 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 165.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 49.18 43.79 22.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.661 0.784 . . . . 0.0 112.768 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.2 76.62 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.082 170.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 55' ' ' ILE . 1.7 t -61.67 -163.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 128.46 2.704 . . . . 0.0 117.349 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -129.11 29.55 5.15 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 157.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.529 ' H ' HG23 ' A' ' 53' ' ' THR . 38.0 mt -60.11 9.16 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 127.129 2.172 . . . . 0.0 114.024 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 tt -159.02 157.94 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 122.647 2.476 . . . . 0.0 112.93 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.61 164.36 23.14 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.841 0.734 . . . . 0.0 112.963 159.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -160.12 177.58 10.55 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.471 1.108 . . . . 0.0 112.142 -170.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.5 p -172.44 148.77 2.08 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.442 1.019 . . . . 0.0 109.172 170.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.1 p -63.96 129.1 38.69 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.428 -0.795 . . . . 0.0 108.975 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 t -97.43 -178.12 4.04 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 158.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -54.44 -65.49 0.57 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.686 -0.634 . . . . 0.0 110.281 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -101.82 2.17 37.98 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -164.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.464 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 6.8 p-80 -160.41 149.75 17.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.25 1.02 . . . . 0.0 109.556 -166.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -89.71 143.19 27.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 161.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.57 141.39 51.75 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.183 0.993 . . . . 0.0 110.275 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -159.46 155.79 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.003 0.921 . . . . 0.0 112.939 -167.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 29.5 t -163.08 165.53 14.57 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.295 1.838 . . . . 0.0 108.093 168.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.46 -56.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 121.853 1.702 . . . . 0.0 111.781 159.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -146.07 -86.17 0.11 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -138.28 -37.56 0.56 Allowed 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.77 1.628 . . . . 0.0 109.936 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.5 tt -57.27 -35.57 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.078 0.854 . . . . 0.0 111.42 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.58 -20.86 8.12 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 126.998 2.237 . . . . 0.0 113.444 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.5 mm -118.15 -14.7 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 127.185 2.194 . . . . 0.0 110.001 -172.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.8 m -81.92 -79.83 0.17 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.023 0.929 . . . . 0.0 109.542 166.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -87.9 -48.08 8.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -164.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -63.94 -19.21 64.96 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.08 -31.86 61.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.611 -1.185 . . . . 0.0 113.145 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -67.91 -52.47 35.98 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.857 0.753 . . . . 0.0 109.684 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.41 82.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.593 0.757 . . . . 0.0 110.982 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.31 -43.75 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.288 1.035 . . . . 0.0 109.699 175.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.15 80.99 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.06 0.944 . . . . 0.0 110.901 -173.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -27.76 57.71 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.015 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.94 8.56 22.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.044 0.838 . . . . 0.0 112.14 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.66 36.82 24.97 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 121.191 -0.943 . . . . 0.0 112.527 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -125.41 154.47 41.89 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.083 0.953 . . . . 0.0 109.721 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.9 t -114.49 124.38 51.76 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.393 0.615 . . . . 0.0 110.746 -163.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.77 159.75 22.43 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.358 0.663 . . . . 0.0 110.728 174.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -118.7 -162.59 0.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.593 1.957 . . . . 0.0 106.153 164.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.466 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -64.59 -31.3 72.46 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 169.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -151.64 -6.07 0.15 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 114.218 0.447 . . . . 0.0 114.218 -156.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.9 pp -146.06 161.82 39.28 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.643 1.577 . . . . 0.0 108.006 169.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -122.15 157.27 31.9 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.464 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -132.03 142.4 49.55 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.504 -177.339 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.6 mp -105.58 142.2 24.25 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.02 151.45 44.76 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.029 2.486 . . . . 0.0 109.578 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -64.61 -19.05 65.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -31.51 72.74 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.88 1.218 . . . . 0.0 112.478 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.66 161.85 37.61 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 123.961 0.904 . . . . 0.0 110.181 -161.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.64 161.6 43.54 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.559 1.506 . . . . 0.0 110.862 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.4 t -89.24 130.71 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.07 89.21 4.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.176 1.39 . . . . 0.0 109.366 -176.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -67.24 -31.7 72.23 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.636 1.174 . . . . 0.0 112.532 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.51 -51.21 70.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.611 1.164 . . . . 0.0 109.753 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -68.28 -41.18 81.38 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 120.611 1.551 . . . . 0.0 110.865 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -50.18 51.87 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 123.473 0.709 . . . . 0.0 109.121 176.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -58.63 -55.48 34.55 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.988 1.315 . . . . 0.0 110.006 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -59.17 -35.74 74.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.492 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -87.8 -6.82 57.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 117.496 -1.24 . . . . 0.0 113.718 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.89 -54.23 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 120.977 1.717 . . . . 0.0 109.224 172.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -53.15 -48.6 67.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.023 1.329 . . . . 0.0 109.777 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -52.77 -45.81 67.28 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.24 -34.65 73.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.004 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.13 -52.03 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -72.23 -15.03 61.93 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.32 -37.9 27.61 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.49 1.516 . . . . 0.0 110.705 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.54 23.29 3.07 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.7 2.4 . . . . 0.0 111.821 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 124.523 1.129 . . . . 0.0 108.921 168.215 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 118.781 -0.628 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 mmt -56.02 -41.38 74.82 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.56 -28.51 55.35 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.857 1.263 . . . . 0.0 113.945 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.62 -53.3 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -81.58 -28.66 33.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.68 1.592 . . . . 0.0 112.556 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.95 0.93 14.14 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.807 1.643 . . . . 0.0 112.087 -171.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 41.3 mt-10 -86.99 -35.44 18.81 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.012 1.325 . . . . 0.0 109.332 167.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.32 -41.09 25.47 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -175.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -51.4 -37.84 50.4 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.233 1.413 . . . . 0.0 112.376 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 12.0 mtmt -61.85 -46.07 91.06 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.049 0.939 . . . . 0.0 110.901 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.55 -9.05 73.2 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.095 1.331 . . . . 0.0 113.729 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.82 103.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 165.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.11 3.43 10.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.097 1.359 . . . . 0.0 112.811 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -116.6 73.83 6.02 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 128.873 2.869 . . . . 0.0 109.705 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.01 -28.05 19.74 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.231 3.287 . . . . 0.0 111.433 -168.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.437 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 26.0 m-20 -64.98 -15.84 62.7 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.726 0.81 . . . . 0.0 110.348 -171.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -133.39 5.0 3.73 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.254 1.422 . . . . 0.0 110.22 178.1 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -66.06 -55.64 15.58 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 120.864 -1.148 . . . . 0.0 109.069 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.66 -14.8 15.34 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.7 1.371 . . . . 0.0 114.7 -165.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -43.18 97.39 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.55 1.068 . . . . 0.0 110.869 169.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -57.68 -37.43 73.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.252 1.421 . . . . 0.0 111.377 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -81.4 -20.71 39.88 Favored 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 120.89 -1.132 . . . . 0.0 113.996 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.17 -47.99 79.84 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.0 mt -61.41 -47.72 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.463 1.105 . . . . 0.0 110.227 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.6 mt -56.56 -49.33 75.14 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.676 0.671 . . . . 0.0 111.061 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 p -68.93 -40.0 79.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.241 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -60.19 -47.75 84.63 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.134 1.774 . . . . 0.0 111.401 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.7 t -56.32 -50.14 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 119.076 0.853 . . . . 0.0 108.716 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.78 3.51 1.9 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.57 -54.01 2.39 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.048 1.339 . . . . 0.0 111.003 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -72.73 -32.9 66.03 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.867 1.212 . . . . 0.0 111.047 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.74 57.54 5.9 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 119.311 0.96 . . . . 0.0 110.877 -173.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -65.26 -11.19 28.94 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.05 2.5 . . . . 0.0 113.636 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -12.16 61.12 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.57 -0.706 . . . . 0.0 112.702 175.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 85.7 mt -80.04 156.69 27.0 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.413 1.006 . . . . 0.0 109.889 169.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -129.23 152.58 79.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.506 1.522 . . . . 0.0 109.708 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.25 159.17 53.98 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.605 2.87 . . . . 0.0 113.186 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -161.95 120.19 2.27 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.507 1.523 . . . . 0.0 109.601 171.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.31 109.28 15.67 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.436 1.095 . . . . 0.0 108.381 166.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -135.56 149.32 49.39 Favored 'General case' 0 C--O 1.218 -0.603 0 O-C-N 120.921 -1.112 . . . . 0.0 108.125 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.1 m95 55.52 16.68 1.94 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 64.59 15.34 9.61 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 128.553 2.741 . . . . 0.0 113.848 -167.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.3 p -116.37 161.36 31.93 Favored Pre-proline 0 N--CA 1.44 -0.975 0 C-N-CA 124.72 1.208 . . . . 0.0 109.152 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.62 116.94 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 125.269 3.979 . . . . 0.0 112.13 171.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.3 ptm -128.43 170.3 13.29 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.683 0.754 . . . . 0.0 108.985 161.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.03 165.0 27.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 169.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.7 120.76 13.71 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -171.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -71.95 99.73 2.3 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 167.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 49.02 42.01 20.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.258 1.023 . . . . 0.0 110.674 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.41 -21.09 40.33 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 116.971 -2.016 . . . . 0.0 117.062 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -171.25 0.91 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 122.055 2.928 . . . . 0.0 112.756 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -117.19 26.51 9.72 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.037 -1.039 . . . . 0.0 113.097 -171.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.0 -1.18 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.05 0.94 . . . . 0.0 112.965 -168.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 tt -155.9 142.61 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 119.263 -2.148 . . . . 0.0 112.025 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.55 149.92 21.18 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.527 1.537 . . . . 0.0 109.324 166.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -145.18 178.48 8.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.954 1.377 . . . . 0.0 110.501 170.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.2 153.83 10.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 168.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.3 p -69.13 138.83 54.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.768 -0.583 . . . . 0.0 109.431 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.38 174.36 5.94 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 169.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.471 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -71.37 -5.12 30.22 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.866 -1.146 . . . . 0.0 113.645 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.28 7.49 0.11 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.1 -178.61 6.71 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.027 1.331 . . . . 0.0 108.692 -173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.09 120.06 18.61 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.494 1.118 . . . . 0.0 108.521 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.34 108.77 21.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.911 1.684 . . . . 0.0 109.913 -160.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 99.2 t -129.46 140.28 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.911 1.232 . . . . 0.0 109.504 -162.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 27.8 t -171.26 144.91 1.76 Allowed Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.033 1.733 . . . . 0.0 109.734 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.2 -56.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.616 1.544 . . . . 0.0 111.344 171.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -148.03 -83.77 0.11 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -131.5 -46.38 0.98 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.129 1.372 . . . . 0.0 110.945 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.26 -35.18 52.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 118.839 0.745 . . . . 0.0 112.753 -166.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.9 -24.74 28.03 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.745 1.641 . . . . 0.0 113.169 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 mm -112.93 -3.49 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.776 1.63 . . . . 0.0 109.819 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 m -91.14 -72.59 0.57 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -85.75 -49.23 8.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.425 0.557 . . . . 0.0 109.541 -171.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -69.45 -13.19 62.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.94 -21.61 66.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.83 -44.96 60.79 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.923 0.783 . . . . 0.0 110.645 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.42 -43.21 88.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.664 0.786 . . . . 0.0 110.643 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.39 -41.46 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.963 0.801 . . . . 0.0 110.331 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.25 -55.55 31.88 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.293 0.497 . . . . 0.0 110.319 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.64 -13.12 61.29 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.107 0.963 . . . . 0.0 112.345 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.15 -26.43 60.31 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.679 0.672 . . . . 0.0 110.579 169.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.39 4.97 6.22 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.972 -0.905 . . . . 0.0 113.735 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -112.88 160.88 17.59 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.848 1.324 . . . . 0.0 110.907 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.2 m -91.74 173.03 8.08 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.049 0.939 . . . . 0.0 108.922 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . . . -133.97 -166.19 1.75 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 166.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.2 p -118.96 -168.73 1.61 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 153.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -68.74 -27.64 66.11 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 120.469 -1.395 . . . . 0.0 112.242 166.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.46 -14.14 10.93 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-O 118.795 -1.003 . . . . 0.0 114.432 -163.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.8 pp -156.39 166.59 32.98 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.42 1.61 . . . . 0.0 110.393 170.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 18.0 p90 -103.62 164.98 11.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.416 0.553 . . . . 0.0 109.94 172.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 126.61 22.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.96 142.69 25.18 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 164.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.54 145.79 14.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.995 2.464 . . . . 0.0 108.896 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -56.42 -30.49 62.88 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -170.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -65.83 -26.64 67.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -115.91 162.19 26.9 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.546 0.738 . . . . 0.0 110.125 -164.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -79.98 148.07 19.32 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 CA-C-N 121.125 1.437 . . . . 0.0 113.605 -169.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.6 t -73.69 124.18 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 170.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -74.99 77.23 2.19 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.526 1.13 . . . . 0.0 110.562 169.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -53.13 -40.92 64.56 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 125.145 1.378 . . . . 0.0 111.32 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -57.89 -60.91 2.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.468 1.507 . . . . 0.0 110.984 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.96 -38.72 65.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.759 0.79 . . . . 0.0 110.888 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.269 0.3 OUTLIER -79.93 -27.93 39.78 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 117.198 -1.382 . . . . 0.0 113.171 -176.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -62.01 -42.67 99.4 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.304 1.411 . . . . 0.0 108.402 170.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.64 -52.59 63.31 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.093 0.557 . . . . 0.0 109.613 -174.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.0 ptp -69.51 -36.61 76.62 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.564 -1.207 . . . . 0.0 113.544 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.7 -46.72 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 120.6 1.546 . . . . 0.0 108.876 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.56 -40.11 90.43 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.543 0.611 . . . . 0.0 109.845 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.4 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 29.1 t80 -60.96 -50.08 74.83 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.394 0.543 . . . . 0.0 110.783 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -38.31 80.7 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.105 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.9 mt -60.3 -52.28 63.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.092 0.957 . . . . 0.0 110.676 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.4 ' HG2' ' HA ' ' A' ' 112' ' ' PHE . 5.4 pt20 -70.28 -22.54 62.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.041 0.837 . . . . 0.0 111.721 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -83.02 -20.56 34.81 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.311 0.644 . . . . 0.0 111.311 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -96.89 20.05 11.71 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.855 1.662 . . . . 0.0 111.236 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.767 166.61 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 30.8 mmm -56.82 -27.04 59.39 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.97 -34.82 70.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 118.337 0.517 . . . . 0.0 111.437 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.59 -44.46 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -78.13 -14.51 59.45 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.46 1.104 . . . . 0.0 112.795 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -34.32 77.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.426 1.491 . . . . 0.0 111.426 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.32 -16.28 61.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.88 1.672 . . . . 0.0 112.848 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -102.26 -37.6 8.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.908 0.883 . . . . 0.0 110.042 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.54 -39.83 65.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.252 0.933 . . . . 0.0 110.571 171.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -58.68 -29.84 66.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.414 0.686 . . . . 0.0 112.034 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.49 -4.52 62.28 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.842 -0.977 . . . . 0.0 114.57 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.3 mm -57.08 132.54 21.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 119.298 1.549 . . . . 0.0 109.334 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.73 -49.33 75.47 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.816 1.646 . . . . 0.0 108.724 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -141.15 143.95 32.85 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.42 -22.66 24.67 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.454 2.77 . . . . 0.0 111.264 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -6.16 13.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.61 173.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -125.29 -9.16 6.99 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -64.42 -60.81 2.72 Favored 'General case' 0 CA--C 1.519 -0.228 0 O-C-N 121.184 -0.947 . . . . 0.0 110.441 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -45.86 -44.55 14.47 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.122 2.169 . . . . 0.0 111.292 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -57.82 -48.1 80.72 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.042 -0.411 . . . . 0.0 110.397 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.0 m -65.67 -45.22 83.73 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.04 1.336 . . . . 0.0 109.885 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.96 -41.27 61.96 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.796 1.239 . . . . 0.0 112.282 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -60.29 -52.68 64.24 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.377 0.535 . . . . 0.0 109.695 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -61.72 -41.49 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.437 1.095 . . . . 0.0 110.056 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.88 -57.1 13.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.303 0.501 . . . . 0.0 110.583 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -60.29 -37.08 79.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 117.833 -1.08 . . . . 0.0 109.808 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 67.1 t90 -59.31 -59.4 5.52 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.797 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.412 HG11 ' CE1' ' A' ' 48' ' ' PHE . 28.3 t -52.64 -46.8 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 120.224 1.374 . . . . 0.0 110.697 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.2 -29.86 69.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.048 0.539 . . . . 0.0 112.012 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.45 -61.14 2.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.994 0.918 . . . . 0.0 110.537 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -65.86 -32.05 73.35 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.427 1.491 . . . . 0.0 111.849 -169.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -127.33 63.75 59.46 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 118.664 0.665 . . . . 0.0 109.253 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.68 -8.56 23.91 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.585 2.857 . . . . 0.0 113.923 -163.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.29 -26.51 62.0 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.262 -0.899 . . . . 0.0 111.799 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.1 mt -65.81 149.76 49.65 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -130.97 150.02 75.39 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 127.025 2.13 . . . . 0.0 110.719 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.12 152.76 40.59 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.329 2.686 . . . . 0.0 113.191 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.35 126.56 6.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.465 1.906 . . . . 0.0 108.967 167.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.34 102.77 15.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 170.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -149.93 141.23 23.21 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.968 -1.083 . . . . 0.0 111.139 -167.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 16.3 m95 54.84 21.96 3.94 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.881 1.272 . . . . 0.0 111.927 -161.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 53.42 14.69 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.828 1.651 . . . . 0.0 112.807 -162.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.7 p -97.87 148.84 35.05 Favored Pre-proline 0 C--O 1.238 0.493 0 CA-C-N 119.703 1.138 . . . . 0.0 109.352 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.24 100.43 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.924 3.083 . . . . 0.0 110.939 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.3 ptm -118.88 164.93 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.413 0.685 . . . . 0.0 109.672 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.412 ' CE1' HG11 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -131.39 169.67 15.72 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 173.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.9 m -141.77 138.86 32.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.858 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -76.28 94.09 3.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.128 1.331 . . . . 0.0 108.388 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 51.48 15.17 0.31 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.646 1.578 . . . . 0.0 114.73 -170.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.79 -20.61 4.3 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 117.896 -1.502 . . . . 0.0 113.941 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -78.16 141.83 38.42 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 121.12 2.46 . . . . 0.0 111.309 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -66.62 29.56 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.039 2.936 . . . . 0.0 116.966 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.25 0.37 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 125.32 1.448 . . . . 0.0 113.17 -167.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 tt -160.6 145.39 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 121.793 2.088 . . . . 0.0 113.516 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.29 136.08 3.92 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 121.466 -0.771 . . . . 0.0 112.337 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -136.01 167.55 21.01 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.093 1.357 . . . . 0.0 110.58 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.8 p -159.24 160.76 35.7 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 54.9 p -75.76 113.99 13.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.05 171.71 13.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 164.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -63.75 -32.69 74.26 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.291 -0.881 . . . . 0.0 111.717 -175.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -137.1 10.57 3.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.371 1.468 . . . . 0.0 113.149 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -156.8 -177.35 6.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.065 1.346 . . . . 0.0 108.839 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tp -124.17 121.43 35.09 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.558 1.543 . . . . 0.0 107.684 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.461 ' HB2' HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -79.03 133.59 36.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 116.238 -1.839 . . . . 0.0 109.417 170.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.8 t -140.37 149.41 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 120.128 1.331 . . . . 0.0 110.566 172.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 t -160.42 158.87 26.01 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.58 1.152 . . . . 0.0 108.959 157.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -79.67 -57.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.098 0 CA-C-N 120.711 1.29 . . . . 0.0 110.519 165.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -138.16 -88.44 0.24 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 164.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -147.34 -36.15 0.23 Allowed 'General case' 0 N--CA 1.474 0.725 0 O-C-N 121.341 -0.85 . . . . 0.0 111.836 -163.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -25.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 123.549 0.74 . . . . 0.0 110.394 165.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.57 -35.93 38.25 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.823 0.725 . . . . 0.0 111.545 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.1 mm -110.43 13.46 8.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.32 1.448 . . . . 0.0 110.841 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.6 m -129.51 -33.57 1.86 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 170.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -63.6 1.33 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.407 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 11.2 m-85 -79.86 0.41 31.21 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.61 -31.42 64.28 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -72.07 -48.52 43.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.75 0.786 . . . . 0.0 109.778 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.2 -42.83 91.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.822 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.53 -48.52 85.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.082 0.953 . . . . 0.0 109.749 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -51.45 70.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.468 0.707 . . . . 0.0 109.706 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -64.82 -37.83 88.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.85 1.26 . . . . 0.0 111.642 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.04 -22.76 67.08 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.951 0.796 . . . . 0.0 111.693 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.12 9.49 10.58 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-O 118.525 -1.153 . . . . 0.0 114.104 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -113.07 95.93 5.66 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.484 1.642 . . . . 0.0 113.251 -162.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.62 105.58 0.06 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 129.251 3.02 . . . . 0.0 113.355 174.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.34 175.87 6.94 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.733 2.013 . . . . 0.0 112.802 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.1 p -94.67 -164.85 1.22 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.108 1.363 . . . . 0.0 107.618 156.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -76.63 -19.31 57.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 117.079 -1.439 . . . . 0.0 112.588 166.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.94 -7.84 4.9 Favored Glycine 0 N--CA 1.47 0.958 0 CA-C-N 120.388 1.449 . . . . 0.0 115.054 -162.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 66' ' ' SER . 2.9 pp -151.54 161.61 42.39 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 164.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -99.45 165.79 11.48 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 166.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.5 153.2 44.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 121.774 -0.579 . . . . 0.0 109.637 169.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.11 143.74 34.63 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -71.64 149.52 55.22 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.496 2.797 . . . . 0.0 110.409 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -57.86 -41.33 82.22 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -54.15 -44.04 71.1 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.024 0.93 . . . . 0.0 112.17 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.83 146.86 32.59 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -159.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.04 139.1 23.78 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.268 1.312 . . . . 0.0 112.052 -163.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -69.69 150.17 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.325 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -109.92 73.66 0.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.328 1.051 . . . . 0.0 111.873 -161.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -58.01 -24.16 57.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.709 0.804 . . . . 0.0 112.962 -171.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -68.09 -60.2 2.67 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.091 -1.006 . . . . 0.0 110.3 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.44 -45.14 62.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.229 1.412 . . . . 0.0 109.076 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -53.97 50.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.835 1.254 . . . . 0.0 111.553 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -68.6 -40.13 80.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 117.484 -1.246 . . . . 0.0 111.786 -172.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -45.62 -57.06 4.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.541 0.736 . . . . 0.0 110.249 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.407 ' HE1' ' HB2' ' A' ' 77' ' ' PHE . 23.4 ptp -72.47 -42.63 64.73 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 118.046 -0.978 . . . . 0.0 112.888 -170.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -42.65 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 120.074 1.306 . . . . 0.0 109.689 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -64.17 -39.92 95.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.967 -0.54 . . . . 0.0 109.923 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -62.22 -46.89 86.85 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.349 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -21.22 63.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.09 1.314 . . . . 0.0 112.261 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.99 -61.6 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.456 1.102 . . . . 0.0 108.49 167.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -75.67 -2.9 31.65 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -171.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.3 -20.14 65.58 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.829 -1.169 . . . . 0.0 110.82 164.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -105.29 5.88 32.34 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.194 1.398 . . . . 0.0 111.344 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 124.697 1.199 . . . . 0.0 108.148 178.457 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 119.049 -0.5 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -6.33 15.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -64.15 -57.49 9.4 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.5 -42.53 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.877 1.671 . . . . 0.0 110.086 -167.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -93.99 -0.48 55.51 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.577 -169.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.58 -39.98 81.86 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.61 0.764 . . . . 0.0 109.609 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -66.33 -20.58 66.13 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -81.56 -55.21 4.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.2 -38.86 77.57 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.751 -0.642 . . . . 0.0 111.893 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -58.1 -33.05 68.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.396 0.678 . . . . 0.0 110.737 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.1 -3.24 82.78 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.529 1.061 . . . . 0.0 112.493 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.6 mt -77.69 90.79 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 171.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -76.11 8.19 3.48 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.182 2.193 . . . . 0.0 113.224 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -116.13 69.3 3.7 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 129.67 3.188 . . . . 0.0 108.767 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.97 -17.16 54.99 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 125.109 3.872 . . . . 0.0 113.856 -167.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.19 -16.39 59.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.135 0.88 . . . . 0.0 111.553 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -131.96 8.73 4.46 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.794 0.725 . . . . 0.0 112.326 -171.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -77.11 -62.33 1.69 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.308 1.443 . . . . 0.0 109.612 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.31 -32.55 38.27 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.134 2.174 . . . . 0.0 112.282 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -47.38 -53.46 13.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.805 0.842 . . . . 0.0 110.14 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.0 m -65.02 -29.24 70.13 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.74 -0.6 . . . . 0.0 111.277 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -72.45 -28.18 62.78 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 120.855 -1.153 . . . . 0.0 111.875 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.21 -54.66 43.12 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.676 1.125 . . . . 0.0 108.526 168.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -49.72 -53.22 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.169 0.987 . . . . 0.0 110.007 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.0 mt -64.63 -50.03 68.72 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.915 -170.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -69.47 -28.0 65.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.136 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -61.69 -60.39 3.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.413 HG11 ' CZ ' ' A' ' 48' ' ' PHE . 37.8 t -48.5 -45.57 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.05 0.841 . . . . 0.0 111.526 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.15 -13.03 5.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.4 -50.58 2.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.509 1.924 . . . . 0.0 111.483 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.9 -35.03 79.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.928 0.785 . . . . 0.0 110.832 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -128.81 74.53 80.73 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.66 -13.1 34.42 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.872 1.715 . . . . 0.0 110.81 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -86.22 33.2 0.61 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.442 2.297 . . . . 0.0 111.158 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 56' ' ' ILE . 51.1 mt -122.02 134.49 54.8 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 120.686 -1.258 . . . . 0.0 109.189 156.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -104.89 149.47 37.57 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 124.621 1.168 . . . . 0.0 109.41 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.71 154.83 49.38 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.599 2.866 . . . . 0.0 112.169 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -162.84 114.18 1.51 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.607 1.163 . . . . 0.0 108.534 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.0 mtp -82.22 121.49 26.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 166.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -138.65 138.44 37.81 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.9 m95 48.84 34.42 5.31 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.532 1.133 . . . . 0.0 112.165 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.26 18.09 10.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.471 1.908 . . . . 0.0 111.19 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.5 p -118.63 149.53 46.47 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.434 1.494 . . . . 0.0 109.304 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.49 106.68 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.251 3.301 . . . . 0.0 110.925 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.2 ptm -114.59 175.85 5.3 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.236 -0.915 . . . . 0.0 110.309 168.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' HG11 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -139.04 156.12 47.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 170.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.63 122.43 27.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -72.09 95.5 1.64 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 57.21 -3.32 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.93 -24.16 0.25 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 127.492 2.472 . . . . 0.0 113.67 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.61 -164.94 0.78 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.856 1.828 . . . . 0.0 114.718 -167.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -131.95 25.44 4.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.58 1.952 . . . . 0.0 111.445 -170.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.7 mt -65.4 -3.54 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.574 1.95 . . . . 0.0 111.725 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.439 HG21 HD13 ' A' ' 37' ' ' LEU . 6.1 tt -155.94 163.77 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 119.448 -2.033 . . . . 0.0 109.647 169.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.75 132.72 1.55 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -138.91 169.46 17.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.668 1.734 . . . . 0.0 110.085 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.59 161.83 38.15 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 159.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.4 p -65.09 149.19 50.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 165.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 t -137.47 168.25 20.03 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -58.7 -30.08 67.14 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -153.227 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -136.36 13.49 3.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.378 1.071 . . . . 0.0 112.638 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -158.32 168.74 26.18 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.143 -0.973 . . . . 0.0 110.38 -166.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.2 tp -107.63 123.22 48.16 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.82 122.19 31.96 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.824 1.193 . . . . 0.0 108.524 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.0 t -135.32 137.43 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.256 1.022 . . . . 0.0 108.516 -174.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.4 p -163.05 165.26 15.01 Favored Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 127.108 2.163 . . . . 0.0 109.851 154.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.43 -56.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.139 1.226 . . . . 0.0 113.005 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -148.48 -83.2 0.11 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.56 1.073 . . . . 0.0 108.11 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -146.97 -27.97 0.39 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.804 1.241 . . . . 0.0 112.216 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.1 tp -63.7 -31.94 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 120.791 -1.193 . . . . 0.0 111.37 176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -48.47 -26.06 4.89 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 126.815 2.15 . . . . 0.0 113.324 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 mm -125.62 7.32 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.167 1.387 . . . . 0.0 109.944 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 t -84.8 -71.56 0.51 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 170.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -88.09 -50.8 6.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -170.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -67.89 -15.33 63.57 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.32 -30.33 38.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.449 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -69.37 -59.47 2.97 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 118.556 0.617 . . . . 0.0 109.94 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.47 -35.48 74.17 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.476 0.58 . . . . 0.0 112.456 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.82 -48.82 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.929 0.891 . . . . 0.0 109.576 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.22 -47.45 86.06 Favored 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 121.488 -0.758 . . . . 0.0 110.902 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -61.4 -16.22 44.48 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 128.253 2.621 . . . . 0.0 111.631 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.68 4.28 50.07 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 112.454 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.33 14.63 47.25 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.261 0.934 . . . . 0.0 114.719 169.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -112.78 90.64 3.4 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.863 1.332 . . . . 0.0 111.701 -168.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 m -53.28 98.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.225 2.61 . . . . 0.0 113.619 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.78 -172.95 4.46 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.78 1.632 . . . . 0.0 112.238 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.7 p -111.15 -164.77 0.94 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.468 1.907 . . . . 0.0 106.694 163.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -80.29 -22.59 41.44 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.939 -1.101 . . . . 0.0 112.93 161.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.16 -28.33 6.53 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.29 -1.284 . . . . 0.0 114.805 -168.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 pp -154.31 172.53 17.51 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.208 2.004 . . . . 0.0 110.226 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -114.57 166.36 11.8 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 120.824 -1.172 . . . . 0.0 109.006 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.78 133.22 20.75 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.95 143.44 26.14 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 168.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.08 157.88 60.0 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.189 1.926 . . . . 0.0 109.925 172.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -61.07 -25.04 66.66 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.33 -0.856 . . . . 0.0 112.006 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -57.88 -62.46 1.79 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.044 1.737 . . . . 0.0 111.696 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -91.57 165.43 20.92 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 125.995 1.718 . . . . 0.0 111.814 -163.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.33 149.25 85.08 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.367 2.045 . . . . 0.0 110.672 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 p -96.94 127.07 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.17 83.34 7.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.462 1.125 . . . . 0.0 111.156 -169.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -57.03 -35.85 69.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.285 1.434 . . . . 0.0 110.222 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -39.33 77.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.486 -0.759 . . . . 0.0 112.339 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -49.06 46.79 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 122.03 0.919 . . . . 0.0 108.641 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.296 0.3 OUTLIER -75.82 -24.08 55.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.138 -169.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -37.71 88.44 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 120.535 1.516 . . . . 0.0 110.565 171.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -56.29 -52.0 66.13 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.102 0.865 . . . . 0.0 109.708 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.9 ptp -68.89 -36.75 78.42 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.312 -172.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -46.76 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 121.159 1.8 . . . . 0.0 109.262 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.75 -47.4 85.84 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.814 0.846 . . . . 0.0 110.352 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -61.87 -40.36 95.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.245 0.475 . . . . 0.0 110.643 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -24.62 66.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.042 0.837 . . . . 0.0 111.36 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 99.3 mt -79.24 -49.43 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.256 1.422 . . . . 0.0 108.905 169.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -61.38 -29.02 69.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.633 1.173 . . . . 0.0 110.826 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -82.97 -19.32 37.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.744 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -93.84 -1.21 55.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.983 1.713 . . . . 0.0 112.212 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 C--O 1.247 0.937 0 C-N-CA 128.546 2.738 . . . . 0.0 110.704 173.415 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.6 mmt -57.16 -14.07 3.69 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.005 1.322 . . . . 0.0 113.142 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -74.06 -30.25 62.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 120.506 -1.371 . . . . 0.0 112.407 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.9 t -70.64 -33.2 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 124.181 0.926 . . . . 0.0 108.745 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -102.61 -2.41 28.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.896 1.278 . . . . 0.0 112.343 -171.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.88 72.12 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 122.382 1.087 . . . . 0.0 110.359 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.46 -12.92 62.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.434 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -75.45 -57.0 4.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.121 0.873 . . . . 0.0 109.978 167.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.77 -44.38 73.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.917 1.287 . . . . 0.0 111.603 -174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -53.68 -32.25 50.94 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.6 -18.22 66.56 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.519 -168.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.7 mt -69.37 114.61 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.78 6.0 14.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.747 1.219 . . . . 0.0 111.71 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.79 74.58 75.68 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 128.013 2.525 . . . . 0.0 110.046 -170.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -59.43 -30.85 93.66 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.094 2.529 . . . . 0.0 112.757 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.428 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 57.4 m-20 -70.03 -1.92 11.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.286 1.034 . . . . 0.0 112.308 -177.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 13.9 m80 -132.6 -30.72 1.42 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.294 1.838 . . . . 0.0 109.751 -176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.26 -48.56 45.75 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.64 1.576 . . . . 0.0 110.548 169.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.69 -36.96 82.39 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.329 0.393 . . . . 0.0 111.767 -168.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -63.78 -30.55 71.63 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.853 -0.529 . . . . 0.0 111.725 175.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.0 m -71.52 -41.65 68.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.859 0.864 . . . . 0.0 109.5 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -50.43 -43.64 55.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.169 0.895 . . . . 0.0 111.903 168.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.89 -27.5 69.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.342 0.974 . . . . 0.0 112.751 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.4 mt -73.53 -47.13 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.74 -63.41 1.21 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.86 0.864 . . . . 0.0 109.744 -169.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -64.37 -25.52 68.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.583 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -68.36 -42.25 79.46 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.208 0.913 . . . . 0.0 110.457 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.57 HG11 ' CD2' ' A' ' 48' ' ' PHE . 41.2 t -59.74 -48.4 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.9 0.773 . . . . 0.0 109.034 174.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.76 -29.37 68.13 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.11 -56.56 4.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.896 -0.503 . . . . 0.0 110.818 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -78.9 -28.99 44.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.792 1.637 . . . . 0.0 111.655 -165.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -131.62 64.42 72.86 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.187 0.995 . . . . 0.0 108.749 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.71 -13.03 31.96 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.673 2.249 . . . . 0.0 113.09 -171.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -74.13 -18.16 60.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.827 0.74 . . . . 0.0 112.253 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.6 mt -69.27 152.98 44.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -124.84 142.73 41.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.19 137.36 28.58 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.213 1.942 . . . . 0.0 110.479 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -147.32 135.66 21.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.356 1.062 . . . . 0.0 108.268 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.63 114.01 27.92 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 175.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.34 146.94 31.81 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.432 1.093 . . . . 0.0 108.079 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.6 m95 55.54 21.11 4.19 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.868 1.213 . . . . 0.0 114.115 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.2 t30 57.67 17.9 4.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 112.598 -165.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 59' ' ' SER . 68.5 p -110.74 142.99 27.3 Favored Pre-proline 0 N--CA 1.449 -0.516 0 O-C-N 120.532 -1.355 . . . . 0.0 109.361 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.31 128.66 15.83 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.532 2.155 . . . . 0.0 110.083 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.6 ptm -142.37 168.82 18.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.98 0.912 . . . . 0.0 109.021 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.57 ' CD2' HG11 ' A' ' 30' ' ' VAL . 1.8 m-85 -140.14 91.55 2.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -172.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 p -65.07 122.66 17.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -71.54 91.01 1.03 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.862 1.21 . . . . 0.0 108.338 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 48.8 18.14 0.18 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.653 1.181 . . . . 0.0 113.717 -170.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.39 -16.73 2.92 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.303 1.906 . . . . 0.0 115.621 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.12 -167.98 1.17 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 120.355 2.078 . . . . 0.0 112.811 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -128.99 43.82 3.08 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.155 1.382 . . . . 0.0 110.408 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.8 mt -75.73 -1.46 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.706 1.602 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 tt -164.92 157.59 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 119.746 -1.846 . . . . 0.0 112.542 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.35 136.2 2.19 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 165.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -131.09 163.76 26.94 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.231 1.015 . . . . 0.0 111.227 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.426 ' HB3' HG22 ' A' ' 45' ' ' THR . 2.4 p -149.48 156.68 42.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.886 0.85 . . . . 0.0 110.388 163.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 53.1 p -59.4 145.26 44.23 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.183 0.993 . . . . 0.0 108.685 167.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 m -133.56 177.61 7.57 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.205 1.402 . . . . 0.0 107.834 168.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.38 -57.22 8.46 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.145 0.978 . . . . 0.0 112.102 -167.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -126.19 4.29 7.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.119 0.968 . . . . 0.0 112.748 -173.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.501 ' CD2' ' HE ' ' A' ' 94' ' ' ARG . 4.1 p-80 -145.81 168.42 20.82 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.096 1.758 . . . . 0.0 108.445 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.2 tp -88.19 169.32 11.99 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 160.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 p -120.09 127.67 52.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.781 1.173 . . . . 0.0 108.136 160.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.417 ' HB ' ' CE1' ' A' ' 93' ' ' PHE . 92.8 t -135.19 148.0 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.2 t -165.94 165.37 10.79 Favored Pre-proline 0 C--O 1.241 0.631 0 C-N-CA 128.399 2.68 . . . . 0.0 105.947 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -83.16 -57.35 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.338 0 CA-C-N 120.153 1.09 . . . . 0.0 111.225 152.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -147.23 -86.34 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.9 -32.97 0.34 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.338 1.455 . . . . 0.0 111.7 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.77 -35.31 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 119.961 1.255 . . . . 0.0 111.064 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.97 -16.26 24.42 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.59 0.614 . . . . 0.0 113.817 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.1 mm -112.17 -14.44 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 126.735 2.014 . . . . 0.0 110.278 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.4 m -104.37 -55.6 2.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.0 0.52 . . . . 0.0 110.248 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -81.2 -63.49 1.39 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.427 ' CG ' ' HG3' ' A' ' 109' ' ' MET . 12.5 m-85 -72.94 -9.2 58.45 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.499 -0.48 . . . . 0.0 112.014 -170.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.28 -30.89 63.07 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.372 0.533 . . . . 0.0 112.23 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -63.92 -44.15 93.76 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 118.439 0.563 . . . . 0.0 110.295 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.508 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -77.53 -29.46 52.35 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.114 -175.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.1 mt -60.22 -48.68 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.684 1.194 . . . . 0.0 108.324 168.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.66 73.13 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.967 0.907 . . . . 0.0 110.712 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -58.06 -30.04 65.88 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.744 0.818 . . . . 0.0 111.983 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.39 95.9 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.502 1.046 . . . . 0.0 110.862 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 132.25 -11.1 5.31 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 127.283 2.373 . . . . 0.0 111.465 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -86.93 174.0 9.0 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 120.93 -1.335 . . . . 0.0 112.747 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.2 t -127.53 175.09 8.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.486 1.914 . . . . 0.0 109.297 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.61 -176.41 4.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.064 1.746 . . . . 0.0 110.618 -166.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.8 p -132.01 -168.75 2.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.796 1.638 . . . . 0.0 108.225 168.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.72 5.92 12.15 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.655 -1.278 . . . . 0.0 113.409 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.08 -14.19 0.03 OUTLIER Glycine 0 CA--C 1.524 0.644 0 CA-C-N 119.544 1.065 . . . . 0.0 115.186 -171.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.6 pp -159.81 -173.37 4.06 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.691 1.246 . . . . 0.0 109.644 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.417 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 12.2 p90 -135.0 165.63 24.91 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.875 -1.141 . . . . 0.0 111.66 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.501 ' HE ' ' CD2' ' A' ' 64' ' ' HIS . 1.8 mmt-85 -139.92 91.24 2.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.721 1.208 . . . . 0.0 111.658 -157.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -86.2 141.1 34.74 Favored Pre-proline 0 C--O 1.239 0.54 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.09 155.77 26.07 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.114 2.543 . . . . 0.0 110.516 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -63.35 -19.89 65.03 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -68.58 -44.96 73.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.759 1.163 . . . . 0.0 111.105 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -90.32 150.24 42.64 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 123.609 0.764 . . . . 0.0 109.85 -159.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.73 123.41 5.83 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.777 2.984 . . . . 0.0 112.169 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.1 m -68.6 9.69 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -166.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 43.76 81.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 128.043 2.537 . . . . 0.0 114.285 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -60.33 -27.71 67.57 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.957 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.72 -56.06 18.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.986 0.514 . . . . 0.0 110.813 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.508 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -61.6 -46.76 88.47 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.595 0.712 . . . . 0.0 109.518 -173.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -27.43 62.14 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.811 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -58.46 -55.86 29.59 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 119.681 1.128 . . . . 0.0 108.933 165.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -59.68 -37.72 79.56 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.044 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.427 ' HG3' ' CG ' ' A' ' 77' ' ' PHE . 6.1 ttm -53.18 -61.19 2.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.532 1.933 . . . . 0.0 111.303 172.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -45.88 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.745 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.74 -46.59 74.32 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.828 0.851 . . . . 0.0 109.435 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.8 -47.97 81.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.389 0.276 . . . . 0.0 111.385 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -20.22 63.27 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.544 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 91.1 mt -78.24 -63.62 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.159 0.984 . . . . 0.0 109.177 165.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -71.37 -13.18 61.78 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -164.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.57 -35.99 82.78 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.979 0.512 . . . . 0.0 109.688 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -79.65 7.03 9.17 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.765 2.026 . . . . 0.0 112.428 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 128.263 2.625 . . . . 0.0 112.212 -162.648 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 117.311 -1.328 . . . . 0.0 113.813 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.32 -36.56 43.23 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 120.814 1.643 . . . . 0.0 112.151 174.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -45.88 -44.58 14.56 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.099 0.959 . . . . 0.0 113.228 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.61 -50.57 43.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -80.24 -9.68 59.73 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -165.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.44 90.5 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.393 1.477 . . . . 0.0 111.446 -167.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.39 -21.99 66.74 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.157 0.983 . . . . 0.0 112.897 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -81.28 -55.1 4.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -51.83 -40.99 61.43 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.682 1.193 . . . . 0.0 111.777 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -58.38 -46.87 85.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.402 0.681 . . . . 0.0 110.431 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.87 -4.77 88.48 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.97 1.272 . . . . 0.0 113.86 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.2 mt -65.22 95.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 164.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.11 3.08 3.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.937 1.295 . . . . 0.0 112.855 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -105.63 75.89 0.33 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 C-N-CA 129.316 3.046 . . . . 0.0 109.212 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.48 -19.86 65.52 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.77 2.313 . . . . 0.0 112.781 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.68 2.33 30.1 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.077 1.351 . . . . 0.0 112.612 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -145.09 15.91 1.53 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.154 1.382 . . . . 0.0 110.127 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -91.11 -50.64 5.73 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.882 1.673 . . . . 0.0 109.569 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -53.91 -26.75 26.65 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 126.593 1.957 . . . . 0.0 113.469 -167.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -52.66 -55.62 21.23 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -58.32 -34.96 71.17 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.525 -0.734 . . . . 0.0 112.499 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -41.16 96.61 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.017 0.927 . . . . 0.0 111.298 172.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.9 -54.63 42.69 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.099 0.863 . . . . 0.0 109.521 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -52.46 -51.12 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.757 0.823 . . . . 0.0 109.937 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.9 mt -63.07 -51.89 64.88 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.714 0.406 . . . . 0.0 110.04 -171.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -65.29 -33.18 75.37 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 123.2 0.313 . . . . 0.0 110.511 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -64.97 -48.36 74.3 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.16 0.984 . . . . 0.0 110.89 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 48' ' ' PHE . 24.7 t -52.75 -47.73 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 118.793 0.724 . . . . 0.0 109.814 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.23 13.58 0.41 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.21 -34.83 0.52 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.748 1.219 . . . . 0.0 114.068 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.5 m -75.92 -39.46 56.18 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.009 -1.057 . . . . 0.0 108.876 168.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -122.87 70.46 39.13 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 122.203 1.001 . . . . 0.0 110.914 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.85 -4.72 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.041 2.494 . . . . 0.0 112.923 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -79.4 -17.8 53.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.33 1.852 . . . . 0.0 113.11 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.444 HD12 HG13 ' A' ' 30' ' ' VAL . 43.5 mt -80.93 144.92 31.54 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.566 -1.334 . . . . 0.0 109.785 175.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -119.8 143.99 36.26 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.024 1.73 . . . . 0.0 110.141 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.51 148.09 37.15 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.655 2.903 . . . . 0.0 113.762 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -153.7 119.4 5.28 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.982 1.313 . . . . 0.0 110.649 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.71 103.5 9.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.375 1.07 . . . . 0.0 108.823 170.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -135.32 149.33 49.73 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.265 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.7 m95 55.73 16.26 1.92 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 66.95 27.48 8.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.891 2.077 . . . . 0.0 112.239 -170.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.0 p -130.82 152.71 81.04 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.91 1.684 . . . . 0.0 108.162 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.29 112.68 3.6 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 124.573 3.515 . . . . 0.0 110.209 170.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.3 ptm -122.84 170.6 9.93 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.753 -0.592 . . . . 0.0 109.772 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CZ ' HG11 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -138.95 167.73 21.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.645 0.736 . . . . 0.0 109.258 176.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.2 p -140.85 112.31 7.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 123.173 0.589 . . . . 0.0 111.444 -165.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.81 102.09 3.3 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 47.39 40.44 10.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.128 0.971 . . . . 0.0 111.579 -171.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.87 -2.32 66.41 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.772 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.5 m -82.65 177.74 8.55 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.272 2.036 . . . . 0.0 109.723 -177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.427 ' H ' HG22 ' A' ' 53' ' ' THR . 62.0 t80 -102.88 9.1 39.05 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.334 -1.479 . . . . 0.0 114.378 -170.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.75 8.58 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.261 0 C-N-CA 127.604 2.361 . . . . 0.0 114.178 -162.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 tt -154.21 150.5 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 O-C-N 117.806 -3.059 . . . . 0.0 111.464 165.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.95 153.32 24.44 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 162.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -147.97 161.4 41.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.147 1.473 . . . . 0.0 110.212 170.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.72 155.84 41.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.518 0.675 . . . . 0.0 110.092 172.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.3 p -66.84 154.33 41.16 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.041 1.336 . . . . 0.0 109.343 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB3' ' CD2' ' A' ' 64' ' ' HIS . 31.2 t -133.9 163.99 28.29 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 156.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -48.12 -40.5 23.8 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.321 1.048 . . . . 0.0 113.517 -168.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -124.95 8.59 8.08 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.413 ' CD2' ' HB3' ' A' ' 61' ' ' SER . 7.7 p-80 -158.55 157.46 32.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.118 0.872 . . . . 0.0 112.315 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.9 tp -85.57 156.9 20.55 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 166.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.23 112.34 16.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.151 1.38 . . . . 0.0 109.906 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.1 t -126.78 141.08 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.236 2.214 . . . . 0.0 110.721 -166.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.5 t -164.45 159.58 15.84 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 108.361 164.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.34 -58.48 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 120.524 1.223 . . . . 0.0 111.138 166.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -134.81 -86.25 0.39 Allowed 'General case' 0 C--O 1.233 0.211 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 168.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -136.96 -30.84 0.86 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.984 1.714 . . . . 0.0 111.69 -172.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -62.35 -32.27 54.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 119.321 0.964 . . . . 0.0 111.781 -165.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.51 -29.52 57.55 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.638 1.589 . . . . 0.0 113.52 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.7 mm -98.13 -5.74 9.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.868 1.667 . . . . 0.0 110.114 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.0 m -97.47 -80.22 0.45 Allowed 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 124.853 1.261 . . . . 0.0 108.879 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -83.68 -37.35 22.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.715 1.143 . . . . 0.0 110.159 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 109' ' ' MET . 59.8 m-85 -80.82 -11.4 59.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.292 0.496 . . . . 0.0 111.82 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.78 67.96 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.734 0.814 . . . . 0.0 113.173 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.38 -52.04 44.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.37 80.63 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.789 0.836 . . . . 0.0 111.597 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.63 -52.34 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.997 0.817 . . . . 0.0 109.237 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.54 -48.64 80.11 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.419 0.688 . . . . 0.0 110.275 -175.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -52.8 -44.17 66.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.56 1.544 . . . . 0.0 111.326 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.17 -5.92 30.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.352 0.661 . . . . 0.0 112.401 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.01 9.52 53.86 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.146 1.355 . . . . 0.0 112.801 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -99.62 163.43 12.5 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.133 1.467 . . . . 0.0 111.208 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.8 m -124.51 93.08 3.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.965 -151.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . . . -80.04 165.36 22.62 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.367 -0.833 . . . . 0.0 112.01 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.0 p -103.23 -164.35 1.07 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.11 1.764 . . . . 0.0 106.249 152.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 -2.18 51.22 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.693 -1.254 . . . . 0.0 112.256 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.03 -2.42 2.14 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.467 1.032 . . . . 0.0 113.749 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.56 177.69 11.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.289 1.545 . . . . 0.0 109.101 162.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 13.1 p90 -124.16 164.23 19.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.59 -0.694 . . . . 0.0 110.779 166.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.65 152.44 48.09 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 121.885 -0.509 . . . . 0.0 111.815 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.3 mm -123.47 142.88 39.97 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.39 150.99 25.73 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.564 2.176 . . . . 0.0 111.53 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -61.89 -20.95 64.3 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.87 -34.95 72.15 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.588 -0.695 . . . . 0.0 111.843 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.99 159.99 44.73 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 122.845 0.458 . . . . 0.0 109.794 -151.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.13 139.35 13.36 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-O 123.503 1.376 . . . . 0.0 111.946 -157.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.47 111.04 20.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 85.61 0.67 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.679 1.192 . . . . 0.0 112.541 -175.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -63.21 -38.53 91.55 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.064 1.346 . . . . 0.0 111.311 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -58.09 9.93 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.454 0.702 . . . . 0.0 110.19 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.99 -41.61 98.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.096 -172.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.275 0.2 OUTLIER -75.66 -26.16 57.44 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.432 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.438 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -68.21 -35.51 78.08 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 121.088 1.767 . . . . 0.0 110.934 174.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -56.42 -59.19 5.33 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.774 0.716 . . . . 0.0 109.543 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . 22.2 ptp -62.22 -43.26 99.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.64 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -68.9 -46.24 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 118.855 0.752 . . . . 0.0 109.206 -174.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -65.92 -40.58 91.57 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.716 1.143 . . . . 0.0 110.743 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.94 -47.27 85.62 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.366 0.53 . . . . 0.0 110.693 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.02 -13.38 11.22 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.735 0.814 . . . . 0.0 110.905 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 62.9 mt -95.74 -49.77 12.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-N 120.063 1.301 . . . . 0.0 110.342 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -72.15 3.48 4.48 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.147 1.34 . . . . 0.0 112.579 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -87.91 -15.82 35.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.52 1.528 . . . . 0.0 112.511 164.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -113.18 32.55 5.66 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.525 1.53 . . . . 0.0 110.136 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.331 157.502 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.4 mmt -59.05 -33.37 70.7 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -172.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.71 -36.49 72.06 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.56 0.618 . . . . 0.0 112.431 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.95 -45.24 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.048 0.939 . . . . 0.0 109.486 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -90.9 -9.42 46.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -167.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.75 91.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.396 1.479 . . . . 0.0 111.789 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.25 -27.08 63.65 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.727 1.211 . . . . 0.0 112.327 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -77.36 -50.57 12.48 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.642 0.777 . . . . 0.0 109.651 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.18 -50.33 62.06 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.608 1.163 . . . . 0.0 109.852 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -58.34 -42.85 87.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.008 0.923 . . . . 0.0 110.688 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.14 -35.86 91.07 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.759 -1.578 . . . . 0.0 114.208 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -54.75 108.74 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -73.34 -3.49 27.45 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.961 1.304 . . . . 0.0 112.611 -171.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 76.05 33.18 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 127.363 2.265 . . . . 0.0 108.7 -170.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.8 -21.56 72.47 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.313 2.675 . . . . 0.0 113.391 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.469 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 6.3 m-20 -63.89 -19.84 65.38 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.611 0.641 . . . . 0.0 111.734 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 3.7 m80 -123.61 -24.03 4.63 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.428 1.491 . . . . 0.0 110.18 -170.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -48.79 -45.58 40.37 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.305 1.042 . . . . 0.0 110.228 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.02 -32.73 9.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.815 1.646 . . . . 0.0 113.424 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -67.31 -14.38 62.87 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.35 -1.469 . . . . 0.0 112.387 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.5 m -100.98 -35.72 9.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.716 1.206 . . . . 0.0 109.789 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -26.2 63.57 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.426 0.557 . . . . 0.0 111.38 172.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -55.82 -62.58 1.6 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.634 1.574 . . . . 0.0 110.156 168.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 mt -57.58 -42.81 82.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 124.45 1.1 . . . . 0.0 112.466 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.11 -49.76 75.83 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.259 0.936 . . . . 0.0 110.036 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -65.57 -36.79 84.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 118.161 -0.923 . . . . 0.0 112.155 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -57.65 -53.55 56.91 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.158 0.89 . . . . 0.0 111.028 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.685 HG11 ' CE2' ' A' ' 48' ' ' PHE . 72.2 t -63.01 -41.69 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 O-C-N 121.196 -0.94 . . . . 0.0 109.689 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.83 5.03 2.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.522 1.129 . . . . 0.0 113.722 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.69 -62.76 1.49 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.619 1.568 . . . . 0.0 110.456 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.1 m -63.65 -32.04 73.4 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.604 1.093 . . . . 0.0 111.871 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -121.72 66.13 19.49 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 119.703 1.138 . . . . 0.0 110.806 -172.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.07 -10.88 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.228 3.285 . . . . 0.0 112.539 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -58.97 -22.03 59.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.916 2.087 . . . . 0.0 113.755 163.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 110' ' ' ILE . 35.6 mt -89.46 160.58 16.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -134.79 149.52 70.88 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 126.786 2.035 . . . . 0.0 108.866 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.61 146.25 66.64 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 122.826 2.351 . . . . 0.0 112.194 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -158.02 119.13 3.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.027 1.331 . . . . 0.0 108.219 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -84.01 119.04 24.46 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -141.49 136.29 31.09 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.671 -0.643 . . . . 0.0 109.939 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.6 m95 56.35 24.0 7.89 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.5 t30 69.89 9.55 7.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.001 2.12 . . . . 0.0 112.909 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -111.91 143.94 29.69 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 125.299 1.44 . . . . 0.0 109.208 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -70.28 125.91 12.4 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.154 1.902 . . . . 0.0 111.782 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.6 ptm -133.0 171.42 13.99 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.433 1.093 . . . . 0.0 108.904 169.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.685 ' CE2' HG11 ' A' ' 30' ' ' VAL . 3.2 m-85 -138.22 105.62 5.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.15 125.71 29.51 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 120.514 -1.366 . . . . 0.0 109.45 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -72.82 83.96 1.21 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 53.08 -19.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 118.829 2.9 . . . . 0.0 118.829 -162.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.49 40.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -168.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.99 -176.58 3.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.011 0.906 . . . . 0.0 110.053 174.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -124.84 32.03 5.53 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.827 1.651 . . . . 0.0 111.132 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.1 mt -70.13 -0.92 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.187 1.395 . . . . 0.0 111.671 -168.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.1 tt -161.59 147.26 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 O-C-N 119.636 -1.915 . . . . 0.0 111.962 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.73 156.11 27.26 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 158.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.3 155.2 41.82 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.365 -1.079 . . . . 0.0 111.642 169.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 t -142.87 153.48 43.19 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.3 p -70.81 159.65 34.18 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.582 1.153 . . . . 0.0 109.81 171.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -146.18 179.78 7.27 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.402 1.481 . . . . 0.0 109.29 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -56.41 -60.24 3.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.075 0.95 . . . . 0.0 112.086 -169.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -121.6 8.7 10.11 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.994 0.918 . . . . 0.0 111.255 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -152.55 172.85 15.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.493 1.117 . . . . 0.0 109.058 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 tp -101.01 158.94 15.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.471 1.909 . . . . 0.0 107.785 166.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 92' ' ' LEU . 46.2 p -124.93 113.11 17.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.974 1.261 . . . . 0.0 111.045 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.23 146.02 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 125.449 1.5 . . . . 0.0 109.408 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.0 t -165.79 157.55 12.41 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.781 1.633 . . . . 0.0 107.335 167.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.1 -56.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.209 0 N-CA-C 109.117 -1.147 . . . . 0.0 109.117 160.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -151.34 -85.32 0.08 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -140.54 -49.47 0.44 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.38 1.872 . . . . 0.0 110.779 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.3 tt -57.91 -34.26 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 121.509 -0.744 . . . . 0.0 111.829 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -44.57 -48.23 8.83 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 172.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mm -91.49 -2.53 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.529 1.132 . . . . 0.0 110.877 -168.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.3 m -105.96 -54.79 2.42 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 120.543 -1.348 . . . . 0.0 111.4 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -78.34 -56.81 4.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.959 1.704 . . . . 0.0 106.84 -170.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -80.63 -18.66 47.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.691 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.57 -21.92 54.37 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.78 -61.28 2.28 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.04 -36.89 68.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.111 0.964 . . . . 0.0 112.27 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.69 -45.33 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.782 1.233 . . . . 0.0 110.254 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.9 -52.62 64.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -21.9 64.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 178.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.29 -21.29 62.96 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.308 0.958 . . . . 0.0 110.716 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.07 10.24 5.28 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.36 -1.245 . . . . 0.0 113.709 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.69 122.33 47.53 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.2 2.0 . . . . 0.0 110.868 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.7 p -75.69 85.13 2.7 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.126 0.97 . . . . 0.0 110.89 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.65 171.23 0.66 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.83 0.852 . . . . 0.0 110.985 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.2 p -101.81 -172.35 2.13 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 167.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -82.85 -19.79 36.85 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 118.063 -0.97 . . . . 0.0 113.023 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -121.23 -14.86 4.83 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 119.079 0.854 . . . . 0.0 113.895 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 66' ' ' SER . 4.6 pp -150.61 164.85 35.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.934 1.694 . . . . 0.0 109.39 167.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -106.85 160.45 15.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.56 1.073 . . . . 0.0 110.55 170.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.81 141.85 23.04 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.865 -0.522 . . . . 0.0 110.139 -166.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.77 143.51 43.89 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -172.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.53 151.84 82.07 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.586 1.524 . . . . 0.0 109.896 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -64.32 -26.13 68.34 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.843 -0.599 . . . . 0.0 112.338 168.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -62.8 -70.0 0.23 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.696 0.798 . . . . 0.0 111.73 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.82 157.53 87.2 Favored Pre-proline 0 C--O 1.236 0.347 0 O-C-N 123.213 0.32 . . . . 0.0 110.228 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.17 161.29 46.47 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.188 1.925 . . . . 0.0 111.182 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.54 136.59 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.02 2.128 . . . . 0.0 108.764 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.86 102.38 5.5 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 163.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -73.56 -15.77 61.28 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.09 0.859 . . . . 0.0 111.207 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -66.62 -65.5 0.67 Allowed 'General case' 0 CA--C 1.527 0.096 0 O-C-N 121.196 -0.94 . . . . 0.0 111.154 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.26 -38.94 77.91 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -46.01 -45.58 15.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.571 2.748 . . . . 0.0 113.863 172.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -71.3 -48.02 53.22 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 125.567 1.547 . . . . 0.0 109.306 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.39 -49.27 78.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -172.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.1 ptp -70.49 3.77 2.81 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.069 1.747 . . . . 0.0 114.616 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -120.46 -48.56 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 120.555 1.525 . . . . 0.0 109.412 175.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -59.59 -45.51 91.68 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.564 1.074 . . . . 0.0 109.008 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -56.63 -49.49 74.83 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 119.669 -0.205 . . . . 0.0 110.536 172.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -18.65 65.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.798 -0.62 . . . . 0.0 112.387 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mt -82.58 -55.46 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -70.97 -12.58 61.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.058 0.845 . . . . 0.0 112.577 -172.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.39 -21.69 48.96 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.506 1.122 . . . . 0.0 111.345 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -93.12 34.75 1.1 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.896 2.078 . . . . 0.0 109.78 174.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.634 1.573 . . . . 0.0 110.963 167.64 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.8 mmt -53.7 -34.04 57.49 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.073 0.949 . . . . 0.0 112.036 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -57.09 -42.94 81.64 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.331 0.969 . . . . 0.0 111.93 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.4 -40.38 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.863 0.865 . . . . 0.0 110.432 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -97.18 -19.93 18.29 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -167.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.51 -33.7 76.5 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.629 1.104 . . . . 0.0 111.529 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.84 -43.17 48.69 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.861 1.264 . . . . 0.0 111.695 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -72.24 -43.72 63.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.451 0.7 . . . . 0.0 110.496 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.83 -47.16 80.96 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -55.54 -43.25 75.61 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.908 0.483 . . . . 0.0 110.697 173.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.82 -24.82 71.6 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.97 -0.906 . . . . 0.0 112.872 -174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.3 mt -64.32 110.24 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 119.302 1.551 . . . . 0.0 107.715 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -72.71 -8.04 53.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.468 1.907 . . . . 0.0 113.939 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.73 70.64 1.71 Allowed Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 126.191 1.796 . . . . 0.0 109.691 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.94 -29.21 87.59 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.965 3.11 . . . . 0.0 113.883 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.07 -8.29 11.45 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.733 0.697 . . . . 0.0 112.218 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -123.77 -13.36 7.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.813 1.645 . . . . 0.0 110.107 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.79 -56.34 9.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.965 1.306 . . . . 0.0 109.681 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -62.63 -30.54 71.43 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.64 0.776 . . . . 0.0 112.069 -161.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -50.45 21.58 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.189 1.395 . . . . 0.0 111.578 169.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 m -59.87 -44.73 94.01 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.549 1.54 . . . . 0.0 111.355 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -35.87 46.48 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.124 2.17 . . . . 0.0 112.883 175.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -68.55 -48.71 63.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.043 0.537 . . . . 0.0 111.539 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mt -55.83 -49.99 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 123.953 0.783 . . . . 0.0 109.341 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 mt -56.61 -49.17 75.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.21 0.459 . . . . 0.0 110.524 -171.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 t -65.49 -40.24 92.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.376 0.671 . . . . 0.0 111.213 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -63.18 -39.32 94.31 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.647 0.779 . . . . 0.0 111.01 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.755 HG11 ' CE2' ' A' ' 48' ' ' PHE . 54.9 t -58.77 -47.33 89.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-O 118.41 -0.805 . . . . 0.0 108.891 174.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.68 -8.76 15.8 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.328 0.967 . . . . 0.0 113.155 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.36 -60.24 1.56 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.221 1.008 . . . . 0.0 111.177 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 m -69.78 -38.82 76.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.569 1.077 . . . . 0.0 110.439 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.436 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -123.9 65.18 35.64 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -173.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.17 -10.3 28.67 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.318 2.012 . . . . 0.0 111.772 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.56 -28.67 66.19 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.838 1.255 . . . . 0.0 112.84 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.642 HD21 ' CD1' ' A' ' 114' ' ' ILE . 3.5 mm? -69.35 146.84 51.82 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 171.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -124.9 147.99 58.34 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.22 148.73 31.05 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.107 2.538 . . . . 0.0 112.323 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -163.82 82.46 0.44 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.412 1.485 . . . . 0.0 107.251 172.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -70.75 134.43 47.42 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.016 -1.678 . . . . 0.0 108.53 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -154.97 152.8 30.13 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.571 1.148 . . . . 0.0 110.337 -170.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.8 m95 47.89 28.98 1.51 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.257 1.423 . . . . 0.0 112.767 -171.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 67.47 24.68 8.7 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.449 1.9 . . . . 0.0 112.492 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.402 HG22 ' HB3' ' A' ' 59' ' ' SER . 26.7 p -124.57 143.2 42.63 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 125.358 1.463 . . . . 0.0 109.267 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.8 124.88 10.03 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.844 2.362 . . . . 0.0 108.93 164.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.0 ptm -137.09 163.36 30.99 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 167.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.755 ' CE2' HG11 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -127.2 158.97 35.69 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 175.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 m -128.21 124.44 36.73 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -173.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -74.78 84.42 2.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.257 16.6 mt-30 64.34 -11.51 0.12 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.878 2.071 . . . . 0.0 114.884 -176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.73 -9.84 0.02 OUTLIER Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.202 1.382 . . . . 0.0 116.056 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.84 -166.98 1.56 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.242 1.521 . . . . 0.0 114.115 -163.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -126.48 26.37 6.35 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.978 1.711 . . . . 0.0 110.841 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.523 HG23 HD22 ' A' ' 113' ' ' ASN . 80.8 mt -67.39 -2.02 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 O-C-N 120.114 -1.616 . . . . 0.0 112.657 -171.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.425 HD12 HG13 ' A' ' 110' ' ' ILE . 10.1 tt -161.08 142.69 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 121.716 2.053 . . . . 0.0 111.795 170.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.22 157.74 29.36 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 161.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -147.27 141.42 26.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.276 1.038 . . . . 0.0 109.224 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -134.45 114.25 12.69 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.037 -1.04 . . . . 0.0 108.446 -176.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.8 p -54.75 134.73 47.7 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.212 0.915 . . . . 0.0 110.613 -168.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -112.49 163.95 13.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -54.51 -27.04 35.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.679 1.592 . . . . 0.0 113.796 -165.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -137.71 0.24 2.21 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.132 0.973 . . . . 0.0 113.383 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -153.17 158.33 41.63 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.382 0.992 . . . . 0.0 110.137 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -104.48 113.12 26.47 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.427 ' HB2' HD22 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -71.07 131.25 43.35 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 167.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.7 t -135.32 138.44 48.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 t -167.86 153.16 6.79 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 125.175 1.39 . . . . 0.0 107.405 161.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.67 -57.61 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 CA-C-N 119.971 1.025 . . . . 0.0 110.699 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -146.24 -79.95 0.16 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -139.63 -38.37 0.48 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.367 1.467 . . . . 0.0 111.614 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -27.86 43.24 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 118.81 0.732 . . . . 0.0 112.422 -166.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -46.56 -43.26 15.11 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.029 0.824 . . . . 0.0 111.155 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 mm -91.31 -11.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 121.998 -0.707 . . . . 0.0 110.235 -168.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.9 m -107.98 -57.19 2.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.151 0.887 . . . . 0.0 110.471 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.76 -60.87 2.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.569 1.948 . . . . 0.0 107.415 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 109' ' ' MET . 59.8 m-85 -77.49 5.99 7.9 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.25 -48.69 12.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.944 1.697 . . . . 0.0 111.775 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -73.42 -41.09 63.71 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.109 0.964 . . . . 0.0 109.132 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -58.95 -43.21 91.21 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.054 0.942 . . . . 0.0 110.169 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.8 mt -66.8 -43.31 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 120.027 1.285 . . . . 0.0 109.493 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.86 -57.02 14.29 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.556 1.143 . . . . 0.0 110.795 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -25.05 68.16 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.404 1.082 . . . . 0.0 112.802 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.39 -17.26 63.66 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.696 0.68 . . . . 0.0 111.281 173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.14 9.21 5.7 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.347 1.927 . . . . 0.0 113.398 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -134.18 111.89 10.66 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 119.087 1.444 . . . . 0.0 110.705 -161.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.7 m -76.59 15.6 0.61 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.985 -1.697 . . . . 0.0 114.541 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 52.46 -155.24 0.18 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.398 1.879 . . . . 0.0 112.548 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.5 p -125.59 -164.35 1.29 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.074 2.15 . . . . 0.0 105.952 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -81.82 -10.29 59.37 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.558 -1.21 . . . . 0.0 112.943 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.79 13.8 0.19 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-N 120.333 1.424 . . . . 0.0 115.235 -167.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 66' ' ' SER . 3.9 pp -166.05 178.97 6.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 130.332 3.453 . . . . 0.0 106.29 162.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -119.84 166.22 13.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 120.235 1.38 . . . . 0.0 108.368 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 171.53 14.18 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.463 -0.773 . . . . 0.0 109.667 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -133.59 143.71 48.99 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 103.952 -2.611 . . . . 0.0 103.952 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.95 159.17 51.04 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 CA-C-N 120.785 1.316 . . . . 0.0 109.227 169.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -63.56 -15.91 59.36 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.301 -0.874 . . . . 0.0 112.562 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -66.7 -19.96 65.87 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.407 2.283 . . . . 0.0 114.217 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -135.28 162.8 55.31 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-N 119.476 1.035 . . . . 0.0 111.373 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.66 133.83 26.71 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.573 2.849 . . . . 0.0 110.519 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.04 145.81 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 167.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.86 90.33 8.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.554 1.541 . . . . 0.0 108.556 -172.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -58.57 -31.97 68.49 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.531 -0.731 . . . . 0.0 109.714 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -69.65 -36.21 75.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.173 -0.954 . . . . 0.0 112.813 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.468 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -84.07 -32.67 24.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.329 0.3 OUTLIER -83.18 -23.46 32.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 117.354 -1.308 . . . . 0.0 111.289 -177.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -65.79 -48.53 71.47 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 120.729 1.604 . . . . 0.0 109.725 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -60.49 -31.63 70.66 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -159.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . 22.1 ptp -83.49 -29.01 28.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.425 HG13 HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -79.83 -44.57 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 119.348 0.977 . . . . 0.0 109.348 -177.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.34 -40.06 73.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.682 0.674 . . . . 0.0 109.533 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -71.61 -54.03 11.75 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.859 1.264 . . . . 0.0 112.036 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.523 HD22 HG23 ' A' ' 55' ' ' ILE . 4.8 t30 -65.17 -21.7 66.81 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 119.644 1.111 . . . . 0.0 111.789 -173.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.642 ' CD1' HD21 ' A' ' 37' ' ' LEU . 47.9 mt -68.93 -54.97 17.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 118.864 0.756 . . . . 0.0 109.729 168.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -70.76 -13.46 62.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.749 0.704 . . . . 0.0 112.371 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.94 -43.46 92.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.895 1.278 . . . . 0.0 111.124 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.42 12.08 3.23 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.285 2.234 . . . . 0.0 113.564 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.529 1.532 . . . . 0.0 110.33 175.835 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 117.176 -1.393 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -47.59 -41.64 22.16 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.226 1.375 . . . . 0.0 111.19 -172.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -54.27 -39.26 66.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.404 0.682 . . . . 0.0 112.56 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.7 t -56.23 -41.52 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.478 0.711 . . . . 0.0 109.744 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -102.19 -6.48 23.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.506 1.122 . . . . 0.0 113.495 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.78 -44.81 63.36 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 123.628 0.771 . . . . 0.0 110.202 -170.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -57.32 -34.91 69.24 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.947 0.899 . . . . 0.0 111.379 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -68.55 -42.9 77.72 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.088 0.955 . . . . 0.0 111.001 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.22 -38.37 86.38 Favored 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 123.937 0.895 . . . . 0.0 110.316 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -56.24 -37.14 69.33 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 122.133 -0.354 . . . . 0.0 110.847 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.18 0.9 88.89 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.079 1.323 . . . . 0.0 113.714 -173.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 mm -66.14 149.47 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.007 1.403 . . . . 0.0 107.312 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.64 -22.88 62.46 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.075 1.35 . . . . 0.0 113.568 -170.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.4 145.18 8.66 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 126.227 1.811 . . . . 0.0 108.724 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.07 -27.66 73.85 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.939 2.426 . . . . 0.0 112.386 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.45 -15.14 47.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.778 -0.576 . . . . 0.0 111.126 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.79 15.2 11.77 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.807 -0.558 . . . . 0.0 110.839 176.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -113.59 -45.09 3.14 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 125.412 1.485 . . . . 0.0 110.883 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -70.77 -5.73 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.603 1.161 . . . . 0.0 112.937 -161.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -102.94 -25.81 13.33 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.324 1.85 . . . . 0.0 112.87 168.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m -61.45 -44.9 96.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.743 0.817 . . . . 0.0 109.522 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.64 -39.0 86.67 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.575 1.15 . . . . 0.0 111.81 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -60.01 -46.95 87.82 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.851 -0.595 . . . . 0.0 110.704 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mt -61.71 -44.91 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.997 0.919 . . . . 0.0 110.455 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.02 -48.09 82.83 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -65.79 -42.87 90.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.25 1.42 . . . . 0.0 110.466 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -63.48 -44.56 94.06 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.25 1.82 . . . . 0.0 110.976 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 t -57.17 -49.21 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.465 1.029 . . . . 0.0 109.297 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.68 2.79 0.88 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.72 -50.23 1.97 Allowed 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.795 1.238 . . . . 0.0 111.435 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 m -70.02 -26.49 64.07 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.715 1.206 . . . . 0.0 109.856 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -131.29 78.53 72.09 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.623 0.769 . . . . 0.0 111.484 -170.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.07 -5.21 16.48 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.86 3.04 . . . . 0.0 114.618 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.6 -20.84 32.99 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.011 -1.056 . . . . 0.0 112.312 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.5 mt -78.36 145.98 34.92 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -123.57 144.77 45.18 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 124.765 1.226 . . . . 0.0 108.031 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.04 162.57 36.81 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.494 2.796 . . . . 0.0 112.745 -172.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -170.04 119.89 0.62 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.212 2.205 . . . . 0.0 105.448 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ptm -95.64 127.45 41.68 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 121.28 1.855 . . . . 0.0 108.005 165.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -136.02 150.63 49.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 124.854 1.262 . . . . 0.0 109.155 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 14.5 m95 61.04 24.73 14.82 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.3 t30 74.53 -0.42 3.35 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 128.295 2.638 . . . . 0.0 111.493 -171.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.7 p -105.31 144.48 28.89 Favored Pre-proline 0 N--CA 1.45 -0.445 0 O-C-N 120.419 -1.426 . . . . 0.0 109.537 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.62 143.27 56.03 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.755 1.637 . . . . 0.0 109.107 164.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 19.1 ptm -145.87 172.75 12.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 164.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.21 152.18 45.78 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 p -129.92 114.25 15.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.444 1.098 . . . . 0.0 108.422 -167.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -70.34 91.56 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.769 1.228 . . . . 0.0 108.071 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 48.11 34.56 4.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.298 0.639 . . . . 0.0 112.507 -170.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.25 -11.39 24.24 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 117.253 -1.859 . . . . 0.0 115.861 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -74.13 -168.43 0.63 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.793 2.297 . . . . 0.0 111.385 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.437 ' H ' HG22 ' A' ' 53' ' ' THR . 36.5 t80 -129.88 18.85 5.58 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.01 1.724 . . . . 0.0 112.476 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mt -70.27 7.61 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 126.099 1.759 . . . . 0.0 111.757 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.433 HD12 HG13 ' A' ' 110' ' ' ILE . 5.3 tt -159.67 143.14 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 O-C-N 119.335 -2.103 . . . . 0.0 111.507 167.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.63 159.97 32.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 162.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -149.63 170.73 17.98 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.045 1.422 . . . . 0.0 110.068 173.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.1 t -153.72 152.95 31.37 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 168.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.1 p -78.87 127.46 32.05 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t -101.51 171.13 7.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.06 -17.92 55.05 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -167.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.46 1.12 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -158.18 154.14 26.89 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.388 0.995 . . . . 0.0 110.461 -168.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 tp -92.74 127.94 38.42 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 167.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.19 119.66 39.08 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.16 139.25 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 127.801 2.44 . . . . 0.0 108.93 -164.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 t -165.33 157.89 13.41 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 125.845 1.658 . . . . 0.0 107.516 167.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.79 -57.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.817 1.678 . . . . 0.0 111.282 161.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -145.94 -86.11 0.11 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 172.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -142.89 -32.55 0.48 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.692 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.41 -34.77 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 120.881 1.673 . . . . 0.0 111.394 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.15 -18.89 29.48 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.654 1.121 . . . . 0.0 113.26 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 mm -111.47 1.6 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 127.185 2.194 . . . . 0.0 109.925 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 m -118.57 -61.34 1.67 Allowed 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.633 -0.667 . . . . 0.0 109.376 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -74.15 -51.99 13.88 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 127.894 2.477 . . . . 0.0 107.647 -173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -85.95 4.32 38.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.605 0.762 . . . . 0.0 112.54 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.3 73.75 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.406 1.082 . . . . 0.0 112.637 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -69.99 -43.33 71.66 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.554 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -62.95 -39.11 93.64 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.829 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.21 -49.6 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.755 0.707 . . . . 0.0 109.816 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.16 69.52 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.041 0.937 . . . . 0.0 110.478 -170.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.63 -22.43 63.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.335 1.454 . . . . 0.0 112.996 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.49 -10.29 59.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.783 0.72 . . . . 0.0 112.039 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.12 11.59 56.08 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.029 0.823 . . . . 0.0 113.977 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -97.77 107.65 20.19 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.563 1.182 . . . . 0.0 111.341 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.12 98.38 0.06 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.044 2.138 . . . . 0.0 111.369 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.96 -176.26 6.24 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.638 1.175 . . . . 0.0 111.535 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 p -118.96 -164.91 1.08 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.161 1.784 . . . . 0.0 107.853 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.406 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -85.53 -9.12 57.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.06 -1.69 2.87 Favored Glycine 0 N--CA 1.462 0.395 0 CA-C-N 119.441 1.019 . . . . 0.0 112.527 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 pp -162.47 176.28 10.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.361 0.664 . . . . 0.0 110.743 170.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -119.09 164.42 15.55 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.398 -0.813 . . . . 0.0 109.495 167.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.7 158.97 44.02 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.915 -1.115 . . . . 0.0 109.58 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.58 142.82 44.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.41 153.65 50.31 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.64 1.56 . . . . 0.0 109.408 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -60.57 -21.63 62.81 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -57.66 -47.5 82.12 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.749 2.02 . . . . 0.0 112.084 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -110.58 162.48 20.43 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.356 1.062 . . . . 0.0 109.519 -161.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.39 148.54 23.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.313 1.342 . . . . 0.0 112.399 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -77.86 143.77 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.93 81.2 5.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.681 1.592 . . . . 0.0 108.468 171.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -56.79 -34.6 67.8 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.344 0.657 . . . . 0.0 110.071 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -60.13 -54.68 43.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.778 0.831 . . . . 0.0 111.288 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.554 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -58.15 -47.15 84.23 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -176.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.339 0.4 OUTLIER -69.1 -29.66 67.79 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 116.877 -1.535 . . . . 0.0 112.352 -176.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -68.98 -42.64 76.28 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 121.094 1.77 . . . . 0.0 110.901 175.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -58.8 -39.26 80.6 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.579 1.081 . . . . 0.0 111.953 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.3 ptp -78.73 -38.36 39.08 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 121.72 -0.612 . . . . 0.0 112.548 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -71.34 -51.32 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -173.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -56.78 -44.36 81.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.584 0.753 . . . . 0.0 110.806 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -54.96 -50.9 67.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.667 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -70.51 -1.05 9.71 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.3 mt -96.12 -47.71 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 C-N-CA 125.464 1.506 . . . . 0.0 108.137 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -68.92 -8.24 42.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.536 1.062 . . . . 0.0 112.111 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -91.56 -0.38 57.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.513 1.525 . . . . 0.0 111.762 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -112.33 5.37 18.2 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.561 2.344 . . . . 0.0 111.164 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.121 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 163.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.7 mmt -61.7 -21.29 64.35 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 117.298 -1.334 . . . . 0.0 112.498 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -65.17 -38.3 90.09 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.254 1.388 . . . . 0.0 110.669 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.28 -40.86 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -96.51 36.83 1.32 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.807 1.643 . . . . 0.0 111.156 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.17 -56.18 2.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.688 1.595 . . . . 0.0 111.682 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.6 -15.65 60.83 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -162.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -73.64 -47.24 41.5 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 125.784 1.634 . . . . 0.0 110.566 164.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.37 -45.53 93.99 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.966 0.906 . . . . 0.0 110.597 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -59.04 -15.58 14.21 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.44 0.12 46.66 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.399 1.952 . . . . 0.0 114.162 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.8 135.56 27.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 119.94 1.87 . . . . 0.0 108.013 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -35.07 79.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.852 1.661 . . . . 0.0 112.293 -175.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.15 143.81 32.35 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.46 -20.12 42.14 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.828 2.352 . . . . 0.0 111.741 172.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.05 -21.48 63.68 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.211 0.46 . . . . 0.0 109.89 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 22' ' ' ARG . 7.7 m80 -116.06 -16.6 11.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.249 0.931 . . . . 0.0 112.079 -175.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -67.05 -57.32 7.06 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 123.641 0.776 . . . . 0.0 111.356 -170.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -44.21 -61.09 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.645 1.978 . . . . 0.0 112.088 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -59.94 -38.55 82.75 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 121.403 -0.811 . . . . 0.0 112.426 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 m -52.8 -50.24 64.01 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.475 0.71 . . . . 0.0 111.347 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -55.81 -46.32 78.1 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.643 1.177 . . . . 0.0 111.121 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -62.69 -40.17 96.28 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 122.838 0.455 . . . . 0.0 111.632 -172.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 mt -57.03 -50.83 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 124.012 0.82 . . . . 0.0 109.451 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.06 -55.3 36.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.602 0.361 . . . . 0.0 110.159 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 m -71.95 -21.43 61.6 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.298 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -69.0 -44.57 72.55 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 120.265 1.393 . . . . 0.0 110.428 170.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.409 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 56.1 t -59.68 -45.6 94.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 119.478 1.035 . . . . 0.0 108.587 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.03 62.83 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.538 0.608 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.29 -61.45 2.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 122.154 -0.341 . . . . 0.0 110.311 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -74.73 -35.69 62.67 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.578 1.551 . . . . 0.0 111.746 -162.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.71 74.47 34.76 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.93 -4.27 14.71 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.567 2.178 . . . . 0.0 112.15 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -28.36 51.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.647 1.179 . . . . 0.0 111.384 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.601 HD22 ' H ' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -75.59 143.62 42.24 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -96.87 150.83 37.34 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.66 151.93 52.82 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.553 2.168 . . . . 0.0 110.577 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -156.15 130.8 8.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.623 1.569 . . . . 0.0 107.169 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -107.91 96.07 6.12 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.48 147.5 30.39 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 125.977 1.711 . . . . 0.0 107.245 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 3.9 m95 57.41 17.89 4.09 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 172.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 t30 57.76 29.48 17.48 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.861 2.464 . . . . 0.0 112.778 -167.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -126.63 144.99 51.65 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.89 134.09 22.96 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.709 2.939 . . . . 0.0 111.757 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.9 ptm -148.25 172.36 14.48 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.097 0.559 . . . . 0.0 110.52 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -132.77 148.92 52.32 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.9 112.29 11.16 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.665 1.186 . . . . 0.0 108.879 -168.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.82 97.34 1.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 44.84 38.58 2.98 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.404 1.002 . . . . 0.0 111.449 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.01 -10.43 34.18 Favored Glycine 0 CA--C 1.533 1.219 0 CA-C-O 116.771 -2.127 . . . . 0.0 117.057 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.54 -170.13 0.97 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 121.643 2.721 . . . . 0.0 111.414 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -131.54 22.43 4.71 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 119.899 -1.751 . . . . 0.0 112.434 -170.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.32 -2.88 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 127.088 2.155 . . . . 0.0 112.413 -165.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 tt -155.91 132.03 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 119.239 -2.163 . . . . 0.0 109.814 165.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.83 150.0 21.71 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 165.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.88 174.59 10.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.682 1.241 . . . . 0.0 109.935 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -152.15 161.19 43.0 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 159.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.1 p -68.64 159.01 32.89 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 m -138.5 175.04 9.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.834 1.254 . . . . 0.0 108.212 168.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.82 -60.29 2.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.418 1.087 . . . . 0.0 112.89 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -123.56 6.72 8.9 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -172.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -146.78 157.96 43.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.042 1.737 . . . . 0.0 109.332 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.1 tp -88.61 155.77 19.43 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 154.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.46 ' HB2' HD22 ' A' ' 92' ' ' LEU . 11.0 p -115.75 114.81 25.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 116.778 -1.582 . . . . 0.0 109.013 172.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 79.0 t -126.19 144.08 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.832 1.196 . . . . 0.0 110.142 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.3 t -169.21 156.92 6.9 Favored Pre-proline 0 C--O 1.239 0.536 0 C-N-CA 127.069 2.148 . . . . 0.0 108.008 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -74.79 -56.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 120.713 0.942 . . . . 0.0 111.434 161.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -156.37 -80.89 0.07 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -147.33 -30.27 0.33 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -33.81 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 120.662 1.574 . . . . 0.0 110.578 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' A' ' 77' ' ' PHE . . . -44.91 -31.93 2.96 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.016 1.293 . . . . 0.0 112.532 169.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.7 mm -104.63 -0.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.936 1.294 . . . . 0.0 110.785 -168.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.8 m -121.35 -46.41 2.29 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -38.93 36.47 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.434 2.294 . . . . 0.0 109.404 -174.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.408 ' CD1' ' HA2' ' A' ' 73' ' ' GLY . 11.2 m-85 -100.84 5.08 43.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.723 0.809 . . . . 0.0 111.498 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.33 -36.73 76.19 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.121 1.369 . . . . 0.0 111.758 -172.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -72.57 -46.77 52.72 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.625 1.17 . . . . 0.0 108.829 -175.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.76 -41.74 91.69 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.419 0.688 . . . . 0.0 111.388 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.7 mt -61.41 -46.18 97.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.038 0.835 . . . . 0.0 109.575 171.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.28 -49.19 76.65 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 123.702 0.801 . . . . 0.0 110.365 -170.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -62.18 -29.31 70.28 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.965 1.306 . . . . 0.0 112.248 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.5 -22.92 62.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.08 0.854 . . . . 0.0 111.315 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.34 16.49 7.11 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.44 1.495 . . . . 0.0 113.99 170.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -108.97 93.44 4.52 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.488 1.144 . . . . 0.0 112.487 -164.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.6 m -52.27 96.61 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.191 2.196 . . . . 0.0 112.837 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.73 177.84 8.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.927 1.691 . . . . 0.0 112.121 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -100.44 -169.51 1.73 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.405 1.882 . . . . 0.0 107.362 159.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -77.26 -24.23 51.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.818 0.847 . . . . 0.0 112.687 168.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.5 -25.62 5.15 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 123.729 0.681 . . . . 0.0 112.759 -168.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 66' ' ' SER . 4.3 pp -152.77 161.11 42.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.051 0.925 . . . . 0.0 110.057 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -98.07 163.47 12.74 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.703 -0.623 . . . . 0.0 109.523 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -117.95 163.52 16.45 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.51 147.94 67.97 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 162.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -59.83 157.44 33.23 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 121.467 1.56 . . . . 0.0 109.59 159.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -65.08 -46.47 81.01 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.48 -0.763 . . . . 0.0 111.714 166.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -71.06 -21.63 62.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -166.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.02 160.63 29.19 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.49 1.116 . . . . 0.0 108.841 -172.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.71 144.4 19.51 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.614 1.543 . . . . 0.0 112.789 -163.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -84.14 123.96 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.415 1.886 . . . . 0.0 109.339 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -78.29 78.77 4.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.384 1.874 . . . . 0.0 112.917 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -51.98 -47.27 64.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.405 1.082 . . . . 0.0 110.423 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -68.9 -24.89 64.37 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -170.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.27 -56.3 5.75 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.508 1.123 . . . . 0.0 108.69 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.87 -23.75 62.37 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.946 -171.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -50.21 -53.98 24.2 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 127.065 2.146 . . . . 0.0 110.346 162.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -60.51 -47.53 85.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.873 0.76 . . . . 0.0 110.036 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 17.9 ptp -78.36 16.98 0.7 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.274 0.1 OUTLIER -117.12 -47.77 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 O-C-N 120.375 -1.453 . . . . 0.0 107.382 162.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.43 -53.27 60.08 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 111.994 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.39 -46.17 90.92 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 121.72 -0.613 . . . . 0.0 109.443 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -29.39 68.85 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.71 0.804 . . . . 0.0 111.539 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.558 HD11 HD11 ' A' ' 37' ' ' LEU . 38.9 mt -75.06 -59.68 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 125.703 1.601 . . . . 0.0 109.728 171.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -66.86 -18.47 65.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.942 0.792 . . . . 0.0 111.71 -168.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.77 -14.04 62.77 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.907 1.283 . . . . 0.0 112.496 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -119.01 20.4 12.73 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 127.024 2.13 . . . . 0.0 111.153 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 123.585 0.754 . . . . 0.0 110.007 -177.62 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.9 mmt -54.14 -27.88 36.32 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.002 0.921 . . . . 0.0 112.232 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -55.26 -60.64 3.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.388 1.475 . . . . 0.0 111.732 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.21 -38.93 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.732 1.213 . . . . 0.0 111.029 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -88.09 -15.13 37.04 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.166 0.586 . . . . 0.0 112.367 -169.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.11 78.45 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.223 1.009 . . . . 0.0 111.535 -175.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.88 -9.05 13.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.12 1.368 . . . . 0.0 113.383 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -112.59 -35.87 5.39 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.981 0.912 . . . . 0.0 110.832 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.3 mt -52.97 -33.68 52.33 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.481 -0.762 . . . . 0.0 111.168 170.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -54.62 -35.5 63.47 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.272 1.029 . . . . 0.0 113.671 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.1 -0.1 56.07 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-O 118.923 -0.932 . . . . 0.0 112.78 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.51 91.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -2.35 0.96 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.58 2.352 . . . . 0.0 113.294 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -114.47 67.02 1.73 Allowed Pre-proline 0 N--CA 1.444 -0.768 0 C-N-CA 129.055 2.942 . . . . 0.0 109.408 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.5 -21.91 65.71 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.862 3.041 . . . . 0.0 113.24 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -71.18 -4.67 26.77 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.727 1.611 . . . . 0.0 112.18 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.0 16.78 1.22 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.45 1.1 . . . . 0.0 110.06 -175.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -87.55 -47.84 8.39 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.092 1.357 . . . . 0.0 109.693 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -55.58 -30.04 60.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.516 2.326 . . . . 0.0 112.938 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -58.52 -38.22 77.25 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.887 -1.133 . . . . 0.0 111.145 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.6 m -66.85 -39.63 87.66 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.362 0.665 . . . . 0.0 109.668 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.1 -44.8 83.57 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.418 1.487 . . . . 0.0 110.622 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -61.17 -44.39 97.39 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.74 0.416 . . . . 0.0 109.974 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.7 mt -61.31 -49.99 82.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.985 1.314 . . . . 0.0 109.109 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.79 -41.37 91.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.477 0.711 . . . . 0.0 109.79 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -65.09 -43.96 90.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.913 0.885 . . . . 0.0 110.868 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.537 ' HZ3' HD11 ' A' ' 106' ' ' LEU . 68.0 t90 -66.93 -38.66 86.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.884 1.274 . . . . 0.0 111.81 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.0 t -61.28 -43.67 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 O-C-N 121.415 -0.803 . . . . 0.0 109.553 175.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.67 -25.03 67.94 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.153 0.581 . . . . 0.0 111.519 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 -70.16 0.59 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.217 1.007 . . . . 0.0 109.543 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.2 m -67.87 -29.48 68.6 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.783 -0.627 . . . . 0.0 112.225 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -123.15 58.34 12.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.167 0.894 . . . . 0.0 110.267 -171.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.09 -18.88 45.74 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.907 3.071 . . . . 0.0 114.983 -160.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -79.0 -7.2 57.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.164 0.893 . . . . 0.0 111.862 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.47 141.07 38.51 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.579 1.081 . . . . 0.0 108.605 165.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -116.42 154.29 48.94 Favored Pre-proline 0 C--N 1.328 -0.362 0 C-N-CA 124.937 1.295 . . . . 0.0 110.39 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.33 138.74 30.73 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.628 2.885 . . . . 0.0 110.337 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -165.56 82.73 0.33 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.05 140.71 54.91 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.057 -1.027 . . . . 0.0 108.694 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -150.15 153.27 36.04 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 124.741 1.217 . . . . 0.0 108.426 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.3 m95 51.6 31.55 7.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.68 0.792 . . . . 0.0 112.256 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 t30 59.12 18.34 6.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.562 1.945 . . . . 0.0 113.784 -173.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -114.13 127.12 27.16 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.727 1.611 . . . . 0.0 107.106 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.13 114.77 3.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.686 2.257 . . . . 0.0 109.978 170.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.6 ptm -130.79 173.66 10.72 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.349 1.06 . . . . 0.0 109.259 173.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -135.18 132.21 37.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.1 p -92.05 125.12 36.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.084 0.954 . . . . 0.0 108.564 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -74.54 85.94 2.07 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 161.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.268 20.8 mt-30 63.19 -15.23 0.06 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.145 1.778 . . . . 0.0 115.605 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.74 -13.01 0.03 OUTLIER Glycine 0 CA--C 1.544 1.859 0 C-N-CA 126.938 2.208 . . . . 0.0 115.094 170.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.84 -165.79 1.15 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.765 1.226 . . . . 0.0 113.237 -163.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.48 29.32 4.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.14 2.176 . . . . 0.0 109.762 -173.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.2 mt -67.72 -19.73 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.527 1.131 . . . . 0.0 112.118 -168.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.4 tt -155.02 136.59 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 120.236 1.38 . . . . 0.0 110.263 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.92 157.08 27.35 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 166.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -138.72 168.84 18.92 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.222 -1.163 . . . . 0.0 109.104 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 81.4 p -150.2 144.13 25.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.8 p -91.28 155.3 18.64 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -173.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 t -135.16 177.99 7.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.113 1.365 . . . . 0.0 108.474 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -49.34 -65.67 0.53 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.059 1.343 . . . . 0.0 109.571 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.408 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 90.2 m-70 -116.2 13.06 15.62 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -172.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -153.83 166.46 32.83 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.901 0.773 . . . . 0.0 111.571 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.1 tp -97.99 158.53 15.48 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 162.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . 4.0 m -126.7 120.62 29.87 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.184 0.902 . . . . 0.0 109.859 174.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.88 140.9 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.189 1.796 . . . . 0.0 109.222 -161.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.2 t -167.43 157.02 9.42 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 127.68 2.392 . . . . 0.0 105.883 168.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.13 -57.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.059 0 CA-C-N 120.65 1.268 . . . . 0.0 108.957 166.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -145.34 -86.18 0.12 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -139.49 -29.57 0.74 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.016 1.327 . . . . 0.0 112.499 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.17 -29.16 45.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 119.192 0.905 . . . . 0.0 111.439 -172.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.16 -24.63 15.94 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.872 2.177 . . . . 0.0 113.205 171.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 92' ' ' LEU . 18.3 mm -107.74 -6.98 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 127.082 2.153 . . . . 0.0 110.171 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -92.35 -85.46 0.26 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -83.83 -45.71 12.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -169.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -67.84 -22.43 65.14 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.112 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.53 -32.14 57.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.196 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -67.33 -45.2 77.14 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.433 0.693 . . . . 0.0 110.05 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.01 89.49 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.932 -1.105 . . . . 0.0 110.819 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.3 mt -66.62 -43.04 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 118.653 0.66 . . . . 0.0 109.722 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.35 89.42 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 124.643 1.177 . . . . 0.0 109.862 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -65.1 -24.65 67.49 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.679 1.191 . . . . 0.0 111.74 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.4 -29.23 41.9 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.353 0.979 . . . . 0.0 110.904 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 142.18 -31.37 2.07 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.999 1.762 . . . . 0.0 112.599 165.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -81.15 102.18 10.13 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.965 1.383 . . . . 0.0 109.76 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.4 m -69.8 9.7 0.49 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 58.47 -172.97 0.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.36 2.264 . . . . 0.0 112.065 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.5 p -110.89 179.31 4.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.85 1.66 . . . . 0.0 106.93 158.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -66.86 27.89 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.734 2.413 . . . . 0.0 113.323 164.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.1 -35.57 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 CA-C-O 118.287 -1.285 . . . . 0.0 114.88 -168.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HA ' HD11 ' A' ' 74' ' ' ILE . 1.1 pp -161.47 173.6 14.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.214 1.007 . . . . 0.0 112.077 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -108.88 119.67 40.23 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 120.89 -1.131 . . . . 0.0 110.37 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.27 138.65 42.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.98 143.81 31.58 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 169.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.55 156.84 29.63 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.439 2.092 . . . . 0.0 110.715 170.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.408 ' CD1' ' HA ' ' A' ' 63' ' ' HIS . 9.0 m95 -59.64 -25.63 64.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.402 168.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.99 -67.91 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.713 0.688 . . . . 0.0 110.796 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.9 164.96 44.16 Favored Pre-proline 0 N--CA 1.465 0.295 0 C-N-CA 124.409 1.083 . . . . 0.0 111.707 -168.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.92 139.42 12.13 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.086 1.191 . . . . 0.0 112.814 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.2 t -72.84 115.83 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -68.42 89.4 0.35 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.054 1.342 . . . . 0.0 111.418 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -58.1 -39.54 78.88 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 124.831 1.253 . . . . 0.0 109.897 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -66.91 -38.64 86.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.719 1.207 . . . . 0.0 113.406 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -48.3 55.71 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.537 HD11 ' HZ3' ' A' ' 29' ' ' TRP 0.285 0.4 OUTLIER -71.11 -26.52 63.06 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.973 -173.439 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -66.73 -43.09 85.15 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.117 -1.42 . . . . 0.0 111.001 171.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -53.45 -52.21 60.19 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.338 1.426 . . . . 0.0 109.677 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.7 ptp -63.02 -47.38 83.32 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.858 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -43.01 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 120.306 1.412 . . . . 0.0 110.736 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -63.01 -44.81 94.97 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.411 0.551 . . . . 0.0 110.441 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -56.23 -45.99 79.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.847 0.459 . . . . 0.0 110.623 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.66 -22.19 65.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.054 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.6 mt -82.17 -47.53 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 119.613 1.097 . . . . 0.0 109.626 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -71.0 -19.27 62.54 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.23 0.923 . . . . 0.0 111.491 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.24 -28.83 57.3 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.101 1.761 . . . . 0.0 110.892 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -106.21 43.04 1.18 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 126.18 1.792 . . . . 0.0 108.054 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--O 1.246 0.889 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.811 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.285 22.3 p-80 . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mmt -50.26 -43.99 53.5 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.899 1.679 . . . . 0.0 109.691 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -54.46 -32.84 58.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.21 -33.0 19.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 123.002 0.521 . . . . 0.0 111.125 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -113.57 32.84 5.52 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.685 1.994 . . . . 0.0 113.73 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.57 -15.33 10.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 121.787 2.085 . . . . 0.0 113.747 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.7 -24.42 21.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -35.87 59.01 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -173.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.484 HD12 HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -57.27 -37.09 71.85 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.9 1.28 . . . . 0.0 112.074 176.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -54.35 -39.61 67.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.819 0.736 . . . . 0.0 110.74 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.88 -7.4 75.44 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.247 1.403 . . . . 0.0 113.997 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.484 HD12 HD12 ' A' ' 11' ' ' LEU . 18.8 mt -86.46 102.87 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.93 -8.4 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.569 1.147 . . . . 0.0 113.452 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.48 84.99 0.68 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.688 1.995 . . . . 0.0 111.18 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.77 -20.44 58.9 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.707 2.938 . . . . 0.0 114.241 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 4.6 m-20 -64.27 -17.04 63.24 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.114 0.416 . . . . 0.0 110.545 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.406 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 8.1 m80 -128.16 -33.97 2.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.177 0.991 . . . . 0.0 111.268 -169.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -48.52 -54.65 13.56 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.301 1.041 . . . . 0.0 109.849 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -13.15 34.55 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.11 1.364 . . . . 0.0 113.178 -175.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -88.32 -51.95 5.47 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.934 1.243 . . . . 0.0 108.36 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.1 m -46.56 -43.31 17.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.608 1.963 . . . . 0.0 112.685 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -71.94 -28.17 63.29 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.366 1.466 . . . . 0.0 112.592 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.13 -47.0 78.64 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.669 -0.644 . . . . 0.0 109.852 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -54.91 -45.71 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 46' ' ' PRO . 21.6 mt -59.22 -52.26 66.44 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.375 0.27 . . . . 0.0 110.969 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 p -62.09 -41.12 97.88 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.622 0.769 . . . . 0.0 112.961 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -56.49 -59.03 5.57 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.913 1.685 . . . . 0.0 109.96 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.6 t -50.53 -48.04 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 120.245 1.384 . . . . 0.0 111.182 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.79 -16.41 64.24 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.54 -54.83 3.98 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.868 0.867 . . . . 0.0 110.669 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -34.26 77.65 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.693 0.797 . . . . 0.0 111.669 -171.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.36 69.62 81.33 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.733 1.213 . . . . 0.0 108.388 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.82 -6.42 18.12 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.035 3.157 . . . . 0.0 115.044 -162.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -73.75 -14.45 61.13 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 120.036 1.289 . . . . 0.0 112.152 168.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.6 mt -75.66 135.15 40.44 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 120.944 -1.097 . . . . 0.0 110.948 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -110.99 149.79 40.95 Favored Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 126.537 1.935 . . . . 0.0 109.203 175.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.08 159.99 40.42 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.895 2.397 . . . . 0.0 111.523 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -158.16 111.83 2.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.209 1.003 . . . . 0.0 108.529 166.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.99 95.38 1.58 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 165.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -118.48 147.42 43.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.5 m95 53.16 23.32 3.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.8 t30 62.23 15.91 7.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.788 1.235 . . . . 0.0 112.327 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 p -121.31 150.23 53.7 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HB2' HD21 ' A' ' 27' ' ' LEU . 72.8 Cg_endo -76.25 113.11 3.62 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.93 2.42 . . . . 0.0 110.564 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.1 ptm -119.18 172.7 7.4 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 166.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.3 139.62 48.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -102.34 127.7 49.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -71.41 87.76 0.87 Allowed 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 166.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 58.75 -8.95 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.156 2.582 . . . . 0.0 114.655 -177.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.47 -11.97 0.06 OUTLIER Glycine 0 CA--C 1.543 1.782 0 C-N-CA 126.745 2.117 . . . . 0.0 114.179 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -84.58 -169.86 2.83 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.374 1.587 . . . . 0.0 111.651 -174.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.507 ' H ' HG22 ' A' ' 53' ' ' THR . 78.4 t80 -125.43 19.19 8.13 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.696 1.998 . . . . 0.0 111.744 -177.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 113' ' ' ASN . 17.4 mt -65.35 4.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 126.852 2.061 . . . . 0.0 113.375 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 tt -156.66 142.53 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 118.465 -2.647 . . . . 0.0 111.085 165.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.47 148.57 17.5 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 166.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -149.85 171.97 15.91 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.257 1.423 . . . . 0.0 108.523 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.18 162.05 41.05 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 166.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 p -61.03 152.92 26.7 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.408 0.623 . . . . 0.0 110.261 167.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -132.89 171.13 14.34 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.412 1.885 . . . . 0.0 106.504 163.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -49.41 -49.67 43.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.606 1.562 . . . . 0.0 112.158 -171.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -129.39 7.79 5.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.48 1.112 . . . . 0.0 112.82 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.456 ' CD2' ' HE ' ' A' ' 94' ' ' ARG . 33.5 p-80 -147.26 169.56 19.13 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.171 -0.956 . . . . 0.0 110.541 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.5 tp -102.77 147.03 27.37 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 162.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB3' HD13 ' A' ' 92' ' ' LEU . 1.5 m -121.81 125.41 46.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.234 0.925 . . . . 0.0 109.394 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.6 t -136.19 141.55 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 127.316 2.246 . . . . 0.0 109.156 -157.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 t -167.72 152.08 6.37 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.802 1.641 . . . . 0.0 108.7 168.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.64 -56.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.7 1.6 . . . . 0.0 111.679 164.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -139.75 -86.0 0.22 Allowed 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -143.14 -33.97 0.43 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.041 0.936 . . . . 0.0 112.746 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.1 tt -61.05 -33.64 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 120.039 1.29 . . . . 0.0 111.569 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -50.45 -22.37 5.3 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.249 1.404 . . . . 0.0 113.112 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.8 mm -110.69 -1.85 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 126.41 1.884 . . . . 0.0 110.157 -171.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.3 m -118.27 -51.31 2.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.163 0.985 . . . . 0.0 110.509 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -84.06 -58.28 2.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 127.431 2.293 . . . . 0.0 107.43 -173.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.55 0.26 17.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.072 1.349 . . . . 0.0 111.314 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.63 -40.3 78.89 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.855 1.262 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -72.8 -35.78 67.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.62 0.646 . . . . 0.0 109.535 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.25 82.3 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.498 0.719 . . . . 0.0 109.632 170.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.69 -44.89 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.108 0.963 . . . . 0.0 110.333 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.99 -55.84 29.49 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.167 0.987 . . . . 0.0 108.952 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -68.11 -15.86 63.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.692 0.797 . . . . 0.0 113.104 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.63 -16.18 52.26 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.399 1.0 . . . . 0.0 111.092 172.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.36 19.54 9.29 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 124.276 0.941 . . . . 0.0 113.998 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -119.81 99.45 6.64 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.028 1.414 . . . . 0.0 111.455 -166.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.9 m -56.55 117.01 3.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.904 1.281 . . . . 0.0 110.176 172.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.41 -168.18 1.55 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.34 1.856 . . . . 0.0 110.668 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 p -120.06 -164.78 1.11 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.75 1.62 . . . . 0.0 107.217 163.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -88.69 -20.48 24.8 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.06 0.846 . . . . 0.0 111.981 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.74 5.68 5.82 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.989 -0.895 . . . . 0.0 114.174 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.441 HD13 ' HB3' ' A' ' 66' ' ' SER . 1.5 pp -156.34 169.66 24.07 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.873 1.337 . . . . 0.0 110.104 158.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -118.68 179.17 4.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.801 1.24 . . . . 0.0 109.52 170.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.456 ' HE ' ' CD2' ' A' ' 64' ' ' HIS . 2.4 ptp85 -140.49 170.77 15.17 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.071 -1.018 . . . . 0.0 113.341 -177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 mp -135.97 142.85 41.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 160.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.53 160.46 47.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.705 1.603 . . . . 0.0 109.414 166.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -73.47 -23.15 60.04 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -65.59 -67.93 0.4 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.663 0.785 . . . . 0.0 110.455 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.48 165.69 51.5 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.481 1.512 . . . . 0.0 111.593 -164.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.78 145.46 40.98 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.624 1.55 . . . . 0.0 112.765 -170.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.45 126.31 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.28 76.04 7.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 168.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -56.94 -32.96 66.51 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 123.367 0.667 . . . . 0.0 109.433 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.46 -48.54 81.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.46 0.704 . . . . 0.0 111.913 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.73 -42.57 73.8 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 122.522 1.153 . . . . 0.0 109.514 -169.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.276 0.5 OUTLIER -70.54 -30.9 67.76 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.747 176.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -58.45 -51.35 70.21 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.778 1.172 . . . . 0.0 110.641 166.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -51.76 -49.48 62.55 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.822 0.849 . . . . 0.0 109.889 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -69.39 -47.67 63.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.93 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -45.56 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 120.452 1.478 . . . . 0.0 109.919 -175.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.58 -47.63 81.58 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.193 0.997 . . . . 0.0 110.968 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -60.53 -46.22 90.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.028 -0.42 . . . . 0.0 110.792 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.452 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 3.0 m120 -64.16 -20.98 66.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.657 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.1 mt -71.46 -56.45 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 169.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.05 -15.2 63.49 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.933 0.788 . . . . 0.0 112.396 -173.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.76 -10.55 59.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.535 1.134 . . . . 0.0 112.708 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -114.7 21.37 14.5 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.749 2.02 . . . . 0.0 110.959 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.84 174.63 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.288 9.4 p-80 . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.7 mmt -44.65 -46.28 10.1 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 126.04 1.736 . . . . 0.0 110.747 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.93 -31.61 72.63 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -168.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.5 t -58.15 -45.87 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.436 1.094 . . . . 0.0 108.701 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -91.58 -9.3 44.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.237 1.415 . . . . 0.0 112.37 -170.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.4 -33.06 70.94 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.468 1.107 . . . . 0.0 111.431 -171.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -68.8 -15.72 63.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.789 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -79.23 -52.96 7.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 166.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -49.18 -45.12 43.68 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.498 1.119 . . . . 0.0 111.791 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -62.46 -25.2 67.86 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 118.051 0.387 . . . . 0.0 111.816 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.35 -2.29 60.46 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.279 1.418 . . . . 0.0 113.577 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 16' ' ' HIS . 54.3 mt -77.84 111.65 14.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 CA-C-N 120.08 1.94 . . . . 0.0 107.369 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -1.07 24.14 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.601 0.76 . . . . 0.0 112.714 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.478 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.2 m170 -110.39 78.83 1.51 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 127.837 2.455 . . . . 0.0 110.021 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -61.11 -32.36 91.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.718 2.278 . . . . 0.0 112.436 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.446 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 36.9 m-20 -68.85 -1.55 7.48 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.398 0.999 . . . . 0.0 111.724 -173.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 14.3 m80 -135.88 -38.38 0.72 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.072 1.749 . . . . 0.0 110.498 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.4 ttp85 -46.14 -54.35 8.78 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 123.898 0.879 . . . . 0.0 109.42 166.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -53.14 -38.69 62.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.784 0.833 . . . . 0.0 112.194 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.67 -45.09 91.68 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.437 -0.789 . . . . 0.0 109.724 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.415 ' HA ' HD13 ' A' ' 26' ' ' ILE . 3.0 m -60.91 -35.21 76.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.13 1.772 . . . . 0.0 111.01 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -59.83 -38.45 82.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.693 1.133 . . . . 0.0 110.484 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -59.81 -46.47 89.13 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.566 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 23' ' ' THR . 2.9 mp -54.33 -52.07 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.48 -57.45 12.25 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 122.833 0.453 . . . . 0.0 110.017 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 m -60.66 -43.01 98.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 123.652 0.595 . . . . 0.0 110.454 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -62.87 -41.42 99.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.75 0.82 . . . . 0.0 110.772 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.534 HG11 ' CE2' ' A' ' 48' ' ' PHE . 26.5 t -58.33 -60.05 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.897 0.771 . . . . 0.0 109.874 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.09 -21.91 66.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.82 0.737 . . . . 0.0 112.597 -174.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.77 -62.38 1.47 Allowed 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.653 0.781 . . . . 0.0 111.562 171.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.3 m -72.27 -35.13 68.66 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.69 1.596 . . . . 0.0 110.753 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -120.65 66.68 13.41 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 124.714 1.206 . . . . 0.0 108.841 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -68.48 -11.63 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.029 1.819 . . . . 0.0 112.362 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -76.18 4.92 7.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.86 0.864 . . . . 0.0 112.477 171.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.42 141.08 36.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.298 1.039 . . . . 0.0 108.277 171.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -122.39 143.95 40.79 Favored Pre-proline 0 C--O 1.239 0.504 0 C-N-CA 124.691 1.196 . . . . 0.0 110.014 -173.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.99 148.04 21.59 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.518 2.812 . . . . 0.0 112.637 -165.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -155.25 119.45 4.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.431 0.693 . . . . 0.0 109.503 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -83.24 113.33 20.6 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 165.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt -150.88 154.99 38.24 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.511 1.125 . . . . 0.0 108.394 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.8 m95 49.77 24.65 1.3 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.659 1.584 . . . . 0.0 113.322 -168.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.48 21.7 8.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.078 1.351 . . . . 0.0 112.186 -171.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.2 p -118.77 158.15 48.29 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 125.783 1.633 . . . . 0.0 109.405 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.25 110.9 2.8 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.281 3.32 . . . . 0.0 110.499 169.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 19.2 ptm -117.73 170.04 9.1 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.054 0.93 . . . . 0.0 109.292 165.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CE2' HG11 ' A' ' 30' ' ' VAL . 0.6 OUTLIER -132.36 176.64 8.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 166.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.8 m -143.13 139.62 30.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -71.63 97.58 1.75 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 161.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.297 21.7 mt-30 59.78 -11.72 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.574 2.75 . . . . 0.0 116.711 174.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.69 -3.45 0.05 OUTLIER Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.526 2.488 . . . . 0.0 114.541 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.59 -166.14 0.25 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 120.406 2.103 . . . . 0.0 111.799 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -126.73 20.95 7.08 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 119.569 -1.957 . . . . 0.0 111.639 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.5 mt -71.19 15.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 O-C-N 120.29 -1.506 . . . . 0.0 111.802 -169.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 tt -160.5 146.22 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 118.62 -2.55 . . . . 0.0 110.799 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.2 144.26 8.89 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 162.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -137.0 174.24 10.84 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.094 1.447 . . . . 0.0 110.043 171.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.5 t -155.76 159.57 39.57 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 160.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.2 p -63.05 144.13 57.17 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 162.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t -120.19 172.81 7.51 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 162.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -58.45 -44.67 89.3 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 121.499 -0.751 . . . . 0.0 110.737 -163.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -137.44 37.12 2.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.881 0.872 . . . . 0.0 111.918 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -166.57 167.16 15.7 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.418 1.487 . . . . 0.0 109.801 171.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -98.74 157.25 16.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.656 1.182 . . . . 0.0 107.922 162.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.422 ' HB2' HD22 ' A' ' 92' ' ' LEU . 34.3 p -119.03 125.41 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.717 1.207 . . . . 0.0 108.604 169.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.7 t -135.46 141.7 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 119.619 1.1 . . . . 0.0 108.643 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -173.23 151.49 2.07 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.09 1.756 . . . . 0.0 107.368 175.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.65 -57.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 119.786 0.959 . . . . 0.0 112.318 165.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -149.49 -86.73 0.08 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -142.45 -32.57 0.49 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.836 1.254 . . . . 0.0 111.745 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.0 tt -63.32 -31.29 52.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 118.817 0.735 . . . . 0.0 110.934 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.69 -24.47 12.61 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 127.247 2.356 . . . . 0.0 113.263 173.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.9 mm -120.6 -3.5 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.98 1.312 . . . . 0.0 110.492 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.0 t -80.02 -71.76 0.44 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -88.65 -41.71 12.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.655 -0.653 . . . . 0.0 109.248 -166.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -71.95 -10.34 59.64 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.091 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.56 -27.39 57.62 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -72.93 -42.44 63.47 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.887 0.851 . . . . 0.0 110.406 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.61 -38.18 90.13 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.426 -0.796 . . . . 0.0 110.843 172.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.7 mt -59.91 -50.6 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.226 1.011 . . . . 0.0 108.926 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.18 -47.4 65.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.82 1.248 . . . . 0.0 111.386 -175.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.43 -30.15 68.28 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.586 1.155 . . . . 0.0 112.987 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.36 -15.8 61.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.378 0.99 . . . . 0.0 111.651 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.23 -14.57 43.74 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 125.339 1.447 . . . . 0.0 113.002 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -73.7 161.85 29.81 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 173.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.48 5.02 5.14 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.471 1.032 . . . . 0.0 113.689 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 55.94 -159.07 0.22 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.856 1.662 . . . . 0.0 111.728 -169.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.5 p -119.38 -164.38 1.05 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.19 2.996 . . . . 0.0 104.815 159.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -70.69 -31.19 67.98 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.068 1.303 . . . . 0.0 113.043 171.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.35 -20.46 1.59 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -162.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 66' ' ' SER . 4.2 pp -137.35 167.98 20.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 121.197 -1.178 . . . . 0.0 110.026 169.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -112.38 150.27 31.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -140.73 145.37 36.36 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 101' ' ' VAL . 0.8 OUTLIER -133.51 143.72 49.11 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -176.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 161.45 42.29 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 121.706 1.645 . . . . 0.0 110.604 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -65.99 -15.28 62.88 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -63.44 -38.9 92.91 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.464 1.106 . . . . 0.0 110.846 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.52 158.46 33.7 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 123.76 0.824 . . . . 0.0 110.127 -156.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.08 126.08 10.88 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.887 2.391 . . . . 0.0 108.197 166.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.439 ' HA ' HD12 ' A' ' 95' ' ' ILE . 5.1 m -78.98 18.16 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.297 0.3 OUTLIER 50.73 78.0 0.11 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.948 2.899 . . . . 0.0 113.492 177.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -69.42 -48.75 60.04 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.944 2.098 . . . . 0.0 111.674 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -58.94 -36.35 74.62 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.01 0.924 . . . . 0.0 111.383 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -50.53 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.579 0.704 . . . . 0.0 110.067 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.289 0.3 OUTLIER -71.29 -29.4 65.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.535 0.734 . . . . 0.0 112.765 -174.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -64.19 -39.36 93.83 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.404 -1.284 . . . . 0.0 110.312 172.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -57.91 -49.47 76.65 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.337 1.426 . . . . 0.0 110.444 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.5 ptp -69.51 -45.16 69.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.191 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -70.63 -46.62 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.697 1.135 . . . . 0.0 110.122 -175.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.13 -31.16 72.24 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.504 1.047 . . . . 0.0 111.998 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.07 -53.42 25.75 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 118.06 0.391 . . . . 0.0 110.358 169.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.72 -18.13 64.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.487 -170.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.05 -71.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 124.983 1.313 . . . . 0.0 108.812 158.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -66.18 -13.41 60.19 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -165.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -77.16 -12.07 59.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.78 2.032 . . . . 0.0 113.13 174.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -129.37 3.9 5.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.268 2.227 . . . . 0.0 110.476 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.251 24.0 tt0 . . . . . 0 C--O 1.255 1.383 0 C-N-CA 128.966 2.906 . . . . 0.0 115.022 166.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.293 8.3 p-80 . . . . . 0 N--CA 1.464 0.257 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mmt -44.74 -49.48 10.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 128.42 2.688 . . . . 0.0 110.349 -170.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.74 -31.15 58.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.433 1.093 . . . . 0.0 112.126 -169.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.09 -45.13 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 123.97 0.908 . . . . 0.0 110.535 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -96.85 -8.72 30.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.226 2.21 . . . . 0.0 112.649 -170.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.77 -12.32 60.31 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 126.231 1.812 . . . . 0.0 112.182 -160.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.482 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 27.4 mt-10 -111.4 -27.46 8.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.554 1.942 . . . . 0.0 109.184 -168.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.68 -34.63 69.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.02 -47.7 44.3 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.862 1.265 . . . . 0.0 112.611 173.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 1.4 mppt? -61.74 -27.09 68.47 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.829 1.195 . . . . 0.0 113.403 176.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.6 -12.47 84.37 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.874 -0.959 . . . . 0.0 113.028 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 16' ' ' HIS . 53.1 mt -76.08 113.02 14.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 119.742 1.771 . . . . 0.0 106.682 168.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -79.19 -4.11 48.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 122.055 0.931 . . . . 0.0 113.478 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.426 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.3 m-70 -100.15 85.91 0.57 Allowed Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 127.645 2.378 . . . . 0.0 111.702 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -62.56 -38.58 50.4 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.861 2.374 . . . . 0.0 111.349 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.21 10.75 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.815 1.246 . . . . 0.0 111.162 -172.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -135.5 -38.8 0.74 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.018 0.927 . . . . 0.0 111.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -43.77 83.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 116.492 -1.718 . . . . 0.0 114.688 -176.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -45.21 -42.89 9.76 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.028 1.285 . . . . 0.0 112.006 -172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -45.5 79.02 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.041 2.136 . . . . 0.0 111.971 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.0 m -59.71 -37.64 79.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.212 1.405 . . . . 0.0 109.744 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.09 -36.2 81.46 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 124.325 1.05 . . . . 0.0 110.788 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -59.84 -46.7 88.45 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.426 0.69 . . . . 0.0 109.722 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 mt -60.13 -44.76 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.021 0.929 . . . . 0.0 109.502 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.0 mt -58.05 -55.27 37.08 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.936 0.789 . . . . 0.0 110.054 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.4 m -62.4 -33.14 74.19 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.451 1.1 . . . . 0.0 113.202 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -73.2 -44.18 60.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.566 -0.709 . . . . 0.0 111.03 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.55 -53.89 38.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.16 -26.19 66.12 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.61 -50.96 8.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.545 0.738 . . . . 0.0 111.034 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.3 m -72.74 -40.39 66.11 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.534 0.734 . . . . 0.0 110.811 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.85 65.63 55.04 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.2 1.0 . . . . 0.0 109.99 -172.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.62 -6.74 19.6 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.09 2.527 . . . . 0.0 114.019 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.31 -16.27 61.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.479 1.036 . . . . 0.0 111.124 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.09 134.71 47.24 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 165.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.92 146.88 32.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.78 147.45 75.29 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.123 1.882 . . . . 0.0 109.787 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -156.57 109.53 2.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.471 -0.768 . . . . 0.0 109.353 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 75.6 mmm -76.54 131.12 38.78 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 161.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -139.17 139.92 37.7 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.0 m95 64.92 0.24 1.16 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 t30 74.58 14.7 3.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.576 2.75 . . . . 0.0 113.37 -162.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.3 p -107.84 147.17 34.93 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.89 138.06 27.94 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.507 2.138 . . . . 0.0 110.494 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.6 ptm -144.05 -179.59 6.59 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 162.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -140.16 161.1 38.44 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 p -125.19 114.36 18.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.154 0.582 . . . . 0.0 110.073 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -71.03 97.17 1.41 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 44.4 48.6 8.17 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.466 1.506 . . . . 0.0 111.758 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.52 35.67 25.3 Favored Glycine 0 CA--C 1.535 1.315 0 O-C-N 121.23 -0.919 . . . . 0.0 114.742 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.7 m -112.85 -164.78 0.94 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 119.339 1.57 . . . . 0.0 109.617 170.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.46 ' H ' HG22 ' A' ' 53' ' ' THR . 46.3 t80 -129.64 13.19 5.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.275 1.83 . . . . 0.0 111.668 -174.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.9 0.94 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 128.797 2.839 . . . . 0.0 113.502 -167.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 tt -157.36 140.74 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 118.956 -2.34 . . . . 0.0 112.101 165.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.39 165.92 29.07 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.142 1.353 . . . . 0.0 110.324 166.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -157.71 176.15 12.97 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.685 0.755 . . . . 0.0 111.464 165.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.14 155.36 22.82 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 165.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.0 p -63.34 127.87 33.25 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.36 173.8 12.11 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 164.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -66.26 -26.78 67.51 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.858 -1.151 . . . . 0.0 112.971 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -140.59 5.45 2.01 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.852 1.261 . . . . 0.0 113.175 -173.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -157.55 -179.76 8.48 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.097 1.759 . . . . 0.0 106.727 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tt -119.74 133.97 55.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.44 125.62 50.8 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.549 -175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.1 t -142.72 152.59 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 120.45 1.477 . . . . 0.0 109.82 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.8 t -161.23 165.16 17.4 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.805 2.042 . . . . 0.0 107.31 165.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -87.04 -56.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.401 2.067 . . . . 0.0 111.514 165.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -145.63 -80.86 0.16 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.69 -36.12 0.22 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.198 1.399 . . . . 0.0 111.772 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.0 tt -60.87 -32.34 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.803 0.729 . . . . 0.0 110.787 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.85 -17.81 44.3 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.386 1.946 . . . . 0.0 113.843 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.9 mm -113.65 -0.66 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.534 1.934 . . . . 0.0 108.792 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 t -90.85 -85.15 0.23 Allowed 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.951 1.3 . . . . 0.0 108.134 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -81.29 -43.18 19.53 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.844 0.857 . . . . 0.0 108.979 -170.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -71.81 -14.4 61.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.864 -0.523 . . . . 0.0 112.104 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.84 -32.71 70.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.511 0.724 . . . . 0.0 112.249 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.15 -45.85 83.29 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.91 82.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.82 1.248 . . . . 0.0 110.827 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.2 mt -58.11 -46.87 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.63 75.84 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.917 -0.489 . . . . 0.0 111.012 -171.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -65.41 -24.08 67.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.887 1.275 . . . . 0.0 113.191 -172.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.24 -47.21 83.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.66 55.59 0.04 OUTLIER Glycine 0 C--N 1.333 0.391 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -135.26 171.19 14.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.09 0.956 . . . . 0.0 109.427 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.8 m -130.4 106.99 8.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.58 1.552 . . . . 0.0 107.953 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.76 -178.09 3.04 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.36 0.6 . . . . 0.0 111.363 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 p -107.61 -164.66 0.99 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 162.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 11.27 39.89 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.663 1.585 . . . . 0.0 111.191 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.13 -35.31 0.59 Allowed Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.04 172.89 17.87 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.135 1.374 . . . . 0.0 109.149 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -104.46 162.79 12.94 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.35 0.977 . . . . 0.0 109.717 170.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 120.48 11.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.299 0.239 . . . . 0.0 110.545 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.75 143.73 26.68 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.18 155.12 68.8 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.591 1.528 . . . . 0.0 109.276 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -64.64 -16.3 62.56 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -71.46 -57.91 4.0 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.761 0.824 . . . . 0.0 112.152 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.79 165.81 46.78 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 123.889 0.875 . . . . 0.0 111.131 -165.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -63.21 173.27 4.24 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.603 1.536 . . . . 0.0 110.665 160.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 p -111.96 175.16 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 127.016 2.126 . . . . 0.0 107.408 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.71 78.06 1.29 Allowed 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 120.947 -1.095 . . . . 0.0 111.482 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -55.78 -30.36 61.17 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.066 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -67.64 -36.37 80.65 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.397 -0.814 . . . . 0.0 112.076 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.25 -36.89 58.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.587 1.085 . . . . 0.0 109.761 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.57 -55.65 23.9 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.93 0.492 . . . . 0.0 109.918 175.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -62.97 -49.58 74.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.761 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -54.16 -49.78 68.48 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.357 0.526 . . . . 0.0 110.448 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.4 ptp -72.46 -40.72 66.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.68 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.73 -46.81 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 120.615 1.552 . . . . 0.0 109.376 -172.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -55.03 -44.73 74.92 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.615 1.166 . . . . 0.0 110.736 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -65.05 -50.89 64.44 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.76 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -23.67 65.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.417 1.008 . . . . 0.0 111.592 -172.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.6 mt -75.16 -57.11 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.284 1.034 . . . . 0.0 109.337 169.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -63.95 -31.32 72.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 123.244 1.497 . . . . 0.0 112.1 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.33 -1.8 25.4 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 126.29 1.836 . . . . 0.0 112.914 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -127.36 -0.03 6.33 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 126.763 2.025 . . . . 0.0 111.931 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.25 1.096 0 C-N-CA 124.92 1.288 . . . . 0.0 109.664 -172.881 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.42 ' CE1' ' HG2' ' A' ' 4' ' ' MET 0.267 2.0 p-80 . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.42 ' HG2' ' CE1' ' A' ' 3' ' ' HIS . 6.6 mmt -51.67 -44.9 63.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.182 1.393 . . . . 0.0 110.627 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.43 -28.15 68.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.995 1.318 . . . . 0.0 112.033 -170.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.4 t -76.18 -39.14 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -89.81 -11.71 41.27 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.874 1.27 . . . . 0.0 112.968 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.96 -20.27 64.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.931 0.892 . . . . 0.0 111.795 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.62 -16.57 51.09 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.567 1.147 . . . . 0.0 112.741 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -81.41 -49.45 10.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.739 1.616 . . . . 0.0 107.008 167.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.485 HD12 ' HE ' ' A' ' 20' ' ' ARG . 1.6 mm? -47.98 -49.58 30.22 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.788 1.235 . . . . 0.0 112.553 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -51.09 -34.97 32.66 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.646 0.778 . . . . 0.0 111.79 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.96 -1.09 80.27 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.7 -1.055 . . . . 0.0 113.23 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.0 mt -74.71 117.81 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 119.537 1.669 . . . . 0.0 106.983 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.81 -1.74 58.01 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.996 0.918 . . . . 0.0 112.73 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.07 79.64 8.57 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.005 1.722 . . . . 0.0 111.149 -176.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.92 -20.44 64.29 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 124.128 3.219 . . . . 0.0 114.428 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -7.91 51.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.018 0.826 . . . . 0.0 111.914 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -134.73 -2.75 2.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.271 0.628 . . . . 0.0 112.192 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.485 ' HE ' HD12 ' A' ' 11' ' ' LEU . 62.4 ttt180 -60.31 -64.62 0.89 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 127.226 2.21 . . . . 0.0 111.073 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -53.71 -32.46 51.98 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 125.65 1.58 . . . . 0.0 111.228 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -56.39 -33.59 65.89 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.188 -0.945 . . . . 0.0 113.468 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 m -69.48 -41.67 75.85 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.552 0.741 . . . . 0.0 109.548 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -65.06 -33.66 76.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.062 1.345 . . . . 0.0 111.27 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -58.66 -48.54 80.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.6 mt -62.64 -47.94 90.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.094 0.957 . . . . 0.0 109.67 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.9 mt -51.57 -65.8 0.49 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.896 0.878 . . . . 0.0 109.816 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -66.46 -30.47 70.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.171 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -60.7 -35.71 76.97 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 118.985 0.811 . . . . 0.0 110.661 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.452 HG21 ' CE2' ' A' ' 48' ' ' PHE . 34.3 m -74.65 -45.69 44.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 C-N-CA 117.045 -1.862 . . . . 0.0 106.681 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.71 -13.92 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.777 -0.63 . . . . 0.0 112.473 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.95 -68.08 0.74 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 123.389 0.676 . . . . 0.0 111.473 159.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.458 ' CG2' ' HE3' ' A' ' 107' ' ' LYS . 9.6 m -73.6 -41.64 62.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.907 0.883 . . . . 0.0 111.879 -163.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.454 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -115.08 72.39 3.04 Favored Pre-proline 0 N--CA 1.44 -0.927 0 C-N-CA 129.045 2.938 . . . . 0.0 108.748 175.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.57 -9.65 21.49 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.324 2.683 . . . . 0.0 111.942 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -38.88 90.99 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.874 1.669 . . . . 0.0 112.318 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.651 HD22 ' H ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -79.09 145.17 33.93 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -172.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -110.98 150.27 41.65 Favored Pre-proline 0 C--N 1.319 -0.743 0 C-N-CA 124.628 1.171 . . . . 0.0 108.26 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.65 139.77 37.89 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.614 2.209 . . . . 0.0 109.764 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -154.03 102.52 2.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.477 ' HE3' ' HA ' ' A' ' 44' ' ' ASN . 53.5 mmm -70.65 105.04 3.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 167.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -110.33 143.0 41.2 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.5 m95 54.51 18.85 2.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.477 ' HA ' ' HE3' ' A' ' 41' ' ' MET . 3.0 t-20 62.44 31.38 17.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.211 1.404 . . . . 0.0 110.943 -170.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.8 p -128.97 147.07 63.24 Favored Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 120.951 -1.093 . . . . 0.0 109.246 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -73.37 129.76 14.26 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.828 3.019 . . . . 0.0 112.717 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.24 165.46 36.31 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.461 1.104 . . . . 0.0 109.138 172.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 30' ' ' VAL . 1.3 m-85 -126.56 163.88 22.42 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.444 0.64 . . . . 0.0 109.918 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.8 m -136.52 119.85 16.83 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -77.14 89.72 3.64 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 50.48 51.17 17.38 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.944 0.878 . . . . 0.0 109.291 -171.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.56 -0.43 56.8 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 117.319 1.688 . . . . 0.0 117.319 171.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -165.92 1.1 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.667 2.734 . . . . 0.0 111.975 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -127.2 12.09 7.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.723 1.609 . . . . 0.0 112.748 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 55' ' ' ILE . 33.6 mt -64.51 5.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.629 1.972 . . . . 0.0 113.816 -163.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.6 tt -160.93 132.48 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 118.709 -2.494 . . . . 0.0 110.608 174.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.53 157.42 29.36 Favored Glycine 0 C--N 1.339 0.718 0 O-C-N 122.094 -0.379 . . . . 0.0 112.662 171.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -155.84 168.56 26.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.871 0.868 . . . . 0.0 111.729 -176.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.79 158.01 22.22 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 120.611 -1.305 . . . . 0.0 110.393 170.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.6 p -77.29 113.04 14.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.007 0.923 . . . . 0.0 110.232 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.8 t -90.35 168.03 12.2 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.21 -29.79 6.14 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.304 1.442 . . . . 0.0 113.97 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -145.92 10.69 1.19 Allowed 'General case' 0 C--O 1.238 0.469 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -158.07 159.04 35.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.634 0.773 . . . . 0.0 109.268 -173.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.533 HD23 ' H ' ' A' ' 66' ' ' SER . 0.6 OUTLIER -85.4 165.45 17.2 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 158.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.533 ' H ' HD23 ' A' ' 65' ' ' LEU . 92.2 p -141.65 131.65 24.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.3 t -146.1 140.54 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.509 1.05 . . . . 0.0 109.274 -168.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 t -163.78 164.34 14.99 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.928 1.291 . . . . 0.0 108.394 165.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -78.98 -58.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 CA-C-N 119.433 0.833 . . . . 0.0 112.357 165.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -154.87 -85.8 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -138.23 -44.61 0.51 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.235 1.014 . . . . 0.0 111.568 -173.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.5 tt -55.15 -31.85 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.106 0.963 . . . . 0.0 113.102 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.66 -28.49 5.19 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.075 1.798 . . . . 0.0 113.162 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.2 mm -113.24 -5.52 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 117.918 0.859 . . . . 0.0 111.188 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.5 m -76.23 -78.13 0.12 Allowed 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.898 -1.126 . . . . 0.0 109.955 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -86.71 -47.23 9.31 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -68.07 -20.15 64.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.172 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.26 -30.65 51.31 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.756 1.162 . . . . 0.0 112.987 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.34 -48.63 80.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.255 1.422 . . . . 0.0 109.508 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.85 -29.9 62.37 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.58 0.752 . . . . 0.0 111.307 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.49 -45.49 97.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.254 1.021 . . . . 0.0 108.526 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.17 -46.47 88.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.04 0.936 . . . . 0.0 110.338 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -54.03 -42.35 69.05 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.792 1.237 . . . . 0.0 110.839 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.15 8.34 9.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.48 34.96 30.55 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 119.538 1.063 . . . . 0.0 113.653 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -123.71 169.18 11.76 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.145 0.978 . . . . 0.0 109.486 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 m -135.94 106.82 6.63 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.353 1.061 . . . . 0.0 111.059 -171.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.24 170.53 4.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.519 0.728 . . . . 0.0 112.285 168.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.4 p -128.93 -179.96 5.39 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.709 2.403 . . . . 0.0 107.186 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.82 62.98 6.69 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 120.393 -1.442 . . . . 0.0 110.15 -177.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.26 -59.03 0.1 OUTLIER Glycine 0 CA--C 1.498 -0.972 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -171.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 66' ' ' SER . 1.5 pt? -157.6 177.28 11.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.447 -1.377 . . . . 0.0 110.573 -165.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -110.89 158.41 18.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 167.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -144.11 136.76 26.98 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.747 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.6 mm -117.29 142.75 30.68 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -169.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.46 154.6 60.5 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.87 1.713 . . . . 0.0 110.597 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -62.48 -21.89 65.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 172.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.59 -70.6 0.22 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.037 1.735 . . . . 0.0 111.405 172.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.72 153.34 43.81 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.348 0.659 . . . . 0.0 111.353 -161.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.21 -178.73 4.63 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.767 2.978 . . . . 0.0 113.599 -164.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.96 146.35 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 125.716 1.606 . . . . 0.0 110.43 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.99 119.54 35.66 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.28 1.432 . . . . 0.0 109.924 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -87.1 -18.08 31.33 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 123.273 0.629 . . . . 0.0 111.742 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.26 -58.98 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.304 1.042 . . . . 0.0 110.821 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.65 -48.88 79.92 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.62 -56.74 4.84 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.614 1.966 . . . . 0.0 109.933 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.458 ' HE3' ' CG2' ' A' ' 33' ' ' THR . 22.9 tttt -60.99 -45.01 96.54 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.124 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -58.5 -53.69 55.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.416 1.007 . . . . 0.0 110.155 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -75.56 6.87 4.2 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.9 -52.1 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 120.199 1.363 . . . . 0.0 107.831 173.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.425 ' OE1' ' HE2' ' A' ' 107' ' ' LYS . 42.6 mt-10 -60.91 -40.71 94.18 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 119.227 0.921 . . . . 0.0 111.464 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -61.78 -48.52 80.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -32.02 73.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.959 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.486 HD11 HD21 ' A' ' 37' ' ' LEU . 71.9 mt -58.9 -63.85 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.096 1.359 . . . . 0.0 109.123 165.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -69.55 -5.93 27.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.618 1.099 . . . . 0.0 113.317 -170.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -78.58 -50.16 12.02 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.403 1.881 . . . . 0.0 111.462 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -85.8 22.92 1.54 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.899 1.679 . . . . 0.0 111.873 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.253 1.246 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 169.167 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 . . . . . 0 N--CA 1.467 0.396 0 CA-C-O 119.483 -0.294 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 mmt -58.13 -19.17 30.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.714 0.806 . . . . 0.0 113.008 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -69.07 -43.65 74.15 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 121.36 -0.837 . . . . 0.0 110.169 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.69 -50.42 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.908 0.883 . . . . 0.0 109.011 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.1 4.41 52.24 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.869 0.868 . . . . 0.0 112.14 -166.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.12 79.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.062 0.945 . . . . 0.0 109.989 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.91 -21.01 64.25 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.124 0.97 . . . . 0.0 112.602 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -79.45 -56.4 4.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.479 0.711 . . . . 0.0 109.22 173.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -55.76 -40.62 72.84 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.427 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -52.06 -38.95 58.83 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.689 0.677 . . . . 0.0 111.247 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.84 -7.37 78.21 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-O 118.487 -1.174 . . . . 0.0 112.534 -166.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -70.54 119.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.8 1.02 56.56 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.953 1.301 . . . . 0.0 111.688 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.33 65.81 1.52 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.732 2.413 . . . . 0.0 109.837 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.46 -30.63 93.07 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 124.087 3.191 . . . . 0.0 113.807 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -59.16 -11.32 3.65 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.844 1.258 . . . . 0.0 113.287 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -126.48 -13.85 5.93 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.302 1.841 . . . . 0.0 110.04 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -66.32 -45.98 78.43 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.627 1.171 . . . . 0.0 110.14 -176.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.66 -33.56 64.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.826 1.25 . . . . 0.0 112.776 -171.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -56.67 -39.98 74.72 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.672 -0.643 . . . . 0.0 111.257 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.1 m -69.42 -39.08 78.09 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.195 1.398 . . . . 0.0 109.294 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -63.09 -45.28 92.85 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.04 -1.038 . . . . 0.0 111.815 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -53.85 -51.71 62.72 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 126.076 1.75 . . . . 0.0 108.984 176.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.6 mt -52.4 -56.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.797 1.639 . . . . 0.0 110.453 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.5 mt -53.35 -53.71 47.07 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.59 0.632 . . . . 0.0 110.197 -174.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.1 m -69.07 -31.98 71.11 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.578 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -63.22 -50.16 71.35 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 124.638 1.175 . . . . 0.0 110.506 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 87.3 t -59.93 -52.03 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.17 -1.46 4.43 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.72 -56.3 2.2 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 120.781 -1.199 . . . . 0.0 109.336 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -67.04 -33.58 75.85 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.734 2.013 . . . . 0.0 111.987 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.518 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -129.86 72.59 81.9 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -178.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.16 -6.73 17.55 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.108 1.872 . . . . 0.0 112.727 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -63.56 -45.8 88.82 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.686 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.602 HD22 ' H ' ' A' ' 37' ' ' LEU . 2.8 mm? -60.35 147.32 41.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.055 0.942 . . . . 0.0 108.955 -171.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -104.64 144.97 29.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 124.234 1.014 . . . . 0.0 108.879 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.79 161.29 46.12 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.497 2.131 . . . . 0.0 111.24 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -158.64 130.27 6.55 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.211 1.404 . . . . 0.0 107.681 161.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.17 112.48 17.53 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.551 1.069 . . . . 0.0 108.334 162.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -123.21 128.33 49.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.645 1.178 . . . . 0.0 108.242 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.9 m95 53.29 25.97 4.86 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.809 0.844 . . . . 0.0 113.062 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.59 29.02 18.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.502 1.121 . . . . 0.0 110.18 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -121.12 147.38 46.56 Favored Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -71.96 133.35 21.45 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.711 2.274 . . . . 0.0 111.758 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.0 ptm -147.28 173.3 12.7 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.804 0.442 . . . . 0.0 110.925 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.48 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -134.05 152.71 51.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.1 p -122.76 138.74 54.54 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.306 1.442 . . . . 0.0 108.006 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -88.35 95.27 10.13 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 163.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 66.78 -13.39 0.19 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.945 1.698 . . . . 0.0 114.046 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.61 -19.63 0.04 OUTLIER Glycine 0 CA--C 1.54 1.646 0 C-N-CA 127.044 2.259 . . . . 0.0 113.887 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.44 -171.05 1.68 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -165.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -125.31 24.99 7.25 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.442 2.297 . . . . 0.0 111.786 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.744 HG23 HD22 ' A' ' 113' ' ' ASN . 97.1 mt -68.65 -2.41 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 126.648 1.979 . . . . 0.0 113.515 -167.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 tt -160.68 145.86 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 119.357 -2.09 . . . . 0.0 109.692 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.13 148.81 11.53 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 165.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -144.1 166.09 25.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.849 0.825 . . . . 0.0 109.944 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 t -150.51 145.42 25.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 57.5 p -62.51 145.86 53.15 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.478 ' HB2' ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -127.75 174.59 8.99 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -59.59 -39.24 83.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.377 -162.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -138.6 14.27 2.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.199 1.0 . . . . 0.0 113.079 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.478 ' CD2' ' HB2' ' A' ' 61' ' ' SER . 3.9 p-80 -150.64 176.74 10.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.962 1.305 . . . . 0.0 108.794 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.27 161.88 14.39 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 166.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.35 114.96 24.31 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.127 1.371 . . . . 0.0 108.63 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.9 136.36 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.3 0.955 . . . . 0.0 109.434 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 t -165.68 161.82 13.37 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 125.261 1.424 . . . . 0.0 107.621 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.51 -57.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.131 0 CA-C-N 120.434 1.191 . . . . 0.0 110.998 157.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -149.55 -85.91 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -133.2 -38.85 0.94 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.444 1.498 . . . . 0.0 111.796 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.7 tp -53.76 -38.09 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.67 1.188 . . . . 0.0 112.981 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.42 -21.87 14.33 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.468 1.509 . . . . 0.0 112.835 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.7 mm -119.93 -5.3 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.437 1.495 . . . . 0.0 110.561 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.2 m -95.06 -64.04 1.11 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 168.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -76.62 -66.52 0.8 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -72.48 -6.24 42.38 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.5 -164.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.32 49.24 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 118.238 -0.887 . . . . 0.0 112.545 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -62.75 -47.54 83.11 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.101 0.864 . . . . 0.0 109.82 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.626 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -78.89 -22.8 45.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.755 0.822 . . . . 0.0 110.977 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.92 -46.98 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.004 0.921 . . . . 0.0 108.935 164.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.83 88.52 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.503 1.121 . . . . 0.0 111.088 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -63.07 -15.64 57.23 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 126.868 2.067 . . . . 0.0 112.894 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.6 -15.35 42.84 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 118.475 0.579 . . . . 0.0 111.623 172.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.96 -22.24 19.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.754 2.121 . . . . 0.0 112.879 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -74.17 114.7 12.82 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.236 1.014 . . . . 0.0 110.191 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.1 m -75.11 4.76 6.25 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 48.21 -155.71 0.07 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.798 2.439 . . . . 0.0 112.026 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.0 p -126.4 -164.7 1.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.549 2.34 . . . . 0.0 105.732 163.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -71.73 -33.0 68.34 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.109 1.322 . . . . 0.0 111.515 172.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.56 -10.56 2.92 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 114.479 0.552 . . . . 0.0 114.479 -160.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 pp -149.6 175.88 11.14 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.646 1.178 . . . . 0.0 109.675 168.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -113.26 157.4 21.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.651 0.66 . . . . 0.0 109.546 167.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.1 mtt85 -128.23 155.18 44.96 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -137.28 142.56 38.16 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 178.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.88 155.09 23.3 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.985 1.79 . . . . 0.0 109.343 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -63.81 -17.73 63.4 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -67.0 -45.15 78.46 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.17 0.988 . . . . 0.0 112.086 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.7 156.12 45.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 122.882 0.473 . . . . 0.0 110.982 -157.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.33 165.93 29.98 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.513 2.142 . . . . 0.0 112.911 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.32 124.86 51.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -75.81 78.58 2.74 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.284 1.04 . . . . 0.0 113.148 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -59.62 -37.22 78.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.842 0.857 . . . . 0.0 112.351 173.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.59 -46.8 71.56 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 120.148 1.34 . . . . 0.0 110.437 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.626 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -68.38 -47.5 67.2 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.435 -0.791 . . . . 0.0 109.289 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.279 0.3 OUTLIER -72.55 -27.07 61.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.339 -175.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -54.33 -52.63 60.94 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.382 0.992 . . . . 0.0 109.591 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -56.73 -52.34 65.37 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.056 -170.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.8 ptp -65.46 -34.63 78.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.025 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -53.01 21.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.988 1.267 . . . . 0.0 109.002 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.63 -50.7 59.77 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -55.66 -52.8 62.6 Favored 'General case' 0 N--CA 1.441 -0.905 0 O-C-N 124.016 0.823 . . . . 0.0 111.068 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.744 HD22 HG23 ' A' ' 55' ' ' ILE . 13.4 t30 -63.67 -22.28 66.82 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.351 0.978 . . . . 0.0 112.844 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.2 mt -71.65 -57.47 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.943 0.897 . . . . 0.0 108.636 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -74.95 -5.93 46.53 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -75.1 -19.86 59.74 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.529 0.731 . . . . 0.0 110.383 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -101.69 16.69 25.0 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.792 2.437 . . . . 0.0 111.071 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 117.351 -1.309 . . . . 0.0 108.198 172.27 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.433 ' CE1' ' HG2' ' A' ' 4' ' ' MET 0.256 2.8 p-80 . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.433 ' HG2' ' CE1' ' A' ' 3' ' ' HIS . 3.4 mmt -55.91 -31.04 62.53 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 119.892 1.224 . . . . 0.0 111.26 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.451 ' H ' ' HG3' ' A' ' 5' ' ' GLU . 1.1 pp20? -53.11 -48.14 68.06 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.519 0.728 . . . . 0.0 111.475 175.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.31 -43.74 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 121.643 -0.661 . . . . 0.0 109.652 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -103.63 50.14 0.81 Allowed 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.156 0.983 . . . . 0.0 111.236 -171.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -126.2 -27.05 3.28 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.682 0.793 . . . . 0.0 110.374 168.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.401 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 50.1 mt-10 -75.83 -12.91 60.26 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.112 -0.993 . . . . 0.0 112.436 -173.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -78.85 -48.77 14.07 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.397 1.479 . . . . 0.0 109.029 163.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -60.2 -22.98 63.63 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.713 2.405 . . . . 0.0 112.923 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 9' ' ' GLU . 51.7 pttt -61.01 -44.13 97.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.741 1.155 . . . . 0.0 109.475 173.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.96 10.23 51.73 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.609 1.1 . . . . 0.0 114.907 -164.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.467 HD12 HG21 ' A' ' 60' ' ' THR . 4.6 mm -58.42 123.94 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.072 1.349 . . . . 0.0 108.254 174.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -56.94 -36.02 69.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.753 1.221 . . . . 0.0 113.107 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -116.78 85.95 18.24 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 126.521 1.929 . . . . 0.0 110.928 -168.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.07 -23.62 75.82 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.305 2.003 . . . . 0.0 111.828 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 23.6 m-20 -65.9 -16.9 64.27 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.306 -0.871 . . . . 0.0 111.888 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 0.8 OUTLIER -128.85 -0.53 5.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.338 1.455 . . . . 0.0 110.763 179.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.9 ttp85 -53.96 -57.45 10.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.142 0.977 . . . . 0.0 109.484 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -48.31 -35.07 11.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.549 1.54 . . . . 0.0 112.39 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -60.63 -39.09 86.97 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.318 -1.489 . . . . 0.0 111.824 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.8 m -63.42 -49.78 72.41 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.675 0.79 . . . . 0.0 109.397 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.53 -30.63 61.08 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.567 1.547 . . . . 0.0 113.33 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.03 -58.94 6.38 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 118.775 0.716 . . . . 0.0 110.297 173.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 mt -57.66 -38.86 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 123.875 0.87 . . . . 0.0 110.415 -173.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.2 mt -56.33 -62.66 1.56 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.157 0.983 . . . . 0.0 110.189 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -64.25 -31.66 72.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -62.24 -43.33 99.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 117.493 -1.241 . . . . 0.0 110.876 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.25 -40.56 80.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.763 0 C-N-CA 116.92 -1.912 . . . . 0.0 107.37 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.96 -25.36 8.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 117.748 -1.12 . . . . 0.0 112.529 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.17 -27.65 14.46 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.471 HG21 ' HE3' ' A' ' 107' ' ' LYS . 7.3 m -94.82 -40.18 9.87 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.645 1.111 . . . . 0.0 111.251 -174.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.451 ' CE1' HG22 ' A' ' 33' ' ' THR . 2.6 m-85 -120.28 58.44 5.91 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 129.575 3.15 . . . . 0.0 111.823 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.08 -13.92 38.38 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.834 2.356 . . . . 0.0 113.722 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.29 -23.67 66.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.165 1.386 . . . . 0.0 112.427 172.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.87 145.58 44.74 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -117.59 150.47 46.83 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 126.964 2.106 . . . . 0.0 108.444 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.27 140.28 13.7 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.872 2.381 . . . . 0.0 111.67 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -164.85 96.49 0.73 Allowed 'General case' 0 C--N 1.346 0.439 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 ptm -70.21 136.39 49.96 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.422 1.01 . . . . 0.0 108.886 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -150.52 155.32 39.25 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.9 m95 52.71 33.37 13.78 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.563 1.145 . . . . 0.0 113.06 -174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 61.78 18.84 10.06 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.207 1.803 . . . . 0.0 112.476 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.0 p -129.49 155.97 79.33 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.92 1.288 . . . . 0.0 110.007 -173.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.81 120.75 5.93 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.968 3.112 . . . . 0.0 110.235 170.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.5 ptm -135.01 162.52 32.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 163.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.93 168.28 14.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 p -134.19 121.63 21.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.144 0.578 . . . . 0.0 109.56 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -68.46 92.9 0.46 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 169.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 53.58 28.67 8.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.478 1.111 . . . . 0.0 111.882 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.3 -17.81 7.89 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 125.636 1.589 . . . . 0.0 115.642 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.6 m -79.32 -179.13 6.59 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 119.799 1.8 . . . . 0.0 111.242 -173.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.548 ' H ' HG22 ' A' ' 53' ' ' THR . 61.6 t80 -111.09 18.25 19.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.462 1.905 . . . . 0.0 113.554 -168.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.67 12.51 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.849 1.66 . . . . 0.0 112.495 -163.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 tt -163.31 146.28 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 119.558 -1.964 . . . . 0.0 111.249 174.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.48 151.03 18.21 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 166.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.421 ' CD2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -153.17 -179.89 8.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.417 0.687 . . . . 0.0 111.078 175.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t 178.79 147.1 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 14' ' ' ILE . 81.4 p -62.86 146.91 51.66 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.302 0.641 . . . . 0.0 110.504 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -126.74 165.18 19.74 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -12.51 18.2 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.52 8.29 0.38 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.485 1.039 . . . . 0.0 112.245 176.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -162.49 -179.88 7.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.869 1.668 . . . . 0.0 108.645 -164.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.522 HD22 ' H ' ' A' ' 66' ' ' SER . 1.8 tm? -127.67 154.22 45.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.801 2.041 . . . . 0.0 107.012 174.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.625 ' HB2' HD22 ' A' ' 92' ' ' LEU . 3.8 p -132.07 122.82 26.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.761 1.624 . . . . 0.0 108.954 -173.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG13 ' CE1' ' A' ' 93' ' ' PHE . 1.6 p -144.78 145.45 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.882 1.219 . . . . 0.0 111.663 -171.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.545 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 13.7 t -160.0 165.03 18.59 Favored Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 125.59 1.556 . . . . 0.0 109.581 169.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -81.49 -57.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.444 2.096 . . . . 0.0 112.936 156.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -149.17 -86.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.122 1.769 . . . . 0.0 106.964 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -152.47 -27.32 0.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.651 1.18 . . . . 0.0 112.55 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.8 tt -62.71 -40.16 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 120.576 1.534 . . . . 0.0 109.891 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.96 -10.91 15.89 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.002 1.286 . . . . 0.0 113.104 173.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 68' ' ' SER . 5.3 mm -117.03 -0.57 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.734 2.014 . . . . 0.0 110.025 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 m -125.62 -50.54 1.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.488 0.585 . . . . 0.0 111.844 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -79.67 -57.42 3.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.987 1.715 . . . . 0.0 107.443 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -73.46 -0.76 15.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.261 1.024 . . . . 0.0 112.5 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.25 -25.47 67.85 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.477 1.911 . . . . 0.0 112.701 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -79.07 -48.02 15.12 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.557 0.743 . . . . 0.0 109.028 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.28 87.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.552 0.741 . . . . 0.0 110.834 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.85 -50.33 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.053 0.941 . . . . 0.0 109.839 171.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.53 -50.58 73.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.97 0.908 . . . . 0.0 111.368 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -60.06 -25.74 65.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.655 1.582 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.41 -27.14 63.1 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.175 0.443 . . . . 0.0 110.854 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 122.61 6.21 8.06 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.466 1.508 . . . . 0.0 113.431 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.07 122.23 44.23 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.459 1.63 . . . . 0.0 110.005 -173.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.43 3.83 12.41 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -170.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 46.52 -168.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.962 2.105 . . . . 0.0 113.277 -172.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.3 p -141.67 -164.7 1.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.347 2.259 . . . . 0.0 108.092 168.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 5.26 13.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.16 2.184 . . . . 0.0 112.047 173.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.5 -7.94 0.03 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 116.667 1.427 . . . . 0.0 116.667 -172.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 66' ' ' SER . 2.9 pp -149.29 170.71 17.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.112 1.456 . . . . 0.0 108.607 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.425 ' CE1' HG13 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -116.22 125.83 52.78 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 164.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -72.37 134.75 45.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.494 170.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.6 mm -125.72 143.71 45.96 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 165.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.68 163.68 38.15 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.154 1.903 . . . . 0.0 110.159 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -70.49 -35.12 73.07 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 171.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -67.76 -59.95 2.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.218 0.533 . . . . 0.0 110.469 -174.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.22 162.83 65.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.48 1.912 . . . . 0.0 109.455 -172.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.15 165.61 25.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.587 1.525 . . . . 0.0 113.391 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.0 t -93.44 134.91 29.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 126.413 1.885 . . . . 0.0 106.719 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.41 76.35 3.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.328 1.451 . . . . 0.0 110.721 171.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -56.47 -44.25 80.38 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.028 0.931 . . . . 0.0 110.461 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -65.18 -26.2 68.05 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.778 0.831 . . . . 0.0 111.749 -174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.96 -53.92 6.56 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.277 0.3 OUTLIER -58.72 -24.87 62.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.77 1.228 . . . . 0.0 112.022 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.471 ' HE3' HG21 ' A' ' 33' ' ' THR . 16.1 tttt -65.52 -54.0 34.4 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.785 2.034 . . . . 0.0 113.252 169.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -57.81 -46.42 84.71 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.877 1.217 . . . . 0.0 111.192 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.0 ptp -66.35 -32.21 73.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.307 -0.854 . . . . 0.0 113.226 -175.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -44.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.195 0.907 . . . . 0.0 108.987 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.08 -43.75 98.15 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.639 0.775 . . . . 0.0 110.717 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.425 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 5.1 t80 -58.26 -48.06 81.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.458 175.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -59.1 -40.47 85.39 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 118.161 0.437 . . . . 0.0 110.383 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.85 -52.06 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 O-C-N 121.319 -0.863 . . . . 0.0 110.084 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 112' ' ' PHE . 17.6 pt20 -71.56 -4.92 29.6 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 120.27 1.396 . . . . 0.0 112.413 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -93.78 2.57 56.2 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.658 1.983 . . . . 0.0 112.281 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -129.38 19.35 5.8 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.317 1.447 . . . . 0.0 111.216 -174.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 124.282 1.033 . . . . 0.0 109.586 175.71 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.2 mmt -60.1 -30.4 69.22 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.652 -0.655 . . . . 0.0 112.534 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.73 -43.85 71.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.57 -44.98 99.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.61 1.164 . . . . 0.0 109.917 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.43 0.05 55.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.953 0.501 . . . . 0.0 112.118 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.54 67.93 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.786 1.235 . . . . 0.0 109.46 173.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.33 -13.36 62.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.273 1.429 . . . . 0.0 113.526 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -82.67 -59.6 2.46 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -55.96 -44.32 78.36 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.821 1.248 . . . . 0.0 110.811 -175.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -56.36 -32.55 64.83 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.424 0.69 . . . . 0.0 112.471 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.0 -22.73 57.09 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 119.251 -0.749 . . . . 0.0 111.379 -171.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.5 mt -74.84 98.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -66.58 -2.83 5.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.227 1.411 . . . . 0.0 113.437 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -100.01 84.97 0.46 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 128.662 2.785 . . . . 0.0 110.978 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.79 -36.79 82.62 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.533 2.155 . . . . 0.0 112.295 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.88 5.79 2.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.013 0.824 . . . . 0.0 112.476 -170.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -137.13 -36.77 0.66 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.395 1.878 . . . . 0.0 110.425 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -52.78 -40.37 63.12 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.85 0.86 . . . . 0.0 110.889 171.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.93 -22.72 60.41 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.616 1.166 . . . . 0.0 112.362 -176.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -81.99 -31.54 31.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.1 0.864 . . . . 0.0 111.853 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.2 m -72.94 -39.69 66.02 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.157 0.983 . . . . 0.0 110.492 -175.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HB3' HD21 ' A' ' 11' ' ' LEU . 3.0 pt-20 -63.19 -26.04 68.62 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.731 0.412 . . . . 0.0 111.906 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.46 -54.65 44.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.835 0.854 . . . . 0.0 110.142 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.9 mp -63.83 -40.59 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -174.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.1 mt -52.92 -53.89 42.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.236 0.614 . . . . 0.0 110.101 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -62.47 -44.45 96.37 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.528 1.131 . . . . 0.0 111.228 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.8 t90 -59.04 -44.31 91.77 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.502 1.121 . . . . 0.0 111.664 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.832 HG11 ' CE2' ' A' ' 48' ' ' PHE . 40.9 t -63.25 -46.16 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.306 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.25 -12.7 21.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.493 1.042 . . . . 0.0 113.452 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.49 -48.59 7.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.348 164.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 m -78.83 -34.47 45.18 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 117.431 -1.271 . . . . 0.0 111.314 -163.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.602 ' HD2' HG13 ' A' ' 30' ' ' VAL . 1.5 m-85 -117.47 76.17 9.56 Favored Pre-proline 0 C--N 1.344 0.333 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.23 -14.04 39.43 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.665 2.243 . . . . 0.0 113.338 -172.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -20.83 59.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.528 0.731 . . . . 0.0 111.658 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.481 HD11 ' CD1' ' A' ' 114' ' ' ILE . 2.7 mp -70.29 151.16 45.6 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.564 1.546 . . . . 0.0 109.085 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -122.93 143.02 39.48 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 113.032 -1.895 . . . . 0.0 108.738 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.54 154.21 35.22 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.19 2.593 . . . . 0.0 110.488 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -176.95 102.58 0.05 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.155 1.782 . . . . 0.0 106.26 171.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 62.2 mmm -60.63 129.95 44.11 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -134.58 138.96 45.01 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.0 m95 58.76 19.77 7.22 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m120 64.03 12.18 6.73 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 126.578 1.951 . . . . 0.0 113.101 -166.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.0 p -114.51 112.54 45.86 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 120.356 1.435 . . . . 0.0 108.169 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.05 132.83 33.34 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.927 2.418 . . . . 0.0 111.648 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 ptm -143.26 159.19 42.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.832 ' CE2' HG11 ' A' ' 30' ' ' VAL . 1.2 m-85 -123.94 109.29 13.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.6 p -73.24 120.82 19.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -67.12 98.33 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 163.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 50.68 -4.64 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 130.207 3.403 . . . . 0.0 117.617 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.44 25.24 0.09 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.76 1.648 . . . . 0.0 113.028 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -117.0 177.32 4.75 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.184 1.394 . . . . 0.0 108.481 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -120.68 25.99 9.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.731 1.612 . . . . 0.0 110.777 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.78 19.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 125.234 1.413 . . . . 0.0 111.552 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.471 ' CG2' ' H ' ' A' ' 48' ' ' PHE . 1.1 tt -165.72 162.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 119.684 -1.885 . . . . 0.0 109.16 166.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.51 91.62 0.08 OUTLIER Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 159.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.509 ' CD2' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -90.98 162.47 14.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.532 0.666 . . . . 0.0 110.897 -175.428 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.0 t -152.92 155.39 36.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.992 0.901 . . . . 0.0 110.399 164.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.6 p -72.8 156.33 39.02 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.185 2.194 . . . . 0.0 109.787 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.28 -179.04 5.43 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.916 1.286 . . . . 0.0 109.739 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -49.66 -59.84 3.43 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 125.085 1.354 . . . . 0.0 111.824 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -132.32 15.31 4.57 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.255 1.022 . . . . 0.0 111.184 -174.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -152.08 173.64 14.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.824 1.249 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.528 HD12 ' H ' ' A' ' 66' ' ' SER . 33.7 tp -111.79 157.87 20.04 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.715 1.606 . . . . 0.0 108.131 170.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.528 ' H ' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -135.51 111.62 9.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.277 1.431 . . . . 0.0 110.281 -171.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG13 ' CZ ' ' A' ' 93' ' ' PHE . 1.5 p -142.15 151.36 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.702 1.601 . . . . 0.0 113.876 -167.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 1.4 t -174.83 165.16 2.29 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.136 2.575 . . . . 0.0 109.422 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.99 -55.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 124.327 3.351 . . . . 0.0 112.956 164.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -156.12 -74.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.776 2.03 . . . . 0.0 108.401 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -156.1 -46.75 0.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.861 1.665 . . . . 0.0 110.722 -168.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 tp -55.96 -42.42 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.516 1.053 . . . . 0.0 110.845 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.13 -16.04 24.62 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.075 0.845 . . . . 0.0 114.178 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.476 HG21 ' H ' ' A' ' 91' ' ' GLY . 34.4 mm -115.9 -6.88 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.032 1.733 . . . . 0.0 110.131 -176.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.8 m -100.95 -61.22 1.4 Allowed 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 121.569 -0.707 . . . . 0.0 109.881 172.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -82.61 -39.97 21.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.889 2.476 . . . . 0.0 109.597 -172.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -99.38 -8.21 25.13 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' A' ' 81' ' ' ILE . . . -61.56 -29.78 70.24 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.896 0.771 . . . . 0.0 112.496 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.64 -51.23 70.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.791 0.805 . . . . 0.0 109.483 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.57 -28.87 66.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.416 1.486 . . . . 0.0 111.359 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 78' ' ' ALA . 77.9 mt -64.91 -48.82 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 123.76 0.824 . . . . 0.0 108.976 168.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.59 79.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.203 0.525 . . . . 0.0 110.403 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.2 -24.67 67.35 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.991 0.917 . . . . 0.0 112.197 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.57 -4.24 41.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.494 0.588 . . . . 0.0 112.344 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.01 29.21 10.66 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 121.243 -0.911 . . . . 0.0 112.817 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -126.01 -179.99 4.95 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.468 1.134 . . . . 0.0 111.377 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.23 158.84 34.62 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.249 1.819 . . . . 0.0 111.034 -172.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.35 169.83 17.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.495 1.518 . . . . 0.0 110.917 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.2 p -136.47 -163.79 1.46 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 127.857 2.463 . . . . 0.0 107.956 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -94.78 77.03 3.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 166.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.476 ' H ' HG21 ' A' ' 74' ' ' ILE . . . 127.14 6.6 5.28 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.726 166.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 0.3 OUTLIER -160.9 159.44 29.69 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.948 1.374 . . . . 0.0 110.706 169.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CZ ' HG13 ' A' ' 67' ' ' VAL . 27.1 p90 -117.84 156.76 27.81 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.927 0.891 . . . . 0.0 108.693 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.99 120.11 30.63 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.996 0.919 . . . . 0.0 108.642 -161.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.0 mm -119.61 142.86 33.6 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.51 155.49 31.92 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.785 1.657 . . . . 0.0 109.385 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -57.85 -15.16 7.56 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 170.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.22 -45.92 65.58 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.379 1.471 . . . . 0.0 113.343 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.97 161.92 21.34 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 123.642 0.777 . . . . 0.0 110.227 -163.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -66.23 154.2 75.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.734 2.29 . . . . 0.0 110.899 172.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.3 t -85.98 132.38 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -73.58 81.62 1.5 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.488 1.515 . . . . 0.0 110.365 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -50.55 -48.17 57.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.728 1.211 . . . . 0.0 110.051 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.44 -46.94 66.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 123.433 0.458 . . . . 0.0 111.286 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.6 -47.51 47.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 119.507 1.049 . . . . 0.0 109.886 -171.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -27.0 66.81 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.591 0.757 . . . . 0.0 110.618 174.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -65.99 -59.5 3.76 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.296 1.438 . . . . 0.0 110.187 172.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -61.32 -38.63 87.55 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.698 0.681 . . . . 0.0 109.677 -170.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.8 ptp -72.25 -17.83 61.86 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.63 -53.18 8.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 121.088 1.767 . . . . 0.0 109.176 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.83 -46.67 42.38 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 125.545 1.538 . . . . 0.0 109.128 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 16.9 t80 -49.56 -41.08 40.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.27 -0.871 . . . . 0.0 113.195 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -29.04 42.65 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 120.33 1.423 . . . . 0.0 109.325 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' HD11 ' A' ' 37' ' ' LEU . 7.2 mt -78.09 -25.94 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 120.711 -1.243 . . . . 0.0 110.202 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 112' ' ' PHE . 16.6 pt20 -84.32 -2.59 57.3 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.278 1.399 . . . . 0.0 112.165 166.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -92.57 -38.07 12.11 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.278 0.561 . . . . 0.0 110.975 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.59 24.34 3.11 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.059 1.344 . . . . 0.0 112.151 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.243 0.712 0 C-N-CA 124.845 1.258 . . . . 0.0 108.807 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 . . . . . 0 CA--C 1.525 0.01 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.9 mmt -60.7 -25.5 66.45 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.361 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.85 -53.06 62.5 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 118.578 0.626 . . . . 0.0 109.931 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.37 -44.63 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -175.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -76.46 -13.16 60.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 111.799 -171.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.6 91.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.787 0.835 . . . . 0.0 110.677 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -72.66 -9.31 58.46 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -83.22 -57.08 3.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.571 -0.706 . . . . 0.0 109.77 159.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.1 mm? -56.59 -37.19 70.28 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -170.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -51.46 -29.82 17.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.479 1.112 . . . . 0.0 112.279 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.35 4.15 62.04 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 117.025 -1.986 . . . . 0.0 113.615 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.08 102.87 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.395 0 CA-C-N 120.963 2.381 . . . . 0.0 107.978 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -0.59 2.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.331 2.253 . . . . 0.0 113.528 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -117.43 64.27 4.05 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 128.779 2.832 . . . . 0.0 109.993 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -62.73 -17.55 59.63 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.92 3.08 . . . . 0.0 112.822 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.64 -14.15 62.69 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.748 1.219 . . . . 0.0 112.592 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.95 -1.25 1.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.493 1.517 . . . . 0.0 110.295 -172.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -55.97 -58.58 7.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.665 1.586 . . . . 0.0 110.352 -173.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -54.01 -31.18 50.32 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.059 1.744 . . . . 0.0 112.471 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -52.88 -35.76 58.24 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.82 -0.55 . . . . 0.0 110.333 174.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -67.75 -47.62 68.73 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.25 1.42 . . . . 0.0 110.435 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.89 -31.95 73.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.821 1.648 . . . . 0.0 110.345 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -58.15 -57.9 10.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.346 1.058 . . . . 0.0 108.513 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.3 mt -56.93 -46.71 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.4 mt -59.25 -49.65 77.01 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.901 0.773 . . . . 0.0 110.334 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -61.13 -43.05 99.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.791 1.236 . . . . 0.0 110.878 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -66.7 -42.75 85.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.627 1.971 . . . . 0.0 111.211 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 t -59.2 -54.59 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-N 119.26 0.936 . . . . 0.0 108.702 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.65 -1.31 1.78 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.612 0.765 . . . . 0.0 112.945 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.61 -68.1 0.87 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.782 1.233 . . . . 0.0 109.027 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -62.66 -32.91 74.05 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.334 1.853 . . . . 0.0 111.368 -170.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.23 68.42 18.73 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.94 -4.77 15.5 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.382 2.721 . . . . 0.0 113.105 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.01 -14.32 50.97 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.634 -1.291 . . . . 0.0 110.768 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 56' ' ' ILE . 46.0 mt -80.92 149.59 29.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.236 0.925 . . . . 0.0 109.383 171.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -132.3 151.12 77.75 Favored Pre-proline 0 C--O 1.221 -0.42 0 C-N-CA 125.517 1.527 . . . . 0.0 111.78 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.42 132.8 18.15 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.521 2.814 . . . . 0.0 112.365 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -148.84 127.16 12.2 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.03 125.31 35.79 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 168.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -153.54 150.7 28.98 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 119.265 0.939 . . . . 0.0 111.701 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.3 m95 53.9 24.66 4.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.1 t30 65.11 10.25 6.19 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.923 2.089 . . . . 0.0 113.312 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.86 149.09 40.29 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.99 136.32 16.37 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.244 1.962 . . . . 0.0 109.88 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 17.4 ptm -142.89 -176.81 5.04 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.628 1.171 . . . . 0.0 108.11 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -140.35 157.12 46.04 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 117.751 -1.119 . . . . 0.0 108.682 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.1 p -117.07 132.58 56.65 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 120.589 1.541 . . . . 0.0 109.543 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -74.34 95.25 2.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 161.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 44.81 41.75 5.4 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.137 1.775 . . . . 0.0 112.941 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 115.06 -20.63 14.13 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.373 1.463 . . . . 0.0 114.502 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.8 m -77.12 -175.92 3.81 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.63 1.972 . . . . 0.0 110.907 -171.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' H ' HG22 ' A' ' 53' ' ' THR . 21.0 t80 -124.11 22.25 8.73 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.256 -1.527 . . . . 0.0 112.88 -169.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 mt -68.23 8.54 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 127.341 2.256 . . . . 0.0 113.464 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 37' ' ' LEU . 4.5 tt -162.52 148.47 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 121.853 2.115 . . . . 0.0 111.42 172.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.49 154.0 23.44 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.384 0.993 . . . . 0.0 111.433 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.41 170.46 20.06 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.637 1.219 . . . . 0.0 110.947 174.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.14 116.24 3.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.313 1.045 . . . . 0.0 108.827 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.2 p -62.22 130.68 46.5 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 119.907 1.231 . . . . 0.0 109.86 -170.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.4 t -90.53 171.25 9.54 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -55.72 -52.71 62.96 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 167.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -134.87 54.56 1.93 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.5 0.72 . . . . 0.0 109.726 -171.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.466 ' CD2' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER 175.84 170.66 0.37 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.638 2.375 . . . . 0.0 110.271 174.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tp -112.99 150.27 32.13 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.589 2.355 . . . . 0.0 106.768 153.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -132.76 121.32 22.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.473 2.709 . . . . 0.0 111.138 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.88 144.1 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 127.273 2.229 . . . . 0.0 111.314 -163.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.9 t -156.82 163.26 25.64 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 159.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.18 -57.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 120.736 0.957 . . . . 0.0 110.511 157.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -150.78 -86.5 0.08 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 171.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.26 -25.9 0.84 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.707 1.203 . . . . 0.0 112.584 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.0 tp -57.4 -41.47 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 121.065 1.757 . . . . 0.0 109.85 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.79 -23.4 10.58 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.445 1.021 . . . . 0.0 113.95 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.9 mm -111.73 -3.56 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.983 2.113 . . . . 0.0 110.237 -172.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.3 m -116.36 -54.31 2.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.349 1.06 . . . . 0.0 109.654 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -78.28 -51.85 9.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.112 2.165 . . . . 0.0 108.288 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -95.39 -3.22 47.5 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -167.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.57 -30.3 70.57 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -69.13 -42.07 76.53 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.984 0.811 . . . . 0.0 109.135 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.44 -45.85 92.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.277 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.0 mt -58.91 -43.41 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.464 0.705 . . . . 0.0 109.67 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.75 -53.47 57.86 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.278 0.631 . . . . 0.0 110.089 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.9 -21.71 62.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.609 0.763 . . . . 0.0 112.014 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.22 8.09 2.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.372 0.987 . . . . 0.0 111.566 170.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.74 37.24 57.54 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 121.142 -0.974 . . . . 0.0 112.043 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -136.8 161.18 36.68 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.055 0.942 . . . . 0.0 110.311 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -122.51 97.57 5.52 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.64 -0.662 . . . . 0.0 110.828 -160.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.87 165.04 7.18 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.518 0.675 . . . . 0.0 111.117 171.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.6 p -105.81 -165.55 1.12 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 157.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -77.62 -4.04 43.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.667 166.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.96 -11.42 0.42 Allowed Glycine 0 CA--C 1.529 0.918 0 CA-C-N 120.444 1.475 . . . . 0.0 115.535 -168.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.19 178.58 9.59 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.116 1.458 . . . . 0.0 110.472 164.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -122.68 144.36 49.19 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 165.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.459 ' HD2' ' NE2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -139.12 154.95 48.19 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 120.625 -1.297 . . . . 0.0 110.047 -170.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.466 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 44.3 mm -143.05 142.36 21.68 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -163.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.08 153.05 72.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 CA-C-N 121.01 1.396 . . . . 0.0 109.886 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -69.88 92.1 0.68 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 157.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.38 -59.46 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 126.305 1.842 . . . . 0.0 108.749 166.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -90.52 157.23 44.71 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.803 -159.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.46 114.86 4.06 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.988 1.792 . . . . 0.0 110.886 -172.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.69 119.68 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.828 1.651 . . . . 0.0 107.99 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -76.03 85.83 2.93 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 126.034 1.734 . . . . 0.0 113.072 -173.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -56.01 -43.82 78.11 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 124.348 1.059 . . . . 0.0 110.854 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -56.46 -51.67 67.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.729 1.212 . . . . 0.0 111.872 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -42.73 95.31 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.607 -0.683 . . . . 0.0 109.888 -177.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.302 0.2 OUTLIER -75.93 -24.66 55.55 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.76 -176.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.77 -44.65 85.17 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 120.19 1.359 . . . . 0.0 109.899 171.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -56.53 -50.44 71.84 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.75 0.704 . . . . 0.0 109.688 -175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 ptp -67.1 -35.35 79.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.224 -0.894 . . . . 0.0 113.192 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -49.65 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.651 1.114 . . . . 0.0 109.068 177.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -58.5 -42.72 88.29 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.694 1.198 . . . . 0.0 110.949 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.41 -51.11 67.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.431 -0.795 . . . . 0.0 109.514 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -69.81 -10.4 58.3 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.883 1.219 . . . . 0.0 113.573 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 76.4 mt -75.17 -59.88 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.396 1.078 . . . . 0.0 108.525 161.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -75.7 -15.62 60.27 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 121.601 -0.687 . . . . 0.0 112.737 -165.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.64 -11.14 59.96 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.676 1.99 . . . . 0.0 112.034 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -106.06 15.08 26.92 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.974 2.109 . . . . 0.0 110.498 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.249 1.071 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.091 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.261 5.6 p-80 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 116.264 1.949 . . . . 0.0 116.264 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 mmt -51.62 -34.09 36.07 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.872 1.669 . . . . 0.0 112.311 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.02 -24.5 54.14 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.66 -25.86 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 120.896 0.379 . . . . 0.0 110.333 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -114.43 -5.53 12.88 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.12 1.768 . . . . 0.0 113.122 -173.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.78 -22.79 45.82 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 120.508 -1.37 . . . . 0.0 112.082 -169.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.27 -8.73 54.75 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.762 -0.587 . . . . 0.0 111.848 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -68.0 -57.75 5.64 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 160.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.434 HD12 ' CG ' ' A' ' 20' ' ' ARG . 1.2 mm? -46.63 -50.18 18.0 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.641 1.577 . . . . 0.0 112.964 -175.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -53.06 -29.91 32.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.8 9.68 29.88 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.058 -1.412 . . . . 0.0 114.635 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.409 HD12 HD13 ' A' ' 11' ' ' LEU . 24.4 mt -69.12 111.53 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 120.705 2.252 . . . . 0.0 105.958 167.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.0 -9.43 59.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.815 0.846 . . . . 0.0 113.208 -173.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.83 73.42 34.14 Favored Pre-proline 0 N--CA 1.445 -0.695 0 C-N-CA 125.017 1.327 . . . . 0.0 110.776 -168.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.77 -18.75 53.36 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.749 2.966 . . . . 0.0 114.875 -167.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -64.15 -10.66 24.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.266 0.626 . . . . 0.0 110.533 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -119.28 -6.84 10.33 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.58 1.952 . . . . 0.0 112.039 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.434 ' CG ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -79.95 -49.02 12.47 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.114 -0.991 . . . . 0.0 110.48 -171.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.68 -42.6 79.32 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.774 0.671 . . . . 0.0 110.064 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.52 -56.96 10.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 123.899 0.88 . . . . 0.0 110.426 171.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.3 m -58.43 -38.83 78.26 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.548 1.139 . . . . 0.0 110.629 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -30.87 66.43 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.769 1.628 . . . . 0.0 114.068 171.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -63.75 -51.1 66.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.972 -0.537 . . . . 0.0 109.806 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mp -57.9 -52.62 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.34 -61.34 2.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.536 1.134 . . . . 0.0 109.941 -170.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m -71.36 -31.53 67.44 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.802 -1.094 . . . . 0.0 111.054 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 74.3 t90 -61.31 -48.07 83.07 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.575 1.079 . . . . 0.0 111.316 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.425 HG13 ' HD2' ' A' ' 34' ' ' PHE . 88.0 t -58.15 -48.89 83.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.96 -15.29 63.54 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.77 -62.4 1.55 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.052 0.941 . . . . 0.0 109.529 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 m -68.97 -27.51 65.79 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.774 0.83 . . . . 0.0 110.886 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.507 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -124.21 73.62 58.32 Favored Pre-proline 0 N--CA 1.443 -0.822 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.111 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.8 -5.58 17.45 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.343 2.029 . . . . 0.0 111.763 175.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.63 -36.55 84.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.54 1.136 . . . . 0.0 112.013 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.578 HD22 ' H ' ' A' ' 37' ' ' LEU . 1.4 mm? -78.84 139.59 38.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -172.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -88.59 147.01 38.55 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 171.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.53 142.04 14.35 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.655 2.903 . . . . 0.0 111.348 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -146.8 139.04 24.77 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.738 0.699 . . . . 0.0 109.966 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 ttm -99.85 107.65 19.72 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -125.48 151.39 46.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.946 1.699 . . . . 0.0 107.078 170.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.0 m95 55.78 21.26 4.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.594 1.558 . . . . 0.0 114.749 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.07 26.23 11.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.341 1.056 . . . . 0.0 111.424 -168.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 59' ' ' SER . 44.4 p -119.1 146.91 41.57 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.459 1.504 . . . . 0.0 109.255 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.24 122.19 7.81 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.629 2.219 . . . . 0.0 109.74 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.5 ptm -137.26 167.38 21.7 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.363 0.601 . . . . 0.0 109.998 169.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -127.23 169.74 13.17 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.466 -2.049 . . . . 0.0 105.466 178.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 p -154.31 135.33 13.86 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 120.253 -1.529 . . . . 0.0 107.702 166.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -76.94 114.41 15.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 164.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 44.52 53.88 6.76 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.144 0.978 . . . . 0.0 112.656 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.7 9.07 86.46 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 170.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 55' ' ' ILE . 1.4 t -69.16 -164.65 0.06 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.007 1.403 . . . . 0.0 112.042 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -132.99 22.19 4.15 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 118.358 2.725 . . . . 0.0 118.358 162.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' A' ' 113' ' ' ASN . 10.1 mt -62.22 10.48 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 O-C-N 119.427 -2.046 . . . . 0.0 115.005 -170.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.3 tt -164.33 141.58 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 123.162 2.71 . . . . 0.0 112.048 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.4 140.33 3.83 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.001 1.286 . . . . 0.0 110.977 166.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -132.35 170.15 15.49 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.94 1.296 . . . . 0.0 111.505 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.441 ' HB3' HG22 ' A' ' 45' ' ' THR . 2.8 p -152.87 161.13 42.94 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.678 156.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p -59.69 153.18 20.81 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 171.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 t -144.58 170.55 15.84 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.224 1.012 . . . . 0.0 108.394 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -62.67 -21.95 66.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -156.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.84 14.13 0.73 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.007 0.821 . . . . 0.0 111.844 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -156.52 169.85 23.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.084 1.754 . . . . 0.0 109.693 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.01 145.11 30.63 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 164.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -104.1 117.34 34.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.928 1.24 . . . . 0.0 109.727 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.454 HG11 HD21 ' A' ' 106' ' ' LEU . 39.0 t -128.42 147.96 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 120.282 1.401 . . . . 0.0 107.835 176.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.0 t -167.31 165.58 8.79 Favored Pre-proline 0 C--O 1.243 0.723 0 C-N-CA 125.709 1.604 . . . . 0.0 107.396 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -94.13 -57.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 119.394 0.819 . . . . 0.0 113.211 158.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -147.08 -85.78 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.162 1.385 . . . . 0.0 107.841 -173.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -143.98 -29.26 0.5 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.854 2.462 . . . . 0.0 110.825 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.0 tt -62.04 -41.53 91.45 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 119.451 1.023 . . . . 0.0 111.413 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.25 -19.89 13.69 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.369 1.938 . . . . 0.0 112.928 177.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.6 mm -121.47 -0.41 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.209 1.804 . . . . 0.0 109.767 -172.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.1 m -98.23 -78.77 0.48 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.37 -51.12 10.54 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.643 0.656 . . . . 0.0 109.294 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -65.75 -17.49 64.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.573 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.89 -32.65 63.91 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.31 -40.54 93.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.959 0.885 . . . . 0.0 110.134 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.464 ' HB3' HD11 ' A' ' 105' ' ' LEU . . . -69.74 -38.77 76.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.401 -0.812 . . . . 0.0 111.462 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.26 -46.27 92.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.538 1.135 . . . . 0.0 108.714 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.39 -47.92 82.29 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.049 1.34 . . . . 0.0 111.861 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -63.91 -30.08 71.2 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.716 0.807 . . . . 0.0 112.044 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.25 83.18 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.842 0.746 . . . . 0.0 109.6 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.12 -2.2 3.54 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.161 1.362 . . . . 0.0 112.965 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -92.76 157.69 16.29 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.514 1.657 . . . . 0.0 111.265 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.0 m -118.93 156.55 29.35 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.137 0.975 . . . . 0.0 110.516 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.24 165.9 17.47 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.13 0.972 . . . . 0.0 110.646 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -83.58 -164.55 0.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 165.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -63.41 -27.44 69.3 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.164 -0.96 . . . . 0.0 112.672 165.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.98 -14.03 0.78 Allowed Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.568 0.987 . . . . 0.0 115.568 -156.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 pp -152.79 163.9 38.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.739 1.77 . . . . 0.0 111.05 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.412 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 20.7 p90 -107.17 146.8 30.9 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.559 -0.713 . . . . 0.0 110.061 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -131.78 91.21 2.95 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 123.225 0.61 . . . . 0.0 110.237 -165.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.697 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -79.83 141.97 55.98 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 -176.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.23 157.34 41.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.318 2.012 . . . . 0.0 109.95 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -69.1 -16.39 63.66 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -63.71 -38.33 90.7 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.669 0.668 . . . . 0.0 112.45 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -129.64 150.97 77.22 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.945 1.298 . . . . 0.0 108.638 -165.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.38 147.14 17.87 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.311 2.674 . . . . 0.0 113.972 -164.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 m -68.3 126.56 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 121.261 -0.899 . . . . 0.0 109.49 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -79.48 98.63 6.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.836 0.854 . . . . 0.0 110.753 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -61.09 -25.56 67.04 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.311 1.044 . . . . 0.0 112.505 -174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -65.69 -56.03 14.25 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.515 -0.74 . . . . 0.0 110.908 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -61.06 -39.76 91.09 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.543 -0.723 . . . . 0.0 110.841 178.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.454 HD21 HG11 ' A' ' 67' ' ' VAL . 2.7 mt -52.2 -53.59 41.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.872 1.669 . . . . 0.0 110.017 176.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -69.51 -42.06 75.21 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.579 -175.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -58.82 -44.47 90.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.346 0.976 . . . . 0.0 111.816 -175.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 ptp -73.27 -41.38 63.69 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 118.254 0.479 . . . . 0.0 111.912 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.42 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -71.8 -47.75 54.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -173.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.61 -41.08 85.07 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.48 1.036 . . . . 0.0 109.461 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -54.85 -49.57 70.78 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.529 0.332 . . . . 0.0 111.395 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.658 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.3 m120 -62.46 -29.59 70.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.023 0.929 . . . . 0.0 112.413 -175.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.89 -31.3 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.631 1.105 . . . . 0.0 110.701 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -81.6 2.18 30.5 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.028 -1.045 . . . . 0.0 112.196 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -90.65 -40.51 11.85 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.442 -0.786 . . . . 0.0 113.032 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -97.12 23.56 7.22 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.184 1.394 . . . . 0.0 110.451 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 117.404 -1.284 . . . . 0.0 111.326 -177.594 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.23 -28.72 19.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.106 0.962 . . . . 0.0 111.294 172.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.83 -30.25 63.59 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.176 1.39 . . . . 0.0 113.333 177.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.3 t -81.0 -33.26 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.497 1.119 . . . . 0.0 111.485 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -89.04 -16.07 32.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.645 1.178 . . . . 0.0 113.378 -174.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.94 77.85 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.192 0.997 . . . . 0.0 112.025 -167.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.68 -5.61 53.54 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.521 1.528 . . . . 0.0 112.52 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -93.69 -45.39 7.71 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.018 1.281 . . . . 0.0 110.057 161.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.574 HD12 ' HD3' ' A' ' 20' ' ' ARG . 1.3 mm? -49.38 -42.68 42.94 Favored 'General case' 0 CA--C 1.523 -0.085 0 C-N-CA 123.95 0.9 . . . . 0.0 111.316 -176.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -49.7 -36.65 25.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.351 1.06 . . . . 0.0 113.379 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.77 0.42 39.2 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 117.703 -1.609 . . . . 0.0 113.045 -168.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.9 mt -71.71 101.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.88 2.57 2.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.232 1.813 . . . . 0.0 113.512 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.52 72.06 2.5 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 128.379 2.672 . . . . 0.0 111.159 -166.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.68 -11.37 31.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 124.125 3.217 . . . . 0.0 114.664 -172.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -81.99 -9.02 59.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.242 0.617 . . . . 0.0 112.365 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -129.07 -28.12 2.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.569 1.148 . . . . 0.0 112.38 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.574 ' HD3' HD12 ' A' ' 11' ' ' LEU . 3.0 tmm_? -52.71 -45.2 66.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.775 1.23 . . . . 0.0 113.137 -175.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -32.39 73.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.11 0.868 . . . . 0.0 110.816 -174.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -68.92 -41.23 78.43 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.637 1.108 . . . . 0.0 111.844 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.9 m -55.08 -39.78 69.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.594 0.758 . . . . 0.0 109.621 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.89 -35.83 80.92 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.483 1.513 . . . . 0.0 112.095 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -62.35 -48.28 80.48 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.396 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.5 mt -61.91 -44.53 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.666 0.666 . . . . 0.0 109.512 -177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.77 -68.01 0.21 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.961 1.305 . . . . 0.0 108.852 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.2 p -66.18 -28.0 68.43 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.591 1.157 . . . . 0.0 112.932 -170.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 43.9 t90 -56.52 -46.74 80.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.63 1.572 . . . . 0.0 110.889 173.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.48 -37.38 70.02 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 C-N-CA 116.791 -1.964 . . . . 0.0 108.499 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.64 -8.44 0.24 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.601 1.16 . . . . 0.0 113.609 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.28 -65.24 1.0 Allowed 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.89 -1.131 . . . . 0.0 110.716 158.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.97 -34.68 59.8 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.297 0.499 . . . . 0.0 111.995 -161.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.7 66.53 10.11 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 127.511 2.324 . . . . 0.0 109.263 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.17 -6.97 19.84 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.021 2.48 . . . . 0.0 112.42 -172.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -81.7 -11.75 58.92 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.119 0.968 . . . . 0.0 111.849 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.0 mt -74.92 143.45 43.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -119.52 152.51 53.15 Favored Pre-proline 0 C--N 1.322 -0.598 0 C-N-CA 127.718 2.407 . . . . 0.0 107.844 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -75.69 156.79 40.02 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.02 2.48 . . . . 0.0 111.073 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -171.96 106.59 0.21 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 126.327 1.851 . . . . 0.0 106.15 163.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 ppp? -78.03 134.09 37.84 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.321 0.964 . . . . 0.0 108.857 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.97 152.4 38.58 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.112 1.365 . . . . 0.0 109.224 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.6 m95 51.87 34.06 12.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.254 1.022 . . . . 0.0 113.171 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 57.74 20.88 6.83 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.444 1.498 . . . . 0.0 112.123 -173.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.5 p -116.6 148.43 41.87 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.022 1.329 . . . . 0.0 108.588 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.05 144.45 42.55 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.451 2.101 . . . . 0.0 109.136 164.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.2 ptm -160.91 177.62 10.2 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 165.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.43 176.11 8.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.508 1.123 . . . . 0.0 108.134 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.4 p -146.98 134.54 20.95 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.984 -1.072 . . . . 0.0 108.752 172.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.442 ' N ' HG22 ' A' ' 53' ' ' THR . 30.7 t30 -75.83 111.32 11.06 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 165.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 49.18 43.79 22.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.661 0.784 . . . . 0.0 112.768 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.2 76.62 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.082 170.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 55' ' ' ILE . 1.7 t -61.67 -163.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 128.46 2.704 . . . . 0.0 117.349 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -129.11 29.55 5.15 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 157.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.529 ' H ' HG23 ' A' ' 53' ' ' THR . 38.0 mt -60.11 9.16 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 127.129 2.172 . . . . 0.0 114.024 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 tt -159.02 157.94 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 122.647 2.476 . . . . 0.0 112.93 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.61 164.36 23.14 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.841 0.734 . . . . 0.0 112.963 159.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -160.12 177.58 10.55 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.471 1.108 . . . . 0.0 112.142 -170.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.5 p -172.44 148.77 2.08 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.442 1.019 . . . . 0.0 109.172 170.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.1 p -63.96 129.1 38.69 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.428 -0.795 . . . . 0.0 108.975 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 t -97.43 -178.12 4.04 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 158.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -54.44 -65.49 0.57 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.686 -0.634 . . . . 0.0 110.281 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -101.82 2.17 37.98 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -164.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.464 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 6.8 p-80 -160.41 149.75 17.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.25 1.02 . . . . 0.0 109.556 -166.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -89.71 143.19 27.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 161.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.57 141.39 51.75 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.183 0.993 . . . . 0.0 110.275 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -159.46 155.79 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.003 0.921 . . . . 0.0 112.939 -167.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 29.5 t -163.08 165.53 14.57 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.295 1.838 . . . . 0.0 108.093 168.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.46 -56.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 121.853 1.702 . . . . 0.0 111.781 159.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -146.07 -86.17 0.11 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -138.28 -37.56 0.56 Allowed 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.77 1.628 . . . . 0.0 109.936 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.5 tt -57.27 -35.57 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.078 0.854 . . . . 0.0 111.42 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.58 -20.86 8.12 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 126.998 2.237 . . . . 0.0 113.444 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.5 mm -118.15 -14.7 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 127.185 2.194 . . . . 0.0 110.001 -172.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.8 m -81.92 -79.83 0.17 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.023 0.929 . . . . 0.0 109.542 166.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -87.9 -48.08 8.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -164.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -63.94 -19.21 64.96 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.08 -31.86 61.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.611 -1.185 . . . . 0.0 113.145 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -67.91 -52.47 35.98 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.857 0.753 . . . . 0.0 109.684 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.41 82.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.593 0.757 . . . . 0.0 110.982 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.31 -43.75 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.288 1.035 . . . . 0.0 109.699 175.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.15 80.99 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.06 0.944 . . . . 0.0 110.901 -173.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -27.76 57.71 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.015 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.94 8.56 22.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.044 0.838 . . . . 0.0 112.14 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.66 36.82 24.97 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 121.191 -0.943 . . . . 0.0 112.527 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -125.41 154.47 41.89 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.083 0.953 . . . . 0.0 109.721 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.9 t -114.49 124.38 51.76 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.393 0.615 . . . . 0.0 110.746 -163.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.77 159.75 22.43 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.358 0.663 . . . . 0.0 110.728 174.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -118.7 -162.59 0.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.593 1.957 . . . . 0.0 106.153 164.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.466 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -64.59 -31.3 72.46 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 169.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -151.64 -6.07 0.15 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 114.218 0.447 . . . . 0.0 114.218 -156.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.9 pp -146.06 161.82 39.28 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.643 1.577 . . . . 0.0 108.006 169.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -122.15 157.27 31.9 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.464 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -132.03 142.4 49.55 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.504 -177.339 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.6 mp -105.58 142.2 24.25 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.02 151.45 44.76 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.029 2.486 . . . . 0.0 109.578 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -64.61 -19.05 65.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -31.51 72.74 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.88 1.218 . . . . 0.0 112.478 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.66 161.85 37.61 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 123.961 0.904 . . . . 0.0 110.181 -161.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.64 161.6 43.54 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.559 1.506 . . . . 0.0 110.862 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.4 t -89.24 130.71 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.07 89.21 4.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.176 1.39 . . . . 0.0 109.366 -176.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -67.24 -31.7 72.23 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.636 1.174 . . . . 0.0 112.532 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.51 -51.21 70.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.611 1.164 . . . . 0.0 109.753 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -68.28 -41.18 81.38 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 120.611 1.551 . . . . 0.0 110.865 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -50.18 51.87 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 123.473 0.709 . . . . 0.0 109.121 176.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -58.63 -55.48 34.55 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.988 1.315 . . . . 0.0 110.006 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -59.17 -35.74 74.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.492 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -87.8 -6.82 57.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 117.496 -1.24 . . . . 0.0 113.718 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.89 -54.23 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 120.977 1.717 . . . . 0.0 109.224 172.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -53.15 -48.6 67.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.023 1.329 . . . . 0.0 109.777 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -52.77 -45.81 67.28 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.24 -34.65 73.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.004 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.13 -52.03 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -72.23 -15.03 61.93 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.32 -37.9 27.61 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.49 1.516 . . . . 0.0 110.705 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.54 23.29 3.07 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.7 2.4 . . . . 0.0 111.821 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 124.523 1.129 . . . . 0.0 108.921 168.215 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.71 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.7 m -62.39 140.4 58.55 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.517 1.159 . . . . 0.0 109.257 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -150.57 -31.88 0.18 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.781 -0.628 . . . . 0.0 112.073 174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 mmt -56.02 -41.38 74.82 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.56 -28.51 55.35 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.857 1.263 . . . . 0.0 113.945 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.62 -53.3 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -81.58 -28.66 33.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.68 1.592 . . . . 0.0 112.556 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.95 0.93 14.14 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.807 1.643 . . . . 0.0 112.087 -171.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 41.3 mt-10 -86.99 -35.44 18.81 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.012 1.325 . . . . 0.0 109.332 167.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.32 -41.09 25.47 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -175.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -51.4 -37.84 50.4 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.233 1.413 . . . . 0.0 112.376 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 12.0 mtmt -61.85 -46.07 91.06 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.049 0.939 . . . . 0.0 110.901 175.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.55 -9.05 73.2 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.095 1.331 . . . . 0.0 113.729 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.82 103.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 165.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.11 3.43 10.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.097 1.359 . . . . 0.0 112.811 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -116.6 73.83 6.02 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 128.873 2.869 . . . . 0.0 109.705 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.01 -28.05 19.74 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.231 3.287 . . . . 0.0 111.433 -168.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.437 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 26.0 m-20 -64.98 -15.84 62.7 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.726 0.81 . . . . 0.0 110.348 -171.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -133.39 5.0 3.73 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.254 1.422 . . . . 0.0 110.22 178.1 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -66.06 -55.64 15.58 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 120.864 -1.148 . . . . 0.0 109.069 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.66 -14.8 15.34 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.7 1.371 . . . . 0.0 114.7 -165.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -43.18 97.39 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.55 1.068 . . . . 0.0 110.869 169.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -57.68 -37.43 73.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.252 1.421 . . . . 0.0 111.377 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -81.4 -20.71 39.88 Favored 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 120.89 -1.132 . . . . 0.0 113.996 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.17 -47.99 79.84 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.0 mt -61.41 -47.72 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.463 1.105 . . . . 0.0 110.227 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.6 mt -56.56 -49.33 75.14 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.676 0.671 . . . . 0.0 111.061 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 p -68.93 -40.0 79.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.241 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -60.19 -47.75 84.63 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.134 1.774 . . . . 0.0 111.401 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.7 t -56.32 -50.14 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 119.076 0.853 . . . . 0.0 108.716 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.78 3.51 1.9 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.57 -54.01 2.39 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.048 1.339 . . . . 0.0 111.003 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -72.73 -32.9 66.03 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.867 1.212 . . . . 0.0 111.047 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.74 57.54 5.9 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 119.311 0.96 . . . . 0.0 110.877 -173.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -65.26 -11.19 28.94 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.05 2.5 . . . . 0.0 113.636 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -12.16 61.12 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.57 -0.706 . . . . 0.0 112.702 175.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 85.7 mt -80.04 156.69 27.0 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.413 1.006 . . . . 0.0 109.889 169.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -129.23 152.58 79.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.506 1.522 . . . . 0.0 109.708 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.25 159.17 53.98 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.605 2.87 . . . . 0.0 113.186 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -161.95 120.19 2.27 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.507 1.523 . . . . 0.0 109.601 171.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.31 109.28 15.67 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.436 1.095 . . . . 0.0 108.381 166.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -135.56 149.32 49.39 Favored 'General case' 0 C--O 1.218 -0.603 0 O-C-N 120.921 -1.112 . . . . 0.0 108.125 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.1 m95 55.52 16.68 1.94 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 64.59 15.34 9.61 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 128.553 2.741 . . . . 0.0 113.848 -167.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.3 p -116.37 161.36 31.93 Favored Pre-proline 0 N--CA 1.44 -0.975 0 C-N-CA 124.72 1.208 . . . . 0.0 109.152 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.62 116.94 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 125.269 3.979 . . . . 0.0 112.13 171.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.3 ptm -128.43 170.3 13.29 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.683 0.754 . . . . 0.0 108.985 161.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.03 165.0 27.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 169.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.7 120.76 13.71 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -171.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -71.95 99.73 2.3 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 167.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 49.02 42.01 20.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.258 1.023 . . . . 0.0 110.674 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.41 -21.09 40.33 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 116.971 -2.016 . . . . 0.0 117.062 174.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -171.25 0.91 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 122.055 2.928 . . . . 0.0 112.756 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -117.19 26.51 9.72 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.037 -1.039 . . . . 0.0 113.097 -171.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.0 -1.18 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.05 0.94 . . . . 0.0 112.965 -168.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 tt -155.9 142.61 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 119.263 -2.148 . . . . 0.0 112.025 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.55 149.92 21.18 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.527 1.537 . . . . 0.0 109.324 166.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -145.18 178.48 8.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.954 1.377 . . . . 0.0 110.501 170.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.2 153.83 10.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 168.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.3 p -69.13 138.83 54.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.768 -0.583 . . . . 0.0 109.431 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.38 174.36 5.94 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 169.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.471 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -71.37 -5.12 30.22 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.866 -1.146 . . . . 0.0 113.645 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.28 7.49 0.11 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.1 -178.61 6.71 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.027 1.331 . . . . 0.0 108.692 -173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.09 120.06 18.61 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.494 1.118 . . . . 0.0 108.521 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.34 108.77 21.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.911 1.684 . . . . 0.0 109.913 -160.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 99.2 t -129.46 140.28 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.911 1.232 . . . . 0.0 109.504 -162.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 27.8 t -171.26 144.91 1.76 Allowed Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.033 1.733 . . . . 0.0 109.734 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.2 -56.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.616 1.544 . . . . 0.0 111.344 171.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -148.03 -83.77 0.11 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -131.5 -46.38 0.98 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.129 1.372 . . . . 0.0 110.945 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.26 -35.18 52.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 118.839 0.745 . . . . 0.0 112.753 -166.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.9 -24.74 28.03 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.745 1.641 . . . . 0.0 113.169 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 mm -112.93 -3.49 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.776 1.63 . . . . 0.0 109.819 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 m -91.14 -72.59 0.57 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -85.75 -49.23 8.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.425 0.557 . . . . 0.0 109.541 -171.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -69.45 -13.19 62.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.94 -21.61 66.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.83 -44.96 60.79 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.923 0.783 . . . . 0.0 110.645 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.42 -43.21 88.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.664 0.786 . . . . 0.0 110.643 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.39 -41.46 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.963 0.801 . . . . 0.0 110.331 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.25 -55.55 31.88 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.293 0.497 . . . . 0.0 110.319 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.64 -13.12 61.29 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.107 0.963 . . . . 0.0 112.345 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.15 -26.43 60.31 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.679 0.672 . . . . 0.0 110.579 169.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.39 4.97 6.22 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.972 -0.905 . . . . 0.0 113.735 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -112.88 160.88 17.59 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.848 1.324 . . . . 0.0 110.907 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.2 m -91.74 173.03 8.08 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.049 0.939 . . . . 0.0 108.922 170.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . . . -133.97 -166.19 1.75 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 166.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.2 p -118.96 -168.73 1.61 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 153.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -68.74 -27.64 66.11 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 120.469 -1.395 . . . . 0.0 112.242 166.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.46 -14.14 10.93 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-O 118.795 -1.003 . . . . 0.0 114.432 -163.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.8 pp -156.39 166.59 32.98 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.42 1.61 . . . . 0.0 110.393 170.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 18.0 p90 -103.62 164.98 11.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.416 0.553 . . . . 0.0 109.94 172.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 126.61 22.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.96 142.69 25.18 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 164.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.54 145.79 14.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.995 2.464 . . . . 0.0 108.896 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -56.42 -30.49 62.88 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -170.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -65.83 -26.64 67.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -115.91 162.19 26.9 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.546 0.738 . . . . 0.0 110.125 -164.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -79.98 148.07 19.32 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 CA-C-N 121.125 1.437 . . . . 0.0 113.605 -169.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.6 t -73.69 124.18 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 170.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -74.99 77.23 2.19 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.526 1.13 . . . . 0.0 110.562 169.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -53.13 -40.92 64.56 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 125.145 1.378 . . . . 0.0 111.32 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -57.89 -60.91 2.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.468 1.507 . . . . 0.0 110.984 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.96 -38.72 65.28 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.759 0.79 . . . . 0.0 110.888 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.269 0.3 OUTLIER -79.93 -27.93 39.78 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 117.198 -1.382 . . . . 0.0 113.171 -176.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -62.01 -42.67 99.4 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.304 1.411 . . . . 0.0 108.402 170.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.64 -52.59 63.31 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.093 0.557 . . . . 0.0 109.613 -174.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.0 ptp -69.51 -36.61 76.62 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.564 -1.207 . . . . 0.0 113.544 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.7 -46.72 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 120.6 1.546 . . . . 0.0 108.876 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.56 -40.11 90.43 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.543 0.611 . . . . 0.0 109.845 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 29.1 t80 -60.96 -50.08 74.83 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.394 0.543 . . . . 0.0 110.783 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -38.31 80.7 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.105 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.9 mt -60.3 -52.28 63.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 124.092 0.957 . . . . 0.0 110.676 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.4 ' HG2' ' HA ' ' A' ' 112' ' ' PHE . 5.4 pt20 -70.28 -22.54 62.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.041 0.837 . . . . 0.0 111.721 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -83.02 -20.56 34.81 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.311 0.644 . . . . 0.0 111.311 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -96.89 20.05 11.71 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.855 1.662 . . . . 0.0 111.236 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.767 166.61 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.86 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.8 m -65.32 164.05 14.28 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.456 -1.026 . . . . 0.0 112.054 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -156.94 -39.99 0.07 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.101 1.36 . . . . 0.0 110.284 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 30.8 mmm -56.82 -27.04 59.39 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.97 -34.82 70.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 118.337 0.517 . . . . 0.0 111.437 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.59 -44.46 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -78.13 -14.51 59.45 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.46 1.104 . . . . 0.0 112.795 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -34.32 77.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.426 1.491 . . . . 0.0 111.426 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -64.32 -16.28 61.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.88 1.672 . . . . 0.0 112.848 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -102.26 -37.6 8.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.908 0.883 . . . . 0.0 110.042 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.54 -39.83 65.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.252 0.933 . . . . 0.0 110.571 171.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -58.68 -29.84 66.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.414 0.686 . . . . 0.0 112.034 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.49 -4.52 62.28 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.842 -0.977 . . . . 0.0 114.57 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.3 mm -57.08 132.54 21.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 119.298 1.549 . . . . 0.0 109.334 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.73 -49.33 75.47 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.816 1.646 . . . . 0.0 108.724 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -141.15 143.95 32.85 Favored Pre-proline 0 N--CA 1.45 -0.434 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.42 -22.66 24.67 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.454 2.77 . . . . 0.0 111.264 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -6.16 13.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.61 173.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -125.29 -9.16 6.99 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -64.42 -60.81 2.72 Favored 'General case' 0 CA--C 1.519 -0.228 0 O-C-N 121.184 -0.947 . . . . 0.0 110.441 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -45.86 -44.55 14.47 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.122 2.169 . . . . 0.0 111.292 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -57.82 -48.1 80.72 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.042 -0.411 . . . . 0.0 110.397 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.0 m -65.67 -45.22 83.73 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.04 1.336 . . . . 0.0 109.885 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -51.96 -41.27 61.96 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.796 1.239 . . . . 0.0 112.282 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -60.29 -52.68 64.24 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.377 0.535 . . . . 0.0 109.695 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mt -61.72 -41.49 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.437 1.095 . . . . 0.0 110.056 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.88 -57.1 13.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.303 0.501 . . . . 0.0 110.583 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -60.29 -37.08 79.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 117.833 -1.08 . . . . 0.0 109.808 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 67.1 t90 -59.31 -59.4 5.52 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.797 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.412 HG11 ' CE1' ' A' ' 48' ' ' PHE . 28.3 t -52.64 -46.8 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 120.224 1.374 . . . . 0.0 110.697 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.2 -29.86 69.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.048 0.539 . . . . 0.0 112.012 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.45 -61.14 2.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.994 0.918 . . . . 0.0 110.537 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -65.86 -32.05 73.35 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.427 1.491 . . . . 0.0 111.849 -169.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -127.33 63.75 59.46 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 118.664 0.665 . . . . 0.0 109.253 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.68 -8.56 23.91 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.585 2.857 . . . . 0.0 113.923 -163.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.29 -26.51 62.0 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.262 -0.899 . . . . 0.0 111.799 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 67.1 mt -65.81 149.76 49.65 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -130.97 150.02 75.39 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 127.025 2.13 . . . . 0.0 110.719 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.12 152.76 40.59 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.329 2.686 . . . . 0.0 113.191 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.35 126.56 6.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.465 1.906 . . . . 0.0 108.967 167.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.34 102.77 15.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 170.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -149.93 141.23 23.21 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.968 -1.083 . . . . 0.0 111.139 -167.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 16.3 m95 54.84 21.96 3.94 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.881 1.272 . . . . 0.0 111.927 -161.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 53.42 14.69 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.828 1.651 . . . . 0.0 112.807 -162.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.7 p -97.87 148.84 35.05 Favored Pre-proline 0 C--O 1.238 0.493 0 CA-C-N 119.703 1.138 . . . . 0.0 109.352 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.24 100.43 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.924 3.083 . . . . 0.0 110.939 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.3 ptm -118.88 164.93 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.413 0.685 . . . . 0.0 109.672 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.412 ' CE1' HG11 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -131.39 169.67 15.72 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 173.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.9 m -141.77 138.86 32.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.858 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -76.28 94.09 3.52 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.128 1.331 . . . . 0.0 108.388 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 51.48 15.17 0.31 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.646 1.578 . . . . 0.0 114.73 -170.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.79 -20.61 4.3 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 117.896 -1.502 . . . . 0.0 113.941 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.6 m -78.16 141.83 38.42 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 121.12 2.46 . . . . 0.0 111.309 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -66.62 29.56 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.039 2.936 . . . . 0.0 116.966 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.25 0.37 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 125.32 1.448 . . . . 0.0 113.17 -167.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 tt -160.6 145.39 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 121.793 2.088 . . . . 0.0 113.516 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.29 136.08 3.92 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 121.466 -0.771 . . . . 0.0 112.337 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -136.01 167.55 21.01 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.093 1.357 . . . . 0.0 110.58 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.8 p -159.24 160.76 35.7 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 54.9 p -75.76 113.99 13.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.05 171.71 13.0 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 164.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -63.75 -32.69 74.26 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.291 -0.881 . . . . 0.0 111.717 -175.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -137.1 10.57 3.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.371 1.468 . . . . 0.0 113.149 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -156.8 -177.35 6.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.065 1.346 . . . . 0.0 108.839 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tp -124.17 121.43 35.09 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.558 1.543 . . . . 0.0 107.684 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.461 ' HB2' HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -79.03 133.59 36.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 116.238 -1.839 . . . . 0.0 109.417 170.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.8 t -140.37 149.41 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 120.128 1.331 . . . . 0.0 110.566 172.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 t -160.42 158.87 26.01 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.58 1.152 . . . . 0.0 108.959 157.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -79.67 -57.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.098 0 CA-C-N 120.711 1.29 . . . . 0.0 110.519 165.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -138.16 -88.44 0.24 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 164.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -147.34 -36.15 0.23 Allowed 'General case' 0 N--CA 1.474 0.725 0 O-C-N 121.341 -0.85 . . . . 0.0 111.836 -163.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -25.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 123.549 0.74 . . . . 0.0 110.394 165.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.57 -35.93 38.25 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.823 0.725 . . . . 0.0 111.545 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.1 mm -110.43 13.46 8.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.32 1.448 . . . . 0.0 110.841 -172.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.6 m -129.51 -33.57 1.86 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 170.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -63.6 1.33 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.407 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 11.2 m-85 -79.86 0.41 31.21 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.61 -31.42 64.28 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -72.07 -48.52 43.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.75 0.786 . . . . 0.0 109.778 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.2 -42.83 91.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.822 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.53 -48.52 85.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.082 0.953 . . . . 0.0 109.749 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -51.45 70.02 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.468 0.707 . . . . 0.0 109.706 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -64.82 -37.83 88.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.85 1.26 . . . . 0.0 111.642 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.04 -22.76 67.08 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.951 0.796 . . . . 0.0 111.693 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.12 9.49 10.58 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-O 118.525 -1.153 . . . . 0.0 114.104 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -113.07 95.93 5.66 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.484 1.642 . . . . 0.0 113.251 -162.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.62 105.58 0.06 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 129.251 3.02 . . . . 0.0 113.355 174.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.34 175.87 6.94 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.733 2.013 . . . . 0.0 112.802 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.1 p -94.67 -164.85 1.22 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.108 1.363 . . . . 0.0 107.618 156.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -76.63 -19.31 57.94 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 117.079 -1.439 . . . . 0.0 112.588 166.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.94 -7.84 4.9 Favored Glycine 0 N--CA 1.47 0.958 0 CA-C-N 120.388 1.449 . . . . 0.0 115.054 -162.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 66' ' ' SER . 2.9 pp -151.54 161.61 42.39 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 164.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -99.45 165.79 11.48 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 166.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.5 153.2 44.77 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 121.774 -0.579 . . . . 0.0 109.637 169.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.11 143.74 34.63 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -71.64 149.52 55.22 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.496 2.797 . . . . 0.0 110.409 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -57.86 -41.33 82.22 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -54.15 -44.04 71.1 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.024 0.93 . . . . 0.0 112.17 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.83 146.86 32.59 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -159.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.04 139.1 23.78 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.268 1.312 . . . . 0.0 112.052 -163.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -69.69 150.17 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.325 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -109.92 73.66 0.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.328 1.051 . . . . 0.0 111.873 -161.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -58.01 -24.16 57.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.709 0.804 . . . . 0.0 112.962 -171.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -68.09 -60.2 2.67 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.091 -1.006 . . . . 0.0 110.3 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.44 -45.14 62.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.229 1.412 . . . . 0.0 109.076 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.01 -53.97 50.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.835 1.254 . . . . 0.0 111.553 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -68.6 -40.13 80.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 117.484 -1.246 . . . . 0.0 111.786 -172.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -45.62 -57.06 4.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.541 0.736 . . . . 0.0 110.249 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.407 ' HE1' ' HB2' ' A' ' 77' ' ' PHE . 23.4 ptp -72.47 -42.63 64.73 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 118.046 -0.978 . . . . 0.0 112.888 -170.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -42.65 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 120.074 1.306 . . . . 0.0 109.689 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -64.17 -39.92 95.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.967 -0.54 . . . . 0.0 109.923 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -62.22 -46.89 86.85 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.349 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -21.22 63.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.09 1.314 . . . . 0.0 112.261 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.99 -61.6 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.456 1.102 . . . . 0.0 108.49 167.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -75.67 -2.9 31.65 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -171.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.3 -20.14 65.58 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.829 -1.169 . . . . 0.0 110.82 164.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -105.29 5.88 32.34 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.194 1.398 . . . . 0.0 111.344 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 124.697 1.199 . . . . 0.0 108.148 178.457 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.875 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -61.51 175.63 0.58 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.936 0.874 . . . . 0.0 110.629 162.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -147.27 -31.13 0.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.614 1.165 . . . . 0.0 109.87 163.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -6.33 15.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -64.15 -57.49 9.4 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.5 -42.53 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.877 1.671 . . . . 0.0 110.086 -167.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -93.99 -0.48 55.51 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.577 -169.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.58 -39.98 81.86 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.61 0.764 . . . . 0.0 109.609 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -66.33 -20.58 66.13 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -81.56 -55.21 4.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.2 -38.86 77.57 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.751 -0.642 . . . . 0.0 111.893 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -58.1 -33.05 68.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.396 0.678 . . . . 0.0 110.737 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.1 -3.24 82.78 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.529 1.061 . . . . 0.0 112.493 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.6 mt -77.69 90.79 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 171.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -76.11 8.19 3.48 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.182 2.193 . . . . 0.0 113.224 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -116.13 69.3 3.7 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 129.67 3.188 . . . . 0.0 108.767 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.97 -17.16 54.99 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 125.109 3.872 . . . . 0.0 113.856 -167.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.19 -16.39 59.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.135 0.88 . . . . 0.0 111.553 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -131.96 8.73 4.46 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.794 0.725 . . . . 0.0 112.326 -171.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -77.11 -62.33 1.69 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.308 1.443 . . . . 0.0 109.612 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.31 -32.55 38.27 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.134 2.174 . . . . 0.0 112.282 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -47.38 -53.46 13.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.805 0.842 . . . . 0.0 110.14 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.0 m -65.02 -29.24 70.13 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.74 -0.6 . . . . 0.0 111.277 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -72.45 -28.18 62.78 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 120.855 -1.153 . . . . 0.0 111.875 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.21 -54.66 43.12 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.676 1.125 . . . . 0.0 108.526 168.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -49.72 -53.22 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.169 0.987 . . . . 0.0 110.007 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.0 mt -64.63 -50.03 68.72 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.915 -170.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -69.47 -28.0 65.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.046 -0.978 . . . . 0.0 113.136 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.4 t90 -61.69 -60.39 3.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.413 HG11 ' CZ ' ' A' ' 48' ' ' PHE . 37.8 t -48.5 -45.57 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.05 0.841 . . . . 0.0 111.526 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.15 -13.03 5.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -115.4 -50.58 2.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.509 1.924 . . . . 0.0 111.483 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.9 -35.03 79.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.928 0.785 . . . . 0.0 110.832 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -128.81 74.53 80.73 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.66 -13.1 34.42 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.872 1.715 . . . . 0.0 110.81 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -86.22 33.2 0.61 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.442 2.297 . . . . 0.0 111.158 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 56' ' ' ILE . 51.1 mt -122.02 134.49 54.8 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 120.686 -1.258 . . . . 0.0 109.189 156.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -104.89 149.47 37.57 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 124.621 1.168 . . . . 0.0 109.41 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.71 154.83 49.38 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.599 2.866 . . . . 0.0 112.169 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -162.84 114.18 1.51 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.607 1.163 . . . . 0.0 108.534 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.0 mtp -82.22 121.49 26.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 166.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -138.65 138.44 37.81 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.9 m95 48.84 34.42 5.31 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.532 1.133 . . . . 0.0 112.165 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.26 18.09 10.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.471 1.908 . . . . 0.0 111.19 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.5 p -118.63 149.53 46.47 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.434 1.494 . . . . 0.0 109.304 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.49 106.68 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.251 3.301 . . . . 0.0 110.925 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.2 ptm -114.59 175.85 5.3 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.236 -0.915 . . . . 0.0 110.309 168.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' HG11 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -139.04 156.12 47.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 170.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.63 122.43 27.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -72.09 95.5 1.64 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 57.21 -3.32 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.93 -24.16 0.25 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 127.492 2.472 . . . . 0.0 113.67 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.61 -164.94 0.78 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.856 1.828 . . . . 0.0 114.718 -167.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -131.95 25.44 4.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.58 1.952 . . . . 0.0 111.445 -170.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.7 mt -65.4 -3.54 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.574 1.95 . . . . 0.0 111.725 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.439 HG21 HD13 ' A' ' 37' ' ' LEU . 6.1 tt -155.94 163.77 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 119.448 -2.033 . . . . 0.0 109.647 169.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.75 132.72 1.55 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -138.91 169.46 17.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.668 1.734 . . . . 0.0 110.085 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.59 161.83 38.15 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 159.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.4 p -65.09 149.19 50.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 165.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 t -137.47 168.25 20.03 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -58.7 -30.08 67.14 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -153.227 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -136.36 13.49 3.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.378 1.071 . . . . 0.0 112.638 174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -158.32 168.74 26.18 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.143 -0.973 . . . . 0.0 110.38 -166.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.2 tp -107.63 123.22 48.16 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.82 122.19 31.96 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.824 1.193 . . . . 0.0 108.524 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.0 t -135.32 137.43 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.256 1.022 . . . . 0.0 108.516 -174.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.4 p -163.05 165.26 15.01 Favored Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 127.108 2.163 . . . . 0.0 109.851 154.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.43 -56.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.139 1.226 . . . . 0.0 113.005 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -148.48 -83.2 0.11 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.56 1.073 . . . . 0.0 108.11 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -146.97 -27.97 0.39 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.804 1.241 . . . . 0.0 112.216 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.1 tp -63.7 -31.94 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 120.791 -1.193 . . . . 0.0 111.37 176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -48.47 -26.06 4.89 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 126.815 2.15 . . . . 0.0 113.324 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 mm -125.62 7.32 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.167 1.387 . . . . 0.0 109.944 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 t -84.8 -71.56 0.51 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 170.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -88.09 -50.8 6.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -170.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -67.89 -15.33 63.57 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.32 -30.33 38.45 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.449 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -69.37 -59.47 2.97 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 118.556 0.617 . . . . 0.0 109.94 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.47 -35.48 74.17 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.476 0.58 . . . . 0.0 112.456 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.82 -48.82 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.929 0.891 . . . . 0.0 109.576 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.22 -47.45 86.06 Favored 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 121.488 -0.758 . . . . 0.0 110.902 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -61.4 -16.22 44.48 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 128.253 2.621 . . . . 0.0 111.631 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.68 4.28 50.07 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 112.454 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.33 14.63 47.25 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.261 0.934 . . . . 0.0 114.719 169.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -112.78 90.64 3.4 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.863 1.332 . . . . 0.0 111.701 -168.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 m -53.28 98.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.225 2.61 . . . . 0.0 113.619 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.78 -172.95 4.46 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.78 1.632 . . . . 0.0 112.238 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.7 p -111.15 -164.77 0.94 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.468 1.907 . . . . 0.0 106.694 163.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -80.29 -22.59 41.44 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.939 -1.101 . . . . 0.0 112.93 161.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.16 -28.33 6.53 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.29 -1.284 . . . . 0.0 114.805 -168.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 pp -154.31 172.53 17.51 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.208 2.004 . . . . 0.0 110.226 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -114.57 166.36 11.8 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 120.824 -1.172 . . . . 0.0 109.006 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.78 133.22 20.75 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.6 mm -94.95 143.44 26.14 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 168.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.08 157.88 60.0 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.189 1.926 . . . . 0.0 109.925 172.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -61.07 -25.04 66.66 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.33 -0.856 . . . . 0.0 112.006 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -57.88 -62.46 1.79 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.044 1.737 . . . . 0.0 111.696 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -91.57 165.43 20.92 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 125.995 1.718 . . . . 0.0 111.814 -163.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.33 149.25 85.08 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.367 2.045 . . . . 0.0 110.672 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 p -96.94 127.07 49.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.17 83.34 7.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.462 1.125 . . . . 0.0 111.156 -169.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -57.03 -35.85 69.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.285 1.434 . . . . 0.0 110.222 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -39.33 77.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.486 -0.759 . . . . 0.0 112.339 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -49.06 46.79 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 122.03 0.919 . . . . 0.0 108.641 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.296 0.3 OUTLIER -75.82 -24.08 55.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.138 -169.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -37.71 88.44 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 120.535 1.516 . . . . 0.0 110.565 171.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -56.29 -52.0 66.13 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.102 0.865 . . . . 0.0 109.708 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.9 ptp -68.89 -36.75 78.42 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.312 -172.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -46.76 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 121.159 1.8 . . . . 0.0 109.262 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.75 -47.4 85.84 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.814 0.846 . . . . 0.0 110.352 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -61.87 -40.36 95.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.245 0.475 . . . . 0.0 110.643 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -24.62 66.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.042 0.837 . . . . 0.0 111.36 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 99.3 mt -79.24 -49.43 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.256 1.422 . . . . 0.0 108.905 169.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -61.38 -29.02 69.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.633 1.173 . . . . 0.0 110.826 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -82.97 -19.32 37.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.744 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -93.84 -1.21 55.19 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.983 1.713 . . . . 0.0 112.212 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 C--O 1.247 0.937 0 C-N-CA 128.546 2.738 . . . . 0.0 110.704 173.415 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.787 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -78.68 159.22 28.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.456 1.128 . . . . 0.0 108.607 163.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -138.95 -33.15 0.65 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.092 0.557 . . . . 0.0 111.412 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.6 mmt -57.16 -14.07 3.69 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.005 1.322 . . . . 0.0 113.142 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -74.06 -30.25 62.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 120.506 -1.371 . . . . 0.0 112.407 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.9 t -70.64 -33.2 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 124.181 0.926 . . . . 0.0 108.745 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -102.61 -2.41 28.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.896 1.278 . . . . 0.0 112.343 -171.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.88 72.12 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 122.382 1.087 . . . . 0.0 110.359 -174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.46 -12.92 62.05 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.434 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -75.45 -57.0 4.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.121 0.873 . . . . 0.0 109.978 167.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.77 -44.38 73.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.917 1.287 . . . . 0.0 111.603 -174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -53.68 -32.25 50.94 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.6 -18.22 66.56 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.519 -168.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.7 mt -69.37 114.61 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.78 6.0 14.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.747 1.219 . . . . 0.0 111.71 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.79 74.58 75.68 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 128.013 2.525 . . . . 0.0 110.046 -170.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -59.43 -30.85 93.66 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.094 2.529 . . . . 0.0 112.757 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.428 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 57.4 m-20 -70.03 -1.92 11.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.286 1.034 . . . . 0.0 112.308 -177.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 13.9 m80 -132.6 -30.72 1.42 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.294 1.838 . . . . 0.0 109.751 -176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.26 -48.56 45.75 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.64 1.576 . . . . 0.0 110.548 169.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.69 -36.96 82.39 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.329 0.393 . . . . 0.0 111.767 -168.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -63.78 -30.55 71.63 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.853 -0.529 . . . . 0.0 111.725 175.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.0 m -71.52 -41.65 68.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.859 0.864 . . . . 0.0 109.5 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -50.43 -43.64 55.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.169 0.895 . . . . 0.0 111.903 168.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.89 -27.5 69.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.342 0.974 . . . . 0.0 112.751 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.4 mt -73.53 -47.13 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.74 -63.41 1.21 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.86 0.864 . . . . 0.0 109.744 -169.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -64.37 -25.52 68.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.583 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -68.36 -42.25 79.46 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.208 0.913 . . . . 0.0 110.457 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.57 HG11 ' CD2' ' A' ' 48' ' ' PHE . 41.2 t -59.74 -48.4 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.9 0.773 . . . . 0.0 109.034 174.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.76 -29.37 68.13 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.11 -56.56 4.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.896 -0.503 . . . . 0.0 110.818 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 m -78.9 -28.99 44.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.792 1.637 . . . . 0.0 111.655 -165.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -131.62 64.42 72.86 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.187 0.995 . . . . 0.0 108.749 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.71 -13.03 31.96 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.673 2.249 . . . . 0.0 113.09 -171.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -74.13 -18.16 60.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.827 0.74 . . . . 0.0 112.253 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.6 mt -69.27 152.98 44.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -124.84 142.73 41.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.19 137.36 28.58 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.213 1.942 . . . . 0.0 110.479 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -147.32 135.66 21.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.356 1.062 . . . . 0.0 108.268 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.63 114.01 27.92 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 175.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.34 146.94 31.81 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.432 1.093 . . . . 0.0 108.079 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.6 m95 55.54 21.11 4.19 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.868 1.213 . . . . 0.0 114.115 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.2 t30 57.67 17.9 4.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 112.598 -165.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 59' ' ' SER . 68.5 p -110.74 142.99 27.3 Favored Pre-proline 0 N--CA 1.449 -0.516 0 O-C-N 120.532 -1.355 . . . . 0.0 109.361 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.31 128.66 15.83 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.532 2.155 . . . . 0.0 110.083 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.6 ptm -142.37 168.82 18.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.98 0.912 . . . . 0.0 109.021 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.57 ' CD2' HG11 ' A' ' 30' ' ' VAL . 1.8 m-85 -140.14 91.55 2.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -172.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 p -65.07 122.66 17.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -71.54 91.01 1.03 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.862 1.21 . . . . 0.0 108.338 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 48.8 18.14 0.18 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.653 1.181 . . . . 0.0 113.717 -170.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.39 -16.73 2.92 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.303 1.906 . . . . 0.0 115.621 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.12 -167.98 1.17 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 120.355 2.078 . . . . 0.0 112.811 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -128.99 43.82 3.08 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.155 1.382 . . . . 0.0 110.408 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.8 mt -75.73 -1.46 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.706 1.602 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 tt -164.92 157.59 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 119.746 -1.846 . . . . 0.0 112.542 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.35 136.2 2.19 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 165.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -131.09 163.76 26.94 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.231 1.015 . . . . 0.0 111.227 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.426 ' HB3' HG22 ' A' ' 45' ' ' THR . 2.4 p -149.48 156.68 42.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.886 0.85 . . . . 0.0 110.388 163.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 53.1 p -59.4 145.26 44.23 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.183 0.993 . . . . 0.0 108.685 167.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 m -133.56 177.61 7.57 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.205 1.402 . . . . 0.0 107.834 168.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.38 -57.22 8.46 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.145 0.978 . . . . 0.0 112.102 -167.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -126.19 4.29 7.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.119 0.968 . . . . 0.0 112.748 -173.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.501 ' CD2' ' HE ' ' A' ' 94' ' ' ARG . 4.1 p-80 -145.81 168.42 20.82 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.096 1.758 . . . . 0.0 108.445 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.2 tp -88.19 169.32 11.99 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 160.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 p -120.09 127.67 52.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.781 1.173 . . . . 0.0 108.136 160.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.417 ' HB ' ' CE1' ' A' ' 93' ' ' PHE . 92.8 t -135.19 148.0 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.2 t -165.94 165.37 10.79 Favored Pre-proline 0 C--O 1.241 0.631 0 C-N-CA 128.399 2.68 . . . . 0.0 105.947 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -83.16 -57.35 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.338 0 CA-C-N 120.153 1.09 . . . . 0.0 111.225 152.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -147.23 -86.34 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.9 -32.97 0.34 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.338 1.455 . . . . 0.0 111.7 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.77 -35.31 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 119.961 1.255 . . . . 0.0 111.064 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.97 -16.26 24.42 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.59 0.614 . . . . 0.0 113.817 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.1 mm -112.17 -14.44 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 126.735 2.014 . . . . 0.0 110.278 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.4 m -104.37 -55.6 2.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.0 0.52 . . . . 0.0 110.248 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -81.2 -63.49 1.39 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.427 ' CG ' ' HG3' ' A' ' 109' ' ' MET . 12.5 m-85 -72.94 -9.2 58.45 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.499 -0.48 . . . . 0.0 112.014 -170.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.28 -30.89 63.07 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.372 0.533 . . . . 0.0 112.23 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -63.92 -44.15 93.76 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 118.439 0.563 . . . . 0.0 110.295 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.508 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -77.53 -29.46 52.35 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.114 -175.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.1 mt -60.22 -48.68 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.684 1.194 . . . . 0.0 108.324 168.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.66 73.13 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.967 0.907 . . . . 0.0 110.712 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -58.06 -30.04 65.88 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.744 0.818 . . . . 0.0 111.983 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.39 95.9 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.502 1.046 . . . . 0.0 110.862 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 132.25 -11.1 5.31 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 127.283 2.373 . . . . 0.0 111.465 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -86.93 174.0 9.0 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 120.93 -1.335 . . . . 0.0 112.747 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.2 t -127.53 175.09 8.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.486 1.914 . . . . 0.0 109.297 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.61 -176.41 4.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.064 1.746 . . . . 0.0 110.618 -166.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.8 p -132.01 -168.75 2.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.796 1.638 . . . . 0.0 108.225 168.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.72 5.92 12.15 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.655 -1.278 . . . . 0.0 113.409 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.08 -14.19 0.03 OUTLIER Glycine 0 CA--C 1.524 0.644 0 CA-C-N 119.544 1.065 . . . . 0.0 115.186 -171.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.6 pp -159.81 -173.37 4.06 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.691 1.246 . . . . 0.0 109.644 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.417 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 12.2 p90 -135.0 165.63 24.91 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.875 -1.141 . . . . 0.0 111.66 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.501 ' HE ' ' CD2' ' A' ' 64' ' ' HIS . 1.8 mmt-85 -139.92 91.24 2.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.721 1.208 . . . . 0.0 111.658 -157.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -86.2 141.1 34.74 Favored Pre-proline 0 C--O 1.239 0.54 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.09 155.77 26.07 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.114 2.543 . . . . 0.0 110.516 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -63.35 -19.89 65.03 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -68.58 -44.96 73.3 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.759 1.163 . . . . 0.0 111.105 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -90.32 150.24 42.64 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 123.609 0.764 . . . . 0.0 109.85 -159.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.73 123.41 5.83 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.777 2.984 . . . . 0.0 112.169 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.1 m -68.6 9.69 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -166.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 43.76 81.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 128.043 2.537 . . . . 0.0 114.285 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -60.33 -27.71 67.57 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.957 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.72 -56.06 18.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.986 0.514 . . . . 0.0 110.813 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.508 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -61.6 -46.76 88.47 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.595 0.712 . . . . 0.0 109.518 -173.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -27.43 62.14 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.811 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -58.46 -55.86 29.59 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 119.681 1.128 . . . . 0.0 108.933 165.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -59.68 -37.72 79.56 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.044 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.427 ' HG3' ' CG ' ' A' ' 77' ' ' PHE . 6.1 ttm -53.18 -61.19 2.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.532 1.933 . . . . 0.0 111.303 172.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -45.88 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.745 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.74 -46.59 74.32 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.828 0.851 . . . . 0.0 109.435 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.8 -47.97 81.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.389 0.276 . . . . 0.0 111.385 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -20.22 63.27 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.544 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 91.1 mt -78.24 -63.62 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.159 0.984 . . . . 0.0 109.177 165.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -71.37 -13.18 61.78 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -164.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.57 -35.99 82.78 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.979 0.512 . . . . 0.0 109.688 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -79.65 7.03 9.17 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.765 2.026 . . . . 0.0 112.428 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 128.263 2.625 . . . . 0.0 112.212 -162.648 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.856 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 m -70.61 173.41 7.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.594 0.758 . . . . 0.0 109.918 169.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -159.14 -37.82 0.06 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 117.311 -1.328 . . . . 0.0 113.813 -176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.32 -36.56 43.23 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 120.814 1.643 . . . . 0.0 112.151 174.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -45.88 -44.58 14.56 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.099 0.959 . . . . 0.0 113.228 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.61 -50.57 43.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -80.24 -9.68 59.73 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -165.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.44 90.5 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.393 1.477 . . . . 0.0 111.446 -167.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.39 -21.99 66.74 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.157 0.983 . . . . 0.0 112.897 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -81.28 -55.1 4.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -51.83 -40.99 61.43 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.682 1.193 . . . . 0.0 111.777 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -58.38 -46.87 85.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.402 0.681 . . . . 0.0 110.431 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.87 -4.77 88.48 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.97 1.272 . . . . 0.0 113.86 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.2 mt -65.22 95.61 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 164.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.11 3.08 3.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.937 1.295 . . . . 0.0 112.855 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -105.63 75.89 0.33 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 C-N-CA 129.316 3.046 . . . . 0.0 109.212 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.48 -19.86 65.52 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.77 2.313 . . . . 0.0 112.781 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.68 2.33 30.1 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.077 1.351 . . . . 0.0 112.612 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -145.09 15.91 1.53 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.154 1.382 . . . . 0.0 110.127 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -91.11 -50.64 5.73 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.882 1.673 . . . . 0.0 109.569 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -53.91 -26.75 26.65 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 126.593 1.957 . . . . 0.0 113.469 -167.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -52.66 -55.62 21.23 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -58.32 -34.96 71.17 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.525 -0.734 . . . . 0.0 112.499 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -41.16 96.61 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.017 0.927 . . . . 0.0 111.298 172.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.9 -54.63 42.69 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.099 0.863 . . . . 0.0 109.521 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -52.46 -51.12 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.757 0.823 . . . . 0.0 109.937 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.9 mt -63.07 -51.89 64.88 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.714 0.406 . . . . 0.0 110.04 -171.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -65.29 -33.18 75.37 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 123.2 0.313 . . . . 0.0 110.511 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -64.97 -48.36 74.3 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.16 0.984 . . . . 0.0 110.89 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 48' ' ' PHE . 24.7 t -52.75 -47.73 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 118.793 0.724 . . . . 0.0 109.814 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.23 13.58 0.41 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.21 -34.83 0.52 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.748 1.219 . . . . 0.0 114.068 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.5 m -75.92 -39.46 56.18 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.009 -1.057 . . . . 0.0 108.876 168.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -122.87 70.46 39.13 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 122.203 1.001 . . . . 0.0 110.914 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.85 -4.72 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.041 2.494 . . . . 0.0 112.923 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -79.4 -17.8 53.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.33 1.852 . . . . 0.0 113.11 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.444 HD12 HG13 ' A' ' 30' ' ' VAL . 43.5 mt -80.93 144.92 31.54 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.566 -1.334 . . . . 0.0 109.785 175.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -119.8 143.99 36.26 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.024 1.73 . . . . 0.0 110.141 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.51 148.09 37.15 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.655 2.903 . . . . 0.0 113.762 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -153.7 119.4 5.28 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.982 1.313 . . . . 0.0 110.649 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.71 103.5 9.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.375 1.07 . . . . 0.0 108.823 170.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -135.32 149.33 49.73 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.265 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.7 m95 55.73 16.26 1.92 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 66.95 27.48 8.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.891 2.077 . . . . 0.0 112.239 -170.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.0 p -130.82 152.71 81.04 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.91 1.684 . . . . 0.0 108.162 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.29 112.68 3.6 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 124.573 3.515 . . . . 0.0 110.209 170.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.3 ptm -122.84 170.6 9.93 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.753 -0.592 . . . . 0.0 109.772 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CZ ' HG11 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -138.95 167.73 21.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.645 0.736 . . . . 0.0 109.258 176.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.2 p -140.85 112.31 7.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 123.173 0.589 . . . . 0.0 111.444 -165.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.81 102.09 3.3 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 47.39 40.44 10.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.128 0.971 . . . . 0.0 111.579 -171.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.87 -2.32 66.41 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.772 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.5 m -82.65 177.74 8.55 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.272 2.036 . . . . 0.0 109.723 -177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.427 ' H ' HG22 ' A' ' 53' ' ' THR . 62.0 t80 -102.88 9.1 39.05 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.334 -1.479 . . . . 0.0 114.378 -170.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.75 8.58 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.261 0 C-N-CA 127.604 2.361 . . . . 0.0 114.178 -162.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 tt -154.21 150.5 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 O-C-N 117.806 -3.059 . . . . 0.0 111.464 165.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.95 153.32 24.44 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 162.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -147.97 161.4 41.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.147 1.473 . . . . 0.0 110.212 170.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.72 155.84 41.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.518 0.675 . . . . 0.0 110.092 172.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.3 p -66.84 154.33 41.16 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.041 1.336 . . . . 0.0 109.343 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB3' ' CD2' ' A' ' 64' ' ' HIS . 31.2 t -133.9 163.99 28.29 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 156.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -48.12 -40.5 23.8 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.321 1.048 . . . . 0.0 113.517 -168.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -124.95 8.59 8.08 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.413 ' CD2' ' HB3' ' A' ' 61' ' ' SER . 7.7 p-80 -158.55 157.46 32.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.118 0.872 . . . . 0.0 112.315 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.9 tp -85.57 156.9 20.55 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 166.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.23 112.34 16.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.151 1.38 . . . . 0.0 109.906 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.1 t -126.78 141.08 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.236 2.214 . . . . 0.0 110.721 -166.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.5 t -164.45 159.58 15.84 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 108.361 164.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.34 -58.48 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 120.524 1.223 . . . . 0.0 111.138 166.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -134.81 -86.25 0.39 Allowed 'General case' 0 C--O 1.233 0.211 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 168.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -136.96 -30.84 0.86 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.984 1.714 . . . . 0.0 111.69 -172.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -62.35 -32.27 54.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 119.321 0.964 . . . . 0.0 111.781 -165.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.51 -29.52 57.55 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.638 1.589 . . . . 0.0 113.52 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.7 mm -98.13 -5.74 9.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.868 1.667 . . . . 0.0 110.114 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.0 m -97.47 -80.22 0.45 Allowed 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 124.853 1.261 . . . . 0.0 108.879 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -83.68 -37.35 22.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.715 1.143 . . . . 0.0 110.159 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 109' ' ' MET . 59.8 m-85 -80.82 -11.4 59.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.292 0.496 . . . . 0.0 111.82 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.78 67.96 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.734 0.814 . . . . 0.0 113.173 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.38 -52.04 44.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.37 80.63 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.789 0.836 . . . . 0.0 111.597 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.63 -52.34 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.997 0.817 . . . . 0.0 109.237 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.54 -48.64 80.11 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.419 0.688 . . . . 0.0 110.275 -175.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -52.8 -44.17 66.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.56 1.544 . . . . 0.0 111.326 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.17 -5.92 30.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.352 0.661 . . . . 0.0 112.401 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.01 9.52 53.86 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.146 1.355 . . . . 0.0 112.801 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -99.62 163.43 12.5 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.133 1.467 . . . . 0.0 111.208 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.8 m -124.51 93.08 3.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.965 -151.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . . . -80.04 165.36 22.62 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.367 -0.833 . . . . 0.0 112.01 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.0 p -103.23 -164.35 1.07 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.11 1.764 . . . . 0.0 106.249 152.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 -2.18 51.22 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.693 -1.254 . . . . 0.0 112.256 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.03 -2.42 2.14 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.467 1.032 . . . . 0.0 113.749 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.56 177.69 11.09 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.289 1.545 . . . . 0.0 109.101 162.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 13.1 p90 -124.16 164.23 19.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.59 -0.694 . . . . 0.0 110.779 166.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.65 152.44 48.09 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 121.885 -0.509 . . . . 0.0 111.815 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.3 mm -123.47 142.88 39.97 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.39 150.99 25.73 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.564 2.176 . . . . 0.0 111.53 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -61.89 -20.95 64.3 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.87 -34.95 72.15 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.588 -0.695 . . . . 0.0 111.843 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.99 159.99 44.73 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 122.845 0.458 . . . . 0.0 109.794 -151.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.13 139.35 13.36 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-O 123.503 1.376 . . . . 0.0 111.946 -157.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.47 111.04 20.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 85.61 0.67 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.679 1.192 . . . . 0.0 112.541 -175.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -63.21 -38.53 91.55 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.064 1.346 . . . . 0.0 111.311 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -58.09 9.93 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.454 0.702 . . . . 0.0 110.19 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.99 -41.61 98.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.096 -172.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.275 0.2 OUTLIER -75.66 -26.16 57.44 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.432 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.438 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -68.21 -35.51 78.08 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 121.088 1.767 . . . . 0.0 110.934 174.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -56.42 -59.19 5.33 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.774 0.716 . . . . 0.0 109.543 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . 22.2 ptp -62.22 -43.26 99.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.64 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -68.9 -46.24 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 118.855 0.752 . . . . 0.0 109.206 -174.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -65.92 -40.58 91.57 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.716 1.143 . . . . 0.0 110.743 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.94 -47.27 85.62 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.366 0.53 . . . . 0.0 110.693 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.02 -13.38 11.22 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.735 0.814 . . . . 0.0 110.905 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 62.9 mt -95.74 -49.77 12.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-N 120.063 1.301 . . . . 0.0 110.342 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -72.15 3.48 4.48 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 120.147 1.34 . . . . 0.0 112.579 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -87.91 -15.82 35.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.52 1.528 . . . . 0.0 112.511 164.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -113.18 32.55 5.66 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.525 1.53 . . . . 0.0 110.136 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.331 157.502 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.757 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -64.64 173.71 2.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.903 -0.763 . . . . 0.0 110.413 171.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -136.99 -42.32 0.58 Allowed 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.809 -0.557 . . . . 0.0 112.363 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.4 mmt -59.05 -33.37 70.7 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -172.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.71 -36.49 72.06 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.56 0.618 . . . . 0.0 112.431 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.95 -45.24 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.048 0.939 . . . . 0.0 109.486 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -90.9 -9.42 46.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -167.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.75 91.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.396 1.479 . . . . 0.0 111.789 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.25 -27.08 63.65 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.727 1.211 . . . . 0.0 112.327 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -77.36 -50.57 12.48 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.642 0.777 . . . . 0.0 109.651 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.18 -50.33 62.06 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.608 1.163 . . . . 0.0 109.852 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -58.34 -42.85 87.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.008 0.923 . . . . 0.0 110.688 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.14 -35.86 91.07 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.759 -1.578 . . . . 0.0 114.208 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -54.75 108.74 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -73.34 -3.49 27.45 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.961 1.304 . . . . 0.0 112.611 -171.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 76.05 33.18 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 127.363 2.265 . . . . 0.0 108.7 -170.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.8 -21.56 72.47 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.313 2.675 . . . . 0.0 113.391 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.469 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 6.3 m-20 -63.89 -19.84 65.38 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.611 0.641 . . . . 0.0 111.734 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 3.7 m80 -123.61 -24.03 4.63 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.428 1.491 . . . . 0.0 110.18 -170.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -48.79 -45.58 40.37 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.305 1.042 . . . . 0.0 110.228 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.02 -32.73 9.81 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.815 1.646 . . . . 0.0 113.424 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -67.31 -14.38 62.87 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.35 -1.469 . . . . 0.0 112.387 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.5 m -100.98 -35.72 9.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.716 1.206 . . . . 0.0 109.789 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -26.2 63.57 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.426 0.557 . . . . 0.0 111.38 172.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -55.82 -62.58 1.6 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.634 1.574 . . . . 0.0 110.156 168.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 mt -57.58 -42.81 82.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 124.45 1.1 . . . . 0.0 112.466 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.11 -49.76 75.83 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.259 0.936 . . . . 0.0 110.036 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -65.57 -36.79 84.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 118.161 -0.923 . . . . 0.0 112.155 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -57.65 -53.55 56.91 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.158 0.89 . . . . 0.0 111.028 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.685 HG11 ' CE2' ' A' ' 48' ' ' PHE . 72.2 t -63.01 -41.69 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 O-C-N 121.196 -0.94 . . . . 0.0 109.689 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.83 5.03 2.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.522 1.129 . . . . 0.0 113.722 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.69 -62.76 1.49 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.619 1.568 . . . . 0.0 110.456 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.1 m -63.65 -32.04 73.4 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.604 1.093 . . . . 0.0 111.871 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -121.72 66.13 19.49 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 119.703 1.138 . . . . 0.0 110.806 -172.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.07 -10.88 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.228 3.285 . . . . 0.0 112.539 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -58.97 -22.03 59.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.916 2.087 . . . . 0.0 113.755 163.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 110' ' ' ILE . 35.6 mt -89.46 160.58 16.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -134.79 149.52 70.88 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 126.786 2.035 . . . . 0.0 108.866 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.61 146.25 66.64 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 122.826 2.351 . . . . 0.0 112.194 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -158.02 119.13 3.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.027 1.331 . . . . 0.0 108.219 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -84.01 119.04 24.46 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -141.49 136.29 31.09 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.671 -0.643 . . . . 0.0 109.939 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.6 m95 56.35 24.0 7.89 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.5 t30 69.89 9.55 7.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.001 2.12 . . . . 0.0 112.909 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -111.91 143.94 29.69 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 125.299 1.44 . . . . 0.0 109.208 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -70.28 125.91 12.4 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.154 1.902 . . . . 0.0 111.782 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.6 ptm -133.0 171.42 13.99 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.433 1.093 . . . . 0.0 108.904 169.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.685 ' CE2' HG11 ' A' ' 30' ' ' VAL . 3.2 m-85 -138.22 105.62 5.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.15 125.71 29.51 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 120.514 -1.366 . . . . 0.0 109.45 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -72.82 83.96 1.21 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 53.08 -19.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 118.829 2.9 . . . . 0.0 118.829 -162.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.49 40.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -168.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.99 -176.58 3.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.011 0.906 . . . . 0.0 110.053 174.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -124.84 32.03 5.53 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.827 1.651 . . . . 0.0 111.132 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.1 mt -70.13 -0.92 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.187 1.395 . . . . 0.0 111.671 -168.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.1 tt -161.59 147.26 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 O-C-N 119.636 -1.915 . . . . 0.0 111.962 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.73 156.11 27.26 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 158.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.3 155.2 41.82 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.365 -1.079 . . . . 0.0 111.642 169.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 t -142.87 153.48 43.19 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.3 p -70.81 159.65 34.18 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.582 1.153 . . . . 0.0 109.81 171.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -146.18 179.78 7.27 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.402 1.481 . . . . 0.0 109.29 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -56.41 -60.24 3.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.075 0.95 . . . . 0.0 112.086 -169.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -121.6 8.7 10.11 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.994 0.918 . . . . 0.0 111.255 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -152.55 172.85 15.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.493 1.117 . . . . 0.0 109.058 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.5 tp -101.01 158.94 15.63 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.471 1.909 . . . . 0.0 107.785 166.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 92' ' ' LEU . 46.2 p -124.93 113.11 17.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.974 1.261 . . . . 0.0 111.045 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.23 146.02 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 125.449 1.5 . . . . 0.0 109.408 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.0 t -165.79 157.55 12.41 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.781 1.633 . . . . 0.0 107.335 167.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.1 -56.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.209 0 N-CA-C 109.117 -1.147 . . . . 0.0 109.117 160.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -151.34 -85.32 0.08 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -140.54 -49.47 0.44 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.38 1.872 . . . . 0.0 110.779 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.3 tt -57.91 -34.26 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 121.509 -0.744 . . . . 0.0 111.829 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -44.57 -48.23 8.83 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 172.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mm -91.49 -2.53 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.529 1.132 . . . . 0.0 110.877 -168.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.3 m -105.96 -54.79 2.42 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 120.543 -1.348 . . . . 0.0 111.4 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -78.34 -56.81 4.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.959 1.704 . . . . 0.0 106.84 -170.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -80.63 -18.66 47.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.691 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.57 -21.92 54.37 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.78 -61.28 2.28 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.04 -36.89 68.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.111 0.964 . . . . 0.0 112.27 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.69 -45.33 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.782 1.233 . . . . 0.0 110.254 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.9 -52.62 64.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -21.9 64.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 178.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.29 -21.29 62.96 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.308 0.958 . . . . 0.0 110.716 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.07 10.24 5.28 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.36 -1.245 . . . . 0.0 113.709 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -111.69 122.33 47.53 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.2 2.0 . . . . 0.0 110.868 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.7 p -75.69 85.13 2.7 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.126 0.97 . . . . 0.0 110.89 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.65 171.23 0.66 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.83 0.852 . . . . 0.0 110.985 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.2 p -101.81 -172.35 2.13 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 167.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -82.85 -19.79 36.85 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 118.063 -0.97 . . . . 0.0 113.023 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -121.23 -14.86 4.83 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 119.079 0.854 . . . . 0.0 113.895 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 66' ' ' SER . 4.6 pp -150.61 164.85 35.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.934 1.694 . . . . 0.0 109.39 167.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -106.85 160.45 15.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.56 1.073 . . . . 0.0 110.55 170.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.81 141.85 23.04 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.865 -0.522 . . . . 0.0 110.139 -166.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.77 143.51 43.89 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -172.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.53 151.84 82.07 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.586 1.524 . . . . 0.0 109.896 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -64.32 -26.13 68.34 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.843 -0.599 . . . . 0.0 112.338 168.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -62.8 -70.0 0.23 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.696 0.798 . . . . 0.0 111.73 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.82 157.53 87.2 Favored Pre-proline 0 C--O 1.236 0.347 0 O-C-N 123.213 0.32 . . . . 0.0 110.228 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.17 161.29 46.47 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.188 1.925 . . . . 0.0 111.182 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.54 136.59 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.02 2.128 . . . . 0.0 108.764 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.86 102.38 5.5 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 163.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -73.56 -15.77 61.28 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.09 0.859 . . . . 0.0 111.207 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -66.62 -65.5 0.67 Allowed 'General case' 0 CA--C 1.527 0.096 0 O-C-N 121.196 -0.94 . . . . 0.0 111.154 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.26 -38.94 77.91 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mt -46.01 -45.58 15.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.571 2.748 . . . . 0.0 113.863 172.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -71.3 -48.02 53.22 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 125.567 1.547 . . . . 0.0 109.306 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.39 -49.27 78.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -172.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.1 ptp -70.49 3.77 2.81 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.069 1.747 . . . . 0.0 114.616 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -120.46 -48.56 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 120.555 1.525 . . . . 0.0 109.412 175.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -59.59 -45.51 91.68 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.564 1.074 . . . . 0.0 109.008 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -56.63 -49.49 74.83 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 119.669 -0.205 . . . . 0.0 110.536 172.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -18.65 65.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.798 -0.62 . . . . 0.0 112.387 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mt -82.58 -55.46 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -70.97 -12.58 61.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.058 0.845 . . . . 0.0 112.577 -172.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.39 -21.69 48.96 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.506 1.122 . . . . 0.0 111.345 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -93.12 34.75 1.1 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.896 2.078 . . . . 0.0 109.78 174.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.634 1.573 . . . . 0.0 110.963 167.64 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.728 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -69.63 178.17 2.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.269 0.628 . . . . 0.0 110.327 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -114.54 -39.77 3.73 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.478 0.711 . . . . 0.0 109.55 164.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.8 mmt -53.7 -34.04 57.49 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.073 0.949 . . . . 0.0 112.036 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -57.09 -42.94 81.64 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.331 0.969 . . . . 0.0 111.93 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.4 -40.38 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.863 0.865 . . . . 0.0 110.432 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -97.18 -19.93 18.29 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -167.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.51 -33.7 76.5 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.629 1.104 . . . . 0.0 111.529 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.84 -43.17 48.69 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.861 1.264 . . . . 0.0 111.695 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -72.24 -43.72 63.95 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.451 0.7 . . . . 0.0 110.496 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.83 -47.16 80.96 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -55.54 -43.25 75.61 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 122.908 0.483 . . . . 0.0 110.697 173.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.82 -24.82 71.6 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.97 -0.906 . . . . 0.0 112.872 -174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 98.3 mt -64.32 110.24 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 119.302 1.551 . . . . 0.0 107.715 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -72.71 -8.04 53.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.468 1.907 . . . . 0.0 113.939 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.73 70.64 1.71 Allowed Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 126.191 1.796 . . . . 0.0 109.691 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.94 -29.21 87.59 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.965 3.11 . . . . 0.0 113.883 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.07 -8.29 11.45 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.733 0.697 . . . . 0.0 112.218 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -123.77 -13.36 7.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.813 1.645 . . . . 0.0 110.107 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.79 -56.34 9.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.965 1.306 . . . . 0.0 109.681 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -62.63 -30.54 71.43 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.64 0.776 . . . . 0.0 112.069 -161.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -50.45 21.58 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.189 1.395 . . . . 0.0 111.578 169.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 m -59.87 -44.73 94.01 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.549 1.54 . . . . 0.0 111.355 -177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -35.87 46.48 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.124 2.17 . . . . 0.0 112.883 175.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -68.55 -48.71 63.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.043 0.537 . . . . 0.0 111.539 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mt -55.83 -49.99 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 123.953 0.783 . . . . 0.0 109.341 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 mt -56.61 -49.17 75.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.21 0.459 . . . . 0.0 110.524 -171.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 t -65.49 -40.24 92.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.376 0.671 . . . . 0.0 111.213 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -63.18 -39.32 94.31 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.647 0.779 . . . . 0.0 111.01 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.755 HG11 ' CE2' ' A' ' 48' ' ' PHE . 54.9 t -58.77 -47.33 89.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-O 118.41 -0.805 . . . . 0.0 108.891 174.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.68 -8.76 15.8 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.328 0.967 . . . . 0.0 113.155 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.36 -60.24 1.56 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.221 1.008 . . . . 0.0 111.177 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 m -69.78 -38.82 76.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.569 1.077 . . . . 0.0 110.439 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.436 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -123.9 65.18 35.64 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -173.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.17 -10.3 28.67 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.318 2.012 . . . . 0.0 111.772 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.56 -28.67 66.19 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.838 1.255 . . . . 0.0 112.84 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.642 HD21 ' CD1' ' A' ' 114' ' ' ILE . 3.5 mm? -69.35 146.84 51.82 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 171.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -124.9 147.99 58.34 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.22 148.73 31.05 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.107 2.538 . . . . 0.0 112.323 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -163.82 82.46 0.44 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.412 1.485 . . . . 0.0 107.251 172.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -70.75 134.43 47.42 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.016 -1.678 . . . . 0.0 108.53 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -154.97 152.8 30.13 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.571 1.148 . . . . 0.0 110.337 -170.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.8 m95 47.89 28.98 1.51 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.257 1.423 . . . . 0.0 112.767 -171.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 67.47 24.68 8.7 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.449 1.9 . . . . 0.0 112.492 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.402 HG22 ' HB3' ' A' ' 59' ' ' SER . 26.7 p -124.57 143.2 42.63 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 125.358 1.463 . . . . 0.0 109.267 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.8 124.88 10.03 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.844 2.362 . . . . 0.0 108.93 164.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.0 ptm -137.09 163.36 30.99 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 167.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.755 ' CE2' HG11 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -127.2 158.97 35.69 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 175.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 m -128.21 124.44 36.73 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -173.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -74.78 84.42 2.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.257 16.6 mt-30 64.34 -11.51 0.12 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.878 2.071 . . . . 0.0 114.884 -176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.73 -9.84 0.02 OUTLIER Glycine 0 CA--C 1.538 1.478 0 C-N-CA 125.202 1.382 . . . . 0.0 116.056 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.84 -166.98 1.56 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.242 1.521 . . . . 0.0 114.115 -163.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -126.48 26.37 6.35 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.978 1.711 . . . . 0.0 110.841 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.523 HG23 HD22 ' A' ' 113' ' ' ASN . 80.8 mt -67.39 -2.02 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 O-C-N 120.114 -1.616 . . . . 0.0 112.657 -171.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.425 HD12 HG13 ' A' ' 110' ' ' ILE . 10.1 tt -161.08 142.69 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 121.716 2.053 . . . . 0.0 111.795 170.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.22 157.74 29.36 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 161.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -147.27 141.42 26.11 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.276 1.038 . . . . 0.0 109.224 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -134.45 114.25 12.69 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.037 -1.04 . . . . 0.0 108.446 -176.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.8 p -54.75 134.73 47.7 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 119.212 0.915 . . . . 0.0 110.613 -168.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -112.49 163.95 13.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -54.51 -27.04 35.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.679 1.592 . . . . 0.0 113.796 -165.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -137.71 0.24 2.21 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.132 0.973 . . . . 0.0 113.383 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -153.17 158.33 41.63 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.382 0.992 . . . . 0.0 110.137 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -104.48 113.12 26.47 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.427 ' HB2' HD22 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -71.07 131.25 43.35 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 167.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.7 t -135.32 138.44 48.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 t -167.86 153.16 6.79 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 125.175 1.39 . . . . 0.0 107.405 161.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.67 -57.61 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 CA-C-N 119.971 1.025 . . . . 0.0 110.699 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -146.24 -79.95 0.16 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -139.63 -38.37 0.48 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.367 1.467 . . . . 0.0 111.614 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -27.86 43.24 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 118.81 0.732 . . . . 0.0 112.422 -166.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -46.56 -43.26 15.11 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.029 0.824 . . . . 0.0 111.155 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 mm -91.31 -11.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 121.998 -0.707 . . . . 0.0 110.235 -168.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.9 m -107.98 -57.19 2.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.151 0.887 . . . . 0.0 110.471 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.76 -60.87 2.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.569 1.948 . . . . 0.0 107.415 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 109' ' ' MET . 59.8 m-85 -77.49 5.99 7.9 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.25 -48.69 12.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.944 1.697 . . . . 0.0 111.775 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -73.42 -41.09 63.71 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.109 0.964 . . . . 0.0 109.132 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -58.95 -43.21 91.21 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.054 0.942 . . . . 0.0 110.169 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.8 mt -66.8 -43.31 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 120.027 1.285 . . . . 0.0 109.493 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.86 -57.02 14.29 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.556 1.143 . . . . 0.0 110.795 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -25.05 68.16 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.404 1.082 . . . . 0.0 112.802 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.39 -17.26 63.66 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.696 0.68 . . . . 0.0 111.281 173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.14 9.21 5.7 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.347 1.927 . . . . 0.0 113.398 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -134.18 111.89 10.66 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 119.087 1.444 . . . . 0.0 110.705 -161.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.7 m -76.59 15.6 0.61 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.985 -1.697 . . . . 0.0 114.541 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 52.46 -155.24 0.18 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.398 1.879 . . . . 0.0 112.548 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.5 p -125.59 -164.35 1.29 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.074 2.15 . . . . 0.0 105.952 167.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -81.82 -10.29 59.37 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.558 -1.21 . . . . 0.0 112.943 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.79 13.8 0.19 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-N 120.333 1.424 . . . . 0.0 115.235 -167.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 66' ' ' SER . 3.9 pp -166.05 178.97 6.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 130.332 3.453 . . . . 0.0 106.29 162.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -119.84 166.22 13.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 120.235 1.38 . . . . 0.0 108.368 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 171.53 14.18 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.463 -0.773 . . . . 0.0 109.667 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -133.59 143.71 48.99 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 103.952 -2.611 . . . . 0.0 103.952 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.95 159.17 51.04 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 CA-C-N 120.785 1.316 . . . . 0.0 109.227 169.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -63.56 -15.91 59.36 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.301 -0.874 . . . . 0.0 112.562 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -66.7 -19.96 65.87 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.407 2.283 . . . . 0.0 114.217 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -135.28 162.8 55.31 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-N 119.476 1.035 . . . . 0.0 111.373 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.66 133.83 26.71 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.573 2.849 . . . . 0.0 110.519 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.04 145.81 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 167.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.86 90.33 8.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.554 1.541 . . . . 0.0 108.556 -172.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -58.57 -31.97 68.49 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.531 -0.731 . . . . 0.0 109.714 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -69.65 -36.21 75.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.173 -0.954 . . . . 0.0 112.813 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.468 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -84.07 -32.67 24.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.329 0.3 OUTLIER -83.18 -23.46 32.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 117.354 -1.308 . . . . 0.0 111.289 -177.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -65.79 -48.53 71.47 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 120.729 1.604 . . . . 0.0 109.725 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -60.49 -31.63 70.66 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -159.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 77' ' ' PHE . 22.1 ptp -83.49 -29.01 28.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.425 HG13 HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -79.83 -44.57 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 119.348 0.977 . . . . 0.0 109.348 -177.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.34 -40.06 73.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 118.682 0.674 . . . . 0.0 109.533 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -71.61 -54.03 11.75 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.859 1.264 . . . . 0.0 112.036 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.523 HD22 HG23 ' A' ' 55' ' ' ILE . 4.8 t30 -65.17 -21.7 66.81 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 119.644 1.111 . . . . 0.0 111.789 -173.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.642 ' CD1' HD21 ' A' ' 37' ' ' LEU . 47.9 mt -68.93 -54.97 17.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 118.864 0.756 . . . . 0.0 109.729 168.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -70.76 -13.46 62.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.749 0.704 . . . . 0.0 112.371 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.94 -43.46 92.67 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.895 1.278 . . . . 0.0 111.124 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.42 12.08 3.23 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.285 2.234 . . . . 0.0 113.564 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.529 1.532 . . . . 0.0 110.33 175.835 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.677 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.7 m -56.91 158.0 5.2 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 121.877 -0.778 . . . . 0.0 110.525 165.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -117.68 -45.69 2.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 117.176 -1.393 . . . . 0.0 111.404 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -47.59 -41.64 22.16 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.226 1.375 . . . . 0.0 111.19 -172.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -54.27 -39.26 66.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.404 0.682 . . . . 0.0 112.56 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.7 t -56.23 -41.52 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.478 0.711 . . . . 0.0 109.744 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -102.19 -6.48 23.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.506 1.122 . . . . 0.0 113.495 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.78 -44.81 63.36 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 123.628 0.771 . . . . 0.0 110.202 -170.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -57.32 -34.91 69.24 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.947 0.899 . . . . 0.0 111.379 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -68.55 -42.9 77.72 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.088 0.955 . . . . 0.0 111.001 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.22 -38.37 86.38 Favored 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 123.937 0.895 . . . . 0.0 110.316 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -56.24 -37.14 69.33 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 122.133 -0.354 . . . . 0.0 110.847 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.18 0.9 88.89 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.079 1.323 . . . . 0.0 113.714 -173.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 mm -66.14 149.47 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.007 1.403 . . . . 0.0 107.312 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.64 -22.88 62.46 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.075 1.35 . . . . 0.0 113.568 -170.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.4 145.18 8.66 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 126.227 1.811 . . . . 0.0 108.724 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.07 -27.66 73.85 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.939 2.426 . . . . 0.0 112.386 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.45 -15.14 47.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.778 -0.576 . . . . 0.0 111.126 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.79 15.2 11.77 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.807 -0.558 . . . . 0.0 110.839 176.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -113.59 -45.09 3.14 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 125.412 1.485 . . . . 0.0 110.883 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -70.77 -5.73 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.603 1.161 . . . . 0.0 112.937 -161.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -102.94 -25.81 13.33 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.324 1.85 . . . . 0.0 112.87 168.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m -61.45 -44.9 96.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.743 0.817 . . . . 0.0 109.522 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.64 -39.0 86.67 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.575 1.15 . . . . 0.0 111.81 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -60.01 -46.95 87.82 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.851 -0.595 . . . . 0.0 110.704 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mt -61.71 -44.91 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.997 0.919 . . . . 0.0 110.455 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.02 -48.09 82.83 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -65.79 -42.87 90.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.25 1.42 . . . . 0.0 110.466 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -63.48 -44.56 94.06 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.25 1.82 . . . . 0.0 110.976 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.5 t -57.17 -49.21 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.465 1.029 . . . . 0.0 109.297 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.68 2.79 0.88 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.72 -50.23 1.97 Allowed 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.795 1.238 . . . . 0.0 111.435 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 m -70.02 -26.49 64.07 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.715 1.206 . . . . 0.0 109.856 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -131.29 78.53 72.09 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.623 0.769 . . . . 0.0 111.484 -170.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.07 -5.21 16.48 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.86 3.04 . . . . 0.0 114.618 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.6 -20.84 32.99 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.011 -1.056 . . . . 0.0 112.312 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.5 mt -78.36 145.98 34.92 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -123.57 144.77 45.18 Favored Pre-proline 0 C--O 1.236 0.38 0 C-N-CA 124.765 1.226 . . . . 0.0 108.031 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.04 162.57 36.81 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.494 2.796 . . . . 0.0 112.745 -172.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -170.04 119.89 0.62 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.212 2.205 . . . . 0.0 105.448 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ptm -95.64 127.45 41.68 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 121.28 1.855 . . . . 0.0 108.005 165.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -136.02 150.63 49.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 124.854 1.262 . . . . 0.0 109.155 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 14.5 m95 61.04 24.73 14.82 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.3 t30 74.53 -0.42 3.35 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 128.295 2.638 . . . . 0.0 111.493 -171.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.7 p -105.31 144.48 28.89 Favored Pre-proline 0 N--CA 1.45 -0.445 0 O-C-N 120.419 -1.426 . . . . 0.0 109.537 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.62 143.27 56.03 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.755 1.637 . . . . 0.0 109.107 164.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 19.1 ptm -145.87 172.75 12.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 164.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.21 152.18 45.78 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 p -129.92 114.25 15.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.444 1.098 . . . . 0.0 108.422 -167.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -70.34 91.56 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.769 1.228 . . . . 0.0 108.071 175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 48.11 34.56 4.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.298 0.639 . . . . 0.0 112.507 -170.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.25 -11.39 24.24 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 117.253 -1.859 . . . . 0.0 115.861 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -74.13 -168.43 0.63 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.793 2.297 . . . . 0.0 111.385 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.437 ' H ' HG22 ' A' ' 53' ' ' THR . 36.5 t80 -129.88 18.85 5.58 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.01 1.724 . . . . 0.0 112.476 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mt -70.27 7.61 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 126.099 1.759 . . . . 0.0 111.757 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.433 HD12 HG13 ' A' ' 110' ' ' ILE . 5.3 tt -159.67 143.14 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 O-C-N 119.335 -2.103 . . . . 0.0 111.507 167.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.63 159.97 32.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 162.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -149.63 170.73 17.98 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.045 1.422 . . . . 0.0 110.068 173.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.1 t -153.72 152.95 31.37 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 168.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.1 p -78.87 127.46 32.05 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t -101.51 171.13 7.76 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.06 -17.92 55.05 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -167.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.46 1.12 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -158.18 154.14 26.89 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.388 0.995 . . . . 0.0 110.461 -168.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 tp -92.74 127.94 38.42 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 167.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.19 119.66 39.08 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.16 139.25 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 127.801 2.44 . . . . 0.0 108.93 -164.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 t -165.33 157.89 13.41 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 125.845 1.658 . . . . 0.0 107.516 167.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.79 -57.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.817 1.678 . . . . 0.0 111.282 161.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -145.94 -86.11 0.11 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 172.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -142.89 -32.55 0.48 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.692 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.41 -34.77 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 120.881 1.673 . . . . 0.0 111.394 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.15 -18.89 29.48 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.654 1.121 . . . . 0.0 113.26 175.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 mm -111.47 1.6 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 127.185 2.194 . . . . 0.0 109.925 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 m -118.57 -61.34 1.67 Allowed 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.633 -0.667 . . . . 0.0 109.376 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -74.15 -51.99 13.88 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 127.894 2.477 . . . . 0.0 107.647 -173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -85.95 4.32 38.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.605 0.762 . . . . 0.0 112.54 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -32.3 73.75 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.406 1.082 . . . . 0.0 112.637 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -69.99 -43.33 71.66 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.554 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -62.95 -39.11 93.64 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.829 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.21 -49.6 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.755 0.707 . . . . 0.0 109.816 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.16 69.52 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.041 0.937 . . . . 0.0 110.478 -170.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.63 -22.43 63.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.335 1.454 . . . . 0.0 112.996 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.49 -10.29 59.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.783 0.72 . . . . 0.0 112.039 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.12 11.59 56.08 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.029 0.823 . . . . 0.0 113.977 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -97.77 107.65 20.19 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.563 1.182 . . . . 0.0 111.341 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.12 98.38 0.06 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.044 2.138 . . . . 0.0 111.369 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.96 -176.26 6.24 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.638 1.175 . . . . 0.0 111.535 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 p -118.96 -164.91 1.08 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.161 1.784 . . . . 0.0 107.853 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.406 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -85.53 -9.12 57.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.06 -1.69 2.87 Favored Glycine 0 N--CA 1.462 0.395 0 CA-C-N 119.441 1.019 . . . . 0.0 112.527 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 pp -162.47 176.28 10.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.361 0.664 . . . . 0.0 110.743 170.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -119.09 164.42 15.55 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.398 -0.813 . . . . 0.0 109.495 167.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.7 158.97 44.02 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.915 -1.115 . . . . 0.0 109.58 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.58 142.82 44.27 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.41 153.65 50.31 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.64 1.56 . . . . 0.0 109.408 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -60.57 -21.63 62.81 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -57.66 -47.5 82.12 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.749 2.02 . . . . 0.0 112.084 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -110.58 162.48 20.43 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.356 1.062 . . . . 0.0 109.519 -161.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.39 148.54 23.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.313 1.342 . . . . 0.0 112.399 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -77.86 143.77 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.93 81.2 5.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.681 1.592 . . . . 0.0 108.468 171.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -56.79 -34.6 67.8 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.344 0.657 . . . . 0.0 110.071 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -60.13 -54.68 43.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.778 0.831 . . . . 0.0 111.288 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.554 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -58.15 -47.15 84.23 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -176.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.339 0.4 OUTLIER -69.1 -29.66 67.79 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 116.877 -1.535 . . . . 0.0 112.352 -176.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -68.98 -42.64 76.28 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 121.094 1.77 . . . . 0.0 110.901 175.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -58.8 -39.26 80.6 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.579 1.081 . . . . 0.0 111.953 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.3 ptp -78.73 -38.36 39.08 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 121.72 -0.612 . . . . 0.0 112.548 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -71.34 -51.32 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -173.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -56.78 -44.36 81.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.584 0.753 . . . . 0.0 110.806 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -54.96 -50.9 67.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.667 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -70.51 -1.05 9.71 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.3 mt -96.12 -47.71 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 C-N-CA 125.464 1.506 . . . . 0.0 108.137 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -68.92 -8.24 42.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.536 1.062 . . . . 0.0 112.111 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -91.56 -0.38 57.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.513 1.525 . . . . 0.0 111.762 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -112.33 5.37 18.2 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.561 2.344 . . . . 0.0 111.164 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.121 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 163.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.98 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 m -71.84 150.42 44.31 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 121.79 -0.83 . . . . 0.0 109.187 166.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -142.77 -33.71 0.45 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.166 0.986 . . . . 0.0 112.1 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.7 mmt -61.7 -21.29 64.35 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 117.298 -1.334 . . . . 0.0 112.498 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -65.17 -38.3 90.09 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.254 1.388 . . . . 0.0 110.669 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.28 -40.86 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -96.51 36.83 1.32 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.807 1.643 . . . . 0.0 111.156 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.17 -56.18 2.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.688 1.595 . . . . 0.0 111.682 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -74.6 -15.65 60.83 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -162.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -73.64 -47.24 41.5 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 125.784 1.634 . . . . 0.0 110.566 164.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.37 -45.53 93.99 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.966 0.906 . . . . 0.0 110.597 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -59.04 -15.58 14.21 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.44 0.12 46.66 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.399 1.952 . . . . 0.0 114.162 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.8 135.56 27.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 119.94 1.87 . . . . 0.0 108.013 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -35.07 79.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.852 1.661 . . . . 0.0 112.293 -175.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.15 143.81 32.35 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.46 -20.12 42.14 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.828 2.352 . . . . 0.0 111.741 172.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.05 -21.48 63.68 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.211 0.46 . . . . 0.0 109.89 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 22' ' ' ARG . 7.7 m80 -116.06 -16.6 11.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.249 0.931 . . . . 0.0 112.079 -175.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -67.05 -57.32 7.06 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 123.641 0.776 . . . . 0.0 111.356 -170.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -44.21 -61.09 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.645 1.978 . . . . 0.0 112.088 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -59.94 -38.55 82.75 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 121.403 -0.811 . . . . 0.0 112.426 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 m -52.8 -50.24 64.01 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.475 0.71 . . . . 0.0 111.347 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -55.81 -46.32 78.1 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.643 1.177 . . . . 0.0 111.121 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -62.69 -40.17 96.28 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 122.838 0.455 . . . . 0.0 111.632 -172.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 mt -57.03 -50.83 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 124.012 0.82 . . . . 0.0 109.451 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.06 -55.3 36.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.602 0.361 . . . . 0.0 110.159 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 m -71.95 -21.43 61.6 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.298 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -69.0 -44.57 72.55 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 120.265 1.393 . . . . 0.0 110.428 170.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.409 ' CG1' ' CE2' ' A' ' 48' ' ' PHE . 56.1 t -59.68 -45.6 94.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-N 119.478 1.035 . . . . 0.0 108.587 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.03 62.83 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.538 0.608 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.29 -61.45 2.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 122.154 -0.341 . . . . 0.0 110.311 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -74.73 -35.69 62.67 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.578 1.551 . . . . 0.0 111.746 -162.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.71 74.47 34.76 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.93 -4.27 14.71 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.567 2.178 . . . . 0.0 112.15 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -28.36 51.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.647 1.179 . . . . 0.0 111.384 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.601 HD22 ' H ' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -75.59 143.62 42.24 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -96.87 150.83 37.34 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.66 151.93 52.82 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.553 2.168 . . . . 0.0 110.577 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -156.15 130.8 8.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.623 1.569 . . . . 0.0 107.169 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -107.91 96.07 6.12 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.48 147.5 30.39 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 125.977 1.711 . . . . 0.0 107.245 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 3.9 m95 57.41 17.89 4.09 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 172.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 t30 57.76 29.48 17.48 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.861 2.464 . . . . 0.0 112.778 -167.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 p -126.63 144.99 51.65 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.89 134.09 22.96 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.709 2.939 . . . . 0.0 111.757 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.9 ptm -148.25 172.36 14.48 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.097 0.559 . . . . 0.0 110.52 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -132.77 148.92 52.32 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.9 112.29 11.16 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.665 1.186 . . . . 0.0 108.879 -168.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.82 97.34 1.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 44.84 38.58 2.98 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.404 1.002 . . . . 0.0 111.449 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.01 -10.43 34.18 Favored Glycine 0 CA--C 1.533 1.219 0 CA-C-O 116.771 -2.127 . . . . 0.0 117.057 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.54 -170.13 0.97 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 121.643 2.721 . . . . 0.0 111.414 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -131.54 22.43 4.71 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 119.899 -1.751 . . . . 0.0 112.434 -170.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.32 -2.88 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 127.088 2.155 . . . . 0.0 112.413 -165.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 tt -155.91 132.03 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 119.239 -2.163 . . . . 0.0 109.814 165.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.83 150.0 21.71 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 165.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.88 174.59 10.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.682 1.241 . . . . 0.0 109.935 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -152.15 161.19 43.0 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 159.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.1 p -68.64 159.01 32.89 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 m -138.5 175.04 9.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.834 1.254 . . . . 0.0 108.212 168.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.82 -60.29 2.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.418 1.087 . . . . 0.0 112.89 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -123.56 6.72 8.9 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -172.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -146.78 157.96 43.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.042 1.737 . . . . 0.0 109.332 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.1 tp -88.61 155.77 19.43 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 154.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.46 ' HB2' HD22 ' A' ' 92' ' ' LEU . 11.0 p -115.75 114.81 25.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 116.778 -1.582 . . . . 0.0 109.013 172.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 79.0 t -126.19 144.08 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.832 1.196 . . . . 0.0 110.142 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.3 t -169.21 156.92 6.9 Favored Pre-proline 0 C--O 1.239 0.536 0 C-N-CA 127.069 2.148 . . . . 0.0 108.008 175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -74.79 -56.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 120.713 0.942 . . . . 0.0 111.434 161.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -156.37 -80.89 0.07 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -147.33 -30.27 0.33 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -33.81 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 120.662 1.574 . . . . 0.0 110.578 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' A' ' 77' ' ' PHE . . . -44.91 -31.93 2.96 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.016 1.293 . . . . 0.0 112.532 169.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.7 mm -104.63 -0.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.936 1.294 . . . . 0.0 110.785 -168.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.8 m -121.35 -46.41 2.29 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -38.93 36.47 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.434 2.294 . . . . 0.0 109.404 -174.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.408 ' CD1' ' HA2' ' A' ' 73' ' ' GLY . 11.2 m-85 -100.84 5.08 43.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.723 0.809 . . . . 0.0 111.498 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.33 -36.73 76.19 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.121 1.369 . . . . 0.0 111.758 -172.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -72.57 -46.77 52.72 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.625 1.17 . . . . 0.0 108.829 -175.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.76 -41.74 91.69 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.419 0.688 . . . . 0.0 111.388 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.7 mt -61.41 -46.18 97.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.038 0.835 . . . . 0.0 109.575 171.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.28 -49.19 76.65 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 123.702 0.801 . . . . 0.0 110.365 -170.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -62.18 -29.31 70.28 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.965 1.306 . . . . 0.0 112.248 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.5 -22.92 62.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.08 0.854 . . . . 0.0 111.315 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.34 16.49 7.11 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.44 1.495 . . . . 0.0 113.99 170.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -108.97 93.44 4.52 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.488 1.144 . . . . 0.0 112.487 -164.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.6 m -52.27 96.61 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.191 2.196 . . . . 0.0 112.837 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.73 177.84 8.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.927 1.691 . . . . 0.0 112.121 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -100.44 -169.51 1.73 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.405 1.882 . . . . 0.0 107.362 159.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -77.26 -24.23 51.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.818 0.847 . . . . 0.0 112.687 168.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -110.5 -25.62 5.15 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 123.729 0.681 . . . . 0.0 112.759 -168.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 66' ' ' SER . 4.3 pp -152.77 161.11 42.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.051 0.925 . . . . 0.0 110.057 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -98.07 163.47 12.74 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.703 -0.623 . . . . 0.0 109.523 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -117.95 163.52 16.45 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.51 147.94 67.97 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 162.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -59.83 157.44 33.23 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 121.467 1.56 . . . . 0.0 109.59 159.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -65.08 -46.47 81.01 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.48 -0.763 . . . . 0.0 111.714 166.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -71.06 -21.63 62.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -166.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.02 160.63 29.19 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.49 1.116 . . . . 0.0 108.841 -172.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.71 144.4 19.51 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.614 1.543 . . . . 0.0 112.789 -163.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -84.14 123.96 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.415 1.886 . . . . 0.0 109.339 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -78.29 78.77 4.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.384 1.874 . . . . 0.0 112.917 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -51.98 -47.27 64.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.405 1.082 . . . . 0.0 110.423 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -68.9 -24.89 64.37 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -170.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.27 -56.3 5.75 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.508 1.123 . . . . 0.0 108.69 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.87 -23.75 62.37 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.946 -171.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -50.21 -53.98 24.2 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 127.065 2.146 . . . . 0.0 110.346 162.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -60.51 -47.53 85.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.873 0.76 . . . . 0.0 110.036 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 17.9 ptp -78.36 16.98 0.7 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . 0.274 0.1 OUTLIER -117.12 -47.77 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 O-C-N 120.375 -1.453 . . . . 0.0 107.382 162.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.43 -53.27 60.08 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.554 1.142 . . . . 0.0 111.994 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.39 -46.17 90.92 Favored 'General case' 0 C--N 1.341 0.215 0 O-C-N 121.72 -0.613 . . . . 0.0 109.443 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -29.39 68.85 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.71 0.804 . . . . 0.0 111.539 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.558 HD11 HD11 ' A' ' 37' ' ' LEU . 38.9 mt -75.06 -59.68 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 125.703 1.601 . . . . 0.0 109.728 171.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -66.86 -18.47 65.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.942 0.792 . . . . 0.0 111.71 -168.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.77 -14.04 62.77 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.907 1.283 . . . . 0.0 112.496 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -119.01 20.4 12.73 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 127.024 2.13 . . . . 0.0 111.153 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 123.585 0.754 . . . . 0.0 110.007 -177.62 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.575 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.8 m 49.9 -157.27 0.09 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.31 1.044 . . . . 0.0 112.378 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 174.8 -37.35 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 128.34 2.656 . . . . 0.0 110.379 161.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.9 mmt -54.14 -27.88 36.32 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.002 0.921 . . . . 0.0 112.232 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -55.26 -60.64 3.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.388 1.475 . . . . 0.0 111.732 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.21 -38.93 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.732 1.213 . . . . 0.0 111.029 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -88.09 -15.13 37.04 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.166 0.586 . . . . 0.0 112.367 -169.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.11 78.45 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.223 1.009 . . . . 0.0 111.535 -175.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.88 -9.05 13.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.12 1.368 . . . . 0.0 113.383 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -112.59 -35.87 5.39 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.981 0.912 . . . . 0.0 110.832 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.3 mt -52.97 -33.68 52.33 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.481 -0.762 . . . . 0.0 111.168 170.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -54.62 -35.5 63.47 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.272 1.029 . . . . 0.0 113.671 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.1 -0.1 56.07 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-O 118.923 -0.932 . . . . 0.0 112.78 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.51 91.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -2.35 0.96 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.58 2.352 . . . . 0.0 113.294 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -114.47 67.02 1.73 Allowed Pre-proline 0 N--CA 1.444 -0.768 0 C-N-CA 129.055 2.942 . . . . 0.0 109.408 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.5 -21.91 65.71 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.862 3.041 . . . . 0.0 113.24 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -71.18 -4.67 26.77 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.727 1.611 . . . . 0.0 112.18 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.0 16.78 1.22 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.45 1.1 . . . . 0.0 110.06 -175.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -87.55 -47.84 8.39 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.092 1.357 . . . . 0.0 109.693 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -55.58 -30.04 60.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.516 2.326 . . . . 0.0 112.938 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -58.52 -38.22 77.25 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.887 -1.133 . . . . 0.0 111.145 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.6 m -66.85 -39.63 87.66 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.362 0.665 . . . . 0.0 109.668 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.1 -44.8 83.57 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.418 1.487 . . . . 0.0 110.622 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -61.17 -44.39 97.39 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.74 0.416 . . . . 0.0 109.974 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.7 mt -61.31 -49.99 82.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.985 1.314 . . . . 0.0 109.109 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.79 -41.37 91.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.477 0.711 . . . . 0.0 109.79 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -65.09 -43.96 90.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.913 0.885 . . . . 0.0 110.868 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.537 ' HZ3' HD11 ' A' ' 106' ' ' LEU . 68.0 t90 -66.93 -38.66 86.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.884 1.274 . . . . 0.0 111.81 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.0 t -61.28 -43.67 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 O-C-N 121.415 -0.803 . . . . 0.0 109.553 175.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.67 -25.03 67.94 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.153 0.581 . . . . 0.0 111.519 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 -70.16 0.59 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.217 1.007 . . . . 0.0 109.543 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.2 m -67.87 -29.48 68.6 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.783 -0.627 . . . . 0.0 112.225 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -123.15 58.34 12.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.167 0.894 . . . . 0.0 110.267 -171.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.09 -18.88 45.74 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.907 3.071 . . . . 0.0 114.983 -160.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -79.0 -7.2 57.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.164 0.893 . . . . 0.0 111.862 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.47 141.07 38.51 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.579 1.081 . . . . 0.0 108.605 165.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -116.42 154.29 48.94 Favored Pre-proline 0 C--N 1.328 -0.362 0 C-N-CA 124.937 1.295 . . . . 0.0 110.39 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.33 138.74 30.73 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.628 2.885 . . . . 0.0 110.337 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -165.56 82.73 0.33 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.05 140.71 54.91 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.057 -1.027 . . . . 0.0 108.694 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -150.15 153.27 36.04 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 124.741 1.217 . . . . 0.0 108.426 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.3 m95 51.6 31.55 7.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.68 0.792 . . . . 0.0 112.256 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 t30 59.12 18.34 6.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.562 1.945 . . . . 0.0 113.784 -173.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -114.13 127.12 27.16 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.727 1.611 . . . . 0.0 107.106 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.13 114.77 3.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.686 2.257 . . . . 0.0 109.978 170.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.6 ptm -130.79 173.66 10.72 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.349 1.06 . . . . 0.0 109.259 173.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -135.18 132.21 37.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.1 p -92.05 125.12 36.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.084 0.954 . . . . 0.0 108.564 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -74.54 85.94 2.07 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 161.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.268 20.8 mt-30 63.19 -15.23 0.06 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.145 1.778 . . . . 0.0 115.605 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.74 -13.01 0.03 OUTLIER Glycine 0 CA--C 1.544 1.859 0 C-N-CA 126.938 2.208 . . . . 0.0 115.094 170.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.84 -165.79 1.15 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.765 1.226 . . . . 0.0 113.237 -163.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.48 29.32 4.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.14 2.176 . . . . 0.0 109.762 -173.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.2 mt -67.72 -19.73 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.527 1.131 . . . . 0.0 112.118 -168.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.4 tt -155.02 136.59 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 120.236 1.38 . . . . 0.0 110.263 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.92 157.08 27.35 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 166.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -138.72 168.84 18.92 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.222 -1.163 . . . . 0.0 109.104 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 81.4 p -150.2 144.13 25.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.8 p -91.28 155.3 18.64 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -173.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.1 t -135.16 177.99 7.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.113 1.365 . . . . 0.0 108.474 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -49.34 -65.67 0.53 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.059 1.343 . . . . 0.0 109.571 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.408 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 90.2 m-70 -116.2 13.06 15.62 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -172.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -153.83 166.46 32.83 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.901 0.773 . . . . 0.0 111.571 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.1 tp -97.99 158.53 15.48 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 162.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . 4.0 m -126.7 120.62 29.87 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.184 0.902 . . . . 0.0 109.859 174.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.88 140.9 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.189 1.796 . . . . 0.0 109.222 -161.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.2 t -167.43 157.02 9.42 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 127.68 2.392 . . . . 0.0 105.883 168.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.13 -57.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.059 0 CA-C-N 120.65 1.268 . . . . 0.0 108.957 166.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -145.34 -86.18 0.12 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -139.49 -29.57 0.74 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.016 1.327 . . . . 0.0 112.499 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.17 -29.16 45.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 119.192 0.905 . . . . 0.0 111.439 -172.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.16 -24.63 15.94 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.872 2.177 . . . . 0.0 113.205 171.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 92' ' ' LEU . 18.3 mm -107.74 -6.98 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 127.082 2.153 . . . . 0.0 110.171 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -92.35 -85.46 0.26 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -83.83 -45.71 12.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -169.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -67.84 -22.43 65.14 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.112 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.53 -32.14 57.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.196 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -67.33 -45.2 77.14 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.433 0.693 . . . . 0.0 110.05 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.01 89.49 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.932 -1.105 . . . . 0.0 110.819 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.3 mt -66.62 -43.04 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 118.653 0.66 . . . . 0.0 109.722 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.35 89.42 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 124.643 1.177 . . . . 0.0 109.862 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -65.1 -24.65 67.49 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.679 1.191 . . . . 0.0 111.74 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.4 -29.23 41.9 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.353 0.979 . . . . 0.0 110.904 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 142.18 -31.37 2.07 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.999 1.762 . . . . 0.0 112.599 165.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -81.15 102.18 10.13 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.965 1.383 . . . . 0.0 109.76 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.4 m -69.8 9.7 0.49 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 58.47 -172.97 0.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.36 2.264 . . . . 0.0 112.065 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.5 p -110.89 179.31 4.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.85 1.66 . . . . 0.0 106.93 158.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -66.86 27.89 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.734 2.413 . . . . 0.0 113.323 164.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.1 -35.57 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 CA-C-O 118.287 -1.285 . . . . 0.0 114.88 -168.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HA ' HD11 ' A' ' 74' ' ' ILE . 1.1 pp -161.47 173.6 14.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.214 1.007 . . . . 0.0 112.077 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -108.88 119.67 40.23 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 120.89 -1.131 . . . . 0.0 110.37 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.27 138.65 42.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.98 143.81 31.58 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 169.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.55 156.84 29.63 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.439 2.092 . . . . 0.0 110.715 170.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.408 ' CD1' ' HA ' ' A' ' 63' ' ' HIS . 9.0 m95 -59.64 -25.63 64.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.402 168.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.99 -67.91 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.713 0.688 . . . . 0.0 110.796 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.9 164.96 44.16 Favored Pre-proline 0 N--CA 1.465 0.295 0 C-N-CA 124.409 1.083 . . . . 0.0 111.707 -168.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.92 139.42 12.13 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.086 1.191 . . . . 0.0 112.814 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.2 t -72.84 115.83 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -68.42 89.4 0.35 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.054 1.342 . . . . 0.0 111.418 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -58.1 -39.54 78.88 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 124.831 1.253 . . . . 0.0 109.897 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -66.91 -38.64 86.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.719 1.207 . . . . 0.0 113.406 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -48.3 55.71 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.537 HD11 ' HZ3' ' A' ' 29' ' ' TRP 0.285 0.4 OUTLIER -71.11 -26.52 63.06 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.973 -173.439 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -66.73 -43.09 85.15 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.117 -1.42 . . . . 0.0 111.001 171.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -53.45 -52.21 60.19 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.338 1.426 . . . . 0.0 109.677 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.7 ptp -63.02 -47.38 83.32 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.858 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -43.01 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 120.306 1.412 . . . . 0.0 110.736 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -63.01 -44.81 94.97 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.411 0.551 . . . . 0.0 110.441 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -56.23 -45.99 79.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.847 0.459 . . . . 0.0 110.623 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.66 -22.19 65.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.054 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.6 mt -82.17 -47.53 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 119.613 1.097 . . . . 0.0 109.626 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -71.0 -19.27 62.54 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.23 0.923 . . . . 0.0 111.491 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.24 -28.83 57.3 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.101 1.761 . . . . 0.0 110.892 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -106.21 43.04 1.18 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 126.18 1.792 . . . . 0.0 108.054 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--O 1.246 0.889 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 175.811 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.892 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.4 m -73.41 -10.96 60.28 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.13 -1.414 . . . . 0.0 113.806 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.285 22.3 p-80 51.51 -47.54 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 131.138 3.775 . . . . 0.0 115.174 -167.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.5 mmt -50.26 -43.99 53.5 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.899 1.679 . . . . 0.0 109.691 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -54.46 -32.84 58.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.21 -33.0 19.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 123.002 0.521 . . . . 0.0 111.125 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -113.57 32.84 5.52 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.685 1.994 . . . . 0.0 113.73 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.57 -15.33 10.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 121.787 2.085 . . . . 0.0 113.747 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.7 -24.42 21.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -76.15 -35.87 59.01 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -173.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.484 HD12 HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -57.27 -37.09 71.85 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.9 1.28 . . . . 0.0 112.074 176.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -54.35 -39.61 67.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.819 0.736 . . . . 0.0 110.74 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.88 -7.4 75.44 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.247 1.403 . . . . 0.0 113.997 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.484 HD12 HD12 ' A' ' 11' ' ' LEU . 18.8 mt -86.46 102.87 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -68.93 -8.4 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.569 1.147 . . . . 0.0 113.452 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.48 84.99 0.68 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.688 1.995 . . . . 0.0 111.18 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.77 -20.44 58.9 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.707 2.938 . . . . 0.0 114.241 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 4.6 m-20 -64.27 -17.04 63.24 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.114 0.416 . . . . 0.0 110.545 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.406 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 8.1 m80 -128.16 -33.97 2.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.177 0.991 . . . . 0.0 111.268 -169.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -48.52 -54.65 13.56 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.301 1.041 . . . . 0.0 109.849 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -13.15 34.55 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.11 1.364 . . . . 0.0 113.178 -175.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -88.32 -51.95 5.47 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.934 1.243 . . . . 0.0 108.36 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.1 m -46.56 -43.31 17.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.608 1.963 . . . . 0.0 112.685 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -71.94 -28.17 63.29 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.366 1.466 . . . . 0.0 112.592 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.13 -47.0 78.64 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 121.669 -0.644 . . . . 0.0 109.852 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -54.91 -45.71 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 46' ' ' PRO . 21.6 mt -59.22 -52.26 66.44 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.375 0.27 . . . . 0.0 110.969 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 p -62.09 -41.12 97.88 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.622 0.769 . . . . 0.0 112.961 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -56.49 -59.03 5.57 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.913 1.685 . . . . 0.0 109.96 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.6 t -50.53 -48.04 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 120.245 1.384 . . . . 0.0 111.182 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.79 -16.41 64.24 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.54 -54.83 3.98 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.868 0.867 . . . . 0.0 110.669 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -34.26 77.65 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.693 0.797 . . . . 0.0 111.669 -171.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.36 69.62 81.33 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.733 1.213 . . . . 0.0 108.388 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.82 -6.42 18.12 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.035 3.157 . . . . 0.0 115.044 -162.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -73.75 -14.45 61.13 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 120.036 1.289 . . . . 0.0 112.152 168.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.6 mt -75.66 135.15 40.44 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 120.944 -1.097 . . . . 0.0 110.948 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -110.99 149.79 40.95 Favored Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 126.537 1.935 . . . . 0.0 109.203 175.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.08 159.99 40.42 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.895 2.397 . . . . 0.0 111.523 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -158.16 111.83 2.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.209 1.003 . . . . 0.0 108.529 166.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.99 95.38 1.58 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 165.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -118.48 147.42 43.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.5 m95 53.16 23.32 3.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.8 t30 62.23 15.91 7.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.788 1.235 . . . . 0.0 112.327 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 p -121.31 150.23 53.7 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HB2' HD21 ' A' ' 27' ' ' LEU . 72.8 Cg_endo -76.25 113.11 3.62 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.93 2.42 . . . . 0.0 110.564 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.1 ptm -119.18 172.7 7.4 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 166.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.3 139.62 48.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -102.34 127.7 49.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -71.41 87.76 0.87 Allowed 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 166.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 58.75 -8.95 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.156 2.582 . . . . 0.0 114.655 -177.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.47 -11.97 0.06 OUTLIER Glycine 0 CA--C 1.543 1.782 0 C-N-CA 126.745 2.117 . . . . 0.0 114.179 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -84.58 -169.86 2.83 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.374 1.587 . . . . 0.0 111.651 -174.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.507 ' H ' HG22 ' A' ' 53' ' ' THR . 78.4 t80 -125.43 19.19 8.13 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.696 1.998 . . . . 0.0 111.744 -177.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 113' ' ' ASN . 17.4 mt -65.35 4.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 126.852 2.061 . . . . 0.0 113.375 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 tt -156.66 142.53 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 118.465 -2.647 . . . . 0.0 111.085 165.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.47 148.57 17.5 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 166.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -149.85 171.97 15.91 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.257 1.423 . . . . 0.0 108.523 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.18 162.05 41.05 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 166.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 p -61.03 152.92 26.7 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.408 0.623 . . . . 0.0 110.261 167.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -132.89 171.13 14.34 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.412 1.885 . . . . 0.0 106.504 163.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -49.41 -49.67 43.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.606 1.562 . . . . 0.0 112.158 -171.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -129.39 7.79 5.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.48 1.112 . . . . 0.0 112.82 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.456 ' CD2' ' HE ' ' A' ' 94' ' ' ARG . 33.5 p-80 -147.26 169.56 19.13 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.171 -0.956 . . . . 0.0 110.541 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.5 tp -102.77 147.03 27.37 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 162.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB3' HD13 ' A' ' 92' ' ' LEU . 1.5 m -121.81 125.41 46.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.234 0.925 . . . . 0.0 109.394 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.6 t -136.19 141.55 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 127.316 2.246 . . . . 0.0 109.156 -157.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 t -167.72 152.08 6.37 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.802 1.641 . . . . 0.0 108.7 168.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.64 -56.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.7 1.6 . . . . 0.0 111.679 164.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -139.75 -86.0 0.22 Allowed 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -143.14 -33.97 0.43 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.041 0.936 . . . . 0.0 112.746 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.1 tt -61.05 -33.64 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 120.039 1.29 . . . . 0.0 111.569 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -50.45 -22.37 5.3 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.249 1.404 . . . . 0.0 113.112 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.8 mm -110.69 -1.85 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 126.41 1.884 . . . . 0.0 110.157 -171.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.3 m -118.27 -51.31 2.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.163 0.985 . . . . 0.0 110.509 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -84.06 -58.28 2.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 127.431 2.293 . . . . 0.0 107.43 -173.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.55 0.26 17.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.072 1.349 . . . . 0.0 111.314 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.63 -40.3 78.89 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.855 1.262 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -72.8 -35.78 67.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.62 0.646 . . . . 0.0 109.535 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.27 -48.25 82.3 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.498 0.719 . . . . 0.0 109.632 170.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.69 -44.89 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.108 0.963 . . . . 0.0 110.333 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.99 -55.84 29.49 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.167 0.987 . . . . 0.0 108.952 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -68.11 -15.86 63.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.692 0.797 . . . . 0.0 113.104 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.63 -16.18 52.26 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.399 1.0 . . . . 0.0 111.092 172.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.36 19.54 9.29 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 124.276 0.941 . . . . 0.0 113.998 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -119.81 99.45 6.64 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.028 1.414 . . . . 0.0 111.455 -166.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.9 m -56.55 117.01 3.45 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.904 1.281 . . . . 0.0 110.176 172.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.41 -168.18 1.55 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.34 1.856 . . . . 0.0 110.668 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 p -120.06 -164.78 1.11 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.75 1.62 . . . . 0.0 107.217 163.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -88.69 -20.48 24.8 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.06 0.846 . . . . 0.0 111.981 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.74 5.68 5.82 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.989 -0.895 . . . . 0.0 114.174 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.441 HD13 ' HB3' ' A' ' 66' ' ' SER . 1.5 pp -156.34 169.66 24.07 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.873 1.337 . . . . 0.0 110.104 158.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -118.68 179.17 4.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.801 1.24 . . . . 0.0 109.52 170.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.456 ' HE ' ' CD2' ' A' ' 64' ' ' HIS . 2.4 ptp85 -140.49 170.77 15.17 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.071 -1.018 . . . . 0.0 113.341 -177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 mp -135.97 142.85 41.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 160.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.53 160.46 47.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.705 1.603 . . . . 0.0 109.414 166.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -73.47 -23.15 60.04 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -65.59 -67.93 0.4 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.663 0.785 . . . . 0.0 110.455 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.48 165.69 51.5 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.481 1.512 . . . . 0.0 111.593 -164.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.78 145.46 40.98 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.624 1.55 . . . . 0.0 112.765 -170.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.45 126.31 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.28 76.04 7.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 168.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -56.94 -32.96 66.51 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 123.367 0.667 . . . . 0.0 109.433 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.46 -48.54 81.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.46 0.704 . . . . 0.0 111.913 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.73 -42.57 73.8 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 122.522 1.153 . . . . 0.0 109.514 -169.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.276 0.5 OUTLIER -70.54 -30.9 67.76 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.747 176.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -58.45 -51.35 70.21 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.778 1.172 . . . . 0.0 110.641 166.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -51.76 -49.48 62.55 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.822 0.849 . . . . 0.0 109.889 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -69.39 -47.67 63.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.93 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -45.56 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 120.452 1.478 . . . . 0.0 109.919 -175.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.58 -47.63 81.58 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.193 0.997 . . . . 0.0 110.968 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -60.53 -46.22 90.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.028 -0.42 . . . . 0.0 110.792 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.452 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 3.0 m120 -64.16 -20.98 66.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.657 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.1 mt -71.46 -56.45 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 169.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.05 -15.2 63.49 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.933 0.788 . . . . 0.0 112.396 -173.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.76 -10.55 59.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.535 1.134 . . . . 0.0 112.708 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -114.7 21.37 14.5 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.749 2.02 . . . . 0.0 110.959 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.84 174.63 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.928 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -74.28 -10.07 59.23 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 117.728 -1.129 . . . . 0.0 113.824 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.288 9.4 p-80 56.79 -55.78 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 129.786 3.234 . . . . 0.0 114.172 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.7 mmt -44.65 -46.28 10.1 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 126.04 1.736 . . . . 0.0 110.747 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.93 -31.61 72.63 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -168.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.5 t -58.15 -45.87 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.436 1.094 . . . . 0.0 108.701 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -91.58 -9.3 44.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.237 1.415 . . . . 0.0 112.37 -170.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.4 -33.06 70.94 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.468 1.107 . . . . 0.0 111.431 -171.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -68.8 -15.72 63.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.789 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -79.23 -52.96 7.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 166.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.3 mt -49.18 -45.12 43.68 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.498 1.119 . . . . 0.0 111.791 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -62.46 -25.2 67.86 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 118.051 0.387 . . . . 0.0 111.816 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.35 -2.29 60.46 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.279 1.418 . . . . 0.0 113.577 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 16' ' ' HIS . 54.3 mt -77.84 111.65 14.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 CA-C-N 120.08 1.94 . . . . 0.0 107.369 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.06 -1.07 24.14 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.601 0.76 . . . . 0.0 112.714 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.478 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.2 m170 -110.39 78.83 1.51 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 127.837 2.455 . . . . 0.0 110.021 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -61.11 -32.36 91.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.718 2.278 . . . . 0.0 112.436 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.446 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 36.9 m-20 -68.85 -1.55 7.48 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.398 0.999 . . . . 0.0 111.724 -173.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 14.3 m80 -135.88 -38.38 0.72 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.072 1.749 . . . . 0.0 110.498 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.4 ttp85 -46.14 -54.35 8.78 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 123.898 0.879 . . . . 0.0 109.42 166.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -53.14 -38.69 62.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.784 0.833 . . . . 0.0 112.194 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.67 -45.09 91.68 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.437 -0.789 . . . . 0.0 109.724 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.415 ' HA ' HD13 ' A' ' 26' ' ' ILE . 3.0 m -60.91 -35.21 76.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.13 1.772 . . . . 0.0 111.01 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -59.83 -38.45 82.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.693 1.133 . . . . 0.0 110.484 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -59.81 -46.47 89.13 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.566 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 23' ' ' THR . 2.9 mp -54.33 -52.07 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.48 -57.45 12.25 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 122.833 0.453 . . . . 0.0 110.017 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 m -60.66 -43.01 98.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 123.652 0.595 . . . . 0.0 110.454 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -62.87 -41.42 99.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.75 0.82 . . . . 0.0 110.772 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.534 HG11 ' CE2' ' A' ' 48' ' ' PHE . 26.5 t -58.33 -60.05 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.897 0.771 . . . . 0.0 109.874 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.09 -21.91 66.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.82 0.737 . . . . 0.0 112.597 -174.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.77 -62.38 1.47 Allowed 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.653 0.781 . . . . 0.0 111.562 171.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.3 m -72.27 -35.13 68.66 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.69 1.596 . . . . 0.0 110.753 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -120.65 66.68 13.41 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 124.714 1.206 . . . . 0.0 108.841 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -68.48 -11.63 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.029 1.819 . . . . 0.0 112.362 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -76.18 4.92 7.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.86 0.864 . . . . 0.0 112.477 171.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.42 141.08 36.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.298 1.039 . . . . 0.0 108.277 171.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -122.39 143.95 40.79 Favored Pre-proline 0 C--O 1.239 0.504 0 C-N-CA 124.691 1.196 . . . . 0.0 110.014 -173.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.99 148.04 21.59 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.518 2.812 . . . . 0.0 112.637 -165.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -155.25 119.45 4.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.431 0.693 . . . . 0.0 109.503 174.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -83.24 113.33 20.6 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 165.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt -150.88 154.99 38.24 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.511 1.125 . . . . 0.0 108.394 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.8 m95 49.77 24.65 1.3 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.659 1.584 . . . . 0.0 113.322 -168.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.48 21.7 8.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.078 1.351 . . . . 0.0 112.186 -171.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.2 p -118.77 158.15 48.29 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 125.783 1.633 . . . . 0.0 109.405 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.25 110.9 2.8 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.281 3.32 . . . . 0.0 110.499 169.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 19.2 ptm -117.73 170.04 9.1 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.054 0.93 . . . . 0.0 109.292 165.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CE2' HG11 ' A' ' 30' ' ' VAL . 0.6 OUTLIER -132.36 176.64 8.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 166.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.8 m -143.13 139.62 30.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -71.63 97.58 1.75 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 161.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.297 21.7 mt-30 59.78 -11.72 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.574 2.75 . . . . 0.0 116.711 174.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.69 -3.45 0.05 OUTLIER Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.526 2.488 . . . . 0.0 114.541 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.59 -166.14 0.25 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 120.406 2.103 . . . . 0.0 111.799 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -126.73 20.95 7.08 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 119.569 -1.957 . . . . 0.0 111.639 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.5 mt -71.19 15.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 O-C-N 120.29 -1.506 . . . . 0.0 111.802 -169.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 tt -160.5 146.22 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 118.62 -2.55 . . . . 0.0 110.799 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.2 144.26 8.89 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 162.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -137.0 174.24 10.84 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.094 1.447 . . . . 0.0 110.043 171.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.5 t -155.76 159.57 39.57 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 160.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.2 p -63.05 144.13 57.17 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 162.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t -120.19 172.81 7.51 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 162.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -58.45 -44.67 89.3 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 121.499 -0.751 . . . . 0.0 110.737 -163.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -137.44 37.12 2.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.881 0.872 . . . . 0.0 111.918 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -166.57 167.16 15.7 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.418 1.487 . . . . 0.0 109.801 171.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.2 tp -98.74 157.25 16.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.656 1.182 . . . . 0.0 107.922 162.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.422 ' HB2' HD22 ' A' ' 92' ' ' LEU . 34.3 p -119.03 125.41 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.717 1.207 . . . . 0.0 108.604 169.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.7 t -135.46 141.7 41.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 119.619 1.1 . . . . 0.0 108.643 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -173.23 151.49 2.07 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.09 1.756 . . . . 0.0 107.368 175.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.65 -57.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 119.786 0.959 . . . . 0.0 112.318 165.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -149.49 -86.73 0.08 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -142.45 -32.57 0.49 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.836 1.254 . . . . 0.0 111.745 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.0 tt -63.32 -31.29 52.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 118.817 0.735 . . . . 0.0 110.934 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.69 -24.47 12.61 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 127.247 2.356 . . . . 0.0 113.263 173.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.9 mm -120.6 -3.5 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.98 1.312 . . . . 0.0 110.492 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.0 t -80.02 -71.76 0.44 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -88.65 -41.71 12.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.655 -0.653 . . . . 0.0 109.248 -166.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -71.95 -10.34 59.64 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.091 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.56 -27.39 57.62 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -72.93 -42.44 63.47 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.887 0.851 . . . . 0.0 110.406 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.61 -38.18 90.13 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.426 -0.796 . . . . 0.0 110.843 172.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.7 mt -59.91 -50.6 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.226 1.011 . . . . 0.0 108.926 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.18 -47.4 65.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.82 1.248 . . . . 0.0 111.386 -175.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -59.43 -30.15 68.28 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.586 1.155 . . . . 0.0 112.987 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.36 -15.8 61.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.378 0.99 . . . . 0.0 111.651 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.23 -14.57 43.74 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 125.339 1.447 . . . . 0.0 113.002 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -73.7 161.85 29.81 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 173.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.48 5.02 5.14 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.471 1.032 . . . . 0.0 113.689 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 55.94 -159.07 0.22 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.856 1.662 . . . . 0.0 111.728 -169.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.5 p -119.38 -164.38 1.05 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.19 2.996 . . . . 0.0 104.815 159.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -70.69 -31.19 67.98 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.068 1.303 . . . . 0.0 113.043 171.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.35 -20.46 1.59 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -162.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 66' ' ' SER . 4.2 pp -137.35 167.98 20.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 121.197 -1.178 . . . . 0.0 110.026 169.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -112.38 150.27 31.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -140.73 145.37 36.36 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 101' ' ' VAL . 0.8 OUTLIER -133.51 143.72 49.11 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -176.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 161.45 42.29 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 121.706 1.645 . . . . 0.0 110.604 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -65.99 -15.28 62.88 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -63.44 -38.9 92.91 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.464 1.106 . . . . 0.0 110.846 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.52 158.46 33.7 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 123.76 0.824 . . . . 0.0 110.127 -156.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.08 126.08 10.88 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.887 2.391 . . . . 0.0 108.197 166.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.439 ' HA ' HD12 ' A' ' 95' ' ' ILE . 5.1 m -78.98 18.16 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.297 0.3 OUTLIER 50.73 78.0 0.11 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.948 2.899 . . . . 0.0 113.492 177.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -69.42 -48.75 60.04 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.944 2.098 . . . . 0.0 111.674 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -58.94 -36.35 74.62 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.01 0.924 . . . . 0.0 111.383 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -50.53 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.579 0.704 . . . . 0.0 110.067 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.289 0.3 OUTLIER -71.29 -29.4 65.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.535 0.734 . . . . 0.0 112.765 -174.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -64.19 -39.36 93.83 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.404 -1.284 . . . . 0.0 110.312 172.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -57.91 -49.47 76.65 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.337 1.426 . . . . 0.0 110.444 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.5 ptp -69.51 -45.16 69.52 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.191 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -70.63 -46.62 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.697 1.135 . . . . 0.0 110.122 -175.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -63.13 -31.16 72.24 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.504 1.047 . . . . 0.0 111.998 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.07 -53.42 25.75 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 118.06 0.391 . . . . 0.0 110.358 169.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.72 -18.13 64.8 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.487 -170.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.05 -71.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 124.983 1.313 . . . . 0.0 108.812 158.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -66.18 -13.41 60.19 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -165.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -77.16 -12.07 59.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.78 2.032 . . . . 0.0 113.13 174.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -129.37 3.9 5.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.268 2.227 . . . . 0.0 110.476 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.251 24.0 tt0 . . . . . 0 C--O 1.255 1.383 0 C-N-CA 128.966 2.906 . . . . 0.0 115.022 166.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.382 0 CA-C-O 119.398 -0.668 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.7 m -70.49 -27.28 64.08 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.75 1.275 . . . . 0.0 111.986 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.293 8.3 p-80 45.0 -54.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.257 1 C-N-CA 132.023 4.129 . . . . 0.0 115.039 -165.328 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mmt -44.74 -49.48 10.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 128.42 2.688 . . . . 0.0 110.349 -170.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.74 -31.15 58.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.433 1.093 . . . . 0.0 112.126 -169.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.09 -45.13 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 123.97 0.908 . . . . 0.0 110.535 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -96.85 -8.72 30.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.226 2.21 . . . . 0.0 112.649 -170.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.77 -12.32 60.31 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 126.231 1.812 . . . . 0.0 112.182 -160.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.482 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 27.4 mt-10 -111.4 -27.46 8.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.554 1.942 . . . . 0.0 109.184 -168.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.68 -34.63 69.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.02 -47.7 44.3 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.862 1.265 . . . . 0.0 112.611 173.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 1.4 mppt? -61.74 -27.09 68.47 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 119.829 1.195 . . . . 0.0 113.403 176.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.6 -12.47 84.37 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.874 -0.959 . . . . 0.0 113.028 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 16' ' ' HIS . 53.1 mt -76.08 113.02 14.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 119.742 1.771 . . . . 0.0 106.682 168.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -79.19 -4.11 48.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 122.055 0.931 . . . . 0.0 113.478 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.426 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.3 m-70 -100.15 85.91 0.57 Allowed Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 127.645 2.378 . . . . 0.0 111.702 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -62.56 -38.58 50.4 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.861 2.374 . . . . 0.0 111.349 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.21 10.75 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.815 1.246 . . . . 0.0 111.162 -172.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -135.5 -38.8 0.74 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.018 0.927 . . . . 0.0 111.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -43.77 83.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 116.492 -1.718 . . . . 0.0 114.688 -176.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -45.21 -42.89 9.76 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.028 1.285 . . . . 0.0 112.006 -172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -45.5 79.02 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.041 2.136 . . . . 0.0 111.971 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.0 m -59.71 -37.64 79.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.212 1.405 . . . . 0.0 109.744 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.09 -36.2 81.46 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 124.325 1.05 . . . . 0.0 110.788 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -59.84 -46.7 88.45 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.426 0.69 . . . . 0.0 109.722 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 mt -60.13 -44.76 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.021 0.929 . . . . 0.0 109.502 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.0 mt -58.05 -55.27 37.08 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.936 0.789 . . . . 0.0 110.054 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.4 m -62.4 -33.14 74.19 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.451 1.1 . . . . 0.0 113.202 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -73.2 -44.18 60.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.566 -0.709 . . . . 0.0 111.03 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.55 -53.89 38.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.16 -26.19 66.12 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.61 -50.96 8.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.545 0.738 . . . . 0.0 111.034 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.3 m -72.74 -40.39 66.11 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.534 0.734 . . . . 0.0 110.811 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.85 65.63 55.04 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.2 1.0 . . . . 0.0 109.99 -172.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.62 -6.74 19.6 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.09 2.527 . . . . 0.0 114.019 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -72.31 -16.27 61.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.479 1.036 . . . . 0.0 111.124 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.09 134.71 47.24 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 165.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.92 146.88 32.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.78 147.45 75.29 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.123 1.882 . . . . 0.0 109.787 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -156.57 109.53 2.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.471 -0.768 . . . . 0.0 109.353 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 75.6 mmm -76.54 131.12 38.78 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 161.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -139.17 139.92 37.7 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.0 m95 64.92 0.24 1.16 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 t30 74.58 14.7 3.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.576 2.75 . . . . 0.0 113.37 -162.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.3 p -107.84 147.17 34.93 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.89 138.06 27.94 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.507 2.138 . . . . 0.0 110.494 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 10.6 ptm -144.05 -179.59 6.59 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 162.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -140.16 161.1 38.44 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 p -125.19 114.36 18.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.154 0.582 . . . . 0.0 110.073 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -71.03 97.17 1.41 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 44.4 48.6 8.17 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.466 1.506 . . . . 0.0 111.758 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.52 35.67 25.3 Favored Glycine 0 CA--C 1.535 1.315 0 O-C-N 121.23 -0.919 . . . . 0.0 114.742 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.7 m -112.85 -164.78 0.94 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 119.339 1.57 . . . . 0.0 109.617 170.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.46 ' H ' HG22 ' A' ' 53' ' ' THR . 46.3 t80 -129.64 13.19 5.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.275 1.83 . . . . 0.0 111.668 -174.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.9 0.94 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 128.797 2.839 . . . . 0.0 113.502 -167.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 tt -157.36 140.74 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 118.956 -2.34 . . . . 0.0 112.101 165.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.39 165.92 29.07 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.142 1.353 . . . . 0.0 110.324 166.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -157.71 176.15 12.97 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.685 0.755 . . . . 0.0 111.464 165.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.14 155.36 22.82 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 165.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.0 p -63.34 127.87 33.25 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.36 173.8 12.11 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 164.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -66.26 -26.78 67.51 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.858 -1.151 . . . . 0.0 112.971 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -140.59 5.45 2.01 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.852 1.261 . . . . 0.0 113.175 -173.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -157.55 -179.76 8.48 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.097 1.759 . . . . 0.0 106.727 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tt -119.74 133.97 55.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.44 125.62 50.8 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.549 -175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.1 t -142.72 152.59 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 120.45 1.477 . . . . 0.0 109.82 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.8 t -161.23 165.16 17.4 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.805 2.042 . . . . 0.0 107.31 165.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -87.04 -56.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.401 2.067 . . . . 0.0 111.514 165.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -145.63 -80.86 0.16 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.69 -36.12 0.22 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.198 1.399 . . . . 0.0 111.772 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.0 tt -60.87 -32.34 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.803 0.729 . . . . 0.0 110.787 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.85 -17.81 44.3 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.386 1.946 . . . . 0.0 113.843 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.9 mm -113.65 -0.66 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.534 1.934 . . . . 0.0 108.792 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 t -90.85 -85.15 0.23 Allowed 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.951 1.3 . . . . 0.0 108.134 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -81.29 -43.18 19.53 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.844 0.857 . . . . 0.0 108.979 -170.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -71.81 -14.4 61.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.864 -0.523 . . . . 0.0 112.104 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.84 -32.71 70.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.511 0.724 . . . . 0.0 112.249 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.15 -45.85 83.29 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.91 82.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.82 1.248 . . . . 0.0 110.827 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.2 mt -58.11 -46.87 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.63 75.84 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.917 -0.489 . . . . 0.0 111.012 -171.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -65.41 -24.08 67.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.887 1.275 . . . . 0.0 113.191 -172.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.24 -47.21 83.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.66 55.59 0.04 OUTLIER Glycine 0 C--N 1.333 0.391 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -135.26 171.19 14.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.09 0.956 . . . . 0.0 109.427 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.8 m -130.4 106.99 8.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.58 1.552 . . . . 0.0 107.953 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.76 -178.09 3.04 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.36 0.6 . . . . 0.0 111.363 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 p -107.61 -164.66 0.99 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 162.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.7 11.27 39.89 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.663 1.585 . . . . 0.0 111.191 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.13 -35.31 0.59 Allowed Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.04 172.89 17.87 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.135 1.374 . . . . 0.0 109.149 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -104.46 162.79 12.94 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.35 0.977 . . . . 0.0 109.717 170.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 120.48 11.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.299 0.239 . . . . 0.0 110.545 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.75 143.73 26.68 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.18 155.12 68.8 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.591 1.528 . . . . 0.0 109.276 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -64.64 -16.3 62.56 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -71.46 -57.91 4.0 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.761 0.824 . . . . 0.0 112.152 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.79 165.81 46.78 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 123.889 0.875 . . . . 0.0 111.131 -165.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -63.21 173.27 4.24 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.603 1.536 . . . . 0.0 110.665 160.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 p -111.96 175.16 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 127.016 2.126 . . . . 0.0 107.408 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.71 78.06 1.29 Allowed 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 120.947 -1.095 . . . . 0.0 111.482 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -55.78 -30.36 61.17 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.066 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -67.64 -36.37 80.65 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.397 -0.814 . . . . 0.0 112.076 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.25 -36.89 58.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.587 1.085 . . . . 0.0 109.761 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.57 -55.65 23.9 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 122.93 0.492 . . . . 0.0 109.918 175.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -62.97 -49.58 74.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.761 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -54.16 -49.78 68.48 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.357 0.526 . . . . 0.0 110.448 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.4 ptp -72.46 -40.72 66.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.68 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.73 -46.81 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 120.615 1.552 . . . . 0.0 109.376 -172.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -55.03 -44.73 74.92 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.615 1.166 . . . . 0.0 110.736 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -65.05 -50.89 64.44 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 118.965 -0.541 . . . . 0.0 110.76 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -23.67 65.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.417 1.008 . . . . 0.0 111.592 -172.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.6 mt -75.16 -57.11 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.284 1.034 . . . . 0.0 109.337 169.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -63.95 -31.32 72.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 123.244 1.497 . . . . 0.0 112.1 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.33 -1.8 25.4 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 126.29 1.836 . . . . 0.0 112.914 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -127.36 -0.03 6.33 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 126.763 2.025 . . . . 0.0 111.931 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.25 1.096 0 C-N-CA 124.92 1.288 . . . . 0.0 109.664 -172.881 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.663 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 m 45.54 -55.74 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 131.409 3.884 . . . . 0.0 119.636 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.42 ' CE1' ' HG2' ' A' ' 4' ' ' MET 0.267 2.0 p-80 55.31 -45.32 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.525 1 C-N-CA 132.796 4.438 . . . . 0.0 116.127 -167.751 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.42 ' HG2' ' CE1' ' A' ' 3' ' ' HIS . 6.6 mmt -51.67 -44.9 63.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.182 1.393 . . . . 0.0 110.627 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.43 -28.15 68.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.995 1.318 . . . . 0.0 112.033 -170.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.4 t -76.18 -39.14 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -89.81 -11.71 41.27 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.874 1.27 . . . . 0.0 112.968 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.96 -20.27 64.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.931 0.892 . . . . 0.0 111.795 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.62 -16.57 51.09 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.567 1.147 . . . . 0.0 112.741 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -81.41 -49.45 10.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.739 1.616 . . . . 0.0 107.008 167.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.485 HD12 ' HE ' ' A' ' 20' ' ' ARG . 1.6 mm? -47.98 -49.58 30.22 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.788 1.235 . . . . 0.0 112.553 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -51.09 -34.97 32.66 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.646 0.778 . . . . 0.0 111.79 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.96 -1.09 80.27 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.7 -1.055 . . . . 0.0 113.23 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.0 mt -74.71 117.81 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 119.537 1.669 . . . . 0.0 106.983 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.81 -1.74 58.01 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.996 0.918 . . . . 0.0 112.73 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.07 79.64 8.57 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.005 1.722 . . . . 0.0 111.149 -176.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.92 -20.44 64.29 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 124.128 3.219 . . . . 0.0 114.428 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -7.91 51.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.018 0.826 . . . . 0.0 111.914 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -134.73 -2.75 2.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.271 0.628 . . . . 0.0 112.192 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.485 ' HE ' HD12 ' A' ' 11' ' ' LEU . 62.4 ttt180 -60.31 -64.62 0.89 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 127.226 2.21 . . . . 0.0 111.073 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -53.71 -32.46 51.98 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 125.65 1.58 . . . . 0.0 111.228 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -56.39 -33.59 65.89 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.188 -0.945 . . . . 0.0 113.468 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 m -69.48 -41.67 75.85 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.552 0.741 . . . . 0.0 109.548 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -65.06 -33.66 76.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.062 1.345 . . . . 0.0 111.27 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -58.66 -48.54 80.72 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.6 mt -62.64 -47.94 90.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.094 0.957 . . . . 0.0 109.67 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.9 mt -51.57 -65.8 0.49 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.896 0.878 . . . . 0.0 109.816 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -66.46 -30.47 70.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.171 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -60.7 -35.71 76.97 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 118.985 0.811 . . . . 0.0 110.661 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.452 HG21 ' CE2' ' A' ' 48' ' ' PHE . 34.3 m -74.65 -45.69 44.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 C-N-CA 117.045 -1.862 . . . . 0.0 106.681 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.71 -13.92 2.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.777 -0.63 . . . . 0.0 112.473 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.95 -68.08 0.74 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 123.389 0.676 . . . . 0.0 111.473 159.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.458 ' CG2' ' HE3' ' A' ' 107' ' ' LYS . 9.6 m -73.6 -41.64 62.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.907 0.883 . . . . 0.0 111.879 -163.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.454 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -115.08 72.39 3.04 Favored Pre-proline 0 N--CA 1.44 -0.927 0 C-N-CA 129.045 2.938 . . . . 0.0 108.748 175.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.57 -9.65 21.49 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.324 2.683 . . . . 0.0 111.942 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -38.88 90.99 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.874 1.669 . . . . 0.0 112.318 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.651 HD22 ' H ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -79.09 145.17 33.93 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -172.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -110.98 150.27 41.65 Favored Pre-proline 0 C--N 1.319 -0.743 0 C-N-CA 124.628 1.171 . . . . 0.0 108.26 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.65 139.77 37.89 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.614 2.209 . . . . 0.0 109.764 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -154.03 102.52 2.49 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.477 ' HE3' ' HA ' ' A' ' 44' ' ' ASN . 53.5 mmm -70.65 105.04 3.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 167.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -110.33 143.0 41.2 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.5 m95 54.51 18.85 2.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.477 ' HA ' ' HE3' ' A' ' 41' ' ' MET . 3.0 t-20 62.44 31.38 17.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.211 1.404 . . . . 0.0 110.943 -170.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.8 p -128.97 147.07 63.24 Favored Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 120.951 -1.093 . . . . 0.0 109.246 172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -73.37 129.76 14.26 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.828 3.019 . . . . 0.0 112.717 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.24 165.46 36.31 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.461 1.104 . . . . 0.0 109.138 172.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 30' ' ' VAL . 1.3 m-85 -126.56 163.88 22.42 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.444 0.64 . . . . 0.0 109.918 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.8 m -136.52 119.85 16.83 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -77.14 89.72 3.64 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 50.48 51.17 17.38 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.944 0.878 . . . . 0.0 109.291 -171.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.56 -0.43 56.8 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 117.319 1.688 . . . . 0.0 117.319 171.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -165.92 1.1 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.667 2.734 . . . . 0.0 111.975 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -127.2 12.09 7.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.723 1.609 . . . . 0.0 112.748 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 55' ' ' ILE . 33.6 mt -64.51 5.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 126.629 1.972 . . . . 0.0 113.816 -163.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.6 tt -160.93 132.48 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 118.709 -2.494 . . . . 0.0 110.608 174.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.53 157.42 29.36 Favored Glycine 0 C--N 1.339 0.718 0 O-C-N 122.094 -0.379 . . . . 0.0 112.662 171.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -155.84 168.56 26.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.871 0.868 . . . . 0.0 111.729 -176.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.79 158.01 22.22 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 120.611 -1.305 . . . . 0.0 110.393 170.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.6 p -77.29 113.04 14.63 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.007 0.923 . . . . 0.0 110.232 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.8 t -90.35 168.03 12.2 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.21 -29.79 6.14 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.304 1.442 . . . . 0.0 113.97 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -145.92 10.69 1.19 Allowed 'General case' 0 C--O 1.238 0.469 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -158.07 159.04 35.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.634 0.773 . . . . 0.0 109.268 -173.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.533 HD23 ' H ' ' A' ' 66' ' ' SER . 0.6 OUTLIER -85.4 165.45 17.2 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 158.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.533 ' H ' HD23 ' A' ' 65' ' ' LEU . 92.2 p -141.65 131.65 24.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.3 t -146.1 140.54 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.509 1.05 . . . . 0.0 109.274 -168.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 t -163.78 164.34 14.99 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.928 1.291 . . . . 0.0 108.394 165.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -78.98 -58.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 CA-C-N 119.433 0.833 . . . . 0.0 112.357 165.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -154.87 -85.8 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -138.23 -44.61 0.51 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.235 1.014 . . . . 0.0 111.568 -173.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.5 tt -55.15 -31.85 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.106 0.963 . . . . 0.0 113.102 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.66 -28.49 5.19 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.075 1.798 . . . . 0.0 113.162 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.2 mm -113.24 -5.52 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 117.918 0.859 . . . . 0.0 111.188 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.5 m -76.23 -78.13 0.12 Allowed 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.898 -1.126 . . . . 0.0 109.955 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -86.71 -47.23 9.31 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -68.07 -20.15 64.93 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.172 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.26 -30.65 51.31 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.756 1.162 . . . . 0.0 112.987 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.34 -48.63 80.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.255 1.422 . . . . 0.0 109.508 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.85 -29.9 62.37 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.58 0.752 . . . . 0.0 111.307 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.49 -45.49 97.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.254 1.021 . . . . 0.0 108.526 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.17 -46.47 88.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.04 0.936 . . . . 0.0 110.338 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -54.03 -42.35 69.05 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.792 1.237 . . . . 0.0 110.839 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.15 8.34 9.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.48 34.96 30.55 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 119.538 1.063 . . . . 0.0 113.653 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -123.71 169.18 11.76 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.145 0.978 . . . . 0.0 109.486 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.6 m -135.94 106.82 6.63 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.353 1.061 . . . . 0.0 111.059 -171.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.24 170.53 4.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.519 0.728 . . . . 0.0 112.285 168.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.4 p -128.93 -179.96 5.39 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.709 2.403 . . . . 0.0 107.186 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.82 62.98 6.69 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 120.393 -1.442 . . . . 0.0 110.15 -177.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.26 -59.03 0.1 OUTLIER Glycine 0 CA--C 1.498 -0.972 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 -171.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 66' ' ' SER . 1.5 pt? -157.6 177.28 11.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.447 -1.377 . . . . 0.0 110.573 -165.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -110.89 158.41 18.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 167.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -144.11 136.76 26.98 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.747 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.6 mm -117.29 142.75 30.68 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -169.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.46 154.6 60.5 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.87 1.713 . . . . 0.0 110.597 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -62.48 -21.89 65.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 172.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.59 -70.6 0.22 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.037 1.735 . . . . 0.0 111.405 172.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.72 153.34 43.81 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.348 0.659 . . . . 0.0 111.353 -161.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.21 -178.73 4.63 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.767 2.978 . . . . 0.0 113.599 -164.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.96 146.35 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 125.716 1.606 . . . . 0.0 110.43 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.99 119.54 35.66 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.28 1.432 . . . . 0.0 109.924 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -87.1 -18.08 31.33 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 123.273 0.629 . . . . 0.0 111.742 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.26 -58.98 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.304 1.042 . . . . 0.0 110.821 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.65 -48.88 79.92 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.62 -56.74 4.84 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.614 1.966 . . . . 0.0 109.933 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.458 ' HE3' ' CG2' ' A' ' 33' ' ' THR . 22.9 tttt -60.99 -45.01 96.54 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.124 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -58.5 -53.69 55.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.416 1.007 . . . . 0.0 110.155 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -75.56 6.87 4.2 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.9 -52.1 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 120.199 1.363 . . . . 0.0 107.831 173.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.425 ' OE1' ' HE2' ' A' ' 107' ' ' LYS . 42.6 mt-10 -60.91 -40.71 94.18 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 119.227 0.921 . . . . 0.0 111.464 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -61.78 -48.52 80.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -32.02 73.16 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.959 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.486 HD11 HD21 ' A' ' 37' ' ' LEU . 71.9 mt -58.9 -63.85 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.096 1.359 . . . . 0.0 109.123 165.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -69.55 -5.93 27.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.618 1.099 . . . . 0.0 113.317 -170.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -78.58 -50.16 12.02 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.403 1.881 . . . . 0.0 111.462 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -85.8 22.92 1.54 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.899 1.679 . . . . 0.0 111.873 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.253 1.246 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 169.167 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.787 0 CA-C-O 119.466 -0.63 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m 57.0 -171.13 0.09 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.231 2.612 . . . . 0.0 113.542 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -146.92 -39.38 0.2 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.824 0.849 . . . . 0.0 111.001 168.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 mmt -58.13 -19.17 30.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.714 0.806 . . . . 0.0 113.008 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -69.07 -43.65 74.15 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 121.36 -0.837 . . . . 0.0 110.169 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.69 -50.42 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.908 0.883 . . . . 0.0 109.011 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.1 4.41 52.24 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.869 0.868 . . . . 0.0 112.14 -166.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.12 79.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.062 0.945 . . . . 0.0 109.989 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.91 -21.01 64.25 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.124 0.97 . . . . 0.0 112.602 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -79.45 -56.4 4.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.479 0.711 . . . . 0.0 109.22 173.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -55.76 -40.62 72.84 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.427 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -52.06 -38.95 58.83 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.689 0.677 . . . . 0.0 111.247 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.84 -7.37 78.21 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-O 118.487 -1.174 . . . . 0.0 112.534 -166.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -70.54 119.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.8 1.02 56.56 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.953 1.301 . . . . 0.0 111.688 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.33 65.81 1.52 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 127.732 2.413 . . . . 0.0 109.837 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.46 -30.63 93.07 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 124.087 3.191 . . . . 0.0 113.807 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -59.16 -11.32 3.65 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.844 1.258 . . . . 0.0 113.287 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -126.48 -13.85 5.93 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.302 1.841 . . . . 0.0 110.04 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -66.32 -45.98 78.43 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.627 1.171 . . . . 0.0 110.14 -176.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.66 -33.56 64.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.826 1.25 . . . . 0.0 112.776 -171.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -56.67 -39.98 74.72 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.672 -0.643 . . . . 0.0 111.257 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.1 m -69.42 -39.08 78.09 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.195 1.398 . . . . 0.0 109.294 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -63.09 -45.28 92.85 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.04 -1.038 . . . . 0.0 111.815 174.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -53.85 -51.71 62.72 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 126.076 1.75 . . . . 0.0 108.984 176.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 67.6 mt -52.4 -56.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.797 1.639 . . . . 0.0 110.453 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.5 mt -53.35 -53.71 47.07 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.59 0.632 . . . . 0.0 110.197 -174.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.1 m -69.07 -31.98 71.11 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.578 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -63.22 -50.16 71.35 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 124.638 1.175 . . . . 0.0 110.506 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 87.3 t -59.93 -52.03 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.17 -1.46 4.43 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.72 -56.3 2.2 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 120.781 -1.199 . . . . 0.0 109.336 175.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -67.04 -33.58 75.85 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.734 2.013 . . . . 0.0 111.987 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.518 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -129.86 72.59 81.9 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -178.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.16 -6.73 17.55 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.108 1.872 . . . . 0.0 112.727 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -63.56 -45.8 88.82 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.686 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.602 HD22 ' H ' ' A' ' 37' ' ' LEU . 2.8 mm? -60.35 147.32 41.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.055 0.942 . . . . 0.0 108.955 -171.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -104.64 144.97 29.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 124.234 1.014 . . . . 0.0 108.879 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.79 161.29 46.12 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.497 2.131 . . . . 0.0 111.24 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -158.64 130.27 6.55 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.211 1.404 . . . . 0.0 107.681 161.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.17 112.48 17.53 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.551 1.069 . . . . 0.0 108.334 162.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -123.21 128.33 49.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.645 1.178 . . . . 0.0 108.242 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.9 m95 53.29 25.97 4.86 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.809 0.844 . . . . 0.0 113.062 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.59 29.02 18.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.502 1.121 . . . . 0.0 110.18 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -121.12 147.38 46.56 Favored Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -71.96 133.35 21.45 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.711 2.274 . . . . 0.0 111.758 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.0 ptm -147.28 173.3 12.7 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.804 0.442 . . . . 0.0 110.925 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.48 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -134.05 152.71 51.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.1 p -122.76 138.74 54.54 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.306 1.442 . . . . 0.0 108.006 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -88.35 95.27 10.13 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 163.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 66.78 -13.39 0.19 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.945 1.698 . . . . 0.0 114.046 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.61 -19.63 0.04 OUTLIER Glycine 0 CA--C 1.54 1.646 0 C-N-CA 127.044 2.259 . . . . 0.0 113.887 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.44 -171.05 1.68 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -165.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -125.31 24.99 7.25 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.442 2.297 . . . . 0.0 111.786 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.744 HG23 HD22 ' A' ' 113' ' ' ASN . 97.1 mt -68.65 -2.41 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 126.648 1.979 . . . . 0.0 113.515 -167.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 tt -160.68 145.86 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 119.357 -2.09 . . . . 0.0 109.692 169.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.13 148.81 11.53 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 165.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -144.1 166.09 25.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.849 0.825 . . . . 0.0 109.944 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 t -150.51 145.42 25.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 57.5 p -62.51 145.86 53.15 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.478 ' HB2' ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -127.75 174.59 8.99 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -59.59 -39.24 83.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.377 -162.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -138.6 14.27 2.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.199 1.0 . . . . 0.0 113.079 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.478 ' CD2' ' HB2' ' A' ' 61' ' ' SER . 3.9 p-80 -150.64 176.74 10.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.962 1.305 . . . . 0.0 108.794 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.27 161.88 14.39 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 166.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.35 114.96 24.31 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.127 1.371 . . . . 0.0 108.63 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.3 t -131.9 136.36 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.3 0.955 . . . . 0.0 109.434 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 t -165.68 161.82 13.37 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 125.261 1.424 . . . . 0.0 107.621 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.51 -57.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.131 0 CA-C-N 120.434 1.191 . . . . 0.0 110.998 157.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -149.55 -85.91 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -133.2 -38.85 0.94 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.444 1.498 . . . . 0.0 111.796 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.7 tp -53.76 -38.09 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.67 1.188 . . . . 0.0 112.981 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.42 -21.87 14.33 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.468 1.509 . . . . 0.0 112.835 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.7 mm -119.93 -5.3 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.437 1.495 . . . . 0.0 110.561 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.2 m -95.06 -64.04 1.11 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 168.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -76.62 -66.52 0.8 Allowed 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -72.48 -6.24 42.38 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.5 -164.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.32 49.24 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 118.238 -0.887 . . . . 0.0 112.545 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -62.75 -47.54 83.11 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.101 0.864 . . . . 0.0 109.82 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.626 ' HB1' HD21 ' A' ' 105' ' ' LEU . . . -78.89 -22.8 45.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.755 0.822 . . . . 0.0 110.977 -174.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.92 -46.98 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.004 0.921 . . . . 0.0 108.935 164.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.83 88.52 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.503 1.121 . . . . 0.0 111.088 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -63.07 -15.64 57.23 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 126.868 2.067 . . . . 0.0 112.894 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.6 -15.35 42.84 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 118.475 0.579 . . . . 0.0 111.623 172.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.96 -22.24 19.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.754 2.121 . . . . 0.0 112.879 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -74.17 114.7 12.82 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.236 1.014 . . . . 0.0 110.191 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.1 m -75.11 4.76 6.25 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 48.21 -155.71 0.07 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.798 2.439 . . . . 0.0 112.026 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.0 p -126.4 -164.7 1.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.549 2.34 . . . . 0.0 105.732 163.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -71.73 -33.0 68.34 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.109 1.322 . . . . 0.0 111.515 172.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.56 -10.56 2.92 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 114.479 0.552 . . . . 0.0 114.479 -160.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 pp -149.6 175.88 11.14 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.646 1.178 . . . . 0.0 109.675 168.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -113.26 157.4 21.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.651 0.66 . . . . 0.0 109.546 167.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.1 mtt85 -128.23 155.18 44.96 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -137.28 142.56 38.16 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 178.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.88 155.09 23.3 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.985 1.79 . . . . 0.0 109.343 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -63.81 -17.73 63.4 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -67.0 -45.15 78.46 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.17 0.988 . . . . 0.0 112.086 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.7 156.12 45.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 122.882 0.473 . . . . 0.0 110.982 -157.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.33 165.93 29.98 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.513 2.142 . . . . 0.0 112.911 -159.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.32 124.86 51.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -75.81 78.58 2.74 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.284 1.04 . . . . 0.0 113.148 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -59.62 -37.22 78.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.842 0.857 . . . . 0.0 112.351 173.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.59 -46.8 71.56 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 120.148 1.34 . . . . 0.0 110.437 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.626 HD21 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -68.38 -47.5 67.2 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.435 -0.791 . . . . 0.0 109.289 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.279 0.3 OUTLIER -72.55 -27.07 61.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.339 -175.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -54.33 -52.63 60.94 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.382 0.992 . . . . 0.0 109.591 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -56.73 -52.34 65.37 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.056 -170.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.8 ptp -65.46 -34.63 78.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.025 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -53.01 21.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.988 1.267 . . . . 0.0 109.002 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.63 -50.7 59.77 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -55.66 -52.8 62.6 Favored 'General case' 0 N--CA 1.441 -0.905 0 O-C-N 124.016 0.823 . . . . 0.0 111.068 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.744 HD22 HG23 ' A' ' 55' ' ' ILE . 13.4 t30 -63.67 -22.28 66.82 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.351 0.978 . . . . 0.0 112.844 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.2 mt -71.65 -57.47 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.943 0.897 . . . . 0.0 108.636 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -74.95 -5.93 46.53 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -75.1 -19.86 59.74 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.529 0.731 . . . . 0.0 110.383 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -101.69 16.69 25.0 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.792 2.437 . . . . 0.0 111.071 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 117.351 -1.309 . . . . 0.0 108.198 172.27 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.807 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.433 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -52.43 -43.61 64.95 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.748 1.619 . . . . 0.0 113.233 -175.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.433 ' CE1' ' HG2' ' A' ' 4' ' ' MET 0.256 2.8 p-80 50.87 -48.47 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.594 1 C-N-CA 132.019 4.127 . . . . 0.0 116.435 -171.769 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.433 ' HG2' ' CE1' ' A' ' 3' ' ' HIS . 3.4 mmt -55.91 -31.04 62.53 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 119.892 1.224 . . . . 0.0 111.26 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.451 ' H ' ' HG3' ' A' ' 5' ' ' GLU . 1.1 pp20? -53.11 -48.14 68.06 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.519 0.728 . . . . 0.0 111.475 175.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.31 -43.74 97.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 121.643 -0.661 . . . . 0.0 109.652 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -103.63 50.14 0.81 Allowed 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.156 0.983 . . . . 0.0 111.236 -171.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -126.2 -27.05 3.28 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.682 0.793 . . . . 0.0 110.374 168.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.401 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 50.1 mt-10 -75.83 -12.91 60.26 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.112 -0.993 . . . . 0.0 112.436 -173.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -78.85 -48.77 14.07 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.397 1.479 . . . . 0.0 109.029 163.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -60.2 -22.98 63.63 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.713 2.405 . . . . 0.0 112.923 -176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 9' ' ' GLU . 51.7 pttt -61.01 -44.13 97.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.741 1.155 . . . . 0.0 109.475 173.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.96 10.23 51.73 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.609 1.1 . . . . 0.0 114.907 -164.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.467 HD12 HG21 ' A' ' 60' ' ' THR . 4.6 mm -58.42 123.94 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.072 1.349 . . . . 0.0 108.254 174.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -56.94 -36.02 69.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.753 1.221 . . . . 0.0 113.107 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -116.78 85.95 18.24 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 126.521 1.929 . . . . 0.0 110.928 -168.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.07 -23.62 75.82 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.305 2.003 . . . . 0.0 111.828 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 23.6 m-20 -65.9 -16.9 64.27 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.306 -0.871 . . . . 0.0 111.888 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 18' ' ' ASP . 0.8 OUTLIER -128.85 -0.53 5.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.338 1.455 . . . . 0.0 110.763 179.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.9 ttp85 -53.96 -57.45 10.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.142 0.977 . . . . 0.0 109.484 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -48.31 -35.07 11.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.549 1.54 . . . . 0.0 112.39 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -60.63 -39.09 86.97 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.318 -1.489 . . . . 0.0 111.824 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.8 m -63.42 -49.78 72.41 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.675 0.79 . . . . 0.0 109.397 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.53 -30.63 61.08 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.567 1.547 . . . . 0.0 113.33 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.03 -58.94 6.38 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 118.775 0.716 . . . . 0.0 110.297 173.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 mt -57.66 -38.86 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 123.875 0.87 . . . . 0.0 110.415 -173.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.2 mt -56.33 -62.66 1.56 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.157 0.983 . . . . 0.0 110.189 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -64.25 -31.66 72.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -62.24 -43.33 99.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 117.493 -1.241 . . . . 0.0 110.876 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.25 -40.56 80.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.763 0 C-N-CA 116.92 -1.912 . . . . 0.0 107.37 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.96 -25.36 8.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 117.748 -1.12 . . . . 0.0 112.529 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.17 -27.65 14.46 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.471 HG21 ' HE3' ' A' ' 107' ' ' LYS . 7.3 m -94.82 -40.18 9.87 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.645 1.111 . . . . 0.0 111.251 -174.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.451 ' CE1' HG22 ' A' ' 33' ' ' THR . 2.6 m-85 -120.28 58.44 5.91 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 129.575 3.15 . . . . 0.0 111.823 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.08 -13.92 38.38 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.834 2.356 . . . . 0.0 113.722 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.29 -23.67 66.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.165 1.386 . . . . 0.0 112.427 172.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.87 145.58 44.74 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -117.59 150.47 46.83 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 126.964 2.106 . . . . 0.0 108.444 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.27 140.28 13.7 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.872 2.381 . . . . 0.0 111.67 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -164.85 96.49 0.73 Allowed 'General case' 0 C--N 1.346 0.439 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 ptm -70.21 136.39 49.96 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.422 1.01 . . . . 0.0 108.886 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -150.52 155.32 39.25 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.9 m95 52.71 33.37 13.78 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.563 1.145 . . . . 0.0 113.06 -174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 61.78 18.84 10.06 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.207 1.803 . . . . 0.0 112.476 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.0 p -129.49 155.97 79.33 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.92 1.288 . . . . 0.0 110.007 -173.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.81 120.75 5.93 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.968 3.112 . . . . 0.0 110.235 170.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.5 ptm -135.01 162.52 32.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 163.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.93 168.28 14.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 p -134.19 121.63 21.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.144 0.578 . . . . 0.0 109.56 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -68.46 92.9 0.46 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 169.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 53.58 28.67 8.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.478 1.111 . . . . 0.0 111.882 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.3 -17.81 7.89 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 125.636 1.589 . . . . 0.0 115.642 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.6 m -79.32 -179.13 6.59 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 119.799 1.8 . . . . 0.0 111.242 -173.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.548 ' H ' HG22 ' A' ' 53' ' ' THR . 61.6 t80 -111.09 18.25 19.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.462 1.905 . . . . 0.0 113.554 -168.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.67 12.51 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.849 1.66 . . . . 0.0 112.495 -163.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 tt -163.31 146.28 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 119.558 -1.964 . . . . 0.0 111.249 174.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.48 151.03 18.21 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 166.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.421 ' CD2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -153.17 -179.89 8.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.417 0.687 . . . . 0.0 111.078 175.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t 178.79 147.1 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 14' ' ' ILE . 81.4 p -62.86 146.91 51.66 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.302 0.641 . . . . 0.0 110.504 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -126.74 165.18 19.74 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -12.51 18.2 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.52 8.29 0.38 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.485 1.039 . . . . 0.0 112.245 176.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -162.49 -179.88 7.27 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.869 1.668 . . . . 0.0 108.645 -164.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.522 HD22 ' H ' ' A' ' 66' ' ' SER . 1.8 tm? -127.67 154.22 45.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.801 2.041 . . . . 0.0 107.012 174.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.625 ' HB2' HD22 ' A' ' 92' ' ' LEU . 3.8 p -132.07 122.82 26.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.761 1.624 . . . . 0.0 108.954 -173.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG13 ' CE1' ' A' ' 93' ' ' PHE . 1.6 p -144.78 145.45 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.882 1.219 . . . . 0.0 111.663 -171.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.545 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 13.7 t -160.0 165.03 18.59 Favored Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 125.59 1.556 . . . . 0.0 109.581 169.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -81.49 -57.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.444 2.096 . . . . 0.0 112.936 156.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -149.17 -86.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.122 1.769 . . . . 0.0 106.964 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -152.47 -27.32 0.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.651 1.18 . . . . 0.0 112.55 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.8 tt -62.71 -40.16 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 120.576 1.534 . . . . 0.0 109.891 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.96 -10.91 15.89 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.002 1.286 . . . . 0.0 113.104 173.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 68' ' ' SER . 5.3 mm -117.03 -0.57 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.734 2.014 . . . . 0.0 110.025 -177.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 m -125.62 -50.54 1.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.488 0.585 . . . . 0.0 111.844 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -79.67 -57.42 3.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.987 1.715 . . . . 0.0 107.443 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -73.46 -0.76 15.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.261 1.024 . . . . 0.0 112.5 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.25 -25.47 67.85 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.477 1.911 . . . . 0.0 112.701 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -79.07 -48.02 15.12 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.557 0.743 . . . . 0.0 109.028 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.28 87.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.552 0.741 . . . . 0.0 110.834 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.85 -50.33 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.053 0.941 . . . . 0.0 109.839 171.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.53 -50.58 73.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.97 0.908 . . . . 0.0 111.368 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -60.06 -25.74 65.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.655 1.582 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.41 -27.14 63.1 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.175 0.443 . . . . 0.0 110.854 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 122.61 6.21 8.06 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.466 1.508 . . . . 0.0 113.431 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -103.07 122.23 44.23 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.459 1.63 . . . . 0.0 110.005 -173.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.43 3.83 12.41 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -170.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 46.52 -168.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.962 2.105 . . . . 0.0 113.277 -172.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.3 p -141.67 -164.7 1.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.347 2.259 . . . . 0.0 108.092 168.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 5.26 13.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.16 2.184 . . . . 0.0 112.047 173.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.5 -7.94 0.03 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 116.667 1.427 . . . . 0.0 116.667 -172.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 66' ' ' SER . 2.9 pp -149.29 170.71 17.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.112 1.456 . . . . 0.0 108.607 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.425 ' CE1' HG13 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -116.22 125.83 52.78 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 164.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -72.37 134.75 45.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.494 170.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.6 mm -125.72 143.71 45.96 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 165.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.68 163.68 38.15 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.154 1.903 . . . . 0.0 110.159 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -70.49 -35.12 73.07 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 171.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -67.76 -59.95 2.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.218 0.533 . . . . 0.0 110.469 -174.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.22 162.83 65.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.48 1.912 . . . . 0.0 109.455 -172.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.15 165.61 25.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.587 1.525 . . . . 0.0 113.391 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.0 t -93.44 134.91 29.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 126.413 1.885 . . . . 0.0 106.719 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.41 76.35 3.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.328 1.451 . . . . 0.0 110.721 171.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -56.47 -44.25 80.38 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.028 0.931 . . . . 0.0 110.461 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -65.18 -26.2 68.05 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.778 0.831 . . . . 0.0 111.749 -174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.96 -53.92 6.56 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.277 0.3 OUTLIER -58.72 -24.87 62.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.77 1.228 . . . . 0.0 112.022 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.471 ' HE3' HG21 ' A' ' 33' ' ' THR . 16.1 tttt -65.52 -54.0 34.4 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.785 2.034 . . . . 0.0 113.252 169.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -57.81 -46.42 84.71 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.877 1.217 . . . . 0.0 111.192 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.0 ptp -66.35 -32.21 73.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.307 -0.854 . . . . 0.0 113.226 -175.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -44.78 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.195 0.907 . . . . 0.0 108.987 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.08 -43.75 98.15 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.639 0.775 . . . . 0.0 110.717 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.425 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 5.1 t80 -58.26 -48.06 81.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.458 175.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -59.1 -40.47 85.39 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 118.161 0.437 . . . . 0.0 110.383 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.85 -52.06 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 O-C-N 121.319 -0.863 . . . . 0.0 110.084 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 112' ' ' PHE . 17.6 pt20 -71.56 -4.92 29.6 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 120.27 1.396 . . . . 0.0 112.413 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -93.78 2.57 56.2 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.658 1.983 . . . . 0.0 112.281 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -129.38 19.35 5.8 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.317 1.447 . . . . 0.0 111.216 -174.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 124.282 1.033 . . . . 0.0 109.586 175.71 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -133.69 92.05 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.905 1.352 . . . . 0.0 110.977 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -56.04 -37.5 69.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.992 0.917 . . . . 0.0 113.302 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.2 mmt -60.1 -30.4 69.22 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.652 -0.655 . . . . 0.0 112.534 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.73 -43.85 71.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.57 -44.98 99.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.61 1.164 . . . . 0.0 109.917 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.43 0.05 55.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.953 0.501 . . . . 0.0 112.118 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.92 -47.54 67.93 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.786 1.235 . . . . 0.0 109.46 173.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.33 -13.36 62.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.273 1.429 . . . . 0.0 113.526 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -82.67 -59.6 2.46 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -55.96 -44.32 78.36 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.821 1.248 . . . . 0.0 110.811 -175.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -56.36 -32.55 64.83 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.424 0.69 . . . . 0.0 112.471 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.0 -22.73 57.09 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 119.251 -0.749 . . . . 0.0 111.379 -171.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.5 mt -74.84 98.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -66.58 -2.83 5.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.227 1.411 . . . . 0.0 113.437 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -100.01 84.97 0.46 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 128.662 2.785 . . . . 0.0 110.978 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.79 -36.79 82.62 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.533 2.155 . . . . 0.0 112.295 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.88 5.79 2.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.013 0.824 . . . . 0.0 112.476 -170.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -137.13 -36.77 0.66 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.395 1.878 . . . . 0.0 110.425 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -52.78 -40.37 63.12 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.85 0.86 . . . . 0.0 110.889 171.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.93 -22.72 60.41 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.616 1.166 . . . . 0.0 112.362 -176.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -81.99 -31.54 31.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.1 0.864 . . . . 0.0 111.853 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.2 m -72.94 -39.69 66.02 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.157 0.983 . . . . 0.0 110.492 -175.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HB3' HD21 ' A' ' 11' ' ' LEU . 3.0 pt-20 -63.19 -26.04 68.62 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.731 0.412 . . . . 0.0 111.906 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.46 -54.65 44.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.835 0.854 . . . . 0.0 110.142 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.9 mp -63.83 -40.59 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -174.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.1 mt -52.92 -53.89 42.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.236 0.614 . . . . 0.0 110.101 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 t -62.47 -44.45 96.37 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.528 1.131 . . . . 0.0 111.228 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.8 t90 -59.04 -44.31 91.77 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.502 1.121 . . . . 0.0 111.664 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.832 HG11 ' CE2' ' A' ' 48' ' ' PHE . 40.9 t -63.25 -46.16 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.306 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.25 -12.7 21.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.493 1.042 . . . . 0.0 113.452 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.49 -48.59 7.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.348 164.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 m -78.83 -34.47 45.18 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 117.431 -1.271 . . . . 0.0 111.314 -163.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.602 ' HD2' HG13 ' A' ' 30' ' ' VAL . 1.5 m-85 -117.47 76.17 9.56 Favored Pre-proline 0 C--N 1.344 0.333 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.23 -14.04 39.43 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.665 2.243 . . . . 0.0 113.338 -172.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -20.83 59.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.528 0.731 . . . . 0.0 111.658 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.481 HD11 ' CD1' ' A' ' 114' ' ' ILE . 2.7 mp -70.29 151.16 45.6 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.564 1.546 . . . . 0.0 109.085 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -122.93 143.02 39.48 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 113.032 -1.895 . . . . 0.0 108.738 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.54 154.21 35.22 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.19 2.593 . . . . 0.0 110.488 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -176.95 102.58 0.05 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.155 1.782 . . . . 0.0 106.26 171.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 62.2 mmm -60.63 129.95 44.11 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -134.58 138.96 45.01 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 7.0 m95 58.76 19.77 7.22 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m120 64.03 12.18 6.73 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 126.578 1.951 . . . . 0.0 113.101 -166.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.0 p -114.51 112.54 45.86 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 120.356 1.435 . . . . 0.0 108.169 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.05 132.83 33.34 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.927 2.418 . . . . 0.0 111.648 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 ptm -143.26 159.19 42.78 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.832 ' CE2' HG11 ' A' ' 30' ' ' VAL . 1.2 m-85 -123.94 109.29 13.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.6 p -73.24 120.82 19.38 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -67.12 98.33 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 163.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 50.68 -4.64 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 130.207 3.403 . . . . 0.0 117.617 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.44 25.24 0.09 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.76 1.648 . . . . 0.0 113.028 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -117.0 177.32 4.75 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.184 1.394 . . . . 0.0 108.481 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -120.68 25.99 9.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.731 1.612 . . . . 0.0 110.777 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.78 19.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 125.234 1.413 . . . . 0.0 111.552 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.471 ' CG2' ' H ' ' A' ' 48' ' ' PHE . 1.1 tt -165.72 162.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 119.684 -1.885 . . . . 0.0 109.16 166.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.51 91.62 0.08 OUTLIER Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 159.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.509 ' CD2' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -90.98 162.47 14.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.532 0.666 . . . . 0.0 110.897 -175.428 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.0 t -152.92 155.39 36.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.992 0.901 . . . . 0.0 110.399 164.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.6 p -72.8 156.33 39.02 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.185 2.194 . . . . 0.0 109.787 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.28 -179.04 5.43 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.916 1.286 . . . . 0.0 109.739 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -49.66 -59.84 3.43 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 125.085 1.354 . . . . 0.0 111.824 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -132.32 15.31 4.57 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.255 1.022 . . . . 0.0 111.184 -174.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -152.08 173.64 14.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.824 1.249 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.528 HD12 ' H ' ' A' ' 66' ' ' SER . 33.7 tp -111.79 157.87 20.04 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.715 1.606 . . . . 0.0 108.131 170.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.528 ' H ' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -135.51 111.62 9.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.277 1.431 . . . . 0.0 110.281 -171.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG13 ' CZ ' ' A' ' 93' ' ' PHE . 1.5 p -142.15 151.36 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.702 1.601 . . . . 0.0 113.876 -167.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 1.4 t -174.83 165.16 2.29 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.136 2.575 . . . . 0.0 109.422 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -82.99 -55.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 124.327 3.351 . . . . 0.0 112.956 164.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -156.12 -74.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.776 2.03 . . . . 0.0 108.401 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -156.1 -46.75 0.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.861 1.665 . . . . 0.0 110.722 -168.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 tp -55.96 -42.42 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.516 1.053 . . . . 0.0 110.845 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.13 -16.04 24.62 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.075 0.845 . . . . 0.0 114.178 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.476 HG21 ' H ' ' A' ' 91' ' ' GLY . 34.4 mm -115.9 -6.88 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.032 1.733 . . . . 0.0 110.131 -176.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.8 m -100.95 -61.22 1.4 Allowed 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 121.569 -0.707 . . . . 0.0 109.881 172.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -82.61 -39.97 21.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.889 2.476 . . . . 0.0 109.597 -172.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -99.38 -8.21 25.13 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' A' ' 81' ' ' ILE . . . -61.56 -29.78 70.24 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.896 0.771 . . . . 0.0 112.496 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.64 -51.23 70.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.791 0.805 . . . . 0.0 109.483 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.57 -28.87 66.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.416 1.486 . . . . 0.0 111.359 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 78' ' ' ALA . 77.9 mt -64.91 -48.82 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 123.76 0.824 . . . . 0.0 108.976 168.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.95 -48.59 79.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.203 0.525 . . . . 0.0 110.403 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.2 -24.67 67.35 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.991 0.917 . . . . 0.0 112.197 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.57 -4.24 41.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.494 0.588 . . . . 0.0 112.344 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.01 29.21 10.66 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 121.243 -0.911 . . . . 0.0 112.817 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -126.01 -179.99 4.95 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.468 1.134 . . . . 0.0 111.377 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.23 158.84 34.62 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.249 1.819 . . . . 0.0 111.034 -172.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.35 169.83 17.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.495 1.518 . . . . 0.0 110.917 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.2 p -136.47 -163.79 1.46 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 127.857 2.463 . . . . 0.0 107.956 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -94.78 77.03 3.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 166.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.476 ' H ' HG21 ' A' ' 74' ' ' ILE . . . 127.14 6.6 5.28 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.726 166.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 0.3 OUTLIER -160.9 159.44 29.69 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.948 1.374 . . . . 0.0 110.706 169.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CZ ' HG13 ' A' ' 67' ' ' VAL . 27.1 p90 -117.84 156.76 27.81 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.927 0.891 . . . . 0.0 108.693 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.99 120.11 30.63 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.996 0.919 . . . . 0.0 108.642 -161.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.0 mm -119.61 142.86 33.6 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.51 155.49 31.92 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.785 1.657 . . . . 0.0 109.385 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -57.85 -15.16 7.56 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 170.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.22 -45.92 65.58 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.379 1.471 . . . . 0.0 113.343 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.97 161.92 21.34 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 123.642 0.777 . . . . 0.0 110.227 -163.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -66.23 154.2 75.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.734 2.29 . . . . 0.0 110.899 172.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.3 t -85.98 132.38 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -73.58 81.62 1.5 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.488 1.515 . . . . 0.0 110.365 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -50.55 -48.17 57.5 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 124.728 1.211 . . . . 0.0 110.051 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.44 -46.94 66.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 123.433 0.458 . . . . 0.0 111.286 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.6 -47.51 47.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 119.507 1.049 . . . . 0.0 109.886 -171.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -27.0 66.81 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.591 0.757 . . . . 0.0 110.618 174.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -65.99 -59.5 3.76 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.296 1.438 . . . . 0.0 110.187 172.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -61.32 -38.63 87.55 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.698 0.681 . . . . 0.0 109.677 -170.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.8 ptp -72.25 -17.83 61.86 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.63 -53.18 8.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 121.088 1.767 . . . . 0.0 109.176 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.83 -46.67 42.38 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 125.545 1.538 . . . . 0.0 109.128 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 16.9 t80 -49.56 -41.08 40.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.27 -0.871 . . . . 0.0 113.195 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -29.04 42.65 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 120.33 1.423 . . . . 0.0 109.325 -177.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' HD11 ' A' ' 37' ' ' LEU . 7.2 mt -78.09 -25.94 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 120.711 -1.243 . . . . 0.0 110.202 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 112' ' ' PHE . 16.6 pt20 -84.32 -2.59 57.3 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.278 1.399 . . . . 0.0 112.165 166.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -92.57 -38.07 12.11 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.278 0.561 . . . . 0.0 110.975 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.59 24.34 3.11 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.059 1.344 . . . . 0.0 112.151 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.243 0.712 0 C-N-CA 124.845 1.258 . . . . 0.0 108.807 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.611 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.51 151.32 20.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.654 0.782 . . . . 0.0 110.406 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -166.93 -35.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.712 1.205 . . . . 0.0 110.593 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.9 mmt -60.7 -25.5 66.45 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.361 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.85 -53.06 62.5 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 118.578 0.626 . . . . 0.0 109.931 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.37 -44.63 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -175.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -76.46 -13.16 60.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.465 0.706 . . . . 0.0 111.799 -171.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.6 91.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.787 0.835 . . . . 0.0 110.677 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -72.66 -9.31 58.46 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -83.22 -57.08 3.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.571 -0.706 . . . . 0.0 109.77 159.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.1 mm? -56.59 -37.19 70.28 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -170.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -51.46 -29.82 17.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.479 1.112 . . . . 0.0 112.279 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.35 4.15 62.04 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 117.025 -1.986 . . . . 0.0 113.615 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.08 102.87 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.395 0 CA-C-N 120.963 2.381 . . . . 0.0 107.978 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -0.59 2.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.331 2.253 . . . . 0.0 113.528 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -117.43 64.27 4.05 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 128.779 2.832 . . . . 0.0 109.993 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -62.73 -17.55 59.63 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.92 3.08 . . . . 0.0 112.822 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.64 -14.15 62.69 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.748 1.219 . . . . 0.0 112.592 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.95 -1.25 1.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.493 1.517 . . . . 0.0 110.295 -172.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -55.97 -58.58 7.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.665 1.586 . . . . 0.0 110.352 -173.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -54.01 -31.18 50.32 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.059 1.744 . . . . 0.0 112.471 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -52.88 -35.76 58.24 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.82 -0.55 . . . . 0.0 110.333 174.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -67.75 -47.62 68.73 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.25 1.42 . . . . 0.0 110.435 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.89 -31.95 73.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.821 1.648 . . . . 0.0 110.345 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -58.15 -57.9 10.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.346 1.058 . . . . 0.0 108.513 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.3 mt -56.93 -46.71 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.4 mt -59.25 -49.65 77.01 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.901 0.773 . . . . 0.0 110.334 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -61.13 -43.05 99.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.791 1.236 . . . . 0.0 110.878 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 71.4 t90 -66.7 -42.75 85.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.627 1.971 . . . . 0.0 111.211 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 t -59.2 -54.59 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-N 119.26 0.936 . . . . 0.0 108.702 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.65 -1.31 1.78 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.612 0.765 . . . . 0.0 112.945 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.61 -68.1 0.87 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.782 1.233 . . . . 0.0 109.027 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -62.66 -32.91 74.05 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.334 1.853 . . . . 0.0 111.368 -170.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.23 68.42 18.73 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.94 -4.77 15.5 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.382 2.721 . . . . 0.0 113.105 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.01 -14.32 50.97 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.634 -1.291 . . . . 0.0 110.768 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 56' ' ' ILE . 46.0 mt -80.92 149.59 29.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.236 0.925 . . . . 0.0 109.383 171.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -132.3 151.12 77.75 Favored Pre-proline 0 C--O 1.221 -0.42 0 C-N-CA 125.517 1.527 . . . . 0.0 111.78 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.42 132.8 18.15 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.521 2.814 . . . . 0.0 112.365 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -148.84 127.16 12.2 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.03 125.31 35.79 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 168.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -153.54 150.7 28.98 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 119.265 0.939 . . . . 0.0 111.701 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.3 m95 53.9 24.66 4.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.1 t30 65.11 10.25 6.19 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.923 2.089 . . . . 0.0 113.312 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.86 149.09 40.29 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.99 136.32 16.37 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.244 1.962 . . . . 0.0 109.88 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 17.4 ptm -142.89 -176.81 5.04 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.628 1.171 . . . . 0.0 108.11 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -140.35 157.12 46.04 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 117.751 -1.119 . . . . 0.0 108.682 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.1 p -117.07 132.58 56.65 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 120.589 1.541 . . . . 0.0 109.543 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -74.34 95.25 2.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 161.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 44.81 41.75 5.4 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.137 1.775 . . . . 0.0 112.941 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 115.06 -20.63 14.13 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.373 1.463 . . . . 0.0 114.502 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 54' ' ' PHE . 1.8 m -77.12 -175.92 3.81 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.63 1.972 . . . . 0.0 110.907 -171.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' H ' HG22 ' A' ' 53' ' ' THR . 21.0 t80 -124.11 22.25 8.73 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.256 -1.527 . . . . 0.0 112.88 -169.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.3 mt -68.23 8.54 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 127.341 2.256 . . . . 0.0 113.464 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 37' ' ' LEU . 4.5 tt -162.52 148.47 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 121.853 2.115 . . . . 0.0 111.42 172.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.49 154.0 23.44 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.384 0.993 . . . . 0.0 111.433 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.41 170.46 20.06 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.637 1.219 . . . . 0.0 110.947 174.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.14 116.24 3.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.313 1.045 . . . . 0.0 108.827 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.2 p -62.22 130.68 46.5 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 119.907 1.231 . . . . 0.0 109.86 -170.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.4 t -90.53 171.25 9.54 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -55.72 -52.71 62.96 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 167.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -134.87 54.56 1.93 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.5 0.72 . . . . 0.0 109.726 -171.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.466 ' CD2' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER 175.84 170.66 0.37 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.638 2.375 . . . . 0.0 110.271 174.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tp -112.99 150.27 32.13 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.589 2.355 . . . . 0.0 106.768 153.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -132.76 121.32 22.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.473 2.709 . . . . 0.0 111.138 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.88 144.1 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 127.273 2.229 . . . . 0.0 111.314 -163.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.9 t -156.82 163.26 25.64 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 159.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.18 -57.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 120.736 0.957 . . . . 0.0 110.511 157.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -150.78 -86.5 0.08 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 171.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.26 -25.9 0.84 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.707 1.203 . . . . 0.0 112.584 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.0 tp -57.4 -41.47 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 121.065 1.757 . . . . 0.0 109.85 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.79 -23.4 10.58 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.445 1.021 . . . . 0.0 113.95 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.9 mm -111.73 -3.56 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.983 2.113 . . . . 0.0 110.237 -172.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.3 m -116.36 -54.31 2.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.349 1.06 . . . . 0.0 109.654 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -78.28 -51.85 9.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.112 2.165 . . . . 0.0 108.288 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -95.39 -3.22 47.5 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -167.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.57 -30.3 70.57 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -69.13 -42.07 76.53 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.984 0.811 . . . . 0.0 109.135 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.44 -45.85 92.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.277 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.0 mt -58.91 -43.41 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.464 0.705 . . . . 0.0 109.67 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.75 -53.47 57.86 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.278 0.631 . . . . 0.0 110.089 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.9 -21.71 62.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.609 0.763 . . . . 0.0 112.014 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.22 8.09 2.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.372 0.987 . . . . 0.0 111.566 170.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.74 37.24 57.54 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 121.142 -0.974 . . . . 0.0 112.043 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -136.8 161.18 36.68 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.055 0.942 . . . . 0.0 110.311 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -122.51 97.57 5.52 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.64 -0.662 . . . . 0.0 110.828 -160.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.87 165.04 7.18 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.518 0.675 . . . . 0.0 111.117 171.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.6 p -105.81 -165.55 1.12 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 157.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -77.62 -4.04 43.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.667 166.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.96 -11.42 0.42 Allowed Glycine 0 CA--C 1.529 0.918 0 CA-C-N 120.444 1.475 . . . . 0.0 115.535 -168.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.19 178.58 9.59 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.116 1.458 . . . . 0.0 110.472 164.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -122.68 144.36 49.19 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 165.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.459 ' HD2' ' NE2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -139.12 154.95 48.19 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 120.625 -1.297 . . . . 0.0 110.047 -170.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.466 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 44.3 mm -143.05 142.36 21.68 Favored Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -163.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.08 153.05 72.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 CA-C-N 121.01 1.396 . . . . 0.0 109.886 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -69.88 92.1 0.68 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 157.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.38 -59.46 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 126.305 1.842 . . . . 0.0 108.749 166.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -90.52 157.23 44.71 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.803 -159.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.46 114.86 4.06 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.988 1.792 . . . . 0.0 110.886 -172.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.69 119.68 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.828 1.651 . . . . 0.0 107.99 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -76.03 85.83 2.93 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 126.034 1.734 . . . . 0.0 113.072 -173.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -56.01 -43.82 78.11 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 124.348 1.059 . . . . 0.0 110.854 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -56.46 -51.67 67.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.729 1.212 . . . . 0.0 111.872 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -42.73 95.31 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.607 -0.683 . . . . 0.0 109.888 -177.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . 0.302 0.2 OUTLIER -75.93 -24.66 55.55 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.76 -176.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.77 -44.65 85.17 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 120.19 1.359 . . . . 0.0 109.899 171.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -56.53 -50.44 71.84 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.75 0.704 . . . . 0.0 109.688 -175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 ptp -67.1 -35.35 79.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.224 -0.894 . . . . 0.0 113.192 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -49.65 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.651 1.114 . . . . 0.0 109.068 177.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -58.5 -42.72 88.29 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.694 1.198 . . . . 0.0 110.949 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.41 -51.11 67.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.431 -0.795 . . . . 0.0 109.514 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -69.81 -10.4 58.3 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.883 1.219 . . . . 0.0 113.573 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 76.4 mt -75.17 -59.88 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.396 1.078 . . . . 0.0 108.525 161.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -75.7 -15.62 60.27 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 121.601 -0.687 . . . . 0.0 112.737 -165.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.64 -11.14 59.96 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.676 1.99 . . . . 0.0 112.034 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -106.06 15.08 26.92 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.974 2.109 . . . . 0.0 110.498 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 C--O 1.249 1.071 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.091 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -23.11 65.12 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 117.999 -1.001 . . . . 0.0 111.549 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.261 5.6 p-80 55.87 -45.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 130.109 3.364 . . . . 0.0 116.264 -173.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 mmt -51.62 -34.09 36.07 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.872 1.669 . . . . 0.0 112.311 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.02 -24.5 54.14 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.66 -25.86 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 120.896 0.379 . . . . 0.0 110.333 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -114.43 -5.53 12.88 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.12 1.768 . . . . 0.0 113.122 -173.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.78 -22.79 45.82 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 120.508 -1.37 . . . . 0.0 112.082 -169.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.27 -8.73 54.75 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.762 -0.587 . . . . 0.0 111.848 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -68.0 -57.75 5.64 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 160.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.434 HD12 ' CG ' ' A' ' 20' ' ' ARG . 1.2 mm? -46.63 -50.18 18.0 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.641 1.577 . . . . 0.0 112.964 -175.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -53.06 -29.91 32.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -174.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.8 9.68 29.88 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.058 -1.412 . . . . 0.0 114.635 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.409 HD12 HD13 ' A' ' 11' ' ' LEU . 24.4 mt -69.12 111.53 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 120.705 2.252 . . . . 0.0 105.958 167.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.0 -9.43 59.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.815 0.846 . . . . 0.0 113.208 -173.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.83 73.42 34.14 Favored Pre-proline 0 N--CA 1.445 -0.695 0 C-N-CA 125.017 1.327 . . . . 0.0 110.776 -168.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.77 -18.75 53.36 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.749 2.966 . . . . 0.0 114.875 -167.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -64.15 -10.66 24.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.266 0.626 . . . . 0.0 110.533 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -119.28 -6.84 10.33 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.58 1.952 . . . . 0.0 112.039 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.434 ' CG ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -79.95 -49.02 12.47 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.114 -0.991 . . . . 0.0 110.48 -171.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.68 -42.6 79.32 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.774 0.671 . . . . 0.0 110.064 -177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.52 -56.96 10.51 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 123.899 0.88 . . . . 0.0 110.426 171.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.3 m -58.43 -38.83 78.26 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.548 1.139 . . . . 0.0 110.629 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -30.87 66.43 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.769 1.628 . . . . 0.0 114.068 171.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -63.75 -51.1 66.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.972 -0.537 . . . . 0.0 109.806 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mp -57.9 -52.62 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.34 -61.34 2.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.536 1.134 . . . . 0.0 109.941 -170.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m -71.36 -31.53 67.44 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.802 -1.094 . . . . 0.0 111.054 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 74.3 t90 -61.31 -48.07 83.07 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.575 1.079 . . . . 0.0 111.316 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.425 HG13 ' HD2' ' A' ' 34' ' ' PHE . 88.0 t -58.15 -48.89 83.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.96 -15.29 63.54 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.77 -62.4 1.55 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.052 0.941 . . . . 0.0 109.529 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 m -68.97 -27.51 65.79 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.774 0.83 . . . . 0.0 110.886 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.507 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -124.21 73.62 58.32 Favored Pre-proline 0 N--CA 1.443 -0.822 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.111 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.8 -5.58 17.45 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.343 2.029 . . . . 0.0 111.763 175.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.63 -36.55 84.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.54 1.136 . . . . 0.0 112.013 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.578 HD22 ' H ' ' A' ' 37' ' ' LEU . 1.4 mm? -78.84 139.59 38.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -172.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -88.59 147.01 38.55 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 171.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.53 142.04 14.35 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.655 2.903 . . . . 0.0 111.348 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -146.8 139.04 24.77 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.738 0.699 . . . . 0.0 109.966 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 ttm -99.85 107.65 19.72 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -125.48 151.39 46.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.946 1.699 . . . . 0.0 107.078 170.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.0 m95 55.78 21.26 4.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.594 1.558 . . . . 0.0 114.749 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.07 26.23 11.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.341 1.056 . . . . 0.0 111.424 -168.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 59' ' ' SER . 44.4 p -119.1 146.91 41.57 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.459 1.504 . . . . 0.0 109.255 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.24 122.19 7.81 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.629 2.219 . . . . 0.0 109.74 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.5 ptm -137.26 167.38 21.7 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.363 0.601 . . . . 0.0 109.998 169.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -127.23 169.74 13.17 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.466 -2.049 . . . . 0.0 105.466 178.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 p -154.31 135.33 13.86 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 120.253 -1.529 . . . . 0.0 107.702 166.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -76.94 114.41 15.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 164.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 44.52 53.88 6.76 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.144 0.978 . . . . 0.0 112.656 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.7 9.07 86.46 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 170.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 55' ' ' ILE . 1.4 t -69.16 -164.65 0.06 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.007 1.403 . . . . 0.0 112.042 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -132.99 22.19 4.15 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 118.358 2.725 . . . . 0.0 118.358 162.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' A' ' 113' ' ' ASN . 10.1 mt -62.22 10.48 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 O-C-N 119.427 -2.046 . . . . 0.0 115.005 -170.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.3 tt -164.33 141.58 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 123.162 2.71 . . . . 0.0 112.048 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.4 140.33 3.83 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.001 1.286 . . . . 0.0 110.977 166.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -132.35 170.15 15.49 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.94 1.296 . . . . 0.0 111.505 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.441 ' HB3' HG22 ' A' ' 45' ' ' THR . 2.8 p -152.87 161.13 42.94 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.678 156.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p -59.69 153.18 20.81 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 171.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 t -144.58 170.55 15.84 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.224 1.012 . . . . 0.0 108.394 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -62.67 -21.95 66.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -156.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.84 14.13 0.73 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.007 0.821 . . . . 0.0 111.844 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -156.52 169.85 23.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.084 1.754 . . . . 0.0 109.693 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.01 145.11 30.63 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 164.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -104.1 117.34 34.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.928 1.24 . . . . 0.0 109.727 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.454 HG11 HD21 ' A' ' 106' ' ' LEU . 39.0 t -128.42 147.96 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 120.282 1.401 . . . . 0.0 107.835 176.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.0 t -167.31 165.58 8.79 Favored Pre-proline 0 C--O 1.243 0.723 0 C-N-CA 125.709 1.604 . . . . 0.0 107.396 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -94.13 -57.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 119.394 0.819 . . . . 0.0 113.211 158.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -147.08 -85.78 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.162 1.385 . . . . 0.0 107.841 -173.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -143.98 -29.26 0.5 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.854 2.462 . . . . 0.0 110.825 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.0 tt -62.04 -41.53 91.45 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 119.451 1.023 . . . . 0.0 111.413 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.25 -19.89 13.69 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.369 1.938 . . . . 0.0 112.928 177.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.6 mm -121.47 -0.41 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.209 1.804 . . . . 0.0 109.767 -172.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.1 m -98.23 -78.77 0.48 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.37 -51.12 10.54 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.643 0.656 . . . . 0.0 109.294 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -65.75 -17.49 64.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.573 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.89 -32.65 63.91 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.31 -40.54 93.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.959 0.885 . . . . 0.0 110.134 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.464 ' HB3' HD11 ' A' ' 105' ' ' LEU . . . -69.74 -38.77 76.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.401 -0.812 . . . . 0.0 111.462 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.26 -46.27 92.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.538 1.135 . . . . 0.0 108.714 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.39 -47.92 82.29 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.049 1.34 . . . . 0.0 111.861 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -63.91 -30.08 71.2 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.716 0.807 . . . . 0.0 112.044 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.25 83.18 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.842 0.746 . . . . 0.0 109.6 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.12 -2.2 3.54 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.161 1.362 . . . . 0.0 112.965 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -92.76 157.69 16.29 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.514 1.657 . . . . 0.0 111.265 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.0 m -118.93 156.55 29.35 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.137 0.975 . . . . 0.0 110.516 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.24 165.9 17.47 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.13 0.972 . . . . 0.0 110.646 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -83.58 -164.55 0.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 165.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -63.41 -27.44 69.3 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.164 -0.96 . . . . 0.0 112.672 165.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.98 -14.03 0.78 Allowed Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.568 0.987 . . . . 0.0 115.568 -156.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 pp -152.79 163.9 38.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.739 1.77 . . . . 0.0 111.05 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.412 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 20.7 p90 -107.17 146.8 30.9 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.559 -0.713 . . . . 0.0 110.061 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -131.78 91.21 2.95 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 123.225 0.61 . . . . 0.0 110.237 -165.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.697 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -79.83 141.97 55.98 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 -176.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.23 157.34 41.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.318 2.012 . . . . 0.0 109.95 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -69.1 -16.39 63.66 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -63.71 -38.33 90.7 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.669 0.668 . . . . 0.0 112.45 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -129.64 150.97 77.22 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.945 1.298 . . . . 0.0 108.638 -165.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.38 147.14 17.87 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.311 2.674 . . . . 0.0 113.972 -164.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 m -68.3 126.56 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 121.261 -0.899 . . . . 0.0 109.49 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -79.48 98.63 6.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.836 0.854 . . . . 0.0 110.753 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -61.09 -25.56 67.04 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.311 1.044 . . . . 0.0 112.505 -174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -65.69 -56.03 14.25 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.515 -0.74 . . . . 0.0 110.908 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -61.06 -39.76 91.09 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.543 -0.723 . . . . 0.0 110.841 178.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.454 HD21 HG11 ' A' ' 67' ' ' VAL . 2.7 mt -52.2 -53.59 41.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.872 1.669 . . . . 0.0 110.017 176.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -69.51 -42.06 75.21 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.579 -175.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -58.82 -44.47 90.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.346 0.976 . . . . 0.0 111.816 -175.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 ptp -73.27 -41.38 63.69 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 118.254 0.479 . . . . 0.0 111.912 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.42 HG22 ' HA ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -71.8 -47.75 54.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -173.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.61 -41.08 85.07 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.48 1.036 . . . . 0.0 109.461 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -54.85 -49.57 70.78 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.529 0.332 . . . . 0.0 111.395 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.658 ' HB3' HG21 ' A' ' 55' ' ' ILE . 1.3 m120 -62.46 -29.59 70.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.023 0.929 . . . . 0.0 112.413 -175.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.89 -31.3 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.631 1.105 . . . . 0.0 110.701 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -81.6 2.18 30.5 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.028 -1.045 . . . . 0.0 112.196 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -90.65 -40.51 11.85 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.442 -0.786 . . . . 0.0 113.032 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -97.12 23.56 7.22 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.184 1.394 . . . . 0.0 110.451 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 117.404 -1.284 . . . . 0.0 111.326 -177.594 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.83 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.7 m -84.29 176.28 8.83 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.625 0.713 . . . . 0.0 110.522 168.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -135.68 -27.88 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.798 1.639 . . . . 0.0 110.046 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.23 -28.72 19.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.106 0.962 . . . . 0.0 111.294 172.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.83 -30.25 63.59 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.176 1.39 . . . . 0.0 113.333 177.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.3 t -81.0 -33.26 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.497 1.119 . . . . 0.0 111.485 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -89.04 -16.07 32.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.645 1.178 . . . . 0.0 113.378 -174.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.94 77.85 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.192 0.997 . . . . 0.0 112.025 -167.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.68 -5.61 53.54 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.521 1.528 . . . . 0.0 112.52 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -93.69 -45.39 7.71 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.018 1.281 . . . . 0.0 110.057 161.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.574 HD12 ' HD3' ' A' ' 20' ' ' ARG . 1.3 mm? -49.38 -42.68 42.94 Favored 'General case' 0 CA--C 1.523 -0.085 0 C-N-CA 123.95 0.9 . . . . 0.0 111.316 -176.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -49.7 -36.65 25.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.351 1.06 . . . . 0.0 113.379 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.77 0.42 39.2 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 117.703 -1.609 . . . . 0.0 113.045 -168.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.9 mt -71.71 101.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.88 2.57 2.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.232 1.813 . . . . 0.0 113.512 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.52 72.06 2.5 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 128.379 2.672 . . . . 0.0 111.159 -166.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.68 -11.37 31.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 124.125 3.217 . . . . 0.0 114.664 -172.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -81.99 -9.02 59.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.242 0.617 . . . . 0.0 112.365 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -129.07 -28.12 2.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.569 1.148 . . . . 0.0 112.38 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.574 ' HD3' HD12 ' A' ' 11' ' ' LEU . 3.0 tmm_? -52.71 -45.2 66.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.775 1.23 . . . . 0.0 113.137 -175.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -32.39 73.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.11 0.868 . . . . 0.0 110.816 -174.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -68.92 -41.23 78.43 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 119.637 1.108 . . . . 0.0 111.844 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.9 m -55.08 -39.78 69.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.594 0.758 . . . . 0.0 109.621 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.89 -35.83 80.92 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.483 1.513 . . . . 0.0 112.095 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -62.35 -48.28 80.48 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.396 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.5 mt -61.91 -44.53 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.666 0.666 . . . . 0.0 109.512 -177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.77 -68.01 0.21 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.961 1.305 . . . . 0.0 108.852 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.2 p -66.18 -28.0 68.43 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.591 1.157 . . . . 0.0 112.932 -170.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 43.9 t90 -56.52 -46.74 80.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.63 1.572 . . . . 0.0 110.889 173.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.48 -37.38 70.02 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 C-N-CA 116.791 -1.964 . . . . 0.0 108.499 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.64 -8.44 0.24 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.601 1.16 . . . . 0.0 113.609 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.28 -65.24 1.0 Allowed 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.89 -1.131 . . . . 0.0 110.716 158.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.97 -34.68 59.8 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.297 0.499 . . . . 0.0 111.995 -161.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.7 66.53 10.11 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 127.511 2.324 . . . . 0.0 109.263 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.17 -6.97 19.84 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.021 2.48 . . . . 0.0 112.42 -172.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -81.7 -11.75 58.92 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.119 0.968 . . . . 0.0 111.849 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.0 mt -74.92 143.45 43.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -119.52 152.51 53.15 Favored Pre-proline 0 C--N 1.322 -0.598 0 C-N-CA 127.718 2.407 . . . . 0.0 107.844 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -75.69 156.79 40.02 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.02 2.48 . . . . 0.0 111.073 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -171.96 106.59 0.21 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 126.327 1.851 . . . . 0.0 106.15 163.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 ppp? -78.03 134.09 37.84 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.321 0.964 . . . . 0.0 108.857 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.97 152.4 38.58 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.112 1.365 . . . . 0.0 109.224 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.6 m95 51.87 34.06 12.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.254 1.022 . . . . 0.0 113.171 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 57.74 20.88 6.83 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.444 1.498 . . . . 0.0 112.123 -173.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 49.5 p -116.6 148.43 41.87 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.022 1.329 . . . . 0.0 108.588 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.05 144.45 42.55 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.451 2.101 . . . . 0.0 109.136 164.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.2 ptm -160.91 177.62 10.2 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 165.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.43 176.11 8.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.508 1.123 . . . . 0.0 108.134 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.4 p -146.98 134.54 20.95 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.984 -1.072 . . . . 0.0 108.752 172.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.442 ' N ' HG22 ' A' ' 53' ' ' THR . 30.7 t30 -75.83 111.32 11.06 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 165.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 49.18 43.79 22.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.661 0.784 . . . . 0.0 112.768 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.2 76.62 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.082 170.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 55' ' ' ILE . 1.7 t -61.67 -163.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 128.46 2.704 . . . . 0.0 117.349 -176.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -129.11 29.55 5.15 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 157.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.529 ' H ' HG23 ' A' ' 53' ' ' THR . 38.0 mt -60.11 9.16 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 127.129 2.172 . . . . 0.0 114.024 174.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 tt -159.02 157.94 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 122.647 2.476 . . . . 0.0 112.93 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.61 164.36 23.14 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.841 0.734 . . . . 0.0 112.963 159.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -160.12 177.58 10.55 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.471 1.108 . . . . 0.0 112.142 -170.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.5 p -172.44 148.77 2.08 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.442 1.019 . . . . 0.0 109.172 170.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.1 p -63.96 129.1 38.69 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.428 -0.795 . . . . 0.0 108.975 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 t -97.43 -178.12 4.04 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 158.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -54.44 -65.49 0.57 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.686 -0.634 . . . . 0.0 110.281 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -101.82 2.17 37.98 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -164.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.464 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 6.8 p-80 -160.41 149.75 17.41 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.25 1.02 . . . . 0.0 109.556 -166.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -89.71 143.19 27.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 161.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.57 141.39 51.75 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.183 0.993 . . . . 0.0 110.275 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -159.46 155.79 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.003 0.921 . . . . 0.0 112.939 -167.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' A' ' 92' ' ' LEU . 29.5 t -163.08 165.53 14.57 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.295 1.838 . . . . 0.0 108.093 168.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.46 -56.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 121.853 1.702 . . . . 0.0 111.781 159.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -146.07 -86.17 0.11 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -138.28 -37.56 0.56 Allowed 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.77 1.628 . . . . 0.0 109.936 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.5 tt -57.27 -35.57 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.078 0.854 . . . . 0.0 111.42 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.58 -20.86 8.12 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 126.998 2.237 . . . . 0.0 113.444 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.5 mm -118.15 -14.7 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 127.185 2.194 . . . . 0.0 110.001 -172.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.8 m -81.92 -79.83 0.17 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.023 0.929 . . . . 0.0 109.542 166.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -87.9 -48.08 8.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -164.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -63.94 -19.21 64.96 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.08 -31.86 61.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.611 -1.185 . . . . 0.0 113.145 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -67.91 -52.47 35.98 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.857 0.753 . . . . 0.0 109.684 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.41 82.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.593 0.757 . . . . 0.0 110.982 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.31 -43.75 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.288 1.035 . . . . 0.0 109.699 175.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.15 80.99 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.06 0.944 . . . . 0.0 110.901 -173.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -27.76 57.71 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.015 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.94 8.56 22.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.044 0.838 . . . . 0.0 112.14 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.66 36.82 24.97 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 121.191 -0.943 . . . . 0.0 112.527 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -125.41 154.47 41.89 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.083 0.953 . . . . 0.0 109.721 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.9 t -114.49 124.38 51.76 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.393 0.615 . . . . 0.0 110.746 -163.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.77 159.75 22.43 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.358 0.663 . . . . 0.0 110.728 174.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -118.7 -162.59 0.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.593 1.957 . . . . 0.0 106.153 164.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.466 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -64.59 -31.3 72.46 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 169.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -151.64 -6.07 0.15 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 114.218 0.447 . . . . 0.0 114.218 -156.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.9 pp -146.06 161.82 39.28 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.643 1.577 . . . . 0.0 108.006 169.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -122.15 157.27 31.9 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.464 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -132.03 142.4 49.55 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.504 -177.339 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.6 mp -105.58 142.2 24.25 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.02 151.45 44.76 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.029 2.486 . . . . 0.0 109.578 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -64.61 -19.05 65.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -31.51 72.74 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.88 1.218 . . . . 0.0 112.478 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.66 161.85 37.61 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 123.961 0.904 . . . . 0.0 110.181 -161.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.64 161.6 43.54 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.559 1.506 . . . . 0.0 110.862 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.4 t -89.24 130.71 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.07 89.21 4.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.176 1.39 . . . . 0.0 109.366 -176.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -67.24 -31.7 72.23 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.636 1.174 . . . . 0.0 112.532 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.51 -51.21 70.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.611 1.164 . . . . 0.0 109.753 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -68.28 -41.18 81.38 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 120.611 1.551 . . . . 0.0 110.865 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -50.18 51.87 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 123.473 0.709 . . . . 0.0 109.121 176.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -58.63 -55.48 34.55 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.988 1.315 . . . . 0.0 110.006 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -59.17 -35.74 74.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.492 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 20.0 ptp -87.8 -6.82 57.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 117.496 -1.24 . . . . 0.0 113.718 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.89 -54.23 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 120.977 1.717 . . . . 0.0 109.224 172.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -53.15 -48.6 67.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.023 1.329 . . . . 0.0 109.777 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -52.77 -45.81 67.28 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.761 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.24 -34.65 73.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.004 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.13 -52.03 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -72.23 -15.03 61.93 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.32 -37.9 27.61 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.49 1.516 . . . . 0.0 110.705 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.54 23.29 3.07 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.7 2.4 . . . . 0.0 111.821 -177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 124.523 1.129 . . . . 0.0 108.921 168.215 . . . . . . . . 0 0 . 1 stop_ save_